falsefalse989989--12-31--12-31trueFYFY201920192019-12-312019-12-31false10-K2211 H.H. Dow Way2211 H.H. Dow WayMidlandMidland4867448674MIMI00017517880000029915falsefalseLarge Accelerated FilerNon-accelerated FilerDEDE363000000000falsefalsefalsefalse636-1000636-1000NYSENYSE420000004200000045000000450000000.010.010.010.0110010050000000001001007512286441000.010.020.010.010.0132000000033790000003886000000169900000016990000001584000000158400000002300000000P50YP25YP25YP50YP5YP0YP3YP3YP1YP1Y097298347100000071000000370000003700000068300000068300000033000000033000000075000000750000003400000034000000 0001751788 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain 2020-01-31 0001751788 2020-01-31 0001751788 2019-06-30 0001751788 dow:TheDowChemicalCompanyDomain 2019-06-30 0001751788 2018-01-01 2018-12-31 0001751788 2017-01-01 2017-12-31 0001751788 2018-12-31 0001751788 2019-12-31 0001751788 us-gaap:PropertyPlantAndEquipmentMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2018-12-31 0001751788 us-gaap:CashAndCashEquivalentsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0001751788 us-gaap:PropertyPlantAndEquipmentMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0001751788 us-gaap:LongTermDebtMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2018-12-31 0001751788 us-gaap:LongTermDebtMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0001751788 us-gaap:CashAndCashEquivalentsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2018-12-31 0001751788 2017-12-31 0001751788 2016-12-31 0001751788 dow:UnearnedEsopSharesMember 2018-01-01 2018-12-31 0001751788 us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001751788 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001751788 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001751788 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001751788 us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001751788 dow:UnearnedEsopSharesMember 2019-01-01 2019-12-31 0001751788 us-gaap:TreasuryStockMember 2017-01-01 2017-12-31 0001751788 us-gaap:CommonStockMember 2018-12-31 0001751788 us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001751788 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-12-31 0001751788 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-12-31 0001751788 us-gaap:TreasuryStockMember 2018-01-01 2018-12-31 0001751788 us-gaap:TreasuryStockMember 2017-12-31 0001751788 us-gaap:RetainedEarningsMember 2019-12-31 0001751788 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001751788 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001751788 us-gaap:RetainedEarningsMember 2017-01-01 2017-12-31 0001751788 us-gaap:RetainedEarningsMember 2016-12-31 0001751788 dow:UnearnedEsopSharesMember 2018-12-31 0001751788 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001751788 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001751788 us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001751788 dow:UnearnedEsopSharesMember 2016-12-31 0001751788 us-gaap:TreasuryStockMember 2019-01-01 2019-12-31 0001751788 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001751788 dow:UnearnedEsopSharesMember 2019-12-31 0001751788 dow:UnearnedEsopSharesMember 2017-01-01 2017-12-31 0001751788 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001751788 us-gaap:TreasuryStockMember 2016-12-31 0001751788 us-gaap:CommonStockMember 2017-01-01 2017-12-31 0001751788 us-gaap:RetainedEarningsMember 2018-12-31 0001751788 us-gaap:RetainedEarningsMember 2017-12-31 0001751788 us-gaap:TreasuryStockMember 2018-12-31 0001751788 dow:UnearnedEsopSharesMember 2017-12-31 0001751788 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001751788 us-gaap:CommonStockMember 2016-12-31 0001751788 us-gaap:CommonStockMember 2017-12-31 0001751788 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001751788 us-gaap:TreasuryStockMember 2019-12-31 0001751788 us-gaap:CommonStockMember 2019-12-31 0001751788 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001751788 dow:TheDowChemicalCompanyDomain 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:CashAndCashEquivalentsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:PropertyPlantAndEquipmentMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:CashAndCashEquivalentsMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:LongTermDebtMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:PropertyPlantAndEquipmentMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:LongTermDebtMember us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain 2016-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowInc.Member 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowInc.Member 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowDuPontMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowDuPontMember 2017-01-01 2017-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowDuPontMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowInc.Member 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:UnearnedEsopSharesMember 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:CommonStockMember 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:RetainedEarningsMember 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:UnearnedEsopSharesMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:UnearnedEsopSharesMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:TreasuryStockMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:UnearnedEsopSharesMember 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:RetainedEarningsMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:RetainedEarningsMember 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowDuPontMember us-gaap:RetainedEarningsMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:CommonStockMember 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowInc.Member us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:UnearnedEsopSharesMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:UnearnedEsopSharesMember 2016-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowDuPontMember us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:TreasuryStockMember 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowInc.Member us-gaap:RetainedEarningsMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:TreasuryStockMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:TreasuryStockMember 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowInc.Member us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:TreasuryStockMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:CommonStockMember 2016-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:TreasuryStockMember 2016-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:CommonStockMember 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:RetainedEarningsMember 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:UnearnedEsopSharesMember 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:CommonStockMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowDuPontMember us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowInc.Member us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:CommonStockMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowDuPontMember us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowDuPontMember us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:RetainedEarningsMember 2016-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:TreasuryStockMember 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowDuPontMember us-gaap:RetainedEarningsMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowInc.Member us-gaap:RetainedEarningsMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowInc.Member us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-12-31 0001751788 dow:DowInc.Member 2019-01-01 2019-12-31 0001751788 srt:MinimumMember 2019-01-01 2019-12-31 0001751788 srt:MaximumMember 2019-01-01 2019-12-31 0001751788 us-gaap:RetainedEarningsMember 2018-01-01 0001751788 us-gaap:AccountingStandardsUpdate201602Member 2019-12-31 0001751788 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 0001751788 us-gaap:RetainedEarningsMember 2019-01-01 0001751788 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0001751788 us-gaap:RetainedEarningsMember 2018-04-01 0001751788 us-gaap:AccountingStandardsUpdate201602Member us-gaap:RetainedEarningsMember 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain 2017-08-31 0001751788 dow:TheDowChemicalCompanyDomain 2017-09-01 0001751788 dow:DowDuPontMember 2017-08-31 0001751788 us-gaap:CommonStockMember 2017-01-01 2017-09-30 0001751788 us-gaap:AdditionalPaidInCapitalMember 2017-01-01 2017-09-30 0001751788 us-gaap:TreasuryStockMember 2017-01-01 2017-09-30 0001751788 us-gaap:SegmentDiscontinuedOperationsMember 2018-12-31 0001751788 dow:AccruedAndOtherCurrentLiabilitiesMember 2019-12-31 0001751788 dow:DowInc.Member 2019-04-01 0001751788 dow:IntegrationandseparationcostsMember 2019-04-01 2019-12-31 0001751788 dow:OtherNoncurrentObligationsMember 2019-12-31 0001751788 2019-04-01 2019-12-31 0001751788 dow:DowDuPontMember 2019-04-01 0001751788 us-gaap:OtherNoncurrentAssetsMember 2019-12-31 0001751788 us-gaap:OtherCurrentAssetsMember 2019-12-31 0001751788 dow:SundryIncomeExpenseNetMember 2019-04-01 2019-12-31 0001751788 dow:DowInc.Member 2019-04-01 2019-04-01 0001751788 us-gaap:SegmentDiscontinuedOperationsMember 2018-01-01 2018-12-31 0001751788 us-gaap:SegmentDiscontinuedOperationsMember 2017-01-01 2017-12-31 0001751788 us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-12-31 0001751788 dow:U.S.CanadaMember 2018-01-01 2018-12-31 0001751788 srt:AsiaPacificMember 2019-01-01 2019-12-31 0001751788 dow:EuropeMiddleEastAfricaandIndiaDomain 2019-01-01 2019-12-31 0001751788 srt:AsiaPacificMember 2018-01-01 2018-12-31 0001751788 srt:LatinAmericaMember 2019-01-01 2019-12-31 0001751788 srt:LatinAmericaMember 2018-01-01 2018-12-31 0001751788 dow:EuropeMiddleEastAfricaandIndiaDomain 2018-01-01 2018-12-31 0001751788 dow:U.S.CanadaMember 2019-01-01 2019-12-31 0001751788 dow:PerformanceMaterialsCoatingsMember 2019-01-01 2019-12-31 0001751788 dow:PerformanceMaterialsCoatingsMember 2018-01-01 2018-12-31 0001751788 dow:IndustrialSolutionsMember dow:IndustrialIntermediatesInfrastructureMember 2018-01-01 2018-12-31 0001751788 dow:PolyurethanesCAVMember dow:IndustrialIntermediatesInfrastructureMember 2018-01-01 2018-12-31 0001751788 dow:ConsumerSolutionsMember dow:PerformanceMaterialsCoatingsMember 2018-01-01 2018-12-31 0001751788 us-gaap:CorporateMember 2019-01-01 2019-12-31 0001751788 dow:PackagingSpecialtyPlasticsMember 2018-01-01 2018-12-31 0001751788 us-gaap:CorporateMember 2018-01-01 2018-12-31 0001751788 dow:IndustrialIntermediatesInfrastructureMember 2019-01-01 2019-12-31 0001751788 dow:HydrocarbonsEnergyMember dow:PackagingSpecialtyPlasticsMember 2019-01-01 2019-12-31 0001751788 dow:PolyurethanesCAVMember dow:IndustrialIntermediatesInfrastructureMember 2019-01-01 2019-12-31 0001751788 dow:PackagingSpecialtyPlasticsMember 2019-01-01 2019-12-31 0001751788 dow:IndustrialIntermediatesInfrastructureMember 2018-01-01 2018-12-31 0001751788 dow:IndustrialSolutionsMember dow:IndustrialIntermediatesInfrastructureMember 2019-01-01 2019-12-31 0001751788 dow:CoatingsandPerformanceMonomersMember dow:PerformanceMaterialsCoatingsMember 2019-01-01 2019-12-31 0001751788 dow:HydrocarbonsEnergyMember dow:PackagingSpecialtyPlasticsMember 2018-01-01 2018-12-31 0001751788 dow:PackagingandSpecialtyPlasticsMember dow:PackagingSpecialtyPlasticsMember 2018-01-01 2018-12-31 0001751788 dow:ConsumerSolutionsMember dow:PerformanceMaterialsCoatingsMember 2019-01-01 2019-12-31 0001751788 dow:OtherMember dow:IndustrialIntermediatesInfrastructureMember 2018-01-01 2018-12-31 0001751788 dow:PackagingandSpecialtyPlasticsMember dow:PackagingSpecialtyPlasticsMember 2019-01-01 2019-12-31 0001751788 dow:CoatingsandPerformanceMonomersMember dow:PerformanceMaterialsCoatingsMember 2018-01-01 2018-12-31 0001751788 dow:OtherMember dow:IndustrialIntermediatesInfrastructureMember 2019-01-01 2019-12-31 0001751788 us-gaap:ProductMember 2017-01-01 2017-12-31 0001751788 us-gaap:ProductMember 2019-01-01 2019-12-31 0001751788 dow:LicensingofTechnologyMemberMember 2019-12-31 0001751788 srt:MaximumMember 2019-12-31 0001751788 us-gaap:ProductMember 2018-01-01 2018-12-31 0001751788 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:GlobalEthyleneAcrylicAcidEAAMember dow:PackagingSpecialtyPlasticsMember 2017-01-01 2017-12-31 0001751788 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:GlobalEthyleneAcrylicAcidEAAMember 2017-09-01 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember dow:IndustrialIntermediatesInfrastructureMember 2018-01-01 2018-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember 2019-01-01 2019-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember 2019-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2017-01-01 2017-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2018-01-01 2018-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember 2017-01-01 2017-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember 2017-01-01 2017-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember dow:IndustrialIntermediatesInfrastructureMember 2017-01-01 2017-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember 2019-01-01 2019-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember 2019-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember dow:IndustrialIntermediatesInfrastructureMember 2018-01-01 2018-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2017-01-01 2017-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2018-01-01 2018-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2017-01-01 2017-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2019-01-01 2019-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember dow:IndustrialIntermediatesInfrastructureMember 2019-01-01 2019-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember 2017-01-01 2017-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember dow:IndustrialIntermediatesInfrastructureMember 2019-01-01 2019-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember 2019-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember 2018-01-01 2018-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2017-01-01 2017-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember 2017-01-01 2017-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember 2019-01-01 2019-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember 2018-01-01 2018-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2019-01-01 2019-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember 2018-01-01 2018-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2019-01-01 2019-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2018-01-01 2018-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember dow:IndustrialIntermediatesInfrastructureMember 2018-01-01 2018-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2018-01-01 2018-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember 2017-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember 2017-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2018-01-01 2018-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember 2017-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2018-01-01 2018-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2019-01-01 2019-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2018-01-01 2018-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2017-01-01 2017-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember dow:IndustrialIntermediatesInfrastructureMember 2019-01-01 2019-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2017-01-01 2017-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2019-01-01 2019-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2017-01-01 2017-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember dow:IndustrialIntermediatesInfrastructureMember 2018-01-01 2018-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2019-01-01 2019-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember 2018-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2017-01-01 2017-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2019-01-01 2019-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2018-01-01 2018-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2018-01-01 2018-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember 2018-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember 2018-01-01 2018-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2018-01-01 2018-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember 2019-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2018-01-01 2018-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember dow:IndustrialIntermediatesInfrastructureMember 2017-01-01 2017-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember 2018-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember dow:IndustrialIntermediatesInfrastructureMember 2017-01-01 2017-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2018-01-01 2018-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2019-01-01 2019-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2017-01-01 2017-12-31 0001751788 dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember dow:IndustrialIntermediatesInfrastructureMember 2019-01-01 2019-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2019-01-01 2019-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2019-01-01 2019-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember dow:IndustrialIntermediatesInfrastructureMember 2017-01-01 2017-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember 2018-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2017-01-01 2017-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2017-01-01 2017-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember 2017-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2017-01-01 2017-12-31 0001751788 us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2019-01-01 2019-12-31 0001751788 dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2019-01-01 2019-12-31 0001751788 dow:AssetRelatedChargesandOtherMiscellaneousAssetWriteDownandWriteOffsMember dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2017-01-01 2017-12-31 0001751788 dow:ManufacturingAssetsEquityMethodInvestmentsandOtherAssetsMember us-gaap:CorporateMember 2017-10-01 2017-12-31 0001751788 dow:AssetRelatedChargesandOtherMiscellaneousAssetWriteDownandWriteOffsMember dow:DowDuPontCostSynergyProgramMember 2017-01-01 2017-12-31 0001751788 dow:PerformanceMaterialsCoatingsMember 2017-10-01 2017-12-31 0001751788 us-gaap:OtherAssetsMember 2017-10-01 2017-12-31 0001751788 us-gaap:OtherNoncurrentLiabilitiesMember dow:DowDuPontCostSynergyProgramMember 2019-12-31 0001751788 us-gaap:ManufacturingFacilityMember dow:PackagingSpecialtyPlasticsMember 2017-10-01 2017-12-31 0001751788 srt:MaximumMember us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember 2017-11-01 0001751788 dow:SadaraChemicalCompanyMember dow:PackagingSpecialtyPlasticsMember 2019-01-01 2019-12-31 0001751788 srt:MaximumMember dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember 2017-11-01 0001751788 us-gaap:OtherNoncurrentLiabilitiesMember dow:DowDuPontCostSynergyProgramMember 2018-12-31 0001751788 srt:MinimumMember dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember 2017-11-01 0001751788 us-gaap:ManufacturingFacilityMember dow:PackagingSpecialtyPlasticsMember 2019-01-01 2019-12-31 0001751788 dow:SadaraChemicalCompanyMember dow:IndustrialIntermediatesInfrastructureMember 2019-01-01 2019-12-31 0001751788 us-gaap:EquityMethodInvestmentsMember 2017-10-01 2017-12-31 0001751788 us-gaap:PropertyPlantAndEquipmentMember dow:DowDuPontCostSynergyProgramMember 2017-01-01 2017-12-31 0001751788 dow:AssetRelatedChargesandOtherMiscellaneousAssetWriteDownandWriteOffsMember dow:DowDuPontCostSynergyProgramMember us-gaap:CorporateMember 2018-01-01 2018-12-31 0001751788 dow:ManufacturingAssetsEquityMethodInvestmentsandOtherAssetsMember dow:PerformanceMaterialsCoatingsMember 2017-10-01 2017-12-31 0001751788 dow:ManufacturingAssetsMember us-gaap:FairValueMeasurementsNonrecurringMember dow:PackagingSpecialtyPlasticsMember 2019-01-01 2019-12-31 0001751788 dow:AssetRelatedChargesandOtherMiscellaneousAssetWriteDownandWriteOffsMember dow:DowDuPontCostSynergyProgramMember 2018-01-01 2018-12-31 0001751788 dow:AssetRelatedChargesandOtherMiscellaneousAssetWriteDownandWriteOffsMember dow:DowDuPontCostSynergyProgramMember dow:IndustrialIntermediatesInfrastructureMember 2017-01-01 2017-12-31 0001751788 dow:AssetRelatedChargesandOtherMiscellaneousAssetWriteDownandWriteOffsMember dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2018-01-01 2018-12-31 0001751788 dow:AssetRelatedChargesandOtherMiscellaneousAssetWriteDownandWriteOffsMember dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2017-01-01 2017-12-31 0001751788 us-gaap:ManufacturingFacilityMember 2019-01-01 2019-12-31 0001751788 us-gaap:ManufacturingFacilityMember dow:PackagingSpecialtyPlasticsMember 2018-01-01 2018-12-31 0001751788 srt:MaximumMember dow:AssetwritedownsandwriteoffsMember dow:DowDuPontCostSynergyProgramMember 2017-11-01 0001751788 dow:AccruedAndOtherCurrentLiabilitiesMember dow:DowDuPontCostSynergyProgramMember 2018-12-31 0001751788 dow:ManufacturingAssetsMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-01-01 2019-12-31 0001751788 dow:ManufacturingAssetsMember 2017-10-01 2017-12-31 0001751788 dow:SadaraChemicalCompanyMember us-gaap:CorporateMember 2019-01-01 2019-12-31 0001751788 dow:ManufacturingAssetsEquityMethodInvestmentsandOtherAssetsMember dow:PackagingSpecialtyPlasticsMember 2017-10-01 2017-12-31 0001751788 dow:ManufacturingAssetsEquityMethodInvestmentsandOtherAssetsMember 2017-10-01 2017-12-31 0001751788 dow:AccruedAndOtherCurrentLiabilitiesMember dow:DowDuPontCostSynergyProgramMember 2019-12-31 0001751788 us-gaap:ManufacturingFacilityMember us-gaap:CorporateMember 2019-01-01 2019-12-31 0001751788 dow:DowDuPontCostSynergyProgramMember 2017-11-01 0001751788 dow:ManufacturingAssetsEquityMethodInvestmentsandOtherAssetsMember dow:IndustrialIntermediatesInfrastructureMember 2017-10-01 2017-12-31 0001751788 srt:MinimumMember us-gaap:EmployeeSeveranceMember dow:DowDuPontCostSynergyProgramMember 2017-11-01 0001751788 srt:MinimumMember dow:CostsAssociatedwithExitandDisposalActivitiesMember dow:DowDuPontCostSynergyProgramMember 2017-11-01 0001751788 dow:AssetRelatedChargesandOtherMiscellaneousAssetWriteDownandWriteOffsMember dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2018-01-01 2018-12-31 0001751788 dow:AssetRelatedChargesandOtherWriteoffofCapitalProjectsandOtherNonmanufacturingAssetsMember dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2017-01-01 2017-12-31 0001751788 dow:ManufacturingAssetsMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:CorporateMember 2019-01-01 2019-12-31 0001751788 dow:AssetRelatedChargesandOtherMiscellaneousAssetWriteDownandWriteOffsMember dow:DowDuPontCostSynergyProgramMember dow:PerformanceMaterialsCoatingsMember 2017-01-01 2017-12-31 0001751788 dow:SadaraChemicalCompanyMember 2019-01-01 2019-12-31 0001751788 us-gaap:ManufacturingFacilityMember dow:PerformanceMaterialsCoatingsMember 2019-01-01 2019-12-31 0001751788 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:MeglobalMember 2017-01-01 2017-12-31 0001751788 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:MeglobalMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowSiliconesCorporationMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:NovaEthyleneAssetMatterMember 2019-01-01 2019-12-31 0001751788 dow:SundryIncomeExpenseNetMember 2017-01-01 2017-12-31 0001751788 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:MeglobalMember 2018-01-01 2018-12-31 0001751788 dow:NovaEthyleneAssetMatterMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:CommercialCreditorsLitigationMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:NovaPatentInfringementMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:BreastImplantandOtherProductsLiabilityClaimsMember 2017-01-01 2017-12-31 0001751788 dow:DowSiliconesCorporationMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:MeglobalMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:NovaPatentInfringementMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:NovaEthyleneAssetMatterMember 2018-01-01 2018-12-31 0001751788 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:GlobalEthyleneAcrylicAcidEAAMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:GlobalEthyleneAcrylicAcidEAAMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:SundryIncomeExpenseNetMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:BreastImplantandOtherProductsLiabilityClaimsMember 2019-01-01 2019-12-31 0001751788 dow:CommercialCreditorsLitigationMember 2017-01-01 2017-12-31 0001751788 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:GlobalEthyleneAcrylicAcidEAAMember 2019-01-01 2019-12-31 0001751788 dow:CommercialCreditorsLitigationMember 2019-01-01 2019-12-31 0001751788 dow:CommercialCreditorsLitigationMember 2018-01-01 2018-12-31 0001751788 dow:SundryIncomeExpenseNetMember 2018-01-01 2018-12-31 0001751788 dow:NovaEthyleneAssetMatterMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:GlobalEthyleneAcrylicAcidEAAMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:CommercialCreditorsLitigationMember 2019-01-01 2019-12-31 0001751788 dow:BreastImplantandOtherProductsLiabilityClaimsMember 2019-01-01 2019-12-31 0001751788 dow:BreastImplantandOtherProductsLiabilityClaimsMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowSiliconesCorporationMember 2017-01-01 2017-12-31 0001751788 dow:NovaPatentInfringementMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:NovaEthyleneAssetMatterMember 2017-01-01 2017-12-31 0001751788 dow:NovaPatentInfringementMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:CommercialCreditorsLitigationMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:NovaPatentInfringementMember 2018-01-01 2018-12-31 0001751788 dow:DowSiliconesCorporationMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:MeglobalMember 2018-01-01 2018-12-31 0001751788 dow:BreastImplantandOtherProductsLiabilityClaimsMember 2018-01-01 2018-12-31 0001751788 dow:SundryIncomeExpenseNetMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DowSiliconesCorporationMember 2019-01-01 2019-12-31 0001751788 us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:GlobalEthyleneAcrylicAcidEAAMember 2018-01-01 2018-12-31 0001751788 dow:NovaEthyleneAssetMatterMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:SundryIncomeExpenseNetMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:MeglobalMember 2017-01-01 2017-12-31 0001751788 dow:NovaPatentInfringementMember 2017-01-01 2017-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:BreastImplantandOtherProductsLiabilityClaimsMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember dow:GlobalEthyleneAcrylicAcidEAAMember 2019-01-01 2019-12-31 0001751788 dow:DowSiliconesCorporationMember 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:SundryIncomeExpenseNetMember 2018-01-01 2018-12-31 0001751788 country:CN 2019-01-01 2019-12-31 0001751788 country:IT 2019-01-01 2019-12-31 0001751788 country:CH 2019-01-01 2019-12-31 0001751788 country:NL 2019-01-01 2019-12-31 0001751788 country:CA 2019-01-01 2019-12-31 0001751788 country:BR 2019-01-01 2019-12-31 0001751788 us-gaap:StateAndLocalJurisdictionMember 2019-01-01 2019-12-31 0001751788 country:DE 2019-01-01 2019-12-31 0001751788 us-gaap:InternalRevenueServiceIRSMember 2019-01-01 2019-12-31 0001751788 country:AR 2019-01-01 2019-12-31 0001751788 dow:ExpiringWithinFiveYearsMember 2019-12-31 0001751788 dow:ExpiringAfterFiveYearsorHavingIndefiniteExpirationMember 2018-12-31 0001751788 dow:ExpiringAfterFiveYearsorHavingIndefiniteExpirationMember 2019-12-31 0001751788 dow:ExpiringWithinFiveYearsMember 2018-12-31 0001751788 dow:ResidualValueGuaranteesMember 2019-01-01 2019-12-31 0001751788 us-gaap:GoodwillMember 2017-01-01 2017-12-31 0001751788 us-gaap:GoodwillMember 2019-01-01 2019-12-31 0001751788 dow:SadaraChemicalCompanyMember 2017-01-01 2017-12-31 0001751788 dow:SadaraChemicalCompanyMember 2018-01-01 2018-12-31 0001751788 us-gaap:GoodwillMember 2018-01-01 2018-12-31 0001751788 dow:NonIncomeTaxContingenciesRelatedToIssuesInUsAndForeignLocationsMember 2019-12-31 0001751788 2017-12-22 2018-12-31 0001751788 dow:NonIncomeTaxContingenciesRelatedToIssuesInUsAndForeignLocationsMember 2018-12-31 0001751788 us-gaap:NoncontrollingInterestMember 2017-01-01 2017-12-31 0001751788 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-12-31 0001751788 us-gaap:NoncontrollingInterestMember 2019-01-01 2019-12-31 0001751788 2019-04-01 0001751788 us-gaap:MachineryAndEquipmentMember 2018-12-31 0001751788 us-gaap:ConstructionInProgressMember 2019-12-31 0001751788 us-gaap:BuildingMember 2019-12-31 0001751788 us-gaap:BuildingMember 2018-12-31 0001751788 us-gaap:LandAndLandImprovementsMember 2018-12-31 0001751788 us-gaap:MachineryAndEquipmentMember 2019-12-31 0001751788 us-gaap:LandAndLandImprovementsMember 2019-12-31 0001751788 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2018-12-31 0001751788 us-gaap:ConstructionInProgressMember 2018-12-31 0001751788 us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2019-12-31 0001751788 srt:MinimumMember us-gaap:BuildingMember 2019-01-01 2019-12-31 0001751788 srt:MaximumMember us-gaap:BuildingMember 2019-01-01 2019-12-31 0001751788 srt:MinimumMember us-gaap:LandAndLandImprovementsMember 2019-01-01 2019-12-31 0001751788 srt:MaximumMember us-gaap:MachineryAndEquipmentMember 2019-01-01 2019-12-31 0001751788 srt:MinimumMember us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2019-01-01 2019-12-31 0001751788 srt:MaximumMember us-gaap:LandAndLandImprovementsMember 2019-01-01 2019-12-31 0001751788 srt:MinimumMember us-gaap:MachineryAndEquipmentMember 2019-01-01 2019-12-31 0001751788 srt:MaximumMember us-gaap:PropertyPlantAndEquipmentOtherTypesMember 2019-01-01 2019-12-31 0001751788 dow:PrincipalNonconsolidatedAffiliatesMember 2017-01-01 2017-12-31 0001751788 dow:PrincipalNonconsolidatedAffiliatesMember 2018-01-01 2018-12-31 0001751788 dow:PrincipalNonconsolidatedAffiliatesMember 2019-01-01 2019-12-31 0001751788 us-gaap:EquityMethodInvesteeMember 2019-12-31 0001751788 us-gaap:EquityMethodInvesteeMember 2018-12-31 0001751788 dow:SCGDowGroupMember us-gaap:EquityMethodInvesteeMember 2017-01-01 2017-12-31 0001751788 dow:MeglobalMember us-gaap:CustomerConcentrationRiskMember us-gaap:EquityMethodInvesteeMember dow:IndustrialIntermediatesInfrastructureMember 2018-01-01 2018-12-31 0001751788 dow:MeglobalMember us-gaap:CustomerConcentrationRiskMember us-gaap:EquityMethodInvesteeMember dow:PackagingSpecialtyPlasticsMember 2019-01-01 2019-12-31 0001751788 dow:ExclusiveofadditionaldifferencesforEQUATESadaraandAFSIMember 2019-12-31 0001751788 dow:SadaraChemicalCompanyMember 2019-12-31 0001751788 dow:EquatePetrochemicalCompanyKscMember 2019-12-31 0001751788 dow:SadaraChemicalCompanyMember us-gaap:EquityMethodInvesteeMember 2019-01-01 2019-12-31 0001751788 dow:SadaraChemicalCompanyMember us-gaap:EquityMethodInvesteeMember 2018-01-01 2018-12-31 0001751788 dow:AgroFreshMember 2018-12-31 0001751788 dow:EquatePetrochemicalCompanyKscMember 2018-12-31 0001751788 dow:MeglobalMember us-gaap:CustomerConcentrationRiskMember us-gaap:EquityMethodInvesteeMember 2019-01-01 2019-12-31 0001751788 dow:AgroFreshMember 2019-12-31 0001751788 dow:MapTaPhutOlefinsCompanyDomain 2019-12-31 0001751788 dow:ExclusiveofadditionaldifferencesforEQUATESadaraandAFSIMember 2018-12-31 0001751788 dow:SadaraChemicalCompanyMember us-gaap:EquityMethodInvesteeMember 2017-10-01 2017-12-31 0001751788 dow:SCGDowGroupMember us-gaap:EquityMethodInvesteeMember 2018-01-01 2018-12-31 0001751788 dow:SadaraChemicalCompanyMember us-gaap:EquityMethodInvesteeMember 2019-12-31 0001751788 dow:SCGDowGroupMember us-gaap:EquityMethodInvesteeMember 2019-01-01 2019-12-31 0001751788 dow:SadaraChemicalCompanyMember us-gaap:EquityMethodInvesteeMember 2017-01-01 2017-12-31 0001751788 dow:MeglobalMember us-gaap:CustomerConcentrationRiskMember us-gaap:EquityMethodInvesteeMember dow:IndustrialIntermediatesInfrastructureMember 2019-01-01 2019-12-31 0001751788 dow:SadaraChemicalCompanyMember 2017-10-01 2017-12-31 0001751788 dow:SiamPolyethyleneCompanyLimitedMember 2019-12-31 0001751788 dow:SiamPolyethyleneCompanyLimitedMember 2018-12-31 0001751788 dow:MapTaPhutOlefinsCompanyDomain 2017-12-31 0001751788 dow:TheKuwaitStyreneCompanyKSCMember 2018-12-31 0001751788 dow:SiamSyntheticLatexCompanyLimitedMember 2018-12-31 0001751788 dow:TheKuwaitStyreneCompanyKSCMember 2017-12-31 0001751788 dow:SiamStyreneMonomerCoLtdMember 2017-12-31 0001751788 dow:SiamPolystyreneCompanyLimitedMember 2019-12-31 0001751788 dow:TheKuwaitStyreneCompanyKSCMember 2019-12-31 0001751788 dow:SiamSyntheticLatexCompanyLimitedMember 2019-12-31 0001751788 dow:SiamPolyethyleneCompanyLimitedMember 2017-12-31 0001751788 dow:KuwaitOlefinsCompanyKscMember 2017-12-31 0001751788 dow:KuwaitOlefinsCompanyKscMember 2019-12-31 0001751788 dow:SadaraChemicalCompanyMember 2017-12-31 0001751788 dow:SiamPolystyreneCompanyLimitedMember 2017-12-31 0001751788 dow:SiamSyntheticLatexCompanyLimitedMember 2017-12-31 0001751788 dow:EquatePetrochemicalCompanyKscMember 2017-12-31 0001751788 dow:SadaraChemicalCompanyMember 2018-12-31 0001751788 dow:SiamStyreneMonomerCoLtdMember 2019-12-31 0001751788 dow:SiamPolystyreneCompanyLimitedMember 2018-12-31 0001751788 dow:SiamStyreneMonomerCoLtdMember 2018-12-31 0001751788 dow:MapTaPhutOlefinsCompanyDomain 2018-12-31 0001751788 dow:KuwaitOlefinsCompanyKscMember 2018-12-31 0001751788 dow:PrincipalNonconsolidatedAffiliatesMember 2019-12-31 0001751788 dow:PrincipalNonconsolidatedAffiliatesMember 2018-12-31 0001751788 dow:SadaraChemicalCompanyMember us-gaap:EquityMethodInvesteeMember 2018-12-31 0001751788 dow:MeglobalMember us-gaap:CustomerConcentrationRiskMember us-gaap:EquityMethodInvesteeMember dow:PackagingSpecialtyPlasticsMember 2018-01-01 2018-12-31 0001751788 dow:MeglobalMember us-gaap:CustomerConcentrationRiskMember us-gaap:EquityMethodInvesteeMember dow:PackagingSpecialtyPlasticsMember 2017-01-01 2017-12-31 0001751788 dow:MeglobalMember us-gaap:CustomerConcentrationRiskMember us-gaap:EquityMethodInvesteeMember dow:IndustrialIntermediatesInfrastructureMember 2017-01-01 2017-12-31 0001751788 dow:MeglobalMember us-gaap:CustomerConcentrationRiskMember us-gaap:EquityMethodInvesteeMember 2018-01-01 2018-12-31 0001751788 dow:MeglobalMember us-gaap:CustomerConcentrationRiskMember us-gaap:EquityMethodInvesteeMember 2017-01-01 2017-12-31 0001751788 us-gaap:InProcessResearchAndDevelopmentMember 2018-12-31 0001751788 us-gaap:ComputerSoftwareIntangibleAssetMember 2019-12-31 0001751788 us-gaap:InProcessResearchAndDevelopmentMember 2019-12-31 0001751788 us-gaap:DevelopedTechnologyRightsMember 2018-12-31 0001751788 us-gaap:CustomerRelatedIntangibleAssetsMember 2019-12-31 0001751788 us-gaap:TrademarksAndTradeNamesMember 2019-12-31 0001751788 us-gaap:CustomerRelatedIntangibleAssetsMember 2018-12-31 0001751788 us-gaap:DevelopedTechnologyRightsMember 2019-12-31 0001751788 us-gaap:TrademarksAndTradeNamesMember 2018-12-31 0001751788 us-gaap:ComputerSoftwareIntangibleAssetMember 2018-12-31 0001751788 dow:IndustrialIntermediatesInfrastructureMember 2018-12-31 0001751788 dow:PackagingSpecialtyPlasticsMember 2017-12-31 0001751788 dow:PerformanceMaterialsCoatingsMember 2019-12-31 0001751788 dow:IndustrialIntermediatesInfrastructureMember 2017-12-31 0001751788 dow:PackagingSpecialtyPlasticsMember 2018-12-31 0001751788 dow:IndustrialIntermediatesInfrastructureMember 2019-12-31 0001751788 dow:PerformanceMaterialsCoatingsMember 2017-12-31 0001751788 dow:PerformanceMaterialsCoatingsMember 2018-12-31 0001751788 dow:PackagingSpecialtyPlasticsMember 2019-12-31 0001751788 us-gaap:OtherIntangibleAssetsMember 2018-01-01 2018-12-31 0001751788 us-gaap:ComputerSoftwareIntangibleAssetMember 2018-01-01 2018-12-31 0001751788 us-gaap:OtherIntangibleAssetsMember 2019-01-01 2019-12-31 0001751788 us-gaap:OtherIntangibleAssetsMember 2017-01-01 2017-12-31 0001751788 us-gaap:ComputerSoftwareIntangibleAssetMember 2019-01-01 2019-12-31 0001751788 us-gaap:ComputerSoftwareIntangibleAssetMember 2017-01-01 2017-12-31 0001751788 dow:CoatingsandPerformanceMonomersMember 2017-12-31 0001751788 dow:CoatingsandPerformanceMonomersMember 2019-12-31 0001751788 dow:AccountsReceivableFacilityNorthAmericaMember 2019-12-31 0001751788 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2017-01-01 2017-12-31 0001751788 dow:SeniorUnsecuredNotes4Point80PercentDue2049Member 2019-10-01 0001751788 dow:SeniorUnsecuredNotesMember 2018-11-30 0001751788 dow:SeniorUnsecuredNotes3Point15PercentDue2024Member 2019-05-31 0001751788 dow:RedemptionofInternotesMember us-gaap:LoansPayableMember 2017-12-31 0001751788 us-gaap:SecuredDebtMember dow:AccountsReceivableSecuritizationFacilityNorthAmericanFacilityMember 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:RevolvingCreditFacilityMember dow:FiveYearCompetitiveAdvanceandRevolvingCreditFacilityMember 2019-12-31 0001751788 dow:SeniorUnsecuredNotes4Point55PercentDue2025Member 2018-11-30 0001751788 dow:FivePointSevenPercentNotesDue2018Member us-gaap:LoansPayableMember 2018-12-31 0001751788 dow:SeniorUnsecuredNotes3Point625PercentDue2026Member 2019-10-01 0001751788 dow:SundryIncomeExpenseNetMember dow:TaxExemptBondsMember 2018-01-01 2018-12-31 0001751788 dow:TaxexemptBondsvaryingmaturitiesthrough2038Member 2018-01-01 2018-12-31 0001751788 dow:TermLoanFacilityDueDecember2023Member 2019-04-01 2019-06-30 0001751788 us-gaap:SecuredDebtMember dow:AccountsReceivableSecuritizationFacilityEuropeanFacilityMember 2019-12-31 0001751788 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-01-01 2019-12-31 0001751788 dow:SeniorUnsecuredNotes4Point80PercentDue2028Member 2018-11-30 0001751788 dow:FourPointOneTwoFivePercentNotesDue2021Member 2019-01-01 2019-12-31 0001751788 dow:TermLoanFacilityDueDecember2023Member dow:SundryIncomeExpenseNetMember 2019-04-01 2019-06-30 0001751788 dow:InterNotesredeemedMember 2018-01-01 2018-12-31 0001751788 dow:SeniorUnsecuredNotes4Point80PercentDue2049Member 2019-05-31 0001751788 dow:SeniorUnsecuredNotes4Point80PercentDue2028Member 2019-10-01 0001751788 dow:TermLoanFacilityDomain 2019-12-31 0001751788 dow:FourPointTwoFivePercentNotesMember 2019-01-01 2019-12-31 0001751788 dow:EightPointFiveFivePercentNotesMember 2018-12-31 0001751788 dow:SeniorUnsecuredNotesMember 2019-05-31 0001751788 dow:EightPointFiveFivePercentNotesMember dow:ImpactToSundryIncomeExpenseMember 2018-12-01 2018-12-31 0001751788 dow:SeniorUnsecuredNotes3Point625PercentDue2026Member 2019-05-31 0001751788 dow:SeniorUnsecuredNotes5Point55PercentDue2048Member 2018-11-30 0001751788 dow:EightPointFiveFivePercentNotesMember 2018-12-01 2018-12-31 0001751788 dow:LongTermDebtRepaymentVariableInterestEntityMember 2019-01-01 2019-12-31 0001751788 dow:LongTermDebtRepaymentVariableInterestEntityMember 2018-01-01 2018-12-31 0001751788 dow:FourPointTwoFivePercentNotesMember 2019-09-30 0001751788 dow:FourPointTwoFivePercentNotesMember dow:SundryIncomeExpenseNetMember 2019-01-01 2019-12-31 0001751788 dow:InterNotesredeemedMember 2019-01-01 2019-12-31 0001751788 dow:SeniorUnsecuredNotes5Point55PercentDue2048Member 2019-10-01 0001751788 dow:SeniorUnsecuredNotes4Point55PercentDue2025Member 2019-10-01 0001751788 dow:SeniorUnsecuredNotes3Point15PercentDue2024Member 2019-10-01 0001751788 dow:SixPointZeroPercentNotesDue2017Member us-gaap:LoansPayableMember 2017-12-31 0001751788 us-gaap:ExchangeableDebtMember 2019-10-01 0001751788 dow:FourPointOneTwoFivePercentNotesDue2021Member 2019-12-31 0001751788 us-gaap:RevolvingCreditFacilityMember dow:BilateralRevolvingCreditFacilityDueAugust2020Member 2019-12-31 0001751788 us-gaap:RevolvingCreditFacilityMember dow:BilateralRevolvingCreditFacilityDueMarch2020FacilityOneMember 2019-12-31 0001751788 us-gaap:RevolvingCreditFacilityMember dow:BilateralRevolvingCreditFacilityDueMarch2020FacilityThreeMember 2019-12-31 0001751788 us-gaap:RevolvingCreditFacilityMember dow:BilateralRevolvingCreditFacilityDueOctober2024FacilityTwoMember 2019-12-31 0001751788 us-gaap:RevolvingCreditFacilityMember dow:EuropeanSecuritizationFacilityDueOctober2020Member 2019-12-31 0001751788 us-gaap:RevolvingCreditFacilityMember dow:FiveYearCompetitiveAdvanceandRevolvingCreditFacilityMember 2019-12-31 0001751788 us-gaap:RevolvingCreditFacilityMember dow:BilateralRevolvingCreditFacilityDueOctober2024FacilityOneMember 2019-12-31 0001751788 us-gaap:RevolvingCreditFacilityMember dow:BilateralRevolvingCreditFacilityDueDecember2021Member 2019-12-31 0001751788 us-gaap:RevolvingCreditFacilityMember dow:BilateralRevolvingCreditFacilityDueMay2020Member 2019-12-31 0001751788 us-gaap:RevolvingCreditFacilityMember dow:BilateralRevolvingCreditFacilityDueJuly2020Member 2019-12-31 0001751788 us-gaap:RevolvingCreditFacilityMember dow:BilateralRevolvingCreditFacilityDueNovember2024Member 2019-12-31 0001751788 us-gaap:RevolvingCreditFacilityMember dow:BilateralRevolvingCreditFacilityDueDecember2020Member 2019-12-31 0001751788 us-gaap:RevolvingCreditFacilityMember dow:BilateralRevolvingCreditFacilityDueMarch2020FacilityTwoMember 2019-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityCurrentYearMember us-gaap:LoansPayableMember 2018-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityCurrentYearMember us-gaap:LoansPayableMember 2019-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityYearFourMember us-gaap:LoansPayableMember 2019-12-31 0001751788 dow:ForeignCurrencyLoansMember us-gaap:LoansPayableMember 2019-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityYearThreeMember us-gaap:LoansPayableMember 2019-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityYearTwoMember us-gaap:LoansPayableMember 2019-12-31 0001751788 dow:U.S.DollarLoansMember us-gaap:LoansPayableMember 2018-12-31 0001751788 dow:U.S.DollarLoansMember us-gaap:LoansPayableMember 2019-12-31 0001751788 us-gaap:MediumTermNotesMember 2019-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityYearSixandThereafterMember us-gaap:LoansPayableMember 2019-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityYearFourMember us-gaap:LoansPayableMember 2018-12-31 0001751788 us-gaap:CapitalLeaseObligationsMember 2019-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityYearFiveMember us-gaap:LoansPayableMember 2018-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityYearFiveMember us-gaap:LoansPayableMember 2019-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityYearSixandThereafterMember us-gaap:LoansPayableMember 2018-12-31 0001751788 dow:ForeignCurrencyLoansMember us-gaap:LoansPayableMember 2018-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityYearOneMember us-gaap:LoansPayableMember 2018-12-31 0001751788 us-gaap:MediumTermNotesMember 2018-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityYearTwoMember us-gaap:LoansPayableMember 2018-12-31 0001751788 us-gaap:CapitalLeaseObligationsMember 2018-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityYearOneMember us-gaap:LoansPayableMember 2019-12-31 0001751788 dow:PromissoryNotesandDebenturesFinalMaturityYearThreeMember us-gaap:LoansPayableMember 2018-12-31 0001751788 us-gaap:NotesPayableToBanksMember 2019-12-31 0001751788 us-gaap:NotesPayableToBanksMember 2018-12-31 0001751788 us-gaap:CommercialPaperMember 2019-12-31 0001751788 us-gaap:CommercialPaperMember 2018-12-31 0001751788 dow:OtherEnvironmentalMattersDomain 2019-12-31 0001751788 dow:OtherEnvironmentalMattersDomain 2018-12-31 0001751788 dow:OtherEnvironmentalMattersDomain 2017-12-31 0001751788 dow:UnionCarbideCorporationMember dow:AsbestosRelatedMattersMember 2018-12-31 0001751788 dow:DowSiliconesCorporationMember dow:BreastImplantandOtherProductsLiabilityClaimsMember dow:OtherNoncurrentObligationsMember 2019-09-30 0001751788 dow:DowSiliconesCorporationMember dow:CommercialCreditorsLitigationMember 2019-09-30 0001751788 dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember 2019-10-01 2019-12-31 0001751788 dow:SadaraChemicalCompanyMember us-gaap:PerformanceGuaranteeMember 2019-12-31 0001751788 dow:DowV.NovaChemicalsCorporationPatentInfringementMatterMember us-gaap:SellingGeneralAndAdministrativeExpensesMember dow:PackagingSpecialtyPlasticsMember 2017-04-01 2017-06-30 0001751788 dow:SuperfundSitesDomain dow:OtherEnvironmentalMattersDomain 2018-12-31 0001751788 dow:DowSiliconesCorporationMember dow:BreastImplantandOtherProductsLiabilityClaimsMember dow:AccruedAndOtherCurrentLiabilitiesMember 2018-12-31 0001751788 dow:DowSiliconesCorporationMember dow:BreastImplantandOtherProductsLiabilityClaimsMember dow:OtherNoncurrentObligationsMember 2018-12-31 0001751788 dow:DowSiliconesCorporationMember dow:BreastImplantandOtherProductsLiabilityClaimsMember 2018-12-31 0001751788 dow:DowSiliconesCorporationMember 2019-09-30 0001751788 us-gaap:CorporateMember 2019-07-01 2019-09-30 0001751788 dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember 2019-07-01 2019-09-30 0001751788 dow:DowV.NovaChemicalsCorporationPatentInfringementMatterMember dow:PackagingSpecialtyPlasticsMember 2017-04-01 2017-06-30 0001751788 dow:DowSiliconesCorporationMember us-gaap:OtherNoncurrentAssetsMember us-gaap:EnvironmentalIssueMember 2019-09-30 0001751788 dow:DowSiliconesCorporationMember dow:BreastImplantandOtherProductsLiabilityClaimsMember 2019-12-31 0001751788 dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember 2019-12-31 0001751788 dow:SadaraChemicalCompanyMember dow:TotalProjectFinancingMember 2018-12-31 0001751788 2019-07-01 2019-09-30 0001751788 dow:DowV.NovaChemicalsCorporationPatentInfringementMatterMember 2018-12-31 0001751788 dow:DowV.NovaChemicalsCorporationPatentInfringementMatterMember 2017-06-29 2017-06-29 0001751788 dow:SadaraChemicalCompanyMember dow:TotalProjectFinancingMember 2019-12-31 0001751788 dow:DowSiliconesCorporationMember dow:ProductIndemnificationPeriodTwoDomain 2016-06-01 2016-06-01 0001751788 dow:IndustrialIntermediatesInfrastructureMember 2019-07-01 2019-09-30 0001751788 dow:DowSiliconesCorporationMember dow:CommercialCreditorsLitigationMember 2004-06-01 2004-06-01 0001751788 dow:DowSiliconesCorporationMember dow:BreastImplantandOtherProductsLiabilityClaimsMember dow:OtherNoncurrentObligationsMember 2019-12-31 0001751788 dow:DowSiliconesCorporationMember us-gaap:EnvironmentalIssueMember 2019-09-30 0001751788 dow:UnionCarbideCorporationMember dow:AsbestosRelatedMattersMember 2019-12-31 0001751788 dow:DowSiliconesCorporationMember dow:CommercialCreditorsLitigationMember 2018-12-31 0001751788 dow:UnionCarbideCorporationMember dow:AsbestosRelatedMattersPendingandFutureClaimsDomain 2002-12-31 0001751788 dow:DowV.NovaChemicalsCorporationPatentInfringementMatterMember us-gaap:NonoperatingIncomeExpenseMember dow:PackagingSpecialtyPlasticsMember 2017-04-01 2017-06-30 0001751788 dow:DowSiliconesCorporationMember dow:BreastImplantandOtherProductsLiabilityClaimsMember 2019-07-01 2019-09-30 0001751788 dow:DowSiliconesCorporationMember dow:BreastImplantandOtherProductsLiabilityClaimsMember 2004-06-01 0001751788 dow:DowSiliconesCorporationMember dow:ProductIndemnificationPeriodThreeDomain 2016-06-01 2016-06-01 0001751788 dow:UnionCarbideCorporationMember 2016-10-01 2016-12-31 0001751788 dow:DowSiliconesCorporationMember dow:CommercialCreditorsLitigationMember dow:AccruedAndOtherCurrentLiabilitiesMember 2019-09-30 0001751788 dow:DowSiliconesCorporationMember dow:BreastImplantandOtherProductsLiabilityClaimsMember dow:AccruedAndOtherCurrentLiabilitiesMember 2019-12-31 0001751788 dow:DowSiliconesCorporationMember dow:BreastImplantandOtherProductsLiabilityClaimsMember dow:Class16receivableMember 2019-07-01 2019-09-30 0001751788 dow:DowSiliconesCorporationMember dow:CommercialCreditorsLitigationMember 2019-07-01 2019-09-30 0001751788 dow:DowSiliconesCorporationMember 2016-06-01 0001751788 dow:OtherEnvironmentalMattersOffSiteMattersDomain 2019-12-31 0001751788 dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember dow:SundryIncomeExpenseNetMember 2019-07-01 2019-09-30 0001751788 dow:DowV.NovaChemicalsCorporationPatentInfringementMatterMember 2017-07-06 2017-07-06 0001751788 dow:DowSiliconesCorporationMember dow:CommercialCreditorIssuesMember srt:MinimumMember 2017-06-30 0001751788 dow:DowSiliconesCorporationMember 2018-12-31 0001751788 dow:DowSiliconesCorporationMember dow:BreastImplantandOtherProductsLiabilityClaimsMember 2004-06-01 2004-06-01 0001751788 dow:OtherEnvironmentalMattersOffSiteMattersDomain 2018-12-31 0001751788 dow:PerformanceMaterialsCoatingsMember 2019-07-01 2019-09-30 0001751788 dow:SuperfundSitesDomain dow:OtherEnvironmentalMattersDomain 2019-12-31 0001751788 dow:PackagingSpecialtyPlasticsMember 2019-07-01 2019-09-30 0001751788 dow:DowSiliconesCorporationMember dow:CommercialCreditorsLitigationMember 2017-04-01 2017-06-30 0001751788 dow:DowSiliconesCorporationMember dow:CommercialCreditorIssuesMember srt:MaximumMember 2017-06-30 0001751788 dow:DowV.NovaChemicalsCorporationPatentInfringementMatterMember 2019-12-31 0001751788 dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember us-gaap:SellingGeneralAndAdministrativeExpensesMember 2019-07-01 2019-09-30 0001751788 us-gaap:PerformanceGuaranteeMember 2018-12-31 0001751788 us-gaap:PerformanceGuaranteeMember 2019-12-31 0001751788 dow:ResidualValueGuaranteesMember 2018-12-31 0001751788 dow:ResidualValueGuaranteesMember 2019-12-31 0001751788 dow:FinanceLeasesMember 2019-12-31 0001751788 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001751788 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001751788 dow:DowInc.Member 2018-12-31 0001751788 dow:DowEsopMember 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain 2019-04-01 0001751788 2013-01-01 2017-08-30 0001751788 dow:DowMember 2017-08-31 0001751788 dow:NonEmployeeDirectorsMember us-gaap:CommonStockMember 2017-01-01 2017-12-31 0001751788 dow:RohmAndHaasMember dow:RohmAndHaasEsopMember 2009-04-02 0001751788 2017-08-31 0001751788 dow:DowEsopMember 2018-01-01 2018-12-31 0001751788 dow:DowEsopMember 2019-01-01 2019-12-31 0001751788 us-gaap:AccountingStandardsUpdate201601Member 2018-01-01 0001751788 dow:RohmAndHaasMember dow:RohmAndHaasEsopMember 2009-04-01 2009-06-30 0001751788 dow:NonEmployeeDirectorsMember us-gaap:CommonStockMember 2019-01-01 2019-12-31 0001751788 dow:DowEsopMember 2017-01-01 2017-12-31 0001751788 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-12-31 0001751788 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-01-01 2017-12-31 0001751788 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0001751788 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0001751788 us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-12-31 0001751788 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-12-31 0001751788 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-12-31 0001751788 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-01-01 2017-12-31 0001751788 us-gaap:RetainedEarningsMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-01-01 2017-12-31 0001751788 us-gaap:RetainedEarningsMember us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-01 2017-12-31 0001751788 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-01-01 2017-12-31 0001751788 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0001751788 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-01-01 2017-12-31 0001751788 us-gaap:RetainedEarningsMember us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-12-31 0001751788 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-12-31 0001751788 us-gaap:RetainedEarningsMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-12-31 0001751788 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-12-31 0001751788 us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-01 2017-12-31 0001751788 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0001751788 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-12-31 0001751788 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-12-31 0001751788 us-gaap:AccumulatedTranslationAdjustmentMember 2016-12-31 0001751788 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-12-31 0001751788 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-12-31 0001751788 us-gaap:RetainedEarningsMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-01-01 2017-12-31 0001751788 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2017-12-31 0001751788 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-12-31 0001751788 us-gaap:AccumulatedTranslationAdjustmentMember 2017-12-31 0001751788 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2016-12-31 0001751788 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0001751788 us-gaap:RetainedEarningsMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-01-01 2018-12-31 0001751788 us-gaap:RetainedEarningsMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-01-01 2018-12-31 0001751788 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0001751788 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0001751788 us-gaap:RetainedEarningsMember us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-12-31 0001751788 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001751788 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0001751788 us-gaap:RetainedEarningsMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-01-01 2018-12-31 0001751788 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2018-01-01 2018-12-31 0001751788 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-12-31 0001751788 us-gaap:RetainedEarningsMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-01-01 2017-12-31 0001751788 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0001751788 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-01 2017-12-31 0001751788 srt:ScenarioPreviouslyReportedMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-12-31 0001751788 us-gaap:RetainedEarningsMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-12-31 0001751788 us-gaap:RetainedEarningsMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-12-31 0001751788 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0001751788 us-gaap:NoncontrollingInterestMember 2017-12-31 0001751788 us-gaap:NoncontrollingInterestMember 2019-12-31 0001751788 us-gaap:NoncontrollingInterestMember 2016-12-31 0001751788 us-gaap:NoncontrollingInterestMember 2018-12-31 0001751788 dow:PropyleneOxideJointVentureMember 2019-01-01 2019-12-31 0001751788 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 country:US 2017-01-01 2017-12-31 0001751788 country:US 2018-01-01 2018-12-31 0001751788 country:US 2018-12-31 0001751788 country:US 2019-01-01 2019-12-31 0001751788 country:US 2019-12-31 0001751788 us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001751788 us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:DefinedBenefitPlanLiabilityAnnuityCoverageMember 2019-01-01 2019-12-31 0001751788 us-gaap:CostOfSalesMember us-gaap:NonqualifiedPlanMember country:US us-gaap:CorporateMember 2017-10-01 2017-12-31 0001751788 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:NonqualifiedPlanMember country:US 2017-10-01 2017-12-31 0001751788 us-gaap:SellingGeneralAndAdministrativeExpensesMember us-gaap:NonqualifiedPlanMember country:US us-gaap:CorporateMember 2017-10-01 2017-12-31 0001751788 us-gaap:NonqualifiedPlanMember country:US us-gaap:CorporateMember 2017-10-01 2017-12-31 0001751788 us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0001751788 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001751788 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-01-01 2017-12-31 0001751788 us-gaap:USTreasuryAndGovernmentMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:FixedIncomeSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:PrivateEquityFundsMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:U.S.EquityMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:OtherInvestmentsMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:NonU.S.EquityMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:RealEstateMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:AlternativeInvestmentsMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:U.S.EquityMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 dow:AlternativeInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:U.S.EquityMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:U.S.EquityMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 dow:U.S.EquityMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 dow:NonU.S.EquityMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:HedgeFundsMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:OtherInvestmentsMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:CashAndCashEquivalentsMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:PrivateEquityFundsMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 dow:AlternativeInvestmentsMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:EquitySecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 dow:NonU.S.EquityMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:U.S.EquityMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 dow:NonU.S.EquityMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:AlternativeInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:AlternativeInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:AlternativeInvestmentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:FixedIncomeSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:RealEstateMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:AssetBackedSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 dow:NonU.S.EquityMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:NonU.S.EquityMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:NonU.S.EquityMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:AssetBackedSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:EquitySecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 dow:U.S.EquityMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:AlternativeInvestmentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:NonU.S.EquityMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:CashAndCashEquivalentsMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:HedgeFundsMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsAssetsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 dow:AlternativeInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:CorporateDebtSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:CorporateDebtSecuritiesMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:DerivativeFinancialInstrumentsLiabilitiesMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:USTreasuryAndGovernmentMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:RealEstateMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:USTreasuryAndGovernmentMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:CashAndCashEquivalentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:U.S.EquityMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:PrivateEquityFundsMember us-gaap:FairValueInputsLevel2Member us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:PensionPlansDefinedBenefitMember 2017-01-01 2017-12-31 0001751788 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001751788 us-gaap:PensionPlansDefinedBenefitMember 2017-01-01 2017-12-31 0001751788 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-01-01 2017-12-31 0001751788 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001751788 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001751788 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001751788 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001751788 dow:AlternativeInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001751788 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001751788 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001751788 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001751788 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0001751788 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001751788 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001751788 us-gaap:OtherInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0001751788 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001751788 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2018-01-01 2018-12-31 0001751788 dow:AlternativeInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0001751788 us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0001751788 us-gaap:FixedIncomeSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2017-12-31 0001751788 dow:AlternativeInvestmentsMember us-gaap:FairValueInputsLevel3Member us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-12-31 0001751788 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-12-31 0001751788 dow:DeferredchargesandotherassetsMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-12-31 0001751788 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-12-31 0001751788 dow:PensionPlanExcludingPlanswithPlanAssetsMember 2018-12-31 0001751788 dow:DeferredchargesandotherassetsMember us-gaap:PensionPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:SegmentDiscontinuedOperationsMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0001751788 us-gaap:NonUsMember 2019-12-31 0001751788 us-gaap:NonUsMember 2018-12-31 0001751788 dow:PensionPlanExcludingPlanswithPlanAssetsMember 2019-12-31 0001751788 dow:DeferredchargesandotherassetsMember us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-12-31 0001751788 dow:OtherPostretirementBenefitPlansExcludingPlanswithPlanAssetsMember 2019-12-31 0001751788 dow:DeferredchargesandotherassetsMember us-gaap:PensionPlansDefinedBenefitMember 2018-12-31 0001751788 dow:OtherPostretirementBenefitPlansExcludingPlanswithPlanAssetsMember 2018-12-31 0001751788 us-gaap:EmployeeStockOptionMember 2017-01-01 2017-12-31 0001751788 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001751788 us-gaap:EmployeeStockOptionMember 2018-01-01 2018-12-31 0001751788 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0001751788 us-gaap:RestrictedStockUnitsRSUMember 2019-12-31 0001751788 us-gaap:RestrictedStockUnitsRSUMember 2018-12-31 0001751788 dow:January12017December312019Member dow:PerformanceStockUnitsPSUsMember 2017-01-01 2017-12-31 0001751788 dow:September12017August312019MemberMember dow:PerformanceStockUnitsPSUsMember 2017-01-01 2017-12-31 0001751788 dow:April12019December312019Member dow:PerformanceStockUnitsPSUsMember 2019-01-01 2019-12-31 0001751788 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-31 0001751788 us-gaap:RestrictedStockUnitsRSUMember 2017-01-01 2017-12-31 0001751788 us-gaap:EmployeeStockOptionMember dow:A2019StockIncentivePlanMember 2019-01-01 2019-12-31 0001751788 us-gaap:EmployeeStockOptionMember dow:A2019StockIncentivePlanMember 2019-12-31 0001751788 us-gaap:EmployeeStockOptionMember dow:A2019StockIncentivePlanMember 2018-12-31 0001751788 dow:PerformanceStockUnitsPSUsMember 2019-01-01 2019-12-31 0001751788 dow:EmployeesStockPurchasePlanMember 2019-01-01 2019-12-31 0001751788 dow:PerformanceStockUnitsPSUsMember 2017-01-01 2017-12-31 0001751788 dow:PerformanceStockUnitsPSUsMember 2018-01-01 2018-12-31 0001751788 us-gaap:RestrictedStockMember dow:NonEmployeeDirectorsStockIncentivePlan2012Member 2018-01-01 2018-12-31 0001751788 us-gaap:RestrictedStockMember dow:NonEmployeeDirectorsStockIncentivePlan2012Member 2018-12-31 0001751788 us-gaap:RestrictedStockMember dow:NonEmployeeDirectorsStockIncentivePlan2012Member 2017-01-01 2017-12-31 0001751788 us-gaap:RestrictedStockMember dow:NonEmployeeDirectorsStockIncentivePlan2012Member 2017-12-31 0001751788 dow:EmployeesStockPurchasePlanMember 2017-01-01 2017-12-31 0001751788 dow:EmployeesStockPurchasePlanMember 2018-01-01 2018-12-31 0001751788 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0001751788 dow:DowInc.Member 2019-01-01 2019-12-31 0001751788 srt:MaximumMember dow:PerformanceStockUnitsPSUsMember 2019-01-01 2019-12-31 0001751788 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001751788 srt:ExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-12-31 0001751788 dow:CortevaMember 2019-01-01 2019-12-31 0001751788 dow:PerformanceStockUnitsPSUsMember 2019-12-31 0001751788 srt:ExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0001751788 us-gaap:EmployeeStockOptionMember 2019-12-31 0001751788 dow:EmployeesStockPurchasePlanMember 2019-12-31 0001751788 us-gaap:RestrictedStockUnitsRSUMember 2017-07-01 2017-12-31 0001751788 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-12-31 0001751788 dow:PerformanceStockUnitsPSUsMember 2018-12-31 0001751788 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2019-01-01 2019-12-31 0001751788 srt:MinimumMember dow:PerformanceStockUnitsPSUsMember 2019-01-01 2019-12-31 0001751788 dow:DeferredchargesandotherassetsMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:NondesignatedMember 2019-12-31 0001751788 dow:AccruedAndOtherCurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2019-12-31 0001751788 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001751788 dow:OtherNoncurrentObligationsMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:NondesignatedMember 2019-12-31 0001751788 us-gaap:NondesignatedMember 2019-12-31 0001751788 dow:AccruedAndOtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001751788 dow:DeferredchargesandotherassetsMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001751788 us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001751788 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001751788 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2019-12-31 0001751788 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0001751788 dow:AccruedAndOtherCurrentLiabilitiesMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:NondesignatedMember 2019-12-31 0001751788 dow:AccruedAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001751788 dow:DeferredchargesandotherassetsMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2019-12-31 0001751788 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2019-12-31 0001751788 dow:OtherNoncurrentObligationsMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001751788 dow:AccruedAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0001751788 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001751788 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001751788 dow:AccruedAndOtherCurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001751788 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:NondesignatedMember 2019-12-31 0001751788 us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001751788 us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0001751788 us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001751788 us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001751788 us-gaap:MoneyMarketFundsMember 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember 2019-12-31 0001751788 us-gaap:CommodityContractMember 2019-12-31 0001751788 dow:MarketableSecuritiesMember 2019-12-31 0001751788 us-gaap:EquitySecuritiesMember 2019-12-31 0001751788 us-gaap:EquitySecuritiesMember 2018-12-31 0001751788 us-gaap:InterestRateContractMember 2018-12-31 0001751788 us-gaap:InterestRateContractMember 2019-12-31 0001751788 us-gaap:HeldtomaturitySecuritiesMember 2018-12-31 0001751788 us-gaap:HeldtomaturitySecuritiesMember 2019-12-31 0001751788 us-gaap:CommodityContractMember 2018-12-31 0001751788 dow:MarketableSecuritiesMember 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember 2018-12-31 0001751788 us-gaap:MoneyMarketFundsMember 2019-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-01-01 2017-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2017-01-01 2017-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember dow:InterestExpenseandAmortizationofDebtDiscountMember 2018-01-01 2018-12-31 0001751788 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2017-01-01 2017-12-31 0001751788 dow:ExcludedComponentsMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember dow:CumulativeTranslationAdjustmentsMember 2019-01-01 2019-12-31 0001751788 dow:ExcludedComponentsMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2018-01-01 2018-12-31 0001751788 us-gaap:DesignatedAsHedgingInstrumentMember 2017-01-01 2017-12-31 0001751788 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2018-01-01 2018-12-31 0001751788 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2017-01-01 2017-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001751788 dow:ExcludedComponentsMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember dow:CumulativeTranslationAdjustmentsMember 2018-01-01 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-12-31 0001751788 us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember dow:InterestExpenseandAmortizationofDebtDiscountMember 2017-01-01 2017-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember dow:InterestExpenseandAmortizationofDebtDiscountMember 2019-01-01 2019-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001751788 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember dow:InterestExpenseandAmortizationofDebtDiscountMember 2017-01-01 2017-12-31 0001751788 dow:ExcludedComponentsMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-01-01 2017-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2017-01-01 2017-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-01-01 2017-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-01-01 2017-12-31 0001751788 dow:ExcludedComponentsMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2017-01-01 2017-12-31 0001751788 dow:ExcludedComponentsMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember dow:CumulativeTranslationAdjustmentsMember 2018-01-01 2018-12-31 0001751788 dow:ExcludedComponentsMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember dow:CumulativeTranslationAdjustmentsMember 2017-01-01 2017-12-31 0001751788 us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-12-31 0001751788 us-gaap:NondesignatedMember 2017-01-01 2017-12-31 0001751788 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember dow:InterestExpenseandAmortizationofDebtDiscountMember 2019-01-01 2019-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember dow:InterestExpenseandAmortizationofDebtDiscountMember 2019-01-01 2019-12-31 0001751788 us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2017-01-01 2017-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-01-01 2018-12-31 0001751788 us-gaap:NondesignatedMember 2018-01-01 2018-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember dow:InterestExpenseandAmortizationofDebtDiscountMember 2017-01-01 2017-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-12-31 0001751788 dow:ExcludedComponentsMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2019-01-01 2019-12-31 0001751788 dow:ExcludedComponentsMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember dow:CumulativeTranslationAdjustmentsMember 2017-01-01 2017-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember dow:InterestExpenseandAmortizationofDebtDiscountMember 2018-01-01 2018-12-31 0001751788 dow:ExcludedComponentsMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember dow:CumulativeTranslationAdjustmentsMember 2019-01-01 2019-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-01-01 2018-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2018-01-01 2018-12-31 0001751788 us-gaap:InterestRateContractMember us-gaap:NondesignatedMember dow:InterestExpenseandAmortizationofDebtDiscountMember 2018-01-01 2018-12-31 0001751788 dow:ExcludedComponentsMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:CostOfSalesMember 2018-01-01 2018-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:FairValueHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2017-01-01 2017-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:NondesignatedMember us-gaap:CostOfSalesMember 2018-01-01 2018-12-31 0001751788 dow:ExcludedComponentsMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:NondesignatedMember 2019-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0001751788 dow:CommodityContractPowerMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0001751788 dow:CommodityContractHydrocarbonMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-01-01 2018-12-31 0001751788 dow:CommodityContractHydrocarbonMember us-gaap:NondesignatedMember 2019-01-01 2019-12-31 0001751788 dow:CommodityContractHydrocarbonMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0001751788 dow:CommodityContractHydrocarbonMember us-gaap:NondesignatedMember 2018-01-01 2018-12-31 0001751788 dow:CommodityContractPowerMember us-gaap:NondesignatedMember 2018-01-01 2018-12-31 0001751788 dow:ExcludedComponentsMember 2019-12-31 0001751788 us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001751788 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2018-12-31 0001751788 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001751788 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001751788 dow:AccruedAndOtherCurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2018-12-31 0001751788 dow:DeferredchargesandotherassetsMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001751788 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2018-12-31 0001751788 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001751788 dow:DeferredchargesandotherassetsMember us-gaap:CommodityContractMember us-gaap:NondesignatedMember 2018-12-31 0001751788 us-gaap:NondesignatedMember 2018-12-31 0001751788 dow:AccruedAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001751788 us-gaap:OtherCurrentAssetsMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001751788 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-12-31 0001751788 dow:AccruedAndOtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2018-12-31 0001751788 dow:AccruedAndOtherCurrentLiabilitiesMember us-gaap:CommodityContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0001751788 dow:ForeignCurrencyDenominatedDebtMember 2018-12-31 0001751788 dow:ForeignCurrencyDenominatedDebtMember 2019-12-31 0001751788 dow:LeasedNonmanufacturingFacilitiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001751788 us-gaap:ManufacturingFacilityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2017-12-31 0001751788 dow:NonmanufacturingAssetsMember us-gaap:FairValueMeasurementsNonrecurringMember dow:PerformanceMaterialsCoatingsMember 2019-01-01 2019-12-31 0001751788 dow:PrivateMarketSecuritiesandRealEstateMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-12-31 0001751788 dow:PerformanceMaterialsCoatingsMember 2019-10-01 2019-12-31 0001751788 us-gaap:RealEstateMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-12-31 0001751788 dow:PrivateMarketSecuritiesandRealEstateMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001751788 us-gaap:ManufacturingFacilityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2018-12-31 0001751788 dow:AssetRelatedChargesandOtherFacilityClosingandWritedownofNonmanufacturingAssetsMember dow:DowDuPontCostSynergyProgramMember dow:PackagingSpecialtyPlasticsMember 2017-01-01 2017-12-31 0001751788 us-gaap:PropertyPlantAndEquipmentMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2017-12-31 0001751788 dow:PrivateMarketSecuritiesMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-12-31 0001751788 dow:NonmanufacturingAssetsMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-01-01 2019-12-31 0001751788 dow:NonmanufacturingAssetsMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:CorporateMember 2019-01-01 2019-12-31 0001751788 dow:NonmanufacturingAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001751788 dow:PrivateMarketSecuritiesMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001751788 us-gaap:ManufacturingFacilityMember us-gaap:FairValueMeasurementsNonrecurringMember dow:PackagingSpecialtyPlasticsMember 2019-01-01 2019-12-31 0001751788 us-gaap:RealEstateMember us-gaap:FairValueMeasuredAtNetAssetValuePerShareMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001751788 us-gaap:PropertyPlantAndEquipmentMember us-gaap:RestructuringChargesMember 2018-01-01 2018-12-31 0001751788 dow:ManufacturingAssetsEquityMethodInvestmentsandOtherAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2017-12-31 0001751788 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2017-12-31 0001751788 us-gaap:ChangeDuringPeriodFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2017-12-31 0001751788 dow:ManufacturingAssetsEquityMethodInvestmentsandOtherAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001751788 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001751788 us-gaap:ChangeDuringPeriodFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2019-12-31 0001751788 dow:ManufacturingAssetsEquityMethodInvestmentsandOtherAssetsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2018-12-31 0001751788 us-gaap:ChangeDuringPeriodFairValueDisclosureMember us-gaap:FairValueMeasurementsNonrecurringMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel3Member 2017-12-31 0001751788 us-gaap:FairValueInputsLevel3Member 2018-01-01 2018-12-31 0001751788 us-gaap:FairValueInputsLevel3Member 2018-12-31 0001751788 us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001751788 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:HeldtomaturitySecuritiesMember 2019-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001751788 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:HeldtomaturitySecuritiesMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:FairValueMeasurementsRecurringMember us-gaap:HeldtomaturitySecuritiesMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:HeldtomaturitySecuritiesMember 2019-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:HeldtomaturitySecuritiesMember 2018-12-31 0001751788 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2019-12-31 0001751788 us-gaap:CommodityContractMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0001751788 us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001751788 us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2019-12-31 0001751788 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:MoneyMarketFundsMember 2019-12-31 0001751788 us-gaap:FairValueMeasurementsRecurringMember us-gaap:HeldtomaturitySecuritiesMember 2019-12-31 0001751788 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2019-12-31 0001751788 us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2019-12-31 0001751788 us-gaap:InterestRateContractMember us-gaap:FairValueMeasurementsRecurringMember 2018-12-31 0001751788 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:CorporateDebtSecuritiesMember 2018-12-31 0001751788 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2018-12-31 0001751788 us-gaap:VariableInterestEntityPrimaryBeneficiaryMember 2019-12-31 0001751788 dow:SiliconInputsJointVenturesMember 2019-12-31 0001751788 dow:MTPHPPOMember 2019-10-01 2019-12-31 0001751788 dow:SiliconInputsJointVenturesMember 2018-12-31 0001751788 dow:AFSIMember 2019-12-31 0001751788 2019-10-01 0001751788 dow:AFSIMember 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DuPontanditsAffiliatesMember 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DuPontanditsAffiliatesMember 2019-01-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain dow:DuPontanditsAffiliatesMember 2018-01-01 2018-12-31 0001751788 dow:MeglobalMember 2018-01-01 2018-12-31 0001751788 us-gaap:CorporateMember 2017-01-01 2017-12-31 0001751788 dow:IndustrialIntermediatesInfrastructureMember 2017-01-01 2017-12-31 0001751788 dow:PerformanceMaterialsCoatingsMember 2017-01-01 2017-12-31 0001751788 dow:PackagingSpecialtyPlasticsMember 2017-01-01 2017-12-31 0001751788 dow:MeglobalMember dow:IndustrialIntermediatesInfrastructureMember 2019-01-01 2019-12-31 0001751788 us-gaap:CorporateMember 2018-12-31 0001751788 us-gaap:CorporateMember 2019-12-31 0001751788 us-gaap:CorporateMember 2017-12-31 0001751788 country:US 2019-01-01 2019-12-31 0001751788 dow:RestofWorldDomain 2018-12-31 0001751788 dow:EuropeMiddleEastAfricaandIndiaDomain 2017-12-31 0001751788 dow:RestofWorldDomain 2017-12-31 0001751788 dow:RestofWorldDomain 2019-01-01 2019-12-31 0001751788 country:US 2018-12-31 0001751788 country:US 2019-12-31 0001751788 dow:RestofWorldDomain 2019-12-31 0001751788 dow:EuropeMiddleEastAfricaandIndiaDomain 2019-12-31 0001751788 country:US 2017-01-01 2017-12-31 0001751788 dow:EuropeMiddleEastAfricaandIndiaDomain 2018-12-31 0001751788 dow:RestofWorldDomain 2018-01-01 2018-12-31 0001751788 dow:EuropeMiddleEastAfricaandIndiaDomain 2017-01-01 2017-12-31 0001751788 dow:RestofWorldDomain 2017-01-01 2017-12-31 0001751788 country:US 2017-12-31 0001751788 country:US 2018-01-01 2018-12-31 0001751788 dow:TheDowChemicalCompanyDomain 2019-01-01 2019-03-31 0001751788 2019-01-01 2019-03-31 0001751788 2019-04-01 2019-06-30 0001751788 dow:TheDowChemicalCompanyDomain 2019-04-01 2019-06-30 0001751788 dow:TheDowChemicalCompanyDomain 2019-07-01 2019-09-30 0001751788 2019-10-01 2019-12-31 0001751788 dow:TheDowChemicalCompanyDomain 2019-10-01 2019-12-31 0001751788 srt:MinimumMember 2019-06-30 0001751788 srt:MaximumMember 2019-06-30 0001751788 srt:MinimumMember 2019-09-30 0001751788 srt:MinimumMember 2019-12-31 0001751788 srt:MaximumMember 2019-09-30 0001751788 dow:TheDowChemicalCompanyDomain dow:ECPMember 2019-01-01 2019-03-31 0001751788 dow:TheDowChemicalCompanyDomain us-gaap:SegmentDiscontinuedOperationsMember 2019-01-01 2019-03-31 0001751788 dow:TheDowChemicalCompanyDomain srt:ScenarioPreviouslyReportedMember 2019-01-01 2019-03-31 0001751788 2018-07-01 2018-09-30 0001751788 2018-01-01 2018-03-31 0001751788 2018-04-01 2018-06-30 0001751788 2018-10-01 2018-12-31 0001751788 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-01-01 2018-12-31 0001751788 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-01-01 2017-12-31 0001751788 us-gaap:AllowanceForCreditLossMember 2018-01-01 2018-12-31 0001751788 us-gaap:AllowanceForCreditLossMember 2016-12-31 0001751788 us-gaap:AllowanceForCreditLossMember 2019-01-01 2019-12-31 0001751788 us-gaap:InventoryValuationReserveMember 2017-01-01 2017-12-31 0001751788 us-gaap:AllowanceForCreditLossMember 2019-12-31 0001751788 us-gaap:AllowanceForCreditLossMember 2018-12-31 0001751788 dow:ValuationAllowanceofOtherInvestmentsandNoncurrentReceivableDomain 2018-01-01 2018-12-31 0001751788 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-01-01 2019-12-31 0001751788 dow:ValuationAllowanceofOtherInvestmentsandNoncurrentReceivableDomain 2019-01-01 2019-12-31 0001751788 us-gaap:InventoryValuationReserveMember 2019-12-31 0001751788 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2017-12-31 0001751788 us-gaap:InventoryValuationReserveMember 2019-01-01 2019-12-31 0001751788 us-gaap:InventoryValuationReserveMember 2017-12-31 0001751788 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2018-12-31 0001751788 dow:ValuationAllowanceofOtherInvestmentsandNoncurrentReceivableDomain 2017-01-01 2017-12-31 0001751788 us-gaap:AllowanceForCreditLossMember 2017-01-01 2017-12-31 0001751788 dow:ValuationAllowanceofOtherInvestmentsandNoncurrentReceivableDomain 2016-12-31 0001751788 us-gaap:InventoryValuationReserveMember 2018-01-01 2018-12-31 0001751788 us-gaap:InventoryValuationReserveMember 2018-12-31 0001751788 dow:ValuationAllowanceofOtherInvestmentsandNoncurrentReceivableDomain 2019-12-31 0001751788 dow:ValuationAllowanceofOtherInvestmentsandNoncurrentReceivableDomain 2018-12-31 0001751788 dow:ValuationAllowanceofOtherInvestmentsandNoncurrentReceivableDomain 2017-12-31 0001751788 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2016-12-31 0001751788 us-gaap:ValuationAllowanceOfDeferredTaxAssetsMember 2019-12-31 0001751788 us-gaap:InventoryValuationReserveMember 2016-12-31 0001751788 us-gaap:AllowanceForCreditLossMember 2017-12-31 0001751788 dow:SadaraChemicalCompanyMember dow:ValuationAllowanceofOtherInvestmentsandNoncurrentReceivableDomain 2019-01-01 2019-12-31 0001751788 dow:SadaraChemicalCompanyMember us-gaap:AllowanceForCreditLossMember 2019-01-01 2019-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure dow:wells dow:ReportingUnits iso4217:EUR dow:manufacturingsites dow:jointventures dow:countries dow:brinesandwells iso4217:CAD utreg:bbl dow:employees utreg:MWh
Table of Contents


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the fiscal year ended December 31, 2019
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________to__________

DOWDIAMONDREDRGB819.JPG
Commission
File Number
Exact Name of Registrant as Specified in its Charter,
Principal Office Address and Telephone Number
State of Incorporation or
Organization
I.R.S. Employer
Identification No.
001-38646
Dow Inc.
Delaware
30-1128146
 
2211 H.H. Dow Way, Midland, MI 48674
 
 
 
(989) 636-1000
 
 
001-03433
The Dow Chemical Company
Delaware
38-1285128
 
2211 H.H. Dow Way, Midland, MI 48674
 
 
 
(989) 636-1000
 
 
Securities registered pursuant to Section 12(b) of the Act:
Registrant
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Dow Inc.
Common Stock, par value $0.01 per share
DOW
New York Stock Exchange
The Dow Chemical Company
4.625% Notes due October 1, 2044
DOW/44
New York Stock Exchange


Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.
Dow Inc.
Yes
No
The Dow Chemical Company
Yes
No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.
Dow Inc.
Yes
No
The Dow Chemical Company
Yes
No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Dow Inc.
Yes
No
The Dow Chemical Company
Yes
No


1

Table of Contents


Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Dow Inc.
Yes
No
The Dow Chemical Company
Yes
No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Dow Inc.
Large accelerated filer þ
Accelerated
filer ¨
Non-accelerated filer ¨
Smaller reporting company ¨
Emerging growth company ¨
The Dow Chemical Company
Large accelerated filer ¨
Accelerated
filer ¨
Non-accelerated filer þ
Smaller reporting company ¨
Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Dow Inc.  
 
The Dow Chemical Company
 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Dow Inc.
Yes
No
The Dow Chemical Company
Yes
No

As of June 30, 2019, the aggregate market value of the common stock of Dow Inc. held by non-affiliates of Dow Inc. was approximately $36.3 billion based on the last reported closing price of $49.31 per share as reported on the New York Stock Exchange.
Dow Inc. had 741,678,966 shares of common stock, $0.01 par value, outstanding at January 31, 2020. The Dow Chemical Company had 100 shares of common stock, $0.01 par value, outstanding at January 31, 2020, all of which were held by the registrant’s parent, Dow Inc.
The Dow Chemical Company meets the conditions set forth in General Instruction I(1)(a) and (b) for Form 10-K and therefore is filing this form in the reduced disclosure format.

DOCUMENTS INCORPORATED BY REFERENCE

Dow Inc.: Portions of Dow Inc.'s Proxy Statement for the 2020 Annual Meeting of Stockholders are incorporated herein by reference in Part III of this Annual Report on Form 10-K to the extent stated herein. Such proxy statement will be filed with the Securities and Exchange Commission within 120 days of Dow Inc.'s fiscal year ended December 31, 2019.

The Dow Chemical Company: None.



2

Table of Contents


Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
ANNUAL REPORT ON FORM 10-K
For the fiscal year ended December 31, 2019
TABLE OF CONTENTS
PAGE
6
17
20
20
21
22
 
 
 
 
23
24
25
57
58
 
Dow Inc. and Subsidiaries:
 
 
64
 
65
 
66
 
67
 
68
 
The Dow Chemical Company and Subsidiaries:
 
 
69
 
70
 
71
 
72
 
73
148
149
152
 
 
 
 
153
153
153
153
153
 
 
 
 
155
158
 
 
 
160

3

Table of Contents


 
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
 
This Annual Report on Form 10-K is a combined report being filed by Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries (“TDCC” and together with Dow Inc., “Dow” or the "Company"). This Annual Report on Form 10-K reflects the results of Dow and its consolidated subsidiaries, after giving effect to the distribution to DowDuPont Inc. (“DowDuPont” and effective June 3, 2019, n/k/a DuPont de Nemours, Inc. or "DuPont") of TDCC’s agricultural sciences business (“AgCo”) and specialty products business (“SpecCo”) and the receipt of E. I. du Pont de Nemours and Company and its consolidated subsidiaries' (“Historical DuPont”) ethylene and ethylene copolymers business (other than its ethylene acrylic elastomers business) ("ECP"). The U.S. GAAP consolidated financial results of Dow Inc. and TDCC reflect the distribution of AgCo and SpecCo as discontinued operations for the applicable periods presented as well as the receipt of ECP as a common control transaction from the closing of the merger with Historical DuPont on August 31, 2017. In addition, following the separation from DowDuPont, the Company changed the manner in which its business activities were managed. The Company's portfolio now includes six global businesses which are organized into the following operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure and Performance Materials & Coatings. Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and the expectation that the financial statements and disclosures of each company will be substantially similar, the companies are filing a combined report for this Annual Report on Form 10-K. The information reflected in this report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Each of Dow Inc. and TDCC is filing information in this report on its own behalf and neither company makes any representation to the information relating to the other company.

Background
On April 1, 2019, DowDuPont completed the separation of its materials science business and Dow Inc. became the direct parent company of TDCC and its consolidated subsidiaries, owning all of the outstanding common shares of TDCC. For filings relating to the period commencing April 1, 2019 and thereafter, TDCC was deemed the predecessor to Dow Inc., and the historical results of TDCC are deemed the historical results of Dow Inc. for periods prior to and including March 31, 2019.

The separation was contemplated by the merger of equals transaction effective August 31, 2017, under the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017. TDCC and Historical DuPont each merged with subsidiaries of DowDuPont and, as a result, TDCC and Historical DuPont became subsidiaries of DowDuPont (the “Merger”). Subsequent to the Merger, TDCC and Historical DuPont engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products. Dow Inc. was formed as a wholly owned subsidiary of DowDuPont to serve as the holding company for the materials science business.

FORWARD-LOOKING STATEMENTS
This report contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forward-looking statements often address expected future business and financial performance, financial condition, and other matters, and often contain words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” "target," “will,” “will be,” “will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties which may cause actual results to differ materially from the forward-looking statements.

Forward-looking statements include, but are not limited to, expectations as to future sales of Dow’s products; the ability to protect Dow’s intellectual property in the United States and abroad; estimates regarding Dow’s capital requirements and need for and availability of financing; estimates of Dow’s expenses, future revenues and profitability; estimates of the size of the markets for Dow’s products and services and Dow’s ability to compete in such markets; expectations related to the rate and degree of market acceptance of Dow’s products; the outcome of certain Dow contingencies, such as litigation and environmental matters; estimates of the success of competing technologies that may become available and expectations regarding the benefits and costs associated with each of the foregoing.


4

Table of Contents


Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Forward-looking statements are based on certain assumptions and expectations of future events which may not be realized and speak only as of the date the statements were made. In addition, forward-looking statements also involve risks, uncertainties and other factors that are beyond Dow’s control that could cause Dow’s actual results to differ materially from those projected, anticipated or implied in the forward-looking statements. These factors include, but are not limited to: fluctuations in energy and raw material prices; failure to develop and market new products and optimally manage product life cycles; significant litigation and environmental matters; failure to appropriately manage process safety and product stewardship issues; changes in laws and regulations or political conditions; global economic and capital markets conditions, such as inflation, market uncertainty, interest and currency exchange rates, and equity and commodity prices; business or supply disruptions; security threats, such as acts of sabotage, terrorism or war; weather events and natural disasters; ability to protect, defend and enforce Dow’s intellectual property rights; increased competition; changes in relationships with Dow’s significant customers and suppliers; unanticipated expenses such as litigation or legal settlement expenses; unanticipated business disruptions; Dow’s ability to predict, identify and interpret changes in consumer preferences and demand; Dow’s ability to complete proposed divestitures or acquisitions; Dow’s ability to realize the expected benefits of acquisitions if they are completed; the availability of financing to Dow in the future and the terms and conditions of such financing; and disruptions in Dow’s information technology networks and systems. Additionally, there may be other risks and uncertainties that Dow is unable to identify at this time or that Dow does not currently expect to have a material impact on its business.

Risks related to achieving the anticipated benefits of Dow's separation from DowDuPont include, but are not limited to, a number of conditions outside the control of Dow, including risks related to (i) Dow's inability to achieve some or all of the benefits that it expects to receive from the separation from DowDuPont, (ii) certain tax risks associated with the separation, (iii) Dow's inability to make necessary changes to operate as a stand-alone company, (iv) the failure of Dow's pro forma financial information to be a reliable indicator of Dow's future results, (v) Dow's inability to enjoy the same benefits of diversity, leverage and market reputation that it enjoyed as a combined company, (vi) Dow's inability to receive third-party consents required under the separation agreement, (vii) Dow's customers, suppliers and others' perception of Dow's financial stability on a stand-alone basis, (viii) non-compete restrictions under the separation agreement, (ix) receipt of less favorable terms in the commercial agreements Dow entered into with DuPont and Corteva, Inc. ("Corteva"), including restrictions under intellectual property cross-license agreements, than Dow would have received from an unaffiliated third party; and (x) Dow's obligation to indemnify DuPont and/or Corteva for certain liabilities.

Where, in any forward-looking statement, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. A detailed discussion of principal risks and uncertainties which may cause actual results and events to differ materially from such forward-looking statements is included in the section of this Annual Report on Form 10-K titled “Risk Factors.” Dow Inc. and TDCC assume no obligation to update or revise publicly any forward-looking statements whether because of new information, future events, or otherwise, except as required by securities and other applicable laws.

5

Table of Contents


 
Dow Inc. and Subsidiaries
 
 
The Dow Chemical Company and Subsidiaries
 
 
PART I
 

ITEM 1. BUSINESS

THE COMPANY
Dow Inc. was incorporated on August 30, 2018, under Delaware law, to serve as a holding company for The Dow Chemical Company and its consolidated subsidiaries ("TDCC" and together with Dow Inc., "Dow" or the "Company"). Dow Inc. operates all of its businesses through TDCC, a wholly owned subsidiary, which was incorporated in 1947 under Delaware law and is the successor to a Michigan corporation, of the same name, organized in 1897. The Company's principal executive offices are located at 2211 H.H. Dow Way, Midland, Michigan 48674.

Available Information
The Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, are available free of charge at www.dow.com/investors, as soon as reasonably practicable after the reports are electronically filed or furnished with the U.S. Securities and Exchange Commission ("SEC"). The SEC maintains a website that contains these reports as well as proxy statements and other information regarding issuers that file electronically. The SEC's website is at www.sec.gov. Dow's website and its content are not deemed incorporated by reference into this report.

MERGER AND SEPARATION
On April 1, 2019, DowDuPont Inc. (“DowDuPont” and effective June 3, 2019, n/k/a DuPont de Nemours, Inc. or "DuPont") completed the separation of its materials science business and Dow Inc. became the direct parent company of TDCC and its consolidated subsidiaries, owning all of the outstanding common shares of TDCC.

The separation was contemplated by the merger of equals transaction effective August 31, 2017, under the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017. TDCC and E. I. du Pont de Nemours and Company and its consolidated subsidiaries (“Historical DuPont”) each merged with subsidiaries of DowDuPont and, as a result, TDCC and Historical DuPont became subsidiaries of DowDuPont (the “Merger”). Subsequent to the Merger, TDCC and Historical DuPont engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products. Dow Inc. was formed as a wholly owned subsidiary of DowDuPont to serve as the holding company for the materials science business.

As of the effective date and time of the distribution, DowDuPont does not beneficially own any equity interest in Dow and no longer consolidates Dow and its consolidated subsidiaries into its financial results. The consolidated financial results of Dow for periods prior to April 1, 2019, reflect the distribution of TDCC’s agricultural sciences business (“AgCo”) and specialty products business (“SpecCo”) as discontinued operations for each period presented as well as reflect the receipt of Historical DuPont’s ethylene and ethylene copolymers businesses (other than its ethylene acrylic elastomers business) (“ECP”) as a common control transaction from the closing of the Merger on August 31, 2017. See Notes 3 and 4 to the Consolidated Financial Statements and Dow Inc.'s Amendment No. 4 to the Registration Statement on Form 10 filed with the SEC on March 8, 2019, for additional information.

Throughout this Annual Report on Form 10-K, unless otherwise indicated, amounts and activity are presented on a continuing operations basis.

About Dow
Dow combines global breadth, asset integration and scale, focused innovation and leading business positions to achieve profitable growth. The Company’s ambition is to become the most innovative, customer centric, inclusive and sustainable materials science company. Dow’s portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure and consumer care. Dow operates 109 manufacturing sites in 31 countries and employs approximately 36,500 people.



6

Table of Contents


BUSINESS SEGMENTS AND PRODUCTS
Effective with the Merger, TDCC's business activities were components of DowDuPont's business operations and were reported as a single operating segment. Following the separation from DowDuPont, the Company changed the manner in which its business activities were managed. The Company's portfolio now includes six global businesses which are organized into the following operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure and Performance Materials & Coatings. Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. The Company did not aggregate any operating segments when determining its reportable segments. See Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations and Note 27 to the Consolidated Financial Statements for additional information concerning the Company’s operating segments.

PACKAGING & SPECIALTY PLASTICS
Packaging & Specialty Plastics consists of two highly integrated global businesses: Hydrocarbons & Energy and Packaging and Specialty Plastics. The segment employs the industry’s broadest polyolefin product portfolio, supported by the Company’s proprietary catalyst and manufacturing process technologies, to work at the customer’s design table throughout the value chain to deliver more reliable and durable, higher performing, and more sustainable plastics to customers in food and specialty packaging; industrial and consumer packaging; health and hygiene; caps, closures and pipe applications; consumer durables; automotive; and infrastructure.

The Company’s unique advantages compared with its competitors include: extensive low-cost feedstock positions around the world; unparalleled scale, global footprint and market reach, with world-class manufacturing sites in every geography; deep customer and brand owner understanding; portfolio of higher-value functional polymers, such as polyolefin elastomers, semiconductive and jacketing compound solutions and wire and cable insulation; and market-driven application development and technical support.

The segment remains agile and adaptive by participating in the entire ethylene-to-polyethylene chain integration, enabling the Company to manage market swings, and therefore optimize returns while reducing long-term earnings volatility. The Company’s unrivaled value chain ownership is further strengthened by its Pack Studio locations in every geography, which help customers and brand owners deliver faster and more efficient packaging product commercialization through a global network of laboratories, technical experts and testing equipment.

Hydrocarbons & Energy
Hydrocarbons & Energy is the largest global producer of ethylene, a key chemical building block that the Company consumes primarily within the Packaging & Specialty Plastics segment. Ethylene is transferred to downstream derivative businesses at market-based prices, which are generally equivalent to prevailing market prices for large volume purchases. In addition to ethylene, the business is a leading producer of propylene and aromatics products that are used to manufacture materials that consumers use every day. The business also produces and procures the power and feedstocks used by the Company’s manufacturing sites.

Packaging and Specialty Plastics
Packaging and Specialty Plastics serves growing, high-value sectors using world-class technology, broad existing product lines, and a rich product pipeline that creates competitive advantages for the entire packaging value chain. The business is a recognized leader in the production, marketing and innovation of polyethylene. The business is also a leader in other ethylene derivatives, such as polyolefin elastomers, ethylene vinyl acetate and ethylene propylene diene monomer ("EPDM") rubber serving automotive, consumer, wire and cable and construction markets. Market growth is expected to be driven by major shifts in population demographics; improving socioeconomic status in emerging geographies; consumer and brand owner demand for increased functionality; global efforts to reduce food waste; growth in telecommunications networks; global development of electrical transmission and distribution infrastructure; and renewable energy applications.

Divestiture
On September 1, 2017, the Company sold its global Ethylene Acrylic Acid copolymers and ionomers business to SK Global Chemical Co., Ltd. See Note 6 to the Consolidated Financial Statements for additional information.


7

Table of Contents


Details on Packaging & Specialty Plastics' 2019 net sales, by business and geographic region, are as follows:

CHART-7F16172932255801A82.JPG CHART-B3A1A10D663F6FA0FE3.JPG
CHART-94C466102324558AAE5.JPG CHART-652A51B7ED46B98231D.JPG
* Europe, Middle East, Africa and India ("EMEAI")

Products
Major applications/market segments and products are listed below by business:

Business
Applications/Market Segments
Major Products
Key Raw Materials
Key Competitors
Hydrocarbons & Energy
Purchaser of feedstocks; production of cost competitive hydrocarbon monomers utilized by Dow's derivative businesses; and energy, principally for use in Dow’s global operations
Ethylene, propylene, benzene, butadiene, octene, aromatics co-products, power, steam, other utilities
Butane, condensate, ethane, naphtha, natural gas, propane
Chevron Phillips Chemical, ExxonMobil, INEOS, LyondellBasell, SABIC, Shell, Sinopec
Packaging and Specialty Plastics
Adhesives; automotive; caps, closures and pipe applications; construction; cosmetics; electrical transmission and distribution; food and supply chain packaging; footwear; health and hygiene; housewares; industrial specialty applications using polyolefin elastomers, ethylene copolymers, and ethylene propylene diene monomer ("EPDM") elastomers; irrigation pipe; photovoltaic encapsulants; sporting goods; telecommunications infrastructure; toys and infant products
Acrylics, bio-based plasticizers, copolymer, elastomers, ethylene copolymer resins, EPDM, ethylene vinyl acetate ("EVA"), methacrylic acid copolymer resins, polyethylene ("PE"), high-density polyethylene ("HDPE"), low-density polyethylene ("LDPE"), linear low-density polyethylene ("LLDPE"), polyolefin plastomers, resin additives and modifiers, semiconductive and jacketing compound solutions and wire and cable insulation

Aliphatic solvent, butene, ethylene, hexene, octene, propylene
Borealis, ExxonMobil, INEOS, Lanxess, LyondellBasell, Nova, SABIC


8

Table of Contents


Joint Ventures
This segment includes a portion of the Company's share of the results of the following joint ventures:

EQUATE Petrochemical Company K.S.C.C. (“EQUATE”) - a Kuwait-based company that manufactures ethylene, polyethylene and ethylene glycol, and manufactures and markets monoethylene glycol, diethylene glycol and polyethylene terephthalate resins; owned 42.5 percent by the Company.
The Kuwait Olefins Company K.S.C.C. (“TKOC”) - a Kuwait-based company that manufactures ethylene and ethylene glycol; owned 42.5 percent by the Company.
Map Ta Phut Olefins Company Limited (“Map Ta Phut”) - a Thailand-based company that manufactures propylene and ethylene; the Company has an effective ownership of 32.77 percent (of which 20.27 percent is owned directly by the Company and aligned with the Industrial Intermediates & Infrastructure segment and 12.5 percent is owned indirectly through the Company’s equity interest in Siam Polyethylene Company Limited, an entity that is part of The SCG-Dow Group and aligned with the Packaging & Specialty Plastics segment).
Sadara Chemical Company ("Sadara") - a Saudi Arabian company that manufactures chlorine, ethylene, propylene and aromatics for internal consumption and manufactures and sells polyethylene, ethylene oxide and propylene oxide derivative products, and isocyanates; owned 35 percent by the Company. The Company is responsible for marketing a majority of Sadara products outside of the Middle East zone through the Company’s established sales channels. As part of this arrangement, the Company purchases and sells Sadara products for a marketing fee.

This segment also includes the Company's share of the results of the following joint ventures:

The Kuwait Styrene Company K.S.C.C. (“TKSC”) - a Kuwait-based company that manufactures styrene monomer; owned 42.5 percent by the Company.
The SCG-Dow Group - a group of Thailand-based companies (consisting of Siam Polyethylene Company Limited; Siam Polystyrene Company Limited; Siam Styrene Monomer Company Limited; and Siam Synthetic Latex Company Limited) that manufacture polyethylene, polystyrene, styrene, latex and specialty elastomers; owned 50 percent by the Company.

Current and Future Investments
In 2017, the Company announced the startup of its new integrated world-scale ethylene production facility and its new ELITE™ Enhanced Polyethylene production facility, both located in Freeport, Texas. In 2018, the Company started up its new LDPE production facility and its new NORDEL™ Metallocene EPDM production facility, both located in Plaquemine, Louisiana. These key milestones enable the Company to capture benefits from increasing supplies of U.S. shale gas to deliver differentiated downstream solutions in its core market verticals. The Company also completed debottlenecking of an existing bi-modal gas phase polyethylene production facility in St. Charles, Louisiana, and started up a new High Melt Index ("HMI") AFFINITY™ polymer production facility in Freeport, Texas, in the fourth quarter of 2018.

Additionally, the Company has announced investments over the next five years that are expected to enhance competitiveness. These include:

Expansion of the capacity of the Company’s new ethylene production facility in Freeport, TX, bringing the facility’s total ethylene capacity to 2,000 kilotonnes per annum ("KTA") and making it the largest ethylene cracker in the world.
Incremental debottleneck projects across its global asset network that will deliver approximately 350 KTA of additional polyethylene, the majority of which will be in U.S. & Canada.
Construction of a world-scale polyethylene unit on the U.S. Gulf Coast based on Dow’s proprietary process technologies, to meet consumer-driven demand in specialty packaging, health and hygiene, and industrial and consumer packaging applications.
A new catalyst production facility for key catalysts licensed by Univation Technologies, LLC, a wholly owned subsidiary of the Company.
On January 29, 2020, the Company announced plans to add another furnace to its ethylene production facility in Alberta, Canada, incrementally expanding capacity by approximately 130,000 metric tons. Dow will co-invest in the expansion with a regional customer, evenly sharing project costs and ethylene output, with the additional ethylene to be consumed by existing polyethylene manufacturing assets in the region. The expansion is expected to come online in the first half of 2021.


9

Table of Contents


The Company's ambition includes becoming the most sustainable materials science company in the world with a strategy to advance the well-being of humanity by helping lead the transition to a sustainable planet and society. This includes lowering energy and greenhouse gas emissions ("GHG") and enabling a shift to a circular economy for plastics by focusing on resource efficiency and integrating recycled content and renewable feedstocks into its production processes. As part of that strategy, Dow announced the following in August 2019:

An agreement with the Fuenix Ecogy Group, based in Weert, The Netherlands, for the supply of pyrolysis oil feedstock, which is made from recycled plastic waste. The feedstock will be used to produce virgin polymers at Dow’s production facilities in Terneuzen, The Netherlands. This is an important step forward to increase feedstock recycling - the process of breaking down mixed waste plastics into their original form to manufacture new virgin polymers. The polymers produced from this pyrolysis oil will be identical to products produced from traditional feedstocks, and as such, they can be used in the same applications, including food packaging.
An agreement with UPM Biofuels, a producer of biofuels, for the supply and integration of wood-based UPM Bio Verno renewable naphtha - a key raw material used to develop plastics - into Dow's slate of raw materials, creating an alternative source for plastics production. The feedstock will be used to produce bio-based polyethylene at Dow's production facilities in Terneuzen, The Netherlands, for use in packaging applications such as food packaging, to reduce food waste.
The retrofit of one of its Louisiana steam crackers with Dow’s proprietary fluidized catalytic dehydrogenation ("FCDh") technology to produce on-purpose propylene. The FCDh technology retrofit further improves Dow’s ability to continue to source the most advantaged feedstocks, while also producing reliable and cost-efficient on-purpose propylene to supply its integrated derivative units in Louisiana. The technology reduces capital outlay by up to 25 percent and lowers energy usage and GHG by up to 20 percent, thereby improving overall sustainability when compared with conventional propane dehydrogenation technologies. The project is expected to begin producing on-purpose propylene by the end of 2021.

INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE
Industrial Intermediates & Infrastructure consists of two customer-centric global businesses - Industrial Solutions and Polyurethanes & Construction Chemicals - that develop important intermediate chemicals that are essential to manufacturing processes, as well as downstream, customized materials and formulations that use advanced development technologies. These businesses primarily produce and market ethylene oxide and propylene oxide derivatives that are aligned to market segments as diverse as appliances, coatings, infrastructure and oil and gas. The global scale and reach of these businesses, world-class technology and R&D capabilities and materials science expertise enable the Company to be a premier solutions provider offering customers value-add sustainable solutions to enhance comfort, energy efficiency, product effectiveness and durability across a wide range of home comfort and appliances, building and construction, adhesives and lubricant applications, among others.

Industrial Solutions
Industrial Solutions provides a broad portfolio of solutions that address world needs by enabling and improving the manufacture of consumer and industrial goods and services. The business’ solutions minimize friction and heat in mechanical processes; manage the oil and water interface; deliver ingredients for maximum effectiveness; facilitate dissolvability; enable product identification; and provide the foundational building blocks for the development of chemical technologies. The business supports manufacturers associated with a large variety of end-markets, notably coatings, detergents and cleaners, crop protection, solvents for electronics processing, inks and textiles. The business is the world's largest producer of purified ethylene oxide.

Polyurethanes & Construction Chemicals
Polyurethanes & Construction Chemicals consists of three businesses: Polyurethanes, Chlor-Alkali & Vinyl (“CAV”) and Construction Chemicals (“DCC”). The Polyurethanes business is the world’s largest producer of propylene oxide, propylene glycol and polyether polyols, and a leading producer of aromatic isocyanates and fully formulated polyurethane systems for rigid, semi-rigid and flexible foams, and coatings, adhesives, sealants, elastomers and composites that serve energy efficiency, consumer comfort, industrial and enhanced mobility market sectors. The CAV business provides cost-advantaged chlorine and caustic soda supply and markets caustic soda, a valuable co-product of the chlor-alkali manufacturing process, and ethylene dichloride and vinyl chloride monomer. The CAV business' assets are predominantly in Western Europe and largely produce materials for internal consumption. The DCC business provides cellulose ethers, redispersible latex powders, and acrylic emulsions used as key building blocks for differentiated building and construction materials across many market segments and applications ranging from roofing and flooring to gypsum-, cement-, concrete- or dispersion-based building materials.

10

Table of Contents


Details on Industrial Intermediates & Infrastructures' 2019 net sales, by business and geographic region, are as follows:

CHART-4B240084C8D85424AB2.JPG CHART-C8BEAD24BFDAE6EC03D.JPG
CHART-9D81ABDFA83754549F2.JPG CHART-ACB056F9AADD8ADE5E6.JPG

Products
Major applications/market segments and products are listed below by business:

Business
Applications/Market Segments
Major Products
Key Raw Materials
Key Competitors
Industrial Solutions
Broad range of products for specialty applications, including agriculture crop protection offerings, aircraft deicing, solvents for coatings, heat transfer fluids for concentrated solar power, construction, solvents for electronics processing, food preservation, fuel markers, home and personal care, infrastructure applications, lubricant additives, paper, transportation and utilities; products for energy markets including exploration, production, transmission, refining, mining and gas processing to optimize supply, improve efficiencies and manage emissions
Acetone derivatives, butyl glycol ethers, VERSENE™ Chelants, UCAR™ Deicing Fluids, ethanolamines, ethylene oxide ("EO"), ethyleneamines, UCON™ Fluids, glycol ethers, UCARTHERM™ Heat Transfer Fluids, higher glycols, isopropanolamines, low-VOC solvents, methoxypolyethylene glycol, methyl isobutyl, polyalkylene glycol, CARBOWAX™ SENTRY™
Polyethylene Glycol, TERGITOL™ and TRITON™ Surfactants, demulsifiers, drilling and completion fluids, heat transfer fluids, rheology modifiers, scale inhibitors, shale inhibitors, specialty amine solvents, surfactants, water clarifiers, frothing separating agents
Ethylene, propylene
BASF, Eastman, Hexion, Huntsman, INEOS, LyondellBasell, SABIC, Sasol, Shell
Polyurethanes & Construction Chemicals
Aircraft deicing fluids; alumina; pulp and paper; appliances; automotive; bedding; building and construction; flooring; footwear; heat transfer fluids; hydraulic fluids; infrastructure; packaging; textiles and transportation; construction; caulks and sealants; cement-based tile adhesives; concrete solutions; elastomeric roof coatings; industrial non-wovens; plasters and renders; roof tiles and siding; sport grounds and tape joint compounds
Aniline, caustic soda, ethylene dichloride ("EDC"), methylene diphenyl diisocyanate (“MDI”), polyether polyols, propylene glycol ("PG"), propylene oxide ("PO"), polyurethane systems, toluene diisocyanate (“TDI”), vinyl chloride monomer ("VCM"), AQUASET™ Acrylic Thermosetting Resins, DOW™ Latex Powder, RHOPLEX™ and PRIMAL™ Acrylic Emulsion Polymers, WALOCEL™ Cellulose Ethers

Aniline, aqueous hydrochloric acid, benzene, carbon monoxide, caustic soda, cell effluent, cellulose chlorine, electric power, ethylene, hydrogen peroxide, propylene, styrene
Arkema, Ashland, BASF, Covestro, Eastman, Huntsman, INEOS, Olin, Owens-Corning, Yantai Wanhua


11

Table of Contents


Joint Ventures
This segment includes a portion of the Company's share of the results of EQUATE, TKOC, Map Ta Phut and Sadara.

Current and Future Investments
The Company expects to make investments over the next five years to enhance competitiveness in the Company’s Polyurethanes & Construction Chemicals and Industrial Solutions businesses. The investments will include alkoxylation capacity expansions and finishing capabilities; investments to support growth in polyurethane systems; and efficiency improvements around the world.

PERFORMANCE MATERIALS & COATINGS
Performance Materials & Coatings includes industry-leading franchises that deliver a wide array of solutions into consumer and infrastructure end-markets. The segment consists of two global businesses: Coatings & Performance Monomers and Consumer Solutions. These businesses primarily utilize the Company's acrylics-, cellulosics- and silicone-based technology platforms to serve the needs of the architectural and industrial coatings, home care and personal care end-markets. Both businesses employ materials science capabilities, global reach and unique products and technology to combine chemistry platforms to deliver differentiated offerings to customers.

Coatings & Performance Monomers
Coatings & Performance Monomers consists of two businesses: Coating Materials and Performance Monomers. The Coating Materials business makes critical ingredients and additives that help advance the performance of paints and coatings. The business offers innovative and sustainable products to accelerate paint and coatings performance across diverse market segments, including architectural paints and coatings, as well as industrial coatings applications used in maintenance and protective industries, wood, metal packaging, traffic markings, thermal paper and leather. These products enhance coatings by improving hiding and coverage characteristics, enhancing durability against nature and the elements, lowering or eliminating volatile organic compounds (“VOC”) content, reducing maintenance and improving ease of application. The Performance Monomers business manufactures acrylics-based building blocks needed for the production of coatings, textiles, and home and personal care products.

Consumer Solutions
Consumer Solutions consists of three businesses: Performance Silicones; Home & Personal Care; and Silicone Feedstocks & Intermediates. Performance Silicones uses innovative, versatile silicone-based technology to provide ingredients and solutions to customers in high performance building, consumer goods, elastomeric applications and the pressure sensitive adhesives industry that help them meet modern consumer preferences in attributes such as texture, feel, scent, durability and consistency. Dow’s wide array of silicone-based products and solutions enables customers to: increase the appeal of their products; extend shelf life; improve performance of products under a wider range of conditions; and provide a more sustainable offering. The Home & Personal Care business collaborates closely with global and regional brand owners to deliver innovative solutions, leveraging acrylics and cellulosics technology platforms for creating new and unrivaled consumer benefits and experiences in cleaning, laundry and skin and hair care applications, among others. Silicone Feedstocks & Intermediates provides standalone silicone materials that are used as intermediates in a wide range of applications including adhesion promoters, coupling agents, crosslinking agents, dispersing agents and surface modifiers.


12

Table of Contents


Details on Performance Materials & Coatings' 2019 net sales, by business and geographic region, are as follows:

CHART-C8361C7B4BD955299B3.JPG CHART-252B601C8EF5AE44964.JPG
CHART-48DAA76F2FDA533E9C6.JPG CHART-30F529E7A6E9DD42C1E.JPG

Products
Major applications/market segments and products are listed below by business:

Business
Applications/Market Segments
Major Products
Key Raw Materials
Key Competitors
Coatings & Performance Monomers
Acrylic binders for architectural paints and coatings, industrial coatings and paper; adhesives; dispersants; impact modifiers; inks and paints; opacifiers and surfactants for both architectural and industrial applications; plastics additives; processing aids; protective and functional coatings; rheology modifiers

ACOUSTICRYL™ Liquid-Applied Sound Damping Technology; acrylates; ACRYSOL™ Rheology Modifiers; AVANSE™ Acrylic Binders; EVOQUE™ Pre-Composite Polymer; foam cell promoters; FORMASHIELD™ Acrylic Binder; high-quality impact modifiers; MAINCOTE™ Acrylic Epoxy Hybrid; methacrylates; processing aids; RHOPLEX™ Acrylic Resin; TAMOL™ Dispersants; vinyl acetate monomers; weatherable acrylic capstock compounds for thermoplastic and thermosetting materials
Acetic acid, acetone, acrylic acid, butyl acrylate, methyl methacrylate, propylene, styrene
Arkema, BASF, Celanese, Evonik, LyondellBasell, Wacker Chemie
Consumer Solutions
Personal care, color cosmetics, baby care, home care and specialty applications with a key focus on hair care, skin care, sun care, cleansing, as well as fabric, dish, floor, hard surface and air care applications; commercial glazing; electrical and high-voltage insulation; lamp and luminaire modules assembly; oil and gas; paints and inks; release liners, specialty films and tapes; sporting goods; 3D printing
Adhesives and sealants; antifoams and surfactants; coatings and controlled release; coupling agents and crosslinkers; EVOLV3D™ Printing Technology; fluids, emulsions and dispersions; formulating and processing aids; granulation and binders; oils; polymers and emollients; opacifiers; reagents; resins, gels and powders; rheology modifiers; rubber; silicone elastomers; solubility enhancers; aerospace composites; surfactants and solvents; SILASTIC™ Silicone Elastomers; DOWSIL™ Silicone Products
Hydrochloric acid, methanol, platinum, silica, silicon metal
Elkem, Momentive, Shin-Etsu, Wacker Chemie

13



Current and Future Investments
The Company has announced investments over the next five years that are expected to enhance competitiveness, including low capital intensity, high return investments in the Company’s silicones franchise. The investments include a series of incremental silicones debottleneck and efficiency improvement projects around the world, a new hydroxyl functional siloxane polymer plant in the U.S. and a new specialty resin plant in China.

CORPORATE
Corporate includes certain enterprise and governance activities (including insurance operations, environmental operations, etc.); non-business aligned joint ventures; non-business aligned litigation expenses; and discontinued or non-aligned businesses.

RAW MATERIALS
The Company operates in an integrated manufacturing environment. Basic raw materials are processed through many stages to produce a number of products that are sold as finished goods at various points in those processes. The major raw material stream that feeds the production of the Company's finished goods is hydrocarbon-based raw materials. The Company purchases hydrocarbon raw materials including ethane, propane, butane, naphtha and condensate as feedstocks. These raw materials are used in the production of both saleable products and energy. The Company also purchases certain monomers, primarily ethylene and propylene, to supplement internal production. The Company purchases natural gas, primarily to generate electricity, and purchases electric power to supplement internal generation. In addition, the Company produces a portion of its electricity needs in Louisiana and Texas; Alberta, Canada; The Netherlands; and Germany.

The Company's primary source of these raw materials are natural gas liquids ("NGLs"), which are derived from shale gas and crude oil production and naphtha, which is produced during the processing and refining of crude oil. Given recent advancements in shale gas, shale oil and conventional drilling techniques, the Company expects these raw materials to be in abundant supply. The Company's suppliers of these raw materials include regional, international and national oil and gas companies.

The Company purchases raw materials on both short- and long-term contracts. The Company had adequate supplies of raw materials in 2019 and expects to continue to have adequate supplies of raw materials in 2020.

INDUSTRY SEGMENTS AND GEOGRAPHIC REGION RESULTS
See Note 27 to the Consolidated Financial Statements for information regarding net sales, pro forma net sales, pro forma Operating EBIT and total assets by segment, as well as net sales and long-lived assets by geographic region.

SIGNIFICANT CUSTOMERS AND PRODUCTS
All products and services are marketed primarily through the Company’s sales force, although in some instances more emphasis is placed on sales through distributors. In 2019, no significant portion of the Company's sales was dependent upon a single customer.

PATENTS, LICENSES AND TRADEMARKS
The Company continually applies for and obtains U.S. and foreign patents and has a substantial number of pending patent applications throughout the world. At December 31, 2019, the Company owned approximately 3,700 active U.S. patents and 19,100 active foreign patents as follows:

  
Remaining Life of Patents Owned at Dec 31, 2019
United States
Foreign
Within 5 years
900

3,800

6 to 10 years
1,000

6,400

11 to 15 years
1,600

8,300

16 to 20 years
200

600

Total
3,700

19,100


The Company’s primary purpose in obtaining patents is to protect the results of its research for use in operations and licensing. The Company is party to a substantial number of patent licenses, including intellectual property cross-license agreements and other technology agreements, and also has a substantial number of trademarks and trademark registrations in the United States and in other countries, including the “Dow in Diamond” trademark. Although the Company considers that its patents, licenses and trademarks in the aggregate constitute a valuable asset, it does not regard its business as being materially dependent on any single or group of related patents, licenses or trademarks.


14



PRINCIPAL PARTLY OWNED COMPANIES
The Company’s principal nonconsolidated affiliates at December 31, 2019, including direct or indirect ownership interest for each, are listed below:

Principal Nonconsolidated Affiliate
Country
Ownership Interest
Business Description
EQUATE Petrochemical Company K.S.C.C.
Kuwait
42.50
%
Manufactures ethylene, polyethylene and ethylene glycol, and manufactures and markets monoethylene glycol, diethylene glycol and polyethylene terephthalate resins
The Kuwait Olefins Company K.S.C.C.
Kuwait
42.50
%
Manufactures ethylene and ethylene glycol
The Kuwait Styrene Company K.S.C.C.
Kuwait
42.50
%
Manufactures styrene monomer
Map Ta Phut Olefins Company Limited 1
Thailand
32.77
%
Manufactures propylene and ethylene
Sadara Chemical Company 2
Saudi Arabia
35.00
%
Manufactures chlorine, ethylene, propylene and aromatics for internal consumption and manufactures and sells polyethylene, ethylene oxide and propylene oxide derivative products, and isocyanates
The SCG-Dow Group:
 
 
 
Siam Polyethylene Company Limited
Thailand
50.00
%
Manufactures polyethylene
Siam Polystyrene Company Limited
Thailand
50.00
%
Manufactures polystyrene
Siam Styrene Monomer Company Limited
Thailand
50.00
%
Manufactures styrene
Siam Synthetic Latex Company Limited
Thailand
50.00
%
Manufactures latex and specialty elastomers
1.
The Company's effective ownership of Map Ta Phut is 32.77 percent, of which the Company directly owns 20.27 percent and indirectly owns 12.5 percent through its equity interest in Siam Polyethylene Company Limited.
2.
The Company is responsible for marketing the majority of Sadara products outside of the Middle East zone through the Company's established sales channels. Under this arrangement, the Company purchases and sells Sadara products for a marketing fee.

See Note 13 to the Consolidated Financial Statements for additional information regarding nonconsolidated affiliates.

PROTECTION OF THE ENVIRONMENT
Matters pertaining to the environment are discussed in Part I, Item 1A. Risk Factors; Part II, Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations; and Notes 1 and 17 to the Consolidated Financial Statements. In addition, detailed information on the Company's performance regarding environmental matters and goals can be found online on the Science & Sustainability webpage at www.dow.com/sustainability. Dow's website and its content are not deemed incorporated by reference into this report.

EMPLOYEES
At December 31, 2019, the Company permanently employed approximately 36,500 people on a full-time basis.

OTHER ACTIVITIES
The Company engages in the property and casualty insurance and reinsurance business primarily through its Liana Limited subsidiaries.


15



EXECUTIVE OFFICERS OF THE REGISTRANT
Set forth below is information related to the Company's executive officers as of February 7, 2020:

Name - Age
Present Position with Registrant
Year Elected to be an Officer
Other Business Experience since January 1, 2015
Karen S. Carter, 49
Chief Human Resources Officer
2019
Dow Inc.: Chief Human Resources Officer since April 1, 2019.

TDCC: Chief Human Resources Officer since October 2018; Chief Inclusion Officer since July 2017; North America Commercial Vice President, Dow Packaging and Specialty Plastics from February 2016 to July 2017; Global Business Director, Low Density & Slurry Polyethylene, Packaging & Specialty Plastics from April 2015 to January 2016; and Global Marketing Director Value Chain, New Business Development & Sustainability, Performance Plastics from September 2011 to April 2015.
Ronald C. Edmonds, 62
Controller and Vice President of Controllers and Tax
2019
Dow Inc.: Controller and Vice President of Controllers and Tax since April 1, 2019.

TDCC: Controller and Vice President since November 2009; Vice President of Tax since January 2016.
Jim Fitterling, 58
Chief Executive Officer
2018
Dow Inc.: Chief Executive Officer since August 2018.

TDCC: Chief Executive Officer since July 2018; President and Chief Operating Officer from February 2016 to July 2018; Vice Chairman and Chief Operating Officer from October 2015 to February 2016; Vice Chairman, Business Operations from October 2014 to October 2015.
Peter Holicki, 59
Senior Vice President, Operations - Manufacturing & Engineering and Environment, Health and Safety Operations
2019
Dow Inc.: Senior Vice President, Operations - Manufacturing & Engineering and Environment, Health and Safety Operations since April 1, 2019.

TDCC: Senior Vice President, Operations - Manufacturing & Engineering and Environment, Health and Safety Operations since October 2015; responsible for oversight of the Emergency Services and Security Expertise Center since September 2014; Corporate Vice President of Manufacturing & Engineering and Environment, Health & Safety Operations January 2014 to October 2015.
A. N. Sreeram, 52
Senior Vice President of Research & Development and Chief Technology Officer
2019
Dow Inc.: Senior Vice President of Research & Development and Chief Technology Officer since April 1, 2019.

TDCC: Chief Technology Officer since October 2015; Senior Vice President of Research & Development since August 2013; Corporate Vice President, Research & Development from August 2013 to October 2015.
Howard Ungerleider, 51
President and Chief Financial Officer
2018
Dow Inc.: President and Chief Financial Officer since August 2018.

TDCC: Chief Financial Officer since October 2014; President since July 2018; Vice Chairman from October 2015 to July 2018; Executive Vice President from October 2014 to October 2015.
Amy E. Wilson, 49
General Counsel and Corporate Secretary
2018
Dow Inc.: General Counsel and Corporate Secretary since April 1, 2019; Secretary from August 2018 to April 1, 2019.

TDCC: General Counsel since October 2018; Corporate Secretary since February 2015; Associate General Counsel from April 2017 to September 2018; Assistant General Counsel from February 2015 to April 2017; Assistant Corporate Secretary from 2008 to February 2015; Director of the Office of the Corporate Secretary from August 2013 to October 2018.


16



ITEM 1A. RISK FACTORS
The factors described below represent the Company's principal risks.

Global Economic Considerations: The Company operates in a global, competitive environment which gives rise to operating and market risk exposure.
The Company sells its broad range of products and services in a competitive, global environment, and competes worldwide for sales on the basis of product quality, price, technology and customer service. Increased levels of competition could result in lower prices or lower sales volume, which could have a negative impact on the Company’s results of operations. Sales of the Company's products are also subject to extensive federal, state, local and foreign laws and regulations, trade agreements, import and export controls and duties and tariffs. The imposition of additional regulations, controls and duties and tariffs or changes to bilateral and regional trade agreements could result in lower sales volume, which could negatively impact the Company’s results of operations.

Economic conditions around the world, and in certain industries in which the Company does business, also impact sales price and volume. As a result, market uncertainty or an economic downturn driven by political tensions, war, terrorism, epidemics or political instability in the geographic regions or industries in which the Company sells its products could reduce demand for these products and result in decreased sales volume, which could have a negative impact on the Company’s results of operations.

In addition, volatility and disruption of financial markets could limit customers’ ability to obtain adequate financing to maintain operations, which could result in a decrease in sales volume and have a negative impact on the Company’s results of operations. The Company’s global business operations also give rise to market risk exposure related to changes in foreign exchange rates, interest rates, commodity prices and other market factors such as equity prices. To manage such risks, the Company enters into hedging transactions pursuant to established guidelines and policies. If the Company fails to effectively manage such risks, it could have a negative impact on its results of operations.

Financial Commitments and Credit Markets: Market conditions could reduce the Company's flexibility to respond to changing business conditions or fund capital needs.
Adverse economic conditions could reduce the Company’s flexibility to respond to changing business and economic conditions or to fund capital expenditures or working capital needs. The economic environment could result in a contraction in the availability of credit in the marketplace and reduce sources of liquidity for the Company. This could result in higher borrowing costs.
Raw Materials: Availability of purchased feedstock and energy, and the volatility of these costs, impact Dow’s operating costs and add variability to earnings.
Purchased feedstock and energy costs account for a substantial portion of the Company’s total production costs and operating expenses. The Company purchases hydrocarbon raw materials including ethane, propane, butane, naphtha and condensate as feedstocks and also purchases certain monomers, primarily ethylene and propylene, to supplement internal production, as well as other raw materials. The Company also purchases natural gas, primarily to generate electricity, and purchases electric power to supplement internal generation.

Feedstock and energy costs generally follow price trends in crude oil and natural gas, which are sometimes volatile. While the Company uses its feedstock flexibility and financial and physical hedging programs to help mitigate feedstock cost increases, the Company is not always able to immediately raise selling prices. Ultimately, the ability to pass on underlying cost increases is dependent on market conditions. Conversely, when feedstock and energy costs decline, selling prices generally decline as well. As a result, volatility in these costs could impact the Company’s results of operations.

The Company has a number of investments on the U.S. Gulf Coast to take advantage of increasing supplies of low-cost natural gas and NGLs derived from shale gas including: the St. Charles Operations ("SCO-2") ethylene production facility in December 2012; an on-purpose propylene production facility, which commenced operations in December 2015; an ethylene production facility in Plaquemine, Louisiana, which included expanding the facility’s ethylene production capacity and modifications to enable full ethane cracking flexibility; completion of a new integrated world-scale ethylene production facility and a new ELITE™ Enhanced Polyethylene production facility, both located in Freeport, Texas, in 2017, and a capacity expansion project which will bring the facility’s total ethylene capacity to 2,000 KTA in 2020; and, the Company commenced operations in 2018 on its new LDPE production facility and its new NORDEL™ Metallocene EPDM production facility, both located in Plaquemine, Louisiana. As a result of these investments, the Company’s exposure to purchased ethylene and propylene is expected to decline, offset by increased exposure to ethane- and propane-based feedstocks.

While the Company expects abundant and cost-advantaged supplies of NGLs in the United States to persist for the foreseeable future, if NGLs become significantly less advantaged than crude oil-based feedstocks, it could have a negative impact on the Company’s results of operations and future investments. Also, if the Company’s key suppliers of feedstocks and energy are unable to provide the raw materials required for production, it could have a negative impact on the Company’s results of operations.

17

Table of Contents


Supply/Demand Balance: Earnings generated by the Company's products vary based in part on the balance of supply relative to demand within the industry.
The balance of supply relative to demand within the industry may be significantly impacted by the addition of new capacity, especially for basic commodities where capacity is generally added in large increments as world-scale facilities are built. This may disrupt industry balances and result in downward pressure on prices due to the increase in supply, which could negatively impact the Company’s results of operations.

Litigation: The Company is party to a number of claims and lawsuits arising out of the normal course of business with respect to product liability, patent infringement, employment matters, governmental tax and regulation disputes, contract and commercial litigation, and other actions.
Certain of the claims and lawsuits facing the Company purport to be class actions and seek damages in very large amounts. All such claims are contested. With the exception of the possible effect of the asbestos-related liability of Union Carbide Corporation (“Union Carbide”) and Chapter 11 related matters of Dow Silicones Corporation (“Dow Silicones,” formerly known as Dow Corning Corporation, which changed its name effective as of February 1, 2018) as described below, it is the opinion of the Company’s management that the possibility is remote that the aggregate of all such claims and lawsuits will have a material adverse impact on the Company’s consolidated financial statements.

Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. At December 31, 2019, Union Carbide's total asbestos-related liability, including future defense and processing costs, was $1,165 million ($1,260 million at December 31, 2018).

In 1995, Dow Silicones, a former 50:50 joint venture, voluntarily filed for protection under Chapter 11 of the U.S. Bankruptcy Code in order to resolve breast implant liabilities and related matters (the “Chapter 11 Proceeding”). Dow Silicones emerged from the Chapter 11 Proceeding on June 1, 2004, and is implementing the Joint Plan of Reorganization (the “Plan”). The Plan provides funding for the resolution of breast implant and other product liability litigation covered by the Chapter 11 Proceeding. Dow Silicones’ liability for breast implant and other product liability claims was $165 million at December 31, 2019 ($263 million at December 31, 2018).

See Note 17 to the Consolidated Financial Statements for additional information on these matters.

Environmental Compliance: The costs of complying with evolving regulatory requirements could negatively impact the Company's financial results. Actual or alleged violations of environmental laws or permit requirements could result in restrictions or prohibitions on plant operations, substantial civil or criminal sanctions, as well as the assessment of strict liability and/or joint and several liability.
The Company is subject to extensive federal, state, local and foreign laws, regulations, rules and ordinances relating to pollution, protection of the environment, greenhouse gas emissions, and the generation, storage, handling, transportation, treatment, disposal and remediation of hazardous substances and waste materials. In addition, the Company may have costs related to environmental remediation and restoration obligations associated with past and current sites as well as related to its past or current waste disposal practices or other hazardous materials handling. Although management will estimate and accrue liabilities for these obligations, it is reasonably possible that the Company’s ultimate cost with respect to these matters could be significantly higher, which could negatively impact the Company’s financial condition and results of operations. Costs and capital expenditures relating to environmental, health or safety matters are subject to evolving regulatory requirements and depend on the timing of the promulgation and enforcement of specific standards which impose the requirements. Moreover, changes in environmental regulations could inhibit or interrupt the Company’s operations, or require modifications to its facilities. Accordingly, environmental, health or safety regulatory matters could result in significant unanticipated costs or liabilities.

Health and Safety: Increased concerns regarding the safe use of chemicals and plastics in commerce and their potential impact on the environment has resulted in more restrictive regulations and could lead to new regulations.
Concerns regarding the safe use of chemicals and plastics in commerce and their potential impact on health and the environment reflect a growing trend in societal demands for increasing levels of product safety and environmental protection. These concerns could manifest themselves in stockholder proposals, preferred purchasing, delays or failures in obtaining or retaining regulatory approvals, delayed product launches, lack of market acceptance and continued pressure for more stringent regulatory intervention and litigation. These concerns could also influence public perceptions, the viability or continued sales of certain of the Company's products, its reputation and the cost to comply with regulations. In addition, terrorist attacks and natural disasters have increased concerns about the security and safety of chemical production and distribution. These concerns could have a negative impact on the Company's results of operations.

Local, state, federal and foreign governments continue to propose new regulations related to the security of chemical plant locations and the transportation of hazardous chemicals, which could result in higher operating costs.

18

Table of Contents


Plastic Waste: Increased concerns regarding plastic waste in the environment, consumers selectively reducing their consumption of plastic products due to recycling concerns, or new or more restrictive regulations and rules related to plastic waste could reduce demand for the Company’s plastic products and could negatively impact the Company’s financial results.
Local, state, federal and foreign governments have been increasingly proposing and in some cases approving bans on certain plastic-based products including single-use plastics, plastic straws and utensils. In addition, plastics have faced increased public scrutiny due to negative coverage of plastic waste in the environment, including the world’s oceans. As Dow is one of the world’s largest producers of plastics, increased regulation on the use of plastics could cause reduced demand for the Company’s polyethylene products which could negatively impact the Company’s financial condition, results of operations and cash flows.

Operational Event: A significant operational event could negatively impact the Company's results of operations.
As a diversified chemical manufacturing company, the Company's operations, the transportation of products, cyber-attacks, or severe weather conditions and other natural phenomena (such as freezing, drought, hurricanes, earthquakes, tsunamis, floods, etc.) could result in an unplanned event that could be significant in scale and could negatively impact operations, neighbors or the public at large, which could have a negative impact on the Company's results of operations.

Major hurricanes have caused significant disruption in the Company's operations on the U.S. Gulf Coast, logistics across the region, and the supply of certain raw materials, which had an adverse impact on volume and cost for some of its products. Due to the Company's substantial presence on the U.S. Gulf Coast, similar severe weather conditions or other natural phenomena in the future could negatively impact the Company's results of operations.

Cyber Threat: The risk of loss of the Company’s intellectual property, trade secrets or other sensitive business information or disruption of operations could negatively impact the Company’s financial results.
Cyber-attacks or security breaches could compromise confidential, business critical information, cause a disruption in the Company’s operations or harm the Company's reputation. The Company has attractive information assets, including intellectual property, trade secrets and other sensitive, business critical information. While the Company has a comprehensive cyber-security program that is continuously reviewed, maintained and upgraded, a significant cyber-attack could result in the loss of critical business information and/or could negatively impact operations, which could have a negative impact on the Company’s financial results.

Company Strategy: Implementing certain elements of the Company's strategy could negatively impact its financial results.
The Company currently has manufacturing operations, sales and marketing activities, and joint ventures in emerging geographies. Activities in these geographic regions are accompanied by uncertainty and risks including: navigating different government regulatory environments; relationships with new, local partners; project funding commitments and guarantees; expropriation, military actions, war, terrorism and political instability; sabotage; uninsurable risks; suppliers not performing as expected resulting in increased risk of extended project timelines; and determining raw material supply and other details regarding product movement. If the manufacturing operations, sales and marketing activities, and/or implementation of these projects is not successful, it could adversely affect the Company’s financial condition, cash flows and results of operations.

Goodwill: An impairment of goodwill could negatively impact the Company’s financial results.
At least annually, the Company assesses goodwill for impairment. If testing indicates that goodwill is impaired, the carrying value is written down based on fair value with a charge against earnings. Where the Company utilizes a discounted cash flow methodology in determining fair value, continued weak demand for a specific product line or business could result in an impairment. Accordingly, any determination requiring the write-off of a significant portion of goodwill could negatively impact the Company's results of operations. See Note 14 to the Consolidated Financial Statements for additional information regarding the Company's goodwill impairment testing.

Pension and Other Postretirement Benefits: Increased obligations and expenses related to the Company's defined benefit pension plans and other postretirement benefit plans could negatively impact its financial condition and results of operations.
The Company has defined benefit pension plans and other postretirement benefit plans (the “plans”) in the United States and a number of other countries. The assets of the Company's funded plans are primarily invested in fixed income securities, equity securities of U.S. and foreign issuers and alternative investments, including investments in real estate, private market securities and absolute return strategies. Changes in the market value of plan assets, investment returns, discount rates, mortality rates, regulations and the rate of increase in compensation levels may affect the funded status of the Company's plans and could cause volatility in the net periodic benefit cost, future funding requirements of the plans and the funded status of the plans. A significant increase in the Company's obligations or future funding requirements could have a negative impact on the Company's results of operations and cash flows for a particular period and on the Company's financial condition.


19

Table of Contents


Separation from DowDuPont: Risks related to achieving the anticipated benefits of Dow's separation from DowDuPont.
Risks related to achieving the anticipated benefits of Dow's separation from DowDuPont include, but are not limited to, a number of conditions outside the control of Dow, including risks related to (i) Dow's inability to achieve some or all of the benefits that it expects to receive from the separation from DowDuPont, (ii) certain tax risks associated with the separation, (iii) Dow's inability to make necessary changes to operate as a stand-alone company, (iv) the failure of Dow's pro forma financial information to be a reliable indicator of Dow's future results, (v) Dow's inability to enjoy the same benefits of diversity, leverage and market reputation that it enjoyed as a combined company, (vi) Dow's inability to receive third-party consents required under the separation agreement, (vii) Dow's customers, suppliers and others' perception of Dow's financial stability on a stand-alone basis, (viii) non-compete restrictions under the separation agreement, (ix) receipt of less favorable terms in the commercial agreements Dow entered into with DuPont and Corteva, Inc. ("Corteva"), including restrictions under intellectual property cross-license agreements, than Dow would have received from an unaffiliated third party; and (x) Dow's obligation to indemnify DuPont and/or Corteva for certain liabilities.


ITEM 1B. UNRESOLVED STAFF COMMENTS
None.


ITEM 2. PROPERTIES
The Company's corporate headquarters are located in Midland, Michigan. The Company's manufacturing, processing, marketing and research and development facilities, as well as regional purchasing offices and distribution centers are located throughout the world. The Company has investments in property, plant and equipment related to global manufacturing operations. Collectively, the Company operates 109 manufacturing sites in 31 countries. The following table includes the major manufacturing sites by segment, including consolidated variable interest entities:
 
Major Manufacturing Sites by Segment
Packaging & Specialty Plastics
Industrial Intermediates & Infrastructure
Performance Materials & Coatings
Location
Bahia Blanca, Argentina
X      
 
 
Candeias, Brazil
X      
X      
 
Canada:
 
 
 
Fort Saskatchewan, Alberta
X      
 
 
Prentiss, Alberta
X      
 
 
Zhangjiagang, China
X      
X      
X      
Germany:
 
 
 
Boehlen
X      
X      
X      
Leuna
X      
 
 
Schkopau
X      
X      
 
Stade
 
X      
 
Terneuzen, The Netherlands
X      
X      
 
Tarragona, Spain
X      
X      
 
Map Ta Phut, Thailand
X
X      
X      
Barry, United Kingdom
 
 
X      
United States:
 
 
 
Carrollton, Kentucky
 
 
X      
Hahnville, Louisiana
X      
X      
X      
Plaquemine, Louisiana
X      
X      
    
Midland, Michigan
 
 
X      
Deer Park, Texas
 
X      
X      
Freeport, Texas
X      
X      
X      
Orange, Texas
X      
 
 
Seadrift, Texas
X      
X      
 


20

Table of Contents


Including the major manufacturing sites, the Company has manufacturing sites and holdings in all geographic regions as follows:
 
Manufacturing Sites by Region
Asia Pacific
19 manufacturing sites in 10 countries
EMEAI
37 manufacturing sites in 15 countries
Latin America
18 manufacturing sites in 4 countries
U.S. & Canada
35 manufacturing sites in 2 countries

Properties of the Company include facilities which, in the opinion of management, are suitable and adequate for their use and will have sufficient capacity for the Company’s current needs and expected near-term growth. All of the Company’s plants are owned or leased, subject to certain easements of other persons which, in the opinion of management, do not substantially interfere with the continued use of such properties or materially affect their value. No title examination of the properties has been made for the purpose of this report. Additional information with respect to the Company's property, plant and equipment and leases is contained in Notes 12, 16 and 18 to the Consolidated Financial Statements.


ITEM 3. LEGAL PROCEEDINGS
Asbestos-Related Matters of Union Carbide Corporation
Union Carbide Corporation (“Union Carbide”), a wholly owned subsidiary of the Company, is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc.

For additional information, see Part II, Item 7. Other Matters, Asbestos-Related Matters of Union Carbide Corporation in Management’s Discussion and Analysis of Financial Condition and Results of Operations, and Notes 1 and 17 to the Consolidated Financial Statements.

Environmental Matters
In April 2012 and May 2015, Dow Silicones Corporation ("Dow Silicones"), a wholly owned subsidiary of the Company, received the following notifications from the U.S. Environmental Protection Agency ("EPA"), Region 5 related to Dow Silicones' Midland, Michigan, manufacturing facility (the “Facility”): 1) a Notice of Violation and Finding of Violation which alleges a number of violations in connection with the detection, monitoring and control of certain organic hazardous air pollutants at the Facility and various recordkeeping and reporting violations under the Clean Air Act and 2) a Notice of Violation alleging a number of violations relating to the management of hazardous wastes at the Facility pursuant to the Resource Conservation and Recovery Act. On June 25, 2019, the U.S. Department of Justice ("DOJ") filed a proceeding on behalf of the EPA against Dow Silicones in the U.S. District Court for the Eastern District of Michigan ("District Court"), which proposes to resolve the previously reported allegations of noncompliance with requirements of federal air, water, waste and chemical release reporting laws at the Facility predating the ownership restructure of Dow Silicones. The consent decree, which was entered by the District Court on January 24, 2020, provides for a penalty of $4.55 million, performance of supplemental environmental projects and enhancements at the site that will cost approximately $2 million, as well as additional environmental studies and other actions. 

On July 5, 2018, the Company received a draft consent decree from the EPA, the DOJ and the Louisiana Department of Environmental Quality (“DEQ”), relating to the operation of steam-assisted flares at the Company’s olefins manufacturing facilities in Freeport, Texas; Plaquemine, Louisiana; and St. Charles, Louisiana. Discussions between the EPA, the DOJ and the DEQ are ongoing.

On October 30, 2018, DC Alabama, Inc. (“DCA”), a wholly owned subsidiary of the Company, finalized and executed a consent order (“Order”) from the Alabama Department of Environmental Management (“ADEM”) relating to alleged unpermitted discharges of industrial process water and certain water quality and equipment violations at DCA’s silicon metal production facility located in Mt. Meigs, Alabama. The Order included, among other remedies, a civil penalty of $250,000 that DCA paid in December 2018. Implementation of the Order has been ongoing and DCA remains compliant with the Order. Discussions between DCA and ADEM are ongoing.


21

Table of Contents


On August 27, 2019, the EPA, DOJ, Texas Environmental Quality Board, and Texas Office of the Attorney General (the “Government Agencies”) added Performance Materials NA, Inc., a wholly owned subsidiary of the Company, as an additional signatory to an existing draft consent decree relating to alleged environmental violations at the Sabine manufacturing facility in Orange, Texas (the “Orange, TX Facility”). Performance Materials NA, Inc. acquired the Orange, TX Facility in February 2019 and became a subsidiary of the Company in April 2019. The alleged violations were first identified during multimedia environmental inspections that the EPA conducted at the Orange, TX Facility while under prior ownership in March 2009 and December 2015, and involve the management of materials in the Orange, TX Facility’s wastewater treatment system, hazardous waste management, flare and air emissions, including leak detection and repair. Discussions are ongoing between the Government Agencies, the Company, and the Orange, TX Facility’s prior owner, who is the other named signatory.

On October 23, 2019, Union Carbide received a proposed Agreed Order from the Texas Commission on Environmental Quality (“TCEQ”) relating to emissions of ethylene oxide from a process leak at Union Carbide’s manufacturing facility in Seadrift, Texas. The proposed Agreed Order included an administrative penalty of $800,000. On December 30, 2019, TCEQ sent a revised Agreed Order reducing the penalty to $600,000 based on Union Carbide’s corrective actions. Discussions between Union Carbide and TCEQ are ongoing.

On November 8, 2019, a proposed consent decree was filed in the U.S. District Court for the Eastern District of Michigan, Civil Action No. 1:19-cv-13292 between the Company and federal, state and tribal trustees to resolve allegations of natural resource damages arising from the historic operations of the Company’s Midland manufacturing facility. On November 14, 2019, a Notice of Lodging and Notice of Availability and Request for Comments on Draft Restoration Plan/Environmental Assessment was published in the Federal Register. Public comments on the proposed consent decree and the draft Restoration Plan/Environmental Assessment were required to be submitted within 45 days of that publication. The proposed consent decree would require the Company to pay a $15 million cash settlement to be used for Trustee-selected remediation projects and $6.75 million to specified local projects managed by third parties, and require the Company to complete 13 additional environmental restoration projects which are valued by the trustees at approximately $77 million. 


ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.


22

Table of Contents


 
Dow Inc. and Subsidiaries
 
 
The Dow Chemical Company and Subsidiaries
 
 
PART II
 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
On April 1, 2019, DowDuPont Inc. (“DowDuPont” and effective June 3, 2019, n/k/a DuPont de Nemours, Inc.) completed the separation of its materials science business and Dow Inc. became the direct parent company of The Dow Chemical Company and its consolidated subsidiaries (“TDCC” and together with Dow Inc., “Dow” or the “Company”), owning all of the outstanding common shares of TDCC. Dow Inc. is now an independent, publicly traded company and Dow Inc. common stock is listed on the New York Stock Exchange under the symbol “DOW.” Dow Inc. common stock began regular-way trading on April 2, 2019.

Dow Inc. has paid dividends on a quarterly basis since the separation from DowDuPont and expects to continue to do so, subject to approval by the Company’s Board of Directors. Quarterly market price of common stock and dividend information can be found in Note 28 to the Consolidated Financial Statements.

At January 31, 2020, there were 81,546 stockholders of record.

See Part III, Item 11. Executive Compensation for information relating to shares authorized for issuance under Dow Inc.'s equity compensation plans.

The Company grants stock-based compensation to employees and non-employee directors in the form of stock incentive plans, which include stock options, restricted stock units ("RSUs") and restricted stock. The Company also provides stock-based compensation in the form of performance stock units ("PSUs"). See Note 22 to the Consolidated Financial Statements for additional information.

Issuer Purchases of Equity Securities
The following table provides information regarding purchases of Dow Inc. common stock by the Company during the three months ended December 31, 2019:

 
Issuer Purchases of Equity Securities
Total number of shares purchased as part of the Company's publicly announced share repurchase program
Approximate dollar value of shares that may yet be purchased under the Company's publicly announced share repurchase program 1
(In millions)
 
Period
Total number of shares purchased
Average price paid per share
 
 
October 2019

$


$
2,594

 
November 2019
735,600

$
53.84

735,600

$
2,555

 
December 2019
1,032,502

$
53.17

1,032,502

$
2,500

 
Fourth quarter 2019
1,768,102

$
53.45

1,768,102

$
2,500

1.
On April 1, 2019, Dow Inc.'s Board of Directors ratified the share repurchase program originally approved on March 15, 2019, authorizing up to $3.0 billion to be spent on the repurchase of the Company's common stock, with no expiration date.


23



ITEM 6. SELECTED FINANCIAL DATA
Selected Financial Data - Dow Inc.
 
 
 
 
 
In millions, except as noted (Unaudited)
2019
2018
2017
2016
2015
Summary of Operations
 
 
 
 
 
Net sales 1
$
42,951

$
49,604

$
43,730

$
36,264

$
37,101

Income (loss) from continuing operations, net of tax 2
$
(1,717
)
$
2,940

$
(1,287
)
$
1,478

$
6,462

Per share of common stock (in dollars):
 
 
 
 
 
Earnings (loss) per common share from continuing operations - basic 2
$
(2.42
)
$
3.80

$
(1.88
)
$
1.57

$
8.64

Earnings (loss) per common share from continuing operations - diluted 2
$
(2.42
)
$
3.80

$
(1.88
)
$
1.55

$
8.31

Cash dividends declared per share of common stock 3
$
2.10

$

$
1.38

$
1.84

$
1.72

Year-end Financial Position
 
 
 
 
 
Total assets
$
60,524

$
83,699

$
85,852

$
79,511

$
67,938

Long-term debt
$
15,975

$
19,253

$
19,757

$
20,444

$
16,202

 
 
 
 
 
 
Financial Ratios
 
 
 
 
 
Research and development expenses as percent of net sales
1.8
 %
1.6
%
1.8
%
2.1
%
2.0
%
Income (loss) from continuing operations before income taxes as percent of net sales 2
(2.9
)%
7.6
%
0.5
%
3.5
%
21.8
%
Return on stockholders' equity 2
(10.0
)%
14.3
%
1.5
%
15.3
%
28.2
%
Gross debt as a percent of total capitalization
54.7
 %
37.2
%
39.1
%
43.9
%
39.5
%
Net debt as a percent of total capitalization
50.9
 %
33.7
%
31.1
%
35.1
%
24.6
%

Selected Financial Data - TDCC
 
 
 
 
 
In millions, except as noted (Unaudited)
2019
2018
2017
2016
2015
Summary of Operations
 
 
 
 
 
Net sales 1
$
42,951

$
49,604

$
43,730

$
36,264

$
37,101

Income (loss) from continuing operations, net of tax 2
$
(1,595
)
$
2,940

$
(1,287
)
$
1,478

$
6,462

Year-end Financial Position
 
 
 
 
 
Total assets
$
60,390

$
83,699

$
85,852

$
79,511

$
67,938

Long-term debt
$
15,975

$
19,253

$
19,757

$
20,444

$
16,202

 
 
 
 
 
 
Financial Ratios
 
 
 
 
 
Research and development expenses as percent of net sales
1.8
 %
1.6
%
1.8
%
2.1
%
2.0
%
Income (loss) from continuing operations before income taxes as percent of net sales 2
(2.6
)%
7.6
%
0.5
%
3.5
%
21.8
%
Return on stockholders' equity 2
(8.6
)%
14.3
%
1.5
%
15.3
%
28.2
%
Gross debt as a percent of total capitalization
53.3
 %
37.2
%
39.1
%
43.9
%
39.5
%
Net debt as a percent of total capitalization
49.6
 %
33.7
%
31.1
%
35.1
%
24.6
%
1.
The Company has certain product and service agreements with DuPont and Corteva that were considered intercompany transactions prior to the separation, but are trade transactions subsequent to the separation. Treatment of these transactions as trade transactions have been reflected in the tables above for 2019, 2018, 2017 and 2016. The amounts for 2015 were not updated as the impact to "Net sales" for this period was not significant.
2.
See Notes 4, 7, 8, 9, 13, 14, 16, 17 and 21 to the Consolidated Financial Statements for information on items materially impacting the results for the years ended December 31, 2019, 2018 and 2017, including the effects of the U.S. Tax Cuts and Jobs Act, enacted on December 22, 2017; Swiss tax reform; loss on early redemption of debt; integration and separation costs; charges related to restructuring programs; goodwill impairment and other asset related charges (including charges related to Sadara Chemical Company); a charge related to environmental remediation; a charge related to payment of plan obligations to certain participants of a U.S. non-qualified pension plan; litigation related charges, awards and adjustments; and charges associated with agreements entered into with DuPont and Corteva as part of the separation from DowDuPont.
3.
Amount shown for 2019 represents dividends declared by Dow Inc. Amounts shown for 2017, 2016 and 2015 represent cash dividends declared by TDCC prior to the Merger. Subsequent to the Merger, TDCC has no common shares outstanding.


24



ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
On April 1, 2019, DowDuPont Inc. (“DowDuPont” and effective June 3, 2019, n/k/a DuPont de Nemours, Inc. or "DuPont") completed the separation of its materials science business and Dow Inc. became the direct parent company of The Dow Chemical Company and its consolidated subsidiaries (“TDCC” and together with Dow Inc., “Dow” or the “Company”), owning all of the outstanding common shares of TDCC. For filings related to the period commencing April 1, 2019 and thereafter, TDCC was deemed the predecessor to Dow Inc., and the historical results of TDCC are deemed the historical results of Dow Inc. for periods prior to and including March 31, 2019. As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and the expectation that the financial statements and disclosures of each company will be substantially similar, the companies are filing a combined report for this Annual Report on Form 10-K. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted.

The separation was contemplated by the merger of equals transaction effective August 31, 2017, under the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017. TDCC and E. I. du Pont de Nemours and Company and its consolidated subsidiaries (“Historical DuPont”) each merged with subsidiaries of DowDuPont and, as a result, TDCC and Historical DuPont became subsidiaries of DowDuPont (the “Merger”). Subsequent to the Merger, TDCC and Historical DuPont engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products. Dow Inc. was formed as a wholly owned subsidiary of DowDuPont to serve as the holding company for the materials science business.

As of the effective date and time of the distribution, DowDuPont does not beneficially own any equity interest in Dow and no longer consolidates Dow and its consolidated subsidiaries into its financial results. The consolidated financial results of Dow for all periods presented reflect the distribution of TDCC’s agricultural sciences business (“AgCo”) and specialty products business (“SpecCo”) as discontinued operations, as well as reflect the receipt of Historical DuPont’s ethylene and ethylene copolymers businesses (other than its ethylene acrylic elastomers business) (“ECP”) as a common control transaction from the closing of the Merger on August 31, 2017. See Notes 3 and 4 to the Consolidated Financial Statements and Dow Inc.'s Amendment No. 4 to the Registration Statement on Form 10 filed with the U.S. Securities and Exchange Commission ("SEC") on March 8, 2019 for additional information.

Throughout this Annual Report on Form 10-K, unless otherwise indicated, amounts and activity are presented on a continuing operations basis.

Except as otherwise indicated by the context, the terms "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of the Company, and "Dow Silicones" means Dow Silicones Corporation (formerly known as Dow Corning Corporation, which changed its name effective as of February 1, 2018), a wholly owned subsidiary of the Company.

Items Affecting Comparability of Financial Results
As a result of the separation from DowDuPont, pro forma net sales and pro forma Operating EBIT are provided in this section and based on the consolidated financial statements of TDCC, adjusted to give effect to the separation from DowDuPont as if it had been consummated on January 1, 2017. Pro forma adjustments include (1) the margin impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva, Inc. ("Corteva") in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont (only included for 2018 and the first three months of 2019), (2) the inclusion of ECP for the period of January 1, 2017 through August 31, 2017, (3) the removal of the amortization of ECP's inventory step-up recognized in connection with the Merger, (4) the elimination of the impact of events directly attributable to the Merger, internal reorganization and business realignment, separation, distribution and other related transactions (e.g., one-time transaction costs), and (5) the elimination of the effect of a consummated divestiture agreed to with certain regulatory agencies as a condition of approval for the Merger. These adjustments impacted the consolidated results as well as the reportable segments. See Note 27 to the Consolidated Financial Statements for a summary of the pro forma adjustments impacting segment measures for the years ended December 31, 2019, 2018 and 2017.




25




ABOUT DOW
Dow combines global breadth, asset integration and scale, focused innovation and leading business positions to achieve profitable growth. The Company’s ambition is to become the most innovative, customer centric, inclusive and sustainable materials science company. Dow’s portfolio of plastics, industrial intermediates, coatings and silicones businesses delivers a broad range of differentiated science-based products and solutions for its customers in high-growth market segments, such as packaging, infrastructure and consumer care. Dow operates 109 manufacturing sites in 31 countries and employs approximately 36,500 people.

In 2019, the Company had annual sales of $43 billion, of which 36 percent of the Company’s sales were to customers in U.S. & Canada; 34 percent were in Europe, Middle East, Africa and India ("EMEAI"); while the remaining 30 percent were to customers in Asia Pacific and Latin America.

In 2019, the Company and its consolidated subsidiaries did not operate in countries subject to U.S. economic sanctions and export controls as imposed by the U.S. State Department or in countries designated by the U.S. State Department as state sponsors of terrorism, including Iran, the Democratic People's Republic of Korea (North Korea), Sudan and Syria. The Company has policies and procedures in place designed to ensure that it and its consolidated subsidiaries remain in compliance with applicable U.S. laws and regulations.

OVERVIEW
The following is a summary of the results from continuing operations and other notable events for the Company for the year ended December 31, 2019:

The Company reported net sales in 2019 of $43 billion, down 13 percent from $49.6 billion in 2018, with declines across all geographic regions and operating segments. These declines were due to a decrease in local price of 11 percent, a volume decline of 2 percent and a 1 percent unfavorable currency impact, partially offset by a 1 percent increase in Portfolio & Other.

Local price decreased 11 percent compared with the same period last year, with decreases in all operating segments, including double-digit declines in Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure (both down 12 percent). Local price decreased in all geographic regions, including double-digit declines in Latin America (down 14 percent), Asia Pacific (down 12 percent) and U.S. & Canada (down 11 percent).

Volume decreased 2 percent compared with 2018, driven primarily by lower hydrocarbon co-product sales. Packaging & Specialty Plastics and Performance Materials & Coatings reported volume declines (both down 3 percent) while Industrial Intermediates & Infrastructure was flat. Volume decreased in EMEAI (down 4 percent) and Latin America and U.S. & Canada (both down 3 percent), partially offset by an increase in Asia Pacific (up 5 percent).

Currency had an unfavorable impact of 1 percent on net sales, driven primarily by EMEAI (down 3 percent).
Research and development ("R&D") expenses were $765 million in 2019, down from $800 million in 2018. Selling, general and administrative ("SG&A") expenses for Dow Inc. and TDCC were $1,590 million and $1,585 million, respectively, in 2019, down from $1,782 million in 2018. R&D and SG&A expenses decreased primarily due to cost reductions, cost synergies, stranded cost removal and lower performance-based compensation costs.


26



Restructuring, goodwill impairment and asset related charges - net were $3,219 million in 2019, primarily reflecting post-merger restructuring actions under the DowDuPont Cost Synergy Program, a goodwill impairment charge of $1,039 million related to the Coatings & Performance Monomers reporting unit and $1,755 million of pretax charges related to Sadara Chemical Company ("Sadara").

Integration and separation costs for Dow Inc. and TDCC were $1,063 million and $1,039 million, respectively, in 2019, down from $1,179 million in 2018, reflecting the wind-down of post-Merger integration and business separation activities.

Equity in earnings (losses) of nonconsolidated affiliates was a loss of $94 million in 2019, down from earnings of $555 million in 2018, primarily due to increased equity losses from Sadara and lower equity earnings from the Kuwait joint ventures and the Thai joint ventures.

Sundry income (expense) - net for Dow Inc. and TDCC was income of $461 million and income of $573 million, respectively, in 2019, compared with income of $96 million in 2018. Sundry income (expense) - net increased primarily due to an increase in foreign currency exchange gains as well as a net gain related to litigation matters.

Net income (loss) available for Dow Inc. and TDCC common stockholder(s) was a loss of $1,359 million and $1,237 million, respectively, in 2019, compared with income of $4,641 million in 2018. Earnings (loss) per share for Dow Inc. was a loss of $1.84 per share in 2019, compared with income of $6.21 per share in 2018.
 
In 2019, Dow Inc. declared and paid dividends of $2.10 per share ($1,550 million), to common stockholders, and TDCC paid a $535 million dividend to DowDuPont.

In 2019, Dow Inc. repurchased $500 million of the Company's common stock.

In 2019, the Company reduced gross debt by nearly $3 billion.

In October 2019, the Company received a $0.8 billion cash payment related to the Nova Chemicals Corporation ("Nova") ethylene asset matter.

Other notable events and highlights from the year ended December 31, 2019 include:

On April 1, 2019, Dow successfully completed its separation from DowDuPont, becoming a more focused and streamlined materials science company.

In April 2019, Dow Inc. was named to the Dow Jones Industrial Average.

On April 25, 2019, the Company announced plans to expand its alkoxylation capacity at its existing facility in Tarragona, Spain, directly benefiting the EMEAI region.

On August 13, 2019, Dow announced that it reached an agreement for the divestiture of its acetone derivatives business to ALTIVIA Ketones & Additives, LLC, an affiliate of ALTIVIA, a privately held producer of chemicals headquartered in Houston, Texas. The transaction closed on November 1, 2019, and included the Company's acetone derivatives related inventory and production assets located in Institute, West Virginia, in addition to the site infrastructure, land and utilities.

On August 20, 2019, as part of the Company's current slate of low capital intensity, high-return incremental growth investments, Dow announced it will retrofit proprietary fluidized catalytic dehydrogenation technology into one of its mixed-feed crackers in Plaquemine, Louisiana, to produce on-purpose propylene.



27



Dow announced two new agreements that contribute to its commitment to incorporate at least 100,000 tonnes of recycled plastics in its product offerings sold in the European Union by 2025. The first was announced on August 29, 2019 with the Fuenix Ecogy Group for the supply of pyrolysis oil feedstock, which is made from plastic waste. The second agreement was announced on September 24, 2019 with UPM Biofuels for the supply of wood-based UPM BioVerno renewable naphtha. These feedstocks will be used to produce new polymers and bio-based polyethylene at Dow's production facilities in Terneuzen, The Netherlands.

Dow was named to the Dow Jones Sustainability World Index - marking the 20th time the Company has been named to this global benchmark.

Dow was named to Fortune's 2019 Change the World list, recognizing the Company's program to pilot the use of recycled plastics in roads as part of the Company's long-standing commitment to reduce plastic waste and drive sustainable solutions.

Dow was named to the 2019 Disability Equality Index® "Best Places to Work," by receiving the top score for the third year in a row.

Dow received four R&D 100 Awards from R&D Magazine for innovative technologies including: IMAGIN3DTM Polyethylene OBC, SYL-OFFTM SL-25 Release Modifier, SILASTICTM MS-4007 Moldable Optical Silicone and GREAT STUFFTM SMART DISPENSERTM.

Dow received four 2019 Sustainability Awards from the Business Intelligence Group, including the Sustainability Initiative of the Year Award for the RENUVATM Mattress Project and the Sustainability Products of the Year Award for Dow PRIMALTM Bio-based Acrylic Emulsion, DOWSILTM TC-3015 Re-workable Thermal Conductive Silicone Gel and RENUVATM Polyols.

Dow received five prestigious Edison Awards for breakthrough technologies, setting a record for the Company, with two gold, two silver and one bronze award including: gold to ENGAGETM PV Polyolefin Elastomers, gold to Tenter Frame Biaxially Orientable Polyethylene Resin, silver to ECOFASTTM Pure Sustainable Textile Treatment, silver to VORARADTM Downhole Radium Sequestration Technology and bronze to OPULUXTM HGT.

On June 13, 2019, Samuel R. Allen was elected to Dow's Board of Directors, effective August 1, 2019.

In addition to the highlights above, the following events occurred subsequent to December 31, 2019:

On January 29, 2020, the Company announced plans to add another furnace to its ethylene production facility in Alberta, Canada, incrementally expanding capacity by approximately 130,000 metric tons. Dow will co-invest in the expansion with a regional customer, evenly sharing project costs and ethylene output, with the additional ethylene to be consumed by existing polyethylene manufacturing assets in the region. The expansion is expected to come online in the first half of 2021.

RESULTS OF OPERATIONS
Net Sales
The following tables summarize net sales, pro forma net sales and sales variance by operating segment and geographic region from the prior year:

Summary of Sales Results
 
 
 
In millions
2019
2018
2017
Net sales
$
42,951

$
49,604

$
43,730

Pro forma net sales
$
42,998

$
49,852

$
44,772



28


Sales Variances by Operating Segment and Geographic Region - As Reported
 
2019
2018
Percentage change from prior year
Local Price & Product Mix
Currency
Volume
Portfolio & Other 1
Total
Local Price & Product Mix
Currency
Volume 
Portfolio & Other 1
Total
Packaging & Specialty Plastics
(12
)%
(1
)%
(3
)%
%
(16
)%
1
%
2
%
5
 %
5
%
13
%
Industrial Intermediates & Infrastructure
(12
)
(1
)


(13
)
5

1

13


19

Performance Materials & Coatings
(6
)
(2
)
(3
)
3

(8
)
10

1

(2
)

9

Total
(11
)%
(1
)%
(2
)%
1
%
(13
)%
4
%
1
%
6
 %
2
%
13
%
U.S. & Canada
(11
)%
 %
(3
)%
1
%
(13
)%
4
%
%
2
 %
2
%
8
%
EMEAI
(9
)
(3
)
(4
)

(16
)
5

3

4

2

14

Asia Pacific
(12
)
(1
)
5


(8
)
2

1

19

3

25

Latin America
(14
)

(3
)

(17
)
5


4

2

11

Total
(11
)%
(1
)%
(2
)%
1
%
(13
)%
4
%
1
%
6
 %
2
%
13
%
1.
Portfolio & Other includes the sales impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation, which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont.
Sales Variances by Operating Segment and Geographic Region - As Reported



Percentage change from prior year
2017
Local Price & Product Mix
Currency
Volume
Portfolio & Other 1
Total
Packaging & Specialty Plastics
8
%
%
6
%
3
%
17
%
Industrial Intermediates & Infrastructure
10

1

6


17

Performance Materials & Coatings
8

1

2

26

37

Total
9
%
%
6
%
6
%
21
%
U.S. & Canada
8
%
%
5
%
6
%
19
%
EMEAI
12

1

6

5

24

Asia Pacific
6


8

13

27

Latin America
4



3

7

Total
9
%
%
6
%
6
%
21
%
1.
Portfolio & Other primarily reflects sales related to the receipt of ECP as a common control transaction from the closing of the Merger on August 31, 2017, and the divestiture of the global Ethylene Acrylic Acid copolymers and ionomers business ("EAA Business"), divested on September 1, 2017 (both impacting Packaging & Specialty Plastics). In addition, Portfolio & Other includes the ownership restructure of Dow Silicones announced on June 1, 2016 (impacting Performance Materials & Coatings).

2019 Versus 2018
The Company reported net sales of $43 billion in 2019, down 13 percent from $49.6 billion in 2018, primarily driven by a decrease in local price, decreased volume and the unfavorable impact of currency. Sales declines were broad-based and occurred in all segments and geographic regions. Local price decreased 11 percent, primarily in response to lower feedstock and raw material costs and pricing pressures. Local price decreased in Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure (both down 12 percent) and in Performance Materials & Coatings (down 6 percent). Local price decreased in all geographic regions. Volume decreased 2 percent with declines in all geographic regions except Asia Pacific (up 5 percent). Volume declines were primarily driven by lower hydrocarbon co-product sales. Volume decreased in Packaging & Specialty Plastics and Performance Materials & Coatings (both down 3 percent), while Industrial Intermediates & Infrastructure volume was flat. Currency unfavorably impacted net sales by 1 percent compared with the prior year, driven primarily by EMEAI (down 3 percent). Portfolio & Other improved sales by 1 percent.

2018 Versus 2017
The Company reported net sales of $49.6 billion in 2018, up 13 percent from $43.7 billion in 2017, driven by higher sales volume, reflecting additional capacity from U.S. Gulf Coast growth projects and increased supply from Sadara, increased local price, the receipt of ECP and the favorable impact of currency. Sales growth was broad-based, with increases in all segments and geographic regions. Volume increased 6 percent compared with the prior year, as increases in Packaging & Specialty Plastics (up 5 percent) and Industrial Intermediates & Infrastructure (up 13 percent) more than offset a decline in Performance Materials & Coatings (down 2 percent). Volume increased in all geographic regions, including a double-digit increase in Asia Pacific (up 19 percent).

29


Local price was up 4 percent compared with the prior year, with increases in all geographic regions, driven by pricing initiatives and higher feedstock and raw material prices. Local price increased in all segments, with the most notable increases in Industrial Intermediates & Infrastructure (up 5 percent) and Performance Materials & Coatings (up 10 percent). Portfolio & Other contributed 2 percent of the sales increase, primarily reflecting the receipt of ECP. Currency was up 1 percent compared with the prior year, driven by a favorable impact in EMEAI and Asia Pacific.

Sales Variances by Operating Segment and Geographic Region - Pro Forma Basis
 
2019
2018
Percentage change from prior year
Local Price & Product Mix
Currency
Volume
Portfolio & Other 1
Total
Local Price & Product Mix
Currency
Volume
Portfolio & Other 1
Total
Packaging & Specialty Plastics
(12
)%
(1
)%
(3
)%
%
(16
)%
1
%
1
%
5
 %
%
7
%
Industrial Intermediates & Infrastructure
(12
)
(2
)
1


(13
)
5

1

13


19

Performance Materials & Coatings
(6
)
(2
)
(1
)

(9
)
10

1

(2
)
2

11

Total
(11
)%
(1
)%
(2
)%
%
(14
)%
4
%
1
%
6
 %
%
11
%
Total, excluding the Hydrocarbons & Energy business
(10
)%
(2
)%
1
 %
%
(11
)%
4
%
1
%
7
 %
%
12
%
U.S. & Canada
(11
)%
 %
(2
)%
%
(13
)%
3
%
%
2
 %
1
%
6
%
EMEAI
(9
)
(3
)
(4
)

(16
)
5

3

4


12

Asia Pacific
(12
)
(1
)
5


(8
)
3

1

18


22

Latin America
(15
)

(3
)

(18
)
5


4


9

Total
(11
)%
(1
)%
(2
)%
%
(14
)%
4
%
1
%
6
 %
%
11
%
1.
Portfolio & Other includes the sales impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation, which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont.

2019 Versus 2018 - Pro Forma
The Company reported pro forma net sales for 2019 of $43 billion, down 14 percent from $49.9 billion for 2018, primarily driven by a decrease in local price, decreased volume and the unfavorable impact of currency. Sales declines were broad-based and occurred in all segments and geographic regions. Local price decreased 11 percent, primarily in response to lower feedstock and raw material costs and pricing pressures. Local price decreased in Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure (both down 12 percent) and in Performance Materials & Coatings (down 6 percent). Local price decreased in all geographic regions. Volume decreased 2 percent with declines in all geographic regions except Asia Pacific (up 5 percent). Volume decreased in Packaging & Specialty Plastics (down 3 percent) and Performance Materials & Coatings (down 1 percent), and increased in Industrial Intermediates & Infrastructure (up 1 percent). Currency unfavorably impacted net sales by 1 percent compared with the prior year, driven primarily by EMEAI (down 3 percent). Portfolio & Other was flat compared with the prior year.

2018 Versus 2017 - Pro Forma
The Company reported pro forma net sales of $49.9 billion in 2018, up 11 percent from pro forma net sales of $44.8 billion in 2017, with increases across all segments and geographic regions. Double-digit net sales increases were reported in Industrial Intermediates & Infrastructure (up 19 percent) and Performance Materials & Coatings (up 11 percent). Net sales increased in Asia Pacific (up 22 percent), EMEAI (up 12 percent), Latin America (up 9 percent) and U.S. & Canada (up 6 percent). Volume increased 6 percent compared with pro forma results in the prior year, reflecting additional capacity from U.S. Gulf Coast growth projects and increased supply from Sadara. Volume increases in Packaging & Specialty Plastics (up 5 percent) and Industrial Intermediates & Infrastructure (up 13 percent) more than offset a decline in Performance Materials & Coatings (down 2 percent). Volume increased in all geographic regions, including a double-digit increase in Asia Pacific (up 18 percent). Local price was up 4 percent compared with pro forma results in the prior year with increases in all geographic regions, driven by pricing initiatives and higher feedstock and raw material prices. Local price increased across all segments, including a double-digit increase in Performance Materials & Coatings (up 10 percent). Currency was up 1 percent compared with the prior year, driven primarily by EMEAI (up 3 percent).


30


Cost of Sales
Cost of sales ("COS") was $36.7 billion in 2019, down $4.4 billion from $41.1 billion in 2018. COS decreased in 2019 primarily due to lower feedstock and other raw material costs, decreased sales volume, cost synergies, stranded cost removal and a favorable adjustment to the warranty accrual of an exited business, which were partially offset by $75 million of transaction-related costs resulting from the separation from DowDuPont (related to the Corporate segment) and $399 million of environmental charges related to Packaging & Specialty Plastics ($5 million), Industrial Intermediates & Infrastructure ($8 million), Performance Materials & Coatings ($50 million) and Corporate ($336 million). COS as a percentage of sales was 85.3 percent in 2019 compared with 82.8 percent in 2018.

COS was $41.1 billion in 2018, up $4.7 billion from $36.4 billion in 2017, primarily due to increased sales volume, which reflected additional capacity from U.S. Gulf Coast growth projects and increased supply from Sadara, higher feedstock and other raw material costs and increased planned maintenance turnaround costs which more than offset lower commissioning expenses related to U.S. Gulf Coast growth projects and cost synergies. COS as a percentage of sales was 82.8 percent in 2018 compared with 83.1 percent in 2017.

Personnel Count
The Company permanently employed approximately 36,500 people at December 31, 2019, down from approximately 37,600 people at December 31, 2018 and 39,200 people at December 31, 2017 primarily due to the Company's restructuring programs.

Research and Development Expenses
R&D expenses were $765 million in 2019, compared with $800 million in 2018 and $803 million in 2017. R&D expenses in 2019 decreased compared with 2018 primarily due to cost reductions and lower performance-based compensation costs. R&D expenses in 2018 were essentially flat compared with 2017.

Selling, General and Administrative Expenses
SG&A expenses for Dow Inc. and TDCC were $1,590 million and $1,585 million, respectively, in 2019, compared with $1,782 million in 2018 and $1,795 million in 2017. In 2019, SG&A expenses decreased primarily due to cost reductions, cost synergies, stranded cost removal and lower performance-based compensation costs. SG&A expenses were favorably impacted by a recovery of a portion of legal costs related to the Nova litigation award in the third quarter of 2019. In 2018, SG&A expenses decreased primarily due to additional cost reductions and lower performance-based compensation costs which more than offset a full year of expense from the ECP business and the absence of the recovery of costs related to the Nova patent infringement award in 2017. See Note 17 to the Consolidated Financial Statements for additional information on the Nova litigation awards.

Amortization of Intangibles
Amortization of intangibles was $419 million in 2019, down from $469 million in 2018, primarily due to certain intangible assets becoming fully amortized. Amortization of intangibles in 2018 increased from $400 million in 2017, primarily due to the receipt of ECP. See Note 14 to the Consolidated Financial Statements for additional information on intangible assets.

Restructuring, Goodwill Impairment and Asset Related Charges - Net
Restructuring, goodwill impairment and asset related charges - net were $3,219 million in 2019, $221 million in 2018 and $2,739 million in 2017.

DowDuPont Cost Synergy Program
In September and November 2017, DowDuPont approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the "Synergy Program") which was designed to integrate and optimize the organization following the Merger and in preparation for the business separations. The Company expected (prior to the impact of any discontinued operations) to record total pretax restructuring charges of approximately $1.3 billion, which included initial estimates of approximately $525 million to $575 million of severance and related benefit costs; $400 million to $440 million of asset write-downs and write-offs, and $290 million to $310 million of costs associated with exit and disposal activities. The restructuring charges below reflect charges from continuing operations.

As a result of the Synergy Program, the Company recorded pretax restructuring charges of $399 million in 2017, consisting of severance and related benefit costs of $307 million, asset write-downs and write-offs of $87 million and costs associated with exit and disposal activities of $5 million. The restructuring charges by segment were as follows: $36 million in Packaging & Specialty Plastics, $12 million in Industrial Intermediates & Infrastructure, $11 million in Performance Materials & Coatings and $340 million in Corporate.


31


For the year ended December 31, 2018, the Company recorded pretax restructuring charges of $184 million, consisting of severance and related benefit costs of $137 million, asset write-downs and write-offs of $33 million and costs associated with exit and disposal activities of $14 million. The restructuring charges by segment were as follows: $13 million in Packaging & Specialty Plastics, $11 million in Industrial Intermediates & Infrastructure, $7 million in Performance Materials & Coatings and $153 million in Corporate.

For the year ended December 31, 2019, the Company recorded pretax restructuring charges of $292 million, consisting of severance and related benefit costs of $123 million, asset write-downs and write-offs of $143 million and costs associated with exit and disposal activities of $26 million. The restructuring charges by segment were as follows: $1 million in Packaging & Specialty Plastics, $7 million in Industrial Intermediates & Infrastructure, $28 million in Performance Materials & Coatings and $256 million in Corporate. The Company expects the Synergy Program to be substantially complete by the end of the second quarter of 2020.

Goodwill Impairment
Upon completion of the goodwill impairment testing in the fourth quarter of 2019, the Company determined the fair value of the Coatings & Performance Monomers reporting unit was lower than its carrying amount. As a result, the Company recorded an impairment charge of $1,039 million in the fourth quarter of 2019 related to Performance Materials & Coatings.

Upon completion of the goodwill impairment testing in the fourth quarter of 2017, the Company determined the fair value of the Coatings & Performance Monomers reporting unit was lower than its carrying amount. As a result, the Company recorded an impairment charge of $1,491 million in the fourth quarter of 2017, related to Performance Materials & Coatings.

Asset Related Charges
2019 Charges
In 2019, the Company recognized additional pretax impairment charges of $58 million related primarily to capital additions made to a biopolymers manufacturing facility in Santa Vitoria, Minas Gerais, Brazil ("Santa Vitoria"), which was impaired in 2017. The impairment charges by segment were as follows: $44 million in Packaging & Specialty Plastics, $9 million in Performance Materials & Coatings and $5 million in Corporate.

On August 13, 2019, the Company entered into a definitive agreement to sell its acetone derivatives business to ALTIVIA Ketones & Additives, LLC. The transaction closed on November 1, 2019 and included the Company's acetone derivatives related inventory and production assets, located in Institute, West Virginia, in addition to the site infrastructure, land, utilities and certain railcars. The Company remains at the Institute site as a tenant. As a result of the divestiture, the Company recognized a pretax impairment charge of $75 million in the third quarter of 2019. The impairment charge by segment was as follows: $24 million in Packaging & Specialty Plastics and $51 million in Corporate.

In the fourth quarter of 2019, the Company concluded that its equity method investment in Sadara was other-than-temporarily impaired. The Company also reserved certain accounts and notes receivable and accrued interest balances due to uncertainty on the timing of collection. As a result, the Company recorded a $1,755 million pretax charge related to Sadara. The charge by segment was as follows: $370 million in Packaging & Specialty Plastics, $1,168 million in Industrial Intermediates & Infrastructure and $217 million in Corporate.

2018 Charges
In 2018, the Company recognized an additional pretax impairment charge of $34 million related primarily to capital additions at its Santa Vitoria manufacturing facility. The impairment charge was related to Packaging & Specialty Plastics.

2017 Charges
In 2017, the Company recognized a $622 million pretax impairment charge related to its Santa Vitoria manufacturing facility. The Company determined it would not pursue an expansion of the facility’s ethanol mill into downstream derivative products, primarily as a result of cheaper ethane-based production as well as the Company’s new assets coming online on the U.S. Gulf Coast which can be used to meet growing market demands in Brazil. As a result of this decision, cash flow analysis indicated the carrying amount of the impacted assets was not recoverable. The impairment charge was related to Packaging & Specialty Plastics.

The Company also recognized other pretax impairment charges of $246 million in the fourth quarter of 2017, including charges related to manufacturing assets of $159 million, an equity method investment of $81 million and other assets of $6 million. The impairment charges by segment were as follows: $58 million in Packaging & Specialty Plastics, $5 million in Industrial Intermediates & Infrastructure, $83 million in Performance Materials & Coatings and $100 million in Corporate.

Refer to Note 7 to the Consolidated Financial Statements for additional information on restructuring, goodwill impairment and asset related charges.

32


Integration and Separation Costs
Integration and separation costs, which reflect costs related to the Merger and the ownership restructure of Dow Silicones (through May 31, 2018), as well as post-Merger integration and business separation activities, were $1,063 million and $1,039 million for Dow Inc. and TDCC, respectively, in 2019, $1,179 million in 2018 and $798 million in 2017, and were related to Corporate. In 2018 and 2019, integration and separation costs were higher as a result of post-merger integration and business separation activities.

Equity in Earnings of Nonconsolidated Affiliates
The Company’s share of the earnings (losses) of nonconsolidated affiliates in 2019 was a loss of $94 million, compared with earnings of $555 million in 2018 and $394 million in 2017. In 2019, equity earnings decreased primarily due to lower equity earnings from the Kuwait joint ventures (due to lower monethylene glycol and polyethylene prices) and the Thai joint ventures and increased equity losses from Sadara. See Note 13 to the Consolidated Financial Statements for additional information on the Company’s evaluation of its equity method investment in Sadara for other-than-temporary impairment.

In 2018, equity earnings increased from 2017 as higher earnings from the Kuwait joint ventures and lower equity losses from Sadara were partially offset by lower equity earnings from the Thai joint ventures.

Sundry Income (Expense) - Net
Sundry income (expense) – net includes a variety of income and expense items such as foreign currency exchange gains and losses, dividends from investments, gains and losses on sales of investments and assets, non-operating pension and other postretirement benefit plan credits or costs, and certain litigation matters.

TDCC
Sundry income (expense) - net for 2019 was income of $573 million, compared with income of $96 million in 2018 and expense of $154 million in 2017.

In 2019, sundry income (expense) - net included an increase in foreign currency exchange gains, non-operating pension and postretirement benefit plan credits and gains on sales of assets and investments, as well as a net gain of $205 million related to litigation matters, which included a $170 million gain related to a legal settlement with Nova (related to Packaging & Specialty Plastics), and an $85 million gain related to an adjustment of the Dow Silicones breast implant liability (related to Corporate), which were partially offset by a $50 million charge (net of indemnifications of $37 million), related to the settlement of the Dow Silicones commercial creditor matters (related to Corporate). In 2019, sundry income (expense) - net also included a $102 million loss on the early extinguishment of debt and a gain of $2 million on post-closing adjustments related to previous divestitures (both related to Corporate). See Notes 8, 16, 17, 21 and 27 to the Consolidated Financial Statements for additional information.

In 2018, sundry income (expense) - net included non-operating pension and other postretirement benefit plan credits, a $20 million gain related to the Company's sale of its equity interest in MEGlobal (related to Corporate) and gains on sales of assets and investments, which more than offset foreign currency exchange losses, a loss of $54 million on the early extinguishment of debt (related to Corporate) and a loss of $20 million for post-closing adjustments related to the Dow Silicones ownership restructure (related to Performance Materials & Coatings). See Notes 8, 16 and 21 to the Consolidated Financial Statements for additional information.

In 2017, sundry income (expense) - net included a $227 million gain on the divestiture of the EAA Business (related to Packaging & Specialty Plastics), a $137 million gain related to the Nova patent infringement matter (related to Packaging & Specialty Plastics), a $7 million gain on post-closing adjustments related to the split-off of the chlorine value chain (related to Corporate) and gains on sales of assets and investments. These gains were more than offset by $676 million of non-operating pension and other postretirement benefit costs, primarily driven by a $687 million settlement charge for a U.S. non-qualified pension plan (related to Corporate), and foreign currency exchange losses. See Notes 6, 8, 17 and 21 to the Consolidated Financial Statements for additional information.

Dow Inc.
Sundry income (expense) - net for 2019 was income of $461 million, compared with income of $96 million in 2018 and an expense of $154 million in 2017. In addition to the amounts previously discussed above for TDCC, sundry income (expense) - net in 2019 included a $51 million loss on post-closing adjustments related to a previous divestiture and $69 million in charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution, which provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after completion of the separation (both related to Corporate). See Notes 4, 8, 17, 21 and 27 to the Consolidated Financial Statements for additional information.


33


Interest Expense and Amortization of Debt Discount
Dow Inc.
Interest expense and amortization of debt discount was $933 million in 2019, down from $1,063 million in 2018, primarily due to debt reductions and lower interest bearing notes issued in the fourth quarter of 2018, which replaced higher interest bearing notes redeemed in the fourth quarter of 2018. Interest expense and amortization of debt discount in 2018 was up from $914 million in 2017, primarily reflecting the effect of lower capitalized interest as a result of decreased capital spending. See Liquidity and Capital Resources in Management's Discussion and Analysis of Financial Condition and Results of Operations and Notes 12 and 16 to the Consolidated Financial Statements for additional information related to debt financing activity.

TDCC
Interest expense and amortization of debt discount was $952 million in 2019, down from $1,063 million in 2018. Interest expense and amortization of debt discount in 2018 was up from $914 million in 2017. In addition to the amounts previously discussed above for Dow Inc., TDCC had interest expense related to an intercompany loan with Dow Inc. See Note 26 to the Consolidated Financial Statements for additional information.

Provision for Income Taxes on Continuing Operations
The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of income relative to tax attributes and the level of equity earnings, since most earnings from the Company's equity method investments are taxed at the joint venture level. The underlying factors affecting the Company's overall tax rate are summarized in Note 9 to the Consolidated Financial Statements.

On December 22, 2017, the Tax Cuts and Jobs Act (“The Act”) was enacted. The Act reduced the U.S. federal corporate income tax rate from 35 percent to 21 percent, required companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously deferred, created new provisions related to foreign sourced earnings, eliminated the domestic manufacturing deduction and moved to a hybrid territorial system. At December 31, 2017, the Company had not completed its accounting for the tax effects of The Act; however, the Company made a reasonable estimate of the effects on its existing deferred tax balances and the one-time transition tax. In accordance with Staff Accounting Bulletin 118, income tax effects of The Act were refined upon obtaining, preparing, and analyzing additional information during the measurement period. At December 31, 2018, the Company had completed its accounting for the tax effects of The Act.

In the fourth quarter of 2019, the Company recorded the impacts of tax law changes enacted in Switzerland. As a result, deferred tax assets increased by $92 million.

The provision for income taxes on continuing operations was $470 million in 2019, compared with $809 million in 2018 and $1,524 million in 2017. The tax rate for 2019 was unfavorably impacted by non-deductible goodwill and investment impairments, geographic mix of earnings and reduced equity earnings. These factors resulted in a negative effective tax rate of 37.7 percent for Dow Inc. in 2019.

The tax rate for 2018 was favorably impacted by the reduced U.S. federal corporate income tax rate as a result of The Act and benefits related to the issuance of stock-based compensation and unfavorably impacted by non-deductible restructuring costs and increases in statutory income in Latin America and Canada due to local currency devaluations. These factors resulted in an effective tax rate of 21.6 percent in 2018.

The tax rate for 2017 was unfavorably impacted by the enactment of The Act, the impairment of goodwill for which there was no corresponding tax deduction, charges related to tax attributes in the United States and Germany as a result of the Merger and certain non-deductible costs associated with the Merger. The tax rate was favorably impacted by the geographic mix of earnings, equity earnings and the adoption of Accounting Standards Update ("ASU") 2016-09, "Compensation - Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting," which resulted in the recognition of excess tax benefits related to the issuance of stock-based compensation in the provision for income taxes on continuing operations. These factors resulted in an effective tax rate of 643.0 percent for 2017.

Income from Discontinued Operations, Net of Tax
Income from discontinued operations, net of tax was $445 million in 2019, $1,835 million in 2018 and $1,882 million in 2017, and was related to the distribution of AgCo and SpecCo to DowDuPont as a result of the separation. See Note 4 to the Consolidated Financial Statements for additional information.


34


Net Income Attributable to Noncontrolling Interests
Net income attributable to noncontrolling interests was $87 million in 2019, $134 million in 2018 and $130 million in 2017. Net income attributable to noncontrolling interests decreased in 2019 compared with 2018, primarily due to the Company's acquisition of full ownership in a propylene oxide manufacturing joint venture on October 1, 2019. Net income attributable to noncontrolling interests increased in 2018 compared with 2017, primarily due to the sale of the Company's ownership interests in the SKC Haas Display Films group of companies on June 30, 2017. Net income attributable to noncontrolling interests from discontinued operations of $13 million in 2019, $32 million in 2018 and $28 million in 2017 are included in the amounts above. See Notes 20 and 25 to the Consolidated Financial Statements for additional information.

Net Income (Loss) Available for the Common Stockholder(s)
Net income (loss) available for Dow Inc. and TDCC common stockholder(s) was a loss of $1,359 million and $1,237 million, respectively, in 2019, compared with income of $4,641 million in 2018 and income of $465 million in 2017. Earnings (loss) per share of Dow Inc. was a loss of $1.84 per share in 2019, compared with income of $6.21 per share in 2018 and income of $0.60 per share in 2017. Following the separation from DowDuPont, TDCC's common shares are owned solely by Dow Inc.

SEGMENT RESULTS
Effective with the Merger, TDCC's business activities were components of DowDuPont's business operations and were reported as a single operating segment. Following the separation from DowDuPont, the Company changed the manner in which its business activities were managed. The Company's portfolio now includes six global businesses which are organized into the following operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure and Performance Materials & Coatings. Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. The Company did not aggregate any operating segments when determining its reportable segments.

Following the separation from DowDuPont, the Company changed its practice of transferring ethylene to its downstream derivative businesses at cost to transferring ethylene at market prices. The Company also changed certain of its Corporate segment allocation practices, including costs previously assigned to AgCo and SpecCo ("stranded costs") which are now allocated to the operating segments. These changes to the Company's segment results have been consistently applied to all periods presented.

Dow reported geographic information for the following regions: U.S. & Canada, Asia Pacific, Latin America, and EMEAI. As a result of the separation from DowDuPont, the Company changed the geographic alignment for the country of India to be reflected in EMEAI (previously reported in Asia Pacific).

The Company’s measure of profit/loss for segment reporting purposes is pro forma Operating EBIT as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines pro forma Operating EBIT as earnings (i.e., "Income (loss) from continuing operations before income taxes") before interest, plus pro forma adjustments, excluding the impact of significant items. Pro forma Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate. The Company also presents pro forma net sales as it is included in management’s measure of segment performance and is regularly reviewed by the CODM. Pro forma net sales includes the impact of ECP from January 1, 2017 through August 31, 2017, as well as the impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont. See Note 27 to the Consolidated Financial Statements for reconciliations of these measures and a summary of the pro forma adjustments impacting segment measures, which are consistent with the pro forma adjustments included in the Current Report on Form 8-K filed on June 3, 2019, with the SEC.

PACKAGING & SPECIALTY PLASTICS
Packaging & Specialty Plastics consists of two highly integrated global businesses: Hydrocarbons & Energy and Packaging and Specialty Plastics. The segment employs the industry’s broadest polyolefin product portfolio, supported by the Company’s proprietary catalyst and manufacturing process technologies, to work at the customer’s design table throughout the value chain to deliver more reliable and durable, higher performing, and more sustainable plastics to customers in food and specialty packaging; industrial and consumer packaging; health and hygiene; caps, closures and pipe applications; consumer durables; automotive; and infrastructure. Ethylene is transferred to downstream derivative businesses at market-based prices, which are generally equivalent to prevailing market prices for large volume purchases.This segment also includes the results of The Kuwait Styrene Company K.S.C.C. and The SCG-Dow Group, as well as a portion of the results of EQUATE Petrochemical Company K.S.C.C. ("EQUATE"), The Kuwait Olefins Company K.S.C.C. ("TKOC"), Map Ta Phut Olefins Company Limited and Sadara, all joint ventures of the Company.

The Company is responsible for marketing a majority of Sadara products outside of the Middle East zone through the Company's established sales channels. As part of this arrangement, the Company purchases and sells Sadara products for a marketing fee.

35


Packaging & Specialty Plastics
 
 
 
In millions
2019
2018
2017
Net sales
$
20,245

$
24,195

$
21,504

Pro forma net sales
$
20,245

$
24,237

$
22,546

Pro forma Operating EBIT
$
2,904

$
3,593

$
3,712

Equity earnings
$
162

$
287

$
190


Packaging & Specialty Plastics
 
 
 
Percentage change from prior year
2019
2018
2017
Change in Net Sales from Prior Period due to:
 
 
 
Local price & product mix
(12
)%
1
%
8
%
Currency
(1
)
2


Volume
(3
)
5

6

Portfolio & other

5

3

Total
(16
)%
13
%
17
%
Change in Pro Forma Net Sales from Prior Period due to:
 
 
 
Local price & product mix
(12
)%
1
%
 
Currency
(1
)
1

 
Volume
(3
)
5

 
Portfolio & other


 
Total
(16
)%
7
%
 

2019 Versus 2018
Packaging & Specialty Plastics net sales were $20,245 million in 2019, down 16 percent from net sales of $24,195 million in 2018. Pro forma net sales were $20,245 million in 2019, a decrease of 16 percent compared with pro forma net sales of $24,237 million in 2018, with local price down 12 percent, volume down 3 percent, and an unfavorable currency impact of 1 percent, primarily in EMEAI. Local price decreased in both businesses and across all geographic regions driven by reduced polyethylene prices and lower prices for Hydrocarbons & Energy co-products. Volume declined for the segment in all geographic regions, except Asia Pacific. Hydrocarbons & Energy volume declines more than offset volume gains in Packaging and Specialty Plastics. Volume decreased in Hydrocarbons & Energy primarily due to planned maintenance turnaround activity in Europe, increased internal consumption of ethylene on the U.S. Gulf Coast and lighter feedslate usage in Europe, leading to lower co-product production. Volume increased in Packaging and Specialty Plastics in Asia Pacific and EMEAI. Packaging and Specialty Plastics volume growth was driven by strong end-market growth in flexible food and specialty packaging, industrial and consumer packaging, and health and hygiene applications.

Pro forma Operating EBIT was $2,904 million in 2019, down 19 percent from pro forma Operating EBIT of $3,593 million in 2018. Pro forma Operating EBIT decreased primarily due to lower selling prices, reduced equity earnings at the Kuwait joint ventures due to lower polyethylene margins, lower sales volume in the Hydrocarbons & Energy business and the impact of an outage in Argentina, which more than offset lower feedstock and other raw material costs, volume gains in the Packaging and Specialty Plastics business and cost synergies.

2018 Versus 2017
Packaging & Specialty Plastics net sales were $24,195 million in 2018, up 13 percent from $21,504 million in 2017. Pro forma net sales were $24,237 million in 2018, up from pro forma net sales of $22,546 million in 2017. Pro forma net sales increased 7 percent compared with 2017, with volume up 5 percent, a currency benefit of 1 percent, primarily in EMEAI, and local price up 1 percent. Volume increased in both businesses and across all geographic regions primarily due to new capacity additions on the U.S. Gulf Coast and increased supply from Sadara. Packaging and Specialty Plastics' volume growth was driven by increased demand in industrial and consumer packaging, food and specialty packaging, health and hygiene solutions and elastomer applications. Hydrocarbons & Energy volume increased primarily due to higher sales of ethylene and ethylene co-products. Local price increased in all geographic regions, except U.S. & Canada. Hydrocarbons & Energy local price increased as a result of higher Brent crude oil prices, which increased approximately 30 percent compared with 2017. Packaging and Specialty Plastics local price was flat when compared with 2017 as local price increases in Latin America were offset by declines in EMEAI.


36


Pro forma Operating EBIT was $3,593 million in 2018, down 3 percent from pro forma Operating EBIT of $3,712 million in 2017. Pro forma Operating EBIT decreased as the impact of higher feedstock and other raw materials costs, increased costs from planned maintenance turnarounds and the unfavorable impact of stranded costs more than offset higher sales volume, reflecting additional capacity from growth projects, higher selling prices, the benefit from currency on sales, cost synergies, higher equity earnings and lower startup and commissioning costs.

INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE
Industrial Intermediates & Infrastructure consists of two customer-centric global businesses - Industrial Solutions and Polyurethanes & Construction Chemicals - that develop important intermediate chemicals that are essential to manufacturing processes, as well as downstream, customized materials and formulations that use advanced development technologies. These businesses primarily produce and market ethylene oxide and propylene oxide derivatives that are aligned to market segments as diverse as appliances, coatings, infrastructure and oil and gas. The global scale and reach of these businesses, world-class technology and R&D capabilities and materials science expertise enable the Company to be a premier solutions provider offering customers value-add sustainable solutions to enhance comfort, energy efficiency, product effectiveness and durability across a wide range of home comfort and appliances, building and construction, adhesives and lubricant applications, among others. This segment also includes a portion of the results of EQUATE, TKOC, Map Ta Phut Olefins Company Limited and Sadara, all joint ventures of the Company.

The Company is responsible for marketing a majority of Sadara products outside of the Middle East zone through the Company's established sales channels. As part of this arrangement, the Company purchases and sells Sadara products for a marketing fee.

Industrial Intermediates & Infrastructure
 
 
 
In millions
2019
2018
2017
Net sales
$
13,440

$
15,447

$
12,951

Pro forma net sales
$
13,449

$
15,465

$
12,951

Pro forma Operating EBIT
$
845

$
1,767

$
1,470

Equity earnings (losses)
$
(241
)
$
284

$
172


Industrial Intermediates & Infrastructure
 
 
 
Percentage change from prior year
2019
2018
2017
Change in Net Sales from Prior Period due to:
 
 
 
Local price & product mix
(12
)%
5
%
10
%
Currency
(1
)
1

1

Volume

13

6

Portfolio & other



Total
(13
)%
19
%
17
%
Change in Pro Forma Net Sales from Prior Period due to:
 
 
 
Local price & product mix
(12
)%
5
%
 
Currency
(2
)
1

 
Volume
1

13

 
Portfolio & other


 
Total
(13
)%
19
%
 

2019 Versus 2018
Industrial Intermediates & Infrastructure net sales were $13,440 million in 2019, down 13 percent from $15,447 million in 2018. Pro forma net sales were $13,449 million in 2019, down from pro forma net sales of $15,465 million in 2018. Pro forma net sales decreased 13 percent in 2019, with local price down 12 percent and an unfavorable currency impact of 2 percent, primarily in EMEAI, which were partially offset by a 1 percent increase in volume. Price decreased in both businesses and all geographic regions, driven by lower feedstock and other raw material costs and unfavorable supply/demand fundamentals. Polyurethanes & Construction Chemicals reported volume increases in all geographic regions, primarily reflecting increased supply from Sadara and growth in polyurethanes systems applications, which were partially offset by a decline of caustic soda volume due to planned maintenance turnaround activities. Industrial Solutions volume decreased in EMEAI and U.S & Canada and was flat in Latin America and Asia Pacific, primarily driven by reduced availability of glycol ethers, performance solvents and monoethylene glycol due to planned and unplanned events that more than offset higher demand for industrial specialties.


37


Pro forma Operating EBIT was $845 million in 2019, down 52 percent from pro forma Operating EBIT of $1,767 million in 2018. Pro forma Operating EBIT decreased as a result of margin compression across both businesses as well as lower equity earnings from the Kuwait joint ventures and increased equity losses from Sadara, which more than offset cost reductions.

2018 Versus 2017
Industrial Intermediates & Infrastructure net sales were $15,447 million in 2018, up 19 percent from $12,951 million in 2017. Pro forma net sales were $15,465 million in 2018, up from pro forma net sales of $12,951 million in 2017. Pro forma net sales increased 19 percent in 2018, with volume up 13 percent, local price up 5 percent and a currency benefit of 1 percent, primarily in EMEAI. Volume increased in both businesses and across all geographic regions. Polyurethanes & Construction Chemicals reported volume increases in all geographic regions, except Latin America, primarily reflecting increased supply from Sadara. Industrial Solutions volume increased in all geographic regions reflecting greater production from Sadara and increased demand in industrial specialties. Local price increased in both businesses and all geographic regions, except Asia Pacific. Local price increases were driven by higher feedstock and other raw material costs, pricing initiatives and strong demand for caustic soda, propylene glycols and propylene oxide which more than offset price declines in isocyanates.

Pro forma Operating EBIT was $1,767 million in 2018, up 20 percent from pro forma Operating EBIT of $1,470 million in 2017. Pro forma Operating EBIT increased as the impact of higher selling prices, cost synergies, higher equity earnings from the Kuwait joint ventures and lower equity losses from Sadara more than offset contraction in isocyanates margins, the unfavorable impact of stranded costs and higher feedstock and other raw material costs.

PERFORMANCE MATERIALS & COATINGS
Performance Materials & Coatings includes industry-leading franchises that deliver a wide array of solutions into consumer and infrastructure end-markets. The segment consists of two global businesses: Coatings & Performance Monomers and Consumer Solutions. These businesses primarily utilize the Company's acrylics-, cellulosics- and silicone-based technology platforms to serve the needs of the architectural and industrial coatings, home care and personal care end-markets. Both businesses employ materials science capabilities, global reach and unique products and technology to combine chemistry platforms to deliver differentiated offerings to customers.

Performance Materials & Coatings
 
 
 
In millions
2019
2018
2017
Net sales
$
8,923

$
9,677

$
8,892

Pro forma net sales
$
8,961

$
9,865

$
8,892

Pro forma Operating EBIT
$
918

$
1,246

$
817

Equity earnings
$
5

$
4

$
40


Performance Materials & Coatings
 
 
 
Percentage change from prior year
2019
2018
2017
Change in Net Sales from Prior Period due to:
 
 
 
Local price & product mix
(6
)%
10
 %
8
%
Currency
(2
)
1

1

Volume
(3
)
(2
)
2

Portfolio & other
3


26

Total
(8
)%
9
 %
37
%
Change in Pro Forma Net Sales from Prior Period due to:
 
 
 
Local price & product mix
(6
)%
10
 %
 
Currency
(2
)
1

 
Volume
(1
)
(2
)
 
Portfolio & other

2

 
Total
(9
)%
11
 %
 

2019 Versus 2018
Performance Materials & Coatings net sales were $8,923 million in 2019, down 8 percent from net sales of $9,677 million in 2018. Pro forma net sales were $8,961 million in 2019, down 9 percent from pro forma net sales of $9,865 million in 2018 with local price down 6 percent, an unfavorable currency impact of 2 percent and volume down 1 percent. Local price decreased in both businesses and all geographic regions. Local price decreased in Consumer Solutions due to lower siloxanes prices, primarily

38


in Asia Pacific and EMEAI. Coatings & Performance Monomers local price declined in all geographic regions in response to lower feedstock and other raw material costs. Volume for the segment declined in all geographic regions except Asia Pacific. Consumer Solutions volume was flat, with volume growth in Asia Pacific, offset by volume declines in Latin America and EMEAI. Consumer Solutions volume was flat in U.S. & Canada. Coatings & Performance Monomers volume declined in all geographic regions. The decline in volume was driven by increased captive use of coatings products which drove soft demand in coating applications, primarily architectural binders, and lower demand for acrylates and methacrylates due to supply/demand balances.

Pro forma Operating EBIT was $918 million in 2019, down 26 percent from pro forma Operating EBIT of $1,246 million in 2018. Pro forma Operating EBIT decreased primarily due to margin compression in both businesses, which more than offset lower planned maintenance turnaround spending and cost synergies.

2018 Versus 2017
Performance Materials & Coatings net sales were $9,677 million in 2018, up from $8,892 million in 2017. Pro forma net sales were $9,865 million in 2018, up from pro forma net sales of $8,892 million in 2017. Pro forma net sales increased 11 percent in 2018, with an increase in local price of 10 percent, a benefit of 2 percent from portfolio actions, a benefit from currency of 1 percent, primarily in EMEAI, and a decrease in volume of 2 percent. Local price increased in both businesses and all geographic regions. Consumer Solutions local price increased primarily due to disciplined price/volume management in upstream silicone intermediates, which more than offset a decrease in volume. Local price increased in Coatings & Performance Monomers in response to higher feedstock and other raw material costs and favorable supply/demand fundamentals. Volume decreased in both businesses and all geographic regions, except Asia Pacific. Volume decreased in Consumer Solutions primarily as a result of targeted reductions of low-margin business, primarily in the home care market sector. Volume decreased slightly for Coatings & Performance Monomers, with a decline in all geographic regions, except Asia Pacific.

Pro forma Operating EBIT was $1,246 million in 2018, up 53 percent from pro forma Operating EBIT of $817 million in 2017. Pro forma Operating EBIT improved compared with 2017 as higher selling prices and the favorable impact of cost synergies more than offset the unfavorable impact of stranded costs and higher feedstock and other raw material costs.

CORPORATE
Corporate includes certain enterprise and governance activities (including insurance operations, environmental operations, etc.); non-business aligned joint ventures; non-business aligned litigation expenses; and discontinued or non-aligned businesses.

Corporate
 
 
 
In millions
2019
2018
2017
Net sales
$
343

$
285

$
383

Pro forma net sales
$
343

$
285

$
383

Pro forma Operating EBIT
$
(315
)
$
(370
)
$
(422
)
Equity losses
$
(20
)
$
(20
)
$
(8
)

2019 Versus 2018
Net sales and pro forma net sales for Corporate, which primarily relate to the Company's insurance operations, were $343 million in 2019, up from net sales and pro forma net sales of $285 million in 2018.

Pro forma Operating EBIT was a loss of $315 million in 2019, compared with a pro forma Operating EBIT loss of $370 million in 2018. Compared with 2018, pro forma Operating EBIT improved primarily due to cost reductions and stranded cost removal.

2018 Versus 2017
Net sales and pro forma net sales for Corporate were $285 million in 2018, compared with net sales and pro forma net sales of $383 million in 2017.

Pro forma Operating EBIT was a loss of $370 million in 2018, compared with a loss of $422 million in 2017. Compared with 2017, pro forma Operating EBIT improved primarily due to lower discontinued business costs and cost reductions.

OUTLOOK
Operating Segments & End-Market Expectations
In 2020, the Company expects crude oil, natural gas and feedstock costs to remain volatile and sensitive to external macroeconomic and geopolitical factors. The Company currently expects crude oil prices to be, on average, flat to slightly higher than 2019. Crude oil fundamentals suggest ample global supply to meet current demand; however, geopolitical tensions could add a risk premium that potentially supports higher prices.

39


The Company expects natural gas prices to be, on average, lower than 2019. In U.S. & Canada, robust supplies of natural gas are expected to keep domestic prices globally competitive. U.S. exports of liquefied natural gas ("LNG") are expected to increase further in 2020. In Europe, the supply of natural gas is expected to continue to be plentiful, both from pipeline supply and from growing LNG imports.

In Packaging & Specialty Plastics, integrated margins are expected to remain stable in U.S. & Canada, supported by delays in new capacity additions, solid underlying demand and regional feedstock cost advantages. Margins in Europe are expected to remain challenged as a result of weaker regional demand and flat to higher feedstock costs. Margins in Asia Pacific commenced 2020 slightly below break-even levels, while full year margins are expected to be comparable to the second half of 2019. Profitability could vary materially depending on global GDP growth, industry operating rates, timing of capacity startups and fluctuations in global crude oil, natural gas and feedstock prices. The Hydrocarbons & Energy business expects to bring online approximately 500,000 metric tons of additional ethylene capacity in Texas as part of its suite of incremental growth investments. The new capacity is expected to come online in the second quarter of 2020.

In Industrial Intermediates & Infrastructure, monoethylene glycol ("MEG") margins are expected to remain constrained in 2020 due to new industry capacity additions. End-market conditions for polyurethane intermediates are expected to remain highly competitive, with demand softness expected in key applications related to infrastructure, household appliances, automotive and furniture and bedding. Methyl diphenyl diisocyanate ("MDI") prices are expected to remain at low levels due to additional industry capacity and weak end-market fundamentals.

In Performance Materials & Coatings, prices for commodity siloxane products are expected to be similar to those observed in the second half of 2019. Downstream silicones volume is expected to grow in excess of GDP, particularly for applications related to home and personal care, high performance building and construction and pressure-sensitive adhesives. The Company will continue to pursue incremental downstream silicones capacity debottleneck projects to meet demand in consumer driven end-markets. Global architectural coatings demand is expected to remain soft in the do-it-yourself and retail market segments. Industrial coatings are also projected to soften in 2020; however, the Company’s focus will be on capturing opportunities from customers’ shift to waterborne chemistries where Dow has unique technologies and solutions.

Other factors impacting operating segment profitability include:
Planned maintenance turnaround spending is expected to be approximately flat compared with 2019.
Equity losses in nonconsolidated affiliates are expected to be slightly unfavorable compared with 2019. With respect to Sadara, which impacts the Packaging & Specialty Plastics and Industrial Intermediates & Infrastructure operating segments, the Company expects to continue to record equity losses due to anticipated funding commitments with the joint venture.

Other Income Statement Expectations
Additional items that may impact the consolidated statements of income in 2020 include:
The service cost component of pension expense is expected to be flat compared with 2019. The non-operating pension benefit is expected to be a headwind of approximately $125 million compared with 2019.
Interest expense and amortization of debt discount is expected to be approximately $850 million in 2020, reflecting lower gross debt compared with 2019.

Projected Uses of Cash
Items that may impact the consolidated statements of cash flows in 2020 include:
Integration and separation spending is expected to be approximately $200 million to $250 million. Year over year reductions in integration and separation spending as well as cash payments related to the DowDuPont Cost Synergy Program will result in reduced cash spending of approximately $1 billion compared with 2019.
Cash contributions to global pension plans are expected to be limited to mandatory minimum contributions. The total cash outflow is projected to be approximately $250 million.
Capital expenditures are expected to be $1.5 billion to $1.75 billion. The Company will adjust its spending within this range through the year as economic conditions develop.
The Company expects to loan approximately $500 million to Sadara and all or a portion of the loan could potentially be converted into equity.
The Company expects to preferentially deploy its free cash flow1 in a balanced way between shareholder returns and debt reduction.


1. Dow defines free cash flow as cash flows from operating activities - continuing operations, excluding the impact of ASU 2016-15, less capital expenditures.

40


LIQUIDITY AND CAPITAL RESOURCES
The Company had cash and cash equivalents of $2,367 million at December 31, 2019 and $2,724 million at December 31, 2018, of which $986 million at December 31, 2019 and $2,013 million at December 31, 2018, was held by subsidiaries in foreign countries, including United States territories. The decrease in cash and cash equivalents held by subsidiaries in foreign countries is due to repatriation activities. For each of its foreign subsidiaries, the Company makes an assertion regarding the amount of earnings intended for permanent reinvestment, with the balance available to be repatriated to the United States.

The cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries' operational activities and future foreign investments. Dow has the ability to repatriate additional funds to the U.S., which could result in an adjustment to the tax liability for foreign withholding taxes, foreign and/or U.S. state income taxes and the impact of foreign currency movements. At December 31, 2019, management believed that sufficient liquidity was available in the United States. The Company has and expects to continue repatriating certain funds from its non-U.S. subsidiaries that are not needed to finance local operations; however, these particular repatriation activities have not and are not expected to result in a significant incremental tax liability to the Company.

The Company’s cash flows from operating, investing and financing activities, as reflected in the consolidated statements of cash flows, are summarized in the following table:

Cash Flow Summary
Dow Inc.
TDCC
In millions
2019
2018
2017 1
2019
2018
2017 1
Cash provided by (used for):
 
 
 
 
 
 
Operating activities - continuing operations
$
5,713

$
3,096

$
(6,443
)
$
5,706

$
3,096

$
(6,443
)
Operating activities - discontinued operations
217

1,158

1,514

371

1,158

1,514

Operating activities
5,930

4,254

(4,929
)
6,077

4,254

(4,929
)
Investing activities - continuing operations
(2,158
)
(1,826
)
6,793

(2,158
)
(1,826
)
6,793

Investing activities - discontinued operations
(34
)
(369
)
725

(34
)
(369
)
725

Investing activities
(2,192
)
(2,195
)
7,518

(2,192
)
(2,195
)
7,518

Financing activities - continuing operations
(4,077
)
(5,351
)
(3,275
)
(4,224
)
(5,351
)
(3,275
)
Financing activities - discontinued operations
(18
)
(53
)
(50
)
(18
)
(53
)
(50
)
Financing activities
(4,095
)
(5,404
)
(3,325
)
(4,242
)
(5,404
)
(3,325
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
(27
)
(99
)
320

(27
)
(99
)
320

Summary












Decrease in cash, cash equivalents and restricted cash
(384
)
(3,444
)
(416
)
(384
)
(3,444
)
(416
)
Cash, cash equivalents and restricted cash at beginning of year
2,764

6,208

6,624

2,764

6,208

6,624

Cash, cash equivalents and restricted cash at end of year
$
2,380

$
2,764

$
6,208

$
2,380

$
2,764

$
6,208

Less: Restricted cash and cash equivalents, included in "Other current assets"
13

40

19

13

40

19

Cash and cash equivalents at end of year
$
2,367

$
2,724

$
6,189

$
2,367

$
2,724

$
6,189

1.
Updated for ASU 2016-15, "Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments" ("ASU 2016-15") (including related SEC interpretive guidance) and ASU 2016-18, "Statement of Cash Flows (Topic 230): Restricted Cash," which the Company adopted in 2018.

Cash Flows from Operating Activities
Cash provided by operating activities from continuing operations increased in 2019 compared with 2018. The increase was primarily due to improvements in working capital, a cash receipt related to the Nova ethylene asset matter, advance payments from customers for product supply agreements, lower pension contributions and higher dividends received from nonconsolidated affiliates, which were partially offset by a decrease in cash earnings. Cash provided by operating activities from continuing operations in 2018 improved from cash used for operating activities from continuing operations in 2017, primarily due to the change in the Company's accounts receivable securitization facilities discussed in the section titled "Non-GAAP Cash Flow Measures" and a decrease in cash used for working capital requirements, which were partially offset by the absence of certain cash receipts in 2017.


41


Net Working Capital at Dec 31
Dow Inc.
TDCC
In millions
2019
2018
2019
2018
Current assets 1
$
16,815

$
19,470

$
16,733

$
19,470

Current liabilities 1
10,679

11,059

10,150

11,059

Net working capital
$
6,136

$
8,411

$
6,583

$
8,411

Current ratio
1.57:1

1.76:1

1.65:1

1.76:1

1.
Amounts exclude assets and liabilities of discontinued operations.

Working Capital Metrics
Twelve Months Ended
 
Dec 31, 2019
Dec 31, 2018
Days sales outstanding in trade receivables 1
45

41

Days sales in inventory 2
65

58

Days payables outstanding 3
65

58

1.
The increase in days sales outstanding in receivables was primarily due to an increase in accounts receivable as a result of the Company’s accounts receivable securitization facilities moving from off-balance sheet arrangements to secured borrowing arrangements in the second half of 2018.
2.
The increase in days sales in inventory is primarily due to a decrease in COS, driven by lower sales and raw material costs, in addition to an increase in average ending inventory.
3.
The increase in days payables outstanding is primarily due to a decrease in average accounts payable and a decrease in COS, which were partially offset by an increase in average ending inventory.

Cash provided by operating activities from discontinued operations decreased in 2019 compared with 2018. The reduction was primarily due to the separation of AgCo and SpecCo on April 1, 2019. The Company had cash payments and receipts with DuPont and Corteva that related to certain agreements and matters related to the separation from DowDuPont. See Note 4 to the Consolidated Financial Statements for additional information. Cash provided by operating activities from discontinued operations decreased in 2018 compared with 2017, primarily due to changes in working capital requirements.

Cash Flows from Investing Activities
Cash used for investing activities from continuing operations in 2019 was primarily for capital expenditures, purchases of investments and investments in and loans to nonconsolidated affiliates, which were partially offset by proceeds from sales and maturities of investments. Cash used for investing activities from continuing operations in 2018 was primarily for capital expenditures and purchases of investments, which were partially offset by proceeds from sales and maturities of investments and proceeds from interests in trade accounts receivable conduits. Cash provided by investing activities from continuing operations in 2017 was primarily from proceeds from interests in trade accounts receivable conduits, proceeds from sales and maturities of investments and proceeds from divestitures, including the divestiture of the EAA Business, which were partially offset by capital expenditures, purchases of investments and investments in and loans to nonconsolidated affiliates, primarily with Sadara.

The Company loaned Sadara $473 million in 2019 (zero in 2018 and $735 million in 2017) and a portion of these loans has been converted to equity. In the fourth quarter of 2019, the Company reserved certain notes receivable and accrued interest balances with Sadara due to uncertainty around timing of collection. The Company expects to loan Sadara approximately $500 million in 2020 and all or a portion of the loan could potentially be converted into equity. Additionally, the Company anticipates providing future financial support to Sadara through loans or capital contributions which will be subject to collectability assessments. See Note 13 to the Consolidated Financial Statements for additional information.
The Company's capital expenditures related to continuing operations, including capital expenditures of consolidated variable interest entities, were $1,961 million in 2019, $2,091 million in 2018 and $2,807 million in 2017. The Company expects capital spending in 2020 to be in the range of $1.5 billion to $1.75 billion. The Company will adjust its spending within this range through the year as economic conditions develop.

Capital spending in 2019, 2018 and 2017 included spending related to certain U.S. Gulf Coast investment projects including: a world-scale ethylene production facility and an ELITE™ Enhanced Polyethylene production facility, both of which commenced operations in 2017; a NORDEL™ Metallocene EPDM production facility, a Low Density Polyethylene ("LDPE") production facility, a High Melt Index ("HMI") AFFINITY™ polymer production facility and debottlenecking of an existing bi-modal gas phase polyethylene production facility, all of which commenced operations in 2018; and an expansion of the Company's new ethylene production facility expected to commence operations in 2020, bringing the facility's total ethylene capacity to 2,000 kilotonnes per annum and making it the largest ethylene cracker in the world.


42


Cash used for investing activities from discontinued operations in 2019 was primarily for capital expenditures, partially offset by proceeds from the sales of property, businesses and ownership interests in nonconsolidated affiliates. Cash used for investing activities from discontinued operations in 2018 was primarily for capital expenditures, partially offset by proceeds from the sales of property and businesses. Cash provided by investing activities from discontinued operations in 2017 was primarily due to proceeds from the sale of property and businesses, which was partially offset by capital expenditures.

Cash Flows from Financing Activities
Cash used for financing activities from continuing operations in 2019 included payments on long-term debt and dividends paid to DowDuPont, which were partially offset by proceeds from issuance of long-term debt. In addition, Dow Inc. received cash as part of the separation from DowDuPont, which was more than offset by dividends paid to stockholders and purchases of treasury stock. Cash used for financing activities from continuing operations in 2018 included dividends paid to DowDuPont and payments of long-term debt, which were partially offset by proceeds from issuance of long-term debt. Cash used for financing activities in continuing operations in 2017 included dividends paid to stockholders through the close of the Merger, a dividend paid to DowDuPont in the fourth quarter of 2017, and payments of long-term debt. See Notes 16 and 19 to the Consolidated Financial Statements for additional information related to the issuance and retirement of debt and the Company's share repurchases and dividends.

Cash used for financing activities from discontinued operations in 2019, 2018 and 2017 primarily related to distributions to noncontrolling interests and employee taxes paid for share-based payment arrangements.

Non-GAAP Cash Flow Measures
Cash Flows from Operating Activities - Continuing Operations - Excluding Impact of ASU 2016-15
Cash flows from operating activities - continuing operations, excluding the impact of ASU 2016-15, is defined as cash provided by (used for) operating activities - continuing operations, excluding the impact of ASU 2016-15 and related interpretive guidance. Management believes this non-GAAP financial measure is relevant and meaningful as it presents cash flows from operating activities inclusive of all trade accounts receivable collection activity, which Dow utilizes in support of its operating activities.

Free Cash Flow
Dow defines free cash flow as cash flows from operating activities - continuing operations, excluding the impact of ASU 2016-15, less capital expenditures. Under this definition, free cash flow represents the cash generated by Dow from operations after investing in its asset base. Free cash flow, combined with cash balances and other sources of liquidity, represent the cash available to fund obligations and provide returns to shareholders. Free cash flow is an integral financial measure used in Dow's financial planning process.

Pro Forma Operating EBITDA
Dow defines pro forma operating EBITDA as pro forma earnings (i.e. "Pro forma income from continuing operations before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.

Cash Flow Conversion (Pro Forma Operating EBITDA to Cash Flow From Operations)
Dow defines cash flow conversion (or pro forma Operating EBITDA to cash flow from operations) as cash flows from operating activities - continuing operations, excluding the impact of ASU 2016-15, divided by pro forma Operating EBITDA. Management believes cash flow conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.

These financial measures are not recognized in accordance with U.S. GAAP and should not be viewed as alternatives to U.S. GAAP financial measures of performance. All companies do not calculate non-GAAP financial measures in the same manner and, accordingly, Dow's definitions may not be consistent with the methodologies used by other companies.

Reconciliation of Non-GAAP Cash Flow Measures
Dow Inc.
In millions
2019
2018
2017
Cash provided by (used for) operating activities - continuing operations (GAAP)
$
5,713

$
3,096

$
(6,443
)
Impact of ASU 2016-15 and related interpretive guidance

657

9,462

Cash flows from operating activities - continuing operations - excluding impact of ASU 2016-15 (Non-GAAP)
$
5,713

$
3,753

$
3,019

Capital expenditures
(1,961
)
(2,091
)
(2,807
)
Free cash flow (Non-GAAP)
$
3,752

$
1,662

$
212



43


Reconciliation of Cash Flow Conversion (Pro Forma Operating EBITDA to Cash Flow From Operations)
Dow Inc.
In millions
2019
2018
2017
Income (loss) from continuing operations, net of tax (GAAP)
$
(1,717
)
$
2,940

$
(1,287
)
+ Provision for income taxes on continuing operations
470

809

1,524

Income (loss) from continuing operations before income taxes
$
(1,247
)
$
3,749

$
237

- Interest income
81

82

66

+ Interest expense and amortization of debt discount
933

1,063

914

+ Pro forma adjustments 1
65

180

1,120

- Significant items
(4,682
)
(1,326
)
(3,372
)
Pro forma Operating EBIT
$
4,352

$
6,236

$
5,577

+ Pro forma depreciation and amortization
2,938

2,909

2,684

Pro forma Operating EBITDA
$
7,290

$
9,145

$
8,261

Cash flows from operating activities - continuing operations - excluding impact of ASU 2016-15 (Non-GAAP)
$
5,713

$
3,753

$
3,019

Cash flow conversion (Pro Forma Operating EBITDA to cash flow from operations) (Non-GAAP)
78.4
%
41.0
%
36.5
%
1.
Pro forma adjustments include: (1) the margin impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont (included for 2019 and 2018 only), (2) the inclusion of ECP for the period of January 1, 2017 through August 31, 2017, (3) the removal of the amortization of ECP's inventory step-up recognized in connection with the Merger (4) the elimination of the impact of events directly attributable to the Merger, internal reorganization and business realignment, separation, distribution and other related transactions (e.g., one-time transaction costs) and (5) the elimination of the effect of a consummated divestiture agreed to with certain regulatory agencies as a condition of approval for the Merger. See Note 27 to the Consolidated Financial Statements for additional information.
 
Liquidity & Financial Flexibility
The Company’s primary source of incremental liquidity is cash flows from operating activities. The generation of cash from operations and the Company's ability to access capital markets is expected to meet the Company’s cash requirements for working capital, capital expenditures, debt maturities, contributions to pension plans, dividend distributions to stockholders, share repurchases and other needs. In addition to cash from operating activities, the Company’s current liquidity sources also include TDCC's U.S. and Euromarket commercial paper programs, committed credit facilities, a committed accounts receivable facility, a U.S. retail note program (“InterNotes®”) and other debt markets. Additional details on sources of liquidity are as follows:

Commercial Paper
TDCC issues promissory notes under its U.S. and Euromarket commercial paper programs. TDCC had $151 million of commercial paper outstanding at December 31, 2019 ($10 million at December 31, 2018). TDCC maintains access to the commercial paper market at competitive rates. Amounts outstanding under TDCC's commercial paper programs during the period may be greater or less than the amount reported at the end of the period. Subsequent to December 31, 2019, TDCC issued approximately $1.5 billion of commercial paper.

Committed Credit Facilities
The Company also has the ability to access liquidity through TDCC's committed and available credit facilities. At December 31, 2019, TDCC had total committed credit facilities of $9.4 billion and available credit facilities of $7.4 billion. See Note 16 to the Consolidated Financial Statements for additional information on committed and available credit facilities.

In connection with the ownership restructure of Dow Silicones on May 31, 2016, Dow Silicones incurred $4.5 billion of indebtedness under a certain third party credit agreement ("Term Loan Facility"). In the second quarter of 2019, Dow Silicones voluntarily repaid $2.5 billion of principal on the Term Loan Facility. In September 2019, Dow Silicones amended the Term Loan Facility to extend the maturity date on the remaining principal balance of $2 billion, making amounts borrowed under the Term Loan Facility repayable in September 2021. In addition, this amendment includes options to extend the maturity date through September 2023, at Dow Silicones' election, which the Company intends to exercise. See Note 16 to the Consolidated Financial Statements for additional information on the Term Loan Facility.

Letters of Credit
TDCC utilizes letters of credit to support commitments made in the ordinary course of business. While the terms and amounts of letters of credit change, TDCC generally has approximately $400 million of outstanding letters of credit at any given time.


44


Shelf Registration - U.S.
On July 26, 2019, Dow Inc. and TDCC filed a shelf registration statement with the SEC. The shelf indicates that Dow Inc. may offer common stock; preferred stock; depositary shares; debt securities; guarantees; warrants to purchase common stock, preferred stock and debt securities; and stock purchase contracts and stock purchase units, with pricing and availability of any such offerings depending on market conditions. The shelf also indicates that TDCC may offer debt securities, guarantees and warrants to purchase debt securities, with pricing and availability of any such offerings depending on market conditions. Also on July 26, 2019, TDCC filed a new prospectus supplement under this shelf registration to register an unlimited amount of securities for issuance under InterNotes®.

Debt
As the Company continues to maintain its strong balance sheet and financial flexibility, management is focused on net debt (a non-GAAP financial measure), as the Company believes this is the best representation of its financial leverage at this point in time. As shown in the following table, net debt is equal to total gross debt minus "Cash and cash equivalents" and "Marketable securities." At December 31, 2019, net debt as a percent of total capitalization for Dow Inc. and TDCC increased to 50.9 percent and 49.6 percent, respectively, compared with 33.7 percent for both companies at December 31, 2018. The increase is primarily due to a reduction in stockholders' equity for both companies as a result of the separation from DowDuPont and a net loss in 2019, which was partially offset by a decrease in debt.

Total Debt at Dec 31
Dow Inc.
TDCC
In millions
2019
2018
2019
2018
Notes payable
$
586

$
298

$
586

$
298

Long-term debt due within one year
435

338

435

338

Long-term debt
15,975

19,253

15,975

19,253

Gross debt
$
16,996

$
19,889

$
16,996

$
19,889

- Cash and cash equivalents
2,367

2,724

2,367

2,724

- Marketable securities
21

100

21

100

Net debt
$
14,608

$
17,065

$
14,608

$
17,065

Gross debt as a percent of total capitalization
54.7
%
37.2
%
53.3
%
37.2
%
Net debt as a percent of total capitalization
50.9
%
33.7
%
49.6
%
33.7
%

In 2019, the Company issued $2 billion of senior unsecured notes in an offering under Rule 144A of the Securities Act of 1933. The offering included $750 million aggregate principal amount of 4.80 percent notes due 2049; $750 million aggregate principal amount of 3.625 percent notes due 2026; and $500 million aggregate principal amount of 3.15 percent notes due 2024. In addition, the Company redeemed $1.5 billion of 4.25 percent notes issued by the Company with maturity in 2020 and $1.25 billion of 4.125 percent notes issued by the Company with maturity in 2021.

In October 2019, TDCC launched exchange offers for $4 billion of all the outstanding, unregistered senior notes that were issued in private offerings on November 30, 2018 and May 20, 2019, for identical, registered notes under the Securities Act of 1933 (the “Exchange Offers”). The Exchange Offers are with respect to the Company’s 3.15 percent notes due 2024, 4.55 percent notes due 2025, 3.625 percent notes due 2026, 4.80 percent notes due 2028, 5.55 percent notes due 2048 and 4.80 percent notes due 2049, and fulfilled the Company’s obligations contained in the registration rights agreements entered into in connection with the issuance of the aforementioned notes.

The Company may at any time repurchase certain debt securities in the open market or in privately negotiated transactions subject to: the applicable terms under which any such debt securities were issued, certain internal approvals of the Company, and applicable laws and regulations of the relevant jurisdiction in which any such potential transactions might take place. This in no way obligates the Company to make any such repurchases nor should it be considered an offer to do so.

TDCC’s public debt instruments and primary, private credit agreements contain, among other provisions, certain customary restrictive covenant and default provisions. TDCC’s most significant debt covenant with regard to its financial position is the obligation to maintain the ratio of its consolidated indebtedness to consolidated capitalization at no greater than 0.65 to 1.00 at any time the aggregate outstanding amount of loans under the Five Year Competitive Advance and Revolving Credit Facility Agreement ("Revolving Credit Agreement") equals or exceeds $500 million. The ratio of TDCC’s consolidated indebtedness as defined in the Revolving Credit Agreement was 0.51 to 1.00 at December 31, 2019. Management believes TDCC was in compliance with all of its covenants and default provisions at December 31, 2019.


45


On April 1, 2019, DowDuPont completed the separation of its materials science business and Dow Inc. became the direct parent company of TDCC. In conjunction with the separation, Dow Inc. is obligated, substantially concurrently with the issuance of any guarantee in respect of outstanding or committed indebtedness under the Revolving Credit Agreement, to enter into a supplemental indenture with TDCC and the trustee under TDCC’s existing 2008 base indenture governing certain notes issued by TDCC. Under such supplemental indenture, Dow Inc. will guarantee all outstanding debt securities and all amounts due under such existing base indenture and will become subject to certain covenants and events of default under the existing base indenture.

In addition, the Revolving Credit Agreement includes an event of default which would be triggered in the event Dow Inc. incurs or guarantees third party indebtedness for borrowed money in excess of $250 million or engages in any material activity or directly owns any material assets, in each case, subject to certain conditions and exceptions. Dow Inc. may, at its option, cure the event of default by delivering an unconditional and irrevocable guarantee to the administrative agent within thirty days of the event or events giving rise to such event of default.

No such events have occurred or have been triggered at the time of the filing of this Annual Report on Form 10-K. See Note 16 to the Consolidated Financial Statements for information related to TDCC’s notes payable and long-term debt activity and information on TDCC’s covenants and default provisions.

Management expects that the Company will continue to have sufficient liquidity and financial flexibility to meet all of its business obligations.

Credit Ratings
TDCC's credit ratings at January 31, 2020 were as follows:

Credit Ratings
Long-Term Rating
Short-Term Rating
Outlook
Standard & Poor’s
BBB
A-2
Stable
Moody’s Investors Service
Baa2
P-2
Stable
Fitch Ratings
BBB+
F2
Stable

Downgrades in TDCC’s credit ratings will increase borrowing costs on certain indentures and could impact its ability to access debt capital markets.

Dividends
Dow Inc.
The following table provides dividends paid to common stockholders for the years ended December 31, 2019, 2018 and 2017:

Dividends Paid for the Years Ended Dec 31
2019 1
2018 2
2017 3
In millions, except per share amounts
Dividends paid, per common share
$
2.10

N/A
$
1.84

Dividends paid to common stockholders
$
1,550

N/A
$
2,179

1.
Reflects Dow Inc. activity subsequent to the separation from DowDuPont.
2.
In 2018, the common stock of Dow Inc. and TDCC was owned solely by DowDuPont and therefore the Company did not have publicly traded stock.
3.
Reflects TDCC activity prior to the Merger.

TDCC
Effective with the Merger, TDCC no longer has publicly traded common stock. From the Merger date through March 31, 2019, TDCC's common shares were owned solely by DowDuPont. Pursuant to the Merger Agreement, TDCC committed to fund a portion of DowDuPont's dividends paid to common stockholders and certain governance expenses. In addition, share repurchases by DowDuPont were partially funded by TDCC through 2018. Funding was accomplished through intercompany loans. On a quarterly basis, TDCC's Board of Directors reviewed and determined a dividend distribution to DowDuPont to settle the intercompany loans. The dividend distribution considered the level of TDCC’s earnings and cash flows and the outstanding intercompany loan balances. For the year ended December 31, 2019, TDCC declared and paid dividends to DowDuPont of $535 million ($3,711 million for the year ended December 31, 2018 and $1,056 for the year ended December 31, 2017). See Note 26 to the Consolidated Financial Statements for additional information.

46


Effective with the separation from DowDuPont on April 1, 2019, TDCC became a wholly owned subsidiary of Dow Inc. TDCC has committed to fund Dow Inc.'s dividends paid to common stockholders, share repurchases and certain governance expenses. Funding is accomplished through intercompany loans. TDCC's Board of Directors reviews and determines a dividend distribution to Dow Inc. to settle the intercompany loans. For the year ended December 31, 2019, TDCC declared and paid dividends to Dow Inc. of $201 million. At December 31, 2019, TDCC's intercompany loan balance with Dow Inc. was zero. See Note 26 to the Consolidated Financial Statements for additional information.

Share Repurchase Program
Dow Inc.
On April 1, 2019, Dow Inc.'s Board of Directors ratified the share repurchase program originally approved on March 15, 2019, authorizing up to $3 billion to be spent on the repurchase of the Company's common stock, with no expiration date. In 2019, Dow Inc. repurchased $500 million of the Company's common stock. At December 31, 2019, approximately $2.5 billion of the share repurchase program authorization remained available for repurchases. Dow Inc. expects to repurchase $250 million of the Company's common stock in 2020.

TDCC
In 2013, TDCC's Board of Directors approved a share repurchase program. As a result of subsequent authorizations approved by TDCC's Board of Directors, the total authorized amount of the share repurchase program was $9.5 billion. Effective with the Merger, the share repurchase program was canceled. Over the duration of the program, a total of $8.1 billion was spent on the repurchase of TDCC Common Stock.

Pension Plans
The Company has both funded and unfunded defined benefit pension plans that cover employees in the United States and a number of other countries. As a result of the Company’s separation from DowDuPont, the number of significant defined benefit pension plans administered by the Company decreased from 45 plans to 35 plans, with approximately $270 million of net unfunded pension liabilities transferred to DowDupont. Plans administered by other subsidiaries of DowDuPont that were transferred to the Company were not significant. There were no changes in the number of significant other postretirement benefit plans administered by the Company as a result of the separation. Existing Company plans that were significantly impacted by the transfer of active plan participants to DowDuPont were remeasured, resulting in curtailment gains and losses and recognition of special termination benefits.

In 2019, 2018 and 2017, the Company contributed $261 million, $1,651 million and $1,672 million to its continuing operations pension plans respectively, including contributions to fund benefit payments for its non-qualified pension plans ($266 million, $1,656 million and $1,676 million, including contributions to plans of discontinued operations). In the third quarter of 2018, the Company made a $1,100 million discretionary contribution to its principal U.S. pension plan, which is included in the 2018 contribution amount above. The discretionary contribution was primarily based on the Company's funding policy, which permits contributions to defined benefit pension plans when economics encourage funding, and reflected considerations relating to tax deductibility and capital structure.

The provisions of a U.S. non-qualified pension plan require the payment of plan obligations to certain participants upon a change in control of the Company, which occurred at the time of the Merger. Certain participants could elect to receive a lump-sum payment or direct the Company to purchase an annuity on their behalf using the after-tax proceeds of the lump sum. In the fourth quarter of 2017, the Company paid $940 million to plan participants and $230 million to an insurance company for the purchase of annuities, which were included in "Pension contributions" in the consolidated statements of cash flows. The Company also paid $205 million for income and payroll taxes for participants electing the annuity option. The Company recorded a settlement charge of $687 million associated with the payout in the fourth quarter of 2017.

The Company expects to contribute approximately $250 million to its pension plans in 2020. See Note 21 to the Consolidated Financial Statements for additional information concerning the Company’s pension plans.

Restructuring, Goodwill Impairment and Asset Related Charges - Net
The activities related to the Synergy Program are expected to result in additional cash payments of approximately $70 million, primarily through the second quarter of 2020, consisting of severance and related benefit costs and costs associated with exit and disposal activities, including environmental remediation (see Note 7 to the Consolidated Financial Statements). The Company expects to incur additional costs in the future related to its restructuring activities. Future costs are expected to include demolition costs related to closed facilities; these costs will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits, related to its other optimization activities. These costs cannot be reasonably estimated at this time.


47


Integration and Separation Costs
Integration and separation costs, which reflect costs related to the Merger, post-Merger integration and business separation activities and costs related to the ownership restructure of Dow Silicones, were $1,063 million and $1,039 million in 2019 for Dow Inc. and TDCC, respectively, $1,179 million in 2018 and $798 million in 2017. Integration and separation costs related to post-Merger integration and business separation activities are expected to continue in 2020 for activities primarily involving the separation of information technology infrastructure and physical plant operations. Integration and separation costs are expected to result in additional cash expenditures of approximately $200 million to $250 million through the end of 2020.

Contractual Obligations
The following table summarizes the Company’s contractual obligations, commercial commitments and expected cash requirements for interest at December 31, 2019. Additional information related to these obligations can be found in Notes 16, 17, 18 and 21 to the Consolidated Financial Statements.

Contractual Obligations at Dec 31, 2019
Payments Due In
 
In millions
2020
2021-2022
2023-2024
2025 and beyond
Total
Dow Inc.
 
 
 
 
 
Long-term debt obligations 1
$
435

$
2,024

$
4,036

$
10,246

$
16,741

Expected cash requirements for interest 2
799

1,529

1,289

7,479

11,096

Pension and other postretirement benefits
379

909

1,944

7,214

10,446

Operating leases 3
492

777

504

803

2,576

Purchase obligations 4
2,548

4,162

3,664

4,737

15,111

Other noncurrent obligations 5

1,390

795

1,062

3,247

Total
$
4,653

$
10,791

$
12,232

$
31,541

$
59,217

TDCC
 
 
 
 
 
Long-term debt obligations 1
$
435

$
2,024

$
4,036

$
10,246

$
16,741

Expected cash requirements for interest 2
799

1,529

1,289

7,479

11,096

Pension and other postretirement benefits
379

909

1,944

7,214

10,446

Operating leases 3
492

777

504

803

2,576

Purchase obligations 4
2,548

4,162

3,664

4,737

15,111

Other noncurrent obligations 5

1,180

633

1,061

2,874

Total
$
4,653

$
10,581

$
12,070

$
31,540

$
58,844

1.
Excludes unamortized debt discount and issuance costs of $331 million. Includes finance lease obligations of $395 million. Assumes the option to extend will be exercised for the $2 billion Dow Silicones Term Loan Facility.
2.
Cash requirements for interest on long-term debt was calculated using current interest rates at December 31, 2019, and includes $2,344 million of various floating rate notes.
3.
Includes imputed interest of $416 million.
4.
Includes outstanding purchase orders and other commitments greater than $1 million obtained through a survey conducted within the Company.
5.
Includes liabilities related to asbestos litigation, environmental remediation, legal settlements and other noncurrent liabilities. In addition to these items, Dow Inc. includes liabilities related to noncurrent obligations with DuPont and Corteva. The table excludes uncertain tax positions due to uncertainties in the timing of the effective settlement of tax positions with the respective taxing authorities and deferred tax liabilities as it is impractical to determine whether there will be a cash impact related to these liabilities. The table also excludes deferred revenue as it does not represent future cash requirements arising from contractual payment obligations.

The Company expects to meet its contractual obligations through its normal sources of liquidity and believes it has the financial resources to satisfy these contractual obligations.

Off-Balance Sheet Arrangements
Off-balance sheet arrangements are obligations the Company has with nonconsolidated entities related to transactions, agreements or other contractual arrangements. The Company holds variable interests in joint ventures accounted for under the equity method of accounting. The Company is not the primary beneficiary of these joint ventures and therefore is not required to consolidate these entities (see Note 25 to the Consolidated Financial Statements). In addition, see Note 15 to the Consolidated Financial Statements for information regarding the transfer of financial assets.

Guarantees arise during the ordinary course of business from relationships with customers, committed accounts receivable facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others if specific triggering events occur. The Company had outstanding guarantees at December 31, 2019 of $3,952 million, compared with $4,273 million at December 31, 2018. Additional information related to guarantees can be found in the “Guarantees” section of Note 17 to the Consolidated Financial Statements.

48


Fair Value Measurements
See Note 21 to the Consolidated Financial Statements for information related to fair value measurements of pension and other postretirement benefit plan assets; see Note 23 for information related to other-than-temporary impairments; and, see Note 24 for additional information concerning fair value measurements.

OTHER MATTERS
Recent Accounting Guidance
See Note 2 to the Consolidated Financial Statements for a summary of recent accounting guidance.

Critical Accounting Estimates
The preparation of financial statements and related disclosures in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make judgments, assumptions and estimates that affect the amounts reported in the consolidated financial statements and accompanying notes. Note 1 to the Consolidated Financial Statements describes the significant accounting policies and methods used in the preparation of the consolidated financial statements. Following are the Company’s accounting policies impacted by judgments, assumptions and estimates:

Litigation
The Company is subject to legal proceedings and claims arising out of the normal course of business including product liability, patent infringement, employment matters, governmental tax and regulation disputes, contract and commercial litigation and other actions. The Company routinely assesses the legal and factual circumstances of each matter, the likelihood of any adverse outcomes to these matters, as well as ranges of probable losses. A determination of the amount of the reserves required, if any, for these contingencies is made after thoughtful analysis of each known claim. The Company has an active risk management program consisting of numerous insurance policies secured from many carriers covering various timeframes. These policies may provide coverage that could be utilized to minimize the financial impact, if any, of certain contingencies. The required reserves may change in the future due to new developments in each matter. For further discussion, see Note 17 to the Consolidated Financial Statements.

Asbestos-Related Matters of Union Carbide Corporation
Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. ("Amchem"). Each year, Ankura Consulting Group, LLC ("Ankura") performs a review for Union Carbide based upon historical asbestos claims, resolution and asbestos-related defense and processing costs, through the terminal year of 2049. Union Carbide compares current asbestos claim and resolution activity, including asbestos-related defense and processing costs, to the results of the most recent Ankura study at each balance sheet date to determine whether the asbestos-related liability continues to be appropriate.

For additional information, see Part I, Item 3. Legal Proceedings; Asbestos-Related Matters of Union Carbide Corporation in Management’s Discussion and Analysis of Financial Condition and Results of Operations; and Notes 1 and 17 to the Consolidated Financial Statements.

Environmental Matters
The Company determines the costs of environmental remediation of its facilities and formerly owned facilities based on evaluations of current law and existing technologies. Inherent uncertainties exist in such evaluations primarily due to unknown environmental conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies. The recorded liabilities are adjusted periodically as remediation efforts progress, or as additional technical or legal information becomes available. At December 31, 2019, the Company had accrued obligations of $1,155 million for probable environmental remediation and restoration costs, including $207 million for the remediation of Superfund sites. This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately one and a half times that amount. For further discussion, see Environmental Matters in Management’s Discussion and Analysis of Financial Condition and Results of Operations and Notes 1 and 17 to the Consolidated Financial Statements.

Goodwill
The Company performs goodwill impairment testing at the reporting unit level. Reporting units are the level at which discrete financial information is available and reviewed by business management on a regular basis. The Company tests goodwill for impairment annually (in the fourth quarter), or more frequently when events or changes in circumstances indicate it is more likely than not that the fair value of a reporting unit has declined below its carrying value. Goodwill is evaluated for impairment using

49


qualitative and/or quantitative testing procedures. The separation from DowDuPont on April 1, 2019, did not impact the composition of the Company's six reporting units: Coatings & Performance Monomers, Consumer Solutions, Hydrocarbons & Energy, Industrial Solutions, Packaging and Specialty Plastics and Polyurethanes & Construction Chemicals. The ECP businesses received as part of the separation from DowDuPont are included in the Hydrocarbons & Energy and Packaging and Specialty Plastics reporting units. At December 31, 2019, goodwill was carried by five out of six of the Company's reporting units.

The Company has the option to first perform qualitative testing to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Qualitative factors assessed at the Company level include, but are not limited to, GDP growth rates, long-term hydrocarbon and energy prices, equity and credit market activity, discount rates, foreign exchange rates and overall financial performance. Qualitative factors assessed at the reporting unit level include, but are not limited to, changes in industry and market structure, competitive environments, planned capacity and new product launches, cost factors such as raw material prices, and financial performance of the reporting unit. If the Company chooses not to complete a qualitative assessment for a given reporting unit or if the initial assessment indicates that it is more likely than not that the estimated fair value of a reporting unit is less than its carrying value, additional quantitative testing is required.

Quantitative testing requires the fair value of the reporting unit to be compared with its carrying value. If the reporting unit's carrying value exceeds its fair value, an impairment charge is recognized for the difference. The Company utilizes a discounted cash flow methodology to calculate the fair value of its reporting units. This valuation technique has been selected by management as the most meaningful valuation method due to the limited number of market comparables for the Company's reporting units. However, where market comparables are available, the Company includes EBIT/EBITDA multiples as part of the reporting unit valuation analysis. The discounted cash flow valuations are completed using the following key assumptions: projected revenue growth rates or compounded annual growth rates, discount rates, tax rates, terminal values, currency exchange rates, and forecasted long-term hydrocarbon and energy prices, by geographic region and by year, which include the Company's key feedstocks as well as natural gas and crude oil (due to its correlation to naphtha). Currency exchange rates and long-term hydrocarbon and energy prices are established for the Company as a whole and applied consistently to all reporting units, while revenue growth rates, discount rates and tax rates are established by reporting unit to account for differences in business fundamentals and industry risk. These key assumptions drive projected EBIT/EBITDA and EBIT/EBITDA margins, which are key elements of management’s internal control over the reporting unit valuation analysis.
2019 Goodwill Impairment Testing
In the fourth quarter of 2019, quantitative testing was performed on two reporting units and a qualitative assessment was performed for the remaining reporting units. For the qualitative assessments, management considered the factors at both the Company level and the reporting unit level. Based on the qualitative assessment, management concluded it is not more likely than not that the fair value of the reporting unit is less than the carrying value of the reporting unit.

Upon completion of the quantitative testing in the fourth quarter of 2019, the Company determined the Coatings & Performance Monomers ("C&PM") reporting unit was impaired. During 2019, the C&PM reporting unit did not consistently meet expected financial performance targets, primarily due to the industry’s increased captive use of coatings products, which led to volume reductions, reduced margins for products across the portfolio due to changes in customer buying patterns and supply and demand balances, as well as a continued trend of customer consolidation in end markets, which reduced growth opportunities. As a result, the C&PM reporting unit lowered its future revenue and profitability projections, which were used in determining the fair value of the C&PM reporting unit using a discounted cash flow methodology. These discounted cash flows did not support the carrying value of the C&PM reporting unit. As a result, the Company recorded a goodwill impairment charge of $1,039 million in the fourth quarter of 2019. The C&PM reporting unit did not carry a goodwill balance at December 31, 2019. The fair value of the other reporting unit exceeded its carrying value and no other goodwill impairments were identified as a result of the 2019 testing.

Pension and Other Postretirement Benefits
As a result of the Company’s separation from DowDuPont, the number of defined benefit pension plans administered by the Company decreased from 45 plans to 35 plans, with approximately $270 million of net unfunded pension liabilities transferring to DowDuPont. Plans administered by other subsidiaries of DowDuPont that were transferred to the Company were not significant. There were no changes in the number of other postretirement benefit plans administered by the Company as a result of the separation.

The amounts recognized in the consolidated financial statements related to pension and other postretirement benefits are determined from actuarial valuations. Inherent in these valuations are assumptions including expected return on plan assets, discount rates at which the liabilities could have been settled at December 31, 2019, rate of increase in future compensation levels, mortality rates and health care cost trend rates. These assumptions are updated annually and are disclosed in Note 21 to the Consolidated Financial Statements. In accordance with U.S. GAAP, actual results that differ from the assumptions are accumulated and amortized over future periods and, therefore, affect expense recognized and obligations recorded in future periods. The U.S. pension plans represent 71 percent of the Company’s pension plan assets and 70 percent of the pension obligations.

50


The Company uses the spot rate approach to determine the discount rate utilized to measure the service cost and interest cost components of net periodic pension and other postretirement benefit costs for the U.S. and other selected countries. Under the spot rate approach, the Company calculates service costs and interest costs by applying individual spot rates from the Willis Towers Watson RATE:Link yield curve (based on high-quality corporate bond yields) for each selected country to the separate expected cash flow components of service cost and interest cost; service cost and interest cost for all other plans (including all plans prior to adoption) are determined on the basis of the single equivalent discount rates derived in determining those plan obligations.

The following information relates to the U.S. plans only; a similar approach is used for the Company’s non-U.S. plans.

The Company determines the expected long-term rate of return on assets by performing a detailed analysis of historical and expected returns based on the strategic asset allocation approved by the Company's Investment Committee and the underlying return fundamentals of each asset class. The Company’s historical experience with the pension fund asset performance is also considered. The expected return of each asset class is derived from a forecasted future return confirmed by historical experience. The expected long-term rate of return is an assumption and not what is expected to be earned in any one particular year. The weighted-average long-term rate of return assumption used for determining net periodic pension expense for 2019 was 7.92 percent. The weighted-average assumption to be used for determining 2020 net periodic pension expense is 7.95 percent. Future actual pension expense will depend on future investment performance, changes in future discount rates and various other factors related to the population of participants in the Company’s pension plans.

The discount rates utilized to measure the pension and other postretirement obligations of the U.S. qualified plans are based on the yield on high-quality corporate fixed income investments at the measurement date. Future expected actuarially determined cash flows for the Company’s U.S. plans are individually discounted at the spot rates under the Willis Towers Watson U.S. RATE:Link 60-90 corporate yield curve (based on 60th to 90th percentile high-quality corporate bond yields) to arrive at the plan’s obligations as of the measurement date. The weighted average discount rate utilized to measure pension obligations decreased to 3.41 percent at December 31, 2019, from 4.39 percent at December 31, 2018.

At December 31, 2019, the U.S. qualified plans were underfunded on a projected benefit obligation basis by $4,768 million. The underfunded amount increased $702 million compared with December 31, 2018. The increase in the underfunded amount in 2019 was primarily due to the impact of lower discount rates, which was partially offset by the reduction in the number of active U.S. pension plan participants after the Company's separation from DowDuPont. The Company did not make contributions to the U.S. qualified plans in 2019.

The assumption for the long-term rate for the compensation levels for the U.S. qualified plans was unchanged. The Company uses a generational mortality table to determine the duration of its pension and other postretirement obligations.

The following discussion relates to the Company’s significant pension plans.

The Company bases the determination of pension expense on a market-related valuation of plan assets that reduces year-to-year volatility. This market-related valuation recognizes investment gains or losses over a five-year period from the year in which they occur. Investment gains or losses for this purpose represent the difference between the expected return calculated using the market-related value of plan assets and the actual return based on the market value of plan assets. Since the market-related value of plan assets recognizes gains or losses over a five-year period, the future value will be impacted when previously deferred gains or losses are recorded. Over the life of the plans, both gains and losses have been recognized and amortized. At December 31, 2019, net gains of $566 million remain to be recognized in the calculation of the market-related value of plan assets. These net gains will result in decreases in future pension expense as they are recognized in the market-related value of assets.

The net increase in the market-related value of assets due to the recognition of prior gains (losses) is presented in the following table:

Net Increase in Market-Related Asset Value Due to Recognition of Prior Gains (Losses)
In millions
2020
$
93

2021
129

2022
(48
)
2023
392

Total
$
566


51


At December 31, 2019, the Company expects pension expense from continuing operations to increase in 2020 by approximately $125 million. The increase in pension expense is primarily due to the decrease in discount rates and curtailment gains of $27 million recognized in 2019 that are not expected to recur in 2020.

A 25 basis point increase or decrease in the long-term return on assets assumption would change the Company’s total pension expense for 2020 by $59 million. A 25 basis point increase in the discount rate assumption would lower the Company's total pension expense for 2020 by $54 million. A 25 basis point decrease in the discount rate assumption would increase the Company's total pension expense for 2020 by $56 million. A 25 basis point change in the long-term return and discount rate assumptions would have an immaterial impact on the other postretirement benefit expense for 2020.

Income Taxes
Deferred tax assets and liabilities are determined based on temporary differences between the financial reporting and tax bases of assets and liabilities, applying enacted tax rates expected to be in effect for the year in which the differences are expected to reverse. Based on the evaluation of available evidence, both positive and negative, the Company recognizes future tax benefits, such as net operating loss carryforwards and tax credit carryforwards, to the extent that realizing these benefits is considered to be more likely than not.

At December 31, 2019, the Company had a net deferred tax asset balance of $1,866 million, after valuation allowances of $1,262 million.

In evaluating the ability to realize the deferred tax assets, the Company relies on, in order of increasing subjectivity, taxable income in prior carryback years, the future reversals of existing taxable temporary differences, tax planning strategies and forecasted taxable income using historical and projected future operating results.

At December 31, 2019, the Company had deferred tax assets for tax loss and tax credit carryforwards of $1,920 million, $295 million of which is subject to expiration in the years 2020 through 2024. In order to realize these deferred tax assets for tax loss and tax credit carryforwards, the Company needs taxable income of approximately $27,010 million across multiple jurisdictions. The taxable income needed to realize the deferred tax assets for tax loss and tax credit carryforwards that are subject to expiration between 2020 through 2024 is approximately $3,388 million.

The Company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on technical merits, that the position will be sustained upon examination. At December 31, 2019, the Company had uncertain tax positions for both domestic and foreign issues of $319 million.

The Company accrues for non-income tax contingencies when it is probable that a liability to a taxing authority has been incurred and the amount of the contingency can be reasonably estimated. At December 31, 2019, the Company had a non-income tax contingency reserve for both domestic and foreign issues of $44 million.

Indemnification Assets and Liabilities
In connection with the 2019 separation from DowDupont and the 2016 ownership restructure of Dow Silicones, Dow entered into agreements that established each party’s indemnification obligations for certain tax, environmental, litigation and other matters, subject to certain conditions and limits. The Company records indemnification assets when collection is deemed probable and engages with indemnifying parties and assesses publicly available information to evaluate collectability. The underlying tax, environmental, litigation and other liabilities for which the Company claims indemnification are subject to significant judgment and potential disputes could adversely impact collectability. The Company assesses the collectability of indemnification assets when events or changes in circumstances indicate the carrying values may not be recoverable. At December 31, 2019, indemnification assets were $210 million and $100 million for Dow Inc. and TDCC respectively (zero for both at December 31, 2018).

The Company records indemnification liabilities when it is probable that a liability has been incurred and the amount can be reasonably estimated. At December 31, 2019, indemnification liabilities related to the agreements were $848 million for Dow Inc. and zero for TDCC (zero for both at December 31, 2018). This represents management’s best estimate of the Company’s obligations under the agreements, although it is reasonably possible that future events could cause the actual values to be higher or lower than those projected or those recorded. For further discussion, see Notes 4 and 17 to the Consolidated Financial Statements.


52


Environmental Matters
Environmental Policies
Dow is committed to world-class environmental, health and safety (“EH&S”) performance, as demonstrated by industry-leading performance, a long-standing commitment to Responsible Care®, and a strong commitment to achieve the Company's 2025 Sustainability Goals – goals that set the standard for sustainability in the chemical industry by focusing on improvements in the Company’s local corporate citizenship and product stewardship, and by actively pursuing methods to reduce its environmental impact.

To meet the Company’s public commitments, as well as the stringent laws and government regulations related to environmental protection and remediation to which its global operations are subject, the Company has well-defined policies, requirements and management systems. The Company's EH&S Management System (“EMS”) defines the “who, what, when and how” needed for the businesses to achieve the Company’s policies, requirements, performance objectives, leadership expectations and public commitments. To ensure effective utilization, the EMS is integrated into a company-wide management system for EH&S, Operations, Quality and Human Resources.

It is the Company's policy to adhere to a waste management hierarchy that minimizes the impact of wastes and emissions on the environment. First, work to eliminate or minimize the generation of waste and emissions at the source through research, process design, plant operations and maintenance. Second, find ways to reuse and recycle materials. Finally, unusable or non-recyclable hazardous waste is treated before disposal to eliminate or reduce the hazardous nature and volume of the waste. Treatment may include destruction by chemical, physical, biological or thermal means. Disposal of waste materials in landfills is considered only after all other options have been thoroughly evaluated. The Company has specific requirements for waste that is transferred to non-Dow facilities, including the periodic auditing of these facilities.

The Company believes third-party verification and transparent public reporting are cornerstones of world-class EH&S performance and building public trust. Numerous Dow sites in Europe, Latin America, Asia Pacific and U.S. & Canada have received third-party verification of the Company’s compliance with Responsible Care® and with outside specifications such as ISO-14001. The Company continues to be a global champion of Responsible Care® and has worked to broaden the application and impact of Responsible Care® around the world through engagement with suppliers, customers and joint venture partners.

The Company’s EH&S policies helped to achieve improvements in many aspects of EH&S performance in 2019. The Company’s process safety performance was excellent in 2019 and improvements were made in injury/illness rates, and safety remains a priority. Further improvement in these areas, as well as environmental compliance, remains a top management priority, with initiatives underway to further improve performance and compliance in 2020 as the Company continues to implement the 2025 Sustainability Goals.

Detailed information on Dow’s performance regarding environmental matters and goals can be found online on the Company's Science & Sustainability webpage at www.dow.com/sustainability. The website and its content are not deemed incorporated by reference into this report.

Chemical Security
Public and political attention continues to be placed on the protection of critical infrastructure, including the chemical industry, from security threats. Terrorist attacks, natural disasters and cyber incidents have increased concern about the security and safety of chemical production and distribution. Many, including the Company and the American Chemistry Council, have called for uniform risk-based and performance-based national standards for securing the U.S. chemical industry. The Maritime Transportation Security Act of 2002 and its regulations further set forth risk-based and performance-based standards that must be met at U.S. Coast Guard-regulated facilities. U.S. Chemical Plant Security legislation was passed in 2006 and the Department of Homeland Security is now implementing the regulations known as the Chemical Facility Anti-Terrorism Standards. The Company is complying with the requirements of the Rail Transportation Security Rule issued by the U.S. Transportation Security Administration. The Company continues to support uniform risk-based national standards for securing the chemical industry.

The focus on security, emergency planning, preparedness and response is not new to the Company. A comprehensive, multi-level security plan has been maintained since 1988. This plan, which has been activated in response to significant world and national events since then, is reviewed on an annual basis. The Company continues to improve its security plans, placing emphasis on the safety of Dow communities and people by being prepared to meet risks at any level and to address both internal and external identifiable risks. The security plan includes regular vulnerability assessments, security audits, mitigation efforts and physical security upgrades designed to reduce vulnerability. The Company’s security plans also are developed to avert interruptions of normal business operations that could materially and adversely affect the Company’s results of operations, liquidity and financial condition.


53


The Company played a key role in the development and implementation of the American Chemistry Council’s Responsible Care® Security Code ("Security Code"), which requires that all aspects of security – including facility, transportation and cyberspace – be assessed and gaps addressed. Through the global implementation of the Security Code, the Company has permanently heightened the level of security – not just in the U.S., but worldwide. The Company employs several hundred employees and contractors in its Emergency Services and Security department worldwide. In 2019, the Company established its Global Security Operations Center ("GSOC") to provide 24-hour/day, 365-day/year real-time monitoring of global risks to Dow assets and people. The GSOC employs state-of-the-art social media monitoring, threat reporting and geo-fencing capabilities to analyze global risks and report those risks facilitating decision-making and actions to prevent Dow crises.

Through the implementation of the Security Code, including voluntary security enhancements and upgrades made since 2002, the Company is well-positioned to comply with U.S. chemical facility regulations and other regulatory security frameworks. The Company is currently participating with the American Chemistry Council to review and update the Security Code.

The Company continues to work collaboratively across the supply chain on Responsible Care®, Supply Chain Design, Emergency Preparedness, Shipment Visibility and transportation of hazardous materials. The Company is cooperating with public and private entities to lead the implementation of advanced tank car design, and track and trace technologies. Further, the Company’s Distribution Risk Review process that has been in place for decades was expanded to address potential threats in all modes of transportation across the Company’s supply chain. To reduce vulnerabilities, the Company maintains security measures that meet or exceed regulatory and industry security standards in all areas in which they operate.

The Company's initiatives relative to chemical security, emergency preparedness and response, Community Awareness and Emergency Responses and crisis management are implemented consistently at all Dow sites on a global basis. The Company participates with chemical associations globally and participates as an active member of the U.S. delegation to the G7 Global Partnership Sub-Working Group on Chemical Security.

Climate Change
Climate change matters for the Company are likely to be driven by changes in regulations, public policy and physical climate parameters.

Regulatory Matters
Regulatory matters include cap and trade schemes; increased greenhouse gas (“GHG”) limits; and taxes on GHG emissions, fuel and energy. The potential implications of each of these matters are all very similar, including increased cost of purchased energy, additional capital costs for installation or modification of GHG emitting equipment, and additional costs associated directly with GHG emissions (such as cap and trade systems or carbon taxes), which are primarily related to energy use. It is difficult to estimate the potential impact of these regulatory matters on energy prices.

Reducing the Company's overall energy usage and GHG emissions through new and unfolding projects will decrease the potential impact of these regulatory matters. The Company also has a dedicated commercial group to handle energy contracts and purchases, including managing emissions trading. The Company has not experienced any material impact related to regulated GHG emissions, and continues to evaluate and monitor this area for future developments.

Physical Climate Parameters
Many scientific academies throughout the world have concluded that it is very likely that human activities are contributing to global warming. At this point, it is difficult to predict and assess the probability and opportunity of a global warming trend on the Company specifically. Preparedness plans are developed that detail actions needed in the event of severe weather. These measures have historically been in place and these activities and associated costs are driven by normal operational preparedness. Dow continues to study the long-term implications of changing climate parameters on water availability, plant siting issues, and impacts and opportunities for products.

Dow’s Energy business and Public Affairs and Sustainability functions are tasked with developing and implementing a comprehensive strategy that addresses the potential challenges of energy security and GHG emissions on the Company. Dow continues to elevate its internal focus and external positions - to focus on the root causes of GHG emissions - including the unsustainable use of energy. The Company's energy plan provides the roadmap:

Conserve - aggressively pursue energy efficiency and conservation
Optimize - increase and diversify energy resources
Accelerate - develop cost-effective, clean, renewable and alternative energy sources
Transition - to a sustainable energy future


54


Through corporate energy efficiency programs and focused GHG management efforts, the Company has and is continuing to reduce its GHG emissions footprint. Dow’s manufacturing intensity, measured in Btu per pound of product, has improved by more than 40 percent since 1990. As part of the 2025 Sustainability Goals, the Company will maintain GHG emissions below 2006 levels on an absolute basis for all GHGs.

The Company intends to implement the recommendations of the Financial Stability Board's Task Force on Climate-related Financial Disclosures ("Task Force") over the next three years, which is aligned with the recommendations of the Task Force.

Environmental Remediation
The Company accrues the costs of remediation of its facilities and formerly owned facilities based on current law and regulatory requirements. The nature of such remediation can include management of soil and groundwater contamination. The accounting policies adopted to properly reflect the monetary impacts of environmental matters are discussed in Note 1 to the Consolidated Financial Statements. To assess the impact on the financial statements, environmental experts review currently available facts to evaluate the probability and scope of potential liabilities. Inherent uncertainties exist in such evaluations primarily due to unknown environmental conditions, changing governmental regulations and legal standards regarding liability, and the ability to apply remediation technologies. These liabilities are adjusted periodically as remediation efforts progress or as additional technical or legal information becomes available. The Company had an accrued liability of $948 million at December 31, 2019, related to the remediation of current or former Dow-owned sites. At December 31, 2018, the liability related to remediation was $654 million.

In addition to current and former Dow-owned sites, under the federal Comprehensive Environmental Response, Compensation and Liability Act ("CERCLA") and equivalent state laws (hereafter referred to collectively as "Superfund Law"), the Company is liable for remediation of other hazardous waste sites where the Company allegedly disposed of, or arranged for the treatment or disposal of, hazardous substances. Because Superfund Law imposes joint and several liability upon each party at a site, the Company has evaluated its potential liability in light of the number of other companies that also have been named potentially responsible parties (“PRPs”) at each site, the estimated apportionment of costs among all PRPs, and the financial ability and commitment of each to pay its expected share. The Company’s remaining liability for the remediation of Superfund sites was $207 million at December 31, 2019 ($156 million at December 31, 2018). The Company has not recorded any third-party recovery related to these sites as a receivable.

Information regarding environmental sites is provided below:

Environmental Sites
Dow-owned Sites 1
Superfund Sites 2
  
2019
2018
2019
2018
Number of sites at Jan 1
178

181

131

131

Sites added during year
7

3

6

2

Sites closed during year
(7
)
(6
)
(4
)
(2
)
Number of sites at Dec 31
178

178

133

131

1.
Dow-owned sites are sites currently or formerly owned by the Company. In the United States, remediation obligations are imposed by the Resource Conservation and Recovery Act or analogous state law. At December 31, 2019, 28 of these sites (32 sites at December 31, 2018) were formerly owned by Dowell Schlumberger, Inc., a group of companies in which the Company previously owned a 50 percent interest. The Company sold its interest in Dowell Schlumberger in 1992.
2.
Superfund sites are sites, including sites not owned by the Company, where remediation obligations are imposed by Superfund Law.

Additional information is provided below for the Company’s Midland, Michigan, manufacturing site and Midland off-site locations (collectively, the "Midland sites"), as well as a Superfund site in Wood-Ridge, New Jersey, the locations for which the Company has the largest potential environmental liabilities.

In the early days of operations at the Midland manufacturing site, wastes were usually disposed of on-site, resulting in soil and groundwater contamination, which has been contained and managed on-site under a series of Resource Conservation and Recovery Act permits and regulatory agreements. The Hazardous Waste Operating License for the Midland manufacturing site, issued in 2003, and renewed and replaced in September 2015, also included provisions for the Company to conduct an investigation to determine the nature and extent of off-site contamination from historic Midland manufacturing site operations. In January 2010, the Company, the U.S. Environmental Protection Agency ("EPA") and the State of Michigan ("State") entered into an Administrative Order on Consent that requires the Company to conduct a remedial investigation, a feasibility study and a remedial design for the Tittabawassee River, the Saginaw River and the Saginaw Bay, and pay the oversight costs of the EPA and the State under the authority of CERCLA. See Note 17 to the Consolidated Financial Statements for further information relating to Midland off-site environmental matters.

Rohm and Haas, a wholly owned subsidiary of the Company, is a PRP at the Wood-Ridge, New Jersey Ventron/Velsicol Superfund Site, and the adjacent Berry’s Creek Study Area ("BCSA") (collectively, the "Wood-Ridge sites"). Rohm and Haas is a successor

55


in interest to a company that owned and operated a mercury processing facility, where wastewater and waste handling resulted in contamination of soils and adjacent creek sediments. In 2018, the Berry’s Creek Study Area Potentially Responsible Party Group (“PRP Group”), consisting of over 100 PRPs, completed a Remedial Investigation/Feasibility Study for the BCSA. During that time, the EPA concluded that an “iterative or adaptive approach” was appropriate for cleaning up the BCSA. Thus, each phase of remediation will be followed by a period of monitoring to assess its effectiveness and determine if there is a need for more work. In September 2018, the EPA signed a Record of Decision ("ROD 1") which describes the initial phase of the EPA’s plan to clean-up the BCSA. ROD 1 will remediate waterways and major tributaries in the most contaminated part of the BCSA. The PRP Group has signed agreements with the EPA to design the selected remedy. Although there is currently much uncertainty as to what will ultimately be required to remediate the BCSA and Rohm and Haas's share of these costs has yet to be determined, the range of activities that are required in the interim Record of Decision is known in general terms.

At December 31, 2019, the Company had accrued liabilities totaling $368 million ($240 million at December 31, 2018) for environmental remediation at the Midland and Wood-Ridge sites. In 2019, the Company spent $32 million ($32 million in 2018) for environmental remediation at the Midland and Wood-Ridge sites.

During the third quarter of 2019, the Company accrued additional liabilities totaling $447 million related to environmental remediation matters at a number of current and historical locations. The additional accrual primarily resulted from: the culmination of long-standing negotiations and discussions with regulators and agencies, including technical studies supporting higher cost estimates for final or staged remediation plans; the Company’s evaluation of the cost required to manage remediation activities at sites affected by Dow’s separation from DowDuPont and related agreements with Corteva and DuPont; and, the Company’s review of its closure strategies and obligations to monitor ongoing operations and maintenance activities. In addition, the Company recorded indemnification assets of $48 million related to Dow Silicones’ environmental matters. Net of indemnifications, the Company recognized a pretax charge of $399 million related to these environmental matters, included in “Cost of sales” in the consolidated statements of income.

In total, the Company’s accrued liability for probable environmental remediation and restoration costs was $1,155 million at December 31, 2019, compared with $810 million at December 31, 2018. This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately one and a half times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company’s results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the Company’s results of operations, financial condition and cash flows.

The amounts charged to income on a pretax basis related to environmental remediation totaled $588 million in 2019, $176 million in 2018 and $163 million in 2017. The amounts charged to income on a pretax basis related to operating the Company's current pollution abatement facilities, excluding internal recharges, totaled $677 million in 2019, $695 million in 2018 and $566 million in 2017. Capital expenditures for environmental protection were $83 million in 2019, $55 million in 2018 and $57 million in 2017.

Asbestos-Related Matters of Union Carbide Corporation
Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem. In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.

The table below provides information regarding asbestos-related claims pending against Union Carbide and Amchem based on criteria developed by Union Carbide and its external consultants:

Asbestos-Related Claim Activity
2019
2018
2017
Claims unresolved at Jan 1
12,780

15,427

16,141

Claims filed
5,743

6,599

7,010

Claims settled, dismissed or otherwise resolved
(7,406
)
(9,246
)
(7,724
)
Claims unresolved at Dec 31
11,117

12,780

15,427

Claimants with claims against both Union Carbide and Amchem
(3,837
)
(4,675
)
(5,530
)
Individual claimants at Dec 31
7,280

8,105

9,897


56


Plaintiffs’ lawyers often sue numerous defendants in individual lawsuits or on behalf of numerous claimants. As a result, the damages alleged are not expressly identified as to Union Carbide, Amchem or any other particular defendant, even when specific damages are alleged with respect to a specific disease or injury. In fact, there are no asbestos personal injury cases in which only Union Carbide and/or Amchem are the sole named defendants. For these reasons and based upon Union Carbide’s litigation and settlement experience, Union Carbide does not consider the damages alleged against Union Carbide and Amchem to be a meaningful factor in its determination of any potential asbestos-related liability.

For additional information see Part I, Item 3. Legal Proceedings and Asbestos-Related Matters of Union Carbide Corporation in Note 17 to the Consolidated Financial Statements.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The Company’s business operations give rise to market risk exposure due to changes in foreign exchange rates, interest rates, commodity prices and other market factors such as equity prices. To manage such risks effectively, the Company enters into hedging transactions, pursuant to established guidelines and policies that enable it to mitigate the adverse effects of financial market risk. Derivatives used for this purpose are designated as hedges per the accounting guidance related to derivatives and hedging activities, where appropriate. A secondary objective is to add value by creating additional non-specific exposure within established limits and policies; derivatives used for this purpose are not designated as hedges. The potential impact of creating such additional exposures is not material to the Company’s results.

The global nature of the Company’s business requires active participation in the foreign exchange markets. The Company has assets, liabilities and cash flows in currencies other than the U.S. dollar. The primary objective of the Company’s foreign currency risk management is to optimize the U.S. dollar value of net assets and cash flows. To achieve this objective, the Company hedges on a net exposure basis using foreign currency forward contracts, over-the-counter option contracts, cross-currency swaps and nonderivative instruments in foreign currencies. Exposures primarily relate to assets, liabilities and bonds denominated in foreign currencies, as well as economic exposure, which is derived from the risk that currency fluctuations could affect the dollar value of future cash flows related to operating activities. The largest exposures are denominated in European currencies, the Japanese yen and the Chinese yuan, although exposures also exist in the Canadian dollar, the Indian rupee and other currencies in Asia Pacific, Latin America, the Middle East and Africa.

The main objective of interest rate risk management is to reduce the total funding cost to the Company and to alter the interest rate exposure to the desired risk profile. To achieve this objective, the Company hedges using interest rate swaps, “swaptions,” and exchange-traded instruments. The Company’s primary exposure is to the U.S. dollar yield curve.

The Company has a portfolio of equity securities derived primarily from the investment activities of its insurance subsidiaries. This exposure is managed in a manner consistent with the Company’s market risk policies and procedures.

Inherent in the Company’s business is exposure to price changes for several commodities. Some exposures can be hedged effectively through liquid tradable financial instruments. Natural gas and crude oil, along with feedstocks for ethylene and propylene production, constitute the main commodity exposures. Over-the-counter and exchange traded instruments are used to hedge these risks, when feasible.

The Company uses value-at-risk (“VAR”), stress testing and scenario analysis for risk measurement and control purposes. VAR estimates the maximum potential loss in fair market values, given a certain move in prices over a certain period of time, using specified confidence levels. The VAR methodology used by the Company is a variance/covariance model. This model uses a 97.5 percent confidence level and includes at least one year of historical data. The 2019 and 2018 year-end and average daily VAR for the aggregate of all positions are shown below. These amounts are immaterial relative to the total equity of the Company.

Total Daily VAR by Exposure Type at Dec 31
2019
2018
In millions
Year-end
Average
Year-end
Average  
Commodities
$
7

$
12

$
26

$
30

Equity securities
10

11

12

7

Foreign exchange
43

36

26

28

Interest rate
77

69

81

80

Composite
$
137

$
128

$
145

$
145


The Company’s composite VAR for the aggregate of all positions decreased from $145 million at December 31, 2018 to $137 million at December 31, 2019. The interest rate and commodities VAR declined due to a decrease in exposure. The equity securities VAR declined due to a decrease in managed exposures and lower equity volatility. The foreign exchange VAR increased due to increased hedging. See Note 23 to the Consolidated Financial Statements for further disclosure regarding market risk.

57



ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and the Board of Directors of Dow Inc.
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of Dow Inc. and subsidiaries (the "Company") as of December 31, 2019 and 2018, the related consolidated statements of income, comprehensive income, equity, and cash flows, for each of the three years in the period ended December 31, 2019, and the related notes and the schedule listed in the Index at Item 15(a)2 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2019, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 7, 2020, expressed an unqualified opinion on the Company's internal control over financial reporting.
Changes in Accounting Principles
As discussed in Note 1 to the financial statements, in the first quarter of 2018, the Company changed its method of accounting for revenue due to the adoption of Accounting Standards Codification (ASC) Topic 606, Revenue From Contracts with Customers and, in the first quarter of 2019, the Company changed the method of accounting for leases due to the adoption of ASC Topic 842, Leases.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Goodwill - Coatings & Performance Monomers Reporting Unit - Refer to Note 1 and Note 14 to the financial statements
Critical Audit Matter Description
The Company tests goodwill for impairment annually (in the fourth quarter), or more frequently when events or changes in circumstances indicate it is more likely than not that the fair value of a reporting unit has declined below its carrying value. The Company utilizes a discounted cash flow methodology to calculate the fair value of its reporting units, which requires management to make significant estimates and assumptions related to projected revenue growth rates, discount rates, and earnings before interest, taxes, depreciation and amortization (“EBITDA”). Changes in these assumptions could have a significant impact on the fair value

58


of the reporting unit and the amount of any goodwill impairment charge. As of December 31, 2019, the Company has six reporting units, all but one of which have goodwill.
Throughout 2019, the Coatings & Performance Monomers reporting unit (“C&PM”) did not consistently meet expected financial targets and experienced volume reductions and reduced margins for products across the portfolio due to changes in customer buying patterns and supply and demand balances, as well as the continued trend of customer consolidation in end markets, which reduced its future revenue and profitability projections. Therefore, in 2019, the Company used a discounted cash flow methodology to determine the fair value of the C&PM reporting unit. These discounted cash flows did not support the carrying value of C&PM. As a result, the Company recorded a goodwill impairment charge of $1,039 million in the fourth quarter of 2019.
Given the significant judgments made by management to estimate the fair value of the C&PM reporting unit, performing audit procedures to evaluate the reasonableness of management’s estimates and assumptions related to projected revenue growth rates, discount rates, EBITDA and EBITDA margin required a high degree of auditor judgment and an increased extent of effort, including the assistance of our fair value specialists.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to management’s estimates and assumptions related to projected revenue growth rates, discount rates, EBITDA and EBITDA margin for the C&PM reporting unit included the following, among other procedures:
We tested the effectiveness of internal controls over the goodwill impairment evaluation, including controls over the selection of the discount rates and over forecasts of future revenue growth rates, EBITDA, and EBITDA margin.
We performed a retrospective review comparing actual revenue and EBITDA results of the reporting unit for 2019 to the forecasted results from 2018.
We performed a retrospective review comparing management’s estimates and assumptions relating to revenue, EBITDA, and EBITDA margin projections for the reporting unit used for the purpose of current year’s annual impairment test to the projections previously used in connection with the prior year annual impairment test.
We evaluated the consistency of estimates and assumptions relating to revenue and EBITDA growth inherent in the discounted cash flow model for the reporting unit to those used by management in other annual forecasting activities.
With the assistance of our fair value specialists, we performed a benchmarking exercise comparing management’s estimates and assumptions related to revenue growth, EBITDA and EBITDA margin for the reporting unit as of the measurement date to the revenue growth, EBITDA and EBITDA margins of a peer group of public companies for the most recent three years and the projection period.
With the assistance of our fair value specialists, we evaluated (1) the valuation methodology used and (2) the projections of long-term revenue growth and the discount rates by testing the underlying source information, and by developing a range of independent estimates and comparing those to the rates selected by management.
Other-Than-Temporary-Impairment (“OTTI”) of the Sadara Chemical Company (“Sadara”) equity method investment - Refer to Note 13 to the financial statements
Critical Audit Matter Description
In 2011, the Company and Saudi Arabian Oil Company formed Sadara Chemical Company (“Sadara”), a joint venture between the two companies that subsequently constructed and now operates a world-scale, fully integrated chemicals complex in Jubail Industrial City, Kingdom of Saudi Arabia. The Company has a 35 percent equity interest in this joint venture and has been, and continues to be, responsible for marketing the majority of Sadara’s products through the Company’s established sales channels.
In 2017, Sadara achieved full commercial operations of all its facilities. In December 2018, the joint venture successfully completed its Creditors Reliability Test, an extensive operational testing program designed to demonstrate the reliability of the joint venture’s full chemical complex by operating at high rates for an extended period of time. While Sadara has reached these operational milestones and has been generating positive EBITDA, the joint venture has yet to report positive net income.
During the fourth quarter of 2019, Sadara tested its long-lived assets for impairment using long-term cash flow projections. Due to Sadara's financial condition and its long-lived asset impairment test, Dow evaluated its equity method investment in Sadara for other-than-temporary impairment. The Company utilized a discounted cash flow methodology to measure the estimated fair value of its investment in Sadara, which was estimated to be zero. The Company determined the decline in value of its investment in Sadara was other-than-temporary due to Sadara’s financial performance since becoming commercially operational in 2017 and uncertainty around the prospects for recovery in Sadara’s financial condition. In the fourth quarter of 2019, the Company recorded

59


an impairment of its investment in Sadara and reserved certain accounts and notes receivable and accrued interest balances due to uncertainty around timing of collection for a total charge of $1,755 million.
We have identified the evaluation of the Sadara investment for other-than-temporary impairment as a critical audit matter because of the significant estimates and assumptions management makes to estimate the fair value of its investment, including the discount rate, terminal value, and long-term growth rates. This required a high degree of auditor judgment and increased extent of effort, including the need to involve our fair value specialists, when performing audit procedures to evaluate the reasonableness of management’s estimates and assumptions.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to management’s judgements, estimates and assumptions, related to the discount rate, terminal value, and long-term growth rate used in the discounted cash flow analysis used in the evaluation of other-than-temporary impairment of the Sadara investment included the following, among others:
We tested the effectiveness of internal controls over management’s evaluation of the Sadara investment for other-than-temporary impairment, including management’s evaluation of the assumptions used such as discount rate, terminal value, and long-term growth rate.
We evaluated the consistency of the assumptions and judgments relating to the discount rate, terminal value, and long-term growth rates by comparing to:
Agreements in place between Sadara and Dow
Independent third-party pricing study
We read external information included in press releases, earnings releases, regulatory filings, and other Sadara communications to search for contradictory information.
With the assistance of our fair value specialists, we evaluated (1) the valuation methodology used and model being used (2) the assumptions used such as the discount rate, terminal value, and the long-term growth rate by testing the underlying source information, and by developing a range of independent estimates and comparing those to the rates selected by management.


/s/ DELOITTE & TOUCHE LLP
Deloitte & Touche LLP
Midland, Michigan
February 7, 2020

We have served as the Company's auditor since 1905.

60


REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholder and the Board of Directors of The Dow Chemical Company
Opinion on the Financial Statements
We have audited the accompanying consolidated balance sheets of The Dow Chemical Company and subsidiaries (the "Company") as of December 31, 2019 and 2018, the related consolidated statements of income, comprehensive income, equity, and cash flows, for each of the three years in the period ended December 31, 2019, and the related notes and the schedule listed in the Index at Item 15(a)2 (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2019, in conformity with accounting principles generally accepted in the United States of America.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 7, 2020, expressed an unqualified opinion on the Company's internal control over financial reporting.
Changes in Accounting Principles
As discussed in Note 1 to the financial statements, in the first quarter of 2018, the Company changed its method of accounting for revenue due to the adoption of Accounting Standards Codification (ASC) Topic 606, Revenue From Contracts with Customers and, in the first quarter of 2019, the Company changed the method of accounting for leases due to the adoption of ASC Topic 842, Leases.
Basis for Opinion
These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current-period audit of the financial statements that were communicated or required to be communicated to the audit committee and that (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Goodwill - Coatings & Performance Monomers Reporting Unit - Refer to Note 1 and Note 14 to the financial statements
Critical Audit Matter Description
The Company tests goodwill for impairment annually (in the fourth quarter), or more frequently when events or changes in circumstances indicate it is more likely than not that the fair value of a reporting unit has declined below its carrying value. The Company utilizes a discounted cash flow methodology to calculate the fair value of its reporting units, which requires management to make significant estimates and assumptions related to projected revenue growth rates, discount rates, and earnings before interest, taxes, depreciation and amortization (“EBITDA”). Changes in these assumptions could have a significant impact on the fair value of the reporting unit and the amount of any goodwill impairment charge. As of December 31, 2019, the Company has six reporting units, all but one of which have goodwill.

61


Throughout 2019, the Coatings & Performance Monomers reporting unit (“C&PM”) did not consistently meet expected financial targets and experienced volume reductions and reduced margins for products across the portfolio due to changes in customer buying patterns and supply and demand balances, as well as the continued trend of customer consolidation in end markets, which reduced its future revenue and profitability projections. Therefore, in 2019, the Company used a discounted cash flow methodology to determine the fair value of the C&PM reporting unit. These discounted cash flows did not support the carrying value of C&PM. As a result, the Company recorded a goodwill impairment charge of $1,039 million in the fourth quarter of 2019.
Given the significant judgments made by management to estimate the fair value of the C&PM reporting unit, performing audit procedures to evaluate the reasonableness of management’s estimates and assumptions related to projected revenue growth rates, discount rates, EBITDA and EBITDA margin required a high degree of auditor judgment and an increased extent of effort, including the assistance of our fair value specialists.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to management’s estimates and assumptions related to projected revenue growth rates, discount rates, EBITDA and EBITDA margin for the C&PM reporting unit included the following, among other procedures:
We tested the effectiveness of internal controls over the goodwill impairment evaluation, including controls over the selection of the discount rates and over forecasts of future revenue growth rates, EBITDA, and EBITDA margin.
We performed a retrospective review comparing actual revenue and EBITDA results of the reporting unit for 2019 to the forecasted results from 2018.
We performed a retrospective review comparing management’s estimates and assumptions relating to revenue, EBITDA, and EBITDA margin projections for the reporting unit used for the purpose of current year’s annual impairment test to the projections previously used in connection with the prior year annual impairment test.
We evaluated the consistency of estimates and assumptions relating to revenue and EBITDA growth inherent in the discounted cash flow model for the reporting unit to those used by management in other annual forecasting activities.
With the assistance of our fair value specialists, we performed a benchmarking exercise comparing management’s estimates and assumptions related to revenue growth, EBITDA and EBITDA margin for the reporting unit as of the measurement date to the revenue growth, EBITDA and EBITDA margins of a peer group of public companies for the most recent three years and the projection period.
With the assistance of our fair value specialists, we evaluated (1) the valuation methodology used and (2) the projections of long-term revenue growth and the discount rates by testing the underlying source information, and by developing a range of independent estimates and comparing those to the rates selected by management.
Other-Than-Temporary-Impairment (“OTTI”) of the Sadara Chemical Company (“Sadara”) equity method investment - Refer to Note 13 to the financial statements
Critical Audit Matter Description
In 2011, the Company and Saudi Arabian Oil Company formed Sadara Chemical Company (“Sadara”), a joint venture between the two companies that subsequently constructed and now operates a world-scale, fully integrated chemicals complex in Jubail Industrial City, Kingdom of Saudi Arabia. The Company has a 35 percent equity interest in this joint venture and has been, and continues to be, responsible for marketing the majority of Sadara’s products through the Company’s established sales channels.
In 2017, Sadara achieved full commercial operations of all its facilities. In December 2018, the joint venture successfully completed its Creditors Reliability Test, an extensive operational testing program designed to demonstrate the reliability of the joint venture’s full chemical complex by operating at high rates for an extended period of time. While Sadara has reached these operational milestones and has been generating positive EBITDA, the joint venture has yet to report positive net income.
During the fourth quarter of 2019, Sadara tested its long-lived assets for impairment using long-term cash flow projections. Due to Sadara's financial condition and its long-lived asset impairment test, Dow evaluated its equity method investment in Sadara for other-than-temporary impairment. The Company utilized a discounted cash flow methodology to measure the estimated fair value of its investment in Sadara, which was estimated to be zero. The Company determined the decline in value of its investment in Sadara was other-than-temporary due to Sadara’s financial performance since becoming commercially operational in 2017 and uncertainty around the prospects for recovery in Sadara’s financial condition. In the fourth quarter of 2019, the Company recorded an impairment of its investment in Sadara and reserved certain accounts and notes receivable and accrued interest balances due to uncertainty around the timing of collection for a total charge of $1,755 million.

62


We have identified the evaluation of the Sadara investment for other-than-temporary impairment as a critical audit matter because of the significant estimates and assumptions management makes to estimate the fair value of its investment, including the discount rate, terminal value, and long-term growth rates. This required a high degree of auditor judgment and increased extent of effort, including the need to involve our fair value specialists, when performing audit procedures to evaluate the reasonableness of management’s estimates and assumptions.
How the Critical Audit Matter Was Addressed in the Audit
Our audit procedures related to management’s judgements, estimates and assumptions, related to the discount rate, terminal value, and long-term growth rate used in the discounted cash flow analysis used in the evaluation of other-than-temporary impairment of the Sadara investment included the following, among others:
We tested the effectiveness of internal controls over management’s evaluation of the Sadara investment for other-than-temporary impairment, including management’s evaluation of the assumptions used such as discount rate, terminal value, and long-term growth rate.
We evaluated the consistency of the assumptions and judgments relating to the discount rate, terminal value, and long-term growth rates by comparing to:
Agreements in place between Sadara and Dow
Independent third-party pricing study
We read external information included in press releases, earnings releases, regulatory filings, and other Sadara communications to search for contradictory information.
With the assistance of our fair value specialists, we evaluated (1) the valuation methodology used and model being used (2) the assumptions used such as the discount rate, terminal value, and the long-term growth rate by testing the underlying source information, and by developing a range of independent estimates and comparing those to the rates selected by management.


/s/ DELOITTE & TOUCHE LLP
Deloitte & Touche LLP
Midland, Michigan
February 7, 2020

We have served as the Company's auditor since 1905.

63


Dow Inc. and Subsidiaries
Consolidated Statements of Income

(In millions, except per share amounts) For the years ended Dec 31,
2019
2018
2017
Net sales
$
42,951

$
49,604

$
43,730

Cost of sales
36,657

41,074

36,350

Research and development expenses
765

800

803

Selling, general and administrative expenses
1,590

1,782

1,795

Amortization of intangibles
419

469

400

Restructuring, goodwill impairment and asset related charges - net
3,219

221

2,739

Integration and separation costs
1,063

1,179

798

Equity in earnings (losses) of nonconsolidated affiliates
(94
)
555

394

Sundry income (expense) - net
461

96

(154
)
Interest income
81

82

66

Interest expense and amortization of debt discount
933

1,063

914

Income (loss) from continuing operations before income taxes
(1,247
)
3,749

237

Provision for income taxes on continuing operations
470

809

1,524

Income (loss) from continuing operations, net of tax
(1,717
)
2,940

(1,287
)
Income from discontinued operations, net of tax
445

1,835

1,882

Net income (loss)
(1,272
)
4,775

595

Net income attributable to noncontrolling interests
87

134

130

Net income (loss) available for Dow Inc. common stockholders
$
(1,359
)
$
4,641

$
465

 
 
 
 
 
 
 
 
Per common share data:
 
 
 
Earnings (loss) per common share from continuing operations - basic
$
(2.42
)
$
3.80

$
(1.88
)
Earnings per common share from discontinued operations - basic
0.58

2.41

2.48

Earnings (loss) per common share - basic
$
(1.84
)
$
6.21

$
0.60

Earnings (loss) per common share from continuing operations - diluted
$
(2.42
)
$
3.80

$
(1.88
)
Earnings per common share from discontinued operations - diluted
0.58

2.41

2.48

Earnings (loss) per common share - diluted
$
(1.84
)
$
6.21

$
0.60

 




 
Weighted-average common shares outstanding - basic
742.5

747.2

744.8

Weighted-average common shares outstanding - diluted
742.5

747.2

744.8

See Notes to the Consolidated Financial Statements.


64



Dow Inc. and Subsidiaries
Consolidated Statements of Comprehensive Income

(In millions) For the years ended Dec 31,
2019
2018
2017
Net income (loss)
$
(1,272
)
$
4,775

$
595

Other comprehensive income (loss), net of tax



Unrealized gains (losses) on investments
115

(67
)
(46
)
Cumulative translation adjustments
(32
)
(225
)
900

Pension and other postretirement benefit plans
(899
)
(40
)
391

Derivative instruments
(338
)
75

(14
)
Total other comprehensive income (loss)
(1,154
)
(257
)
1,231

Comprehensive income (loss)
(2,426
)
4,518

1,826

Comprehensive income attributable to noncontrolling interests, net of tax
99

97

172

Comprehensive income (loss) attributable to Dow Inc.
$
(2,525
)
$
4,421

$
1,654

See Notes to the Consolidated Financial Statements.


65



Dow Inc. and Subsidiaries
Consolidated Balance Sheets

(In millions, except share amounts) At Dec 31,
2019
2018
Assets
 
 
Current Assets


Cash and cash equivalents (variable interest entities restricted - 2019: $37; 2018: $71)
$
2,367

$
2,724

Marketable securities
21

100

Accounts and notes receivable:


Trade (net of allowance for doubtful receivables - 2019: $45; 2018: $42)
4,844

5,646

Other
2,711

3,389

Inventories
6,214

6,899

Other current assets
658

712

Assets of discontinued operations - current

19,900

Total current assets
16,815

39,370

Investments


Investment in nonconsolidated affiliates
1,404

3,320

Other investments (investments carried at fair value - 2019: $1,584; 2018: $1,699)
2,588

2,646

Noncurrent receivables
1,063

360

Total investments
5,055

6,326

Property


Property
54,910

53,984

Less accumulated depreciation
33,914

32,566

Net property (variable interest entities restricted - 2019: $330; 2018: $683)
20,996

21,418

Other Assets


Goodwill
8,796

9,846

Other intangible assets (net of accumulated amortization - 2019: $3,886; 2018: $3,379)
3,759

4,225

Operating lease right-of-use assets
2,072


Deferred income tax assets
2,213

1,779

Deferred charges and other assets
818

735

Total other assets
17,658

16,585

Total Assets
$
60,524

$
83,699

Liabilities and Equity


Current Liabilities


Notes payable
$
586

$
298

Long-term debt due within one year
435

338

Accounts payable:


Trade
3,889

4,456

Other
2,064

2,479

Operating lease liabilities - current
421


Income taxes payable
522

557

Accrued and other current liabilities
2,762

2,931

Liabilities of discontinued operations - current

4,488

Total current liabilities
10,679

15,547

Long-Term Debt (variable interest entities nonrecourse - 2019: $34; 2018: $75)
15,975

19,253

Other Noncurrent Liabilities


Deferred income tax liabilities
347

501

Pension and other postretirement benefits - noncurrent
10,083

8,926

Asbestos-related liabilities - noncurrent
1,060

1,142

Operating lease liabilities - noncurrent
1,739


Other noncurrent obligations
6,547

4,709

Total other noncurrent liabilities
19,776

15,278

Stockholders’ Equity


Common stock (2019: authorized 5,000,000,000 shares and issued 751,228,644 shares of $0.01 par value each;
2018: authorized and issued 100 shares of $0.01 par value each)
8


Additional paid-in capital
7,325

7,042

Retained earnings
17,045

35,460

Accumulated other comprehensive loss
(10,246
)
(9,885
)
Unearned ESOP shares
(91
)
(134
)
Treasury stock at cost (2019: 9,729,834 shares; 2018: zero shares)
(500
)

Dow Inc.’s stockholders’ equity
13,541

32,483

Noncontrolling interests
553

1,138

Total equity
14,094

33,621

Total Liabilities and Equity
$
60,524

$
83,699

See Notes to the Consolidated Financial Statements.

66



Dow Inc. and Subsidiaries
Consolidated Statements of Cash Flows

(In millions) For the years ended Dec 31,
2019
2018
2017
Operating Activities


 
Net income (loss)
$
(1,272
)
$
4,775

$
595

Less: Income from discontinued operations, net of tax
445

1,835

1,882

Income (loss) from continuing operations, net of tax
(1,717
)
2,940

(1,287
)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:



Depreciation and amortization
2,938

2,909

2,546

Provision (credit) for deferred income tax
(228
)
(429
)
1,413

Earnings of nonconsolidated affiliates less than dividends received
1,114

108

253

Net periodic pension benefit cost
144

279

1,032

Pension contributions
(261
)
(1,651
)
(1,672
)
Net gain on sales of assets, businesses and investments
(81
)
(38
)
(419
)
Restructuring, goodwill impairment and asset related charges - net
3,219

221

2,739

Other net loss
198

415

451

Changes in assets and liabilities, net of effects of acquired and divested companies:






Accounts and notes receivable
1,253

(855
)
(11,431
)
Inventories
668

(859
)
(891
)
Accounts payable
(948
)
787

1,081

Other assets and liabilities, net
(586
)
(731
)
(258
)
Cash provided by (used for) operating activities - continuing operations
5,713

3,096

(6,443
)
Cash provided by operating activities - discontinued operations
217

1,158

1,514

Cash provided by (used for) operating activities
5,930

4,254

(4,929
)
Investing Activities




 
Capital expenditures
(1,961
)
(2,091
)
(2,807
)
Investment in gas field developments
(76
)
(114
)
(121
)
Purchases of previously leased assets
(9
)
(26
)
(187
)
Proceeds from sales of property and businesses, net of cash divested
84

47

522

Acquisitions of property and businesses, net of cash acquired

(20
)
47

Investments in and loans to nonconsolidated affiliates
(638
)
(18
)
(749
)
Distributions and loan repayments from nonconsolidated affiliates
89

55

69

Purchases of investments
(899
)
(1,530
)
(642
)
Proceeds from sales and maturities of investments
1,252

1,214

1,165

Proceeds from interests in trade accounts receivable conduits

657

9,462

Other investing activities, net


34

Cash provided by (used for) investing activities - continuing operations
(2,158
)
(1,826
)
6,793

Cash provided by (used for) investing activities - discontinued operations
(34
)
(369
)
725

Cash provided by (used for) investing activities
(2,192
)
(2,195
)
7,518

Financing Activities






Changes in short-term notes payable
307

(178
)
268

Proceeds from issuance of long-term debt
2,287

1,999


Payments on long-term debt
(5,561
)
(3,054
)
(617
)
Purchases of treasury stock
(500
)


Proceeds from issuance of parent company stock
93

112

66

Proceeds from sales of common stock


423

Transaction financing, debt issuance and other costs
(119
)
(70
)

Employee taxes paid for share-based payment arrangements
(60
)
(77
)
(81
)
Distributions to noncontrolling interests
(77
)
(135
)
(101
)
Purchases of noncontrolling interests
(297
)


Dividends paid to stockholders
(1,550
)

(2,179
)
Dividends paid to DowDuPont Inc.
(535
)
(3,711
)
(1,056
)
Settlements and transfers related to separation from DowDuPont Inc.
1,935

(240
)
6

Other financing activities, net

3

(4
)
Cash used for financing activities - continuing operations
(4,077
)
(5,351
)
(3,275
)
Cash used for financing activities - discontinued operations
(18
)
(53
)
(50
)
Cash used for financing activities
(4,095
)
(5,404
)
(3,325
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
(27
)
(99
)
320

Summary






Decrease in cash, cash equivalents and restricted cash
(384
)
(3,444
)
(416
)
Cash, cash equivalents and restricted cash at beginning of year
2,764

6,208

6,624

Cash, cash equivalents and restricted cash at end of year
$
2,380

$
2,764

$
6,208

Less: Restricted cash and cash equivalents, included in "Other current assets"
13

40

19

Cash and cash equivalents at end of year
$
2,367

$
2,724

$
6,189

See Notes to the Consolidated Financial Statements.

67



Dow Inc. and Subsidiaries
Consolidated Statements of Equity

(In millions, except per share amounts) For the years ended Dec 31,
2019
2018
2017
Common Stock



Balance at beginning of year
$

$

$
3,107

Merger impact


(3,107
)
Common stock issued
8



Balance at end of year
8



Additional Paid-in Capital



Balance at beginning of year
7,042

6,553

4,262

Common stock issued / sold
57


423

Issuance of parent company stock - DowDuPont Inc.
28

112

66

Stock-based compensation and allocation of ESOP shares
235

377

(368
)
Merger impact


2,172

Other
(37
)

(2
)
Balance at end of year
7,325

7,042

6,553

Retained Earnings



Balance at beginning of year
35,460

33,742

30,338

Adoption of accounting standards (Note 1)
(151
)
989


Net income (loss) available for Dow Inc.'s common stockholders
(1,359
)
4,641

465

Dividends to stockholders
(1,550
)

(1,673
)
Dividends to DowDuPont Inc.
(535
)
(3,711
)
(1,056
)
Common control transaction
(14,806
)
(182
)
5,693

Other
(14
)
(19
)
(25
)
Balance at end of year
17,045

35,460

33,742

Accumulated Other Comprehensive Loss



Balance at beginning of year
(9,885
)
(8,591
)
(9,822
)
Adoption of accounting standards (Note 1)

(1,037
)

Other comprehensive income (loss)
(1,154
)
(257
)
1,231

Common control transaction
793



Balance at end of year
(10,246
)
(9,885
)
(8,591
)
Unearned ESOP Shares



Balance at beginning of year
(134
)
(189
)
(239
)
Stock-based compensation and allocation of ESOP shares
45

55

50

ESOP shares acquired
(2
)


Balance at end of year
(91
)
(134
)
(189
)
Treasury Stock



Balance at beginning of year


(1,659
)
Common stock issued/sold


724

Treasury stock purchases
(500
)


Merger impact


935

Balance at end of year
(500
)


Dow Inc.'s stockholders' equity
13,541

32,483

31,515

Noncontrolling Interests
553

1,138

1,186

Total Equity
$
14,094

$
33,621

$
32,701

 
 
 
 
Dividends declared per share of common stock
$
2.10

$

$
1.38

See Notes to the Consolidated Financial Statements.


68



The Dow Chemical Company and Subsidiaries
Consolidated Statements of Income

(In millions) For the years ended Dec 31,
2019
2018
2017
Net sales
$
42,951

$
49,604

$
43,730

Cost of sales
36,657

41,074

36,350

Research and development expenses
765

800

803

Selling, general and administrative expenses
1,585

1,782

1,795

Amortization of intangibles
419

469

400

Restructuring, goodwill impairment and asset related charges - net
3,219

221

2,739

Integration and separation costs
1,039

1,179

798

Equity in earnings (losses) of nonconsolidated affiliates
(94
)
555

394

Sundry income (expense) - net
573

96

(154
)
Interest income
81

82

66

Interest expense and amortization of debt discount
952

1,063

914

Income (loss) from continuing operations before income taxes
(1,125
)
3,749

237

Provision for income taxes on continuing operations
470

809

1,524

Income (loss) from continuing operations, net of tax
(1,595
)
2,940

(1,287
)
Income from discontinued operations, net of tax
445

1,835

1,882

Net income (loss)
(1,150
)
4,775

595

Net income attributable to noncontrolling interests
87

134

130

Net income (loss) available for The Dow Chemical Company common stockholder
$
(1,237
)
$
4,641

$
465

See Notes to the Consolidated Financial Statements.


69



The Dow Chemical Company and Subsidiaries
Consolidated Statements of Comprehensive Income

(In millions) For the years ended Dec 31,
2019
2018
2017
Net income (loss)
$
(1,150
)
$
4,775

$
595

Other comprehensive income (loss), net of tax
 
 
 
Unrealized gains (losses) on investments
115

(67
)
(46
)
Cumulative translation adjustments
(32
)
(225
)
900

Pension and other postretirement benefit plans
(899
)
(40
)
391

Derivative instruments
(338
)
75

(14
)
Total other comprehensive income (loss)
(1,154
)
(257
)
1,231

Comprehensive income (loss)
(2,304
)
4,518

1,826

Comprehensive income attributable to noncontrolling interests, net of tax
99

97

172

Comprehensive income (loss) attributable to The Dow Chemical Company
$
(2,403
)
$
4,421

$
1,654

See Notes to the Consolidated Financial Statements.


70



The Dow Chemical Company and Subsidiaries
Consolidated Balance Sheets

(In millions, except share amounts) At Dec 31,
2019
2018
Assets
 
 
Current Assets
 
 
Cash and cash equivalents (variable interest entities restricted - 2019: $37; 2018: $71)
$
2,367

$
2,724

Marketable securities
21

100

Accounts and notes receivable:
 
 
Trade (net of allowance for doubtful receivables - 2019: $45; 2018: $42)
4,844

5,646

Other
2,716

3,389

Inventories
6,214

6,899

Other current assets
571

712

Assets of discontinued operations - current

19,900

Total current assets
16,733

39,370

Investments
 
 
Investment in nonconsolidated affiliates
1,404

3,320

Other investments (investments carried at fair value - 2019: $1,584; 2018: $1,699)
2,588

2,646

Noncurrent receivables
1,011

360

Total investments
5,003

6,326

Property
 
 
Property
54,910

53,984

Less accumulated depreciation
33,914

32,566

Net property (variable interest entities restricted - 2019: $330; 2018: $683)
20,996

21,418

Other Assets
 
 
Goodwill
8,796

9,846

Other intangible assets (net of accumulated amortization - 2019: $3,886; 2018: $3,379)
3,759

4,225

Operating lease right-of-use assets
2,072


Deferred income tax assets
2,213

1,779

Deferred charges and other assets
818

735

Total other assets
17,658

16,585

Total Assets
$
60,390

$
83,699

Liabilities and Equity
 
 
Current Liabilities
 
 
Notes payable
$
586

$
298

Long-term debt due within one year
435

338

Accounts payable:
 
 
Trade
3,889

4,456

Other
2,064

2,479

Operating lease liabilities - current
421


Income taxes payable
522

557

Accrued and other current liabilities
2,233

2,931

Liabilities of discontinued operations - current

4,488

Total current liabilities
10,150

15,547

Long-Term Debt (variable interest entities nonrecourse - 2019: $34; 2018: $75)
15,975

19,253

Other Noncurrent Liabilities
 
 
Deferred income tax liabilities
347

501

Pension and other postretirement benefits - noncurrent
10,083

8,926

Asbestos-related liabilities - noncurrent
1,060

1,142

Operating lease liabilities - noncurrent
1,739


Other noncurrent obligations
6,174

4,709

Total other noncurrent liabilities
19,403

15,278

Stockholder's Equity
 
 
Common stock (authorized and issued 100 shares of $0.01 par value each)


Additional paid-in capital
7,333

7,042

Retained earnings
17,313

35,460

Accumulated other comprehensive loss
(10,246
)
(9,885
)
Unearned ESOP shares
(91
)
(134
)
The Dow Chemical Company’s stockholder's equity
14,309

32,483

Noncontrolling interests
553

1,138

Total equity
14,862

33,621

Total Liabilities and Equity
$
60,390

$
83,699

See Notes to the Consolidated Financial Statements.

71



The Dow Chemical Company and Subsidiaries
Consolidated Statements of Cash Flows

(In millions) For the years ended Dec 31,
2019
2018
2017
Operating Activities
 
 
 
Net income (loss)
$
(1,150
)
$
4,775

$
595

Less: Income from discontinued operations, net of tax
445

1,835

1,882

Income (loss) from continuing operations, net of tax
(1,595
)
2,940

(1,287
)
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:



Depreciation and amortization
2,938

2,909

2,546

Provision (credit) for deferred income tax
(228
)
(429
)
1,413

Earnings of nonconsolidated affiliates less than dividends received
1,114

108

253

Net periodic pension benefit cost
144

279

1,032

Pension contributions
(261
)
(1,651
)
(1,672
)
Net gain on sales of assets, businesses and investments
(81
)
(38
)
(419
)
Restructuring, goodwill impairment and asset related charges - net
3,219

221

2,739

Other net loss
213

415

451

Changes in assets and liabilities, net of effects of acquired and divested companies:






Accounts and notes receivable
1,253

(855
)
(11,431
)
Inventories
668

(859
)
(891
)
Accounts payable
(948
)
787

1,081

Other assets and liabilities, net
(730
)
(731
)
(258
)
Cash provided by (used for) operating activities - continuing operations
5,706

3,096

(6,443
)
Cash provided by operating activities - discontinued operations
371

1,158

1,514

Cash provided by (used for) operating activities
6,077

4,254

(4,929
)
Investing Activities






Capital expenditures
(1,961
)
(2,091
)
(2,807
)
Investment in gas field developments
(76
)
(114
)
(121
)
Purchases of previously leased assets
(9
)
(26
)
(187
)
Proceeds from sales of property and businesses, net of cash divested
84

47

522

Acquisitions of property and businesses, net of cash acquired

(20
)
47

Investments in and loans to nonconsolidated affiliates
(638
)
(18
)
(749
)
Distributions and loan repayments from nonconsolidated affiliates
89

55

69

Purchases of investments
(899
)
(1,530
)
(642
)
Proceeds from sales and maturities of investments
1,252

1,214

1,165

Proceeds from interests in trade accounts receivable conduits

657

9,462

Other investing activities, net


34

Cash provided by (used for) investing activities - continuing operations
(2,158
)
(1,826
)
6,793

Cash provided by (used for) investing activities - discontinued operations
(34
)
(369
)
725

Cash provided by (used for) investing activities
(2,192
)
(2,195
)
7,518

Financing Activities






Changes in short-term notes payable
307

(178
)
268

Proceeds from issuance of long-term debt
2,287

1,999


Payments on long-term debt
(5,561
)
(3,054
)
(617
)
Proceeds from issuance of parent company stock
93

112

66

Proceeds from sales of common stock


423

Transaction financing, debt issuance and other costs
(119
)
(70
)

Employee taxes paid for share-based payment arrangements
(60
)
(77
)
(81
)
Distributions to noncontrolling interests
(77
)
(135
)
(101
)
Purchases of noncontrolling interests
(297
)


Dividends paid to stockholders


(2,179
)
Dividends paid to DowDuPont Inc.
(535
)
(3,711
)
(1,056
)
Dividends paid to Dow Inc.
(201
)


Settlements and transfers related to separation from DowDuPont Inc.
(61
)
(240
)
6

Other financing activities, net

3

(4
)
Cash used for financing activities - continuing operations
(4,224
)
(5,351
)
(3,275
)
Cash used for financing activities - discontinued operations
(18
)
(53
)
(50
)
Cash used for financing activities
(4,242
)
(5,404
)
(3,325
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
(27
)
(99
)
320

Summary






Decrease in cash, cash equivalents and restricted cash
(384
)
(3,444
)
(416
)
Cash, cash equivalents and restricted cash at beginning of year
2,764

6,208

6,624

Cash, cash equivalents and restricted cash at end of year
$
2,380

$
2,764

$
6,208

Less: Restricted cash and cash equivalents, included in "Other current assets"
13

40

19

Cash and cash equivalents at end of year
$
2,367

$
2,724

$
6,189

See Notes to the Consolidated Financial Statements.


72



The Dow Chemical Company and Subsidiaries
Consolidated Statements of Equity

(In millions, except per share amounts) For the years ended Dec 31,
2019
2018
2017
Common Stock
 
 
 
Balance at beginning of year
$

$

$
3,107

Merger impact


(3,107
)
Balance at end of year



Additional Paid-in Capital
 
 
 
Balance at beginning of year
7,042

6,553

4,262

Common stock issued / sold


423

Issuance of parent company stock - Dow Inc.
65



Issuance of parent company stock - DowDuPont Inc.
28

112

66

Stock-based compensation and allocation of ESOP shares
235

377

(368
)
Merger impact


2,172

Other
(37
)

(2
)
Balance at end of year
7,333

7,042

6,553

Retained Earnings
 
 
 
Balance at beginning of year
35,460

33,742

30,338

Adoption of accounting standards (Note 1)
(151
)
989


Net income (loss) available for The Dow Chemical Company's common stockholder
(1,237
)
4,641

465

Dividends to stockholders


(1,673
)
Dividends to DowDuPont Inc.
(535
)
(3,711
)
(1,056
)
Dividends to Dow Inc.
(201
)


Common control transaction
(16,009
)
(182
)
5,693

Other
(14
)
(19
)
(25
)
Balance at end of year
17,313

35,460

33,742

Accumulated Other Comprehensive Loss
 
 
 
Balance at beginning of year
(9,885
)
(8,591
)
(9,822
)
Adoption of accounting standards (Note 1)

(1,037
)

Other comprehensive income (loss)
(1,154
)
(257
)
1,231

Common control transaction
793



Balance at end of year
(10,246
)
(9,885
)
(8,591
)
Unearned ESOP Shares
 
 
 
Balance at beginning of year
(134
)
(189
)
(239
)
Stock-based compensation and allocation of ESOP shares
45

55

50

ESOP shares acquired
(2
)


Balance at end of year
(91
)
(134
)
(189
)
Treasury Stock
 
 
 
Balance at beginning of year


(1,659
)
Common stock issued/sold


724

Merger impact


935

Balance at end of year



The Dow Chemical Company's stockholder's equity
14,309

32,483

31,515

Noncontrolling Interests
553

1,138

1,186

Total Equity
$
14,862

$
33,621

$
32,701

See Notes to the Consolidated Financial Statements.


73



Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
Notes to the Consolidated Financial Statements
Table of Contents

Note
 
Page
1
74
2
80
3
81
4
82
5
84
6
87
7
87
8
90
9
91
10
95
11
96
12
96
13
96
14
99
15
101
16
102
17
105
18
112
19
115
20
118
21
119
22
126
23
131
24
138
25
141
26
142
27
143
28
147


NOTE 1 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Merger and Separation
On April 1, 2019, DowDuPont Inc. (“DowDuPont” and effective June 3, 2019, n/k/a DuPont de Nemours, Inc. or "DuPont") completed the separation of its materials science business and Dow Inc. became the direct parent company of The Dow Chemical Company and its consolidated subsidiaries (“TDCC” and together with Dow Inc., “Dow” or the “Company”). The separation was contemplated by the merger of equals transaction effective August 31, 2017, under the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017. TDCC and E. I. du Pont de Nemours and Company and its consolidated subsidiaries (“Historical DuPont”) each merged with subsidiaries of DowDuPont and, as a result, TDCC and Historical DuPont became subsidiaries of DowDuPont (the “Merger”). Subsequent to the Merger, TDCC and Historical DuPont engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products. Dow Inc. was formed as a wholly owned subsidiary of DowDuPont to serve as the holding company for the materials science business. See Notes 3 and 4 for additional information.


74



Principles of Consolidation and Basis of Presentation
The accompanying consolidated financial statements of Dow Inc. and TDCC were prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and include the assets, liabilities, revenues and expenses of all majority-owned subsidiaries over which Dow exercises control and, when applicable, entities for which Dow has a controlling financial interest or is the primary beneficiary. Intercompany transactions and balances are eliminated in consolidation. Investments in nonconsolidated affiliates (20-50 percent owned companies or less than 20 percent owned companies over which significant influence is exercised) are accounted for using the equity method.

Effective April 1, 2019, Dow Inc. owns all of the outstanding common shares of TDCC. TDCC is deemed the predecessor to Dow Inc. and the historical results of TDCC are deemed the historical results of Dow Inc. for periods prior to and including March 31, 2019. As a result of the parent/subsidiary relationship between Dow Inc. and TDCC, and the expectation that the financial statements and disclosures of each company will be substantially similar, the companies are filing a combined report for this Annual Report on Form 10-K. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted.

As of the effective date and time of the distribution, DowDuPont does not beneficially own any equity interest in Dow and no longer consolidates Dow and its consolidated subsidiaries into its financial results. The consolidated financial results of Dow for all periods presented reflect the distribution of TDCC’s agricultural sciences business (“AgCo”) and specialty products business (“SpecCo”) as discontinued operations, as well as the receipt of Historical DuPont’s ethylene and ethylene copolymers businesses (other than its ethylene acrylic elastomers business) (“ECP”) as a common control transaction from the closing of the Merger on August 31, 2017 ("Merger Date"). See Notes 3 and 4 for additional information.

Effective with the Merger, the Company's business activities were components of DowDuPont's business operations and therefore, were reported as a single operating segment. Following the separation from DowDuPont, the Company changed the manner in which its business activities were managed. The Company's portfolio now includes six global businesses which are organized into the following operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure and Performance Materials & Coatings. Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. See Note 27 for additional information.

From the Merger Date through the separation, transactions between DowDuPont, TDCC and Historical DuPont and their affiliates were treated as related party transactions. Transactions between TDCC and Historical DuPont primarily consisted of the sale and procurement of certain raw materials that were consumed in each company's manufacturing process. Transactions between TDCC and Dow Inc. are treated as related party transactions for TDCC. See Note 26 for additional information.

Throughout this Annual Report on Form 10-K, unless otherwise indicated, amounts and activity are presented on a continuing operations basis.

Except as otherwise indicated by the context, the terms "Union Carbide" means Union Carbide Corporation, a wholly owned subsidiary of the Company, and "Dow Silicones" means Dow Silicones Corporation (formerly known as Dow Corning Corporation, which changed its name effective as of February 1, 2018), a wholly owned subsidiary of the Company.

Use of Estimates in Financial Statement Preparation
The preparation of financial statements in accordance with U.S. GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company’s consolidated financial statements include amounts that are based on management’s best estimates and judgments. Actual results could differ from those estimates.

Significant Accounting Policies
Asbestos-Related Matters
Accruals for asbestos-related matters, including defense and processing costs, are recorded based on an analysis of claim and resolution activity, defense spending, and pending and future claims. These accruals are assessed at each balance sheet date to determine if the asbestos-related liability remains appropriate. Accruals for asbestos-related matters are included in the consolidated balance sheets in “Accrued and other current liabilities” and “Asbestos-related liabilities - noncurrent.” See Note 17 for additional information.

Legal Costs
The Company expenses legal costs as incurred, with the exception of defense and processing costs associated with asbestos-related matters.


75



Foreign Currency Translation
The local currency has been primarily used as the functional currency throughout the world. Translation gains and losses of those operations that use local currency as the functional currency are included in the consolidated balance sheets in "Accumulated other comprehensive loss" ("AOCL"). For certain subsidiaries, the U.S. dollar is used as the functional currency. This occurs when the subsidiary operates in an economic environment where the products produced and sold are tied to U.S. dollar-denominated markets, or when the foreign subsidiary operates in a hyper-inflationary environment. Where the U.S. dollar is used as the functional currency, foreign currency translation gains and losses are reflected in income.

Environmental Matters
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. These accruals are adjusted periodically as assessment and remediation efforts progress or as additional technical or legal information becomes available. Accruals for environmental liabilities are included in the consolidated balance sheets in “Accrued and other current liabilities” and “Other noncurrent obligations” at undiscounted amounts. Accruals for related insurance or other third-party recoveries for environmental liabilities are recorded when it is probable that a recovery will be realized and are included in the consolidated balance sheets in “Accounts and notes receivable - Other” or "Noncurrent receivables."

Environmental costs are capitalized if the costs extend the life of the property, increase its capacity and/or mitigate or prevent contamination from future operations. Environmental costs are also capitalized in recognition of legal asset retirement obligations resulting from the acquisition, construction and/or normal operation of a long-lived asset. Costs related to environmental contamination treatment and cleanup are charged to expense. Estimated future incremental operations, maintenance and management costs directly related to remediation are accrued when such costs are probable and reasonably estimable.

Cash and Cash Equivalents
Cash and cash equivalents include time deposits and investments with maturities of three months or less at the time of purchase.

Financial Instruments
The Company calculates the fair value of financial instruments using quoted market prices when available. When quoted market prices are not available for financial instruments, the Company uses standard pricing models with market-based inputs that take into account the present value of estimated future cash flows.

The Company utilizes derivatives to manage exposures to foreign currency exchange rates, commodity prices and interest rate risk. The fair values of all derivatives are recognized as assets or liabilities at the balance sheet date. Changes in the fair values of these instruments are reported in income or AOCL, depending on the use of the derivative and whether the Company has elected hedge accounting treatment.

Gains and losses on derivatives that are designated and qualify as cash flow hedging instruments are recorded in AOCL until the underlying transactions are recognized in income. Gains and losses on derivative and non-derivative instruments used as hedges of the Company’s net investment in foreign operations are recorded in AOCL as part of the cumulative translation adjustment. Prior to the adoption of Accounting Standards Update ("ASU") 2017-12, "Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities" in 2018, the ineffective portions of hedges, if any, were recognized in income immediately.

Gains and losses on derivatives designated and qualifying as fair value hedging instruments, as well as the offsetting losses and gains on the hedged items, are reported in income in the same accounting period. Derivatives not designated as hedging instruments are marked-to-market at the end of each accounting period with the results included in income.

Inventories
Inventories are stated at the lower of cost or net realizable value. The method of determining cost for each subsidiary varies among last-in, first-out (“LIFO”); first-in, first-out (“FIFO”); and average cost, and is used consistently from year to year. At December 31, 2019, approximately 32 percent, 58 percent and 10 percent of the Company's inventories were accounted for under the LIFO, FIFO and average cost methods, respectively. At December 31, 2018, approximately 34 percent, 57 percent and 9 percent of the Company's inventories were accounted for under the LIFO, FIFO and average cost methods, respectively.

The Company routinely exchanges and swaps raw materials and finished goods with other companies to reduce delivery time, freight and other transportation costs. These transactions are treated as non-monetary exchanges and are valued at cost.


76



Property
Land, buildings and equipment are carried at cost less accumulated depreciation or amortization. Property under finance lease agreements is carried at the present value of lease payments over the lease term less accumulated amortization. Depreciation is based on the estimated service lives of depreciable assets and is calculated using the straight-line method, unless the asset was capitalized before 1997 when the declining balance method was used. Fully depreciated assets are retained in property and accumulated depreciation accounts until they are removed from service. In the case of disposals, assets and related accumulated depreciation are removed from the accounts, and the net amounts, less proceeds from disposal, are included in income.

Impairment and Disposal of Long-Lived Assets
The Company evaluates long-lived assets and certain identifiable intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. When undiscounted future cash flows are not expected to be sufficient to recover an asset’s carrying amount, the asset is written down to its fair value based on bids received from third parties or a discounted cash flow analysis based on market participant assumptions.

Long-lived assets to be disposed of by sale, if material, are classified as held for sale and reported at the lower of carrying amount or fair value less cost to sell, and depreciation is ceased. Long-lived assets to be disposed of other than by sale are classified as held and used until they are disposed of and reported at the lower of carrying amount or fair value, and depreciation is recognized over the remaining useful life of the assets.

Goodwill and Other Intangible Assets
The Company records goodwill when the purchase price of a business combination exceeds the estimated fair value of net identified tangible and intangible assets acquired. Goodwill is tested for impairment at the reporting unit level annually in the fourth quarter, or more frequently when events or changes in circumstances indicate that the fair value of a reporting unit has more likely than not declined below its carrying value. When testing goodwill for impairment, the Company may first assess qualitative factors. If an initial qualitative assessment identifies that it is more likely than not that the fair value of a reporting unit is less than its carrying value, additional quantitative testing is performed. The Company may also elect to skip the qualitative testing and proceed directly to the quantitative testing. If the quantitative testing indicates that goodwill is impaired, an impairment charge is recognized based on the difference between the reporting unit's carrying value and its fair value. The Company primarily utilizes a discounted cash flow methodology to calculate the fair value of its reporting units.

Finite-lived intangible assets such as purchased customer lists, developed technology, patents, trademarks and software, are amortized over their estimated useful lives, generally on a straight-line basis for periods ranging primarily from 3 to 20 years. Indefinite-lived intangible assets are reviewed for impairment or obsolescence annually, or more frequently when events or changes in circumstances indicate that the carrying amount of an intangible asset may not be recoverable. If impaired, intangible assets are written down to fair value based on discounted cash flows.

Asset Retirement Obligations
The Company records asset retirement obligations as incurred and reasonably estimable, including obligations for which the timing and/or method of settlement are conditional on a future event that may or may not be within the control of the Company. The fair values of obligations are recorded as liabilities on a discounted basis and are accreted over time for the change in present value. Costs associated with the liabilities are capitalized and amortized over the estimated remaining useful life of the asset, generally for periods of 10 years or less.

Investments
Investments in debt securities, primarily held by the Company's insurance operations, are classified as trading, available-for-sale or held-to-maturity. Investments classified as trading are reported at fair value with unrealized gains and losses related to mark-to-market adjustments included in income. Those classified as available-for-sale are reported at fair value with unrealized gains and losses recorded in AOCL. Those classified as held-to-maturity are recorded at amortized cost. The cost of investments sold is determined by FIFO or specific identification.

Investments in equity securities with a readily determinable fair value are reported at fair value with unrealized gains and losses related to mark-to-market adjustments included in income. Equity securities without a readily determinable fair value are accounted for at cost, adjusted for impairments and observable price changes in orderly transactions.

The Company routinely reviews its investments for declines in fair value below the cost basis. When events or changes in circumstances indicate the carrying value of an asset may not be recoverable, the security is written down to fair value, establishing a new cost basis.


77



Leases
Effective January 1, 2019, the Company adopted ASU 2016-02, “Leases (Topic 842),” and the associated ASUs (collectively, “Topic 842”). The Company added the following significant accounting policy for leases as a result of the adoption of Topic 842.

The Company determines whether a contract contains a lease at contract inception. A contract contains a lease if there is an identified asset and the Company has the right to control the asset.

Operating lease right-of-use (“ROU”) assets represent the Company's right to use an underlying asset for the lease term, and lease liabilities represent the Company's obligation to make lease payments arising from the lease. Operating lease ROU assets and lease liabilities are recognized at commencement date based on the present value of lease payments over the lease term. The Company uses the incremental borrowing rate in determining the present value of lease payments, unless the implicit rate is readily determinable. If lease terms include options to extend or terminate the lease, the ROU asset and lease liability are measured based on the reasonably certain decision. Leases with a term of 12 months or less at the commencement date are not recognized on the balance sheet and are expensed as incurred.

The Company has lease agreements with lease and non-lease components, which are accounted for as a single lease component for all classes of leased assets for which the Company is the lessee. Additionally, for certain equipment leases, the portfolio approach is applied to account for the operating lease ROU assets and lease liabilities. In the consolidated statements of income, lease expense for operating lease payments is recognized on a straight-line basis over the lease term. For finance leases, interest expense is recognized on the lease liability and the ROU asset is amortized over the lease term.

Some leasing arrangements require variable payments that are dependent upon usage or output, or may vary for other reasons, such as insurance or tax payments. Variable lease payments are recognized as incurred and are not presented as part of the ROU asset or lease liability. See Notes 2 and 18 for additional information.

Revenue
Effective with the January 1, 2018 adoption of ASU 2014-09, "Revenue from Contracts with Customers (Topic 606)," and the associated ASUs (collectively, "Topic 606"), the Company recognizes revenue when its customer obtains control of promised goods or services in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. To determine revenue recognition for the arrangements that the Company determines are within the scope of Topic 606, the Company performs the following five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations in the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract and (5) recognize revenue when (or as) the entity satisfies a performance obligation. See Note 5 for additional information.

Revenue related to the Company's insurance operations includes third-party insurance premiums, which are earned over the terms of the related insurance policies and reinsurance contracts.

In periods prior to the adoption of Topic 606, the Company's accounting policy was to recognize revenue when it was realized or realizable, and the earnings process was complete. Revenue for product sales was recognized as risk and title to the product transferred to the customer, which usually occurred at the time shipment was made. As such, title to the product passed when the product was delivered to the freight carrier. The Company’s standard terms of delivery were included in its contracts of sale, order confirmation documents and invoices. Revenue related to the initial licensing of patent and technology was recognized when earned; revenue related to running royalties was recognized according to licensee production levels.

Severance Costs
The Company routinely reviews its operations around the world in an effort to ensure competitiveness across its businesses and geographic regions. When the reviews result in a workforce reduction related to the shutdown of facilities or other optimization activities, severance benefits are provided to employees primarily under the Company’s ongoing benefit arrangements. These severance costs are accrued once management commits to a plan of termination and it becomes probable that employees will be entitled to benefits at amounts that can be reasonably estimated.

Integration and Separation Costs
The Company classifies expenses related to the Merger and separation and the ownership restructure of Dow Silicones as "Integration and separation costs" in the consolidated statements of income. Merger and separation related costs include: costs incurred to prepare for and close the Merger, post-Merger integration expenses, costs incurred for the separation of AgCo and SpecCo and costs related to the integration of ECP. The Dow Silicones-related costs include integration expenses incurred after the close of the ownership restructure. Integration and separation costs primarily consist of financial adviser, information technology, legal, accounting, consulting and other professional advisory fees associated with preparation and execution of these activities. 

78



Income Taxes
The Company accounts for income taxes using the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences of temporary differences between the carrying amounts and tax bases of assets and liabilities using enacted tax rates. The effect of a change in tax rates on deferred tax assets or liabilities is recognized in income in the period that includes the enactment date. The Company uses the portfolio approach for releasing income tax effects from AOCL.

Effective with the Merger, TDCC and Historical DuPont were subsidiaries of DowDuPont. Prior to the separation, TDCC was included in DowDuPont's consolidated tax groups and related income tax returns within certain jurisdictions. The Company records a separate tax liability for its share of the taxable income and tax attributes and obligations on DowDuPont’s consolidated income tax returns following a formula consistent with the economic sharing of tax attributes and obligations. The Company and Historical DuPont compute the amount due to DowDuPont for their share of taxable income and tax attributes and obligations on DowDuPont’s consolidated tax return. The amounts reported as income tax payable or receivable represent the Company’s payment obligation (or refundable amount) to DowDuPont based on a theoretical tax liability calculated based on the methodologies agreed, elected or required in each combined or consolidated filing jurisdiction.

The Company recognizes the financial statement effects of an uncertain income tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. The Company accrues for other tax contingencies when it is probable that a liability to a taxing authority has been incurred and the amount of the contingency can be reasonably estimated. The current portion of uncertain income tax positions is included in “Income taxes payable” and the long-term portion is included in “Other noncurrent obligations” in the consolidated balance sheets.

Provision is made for taxes on undistributed earnings of foreign subsidiaries and related companies to the extent that such earnings are not deemed to be permanently invested.

See Note 9 for further information relating to the enactment of the Tax Cuts and Jobs Act ("The Act") in 2017.

Earnings per Common Share
The calculation of earnings per common share is based on the weighted-average number of the Company's common shares outstanding for the applicable period. The calculation of diluted earnings per common share reflects the effect of all potential common shares that were outstanding during the respective periods, unless the effect of doing so is antidilutive.

Adoption of Accounting Standards
Effective January 1, 2019, the Company adopted Topic 842 and added the accounting policy discussed in the section above. Adoption of the new standard resulted in the recording of operating lease ROU assets and lease liabilities of $2.3 billion at January 1, 2019. The net impact to “Retained earnings” was an increase of $32 million and was primarily a result of the recognition of a deferred gain associated with a prior sale-leaseback transaction. The adoption of the new guidance did not have a material impact on Dow's consolidated statements of income and had no impact on cash flows. See Notes 2 and 18 for additional information.

Additionally, the Company's consolidated balance sheets reflect the impact of the adoption of Topic 606 at January 1, 2019, by certain nonconsolidated affiliates of the Company, which were subsequently distributed as part of the separation from DowDuPont. The net impact is reflected in assets and liabilities of discontinued operations with a corresponding reduction to "Retained earnings" of $183 million in the consolidated balance sheets at January 1, 2019.

2018
In the first quarter of 2018, the Company adopted Topic 606, ASU 2016-01, "Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities" and ASU 2016-16, "Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory." The adoption of these ASUs resulted in a net decrease of $68 million to "Retained earnings" and a decrease of $20 million to "Accumulated other comprehensive loss" ("AOCL") in the consolidated statements of equity at January 1, 2018. In the second quarter of 2018, the Company early adopted ASU 2018-02, "Income Statement - Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income ("ASU 2018-02")." The adoption of this standard resulted in a $1,057 million increase to "Retained earnings" due to the reclassification from AOCL in the consolidated statements of equity at April 1, 2018.


79



Dividends
Prior to the Merger, TDCC declared dividends of $1.38 per share in 2017, based on the historical number of shares of common stock of TDCC held by shareholders of record for each dividend. Effective with the Merger, TDCC no longer had publicly traded common stock. TDCC's common shares were owned solely by its parent company, DowDuPont, prior to separation, and TDCC's Board of Directors determined whether or not there would be a dividend distribution to DowDuPont. Effective with the separation from DowDuPont, TDCC became a wholly owned subsidiary of Dow Inc. and TDCC's Board of Directors determines whether or not there will be a dividend distribution to Dow Inc. Subsequent to the separation from DowDuPont, Dow Inc. declared dividends of $2.10 per share in 2019. See Notes 19 and 26 for additional information.


NOTE 2 – RECENT ACCOUNTING GUIDANCE
Recently Adopted Accounting Guidance
In 2019, the Company adopted Topic 842, which requires organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. The new guidance requires that a lessee recognize assets and liabilities for leases, and recognition, presentation and measurement in the financial statements will depend on its classification as a finance or operating lease. In addition, the new guidance requires disclosures to help investors and other financial statement users better understand the amount, timing and uncertainty of cash flows arising from leases. Lessor accounting remains largely unchanged from legacy U.S. GAAP but does contain some targeted improvements to align with the new revenue recognition guidance in Topic 606. The new standard was effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2018, and early adoption was permitted.

The Company adopted Topic 842 using the modified retrospective transition approach, applying the new standard to leases existing at the date of initial adoption. The Company elected to apply the transition requirements at the effective date rather than at the beginning of the earliest comparative period presented with a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption, and prior periods were not restated. In addition, the Company elected to apply the package of practical expedients permitted under the transition guidance which does not require reassessment of prior conclusions, lease classification and initial direct lease costs. The Company did not elect to use the hindsight practical expedient in determining the lease term or assessing impairment of ROU assets. Adoption of the new standard resulted in the recording of operating lease ROU assets and lease liabilities of $2.3 billion at January 1, 2019. The net impact to retained earnings was an increase of $32 million and was primarily a result of the recognition of a deferred gain associated with a prior sale-leaseback transaction. The adoption of the new guidance did not have a material impact on Dow's consolidated statements of income and had no impact on cash flows. See Notes 1 and 18 for additional information.

Accounting Guidance Issued But Not Adopted at December 31, 2019
In August 2018, the Financial Accounting Standards Board ("FASB") issued ASU 2018-13, "Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement," which is part of the FASB disclosure framework project to improve the effectiveness of disclosures in the notes to the financial statements. The amendments in the new guidance remove, modify and add certain disclosure requirements related to fair value measurements covered in Topic 820, "Fair Value Measurement." The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted for either the entire standard or only the requirements that modify or eliminate the disclosure requirements, with certain requirements applied prospectively, and all other requirements applied retrospectively to all periods presented. The Company expects to adopt the new guidance in the first quarter of 2020 and the adoption of this guidance is not expected to have a material impact on the consolidated financial statements.

In August 2018, the FASB issued ASU 2018-15, "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40): Customer's Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That is a Service Contract," which requires a customer in a cloud computing arrangement that is a service contract to follow the internal-use software guidance in Topic 350, "Intangibles - Goodwill and Other" to determine which implementation costs to capitalize as assets or expense as incurred. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted and an entity can elect to apply the new guidance on a prospective or retrospective basis. The Company expects to adopt the new guidance in the first quarter of 2020 and the adoption of this guidance is not expected to have a material impact on the consolidated financial statements.

In December 2019, the FASB issued ASU 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes." The amendments simplify the accounting for income taxes by removing certain exceptions to the general principles of Topic 740, "Income Taxes" and also improve consistent application by clarifying and amending existing guidance. The new standard is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted, with the amendments to be applied on a retrospective, modified retrospective or prospective basis, depending on the specific amendment. The Company is currently evaluating the impact of adopting this guidance.

80



NOTE 3 - MERGER WITH HISTORICAL DUPONT
Effective August 31, 2017, TDCC and Historical DuPont completed the merger of equals transaction contemplated by the Merger Agreement, by and among TDCC, Historical DuPont, DowDuPont, Diamond Merger Sub, Inc. and Orion Merger Sub, Inc. Pursuant to the Merger Agreement, (i) Diamond Merger Sub, Inc. was merged with and into TDCC, with TDCC surviving the merger as a subsidiary of DowDuPont (the "Diamond Merger") and (ii) Orion Merger Sub, Inc. was merged with and into Historical DuPont, with Historical DuPont surviving the merger as a subsidiary of DowDuPont (the "Orion Merger" and, together with the Diamond Merger, the "Mergers"). Following the consummation of the Mergers, each of TDCC and Historical DuPont became subsidiaries of DowDuPont. Subsequent to the Merger, TDCC and Historical DuPont engaged in a series of internal reorganization and realignment steps to realign their businesses into three subgroups: agriculture, materials science and specialty products. Dow Inc. was formed as a wholly owned subsidiary of DowDuPont to serve as the holding company for the materials science business.

Upon completion of the Diamond Merger, each share of common stock, par value $2.50 per share, of TDCC ("TDCC Common Stock") (excluding any shares of TDCC Common Stock that were held in treasury immediately prior to the effective time of the Diamond Merger, which were automatically canceled and retired for no consideration) was converted into the right to receive one fully paid and non-assessable share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). As provided in the Merger Agreement, at the effective time of the Mergers, (i) all options, deferred stock, performance deferred stock and other equity awards relating to shares of TDCC Common Stock outstanding immediately prior to the effective time of the Mergers were generally automatically converted into options and deferred stock and other equity awards relating to shares of DowDuPont Common Stock after giving effect to appropriate adjustments to reflect the Mergers and otherwise generally on the same terms and conditions as applied under the applicable plans and award agreements immediately prior to the effective time of the Mergers. See Note 22 for additional information on the conversion of the equity awards.

In the third quarter of 2017, as a result of the Diamond Merger and the Merger, TDCC recorded a reduction in "Treasury stock" of $935 million, a reduction in "Common stock" of $3,107 million and an increase in "Additional paid in capital" of $2,172 million. At September 1, 2017, TDCC had 100 shares of common stock issued and outstanding, par value $0.01 per share, owned solely by its parent, DowDuPont. Following the separation from DowDuPont, these shares are now solely owned by Dow Inc.

On August 31, 2017, following the Diamond Merger, TDCC requested that the New York Stock Exchange ("NYSE") withdraw the shares of TDCC Common Stock from listing on the NYSE and filed a Form 25 with the SEC to report that the shares of TDCC Common Stock are no longer listed on the NYSE. The shares of TDCC Common Stock were suspended from trading on the NYSE prior to the open of trading on September 1, 2017.

As a condition of the regulatory approval of the Merger, TDCC and Historical DuPont agreed to certain closing conditions, which are as follows:

TDCC divested its global Ethylene Acrylic Acid copolymers and ionomers business ("EAA Business") to SK Global Chemical Co., Ltd., on September 1, 2017, as part of a divestiture commitment given to the European Commission ("EC") in connection with the EC's conditional approval of the Merger granted on March 27, 2017. See Note 6 for additional information on this transaction.

Historical DuPont divested its Cereal Broadleaf Herbicides and Chewing Insecticides portfolios as well as its Crop Protection research and development ("R&D") pipeline and organization (excluding seed treatment, nematicides, late-stage R&D programs and certain personnel needed to support marketed products and R&D programs that remained with Historical DuPont) (collectively, the "DuPont Divested Assets") to FMC Corporation ("FMC") on November 1, 2017, as part of the EC's conditional approval granted on March 27, 2017. Also on November 1, 2017, Historical DuPont completed its acquisition of FMC's Health and Nutrition business, excluding its Omega-3 products.

On May 2, 2017, TDCC and Historical DuPont announced that China's Ministry of Commerce ("MOFCOM") granted conditional regulatory approval for the companies' proposed merger of equals which included commitments already made to the EC including Historical DuPont's divestiture of the DuPont Divested Assets and TDCC's divestiture of the EAA Business. In addition, TDCC and Historical DuPont made commitments related to the supply and distribution in China of certain herbicide and insecticide ingredients and formulations for rice crops for five years after the closing of the Merger.



81



TDCC divested a select portion of Dow AgroSciences' corn seed business in Brazil to CITIC Agri Fund on November 30, 2017. The divestiture was part of the commitment given to Brazil's Administrative Council for Economic Defense ("CADE") in connection with the CADE's conditional approval of the Merger granted on May 17, 2017, which was incremental to commitments already made to the EC, China and regulatory agencies in other jurisdictions. This divestiture was included in discontinued operations of the Company.

On June 15, 2017, TDCC and Historical DuPont announced that a proposed agreement had been reached with the Antitrust Division of the United States Department of Justice that permitted the companies to proceed with the proposed merger of equals transaction. The proposed agreement was consistent with commitments already made to the EC.


NOTE 4 – SEPARATION FROM DOWDUPONT
On April 1, 2019, DowDuPont completed the previously announced separation of its materials science business. The separation was effected by way of a pro rata distribution of all of the then-issued and outstanding shares of Dow Inc. common stock to DowDuPont stockholders of record as of the close of business, Eastern Time, on March 21, 2019 (the “Record Date”). The shareholders of record of DowDuPont received one share of Dow Inc. common stock, par value $0.01 per share, for every three shares of DowDuPont common stock, par value $0.01 per share, held as of the Record Date ("Distribution Ratio"). No fractional shares of Dow Inc. common stock were issued. Instead, cash in lieu of any fractional shares was paid to DowDuPont registered shareholders. The number of shares of Dow Inc. common stock issued on April 1, 2019 was 748.8 million shares. Dow Inc. is now an independent, publicly traded company and Dow Inc. common stock is listed on the NYSE under the symbol “DOW.” Dow Inc. common stock began regular-way trading on April 2, 2019, the first day following the distribution.

Effective April 1, 2019, TDCC became a wholly owned subsidiary of Dow Inc. As of the effective date and time of the distribution, DowDuPont does not beneficially own any equity interest in Dow and will no longer consolidate Dow and its consolidated subsidiaries into its financial results. Beginning in the second quarter of 2019, Dow’s consolidated financial results reflect the results of Dow Inc. and its consolidated subsidiaries - that is, TDCC after giving effect to the distribution of AgCo and SpecCo and the receipt of ECP. The consolidated financial results of Dow for periods prior to April 1, 2019, reflect the distribution of AgCo and SpecCo as discontinued operations for each period presented as well as reflect the receipt of ECP as a common control transaction from the closing of the Merger on August 31, 2017.

On April 1, 2019, Dow Inc. received a cash contribution of $2,024 million from DowDuPont as part of the internal reorganization and business realignment steps between Dow Inc., TDCC and DowDuPont. Dow Inc. recognized a reduction to "Retained earnings" of $14,806 million in 2019 as a result of the cash contribution, the distribution of AgCo and SpecCo, and other separation related adjustments. TDCC recognized a reduction to "Retained earnings" of $16,009 million in 2019 as a result of the distribution of AgCo and SpecCo.

Receipt of ECP
As the receipt of ECP was accounted for as a transfer between entities under common control, the consolidated financial statements have been retrospectively adjusted to reflect the receipt of ECP from the closing of the Merger on August 31, 2017. All intercompany transactions have been eliminated in consolidation.


82



Distribution of AgCo and SpecCo
Upon distribution, the Company retrospectively adjusted the previously issued consolidated financial statements and presented AgCo and SpecCo as discontinued operations based on the guidance in Accounting Standards Codification (“ASC”) 205-20 “Discontinued Operations” (“ASC 205-20”). The results of operations of AgCo and SpecCo are presented as discontinued operations in the consolidated statements of income and are summarized in the following table:

Results of Operations of AgCo and SpecCo
2019 1
2018
2017
In millions
Net sales
$
2,953

$
12,187

$
12,337

Cost of sales
1,804

7,668

7,769

Research and development expenses
175

761

854

Selling, general and administrative expenses
262

1,108

1,143

Amortization of intangibles
61

249

255

Restructuring and asset related charges - net
78

411

376

Integration and separation costs


18

Equity in earnings of nonconsolidated affiliates
28

400

372

Sundry income (expense) - net
(18
)
(13
)
245

Interest income
3

26

40

Interest expense and amortization of debt discount
7

56

61

Income from discontinued operations before income taxes
$
579

$
2,347

$
2,518

Provision for income taxes
134

512

636

Income from discontinued operations, net of tax
$
445

$
1,835

$
1,882

1. Results through March 31, 2019.

The carrying amount of major classes of assets and liabilities related to the distribution of AgCo and SpecCo consisted of the following:

Carrying Values of AgCo and SpecCo 1
Dec 31, 2018
In millions
Accounts and notes receivable - Trade
$
2,768

Accounts and notes receivable - Other
773

Inventories
2,826

Other current assets
151

Investment in nonconsolidated affiliates
612

Other investments
2

Noncurrent receivables
35

Net property
3,014

Goodwill
7,590

Other intangible assets
1,830

Deferred income tax assets
239

Deferred charges and other assets
60

Total assets of discontinued operations
$
19,900

Notes payable
$
7

Long-term debt due within one year
4

Accounts payable - Trade
1,118

Accounts payable - Other
868

Income taxes payable
234

Accrued and other current liabilities
716

Long-Term Debt
5

Deferred income tax liabilities
568

Pension and other postretirement benefits - noncurrent
306

Other noncurrent obligations
662

Total liabilities of discontinued operations
$
4,488

1.
Includes assets and liabilities of consolidated variable interest entities related to discontinued operations.


83


Agreements Related to the Separation and Distribution
In connection with the separation, Dow Inc. entered into certain agreements with DuPont and/or Corteva, Inc. ("Corteva"), including the following: Separation and Distribution Agreement, Tax Matters Agreement and Employee Matters Agreement (collectively, the "Agreements"). In addition to establishing the terms of the separation, the Agreements provide a framework for Dow’s interaction with DuPont and Corteva after the separation and also provide for the allocation among Dow, DuPont and Corteva of assets, liabilities and obligations attributable to periods prior to, at and after the completion of the separation. The Agreements also contain certain indemnity and/or cross-indemnity provisions that are intended to set forth each party’s respective rights, responsibilities and obligations for matters subject to indemnification. Except in certain instances, the parties’ indemnification obligations are uncapped. Certain indemnification obligations will be subject to reduction by insurance proceeds or other third-party proceeds of the indemnified party that reduces the amount of the loss. In addition, indemnifiable losses will be subject to, in certain cases, “de minimis” threshold amounts and, in certain cases, deductible amounts.

The impacts of indemnifications and other post-separation matters relating to the Agreements are primarily reflected in the consolidated financial statements of Dow Inc. In 2019, the Company recorded pretax charges related to the Agreements of $24 million in "Integration and separation costs" and $69 million in "Sundry income (expense) - net" in the consolidated statements of income of Dow Inc., and related to Corporate. At December 31, 2019, the Company had assets of $58 million included in "Other current assets" and $52 million included in "Noncurrent receivables," and liabilities of $352 million included in "Accrued and other current liabilities" and $96 million included in "Other noncurrent obligations" in the consolidated balance sheets of Dow Inc. related to the Agreements. Any adjustments to these assets and liabilities in subsequent periods will be recorded in Dow Inc.'s results of operations. In addition, the Company deferred approximately $400 million of the cash distribution received from DowDuPont at separation and recorded an associated liability with an offset to "Retained earnings" in the consolidated balance sheets of Dow Inc. At December 31, 2019, $130 million of this liability was recorded in "Accrued and other current liabilities" and $270 million was recorded in "Other noncurrent obligations" in the consolidated balance sheets of Dow Inc. The final resolution of this liability is uncertain and any subsequent adjustments to the carrying value of this liability will be reflected in equity of Dow Inc. Following the separation, Dow Inc. made cash payments of $215 million related to the Agreements, recorded in "Cash flows from operating activities - discontinued operations" in the Dow Inc. consolidated statements of cash flows. The Company also received $98 million related to the Agreements, recorded in "Other assets and liabilities, net" within "Cash flows from operating activities - continuing operations" in the Dow Inc. consolidated statements of cash flows.

Continuing Involvement
The Company has certain product and service agreements with DuPont and Corteva that were considered intercompany transactions prior to the separation, but are trade transactions subsequent to the separation. These transactions have been retrospectively reclassified as trade transactions in the consolidated financial statements. Based on the Company’s assessment of the specific factors identified in ASC Topic 205, “Presentation of Financial Statements,” the Company concluded that these agreements do not constitute significant continuing involvement in AgCo or SpecCo.

Integration and Separation Costs
Integration and separation costs, which reflect costs related to post-Merger integration and business separation activities, as well as the ownership restructure of Dow Silicones (through May 31, 2018), were $1,063 million and $1,039 million for Dow Inc. and TDCC, respectively, in 2019, compared with $1,179 million in 2018 and $798 million in 2017. Integration and separation costs related to post-Merger integration and business separation activities are expected to be substantially complete by the end of 2020.


NOTE 5 – REVENUE
The majority of the Company's revenue is derived from product sales. In 2019, 98 percent of the Company's revenue related to product sales (99 percent in 2018 and 98 percent in 2017). The remaining sales were primarily related to the Company's insurance operations and licensing of patents and technologies.

Product Sales
Product sales consist of sales of the Company's products to manufacturers and distributors. The Company considers order confirmations or purchase orders, which in some cases are governed by master supply agreements, to be contracts with a customer. Product sale contracts are generally short-term contracts where the time between order confirmation and satisfaction of all performance obligations is less than one year. However, the Company has some long-term contracts which can span multiple years.

Revenues from product sales are recognized when the customer obtains control of the product, which occurs at a point in time, usually upon shipment, with payment terms typically in the range of 30 to 60 days after invoicing, depending on business and geographic region. When the Company performs shipping and handling activities after the transfer of control to the customer (e.g., when control transfers prior to shipment), these are considered fulfillment activities, and accordingly, the costs are accrued when

84


the related revenue is recognized. Taxes collected from customers relating to product sales and remitted to governmental authorities are excluded from revenues. The Company elected to use the practical expedient to expense cash and non-cash sales incentives, as the amortization period for the costs to obtain the contract would have been one year or less.

Certain long-term contracts include a series of distinct goods that are delivered continuously to the customer through a pipeline (e.g., feedstocks). For these types of product sales, the Company invoices the customer in an amount that directly corresponds with the value to the customer of the Company’s performance to date. As a result, the Company recognizes revenue based on the amount billable to the customer in accordance with the right to invoice practical expedient.

The transaction price includes estimates for reductions in revenue from customer rebates and right of returns on product sales. These amounts are estimated based upon the most likely amount of consideration to which the customer will be entitled. All estimates are based on historical experience, anticipated performance and the Company’s best judgment at the time to the extent it is probable that a significant reversal of revenue recognized will not occur. All estimates for variable consideration are reassessed periodically. The Company elected the practical expedient to not adjust the amount of consideration for the effects of a significant financing component for all instances in which the period between payment and transfer of the goods will be one year or less.

For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation based on the relative standalone selling price. The standalone selling price is the observable price which depicts the price as if sold to a similar customer in similar circumstances.

Patents, Trademarks and Licenses
The Company enters into licensing arrangements in which it licenses certain rights of its patents and technology to customers. Revenue from the majority of the Company’s licenses for patents and technology is derived from sales-based royalties. The Company estimates the amount of sales-based royalties it expects to be entitled to based on historical sales to the customer. For the remaining revenue from licensing arrangements, payments are typically received from the Company's licensees based on billing schedules established in each contract. Revenue is recognized when the performance obligation is satisfied.

Remaining Performance Obligations
Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. At December 31, 2019, the Company had unfulfilled performance obligations for the licensing of technology of $826 million, and expects revenue to be recognized for the remaining performance obligations over the next one to seven years.

The remaining performance obligations are for product sales that have expected durations of one year or less, product sales of materials delivered through a pipeline for which the Company has elected the right to invoice practical expedient, or variable consideration attributable to royalties for licenses of patents and technology. The Company has received advance payments from customers related to long-term supply agreements that are deferred and recognized over the life of the contract, with remaining contract terms that range up to 21 years. The Company will have rights to future consideration for revenue recognized when product is delivered to the customer. These payments are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets.


85


Disaggregation of Revenue
The Company disaggregates its revenue from contracts with customers by segment and business, as the Company believes it best depicts the nature, amount, timing and uncertainty of its revenue and cash flows. See details in the tables below:

Net Trade Sales by Segment and Business
2019
2018
In millions
Hydrocarbons & Energy
$
5,357

$
7,587

Packaging and Specialty Plastics
14,888

16,608

Packaging & Specialty Plastics
$
20,245

$
24,195

Industrial Solutions
$
4,310

$
4,812

Polyurethanes & Construction Chemicals
9,117

10,615

Others
13

20

Industrial Intermediates & Infrastructure
$
13,440

$
15,447

Coatings & Performance Monomers
$
3,517

$
3,979

Consumer Solutions
5,406

5,698

Performance Materials & Coatings
$
8,923

$
9,677

Corporate
$
343

$
285

Total
$
42,951

$
49,604


Net Trade Sales by Geographic Region
2019
2018
In millions
U.S. & Canada
$
15,549

$
17,809

EMEAI 1
14,612

17,406

Asia Pacific
8,676

9,404

Latin America
4,114

4,985

Total
$
42,951

$
49,604

1. Europe, Middle East, Africa and India.

Contract Assets and Liabilities
The Company receives payments from customers based upon contractual billing schedules. Accounts receivable are recorded when the right to consideration becomes unconditional. Contract assets include amounts related to the Company’s contractual right to consideration for completed performance obligations not yet invoiced. Contract liabilities include payments received in advance of performance under the contract, and are realized when the associated revenue is recognized under the contract. "Contract liabilities - current" primarily reflects deferred revenue from prepayments from customers for product to be delivered in 12 months or less. "Contract liabilities - noncurrent" includes advance payments that the Company has received from customers related to long-term supply agreements and royalty payments that are deferred and recognized over the life of the contract.

The Company's contract liabilities increased from December 31, 2018 to December 31, 2019 due to advanced payments from customers related to long-term product supply agreements. Revenue recognized in 2019 from amounts included in contract liabilities at the beginning of the period was approximately $145 million ($205 million in 2018). In 2019, the amount of contract assets reclassified to receivables as a result of the right to the transaction consideration becoming unconditional was approximately $15 million ($12 million in 2018). The Company did not recognize any asset impairment charges related to contract assets in 2019 or 2018.


86


The following table summarizes the contract assets and liabilities at December 31, 2019 and 2018:

Contract Assets and Liabilities at Dec 31
2019
2018
In millions
Accounts and notes receivable - Trade
$
4,844

$
5,646

Contract assets - current 1
$
41

$
19

Contract assets - noncurrent 2
$
4

$
1

Contract liabilities - current 3
$
193

$
134

Contract liabilities - noncurrent 4
$
1,607

$
1,318

1. Included in "Other current assets" in the consolidated balance sheets.
2. Included in "Deferred charges and other assets" in the consolidated balance sheets.
3. Included in "Accrued and other current liabilities" in the consolidated balance sheets.
4. Included in "Other noncurrent obligations" in the consolidated balance sheets.


NOTE 6 – DIVESTITURES
Merger Remedy - Divestiture of the Global Ethylene Acrylic Acid Copolymers and Ionomers Business
On February 2, 2017, as a condition of regulatory approval of the Merger, the Company announced it would divest its global EAA Business to SK Global Chemical Co., Ltd. The divestiture included production assets located in Freeport, Texas, and Tarragona, Spain, along with associated intellectual property and product trademarks. Under terms of the purchase agreement, SK Global Chemical Co., Ltd will honor certain customer and supplier contracts and other agreements. On September 1, 2017, the sale was completed for $296 million, net of working capital adjustments, costs to sell and other adjustments, with proceeds subject to customary post-closing adjustments. As a result, in 2017, the Company recognized a pretax gain of $227 million on the sale, included in "Sundry income (expense) - net" in the consolidated statements of income and related to the Packaging & Specialty Plastics segment.

The Company evaluated the divestiture of the EAA Business and determined it did not represent a strategic shift that had a major effect on the Company’s operations and financial results and did not qualify as an individually significant component of the Company. As a result, this divestiture was not reported in discontinued operations.


NOTE 7 – RESTRUCTURING, GOODWILL IMPAIRMENT AND ASSET RELATED CHARGES - NET
The "Restructuring, goodwill impairment and asset related charges - net" line in the consolidated statements of income is used to record charges for restructuring programs, goodwill impairments, and other asset related charges, which includes other asset impairments.

DowDuPont Cost Synergy Program
In September and November 2017, DowDuPont approved post-merger restructuring actions under the DowDuPont Cost Synergy Program (the "Synergy Program") which was designed to integrate and optimize the organization following the Merger and in preparation for the business separations. The Company expected (prior to the impact of any discontinued operations) to record total pretax restructuring charges of approximately $1.3 billion, which included initial estimates of approximately $525 million to $575 million of severance and related benefit costs, $400 million to $440 million of asset write-downs and write-offs, and $290 million to $310 million of costs associated with exit and disposal activities. The restructuring charges below reflect charges from continuing operations.

The Company recorded pretax restructuring charges of $399 million in 2017, consisting of severance and related benefit costs of $307 million, asset write-downs and write-offs of $87 million and costs associated with exit and disposal activities of $5 million.
The Company recorded pretax restructuring charges of $184 million in 2018, consisting of severance and related benefit costs of $137 million, assets write-downs and write-offs of $33 million and costs associated with exit and disposal activities of $14 million.
For the year ended December 31, 2019, the Company recorded pretax restructuring charges of $292 million, consisting of severance and related benefit costs of $123 million, asset write-downs and write-offs of $143 million and costs associated with exit and disposal activities of $26 million. The impact of these charges is shown as "Restructuring, goodwill impairment and asset related charges ‑ net" in the consolidated statements of income. The Company expects the Synergy Program to be substantially complete by the end of the second quarter of 2020.


87


The following table summarizes the activities related to the Synergy Program. At December 31, 2019, $52 million was included in "Accrued and other current liabilities" ($205 million at December 31, 2018) and $19 million was included in "Other noncurrent obligations" ($12 million at December 31, 2018) in the consolidated balance sheets.

DowDuPont Synergy Program
Severance and Related Benefit Costs
Asset Write-downs and Write-offs
Costs Associated with Exit and Disposal Activities
Total
In millions
2017 restructuring charges
 
 
 
 
Packaging & Specialty Plastics
$

$
33

$
3

$
36

Industrial Intermediates & Infrastructure

12


12

Performance Materials & Coatings

9

2

11

Corporate
307

33


340

Total 2017 restructuring charges
$
307

$
87

$
5

$
399

Charges against the reserve

(87
)

(87
)
Cash payments
(37
)


(37
)
Reserve balance at Dec 31, 2017
$
270

$

$
5

$
275

2018 restructuring charges
 
 
 

Packaging & Specialty Plastics
$

$
10

$
3

$
13

Industrial Intermediates & Infrastructure


11

11

Performance Materials & Coatings

7


7

Corporate
137

16


153

Total 2018 restructuring charges
$
137

$
33

$
14

$
184

Charges against the reserve

(33
)

(33
)
Cash payments
(197
)

(12
)
(209
)
Reserve balance at Dec 31, 2018
$
210

$

$
7

$
217

2019 restructuring charges
 
 
 
 
Packaging & Specialty Plastics
$

$

$
1

$
1

Industrial Intermediates & Infrastructure

2

5

7

Performance Materials & Coatings

28


28

Corporate
123

113

20

256

Total 2019 restructuring charges
$
123

$
143

$
26

$
292

Charges against the reserve

(143
)

(143
)
Cash payments
(279
)

(16
)
(295
)
Reserve balance at Dec 31, 2019
$
54

$

$
17

$
71



Asset Write-downs and Write-offs
The restructuring charges related to the write-down and write-off of assets in 2017 are as follows:

The Company recorded a charge of $22 million for asset write-downs and write-offs aligned with an energy project, including the write-off of capital projects and other non-manufacturing assets in Packaging & Specialty Plastics.

The Company recorded a charge of $65 million for other miscellaneous asset write-downs and write-offs, including the shutdown of several small manufacturing facilities and the write-off of non-manufacturing assets, certain corporate facilities and data centers. The charge related to Packaging & Specialty Plastics ($11 million), Industrial Intermediates & Infrastructure ($12 million), Performance Materials & Coatings ($9 million) and Corporate ($33 million). These manufacturing facilities were shut down primarily by the end of 2019.

The restructuring charges related to the write-down and write-off of assets in 2018 are as follows:

The Company recorded a charge of $33 million for other miscellaneous asset write-downs and write-offs, including the shutdown of several small manufacturing facilities and the write-off of leased, non-manufacturing assets and certain corporate facilities. The charge related to Packaging & Specialty Plastics ($10 million), Performance Materials & Coatings ($7 million) and Corporate ($16 million). These manufacturing facilities were shut down by the end of 2019.


88


The restructuring charges related to the write-down and write-off of assets in 2019 are as follows:

The Company recorded a charge of $143 million for other miscellaneous asset write-downs and write-offs, including the shutdown of several small manufacturing facilities and the write-off of non-manufacturing assets and certain corporate facilities. The charge related to Industrial Intermediates & Infrastructure ($2 million), Performance Materials & Coatings ($28 million) and Corporate ($113 million). These manufacturing facilities will be shut down by the end of the second quarter of 2020.

Costs Associated with Exit and Disposal Activities
The restructuring charges for costs associated with exit and disposal activities, including contract cancellation penalties and environmental remediation liabilities, totaled $5 million in 2017, $14 million in 2018 and $26 million in 2019.

The Company expects to incur additional costs in the future related to its restructuring activities. Future costs are expected to include demolition costs related to closed facilities. These costs will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits, related to its other optimization activities. These costs cannot be reasonably estimated at this time.

Goodwill Impairment
Upon completion of the goodwill impairment testing in the fourth quarter of 2019, the Company determined the fair value of the Coatings & Performance Monomers reporting unit was lower than its carrying amount. As a result, the Company recorded an impairment charge of $1,039 million in the fourth quarter of 2019, included in "Restructuring, goodwill impairment and asset related charges - net" in the consolidated statements of income and related to Performance Materials & Coatings.

In 2017, upon completion of the annual goodwill impairment testing, the Company determined the fair value of the Coatings & Performance Monomers reporting unit was lower than its carrying amount and as a result, recorded an impairment charge of $1,491 million in the fourth quarter of 2017, included in “Restructuring, goodwill impairment and asset related charges - net” in the consolidated statements of income and related to Performance Materials & Coatings. See Note 14 for additional information on these impairment charges.

Asset Related Charges
2019 Charges
In 2019, the Company recognized additional pretax impairment charges of $58 million related primarily to capital additions made to a biopolymers manufacturing facility in Santa Vitoria, Minas Gerais, Brazil ("Santa Vitoria"), which was impaired in 2017. The impairment charges were included in “Restructuring, goodwill impairment and asset related charges - net” in the consolidated statements of income and related to Packaging & Specialty Plastics ($44 million), Performance Materials & Coatings ($9 million) and Corporate ($5 million). See Note 24 for additional information.

On August 13, 2019, the Company entered into a definitive agreement to sell its acetone derivatives business to ALTIVIA Ketones & Additives, LLC. The transaction closed on November 1, 2019 and included the Company's acetone derivatives related inventory and production assets, located in Institute, West Virginia, in addition to the site infrastructure, land, utilities and certain railcars. The Company remains at the Institute site as a tenant. As a result of the planned transaction, the Company recognized a pretax impairment charge of $75 million in the third quarter of 2019, included in "Restructuring, goodwill impairment and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($24 million) and Corporate ($51 million). See Note 24 for additional information.

In the fourth quarter of 2019, upon completion of an evaluation of its equity method investment in Sadara Chemical Company ("Sadara") for other-than-temporary impairment, the Company determined that its investment in Sadara was other-than-temporarily impaired and it was written down to zero. Additionally, as part of Dow's evaluation of Sadara, the Company reserved certain of its notes and accounts receivable with Sadara due to uncertainty on the timing of collection. As a result, the Company recorded a $1,755 million charge related to Sadara, included in “Restructuring, goodwill impairment and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($370 million), Industrial Intermediates & Infrastructure ($1,168 million) and Corporate ($217 million). See Notes 13 and 24 for additional information.
  
2018 Charges
In 2018, the Company recognized an additional pretax impairment charge of $34 million related primarily to capital additions at Santa Vitoria. The impairment charge was included in “Restructuring, goodwill impairment and asset related charges - net” in the consolidated statements of income and related to the Packaging & Specialty Plastics segment. See Note 24 for additional information.


89


2017 Charges
In 2017, the Company recognized a $622 million pretax impairment charge related to Santa Vitoria. The Company determined it would not pursue an expansion of the facility’s ethanol mill into downstream derivative products, primarily as a result of cheaper ethane-based production as well as the Company’s new assets coming online on the U.S. Gulf Coast which can be used to meet growing market demands in Brazil. As a result of this decision, cash flow analysis indicated the carrying amount of the impacted assets was not recoverable. The impairment charge was included in “Restructuring, goodwill impairment and asset related charges - net” in the consolidated statements of income and related to the Packaging & Specialty Plastics segment. See Note 24 for additional information.

The Company also recognized other pretax impairment charges of $246 million in the fourth quarter of 2017, including charges related to manufacturing assets of $159 million, an equity method investment of $81 million and other assets of $6 million. The impairment charges were included in "Restructuring, goodwill impairment and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($58 million), Industrial Intermediates & Infrastructure ($5 million), Performance Materials & Coatings ($83 million) and Corporate ($100 million). See Note 24 for additional information.


NOTE 8 – SUPPLEMENTARY INFORMATION
Sundry Income (Expense) – Net
Dow Inc.
TDCC
In millions
2019
2018
2017
2019
2018
2017
Non-operating pension and other postretirement benefit plan net credits (costs) 1
$
205

$
123

$
(676
)
$
205

$
123

$
(676
)
Foreign exchange gains (losses)
91

(119
)
(72
)
77

(119
)
(72
)
Gain related to Nova ethylene asset matter 2
170



170



Dow Silicones breast implant liability adjustment 2
85



85



Gain (loss) on Dow Silicones commercial creditor matters 2
(50
)

33

(50
)

33

Indemnification and other transaction related costs 3
(69
)


6



Loss on early extinguishment of debt 4
(102
)
(54
)

(102
)
(54
)

Gain (loss) on divestitures 5
(49
)

7

2


7

Gain on sales of other assets and investments
67

18

117

67

18

117

Reclassification of cumulative translation adjustments
10

4

8

10

4

8

Post-closing adjustments related to Dow Silicones ownership restructure

(20
)


(20
)

Post-closing adjustments on divestiture of MEGlobal

20



20


Gain on divestiture of the EAA business 6


227



227

Gain related to Nova patent infringement award 2


137



137

Other - net
103

124

65

103

124

65

Total sundry income (expense) – net
$
461

$
96

$
(154
)
$
573

$
96

$
(154
)
1.
See Note 21 for additional information.
2.
See Note 17 for additional information.
3.
See Note 4 for additional information.
4.
See Note 16 for additional information.
5.
Primarily related to post-closing adjustments on previous divestitures.
6.
See Note 6 for additional information.

Accrued and Other Current Liabilities
“Accrued and other current liabilities” were $2,762 million and $2,233 million at December 31, 2019 for Dow Inc. and TDCC, respectively, and $2,931 million at December 31, 2018. Accrued payroll, which is a component of "Accrued and other current liabilities" and includes liabilities related to payroll, incentive compensation and severance, was $284 million at December 31, 2019 and $759 million at December 31, 2018. No other components of "Accrued and other current liabilities" were more than 5 percent of total current liabilities.


90


Supplemental Cash Flow Information
The following table shows cash paid for interest and income taxes for the years ended December 31, 2019, 2018 and 2017:

Supplemental Cash Flow Information
2019
2018
2017
In millions
Cash paid during year for:
 
 
 
Interest, net of amounts capitalized
$
993

$
1,143

$
1,115

Income taxes
$
881

$
1,193

$
1,259




NOTE 9 – INCOME TAXES
The financial statements for Dow Inc. and TDCC are substantially similar, including the reporting of current and deferred tax expense (benefit), provision for income taxes on continuing operations, and deferred tax asset and liability balances. As a result, the following income tax discussion pertains to Dow Inc. only.

Geographic Allocation of Income and Provision for Income Taxes on Continuing Operations
 
 
 
In millions
2019
2018
2017
Income (loss) from continuing operations before income taxes
 
 
 
Domestic 1
$
(1,196
)
$
745

$
(2,226
)
Foreign 2 
(51
)
3,004

2,463

Income (loss) from continuing operations before income taxes
$
(1,247
)
$
3,749

$
237

Current tax expense (benefit)
 
 
 
Federal
$
(287
)
$
324

$
(864
)
State and local
25

13

4

Foreign
960

901

971

Total current tax expense
$
698

$
1,238

$
111

Deferred tax expense (benefit)
 
 
 
Federal 3
$
52

$
(318
)
$
1,499

State and local
19

(32
)
85

Foreign
(299
)
(79
)
(171
)
Total deferred tax expense (benefit)
$
(228
)
$
(429
)
$
1,413

Provision for income taxes on continuing operations
$
470

$
809

$
1,524

Income (loss) from continuing operations, net of tax
$
(1,717
)
$
2,940

$
(1,287
)
1.
The 2019 amount includes approximately $1.4 billion of expense related to goodwill impairment and environmental matters. The 2017 amount includes approximately $1.4 billion of expense related to goodwill impairment and litigation settlements. See Notes 14 and 17 for additional information.
2.
The 2019 amount includes approximately $1.8 billion of expense related to Sadara related charges. See Note 13 for additional information.
3.
The 2018 and 2017 amounts reflect the tax impact of The Act which accelerated the utilization of tax credits and required remeasurement of all U.S. deferred tax assets and liabilities.

In 2017, as a result of the Merger and subsequent change in the Company's ownership, certain net operating loss carryforwards available for the Company’s consolidated German tax group were derecognized. In addition, the sale of stock between two consolidated subsidiaries in 2014 created a gain that was initially deferred for tax purposes. This deferred gain became taxable as a result of activities executed in anticipation of the business separations. As a result, in 2017, the Company recorded a charge of $267 million to “Provision for income taxes on continuing operations” in the consolidated statements of income.


91


Reconciliation to U.S. Statutory Rate
2019
2018
2017
Statutory U.S. federal income tax rate
21.0
 %
21.0
 %
35.0
 %
Equity earnings effect
(3.2
)
(3.3
)
(52.7
)
Foreign income taxed at rates other than the statutory U.S. federal income tax rate 1
(14.8
)
6.7

(61.2
)
U.S. tax effect of foreign earnings and dividends
1.9

(0.7
)
(8.4
)
Unrecognized tax benefits
1.0

0.2

13.5

Divestitures 2

0.8

142.0

Impact of tax reform 3
11.1

(3.4
)
367.8

Federal tax accrual adjustment 4
10.4



State and local income taxes
(4.4
)
0.4

11.4

Sadara related charges 5
(29.5
)


Goodwill impairment 6
(17.5
)

220.8

Excess tax benefits from stock-based compensation
1.2

(1.0
)
(39.7
)
Other - net
(14.9
)
0.9

14.5

Effective Tax Rate
(37.7
)%
21.6
 %
643.0
 %
1.
Includes the impact of valuation allowances in foreign jurisdictions.
2.
See Note 6 for additional information.
3.
Includes the impact of tax reform in Switzerland and the U.S.
4.
Primarily related to the favorable impact of the restoration of tax basis in assets, driven by a recent court judgment that did not involve the Company.
5.
See Note 13 for additional information.
6.
See Note 14 for additional information.

On December 22, 2017, The Act was enacted. The Act reduced the U.S. federal corporate income tax rate from 35 percent to 21 percent, required companies to pay a one-time transition tax on earnings of certain foreign subsidiaries that were previously deferred, created new provisions related to foreign sourced earnings, eliminated the domestic manufacturing deduction and moved to a hybrid territorial system. At December 31, 2017, the Company had not completed its accounting for the tax effects of The Act; however, the Company made a reasonable estimate of the effects on its existing deferred tax balances and the one-time transition tax. In accordance with Staff Accounting Bulletin 118, income tax effects of The Act were refined upon obtaining, preparing, and analyzing additional information during the measurement period. At December 31, 2018, the Company had completed its accounting for the tax effects of The Act.

As a result of The Act, the Company remeasured its U.S. federal deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21 percent. The Company recorded a cumulative benefit of $81 million ($79 million benefit in 2018 and $2 million benefit in 2017) to “Provision for income taxes on continuing operations” in the consolidated statements of income with respect to the remeasurement of the Company's deferred tax balances.

The Act required a mandatory deemed repatriation of post-1986 undistributed foreign earnings and profits, which resulted in a one-time transition tax. The Company recorded a cumulative charge of $789 million ($85 million benefit in 2018 and $874 million charge in 2017) to "Provision for income taxes on continuing operations" in the consolidated statements of income with respect to the one-time transition tax.

In 2018, the Company recorded an indirect impact of The Act related to prepaid tax on the intercompany sale of inventory. The amount recorded related to inventory was a charge of $38 million to "Provision for income taxes on continuing operations" in the consolidated statements of income.

For tax years beginning after December 31, 2017, The Act introduced new provisions for U.S. taxation of certain global intangible low-taxed income (“GILTI”). The Company has made the policy election to record any liability associated with GILTI in the period in which it is incurred.


92


Deferred Tax Balances at Dec 31
2019
2018
In millions
Assets
Liabilities
Assets
Liabilities
Property
$
494

$
3,177

$
406

$
2,519

Tax loss and credit carryforwards
1,920


2,079


Postretirement benefit obligations
2,432

210

2,115

143

Other accruals and reserves
1,678

43

1,220

151

Intangibles
120

688

157

954

Inventory
28

234

53

239

Investments
125

48

190

84

Other – net
851

120

620

247

Subtotal
$
7,648

$
4,520

$
6,840

$
4,337

Valuation allowances
(1,262
)

(1,225
)

Total
$
6,386

$
4,520

$
5,615

$
4,337


Operating Loss and Tax Credit Carryforwards at Dec 31
2019
2018
In millions
Assets
Assets
Operating loss carryforwards
 
 
Expire within 5 years
$
263

$
245

Expire after 5 years or indefinite expiration
1,133

1,196

Total operating loss carryforwards
$
1,396

$
1,441

Tax credit carryforwards
 
 
Expire within 5 years
$
32

$
32

Expire after 5 years or indefinite expiration
492

606

Total tax credit carryforwards
$
524

$
638

Total operating loss and tax credit carryforwards
$
1,920

$
2,079


Undistributed earnings of foreign subsidiaries and related companies that are deemed to be permanently invested amounted to $6,851 million at December 31, 2019 and $6,014 million at December 31, 2018. The Act imposed U.S. tax on all post-1986 foreign unrepatriated earnings accumulated through December 31, 2017. Unrepatriated earnings generated after December 31, 2017, are now subject to tax in the current year. All undistributed earnings are still subject to certain taxes upon repatriation, primarily where foreign withholding taxes apply. It is not practicable to calculate the unrecognized deferred tax liability on undistributed earnings.

The following table provides a reconciliation of the Company's unrecognized tax benefits:

Total Gross Unrecognized Tax Benefits
 
 
 
In millions
2019
2018
2017
Total unrecognized tax benefits at Jan 1
$
314

$
255

$
231

Decreases related to positions taken on items from prior years
(1
)
(8
)
(4
)
Increases related to positions taken on items from prior years
16

68

37

Increases related to positions taken in the current year
10

2

12

Settlement of uncertain tax positions with tax authorities
(19
)

(12
)
Decreases due to expiration of statutes of limitations

(1
)
(9
)
Foreign exchange gain
(1
)
(2
)

Total unrecognized tax benefits at Dec 31
$
319

$
314

$
255

Total unrecognized tax benefits that, if recognized, would impact the effective tax rate
$
234

$
235

$
245

Total amount of interest and penalties (benefit) recognized in "Provision for income taxes on continuing operations"
$
(11
)
$
(12
)
$
2

Total accrual for interest and penalties recognized in the consolidated balance sheets
$
100

$
109

$
110


On January 9, 2017, the U.S. Supreme Court denied certiorari in the Company’s tax treatment of partnerships and transactions associated with Chemtech, a wholly owned subsidiary. The Company has fully accrued the position and does not expect a future impact to “Provision for income taxes on continuing operations” in the consolidated statements of income as a result of the ruling.


93


Prior to the separation, TDCC and its consolidated subsidiaries were included in DowDuPont's consolidated federal income tax group and consolidated tax return. Generally, the consolidated tax liability of the DowDuPont U.S. tax group for each year will be apportioned among the members of the consolidated group based on each member’s separate taxable income. TDCC and DuPont intend that, to the extent federal and/or state corporate income tax liabilities are reduced through the utilization of tax attributes of the other, settlement of any receivable and payable generated from the use of the other party’s sub-group attributes will be in accordance with a tax sharing agreement and/or tax matters agreement. At December 31, 2019, the Company had a receivable of $312 million as part of the tax sharing agreement, which is included in "Noncurrent receivables" in the consolidated balance sheets. At December 31, 2018, the Company had a receivable related to the tax sharing agreement of $89 million, included in "Accounts and notes receivable - Other" in the consolidated balance sheets.

Each year, the Company files tax returns in the various national, state and local income taxing jurisdictions in which it operates. These tax returns are subject to examination and possible challenge by the tax authorities. Positions challenged by the tax authorities may be settled or appealed by the Company. As a result, there is an uncertainty in income taxes recognized in the Company’s financial statements in accordance with accounting for income taxes and accounting for uncertainty in income taxes. The ultimate resolution of such uncertainties is not expected to have a material impact on the Company's results of operations.

Tax years that remain subject to examination for the Company’s major tax jurisdictions are shown below:

Tax Years Subject to Examination by Major Tax Jurisdiction at Dec 31, 2019
Earliest Open Year
Jurisdiction
Argentina
2013
Brazil
2006
Canada
2012
China
2009
Germany
2010
Italy
2015
The Netherlands
2016
Switzerland
2016
United States:
 
Federal income tax
2004
State and local income tax
2004


The reserve for non-income tax contingencies related to issues in the United States and foreign locations was $44 million at December 31, 2019 ($91 million at December 31, 2018). This is management’s best estimate of the potential liability for non-income tax contingencies. Inherent uncertainties exist in estimates of tax contingencies due to changes in tax law, both legislated and concluded through the various jurisdictions’ tax court systems. It is the opinion of the Company’s management that the possibility is remote that costs in excess of those accrued will have a material impact on the Company’s consolidated financial statements.



94


NOTE 10 - EARNINGS PER SHARE CALCULATIONS
The following tables provide earnings per share calculations of Dow Inc. for the years ended December 31, 2019, 2018, and 2017. In accordance with the accounting guidance for earnings per share, earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries.

Net Income (Loss) for Earnings Per Share Calculations
2019
2018
2017
In millions
Income (loss) from continuing operations, net of tax
$
(1,717
)
$
2,940

$
(1,287
)
Net income attributable to noncontrolling interests - continuing operations
(74
)
(102
)
(102
)
Net income attributable to participating securities - continuing operations 1
(6
)

(8
)
Income (loss) from continuing operations attributable to common stockholders
$
(1,797
)
$
2,838

$
(1,397
)
Income from discontinued operations, net of tax
$
445

$
1,835

$
1,882

Net income attributable to noncontrolling interests - discontinued operations
(13
)
(32
)
(28
)
Net income attributable to participating securities - discontinued operations 1


(6
)
Income from discontinued operations attributable to common stockholders
$
432

$
1,803

$
1,848

Net income (loss) attributable to common stockholders
$
(1,365
)
$
4,641

$
451

Earnings Per Share Calculations - Basic
2019
2018
2017
Dollars per share
Income (loss) from continuing operations attributable to common stockholders
$
(2.42
)
$
3.80

$
(1.88
)
Income from discontinued operations, net of tax
0.58

2.41

2.48

Net income (loss) attributable to common stockholders
$
(1.84
)
$
6.21

$
0.60

Earnings Per Share Calculations - Diluted
2019
2018
2017
Dollars per share
Income (loss) from continuing operations attributable to common stockholders
$
(2.42
)
$
3.80

$
(1.88
)
Income from discontinued operations, net of tax
0.58

2.41

2.48

Net income (loss) attributable to common stockholders
$
(1.84
)
$
6.21

$
0.60

Share Count Information
2019
2018
2017
Shares in millions
Weighted-average common shares - basic 2, 3
742.5

747.2

744.8

Plus dilutive effect of equity compensation plans



Weighted-average common shares - diluted 2, 3, 4
742.5

747.2

744.8

Stock options and restricted stock units excluded from EPS calculations 5
20.8


1.1

1.
Restricted stock units (formerly termed deferred stock) are considered participating securities due to the Company's practice of paying dividend equivalents on unvested shares.
2.
Share amounts for the year ended December 31, 2018 were based on 2,246.3 million DowDuPont common shares outstanding as of the Record Date for the April 1, 2019 distribution, less 4.6 million Employee Stock Ownership Plan ("ESOP") shares that had not been released and were not considered outstanding, adjusted for the Distribution Ratio. There was no dilutive effect for the year ended December 31, 2018 as the Company did not engage in activities giving rise to dilution.
3.
Share amounts for the year ended December 31, 2017 were based on 2,246.3 million DowDuPont common shares outstanding as of the Record Date for the April 1, 2019 distribution, less 4.6 million ESOP shares that had not been released and were not considered outstanding, adjusted for the Distribution Ratio and further adjusted by 2.4 million shares for the effect of TDCC basic common shares outstanding during the pre-Merger period. The year ended December 31, 2017 reflected a loss from continuing operations, and as such, the basic share count was used for purposes of calculating earnings per share on a diluted basis.
4.
The year ended December 31, 2019 reflected a loss from continuing operations, and as such, the basic share count was used for purposes of calculating earnings per share on a diluted basis.
5.
These outstanding options to purchase shares of common stock and restricted stock units were excluded from the calculation of diluted earnings per share because the effect of including them would have been antidilutive. For the year ended December 31, 2018, the Company did not engage in activities giving rise to dilution.


95


NOTE 11 – INVENTORIES
The following table provides a breakdown of inventories:
Inventories at Dec 31
 
 
In millions
2019
2018
Finished goods
$
3,505

$
4,313

Work in process
1,122

1,335

Raw materials
628

674

Supplies
845

826

Total
$
6,100

$
7,148

Adjustment of inventories to a LIFO basis
114

(249
)
Total inventories
$
6,214

$
6,899



Inventories valued on a LIFO basis represented 32 percent of the total inventories at December 31, 2019 and 34 percent of the total inventories at December 31, 2018.


NOTE 12 – PROPERTY
The following table provides a breakdown of property:
 
Property at Dec 31
Estimated Useful 
Lives (Years)
2019
2018
In millions
Land and land improvements
0-25

$
2,177

$
2,059

Buildings
5-50

4,742

4,745

Machinery and equipment
3-25

40,651

40,250

Other property
3-50

5,354

5,084

Construction in progress

1,986

1,846

Total property
 
$
54,910

$
53,984


 
In millions
2019
2018
2017
Depreciation expense
$
2,156

$
2,174

$
1,955

Capitalized interest
$
80

$
88

$
240




NOTE 13 – NONCONSOLIDATED AFFILIATES
The Company’s investments in companies accounted for using the equity method (“nonconsolidated affiliates”) and dividends received from nonconsolidated affiliates are shown in the following tables:

Investments in Nonconsolidated Affiliates at Dec 31
2019 1
2018 1
In millions
Investment in nonconsolidated affiliates
$
1,404

$
3,320

Other noncurrent obligations
(80
)

Net investment in nonconsolidated affiliates
$
1,324

$
3,320

1.
The carrying amount of the Company’s investments in nonconsolidated affiliates at December 31, 2019, was $51 million less than its share of the investees’ net assets, ($39 million less at December 31, 2018), exclusive of additional differences relating to EQUATE Petrochemical Company K.S.C.C. ("EQUATE"), Sadara and AgroFresh Solutions Inc. ("AFSI"), which are discussed separately in the disclosures that follow.

Dividends Received from Nonconsolidated Affiliates
2019
2018
2017 1
In millions
Dividends from nonconsolidated affiliates
$
1,020

$
663

$
654


1.
Includes a non-cash dividend of $7 million.


96


Except for AFSI, the nonconsolidated affiliates in which the Company has investments are privately held companies; therefore, quoted market prices are not available.

Sadara
In 2011, the Company and Saudi Arabian Oil Company formed Sadara - a joint venture between the two companies that subsequently constructed and now operates a world-scale, fully integrated chemicals complex in Jubail Industrial City, Kingdom of Saudi Arabia. The Company has a 35 percent equity interest in this joint venture and has been, and continues to be, responsible for marketing the majority of Sadara’s products through the Company’s established sales channels. 
 
In 2017, Sadara achieved full commercial operations of all its facilities. In December 2018, the joint venture successfully completed its Creditors Reliability Test, an extensive operational testing program designed to demonstrate the reliability of the joint venture’s full chemical complex by operating at high rates for an extended period of time. While Sadara has reached these operational milestones and has been generating positive EBITDA (a non-GAAP measure defined as earnings before interest, taxes, depreciation and amortization), the joint venture has yet to report positive net income. During the fourth quarter of 2019, Sadara tested its long-lived assets for impairment using long-term cash flow projections. Sadara’s U.S. GAAP impairment test utilized an undiscounted cash flow methodology, under which Sadara concluded its long-lived assets were recoverable. Due to Sadara's financial condition and its long-lived asset impairment test, Dow evaluated its equity method investment in Sadara for other-than-temporary impairment. The Company utilized a discounted cash flow methodology to measure the estimated fair value of its investment in Sadara, which was estimated to be zero (see Note 24 for additional information on the fair value measurement). The Company determined the decline in value of its investment in Sadara was other-than-temporary due to Sadara’s financial performance since becoming commercially operational in 2017 and uncertainty around prospects for recovery in Sadara’s financial condition. In addition, the Company reserved certain accounts and notes receivable and accrued interest balances associated with Sadara due to uncertainty around the timing of collection. In total, the Company recorded a $1,755 million pretax charge in the fourth quarter of 2019 related to Sadara, included in “Restructuring, goodwill impairment and asset related charges - net” in the consolidated statements of income and related to Packaging & Specialty Plastics ($370 million), Industrial Intermediates & Infrastructure ($1,168 million) and Corporate ($217 million).

At December 31, 2019, the Company’s investment in Sadara was $1,705 million less than Dow’s proportionate share of the carrying value of the underlying net assets held by Sadara. This basis difference is attributed to the long-lived assets of Sadara and will be amortized over a period of 22 years as Sadara recognizes the associated depreciation expense, which represents the estimated remaining useful lives of Sadara’s long-lived assets. Due to the potential for Dow to continue providing financial support to Sadara, the Company expects to continue to recognize its share of potential future losses reported by Sadara.

Prior to the impairment of the Company’s investment in Sadara and reserve of certain notes receivable at December 31, 2019, the Company loaned $473 million to Sadara and converted $380 million of the notes and accounts receivable into equity during 2019. In 2018, the Company converted $382 million of outstanding notes and accounts receivable with Sadara into equity, primarily due to a shareholder loan reduction agreement with Sadara. In 2017, the Company loaned $735 million to Sadara and converted $718 million to equity. At December 31, 2019 and 2018, the Company's note receivable with Sadara was zero. Potential future loans and investments will continue to be subject to evaluation for reserve and impairments.

EQUATE
The Company had a negative investment balance in EQUATE of $80 million at December 31, 2019, classified as "Other noncurrent obligations" in the consolidated balance sheets. At December 31, 2018, the Company had an investment balance in EQUATE of $131 million, classified as "Investment in nonconsolidated affiliates" in the consolidated balance sheets. The Company's investment in EQUATE was $489 million less than the Company's proportionate share of EQUATE's underlying net assets at December 31, 2019 ($502 million less at December 31, 2018), which represents the difference between the fair values of certain MEGlobal assets acquired by EQUATE and the Company's related valuation on a U.S. GAAP basis. A basis difference of $169 million at December 31, 2019 ($184 million at December 31, 2018) is being amortized over the remaining useful lives of the assets and the remainder is considered a permanent difference.

AFSI
At December 31, 2019, the Company had an investment in AFSI of $35 million ($48 million at December 31, 2018), classified as "Investment in nonconsolidated affiliates" in the consolidated balance sheets. At December 31, 2019, the Company's investment in AFSI was $102 million less than the Company's proportionate share of AFSI's underlying net assets ($101 million less at December 31, 2018). This amount primarily relates to an other-than-temporary decline in the Company's investment in AFSI. At December 31, 2019, the Company held a 41 percent ownership interest in AFSI (42 percent at December 31, 2018). See Note 25 for additional information on this investment.


97


Transactions with Nonconsolidated Affiliates
The Company has service agreements with certain nonconsolidated affiliates, including contracts to manage the operations of manufacturing sites and the construction of new facilities; licensing and technology agreements; and marketing, sales, purchase, lease and sublease agreements.

The Company sells excess ethylene glycol produced at manufacturing facilities in the United States and Europe to MEGlobal, a subsidiary of EQUATE. The Company also sells ethylene to MEGlobal as a raw material for its ethylene glycol plants in Canada. Sales of these products to MEGlobal represented 1 percent of total net sales in 2019, 2018 and 2017. Sales of ethylene to MEGlobal are reflected in the Packaging & Specialty Plastics segment and represented 1 percent of the segment's sales in 2019, 2018 and 2017. Sales of ethylene glycol to MEGlobal are reflected in the Industrial Intermediates & Infrastructure segment and represented 1 percent of the segment's sales in 2019, and 2 percent of the segment's sales in 2018 and 2017.

The Company is responsible for marketing the majority of Sadara products outside of the Middle East zone through the Company’s established sales channels. Under this arrangement, the Company purchases and sells Sadara products for a marketing fee. Purchases of Sadara products represented 8 percent of "Cost of sales" in 2019 (9 percent in 2018 and 4 percent in 2017).

The Company purchases products from The SCG-Dow Group, primarily for marketing and distribution in Asia Pacific. Purchases of products from The SCG-Dow Group represented 2 percent of "Cost of sales" in 2019 (2 percent in 2018 and 3 percent in 2017).

Sales to and purchases from other nonconsolidated affiliates were not material to the consolidated financial statements.

Balances due to or due from nonconsolidated affiliates at December 31, 2019 and 2018 were as follows:

Balances Due To or Due From Nonconsolidated Affiliates at Dec 31
2019
2018
In millions
Accounts and notes receivable - Other
$
211

$
556

Noncurrent receivables

8

Total assets
$
211

$
564

Accounts payable - Other
$
1,092

$
1,347


Principal Nonconsolidated Affiliates
The Company had an ownership interest in 37 nonconsolidated affiliates at December 31, 2019 (38 at December 31, 2018). The Company's principal nonconsolidated affiliates and its ownership interest (direct and indirect) for each at December 31, 2019, 2018 and 2017 are as follows:

Principal Nonconsolidated Affiliates at Dec 31
Country
Ownership Interest
 
2019
2018
2017
EQUATE Petrochemical Company K.S.C.C.
Kuwait
42.5
%
42.5
%
42.5
%
The Kuwait Olefins Company K.S.C.C.
Kuwait
42.5
%
42.5
%
42.5
%
The Kuwait Styrene Company K.S.C.C.
Kuwait
42.5
%
42.5
%
42.5
%
Map Ta Phut Olefins Company Limited 1
Thailand
32.77
%
32.77
%
32.77
%
Sadara Chemical Company
Saudi Arabia
35
%
35
%
35
%
The SCG-Dow Group:
 
 
 
 
Siam Polyethylene Company Limited
Thailand
50
%
50
%
50
%
Siam Polystyrene Company Limited
Thailand
50
%
50
%
50
%
Siam Styrene Monomer Company Limited
Thailand
50
%
50
%
50
%
Siam Synthetic Latex Company Limited
Thailand
50
%
50
%
50
%

1.
The Company's effective ownership of Map Ta Phut Olefins Company Limited ("Map Ta Phut") is 32.77 percent, of which the Company directly owns 20.27 percent and indirectly owns 12.5 percent through its equity interest in Siam Polyethylene Company Limited.


98


The Company’s investment in and equity earnings from its principal nonconsolidated affiliates are shown in the tables below:

Investment in Principal Nonconsolidated Affiliates at Dec 31
2019
2018
In millions
Investment in nonconsolidated affiliates
$
963

$
2,876

Other noncurrent obligations
(80
)

Net investment in principal nonconsolidated affiliates
$
883

$
2,876



Equity Earnings from Principal Nonconsolidated Affiliates
2019
2018
2017
In millions
Equity in earnings of principal nonconsolidated affiliates
$
21

$
561

$
347



The summarized financial information that follows represents the combined accounts (at 100 percent) of the principal nonconsolidated affiliates.

Summarized Balance Sheet Information at Dec 31
2019
2018
In millions
Current assets
$
5,302

$
7,553

Noncurrent assets
26,477

25,971

Total assets
$
31,779

$
33,524

Current liabilities
$
3,743

$
5,163

Noncurrent liabilities
20,271

19,089

Total liabilities
$
24,014

$
24,252

Noncontrolling interests
$
110

$
72



Summarized Income Statement Information 1
2019
2018
2017
In millions
Sales
$
10,905

$
14,461

$
11,629

Gross profit
$
644

$
2,320

$
1,992

Income (loss) from continuing operations, net of tax
$
(277
)
$
1,173

$
689


1.
The results in this table reflect purchase and sale activity between certain principal nonconsolidated affiliates and the Company, as previously discussed in the "Transactions with Nonconsolidated Affiliates" section.


NOTE 14 – GOODWILL AND OTHER INTANGIBLE ASSETS
The following table shows changes in the carrying amounts of goodwill by reportable segment for the years ended December 31, 2019 and 2018:

Goodwill
Packaging & Specialty Plastics
Industrial Intermediates & Infrastructure
Performance Materials & Coatings
Total
In millions
Balance at Jan 1, 2018
$
5,043

$
1,101

$
3,689

$
9,833

Foreign currency impact
(24
)
(6
)
(39
)
(69
)
Measurement period adjustment - ECP 1
82



82

Balance at Dec 31, 2018
$
5,101

$
1,095

$
3,650

$
9,846

Foreign currency impact
8

6

(24
)
(10
)
Goodwill impairment


(1,039
)
(1,039
)
Other

(1
)

(1
)
Balance at Dec 31, 2019
$
5,109

$
1,100

$
2,587

$
8,796


1. Goodwill recognized from the receipt of the ECP businesses as part of the separation from DowDuPont. See Note 4 for additional information.


99



The separation from DowDuPont did not impact the composition of the Company's six reporting units: Coatings & Performance Monomers, Consumer Solutions, Hydrocarbons & Energy, Industrial Solutions, Packaging and Specialty Plastics and Polyurethanes & Construction Chemicals. The ECP businesses received as part of the separation from DowDuPont are included in the Hydrocarbons & Energy and Packaging and Specialty Plastics reporting units. At December 31, 2019, goodwill was carried by all reporting units except Coatings & Performance Monomers (“C&PM”).

Goodwill Impairments
The carrying amounts of goodwill at December 31, 2019 were net of accumulated impairments of $309 million in Industrial Intermediates & Infrastructure ($309 million at December 31, 2018) and $2,530 million in Performance Materials & Coatings ($1,491 million at December 31, 2018).

Goodwill Impairment Testing
The Company performs an impairment test of goodwill annually in the fourth quarter. In 2019, the Company performed quantitative testing for two reporting units (one in 2018 and four in 2017) and a qualitative assessment was performed for the remaining reporting units. The qualitative assessments indicated that it was not more likely than not that fair value was less than the carrying value for those reporting units included in the qualitative test.

Upon completion of the quantitative testing in the fourth quarter of 2017, the Company determined the C&PM reporting unit was impaired. Throughout 2017, the C&PM reporting unit did not consistently meet expected financial performance targets, primarily due to increasing commoditization in coatings markets and competition, as well as customer consolidation in end markets which reduced growth opportunities. As a result, the C&PM reporting unit lowered future revenue and profitability expectations. The fair value of the C&PM reporting unit was determined using a discounted cash flow methodology that reflected reductions in projected revenue growth rates, primarily driven by modified sales volume and pricing assumptions, as well as revised expectations for future growth rates. These discounted cash flows did not support the carrying value of the C&PM reporting unit. As a result, the Company recorded a goodwill impairment charge for the C&PM reporting unit of $1,491 million in the fourth quarter of 2017, included in “Restructuring, goodwill impairment and asset related charges - net” in the consolidated statements of income and related to the Performance Materials & Coatings segment. The C&PM reporting unit carried $1,071 million of goodwill at December 31, 2017. No other goodwill impairments were identified as a result of the 2017 testing.

Quantitative testing was performed on the C&PM reporting unit in the fourth quarter of 2018. The fair value of the reporting unit was determined using a discounted cash flow methodology that included plans to undertake modest, higher-return investments in several existing assets, improvements in cost performance and leveraging of technologies. While assessments supported a case for sustaining market growth consistent with GDP projections, the valuation also included adverse impacts related to increased customer purchasing leverage from ongoing customer consolidation. The resulting valuation was compared with the carrying value of the C&PM reporting and the Company concluded that no goodwill impairment existed.

Upon completion of the quantitative testing in the fourth quarter of 2019, the Company determined the C&PM reporting unit was impaired. During 2019, the C&PM reporting unit did not consistently meet expected financial performance targets, primarily due to the industry’s increased captive use of coatings products, which led to volume reductions; reduced margins for products across the portfolio due to changes in customer buying patterns and supply and demand balances; as well as a continuous trend of customer consolidation in end markets, which reduced growth opportunities. As a result, the C&PM reporting unit lowered its future revenue and profitability projections. The fair value of the C&PM reporting unit was determined using a discounted cash flow methodology that reflected reductions in projected revenue growth rates due to lower sales volume and price assumptions, as well as reductions to future growth rates. These discounted cash flows did not support the carrying value of the C&PM reporting unit. As a result, the Company recorded a goodwill impairment charge of $1,039 million in the fourth quarter of 2019, included in “Restructuring, goodwill impairment and asset related charges - net” in the consolidated statements of income and related to the Performance Materials & Coatings segment. The carrying value of the C&PM reporting unit's goodwill was zero at December 31, 2019. No other goodwill impairments were identified as a result of the 2019 testing.


100



Other Intangible Assets
The following table provides information regarding the Company’s other intangible assets:

Other Intangible Assets at Dec 31
2019
2018
In millions
Gross
Carrying
Amount
Accum
Amort
Net
Gross
Carrying
Amount
Accum
Amort
Net  
Intangible assets with finite lives:
 
 
 
 
 
 
Developed technology
$
2,634

$
(1,467
)
$
1,167

$
2,634

$
(1,252
)
$
1,382

Software
1,449

(893
)
556

1,404

(805
)
599

Trademarks/tradenames
352

(342
)
10

352

(329
)
23

Customer-related
3,207

(1,184
)
2,023

3,211

(993
)
2,218

Total other intangible assets, finite lives
$
7,642

$
(3,886
)
$
3,756

$
7,601

$
(3,379
)
$
4,222

In-process research and development
3


3

3


3

Total other intangible assets
$
7,645

$
(3,886
)
$
3,759

$
7,604

$
(3,379
)
$
4,225



The following table provides information regarding amortization expense from continuing operations related to intangible assets:

Amortization Expense from Continuing Operations
2019
2018
2017
In millions
Other intangible assets, excluding software
$
419

$
469

$
400

Software 1
$
96

$
93

$
82


1.
Included in "Cost of sales" in the consolidated statements of income.

Total estimated amortization expense from continuing operations for the next five fiscal years, including amounts expected to be capitalized, is as follows:

Estimated Amortization Expense for Next Five Years
In millions
2020
$
492

2021
$
472

2022
$
411

2023
$
380

2024
$
364




NOTE 15 – TRANSFERS OF FINANCIAL ASSETS
Accounts Receivable Securitization Facilities
The Company historically sold trade accounts receivable of select North American entities and qualifying trade accounts receivable of select European entities on a revolving basis to certain multi-seller commercial paper conduit entities ("conduits"). The proceeds received were comprised of cash and interests in specified assets of the conduits (the receivables sold by the Company) that entitled the Company to the residual cash flows of such specified assets in the conduits after the commercial paper had been repaid. Neither the conduits nor the investors in those entities had recourse to other assets of the Company in the event of nonpayment by the debtors.

In the fourth quarter of 2017, the Company suspended further sales of trade accounts receivable through these facilities and began reducing outstanding balances through collections of trade accounts receivable previously sold to such conduits. In September and October 2018, the North American and European facilities, respectively, were amended and the terms of the agreements changed from off-balance sheet arrangements to secured borrowing arrangements. See Note 16 for additional information on the secured borrowing arrangements.

In 2018, the Company recognized a loss of $7 million on the sale of these receivables (loss of $25 million in 2017), which is included in “Interest expense and amortization of debt discount” in the consolidated statements of income. There were no sales of receivables through these facilities in 2019.


101



Following is an analysis of certain cash flows between the Company and the conduits:

Cash Proceeds
 
 
In millions
2018
2017
Sale of receivables
$

$
1

Collections reinvested in revolving receivables
$

$
21,293

Interests in conduits 1
$
657

$
9,462


1.
Presented in "Investing Activities" in the consolidated statements of cash flows.

North America Accounts Receivable Program
The Company maintains a committed accounts receivable facility in North America (“North America A/R Program”) with various financial institutions, which expires in November 2022. Under the terms of the North America A/R Program, the Company may sell certain eligible trade accounts receivable, up to $900 million, at any point in time. The Company continues to service the receivables from the customer, but retains no interest in the receivables, and remits payment to the financial institutions. The Company also provides a guarantee to the financial institutions for the creditworthiness and collection of the receivables in satisfaction of the facility. See Note 17 for additional information related to guarantees. There were no receivables sold during the year ended December 31, 2019.


NOTE 16 – NOTES PAYABLE, LONG-TERM DEBT AND AVAILABLE CREDIT FACILITIES
Notes Payable at Dec 31
 
 
In millions
2019
2018
Commercial paper
$
151

$
10

Notes payable to banks and other lenders
435

288

Total notes payable
$
586

$
298

Year-end average interest rates
6.30
%
8.28
%


Long-Term Debt at Dec 31
2019 Average Rate
2019
2018
Average
Rate
2018
In millions
Promissory notes and debentures:
 
 
 
 
Final maturity 2019
%
$

9.80
%
$
7

Final maturity 2020
8.44
%
76

4.46
%
1,547

Final maturity 2021
8.95
%
174

4.71
%
1,424

Final maturity 2022
3.50
%
1,372

3.50
%
1,373

Final maturity 2023
7.64
%
325

7.64
%
325

Final maturity 2024
3.37
%
1,397

3.50
%
896

Final maturity 2025 and thereafter
5.70
%
9,482

5.98
%
7,963

Other facilities:
 
 
 
 
U.S. dollar loans, various rates and maturities
2.55
%
2,000

3.59
%
4,533

Foreign currency loans, various rates and maturities
3.26
%
592

3.20
%
708

InterNotes®, varying maturities through 2049
3.44
%
928

3.26
%
778

Finance lease obligations 1
 
395

 
371

Unamortized debt discount and issuance costs
 
(331
)
 
(334
)
Long-term debt due within one year 2
 
(435
)
 
(338
)
Long-term debt


$
15,975



$
19,253


1.
See Note 18 for additional information.
2.
Presented net of current portion of unamortized debt issuance costs.


102



Maturities of Long-Term Debt for Next Five Years at Dec 31, 2019
In millions
2020
$
435

2021
$
511

2022
$
1,513

2023 1
$
2,508

2024
$
1,528


1.
Assumes the option to extend maturity to 2023 will be exercised for the $2 billion Dow Silicones Term Loan Facility.

2019 Activity
In 2019, the Company issued $2 billion of senior unsecured notes in an offering under Rule 144A of the Securities Act of 1933. The offering included $750 million aggregate principal amount of 4.80 percent notes due 2049; $750 million aggregate principal amount of 3.625 percent notes due 2026; and $500 million aggregate principal amount of 3.15 percent notes due 2024. In addition, the Company redeemed $1.5 billion of 4.25 percent notes with maturity in 2020 and $1.25 billion of 4.125 percent notes with maturity in 2021. As a result, the Company recognized a pretax loss of $100 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income and related to the Corporate segment. The Company also issued an aggregate principal amount of $277 million of InterNotes®, and redeemed an aggregate principal amount of $122 million at maturity. Approximately $149 million of long-term debt (net of $16 million of issuances) was repaid by consolidated variable interest entities.

In 2019, Dow Silicones voluntarily repaid $2.5 billion of principal under a certain third party credit agreement ("Term Loan Facility"). As a result, Dow Silicones recognized a pretax loss of $2 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income and related to the Corporate segment. Dow Silicones also amended the Term Loan Facility to extend the maturity date on the remaining principal balance of $2 billion, making amounts borrowed under the Term Loan Facility payable in September 2021. In addition, this amendment includes options to extend the maturity date through September 2023, at Dow Silicones' election, which the Company intends to exercise.

In October 2019, TDCC launched exchange offers for $4 billion of all the outstanding, unregistered senior notes that were issued in private offerings on November 30, 2018 and May 20, 2019, for identical, registered notes under the Securities Act of 1933 (the “Exchange Offers”). The Exchange Offers are with respect to the Company’s 3.15 percent notes due 2024, 4.55 percent notes due 2025, 3.625 percent notes due 2026, 4.80 percent notes due 2028, 5.55 percent notes due 2048 and 4.80 percent notes due 2049, and fulfilled the Company’s obligations contained in the registration rights agreements entered into in connection with the issuance of the aforementioned notes.

2018 Activity
In 2018, the Company redeemed $333 million of 5.70 percent notes at maturity and an aggregate principal amount of $91 million of InterNotes® at maturity. In addition, approximately $138 million of long-term debt was repaid by consolidated variable interest entities. The Company also called an aggregate principal amount of $343 million tax-exempt bonds of various interest rates and maturities in 2029, 2033 and 2038. As a result of these redemptions, the Company recognized a pretax loss of $6 million on the early extinguishment of debt, included in “Sundry income (expense) - net” in the consolidated statements of income and related to Corporate.

In November 2018, the Company issued $2 billion of senior unsecured notes in an offering under Rule 144A of the Securities Act of 1933. The offering included $900 million aggregate principal amount of 5.55 percent notes due 2048; $600 million aggregate principal amount of 4.80 percent notes due 2028; and $500 million aggregate principal amount of 4.55 percent notes due 2025.

In December 2018, the Company tendered and redeemed $2.1 billion of 8.55 percent notes issued by the Company with maturity in 2019. As a result, the Company recognized a pretax loss of $48 million on the early extinguishment of debt, included in "Sundry income (expense) - net" in the consolidated statements of income and related to Corporate.

2017 Activity
In 2017, the Company redeemed $436 million of 6.00 percent notes that matured on September 15, 2017, and an aggregate principal amount of $32 million of InterNotes® at maturity. In addition, approximately $119 million of long-term debt was repaid by consolidated variable interest entities.


103



Available Credit Facilities
The following table summarizes the Company's credit facilities:

Committed and Available Credit Facilities at Dec 31, 2019
In millions
Committed Credit
Credit Available
Maturity Date
Interest
Five Year Competitive Advance and Revolving Credit Facility
$
5,000

$
5,000

October 2024
Floating rate
Term Loan Facility 1
2,000


September 2023
Floating rate
European Securitization Facility 2
448

448

October 2020
Floating rate
Bilateral Revolving Credit Facility
100

100

March 2020
Floating rate
Bilateral Revolving Credit Facility
100

100

March 2020
Floating rate
Bilateral Revolving Credit Facility
280

280

March 2020
Floating rate
Bilateral Revolving Credit Facility
200

200

May 2020
Floating rate
Bilateral Revolving Credit Facility
200

200

July 2020
Floating rate
Bilateral Revolving Credit Facility
100

100

August 2020
Floating rate
Bilateral Revolving Credit Facility
300

300

December 2020
Floating rate
Bilateral Revolving Credit Facility
300

300

December 2021
Floating rate
Bilateral Revolving Credit Facility
100

100

October 2024
Floating rate
Bilateral Revolving Credit Facility
100

100

October 2024
Floating rate
Bilateral Revolving Credit Facility
200

200

November 2024
Floating rate
Total Committed and Available Credit Facilities
$
9,428

$
7,428

 
 

1.
Assumes the option to extend the Term Loan Facility will be exercised.
2.
Equivalent to Euro 400 million.

Secured Borrowings
In September 2018, the Company renewed its North American accounts receivable securitization facility for a one year term and amended the terms of the agreement from an off-balance sheet arrangement to a secured borrowing arrangement, with a borrowing capacity up to $800 million. Under the structure of the amended agreement, the Company had the option to use select trade accounts receivable to collateralize the credit facility with certain lenders. In November 2019, the facility was amended and is no longer a secured borrowing arrangement. It had not been drawn upon during its term as a secured borrowing arrangement.

In October 2018, the Company renewed its European accounts receivable securitization facility for a two year term and amended the terms of the agreement from an off-balance sheet arrangement to a secured borrowing arrangement, with a borrowing capacity up to Euro 400 million. Under the structure of the amended agreement, the Company will use select trade accounts receivable to collateralize the credit facility with certain lenders. At December 31, 2019 and 2018, the facility had not been drawn upon.

Letters of Credit
The Company utilizes letters of credit to support commitments made in the ordinary course of business. While the terms and amounts of letters of credit change, the Company generally has approximately $400 million of outstanding letters of credit at any given time.

Debt Covenants and Default Provisions
TDCC’s outstanding long-term debt has been issued primarily under indentures which contain, among other provisions, certain customary restrictive covenants with which TDCC must comply while the underlying notes are outstanding. Failure of TDCC to comply with any of its covenants, could result in a default under the applicable indenture and allow the note holders to accelerate the due date of the outstanding principal and accrued interest on the underlying notes.

TDCC's indenture covenants include obligations to not allow liens on principal U.S. manufacturing facilities, enter into sale and lease-back transactions with respect to principal U.S. manufacturing facilities, merge or consolidate with any other corporation, or sell, lease or convey, directly or indirectly, all or substantially all of TDCC’s assets. The outstanding debt also contains customary default provisions. TDCC remains in compliance with these covenants.


104



TDCC’s primary, private credit agreements also contain certain customary restrictive covenant and default provisions in addition to the covenants set forth above with respect to TDCC’s debt. Significant other restrictive covenants and default provisions related to these agreements include:

(a)
the obligation to maintain the ratio of TDCC’s consolidated indebtedness to consolidated capitalization at no greater than 0.65 to 1.00 at any time the aggregate outstanding amount of loans under the Five Year Competitive Advance and Revolving Credit Facility Agreement ("Revolving Credit Agreement") dated October 30, 2018, equals or exceeds $500 million,

(b)
a default if TDCC or an applicable subsidiary fails to make any payment, including principal, premium or interest, under the applicable agreement on other indebtedness of, or guaranteed by, TDCC or such applicable subsidiary in an aggregate amount of $100 million or more when due, or any other default or other event under the applicable agreement with respect to such indebtedness occurs which permits or results in the acceleration of $400 million or more in the aggregate of principal, and

(c)
a default if TDCC or any applicable subsidiary fails to discharge or stay within 60 days after the entry of a final judgment against TDCC or such applicable subsidiary of more than $400 million.

Failure of TDCC to comply with any of the covenants or default provisions could result in a default under the applicable credit agreement which would allow the lenders to not fund future loan requests and to accelerate the due date of the outstanding principal and accrued interest on any outstanding indebtedness.

On April 1, 2019, DowDuPont completed the separation of its materials science business and Dow Inc. became the direct parent company of TDCC. In conjunction with the separation, Dow Inc. is obligated, substantially concurrently with the issuance of any guarantee in respect of outstanding or committed indebtedness under TDCC's Revolving Credit Agreement, to enter into a supplemental indenture with TDCC and the trustee under TDCC’s existing 2008 base indenture governing certain notes issued by TDCC. Under such supplemental indenture, Dow Inc. will guarantee all outstanding debt securities and all amounts due under such existing base indenture and will become subject to certain covenants and events of default under the existing base indenture.

In addition, the Revolving Credit Agreement includes an event of default which would be triggered in the event Dow Inc. incurs or guarantees third party indebtedness for borrowed money in excess of $250 million or engages in any material activity or directly owns any material assets, in each case, subject to certain conditions and exceptions. Dow Inc. may, at its option, cure the event of default by delivering an unconditional and irrevocable guarantee to the administrative agent within thirty days of the event or events giving rise to such event of default.

No such events have occurred or have been triggered at the time of the filing of this Annual Report on Form 10-K.


NOTE 17 – COMMITMENTS AND CONTINGENT LIABILITIES
Environmental Matters
Introduction
Accruals for environmental matters are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated based on current law and existing technologies. At December 31, 2019, the Company had accrued obligations of $1,155 million for probable environmental remediation and restoration costs, including $207 million for the remediation of Superfund sites. These obligations are included in "Accrued and other current liabilities" and "Other noncurrent obligations" in the consolidated balance sheets. This is management’s best estimate of the costs for remediation and restoration with respect to environmental matters for which the Company has accrued liabilities, although it is reasonably possible that the ultimate cost with respect to these particular matters could range up to approximately one and a half times that amount. Consequently, it is reasonably possible that environmental remediation and restoration costs in excess of amounts accrued could have a material impact on the Company’s results of operations, financial condition and cash flows. It is the opinion of the Company’s management, however, that the possibility is remote that costs in excess of the range disclosed will have a material impact on the Company’s results of operations, financial condition or cash flows. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards regarding liability, and emerging remediation technologies for handling site remediation and restoration. As new or additional information becomes available and/or certain spending trends become known, management will evaluate such information in determination of the current estimate of the environmental liability. At December 31, 2018, the Company had accrued obligations of $810 million for probable environmental remediation and restoration costs, including $156 million for the remediation of Superfund sites.


105



In the third quarter of 2019, the Company recorded a pretax charge related to environmental remediation matters at a number of current and historical locations. The charge primarily resulted from: the culmination of long-standing negotiations and discussions with regulators and agencies, including technical studies supporting higher cost estimates for final or staged remediation plans; the Company’s evaluation of the cost required to manage remediation activities at sites affected by Dow’s separation from DowDuPont and related agreements with Corteva and DuPont; and, the Company’s review of its closure strategies and obligations to monitor ongoing operations and maintenance activities. In addition, the Company recorded indemnification assets of $48 million related to Dow Silicones’ environmental matters. The Company recognized a pretax charge, net of indemnifications, of $399 million related to these environmental matters, included in “Cost of sales” in the consolidated statements of income and related to Packaging & Specialty Plastics ($5 million), Industrial Intermediates & Infrastructure ($8 million), Performance Materials & Coatings ($50 million) and Corporate ($336 million).  

The following table summarizes the activity in the Company's accrued obligations for environmental matters for the years ended December 31, 2019 and 2018:

Accrued Obligations for Environmental Matters
2019
2018
In millions
Balance at Jan 1
$
810

$
865

Accrual adjustment
590

176

Payments against reserve
(241
)
(208
)
Foreign currency impact
(4
)
(23
)
Balance at Dec 31
$
1,155

$
810



The amounts charged to income on a pretax basis related to environmental remediation totaled $588 million in 2019, $176 million in 2018 and $163 million in 2017. Capital expenditures for environmental protection were $83 million in 2019, $55 million in 2018 and $57 million in 2017.

Midland Off-Site Environmental Matters
On June 12, 2003, the Michigan Department of Environmental Quality ("MDEQ") issued a Hazardous Waste Operating License (the "License") to the Company’s Midland, Michigan, manufacturing site (the “Midland Site”), which was renewed and replaced by the MDEQ on September 25, 2015, and included provisions requiring the Company to conduct an investigation to determine the nature and extent of off-site contamination in the City of Midland soils, the Tittabawassee River and Saginaw River sediment and floodplain soils, and the Saginaw Bay, and, if necessary, undertake remedial action. In 2016, final regulatory approval was received from the MDEQ for the City of Midland and the Company is continuing the long term monitoring requirements of the Remedial Action Plan.

Tittabawassee and Saginaw Rivers, Saginaw Bay
The Company, the U.S. Environmental Protection Agency (“EPA”) and the State of Michigan ("State") entered into an administrative order on consent (“AOC”), effective January 21, 2010, that requires the Company to conduct a remedial investigation, a feasibility study and a remedial design for the Tittabawassee River, the Saginaw River and the Saginaw Bay, and pay the oversight costs of the EPA and the State under the authority of the Comprehensive Environmental Response, Compensation, and Liability Act. These actions, to be conducted under the lead oversight of the EPA, will build upon the investigative work completed under the State Resource Conservation Recovery Act program from 2005 through 2009.

The Tittabawassee River, beginning at the Midland Site and extending down to the first six miles of the Saginaw River, are designated as the first Operable Unit for purposes of conducting the remedial investigation, feasibility study and remedial design work. This work will be performed in a largely upriver to downriver sequence for eight geographic segments of the Tittabawassee and upper Saginaw Rivers. In the first quarter of 2012, the EPA requested the Company address the Tittabawassee River floodplain ("Floodplain") as an additional segment. In January 2015, the Company and the EPA entered into an order to address remediation of the Floodplain. The remedial work is expected to continue over the next three years. The remainder of the Saginaw River and the Saginaw Bay are designated as a second Operable Unit and the work associated with that unit may also be geographically segmented. The AOC does not obligate the Company to perform removal or remedial action; that action can only be required by a separate order. The Company and the EPA have been negotiating orders separate from the AOC that obligate the Company to perform remedial actions under the scope of work of the AOC. The Company and the EPA have entered into six separate orders to perform limited remedial actions in seven of the eight geographic segments in the first Operable Unit, including the Floodplain. Dow has received from the EPA a Notice of Completion of Work for three of these six orders and the Company continues the long-term monitoring requirements.


106



Alternative Dispute Resolution Process
The Company, the EPA, the U.S. Department of Justice ("DOJ"), and the natural resource damage trustees (which include the Michigan Office of the Attorney General, the Michigan Department of Environment, Great Lakes and Energy, the Michigan Department of Natural Resources, the U.S. Fish and Wildlife Service, the U.S. Bureau of Indian Affairs and the Saginaw-Chippewa Indian Tribe of Michigan) have been engaged in negotiations to seek to resolve potential governmental claims against the Company for natural resource damages related to historical off-site contamination associated with the City of Midland, the Tittabawassee and Saginaw Rivers and the Saginaw Bay. The Company and the governmental parties started meeting in the fall of 2005 and entered into a Confidentiality Agreement in December 2005.

On November 8, 2019, a proposed consent decree on this matter was filed in the U.S. District Court for the Eastern District of Michigan ("District Court"), Civil Action No. 1:19-cv-13292 between the Company and federal, state and tribal trustees to resolve allegations of natural resource damages arising from the historic operations of the Company’s Midland Site. On November 14, 2019, a Notice of Lodging and Notice of Availability and Request for Comments on Draft Restoration Plan/Environmental Assessment was published in the Federal Register. Public comments on the proposed consent decree and the draft Restoration Plan/Environmental Assessment were required to be submitted within 45 days of that publication.

At December 31, 2019, the accrual for these off-site matters was $135 million (included in the total accrued obligation of $1,155 million). At December 31, 2018, the Company had an accrual for these off-site matters of $95 million (included in the total accrued obligation of $810 million).

Environmental Matters Summary
It is the opinion of the Company’s management that the possibility is remote that costs in excess of those disclosed will have a material impact on the Company’s results of operations, financial condition or cash flows.

Litigation
Asbestos-Related Matters of Union Carbide Corporation
Introduction
Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos-containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. ("Amchem"). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products. Union Carbide expects more asbestos-related suits to be filed against Union Carbide and Amchem in the future, and will aggressively defend or reasonably resolve, as appropriate, both pending and future claims.

Estimating the Asbestos-Related Liability

Based on a study completed by Ankura Consulting Group, LLC ("Ankura") in January 2003, Union Carbide increased its December 31, 2002, asbestos-related liability for pending and future claims for a 15-year period ending in 2017 to $2.2 billion, excluding future defense and processing costs. In subsequent years, Union Carbide compared current asbestos claim and resolution activity to the results of the most recent Ankura study at each balance sheet date to determine whether the accrual continued to be appropriate.

In 2016, Ankura completed a study to provide estimates for the undiscounted cost of disposing of pending and future claims against Union Carbide and Amchem through the terminal year of 2049, including a reasonable forecast of future defense and processing costs. Based on the study and Union Carbide’s internal review of asbestos claim and resolution activity, Union Carbide determined estimating the liability through the terminal year of 2049 was more appropriate due to increased knowledge and data about the costs to resolve claims and diminished volatility in filing rates. Union Carbide and the Company also determined that estimating and accruing a liability for future asbestos-related defense and processing costs was more appropriate as such costs represent expenditures related to legacy activities that do not contribute to current or future revenue generating activities of Union Carbide and the Company and is also reflective of the manner in which Union Carbide manages its asbestos-related exposure, including careful monitoring of the correlation between defense spending and resolution costs. As a result, in the fourth quarter of 2016, Union Carbide recorded a $1,113 million increase in its asbestos-related liability for pending and future claims, including future defense and processing costs. Each October, Union Carbide requests Ankura to review its historical asbestos claim and resolution activity through the third quarter of the current year, including asbestos-related defense and processing costs, to determine the appropriateness of updating the most recent study.


107



In December 2017, Ankura stated that an update of its December 2016 study would not provide a more likely estimate of future events than the estimate reflected in the study and, therefore, the estimate in the study remained applicable. Based on Union Carbide's internal review process and Ankura's response, Union Carbide determined that no change to the accrual was required.

In December 2018, Ankura completed a study of Union Carbide's historical asbestos claim and resolution activity through September 30, 2018, including asbestos-related defense and processing costs, and provided estimates for the undiscounted cost of disposing of pending and future claims against Union Carbide and Amchem through the terminal year of 2049. Based on the study and Union Carbide's internal review process, it was determined that no adjustment to the accrual was required. At December 31, 2018, Union Carbide's asbestos-related liability for pending and future claims and defense and processing costs was $1,260 million, and approximately 16 percent of the recorded liability related to pending claims and approximately 84 percent related to future claims.

In December 2019, Ankura stated that an update of its December 2018 study would not provide a more likely estimate of future events than the estimate reflected in the study and, therefore, the estimate in the study remained applicable. Based on Union Carbide's internal review process and Ankura's response, Union Carbide determined that no change to the accrual was required. At December 31, 2019, the asbestos-related liability for pending and future claims against Union Carbide and Amchem, including future asbestos-related defense and processing costs, was $1,165 million, and approximately 18 percent of the recorded liability related to pending claims and approximately 82 percent related to future claims.

Summary
The Company's management believes the amounts recorded by Union Carbide for the asbestos-related liability, including defense and processing costs, reflect reasonable and probable estimates of the liability based upon current, known facts. However, future events, such as the number of new claims to be filed and/or received each year, the average cost of defending and disposing of each such claim, as well as the numerous uncertainties surrounding asbestos litigation in the United States over a significant period of time, could cause the actual costs for Union Carbide to be higher or lower than those projected or those recorded. Any such events could result in an increase or decrease in the recorded liability.

Because of the uncertainties described above, Union Carbide cannot estimate the full range of the cost of resolving pending and future asbestos-related claims facing Union Carbide and Amchem. As a result, it is reasonably possible that an additional cost of disposing of Union Carbide's asbestos-related claims, including future defense and processing costs, could have a material impact on the Company's results of operations and cash flows for a particular period and on the consolidated financial position.

Dow Silicones Chapter 11 Related Matters
Introduction
In 1995, Dow Silicones, then a 50:50 joint venture between the Company and Corning Incorporated ("Corning"), voluntarily filed for protection under Chapter 11 of the U.S. Bankruptcy Code in order to resolve Dow Silicones’ breast implant liabilities and related matters (the “Chapter 11 Proceeding”). Dow Silicones emerged from the Chapter 11 Proceeding on June 1, 2004 (the “Effective Date”) and is implementing the Joint Plan of Reorganization (the “Plan”). The Plan provides funding for the resolution of breast implant and other product liability litigation covered by the Chapter 11 Proceeding and provides a process for the satisfaction of commercial creditor claims in the Chapter 11 Proceeding. As of June 1, 2016, Dow Silicones is a wholly owned subsidiary of the Company.

Breast Implant and Other Product Liability Claims
Under the Plan, a product liability settlement program administered by an independent claims office (the “Settlement Facility”) was created to resolve breast implant and other product liability claims. Product liability claimants rejecting the settlement program in favor of pursuing litigation must bring suit against a litigation facility (the “Litigation Facility”). Under the Plan, total payments committed by Dow Silicones to resolving product liability claims are capped at a maximum $2,350 million net present value (“NPV”) determined as of the Effective Date using a discount rate of seven percent (approximately $4,019 million undiscounted at December 31, 2019). Of this amount, no more than $400 million NPV determined as of the Effective Date can be used to fund the Litigation Facility.

Dow Silicones has an obligation to fund the Settlement Facility and the Litigation Facility over a 16-year period, commencing at the Effective Date. At
December 31, 2019, Dow Silicones and its insurers have made life-to-date payments of $1,762 million to the Settlement Facility and the Settlement Facility reported an unexpended balance of $74 million.


108



In accordance with ASC 450 "Accounting for Contingencies," the Company records a liability for breast implant and other product liability claims (“Implant Liability”), which reflects the estimated impact of the settlement of future claims primarily based on reported claim filing levels in the Revised Settlement Program (the “RSP”) and on the resolution of almost all cases pending against the Litigation Facility. The RSP was a program sponsored by certain other breast implant manufacturers in the context of multi-district, coordinated federal breast implant cases and was open from 1995 through 2010. The RSP was also a revised successor to an earlier settlement plan involving Dow Silicones (prior to its bankruptcy filing). While Dow Silicones withdrew from the RSP, many of the benefit categories and payment levels in Dow Silicones settlement program were drawn from the RSP. Based on the comparability in design and actual claim experience of both plans, management concluded that claim information from the RSP provides a reasonable basis to estimate future claim filing levels for the Settlement Facility.

In the third quarter of 2019, with the assistance of a third party consultant ("Consultant"), Dow Silicones updated its Implant Liability estimate to $165 million, primarily reflecting a decrease in Class 16 claims, a decrease resulting from the passage of time, decreased claim filing activity and administrative costs compared with the previous estimate, and an increase in investment income resulting from insurance proceeds. Based on the Consultant's updated estimate and Dow Silicones own review of claim filing activity, Dow Silicones determined that an adjustment to the Implant Liability was required. Accordingly, Dow Silicones decreased its Implant Liability in the third quarter of 2019 by $98 million, included in "Sundry income (expense) - net" in the consolidated statements of income, and also decreased its corresponding Class 16 receivable in the third quarter of 2019, resulting in a charge of $13 million, included in “Sundry income (expense) - net” in the consolidated statements of income (both related to the Corporate segment). Dow Silicones' Implant Liability was $165 million at December 31, 2019 ($263 million at December 31, 2018), of which $20 million at December 31, 2019 ($111 million at December 31, 2018) was included in “Accrued and other current liabilities” and $145 million at December 31, 2019 ($152 million at December 31, 2018) was included in "Other noncurrent obligations" in the consolidated balance sheets.

Dow Silicones is not aware of circumstances that would change the factors used in estimating the Implant Liability and believes the recorded liability reflects the best estimate of the remaining funding obligations under the Plan; however, the estimate relies upon a number of significant assumptions, including: future acceptance rates, disease mix, and payment values will be materially consistent with historical experience; no material negative outcomes in future controversies or disputes over Plan interpretation will occur; and the Plan will not be modified. If actual outcomes related to any of these assumptions prove to be materially different, the future liability to fund the Plan may be materially different than the amount estimated. If Dow Silicones was ultimately required to fund the full liability up to the maximum capped value, the liability would be $2,257 million at December 31, 2019.

Commercial Creditor Issues
The Plan provides that each of Dow Silicones commercial creditors (the “Commercial Creditors”) would receive in cash the sum of (a) an amount equal to the principal amount of their claims and (b) interest on such claims. Upon the Plan becoming effective, Dow Silicones paid approximately $1,500 million to the Commercial Creditors, representing principal and an amount of interest that Dow Silicones considers undisputed.

In 2006, the U.S. Court of Appeals for the Sixth Circuit concluded that there is a general presumption that contractually specified default interest should be paid by a solvent debtor to unsecured creditors (the “Interest Rate Presumption”) and permitting the Commercial Creditors to recover fees, costs, and expenses where allowed by relevant loan agreements. The matter was remanded to the U.S. District Court for the Eastern District of Michigan ("District Court") for further proceedings, including rulings on the facts surrounding specific claims and consideration of any equitable factors that would preclude the application of the Interest Rate Presumption. On May 10, 2017, the District Court entered a stipulated order resolving pending discovery motions and established a discovery schedule for the Commercial Creditors matter. As a result, Dow Silicones and its third party consultants conducted further analysis of the Commercial Creditors claims and defenses. This analysis indicated the estimated remaining liability to the Commercial Creditors to be within a range of $77 million to $260 million. No single amount within the range appeared to be a better estimate than any other amount within the range. Therefore, Dow Silicones recorded the minimum liability within the range, which resulted in a decrease to the Commercial Creditor liability of $33 million in the second quarter of 2017, which was included in "Sundry income (expense) - net" in the consolidated statements of income and related to Corporate. At December 31, 2018, the liability related to Dow Silicones' potential obligation to its Commercial Creditors was $82 million, included in "Accrued and other current liabilities" in the consolidated balance sheets.

On August 19, 2019, Dow Silicones entered into a settlement agreement with the Commercial Creditors, obligating Dow Silicones to pay $172 million, inclusive of the Commercial Creditors' legal costs. The settlement was approved by the District Court. As a result of the settlement agreement, in the third quarter of 2019, the Company recorded a pretax charge of $50 million, net of indemnifications of $37 million, included in "Sundry Income (expense) - net" in the consolidated statements of income and related to the Corporate segment. The settlement was paid to the Commercial Creditors in the fourth quarter of 2019. The litigation is now concluded.


109



Summary
The amounts recorded by Dow Silicones for the Chapter 11 related matters described above were based upon current, known facts, which management believes reflect reasonable and probable estimates of the liability. However, future events could cause the actual costs for Dow Silicones to be higher or lower than those projected or those recorded. Any such events could result in an increase or decrease in the recorded liability.

Other Litigation Matters
In addition to the specific matters described above, the Company is party to a number of other claims and lawsuits arising out of the normal course of business with respect to product liability, patent infringement, employment matters, governmental tax and regulation disputes, contract and commercial litigation, and other actions. Certain of these actions purport to be class actions and seek damages in very large amounts. All such claims are being contested. The Company has an active risk management program consisting of numerous insurance policies secured from many carriers at various times. These policies may provide coverage that could be utilized to minimize the financial impact, if any, of certain contingencies described above. It is the opinion of the Company’s management that the possibility is remote that the aggregate of all such other claims and lawsuits will have a material adverse impact on the results of operations, financial condition and cash flows of the Company.

Indemnifications with Corning
In connection with the June 1, 2016 ownership restructure of Dow Silicones, the Company is indemnified by Corning for at least 50 percent of future losses associated with certain pre-closing liabilities, including the Implant Liability, Commercial Creditors issues and certain environmental matters described in the preceding sections, subject to certain conditions and limits. The maximum amount of indemnified losses which may be recovered are subject to a cap that declines over time. Indemnified losses are capped at (1) $1 billion between May 31, 2018 and May 31, 2023, and (2) no recoveries are permitted after May 31, 2023. The Company had indemnification assets of $100 million at December 31, 2019 (zero at December 31, 2018), of which $37 million was included in "Other current assets" and $63 million was included in "Noncurrent receivables" in the consolidated balance sheets.

Gain Contingency - Dow v. Nova Chemicals Corporation Patent Infringement Matter
On December 9, 2010, Dow filed suit in the Federal Court in Ontario, Canada ("Federal Court") alleging that Nova Chemicals Corporation ("Nova") was infringing the Company's Canadian polyethylene patent 2,106,705 (the "'705 Patent"). Nova counterclaimed on the grounds of invalidity and non-infringement. In accordance with Canadian practice, the suit was bifurcated into a merits phase, followed by a damages phase. Following trial in the merits phase, in May 2014 the Federal Court ruled that the Company's '705 Patent was valid and infringed by Nova. Nova appealed to the Canadian Federal Court of Appeal, which affirmed the Federal Court decision in August 2016. Nova then sought leave to appeal its loss to the Supreme Court of Canada, which dismissed Nova’s petition in April 2017. As a result, Nova has exhausted all appeal rights on the merits, and it is undisputed that Nova owes the Company the profits it earned from its infringing sales as determined in the trial for the damages phase.

On April 19, 2017, the Federal Court issued a Public Judgment in the damages phase, which detailed its conclusions on how to calculate the profits to be awarded to the Company. The Company and Nova submitted their respective calculations of the damages to the Federal Court in May 2017. On June 29, 2017, the Federal Court issued a Confidential Supplemental Judgment, concluding that Nova must pay $645 million Canadian dollars (equivalent to $495 million U.S. dollars) to the Company, plus pre- and post-judgment interest, for which the Company received payment of $501 million from Nova on July 6, 2017. Although Nova is appealing portions of the damages judgment, certain portions of it are indisputable and will be owed to the Company regardless of the outcome of any further appeals by Nova. As a result of these actions and in accordance with ASC 450-30 "Gain Contingencies," the Company recorded a $160 million pretax gain in the second quarter of 2017, related to the Packaging & Specialty Plastics segment, of which $137 million was included in "Sundry income (expense) - net" and $23 million was included in "Selling, general and administrative expenses" in the consolidated statements of income. At December 31, 2019, the Company had $341 million ($341 million at December 31, 2018) included in "Other noncurrent obligations" related to the disputed portion of the damages judgment. The Company is confident of its chances of defending the entire judgment on appeal, particularly the trial court's determinations on important factual issues, which will be accorded deferential review on appeal.

Gain Contingency - Dow v. Nova Chemicals Corporation Ethylene Asset Matter
On September 18, 2019, the Court of the Queen’s Bench in Alberta, Canada, signed a judgment ordering Nova to pay the Company $1.43 billion Canadian dollars (equivalent to approximately $1.08 billion U.S. dollars) by October 11, 2019, for damages the Company incurred through 2012 related to the companies’ jointly-owned ethylene asset in Joffre, Alberta, Canada. The Court, which initially ruled in June 2018, found that Nova failed to operate the ethylene asset at full capacity for more than ten years, and furthermore, that Nova violated several contractual agreements related to the Company receiving its share of the asset’s ethylene production. These actions resulted in reduced productivity and sales for the Company. Nova has appealed the judgment, however, certain portions of it are not in dispute and are owed to the Company regardless of the outcome of Nova's appeal. As a result of these actions and in accordance with ASC 450-30 “Gain Contingencies,” the Company recorded a $186 million pretax gain in the third quarter of 2019, of which $170 million was included in "Sundry income (expense) - net" and $16 million was included in

110



"Selling, general and administrative expenses" in the consolidated statements of income and related to Packaging & Specialty Plastics. In October 2019, Nova paid $1.08 billion Canadian dollars (equivalent to approximately $0.8 billion U.S. dollars) directly to the Company, and remitted $347 million Canadian dollars to the Canada Revenue Agency ("CRA") for the tax account of one of the Company's subsidiaries. The Company has sought a refund of the entire amount remitted to the CRA. At December 31, 2019, $265 million was included in "Noncurrent receivables" in the Company's consolidated balance sheets related to the withholding tax and $893 million was included in "Other noncurrent obligations" in the Company's consolidated balance sheets related to the disputed portion of the damages judgment. Dow is confident of its chances of defending the entire judgment on appeal, particularly the trial court's determinations on important factual and discretionary issues, which will be accorded deferential review on appeal.

Purchase Commitments
The Company has outstanding purchase commitments and various commitments for take-or-pay or throughput agreements. The Company was not aware of any purchase commitments that were negotiated as part of a financing arrangement for the facilities that will provide the contracted goods or services or for the costs related to those goods or services at December 31, 2019 and 2018.

Guarantees
The following table provides a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for guarantees:

Guarantees
Dec 31, 2019
Dec 31, 2018
In millions
Final
Expiration
Maximum 
Future Payments
Recorded  
Liability  
Final
Expiration
Maximum 
Future Payments
Recorded  
Liability  
Guarantees
2023
$
3,952

$
10

2023
$
4,273

$
22



Guarantees arise during the ordinary course of business from relationships with customers, committed accounts receivable facilities and nonconsolidated affiliates when the Company undertakes an obligation to guarantee the performance of others (via delivery of cash or other assets) if specified triggering events occur. With guarantees, such as commercial or financial contracts, non-performance by the guaranteed party triggers the obligation of the Company to make payments to the beneficiary of the guarantee. The majority of the Company’s guarantees relate to debt of nonconsolidated affiliates, which have expiration dates ranging from less than one year to less than four years. The Company’s current expectation is that future payment or performance related to the non-performance of others is considered remote.

The Company has entered into guarantee agreements (“Guarantees”) related to project financing for Sadara. The total of an Islamic bond and additional project financing (collectively “Total Project Financing”) obtained by Sadara is approximately $12.5 billion. Sadara had $10.8 billion of Total Project Financing outstanding at December 31, 2019 ($11.7 billion at December 31, 2018). The Company's guarantee of the Total Project Financing is in proportion to the Company's 35 percent ownership interest in Sadara, or up to approximately $3.9 billion when the project financing is fully drawn. Sadara successfully completed an extensive operational testing program in December 2018, however, the Guarantees will be released upon the satisfactory fulfillment of certain project completion conditions, which is expected by the end of the first quarter of 2020, and must occur no later than December 2020.

Asset Retirement Obligations
The Company has 109 manufacturing sites in 31 countries. Most of these sites contain numerous individual manufacturing operations, particularly at the Company’s larger sites. Asset retirement obligations are recorded as incurred and reasonably estimable, including obligations for which the timing and/or method of settlement are conditional on a future event that may or may not be within the control of the Company. The retirement of assets may involve such efforts as remediation and treatment of asbestos, contractually required demolition, and other related activities, depending on the nature and location of the assets; and retirement obligations are typically realized only upon demolition of those facilities. In identifying asset retirement obligations, the Company considers identification of legally enforceable obligations, changes in existing law, estimates of potential settlement dates and the calculation of an appropriate discount rate to be used in calculating the fair value of the obligations. The Company has a well-established global process to identify, approve and track the demolition of retired or to-be-retired facilities; and no assets are retired from service until this process has been followed. The Company typically forecasts demolition projects based on the usefulness of the assets; environmental, health and safety concerns; and other similar considerations. Under this process, as demolition projects are identified and approved, reasonable estimates are determined for the time frames during which any related asset retirement obligations are expected to be settled. For those assets where a range of potential settlement dates may be reasonably estimated, obligations are recorded. The Company routinely reviews all changes to items under consideration for demolition to determine if an adjustment to the value of the asset retirement obligation is required.

111



The Company has recognized asset retirement obligations for the following activities: demolition and remediation activities at manufacturing sites primarily in the United States, Canada, Brazil, Argentina, Japan, United Arab Emirates, Australia and Europe; and capping activities at landfill sites in the United States, Canada and Brazil. The Company has also recognized conditional asset retirement obligations related to asbestos encapsulation as a result of planned demolition and remediation activities at manufacturing and administrative sites primarily in the United States, Canada, Argentina, Australia and Europe. The aggregate carrying amount of conditional asset retirement obligations recognized by the Company (included in the asset retirement obligations balance shown below) was $19 million at December 31, 2019 ($22 million at December 31, 2018).

The following table shows changes in the aggregate carrying amount of the Company’s asset retirement obligations for the years ended December 31, 2019 and 2018:

Asset Retirement Obligations
2019
2018
In millions
Balance at Jan 1
$
109

$
100

Additional accruals
10

9

Liabilities settled
(7
)
(3
)
Accretion expense
2

3

Revisions in estimated cash flows
3


Other
(13
)

Balance at Dec 31
$
104

$
109



The discount rate used to calculate the Company’s asset retirement obligations at December 31, 2019, was 2.12 percent (3.54 percent at December 31, 2018). These obligations are included in the consolidated balance sheets as "Accrued and other current liabilities" and "Other noncurrent obligations."

The Company has not recognized conditional asset retirement obligations for which a fair value cannot be reasonably estimated in its consolidated financial statements. Assets that have not been submitted/reviewed for potential demolition activities are considered to have continued usefulness and are generally still operating normally. Therefore, without a plan to demolish the assets or the expectation of a plan, such as shortening the useful life of assets for depreciation purposes in accordance with the accounting guidance related to property, plant and equipment, the Company is unable to reasonably forecast a time frame to use for present value calculations. As such, the Company has not recognized obligations for individual plants/buildings at its manufacturing sites where estimates of potential settlement dates cannot be reasonably made. In addition, the Company has not recognized conditional asset retirement obligations for the capping of its approximately 36 underground storage wells and 131 underground brine mining and other wells at Company-owned sites when there are no plans or expectations of plans to exit the sites. It is the opinion of the Company’s management that the possibility is remote that such conditional asset retirement obligations, when estimable, will have a material impact on the Company’s consolidated financial statements based on current costs.


NOTE 18 - LEASES
Operating lease ROU assets are included in "Operating lease right-of-use assets" while finance lease ROU assets are included in "Net property" in the consolidated balance sheets. With respect to lease liabilities, operating lease liabilities are included in "Operating lease liabilities - current" and "Operating lease liabilities - noncurrent," and finance lease liabilities are included in "Long-term debt due within one year" and "Long-Term Debt" in the consolidated balance sheets.

Dow routinely leases sales and administrative offices, power plants, production facilities, warehouses and tanks for product storage, aircraft, motor vehicles, railcars, computers, office machines and equipment. Some leases contain renewal provisions, purchase options and escalation clauses and the terms for these leased assets vary depending on the lease agreement. These leased assets have remaining lease terms of up to 50 years. See Notes 1 and 2 for additional information on leases.


112



The components of lease cost for operating and finance leases for the year ended December 31, 2019 were as follows:

Lease Cost
Year Ended Dec 31, 2019
In millions
Operating lease cost
$
532

Finance lease cost
 
Amortization of right-of-use assets - finance
$
39

Interest on lease liabilities - finance
25

Total finance lease cost
$
64

Short-term lease cost
$
204

Variable lease cost
198

Sublease income
(4
)
Total lease cost
$
994



The following table provides supplemental cash flow information related to leases:

Other Lease Information
Year Ended Dec 31, 2019
In millions
Cash paid for amounts included in the measurement of lease liabilities:
 
Operating cash flows for operating leases
$
544

Operating cash flows for finance leases
$
25

Financing cash flows for finance leases
$
34



The following table summarizes the lease-related assets and liabilities recorded in the consolidated balance sheets at December 31, 2019.

Lease Position
Balance Sheet Classification
Dec 31, 2019
In millions
Right-of-use assets obtained in exchange for lease obligations:
 
 
Operating leases 1
 
$
2,476

Finance leases
 
$
89

Assets
 
 
Operating lease assets
Operating lease right-of-use assets
$
2,072

Finance lease assets
Property
486

Finance lease amortization
Accumulated depreciation
(167
)
Total lease assets
 
$
2,391

Liabilities
 
 
Current
 
 
Operating
Operating lease liabilities - current
$
421

Finance
Long-term debt due within one year
32

Noncurrent
 
 
Operating
Operating lease liabilities - noncurrent
1,739

Finance
Long-Term Debt
363

Total lease liabilities
 
$
2,555

1.
Includes $2.3 billion related to the adoption of Topic 842. See Note 2 for additional information.


113



Lease Term and Discount Rate
Dec 31, 2019
Weighted-average remaining lease term
 
Operating leases
8.0 years

Finance leases
12.3 years

Weighted-average discount rate
 
Operating leases
4.09
%
Finance leases
6.28
%


The following table provides the maturities of lease liabilities at December 31, 2019:

Maturities of Lease Liabilities at Dec 31, 2019
Operating Leases
Finance Leases
In millions
2020
$
492

$
60

2021
422

55

2022
355

50

2023
285

84

2024
219

29

2025 and thereafter
803

310

Total future undiscounted lease payments
$
2,576

$
588

Less imputed interest
416

193

Total present value of lease liabilities
$
2,160

$
395



At December 31, 2019, Dow had additional leases of approximately $71 million, primarily for equipment, which had not yet commenced. These leases are expected to commence in 2020 and 2021, with lease terms of up to 20 years.

Future minimum lease payments for operating leases accounted for under ASC 840, "Leases," with remaining non-cancelable terms in excess of one year at December 31, 2018 were as follows:

Minimum Lease Commitments at Dec 31, 2018
 
In millions
 
2019
$
366

2020
329

2021
296

2022
269

2023
227

2024 and thereafter
855

Total
$
2,342



Dow provides guarantees related to certain leased assets, specifying the residual value that will be available to the lessor at lease termination through the sale of the assets to the lessee or third parties. The following table provides a summary of the final expiration, maximum future payments and recorded liability reflected in the consolidated balance sheets for residual value guarantees at December 31, 2019 and 2018. There was no recorded liability related to these residual value guarantees at December 31, 2019, as payment of such residual value guarantees was not determined to be probable. The lease agreements do not contain any material restrictive covenants.

Lease Guarantees
Dec 31, 2019
Dec 31, 2018
In millions
Final Expiration
Maximum Future Payments
Recorded Liability
Final Expiration
Maximum Future Payments
Recorded Liability
Residual value guarantees
2028
$
792

$

2028
$
885

$
130





114



NOTE 19 – STOCKHOLDERS’ EQUITY
Merger with Historical DuPont
Effective with the Merger, each share of TDCC Common Stock (excluding any shares of TDCC Common Stock that were held in treasury, which were automatically canceled and retired for no consideration) was converted into the right to receive one fully paid and non-assessable share of DowDuPont Common Stock. As a result, in the third quarter of 2017, the Company recorded a reduction in "Treasury stock" of $935 million, a reduction in "Common stock" of $3,107 million and an increase in "Additional paid in capital" of $2,172 million in the consolidated balance sheets. See Note 3 for additional information.

Common Stock
Dow Inc.
Dow Inc. was incorporated in 2018 with 100 authorized and issued shares of common stock, par value $0.01 per share, owned solely by its parent company, DowDuPont. In the first quarter of 2019, in connection with the separation and distribution of DowDuPont’s materials science business, the number of authorized shares of common stock was increased to 5,000,000,000 shares, par value $0.01 per share, and Dow Inc.'s 100 shares of issued common stock were recapitalized into 748,771,240 shares of common stock. Dow Inc.'s common stock was solely owned by DowDuPont through March 31, 2019, and on April 1, 2019, Dow Inc. became an independent, publicly traded company. Dow Inc. common stock is listed on the NYSE under the symbol “DOW.” See Notes 3 and 4 for additional information.

The Company may issue Dow Inc. common stock shares out of treasury stock or as new common stock shares for purchases under the Employee Stock Purchase Plan ("ESPP"), for options exercised and for the release of restricted stock units ("RSUs") (formerly termed deferred stock), performance stock units ("PSUs") (formerly termed performance deferred stock) and restricted stock. Subsequent to the separation from DowDuPont, the number of new Dow Inc. common stock shares issued to employees and non-employee directors was approximately 2.5 million in 2019. Prior to the Merger, the number of new TDCC common stock shares issued to employees and non-employee directors was zero in 2017. See Note 22 for additional information on changes to the Company's equity awards in connection with the Merger and separation from DowDuPont.

TDCC
Effective with the Merger and through March 31, 2019, TDCC had 100 authorized and issued shares of common stock, par value $0.01 per share, owned solely by DowDuPont. Effective with the separation from DowDuPont, TDCC became a wholly owned subsidiary of Dow Inc., which now holds all 100 authorized and issued shares of common stock of TDCC. See Notes 3 and 4 for additional information.

Retained Earnings
Dow Inc.
There are no significant restrictions limiting Dow Inc.’s ability to pay dividends. Subsequent to the separation from DowDuPont, Dow Inc. declared dividends of $2.10 per share in 2019.

Undistributed earnings of nonconsolidated affiliates included in retained earnings were $852 million at December 31, 2019 and $1,856 million at December 31, 2018.

TDCC
Prior to the Merger, TDCC declared dividends of $1.38 per share in 2017. Effective with the Merger, TDCC no longer had publicly traded common stock. TDCC's common shares were owned solely by DowDuPont, prior to the separation on April 1, 2019, and TDCC's Board of Directors determined whether or not there would be a dividend distribution to DowDuPont. Effective with the separation from DowDuPont on April 1, 2019, TDCC became a wholly owned subsidiary of Dow Inc. and TDCC's Board of Directors determines whether or not there will be a dividend distribution to Dow Inc. See Note 26 for additional information on dividends paid by TDCC to DowDuPont and Dow Inc.

See Note 4 for information on the impact of the receipt of ECP, which was accounted for as a transfer between entities under common control.

Employee Stock Ownership Plan
The Dow Employee Stock Ownership Plan (the “ESOP”) is an integral part of The Dow Chemical Company Employees’ Savings Plan (the “Plan”). A significant majority of full-time employees in the United States are eligible to participate in the Plan. The Company uses the ESOP to provide its matching contribution in the form of stock to Plan participants. Prior to the Merger, contributions were in the form of TDCC Common Stock. Effective with the Merger, shares of TDCC Common Stock held by the ESOP were converted into shares of DowDuPont Common Stock at a ratio of 1:1. Effective with the separation from DowDuPont, the DowDuPont Common Stock held by the ESOP received a Dow Inc. Common Stock share dividend at a ratio of 3:1, resulting

115



in the ESOP holding both DowDuPont and Dow Inc. shares. Subsequent to the separation from DowDuPont, the ESOP independent fiduciary sold the DowDuPont shares and purchased additional Dow Inc. shares with the proceeds.

In connection with the acquisition of Rohm and Haas on April 1, 2009, the Rohm and Haas Employee Stock Ownership Plan (the "Rohm and Haas ESOP") was merged into the Plan, and the Company assumed the $78 million balance of debt at 9.8 percent interest with final maturity in 2020 that was used to finance share purchases by the Rohm and Haas ESOP in 1990. The outstanding balance of the debt was $3 million at December 31, 2019 and $10 million at December 31, 2018.

Dividends on unallocated shares held by the ESOP are used by the ESOP to make debt service payments and to purchase additional shares if dividends exceed the debt service payments. Dividends on allocated shares are used by the ESOP to make debt service payments to the extent needed; otherwise, they are paid to the Plan participants. Shares are released for allocation to participants based on the ratio of the current year’s debt service to the sum of the principal and interest payments over the life of the loan. The shares are allocated to Plan participants in accordance with the terms of the Plan.

Compensation expense for allocated shares is recorded at the fair value of the shares on the date of allocation. Compensation expense reflected in income from continuing operations for ESOP shares was $77 million in 2019, $144 million in 2018 and $200 million in 2017. At December 31, 2019, 12.6 million shares out of a total 16.1 million shares held by the ESOP had been allocated to participants’ accounts and 3.5 million shares, at a fair value of $190 million, were considered unearned.

Treasury Stock
Dow Inc.
On April 1, 2019, Dow Inc.'s Board of Directors ratified the share repurchase program originally approved on March 15, 2019, authorizing up to $3 billion to be spent on the repurchase of the Company's common stock, with no expiration date. In 2019, Dow Inc. repurchased $500 million of Dow Inc. common stock. At December 31, 2019, $2.5 billion of the share repurchase program authorization remained available for repurchases.

TDCC
In 2013, TDCC's Board of Directors approved a share buy-back program. As a result of subsequent authorizations approved by TDCC's Board of Directors, the total authorized amount of the share repurchase program was $9.5 billion. Effective with the Merger, the share repurchase program was canceled. Over the duration of the program, a total of $8.1 billion was spent on the repurchase of TDCC Common Stock.

The Company may issue shares for purchases under the ESPP, for options exercised as well as for the release of RSUs, PSUs and restricted stock out of treasury stock or as new common stock shares. The number of treasury shares issued to employees and non-employee directors under the Company’s stock-based compensation programs are summarized in the following table. See Note 22 for additional information on changes to the Company equity awards in connection with the Merger and separation from DowDuPont.

Treasury Shares Issued Under Stock-Based Compensation Programs
2019 1
2018
2017 2
To employees and non-employee directors

N/A
14,194,282

1.
Reflects Dow Inc. activity subsequent to the separation from DowDuPont.
2.
Reflects TDCC activity prior to the Merger.

The following table provides a reconciliation of Dow Inc. common stock activity for the years ended December 31, 2019 and 2018:

Shares of Dow Inc. Common Stock
Issued
Held in Treasury
 
Balance at Jan 1, 2018


Issued 1
100


Balance at Jan 1, 2019
100


Impact of recapitalization
748,771,140


Issued 2
2,457,404


Repurchased

9,729,834

Balance at Dec 31, 2019
751,228,644

9,729,834

1.
Dow Inc. was incorporated in 2018 with 100 authorized and issued shares of common stock, par value $0.01 per share.
2.
Shares issued to employees and non-employee directors under the Company's equity compensation plans.

116



Accumulated Other Comprehensive Loss
The changes in each component of AOCL for the years ended December 31, 2019, 2018 and 2017 were as follows:

Accumulated Other Comprehensive Loss
2019
2018
2017
In millions
Unrealized Gains (Losses) on Investments
 
 
 
Beginning balance 1
$
(51
)
$
17

$
43

Unrealized gains (losses) on investments
178

(93
)
38

Less: Tax (expense) benefit
(38
)
19

(13
)
Net unrealized gains (losses) on investments
140

(74
)
25

(Gains) losses reclassified from AOCL to net income 2
(33
)
9

(110
)
Less: Tax expense (benefit) 3
8

(2
)
39

Net (gains) losses reclassified from AOCL to net income
(25
)
7

(71
)
Other comprehensive income (loss), net of tax
115

(67
)
(46
)
Reclassification of stranded tax effects 4

(1
)

Ending balance
$
64

$
(51
)
$
(3
)
Cumulative Translation Adjustment
 
 
 
Beginning balance
$
(1,813
)
$
(1,481
)
$
(2,381
)
Gains (losses) on foreign currency translation
59

(215
)
1,006

Less: Tax (expense) benefit
(2
)
(6
)
(98
)
Net gains (losses) on foreign currency translation
57

(221
)
908

(Gains) losses reclassified from AOCL to net income 5
(89
)
(4
)
(8
)
Other comprehensive income (loss), net of tax
(32
)
(225
)
900

Impact of common control transaction 6
710



Reclassification of stranded tax effects 4

(107
)

Ending balance
$
(1,135
)
$
(1,813
)
$
(1,481
)
Pension and Other Postretirement Benefits
 
 
 
Beginning balance
$
(7,965
)
$
(6,998
)
$
(7,389
)
Gains (losses) arising during the period
(1,699
)
(625
)
(3
)
Less: Tax (expense) benefit
413

130

(20
)
Net gains (losses) arising during the period
(1,286
)
(495
)
(23
)
Amortization and recognition of net loss and prior service credits 7
504

594

607

Less: Tax expense (benefit) 3
(117
)
(139
)
(193
)
Net loss and prior service credits reclassified from AOCL to net income
387

455

414

Other comprehensive income (loss), net of tax
(899
)
(40
)
391

Impact of common control transaction 6
83



Reclassification of stranded tax effects 4

(927
)

Ending balance
$
(8,781
)
$
(7,965
)
$
(6,998
)
Derivative Instruments
 
 
 
Beginning balance
$
(56
)
$
(109
)
$
(95
)
Gains (losses) on derivative instruments
(470
)
6

2

Less: Tax (expense) benefit
101

(2
)
(1
)
Net gains (losses) on derivative instruments
(369
)
4

1

(Gains) losses reclassified from AOCL to net income 8
44

89

(13
)
Less: Tax expense (benefit) 3
(13
)
(18
)
(2
)
Net (gains) losses reclassified from AOCL to net income
31

71

(15
)
Other comprehensive income (loss), net of tax
(338
)
75

(14
)
Reclassification of stranded tax effects 4

(22
)

Ending balance
$
(394
)
$
(56
)
$
(109
)
Total AOCL ending balance
$
(10,246
)
$
(9,885
)
$
(8,591
)

1.
The beginning balance of "Unrealized gains (losses) on investments" for 2018 was increased by $20 million to reflect the impact of adoption of ASU 2016-01.
2.
Reclassified to "Net sales" and "Sundry income (expense) - net."
3.
Reclassified to "Provision for income taxes."
4.
Amounts reclassified to "Retained earnings" as a result of the adoption of ASU 2018-02.
5.
Reclassified to "Sundry income (expense) - net."
6.
Reclassified to "Retained earnings" as a result of the separation from DowDuPont on April 1, 2019. See Note 4 for additional information.
7. These AOCL components are included in the computation of net periodic benefit cost of the Company's defined benefit pension and other postretirement benefit plans. See Note 21 for additional information.
8. Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."

117



NOTE 20 – NONCONTROLLING INTERESTS
Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income.

The following table summarizes the activity for equity attributable to noncontrolling interests for the years ended December 31, 2019, 2018 and 2017:

Noncontrolling Interests
 
 
 
In millions
2019
2018
2017
Balance at Jan 1
$
1,138

$
1,186

$
1,242

Net income attributable to noncontrolling interests - continuing operations
74

102

102

Net income attributable to noncontrolling interests - discontinued operations
13

32

28

Distributions to noncontrolling interests 1
(77
)
(145
)
(109
)
Impact of common control transaction 2
(353
)


Purchase of noncontrolling interests 3
(254
)


Deconsolidation of noncontrolling interests 4


(119
)
Cumulative translation adjustments
12

(39
)
41

Other

2

1

Balance at Dec 31
$
553

$
1,138

$
1,186

1.
Distributions to noncontrolling interests are net of $7 million in 2019 ($27 million in 2018 and $20 million in 2017) in dividends paid to a joint venture, which were reclassified to "Equity in earnings of nonconsolidated affiliates" in the consolidated statements of income. Also includes amounts attributable to discontinued operations of $7 million in 2019 ($37 million in 2018 and $28 million in 2017)
2.
Related to the separation from DowDuPont. See Note 4 for additional information.
3.
Relates to the acquisition of full ownership in a propylene oxide manufacturing joint venture, which occurred on October 1, 2019. See Note 25 for additional information. As a result of this arrangement, the carrying value of the noncontrolling interest was removed, and “Additional paid-in capital” was adjusted by $38 million.
4.
On June 30, 2017, the Company sold its ownership interest in the SKC Haas Display Films group of companies.



118



NOTE 21 – PENSION PLANS AND OTHER POSTRETIREMENT BENEFITS
As a result of the Company’s separation from DowDuPont, the number of significant defined benefit pension plans administered by the Company decreased from 45 plans to 35 plans, with approximately $270 million of net unfunded pension liabilities transferred to DowDupont. Plans administered by other subsidiaries of DowDuPont that were transferred to the Company were not significant. There were no changes in the number of significant other postretirement benefit plans administered by the Company as a result of the separation. Existing Company plans that were significantly impacted by the transfer of active plan participants to DowDuPont were remeasured, resulting in curtailment gains and losses and recognition of special termination benefits.

Defined Benefit Pension Plans
The Company has both funded and unfunded defined benefit pension plans that cover employees in the United States and a number of other countries. The U.S. qualified plan covering the parent company is the largest plan. Benefits for employees hired before January 1, 2008, are based on length of service and the employee’s three highest consecutive years of compensation. Employees hired after January 1, 2008, earn benefits that are based on a set percentage of annual pay, plus interest.

The Company's funding policy is to contribute to the plans when pension laws and/or economics either require or encourage funding. In 2019, the Company contributed $261 million to its continuing operations pension plans ($266 million, including contributions to plans of discontinued operations). Total contributions in 2019 also included contributions to fund benefit payments for the Company's non-qualified pension plans. The Company expects to contribute approximately $250 million to its pension plans in 2020.

The provisions of a U.S. non-qualified pension plan require the payment of plan obligations to certain participants upon a change in control of the Company, which occurred at the time of the Merger. Certain participants could elect to receive a lump-sum payment or direct the Company to purchase an annuity on their behalf using the after-tax proceeds of the lump sum. In the fourth quarter of 2017, the Company paid $940 million to plan participants and $230 million to an insurance company for the purchase of annuities, which were included in "Pension contributions" in the consolidated statements of cash flows. The Company also paid $205 million for income and payroll taxes for participants electing the annuity option, of which $201 million was included in "Cost of sales" and $4 million was included in "Selling, general and administrative expenses" in the consolidated statements of income and related to the Corporate segment. The Company recorded a settlement charge of $687 million associated with the payout in the fourth quarter of 2017, which was included in "Sundry income (expense) - net" in the consolidated statements of income and related to the Corporate segment.

The weighted-average assumptions used to determine pension plan obligations and net periodic benefit costs for all plans are summarized in the table below:

Weighted-Average Assumptions for All Pension Plans
Benefit Obligations
 at Dec 31
Net Periodic Costs
for the Year Ended
 
2019
2018
2019
2018
2017
Discount rate
2.81
%
3.69
%
3.50
%
3.17
%
3.52
%
Interest crediting rate for applicable benefits
3.51
%
3.72
%
3.72
%
3.61
%
3.45
%
Rate of compensation increase
3.92
%
3.84
%
3.92
%
3.88
%
3.90
%
Expected return on plan assets


7.11
%
7.11
%
7.16
%

The weighted-average assumptions used to determine pension plan obligations and net periodic benefit costs for U.S. plans are summarized in the table below:

Weighted-Average Assumptions for U.S. Pension Plans
Benefit Obligations
 at Dec 31
Net Periodic Costs
for the Year Ended
 
2019
2018
2019
2018
2017
Discount rate
3.41
%
4.39
%
4.15
%
3.66
%
4.11
%
Interest crediting rate for applicable benefits
4.50
%
4.50
%
4.50
%
4.50
%
4.50
%
Rate of compensation increase
4.25
%
4.25
%
4.25
%
4.25
%
4.25
%
Expected return on plan assets


7.92
%
7.92
%
7.91
%



119



Other Postretirement Benefit Plans
The Company provides certain health care and life insurance benefits to retired employees and survivors. The Company’s plans outside of the United States are not significant; therefore, this discussion relates to the U.S. plans only. The plans provide health care benefits, including hospital, physicians’ services, drug and major medical expense coverage, and life insurance benefits. In general, for employees hired before January 1, 1993, the plans provide benefits supplemental to Medicare when retirees are eligible for these benefits. The Company and the retiree share the cost of these benefits, with the Company portion increasing as the retiree has increased years of credited service, although there is a cap on the Company portion. The Company has the ability to change these benefits at any time. Employees hired after January 1, 2008, are not covered under the plans.

The Company funds most of the cost of these health care and life insurance benefits as incurred. In 2019, the Company did not make any contributions to its other postretirement benefit plan trusts. The trusts did not hold assets at December 31, 2019. The Company does not expect to contribute assets to its other postretirement benefit plan trusts in 2020.

The weighted-average assumptions used to determine other postretirement benefit plan obligations and net periodic benefit costs for the U.S. plans are provided below:

Weighted-Average Assumptions for U.S. Other Postretirement Benefits Plans
Benefit Obligations
 at Dec 31
Net Periodic Costs
for the Year Ended
 
2019
2018
2019
2018
2017
Discount rate
3.19
%
4.24
%
4.01
%
3.51
%
3.83
%
Health care cost trend rate assumed for next year
6.25
%
6.50
%
6.50
%
6.75
%
7.00
%
Rate to which the cost trend rate is assumed to decline (the ultimate health care cost trend rate)
5.00
%
5.00
%
5.00
%
5.00
%
5.00
%
Year that the rate reaches the ultimate health care cost trend rate
2025
2025
2025
2025
2025


Assumptions
The Company determines the expected long-term rate of return on plan assets by performing a detailed analysis of key economic and market factors driving historical returns for each asset class and formulating a projected return based on factors in the current environment. Factors considered include, but are not limited to, inflation, real economic growth, interest rate yield, interest rate spreads and other valuation measures and market metrics. The expected long-term rate of return for each asset class is then weighted based on the strategic asset allocation approved by the governing body for each plan. The Company’s historical experience with the pension fund asset performance is also considered.

The Company uses the spot rate approach to determine the discount rate utilized to measure the service cost and interest cost components of net periodic pension and other postretirement benefit costs for the U.S. and other selected countries. Under the spot rate approach, the Company calculates service costs and interest costs by applying individual spot rates from the Willis Towers Watson RATE:Link yield curve (based on high-quality corporate bond yields) for each selected country to the separate expected cash flow components of service cost and interest cost. Service cost and interest cost for all other plans are determined on the basis of the single equivalent discount rates derived in determining those plan obligations.

The discount rates utilized to measure the pension and other postretirement obligations of the U.S. qualified plans are based on the yield on high-quality corporate fixed income investments at the measurement date. Future expected actuarially determined cash flows for the Company’s U.S. plans are individually discounted at the spot rates under the Willis Towers Watson U.S. RATE:Link 60-90 corporate yield curve (based on 60th to 90th percentile high-quality corporate bond yields) to arrive at the plan’s obligations as of the measurement date.

The Company utilizes a modified version of the Society of Actuaries’ mortality tables released in 2014 and a modified version of the generational mortality improvement scale released in 2018 for purposes of measuring the U.S. pension and other postretirement obligations, based on an evaluation of the mortality experience of the Company’s pension plans. 


120



Summarized information on the Company's pension and other postretirement benefit plans is as follows:

Change in Projected Benefit Obligations, Plan Assets and Funded Status of All Significant Plans
Defined Benefit Pension Plans
Other Postretirement Benefit Plans
In millions
2019
2018
2019
2018
Change in projected benefit obligations:
 
 
 
 
Benefit obligations at beginning of year
$
29,600

$
31,851

$
1,478

$
1,567

Impact of plans transferred to DowDuPont at separation
(331
)



Service cost
396

520

8

12

Interest cost
921

886

49

45

Plan participants' contributions
12

19



Actuarial changes in assumptions and experience
3,904

(1,754
)
148

(13
)
Benefits paid
(1,684
)
(1,476
)
(148
)
(123
)
Plan amendments

17



Acquisitions/divestitures/other 1
(37
)
(45
)


Effect of foreign exchange rates
14

(418
)
3

(10
)
Termination benefits/curtailments/settlements
(174
)

(3
)

Benefit obligations at end of year
$
32,621

$
29,600

$
1,535

$
1,478

 
 
 
 
 
Change in plan assets:
 
 
 
 
Fair value of plan assets at beginning of year
$
22,544

$
23,401

$

$

Impact of plans transferred to DowDuPont at separation
(61
)



Actual return on plan assets
3,790

(742
)


Employer contributions
266

1,656



Plan participants' contributions
12

19



Benefits paid
(1,684
)
(1,476
)


Effect of foreign exchange rates
41

(314
)


Fair value of plan assets at end of year
$
24,908

$
22,544

$

$

 
 
 
 
 
Funded status:




U.S. plans with plan assets
$
(4,768
)
$
(4,066
)
$

$

Non-U.S. plans with plan assets
(2,207
)
(2,041
)


All other plans
(738
)
(695
)
(1,535
)
(1,478
)
Plans of discontinued operations

(254
)


Funded status at end of year
$
(7,713
)
$
(7,056
)
$
(1,535
)
$
(1,478
)
 
 
 
 
 
Amounts recognized in the consolidated balance sheets at Dec 31:
 
 
 
 
Deferred charges and other assets
$
623

$
491

$

$

Accrued and other current liabilities
(49
)
(50
)
(128
)
(131
)
Pension and other postretirement benefits - noncurrent
(8,287
)
(7,227
)
(1,407
)
(1,347
)
Liabilities of discontinued operations - current

(270
)


Net amount recognized
$
(7,713
)
$
(7,056
)
$
(1,535
)
$
(1,478
)
 
 
 
 
 
Pretax amounts recognized in accumulated other comprehensive loss at Dec 31:
 
 
 
 
Net loss (gain)
$
11,761

$
10,841

$
(147
)
$
(315
)
Prior service credit
(177
)
(224
)


Pretax balance in accumulated other comprehensive loss at end of year
$
11,584

$
10,617

$
(147
)
$
(315
)
1.
The 2019 impact includes the divestiture of a business with pension benefit obligations of $53 million.The 2018 impact includes the divestiture of a business with pension benefit obligations of $37 million.


121



A significant component of the overall increase in the Company's benefit obligation for the year ended December 31, 2019 was due to the change in weighted-average discount rates, which decreased from 3.69 percent at December 31, 2018 to 2.81 percent at December 31, 2019. A significant component of the overall decrease in the Company's benefit obligation for the year ended December 31, 2018 was due to the change in weighted-average discount rates, which increased from 3.17 percent at December 31, 2017 to 3.69 percent at December 31, 2018.

The accumulated benefit obligation for all significant pension plans was $31.4 billion and $28.3 billion at December 31, 2019 and 2018, respectively.

Pension Plans with Accumulated Benefit Obligations in Excess of Plan Assets at Dec 31
2019
2018
In millions
Accumulated benefit obligations
$
26,959

$
25,392

Fair value of plan assets
$
19,571

$
18,902



Pension Plans with Projected Benefit Obligations in Excess of Plan Assets at Dec 31
2019
2018
In millions
Projected benefit obligations
$
28,013

$
26,599

Fair value of plan assets
$
19,677

$
19,051



Net Periodic Benefit Costs for All Significant Plans for the Year Ended Dec 31
Defined Benefit Pension Plans
Other Postretirement Benefit Plans
In millions
2019
2018
2017
2019
2018
2017
Net Periodic Benefit Costs:
 
 
 
 
 
 
Service cost
$
396

$
520

$
506

$
8

$
12

$
14

Interest cost
921

886

883

49

45

54

Expected return on plan assets
(1,679
)
(1,644
)
(1,548
)



Amortization of prior service credit
(20
)
(24
)
(25
)



Amortization of unrecognized (gain) loss
574

642

638

(20
)
(24
)
(6
)
Curtailment/settlement/other 1
(27
)

683

(3
)


Net periodic benefit costs
$
165

$
380

$
1,137

$
34

$
33

$
62

Less: discontinued operations
21

101

105


3

3

Net periodic benefit costs - continuing operations
$
144

$
279

$
1,032

$
34

$
30

$
59

Changes in plan assets and benefit obligations recognized in other comprehensive (income) loss:
 
 
 
 
 
 
Net (gain) loss
$
1,606

$
584

$
845

$
145

$
(13
)
$
(199
)
Prior service cost

17

14




Amortization of prior service credit
20

24

25




Amortization of unrecognized gain (loss)
(574
)
(642
)
(638
)
20

24

6

Common control transaction 2
(112
)





Curtailment and settlement (gain) loss 1
27


(687
)
3



Total recognized in other comprehensive (income) loss
$
967

$
(17
)
$
(441
)
$
168

$
11

$
(193
)
Total recognized in net periodic benefit cost and other comprehensive (income) loss
$
1,132

$
363

$
696

$
202

$
44

$
(131
)
1.
The 2019 impact relates to plan curtailments and associated special termination benefits resulting from the reduction in plan participation due to the separation of the Company from DowDuPont. The 2017 impact relates to the settlement of a U.S. non-qualified plan triggered by a change in control provision.
2.
The 2019 impact is the result of the separation of the Company from DowDuPont.

Net periodic benefit cost, other than the service cost component, is included in "Sundry income (expense) - net" in the consolidated statements of income. See Note 8 for additional information.


122



Estimated Future Benefit Payments
The estimated future benefit payments of continuing operations, reflecting expected future service, as appropriate, are presented in the following table:

Estimated Future Benefit Payments at Dec 31, 2019
Defined Benefit Pension Plans
Other Postretirement Benefit Plans
In millions
2020
$
1,561

$
129

2021
1,571

124

2022
1,603

121

2023
1,636

118

2024
1,646

114

2025-2029
8,523

496

Total
$
16,540

$
1,102



Plan Assets
Plan assets consist primarily of equity and fixed income securities of U.S. and foreign issuers, and include alternative investments such as real estate, private market securities and absolute return strategies. At December 31, 2019, plan assets totaled $24.9 billion and included no directly held common stock of Dow Inc. At December 31, 2018, plan assets totaled $22.5 billion and included no directly held DowDuPont common stock.

The Company's investment strategy for the plan assets is to manage the assets in relation to the liability in order to pay retirement benefits to plan participants over the life of the plans. This is accomplished by identifying and managing the exposure to various market risks, diversifying investments across various asset classes and earning an acceptable long-term rate of return consistent with an acceptable amount of risk, while considering the liquidity needs of the plans.

The plans are permitted to use derivative instruments for investment purposes, as well as for hedging the underlying asset and liability exposure and rebalancing the asset allocation. The plans use value-at-risk, stress testing, scenario analysis and Monte Carlo simulations to monitor and manage both the risk within the portfolios and the surplus risk of the plans.

Equity securities primarily include investments in large- and small-cap companies located in both developed and emerging markets around the world. Fixed income securities include investment and non-investment grade corporate bonds of companies diversified across industries, U.S. treasuries, non-U.S. developed market securities, U.S. agency mortgage-backed securities, emerging market securities and fixed income related funds. Alternative investments primarily include investments in real estate, private equity limited partnerships and absolute return strategies. Other significant investment types include various insurance contracts and interest rate, equity, commodity and foreign exchange derivative investments and hedges.

The Company mitigates the credit risk of investments by establishing guidelines with investment managers that limit investment in any single issue or issuer to an amount that is not material to the portfolio being managed. These guidelines are monitored for compliance both by the Company and external managers. Credit risk related to derivative activity is mitigated by utilizing multiple counterparties, collateral support agreements and centralized clearing, where appropriate.

The Northern Trust Collective Government Short Term Investment money market fund is utilized as the sweep vehicle for the U.S. plans, which from time to time can represent a significant investment. For one U.S. plan, approximately 34 percent of the liability is covered by a participating group annuity issued by Prudential Insurance Company.


123



The weighted-average target allocation for plan assets of the Company's pension plans is summarized as follows:

Target Allocation for Plan Assets at Dec 31, 2019
Target Allocation
Asset Category
Equity securities
35
%
Fixed income securities
36

Alternative investments
28

Other investments
1

Total
100
%


Fair value calculations may not be indicative of net realizable value or reflective of future fair values. Furthermore, although the Company believes its valuation methods are appropriate and consistent with other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different fair value measurement at the reporting date.

For pension plan assets classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.

For pension plan assets classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks. For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources. For other pension plan assets for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models.

For pension plan assets classified as Level 3 measurements, total fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity for the investment.

Certain pension plan assets are held in funds where fair value is based on an estimated net asset value per share (or its equivalent) as of the most recently available fund financial statements which are received on a monthly or quarterly basis. These valuations are reviewed for reasonableness based on applicable sector, benchmark and company performance. Adjustments to valuations are made where appropriate to arrive at an estimated net asset value per share at the measurement date. These funds are not classified within the fair value hierarchy.


124



The following table summarizes the bases used to measure the Company’s pension plan assets at fair value for the years ended December 31, 2019 and 2018:

Basis of Fair Value Measurements
Dec 31, 2019
Dec 31, 2018
In millions
Total
Level 1
Level 2
Level 3
Total
Level 1
Level 2
Level 3
Cash and cash equivalents
$
754

$
675

$
79

$

$
877

$
818

$
59

$

Equity securities:
 
 
 
 
 
 
 
 
U.S. equity securities 1
$
3,844

$
3,752

$
91

$
1

$
3,493

$
3,251

$
241

$
1

Non - U.S. equity securities
4,646

3,819

801

26

4,242

3,497

707

38

Total equity securities
$
8,490

$
7,571

$
892

$
27

$
7,735

$
6,748

$
948

$
39

Fixed income securities:
 
 
 
 
 
 
 
 
Debt - government-issued
$
4,992

$
197

$
4,795

$

$
4,751

$
285

$
4,466

$

Debt - corporate-issued
3,697

607

3,089

1

2,929

411

2,518


Debt - asset-backed
70


69

1

90


89

1

Total fixed income securities
$
8,759

$
804

$
7,953

$
2

$
7,770

$
696

$
7,073

$
1

Alternative investments:
 
 
 
 
 
 
 
 
Private market securities
$
11

$

$

$
11

$
1

$

$

$
1

Real estate
25

25



19

19



Derivatives - asset position
574

2

572


451

17

434


Derivatives - liability position
(513
)
(2
)
(511
)

(506
)
(19
)
(487
)

Total alternative investments
$
97

$
25

$
61

$
11

$
(35
)
$
17

$
(53
)
$
1

Other investments
$
411

$
28

$
383

$

$
380

$
47

$
333

$

Subtotal
$
18,511

$
9,103

$
9,368

$
40

$
16,727

$
8,326

$
8,360

$
41

Investments measured at net asset value:
 
 
 
 
 
 
 
 
Hedge funds
$
1,595

 
 
 
$
1,637

 
 
 
Private market securities
2,794

 
 
 
2,196

 
 
 
Real estate
2,110

 
 
 
2,080

 
 
 
Total investments measured at net asset value
$
6,499

 
 
 
$
5,913

 
 
 
Items to reconcile to fair value of plan assets:
 
 
 
 
 
 
 
 
Pension trust receivables 2
$
70

 

 

 

$
29

 

 

 

Pension trust payables 3
(172
)
 

 

 

(125
)
 

 

 

Total
$
24,908

 

 

 

$
22,544

 

 

 

1.
No Dow Inc. common stock was directly held at December 31, 2019. No DowDuPont common stock was directly held at December 31, 2018.
2.
Primarily receivables for investment securities sold.
3.
Primarily payables for investment securities purchased.


125



The following table summarizes the changes in the fair value of Level 3 pension plan assets for the years ended December 31, 2019 and 2018:

Fair Value Measurement of Level 3 Pension Plan Assets
Equity Securities
Fixed Income Securities
Alternative Investments
Other Investments
Total
In millions
Balance at Jan 1, 2018
$
40

$
16

$

$

$
56

Actual return on assets:
 
 
 
 

Relating to assets sold during 2018

4

(1
)
1

4

Relating to assets held at Dec 31, 2018
(3
)
(4
)


(7
)
Purchases, sales and settlements, net
2

(15
)
2

(1
)
(12
)
Balance at Dec 31, 2018
$
39

$
1

$
1

$

$
41

Actual return on assets:
 
 
 
 
 
Relating to assets sold during 2019
(2
)



(2
)
Relating to assets held at Dec 31, 2019
1


(14
)

(13
)
Purchases, sales and settlements, net
(11
)
1

24


14

Balance at Dec 31, 2019
$
27

$
2

$
11

$

$
40



Defined Contribution Plans
U.S. employees may participate in defined contribution plans (Employee Savings Plans or 401(k) plans) by contributing a portion of their compensation, which is partially matched by the Company. Defined contribution plans also cover employees in some subsidiaries in other countries, including Australia, Brazil, Canada, Italy, Spain and the United Kingdom. Expense of continuing operations recognized for all defined contribution plans was $163 million in 2019, $186 million in 2018 and $286 million in 2017.


NOTE 22 – STOCK-BASED COMPENSATION
The Company grants stock-based compensation to employees and non-employee directors in the form of stock incentive plans, which include stock options, RSUs and restricted stock. The Company also provides stock-based compensation in the form of PSUs. The Company previously provided the Employee Stock Purchase Plan (“ESPP”), which granted eligible employees the right to purchase shares of the Company's common stock at a discounted price.

In connection with the Merger, on August 31, 2017 ("Conversion Date"), all outstanding TDCC stock options and RSU awards were converted into stock options and RSU awards with respect to DowDuPont common stock. The stock options and RSU awards had the same terms and conditions under the applicable plans and award agreements prior to the Merger. All outstanding and nonvested PSU awards were converted into RSU awards with respect to DowDuPont common stock at the greater of the applicable performance target or the actual performance as of the effective time of the Merger. Changes in the fair value of liability instruments are recognized as compensation expense each quarter. TDCC and Historical DuPont did not merge their stock-based compensation plans as a result of the Merger. TDCC and Historical DuPont stock-based compensation plans were assumed by DowDuPont and continued in place with the ability to grant and issue DowDuPont common stock until separation.

In connection with the separation on April 1, 2019, outstanding stock options, RSU and PSU awards were converted to Dow Inc. denominated awards under the “Employer Method,” or DowDuPont denominated awards under the “Shareholder Method,” and adjusted to maintain the intrinsic value of those awards before and after the date of the separation. In connection with the Corteva separation transaction on June 3, 2019, the outstanding DowDuPont denominated stock options, RSU and PSU awards were converted to Corteva and DuPont denominated awards and adjusted to maintain the intrinsic value of those awards before and after the date of the Corteva separation. The awards have the same terms and conditions under the applicable plans and award agreements prior to the separation transactions.

The conversions of stock awards resulted in no incremental compensation expense. Approximately 5,000 employees were impacted by the conversion on April 1, 2019 in connection with Dow Inc.'s separation from DowDuPont. Approximately 4,000 employees were impacted by the conversion on June 3, 2019 in connection with the Corteva separation transaction.

The total stock-based compensation expense included in continuing operations in the consolidated statements of income was $158 million, $188 million and $310 million in 2019, 2018 and 2017, respectively. The income tax benefits related to stock-based compensation arrangements were $36 million, $42 million and $115 million in 2019, 2018 and 2017, respectively. Amounts disclosed throughout the remainder of this footnote are inclusive of activity attributable to both continuing operations and discontinued operations, as the impact of discontinued operations is not significant.

126



Accounting for Stock-Based Compensation
The Company grants stock-based compensation awards that vest over a specified period or upon employees meeting certain performance and/or retirement eligibility criteria. The fair value of equity instruments issued to employees is measured on the grant date. The fair value of liability instruments (granted to executive employees subject to stock ownership requirements, that provide the recipient the option to elect to receive a cash payment equal to the value of the stock award on the date of delivery) is measured at the end of each quarter. The fair value of equity and liability instruments is expensed over the vesting period or, in the case of retirement, from the grant date to the date on which retirement eligibility provisions have been met and additional service is no longer required. The Company estimates expected forfeitures.

The Company historically used a lattice-based option valuation model to estimate the fair value of stock options and used a Monte Carlo simulation for the market portion of PSU awards. Effective with the first quarter of 2018 grant, the Company began using the Black-Scholes option valuation model to estimate the fair value of stock options. This valuation methodology was adopted as a result of the Merger to align valuation methodologies with Historical DuPont and better align with industry practice. The Company used the Black-Scholes option valuation model for subscriptions to purchase shares under the ESPP. The weighted-average assumptions used to calculate total stock-based compensation are included in the following table:

Weighted-Average Assumptions
2019
2018
2017
Dividend yield
5.10
%
2.13
%
3.01
%
Expected volatility
26.10
%
23.34
%
23.71
%
Risk-free interest rate
2.43
%
2.83
%
1.28
%
Expected life of stock options granted during period (years)
6.1

6.2

7.5

Life of Employee Stock Purchase Plan (months)
0

0

3



The dividend yield assumption was equal to the dividend yield on the grant date, which reflected the Company's quarterly dividend payments of $0.70 per share in 2019 on Dow Inc. Common Stock ($0.38 per share in 2018 on DowDuPont Common Stock and $0.46 per share in 2017 on TDCC Common Stock). The expected volatility assumptions for the 2017 stock options and ESPP were based on an equal weighting of the historical daily volatility for the contractual term of the awards and current implied volatility from exchange-traded options. The expected volatility assumptions for the 2018 and 2019 stock options were based on an equal weighting of the historical daily volatility for the expected term of the awards and current implied volatility from exchange-traded options. The expected volatility assumption for the market portion of the 2017 and 2019 PSU awards were based on historical daily volatility for the term of the award. The risk-free interest rate was based on the weighted-average of U.S. Treasury strip rates over the contractual term of the 2017 options. The risk-free interest rate was based on the U.S. Treasury strip rates over the expected life of the 2018 and 2019 options. The expected life of stock options granted was based on an analysis of historical exercise patterns.

Stock Incentive Plan
The Company has historically granted equity awards under various plans (the "Prior Plans"). On February 9, 2012, the Board authorized The Dow Chemical Company 2012 Stock Incentive Plan (the "2012 Plan"), which was approved by stockholders at TDCC's annual meeting on May 10, 2012 ("2012 Plan Effective Date") and became effective on that date. On February 13, 2014, the Board adopted The Dow Chemical Company Amended and Restated 2012 Stock Incentive Plan (the "2012 Restated Plan"). The 2012 Restated Plan was approved by stockholders at TDCC's annual meeting on May 15, 2014, and became effective on that date. The Prior Plans were superseded by the 2012 Plan and the 2012 Restated Plan (collectively, the "2012 Plan"). Under the 2012 Plan, the Company may grant options, RSUs, PSUs, restricted stock, stock appreciation rights and stock units to employees and non-employee directors until the tenth anniversary of the 2012 Plan Effective Date, subject to an aggregate limit and annual individual limits. The terms of the grants are fixed at the grant date. TDCC's stock-based compensation programs were assumed by DowDuPont and continued in place with the ability to grant and issue DowDuPont common stock until separation.

On April 1, 2019 ("Original Effective Date"), in connection with the separation, the Company adopted the 2019 Stock Incentive Plan (the "2019 Plan"). Under the 2019 Plan, the Company may grant stock options, RSUs, PSUs, stock appreciation rights and stock units to employees and non-employee directors until the tenth anniversary of the Original Effective Date, subject to an aggregate limit and annual individual limits. The terms of the grants are fixed at the grant date. At December 31, 2019, there were approximately 25 million shares of common stock available for grant under the 2019 Plan.

Stock Options
The Company grants stock options to certain employees, subject to certain annual and individual limits, with terms of the grants fixed at the grant date. The exercise price of each stock option equals the market price of the common stock on the grant date. Options vest from one to three years and have a maximum term of ten years.

127



The following table summarizes stock option activity for 2019:

Stock Options
2019
Shares in thousands
Shares
Exercise
Price 1
Outstanding at Jan 1, 2019
28,846

$
46.70

Granted
1,588

$
54.89

Exercised
(3,196
)
$
30.02

Forfeited/Expired
(239
)
$
60.77

Conversion impact 2
(5,734
)
$
59.62

Outstanding at Dec 31, 2019
21,265

$
45.96

Remaining contractual life in years


4.62

Aggregate intrinsic value in millions
$
237



Exercisable at Dec 31, 2019
18,248

$
43.34

Remaining contractual life in years


3.99

Aggregate intrinsic value in millions
$
237



1. Weighted-average per share.
2. Awards converted at April 1 and June 3 separations.

Additional Information about Stock Options
 
 
 
In millions, except per share amounts
2019
2018
2017
Weighted-average fair value per share of options granted
$
7.99

$
15.38

$
14.44

Total compensation expense for stock option plans
$
23

$
68

$
37

Related tax benefit
$
5

$
15

$
14

Total amount of cash received from the exercise of options
$
93

$
112

$
310

Total intrinsic value of options exercised 1
$
77

$
160

$
286

Related tax benefit
$
17

$
36

$
106


1. Difference between the market price at exercise and the price paid by the employee to exercise the options.

Total unrecognized compensation cost related to unvested stock option awards of $18 million at December 31, 2019, is expected to be recognized over a weighted-average period of 1.37 years.

Restricted Stock Units
The Company grants RSUs to certain employees and non-employee directors. The grants vest after a designated period of time, generally three years for employees and two years for non-employee directors. The following table shows changes in nonvested RSUs:

RSU Awards
2019
Shares in thousands
Shares
Grant Date
Fair Value 1
Nonvested at Jan 1, 2019
9,735

$
57.41

Granted
1,821

$
54.78

Vested
(7,045
)
$
53.22

Canceled
(156
)
$
60.84

Conversion impact 2
(1,901
)
$
65.87

Nonvested at Dec 31, 2019
2,454

$
59.98

1. Weighted-average per share.
2. Awards converted at April 1 and June 3 separations.


128



Additional Information about RSUs
 
 
 
In millions, except per share amounts
2019
2018
2017
Weighted-average fair value per share of RSUs granted
$
54.78

$
71.46

$
61.29

Total fair value of RSUs vested 1
$
375

$
382

$
179

Related tax benefit
$
84

$
86

$
66

Total compensation expense for RSU awards
$
110

$
144

$
178

Related tax benefit
$
25

$
32

$
66


1.
Includes the fair value of shares vested in prior years and delivered in the reporting year.

In 2019, the Company paid $17 million in cash, equal to the value of the stock award on the date of delivery, to certain executive employees to settle approximately 341,000 RSUs (625,000 RSUs settled in cash for $45 million in 2018 and no RSUs settled in cash in 2017). Total unrecognized compensation cost related to RSU awards of $80 million at December 31, 2019 is expected to be recognized over a weighted-average period of 1.83 years. At December 31, 2019, approximately 2.2 million RSUs with a grant date weighted-average fair value per share of $60.79 had previously vested, but were not issued. These shares are scheduled to be issued to employees within six months to three years or upon retirement.

Total incremental pretax compensation expense resulting from the conversion of PSU awards into RSU awards was $25 million ($20 million was recognized in the second half of 2017 and $5 million was recognized over the remaining service period). Approximately 5,000 employees were impacted by the conversion.

Performance Stock Units
The Company grants PSUs to certain employees. The grants vest when the Company attains specified performance targets, such as return on capital and relative total shareholder return, over a predetermined period, generally one to three years. In November 2017, the Company granted PSUs to senior leadership measured on the realization of cost savings in connection with cost synergy commitments, as well as the Company’s ability to complete the business separations. Performance and payouts are determined independently for each metric. Compensation expense related to PSU awards is recognized over the lesser of the service or performance period. Changes in the fair value of liability instruments are recognized as compensation expense each quarter.

The following table shows the PSU awards granted:

PSU Awards
Target
Shares
Granted 1
Grant Date
Fair Value 2
Shares in thousands
Year
Performance Period
2019
Apr 1, 2019 – Dec 31, 2021
1,173

$
57.58

2017
Sep 1, 2017 – Aug 31, 2019
232

$
71.16

2017 3
Jan 1, 2017 – Dec 31, 2019
1,728

$
81.99


1.
At the end of the performance period, the actual number of shares issued can range from zero to 200 percent of target shares granted.
2.
Weighted-average per share.
3. Converted to RSUs as a result of the Merger.

The following table shows changes in nonvested PSUs:

PSUs
2019
Shares in thousands
Shares
Grant Date
Fair Value 1
Nonvested at Jan 1, 2019
232

$
71.16

Granted
1,173

$
57.58

Vested
(232
)
$
71.16

Canceled
(52
)
$
57.58

Nonvested at Dec 31, 2019
1,121

$
57.58

1. Weighted-average per share.


129



Additional Information about PSUs
 
 
 
In millions, except share amounts
2019
2018
2017
Total fair value of PSUs vested and delivered 1
$
18

$

$
202

Related tax benefit
$
4

$

$
75

Total compensation expense for PSU awards
$
25

$
12

$
106

Related tax benefit
$
6

$
3

$
39

Shares of PSUs settled in cash (in thousands) 2
162


616

Total cash paid to settle PSUs 3
$
13

$

$
38

1.
Includes the fair value of shares vested in prior years and delivered in the reporting year.
2.
PSU awards vested in prior years and delivered in the reporting year.
3.
Cash paid to certain executive employees for PSU awards vested in prior periods and delivered in the reporting year, equal to the value of the stock award on the date of delivery.

Total unrecognized compensation cost related to PSU awards of $12 million at December 31, 2019, is expected to be recognized over a weighted-average period of 1.86 years.

Restricted Stock
Under the 2012 Plan, the Company granted shares (including options, stock appreciation rights, stock units and restricted stock) to non-employee directors over the 10-year duration of the program, subject to the plan's aggregate limit as well as annual individual limits. The restricted stock issued under this plan cannot be sold, assigned, pledged or otherwise transferred by the non-employee director, until retirement or termination of service to the Company. The following table shows the restricted stock issued under this plan:
 
Restricted Stock
Shares Issued
(in thousands)
Weighted-Average Fair Value
Year
2019
N/A

N/A

2018
36

$
62.82

2017
33

$
62.04



Employee Stock Purchase Plan
On February 9, 2012, the Board authorized The Dow Chemical Company 2012 Employee Stock Purchase Plan (the "2012 ESPP") which was approved by stockholders at TDCC’s annual meeting on May 10, 2012. When offered, most employees are eligible to purchase shares of common stock of TDCC valued at up to 10 percent of their annual base salary. The value is determined using the plan price multiplied by the number of shares subscribed to by the employee. The plan price of the stock is set at an amount equal to at least 85 percent of the fair market value (closing price) of the common stock on a date during the fourth quarter of the year prior to the offering, or the average fair market value (closing price) of the common stock over a period during the fourth quarter of the year prior to the offering, in each case, specified by the Chief Human Resources Officer. The most recent offering of the 2012 ESPP closed on July 15, 2017. The ESPP was not offered in 2018 and 2019 and no current offerings remain outstanding.

Additional Information about Employee Stock Purchase Plan
 
In millions, except per share amounts
2017
Weighted-average fair value per share of purchase rights granted
$
10.70

Total compensation expense for ESPP
$
38

Related tax benefit
$
14

Total amount of cash received from the exercise of purchase rights
$
179

Total intrinsic value of purchase rights exercised 1
$
48

Related tax benefit
$
18

1.
Difference between the market price at exercise and the price paid by the employee to exercise the purchase rights.



130



NOTE 23 – FINANCIAL INSTRUMENTS
The following table summarizes the fair value of financial instruments at December 31, 2019 and 2018:

Fair Value of Financial Instruments at Dec 31 1
2019
2018
In millions
Cost
Gain
Loss
Fair Value
Cost
Gain
Loss
Fair Value
Cash equivalents:
 
 
 
 
 
 
 
 
Held to maturity securities 2
$
220

$

$

$
220

$
410

$

$

$
410

Money market funds
408



408

156



156

Total cash equivalents
$
628

$

$

$
628

$
566

$

$

$
566

Marketable securities
$
21

$

$

$
21

$
100

$

$

$
100

Other investments:
 
 
 
 
 
 
 
 
Debt securities:
 
 
 
 
 
 
 
 
Government debt 3
$
533

$
33

$
(11
)
$
555

$
714

$
9

$
(23
)
$
700

Corporate bonds
944

80

(10
)
1,014

1,026

20

(63
)
983

Total debt securities
$
1,477

$
113

$
(21
)
$
1,569

$
1,740

$
29

$
(86
)
$
1,683

Equity securities 4
10

6

(1
)
15

16

1

(1
)
16

Total other investments
$
1,487

$
119

$
(22
)
$
1,584

$
1,756

$
30

$
(87
)
$
1,699

Total cash equivalents, marketable securities and other investments
$
2,136

$
119

$
(22
)
$
2,233

$
2,422

$
30

$
(87
)
$
2,365

Long-term debt including debt due within one year 5
$
(16,410
)
$
7

$
(2,258
)
$
(18,661
)
$
(19,591
)
$
351

$
(972
)
$
(20,212
)
Derivatives relating to:
 
 
 
 
 
 
 
 
Interest rates 6
$

$
8

$
(283
)
$
(275
)
$

$

$
(64
)
$
(64
)
Foreign currency

101

(21
)
80


120

(43
)
77

Commodities 6

59

(115
)
(56
)

91

(178
)
(87
)
Total derivatives
$

$
168

$
(419
)
$
(251
)
$

$
211

$
(285
)
$
(74
)

1.
Prior period amounts were updated to conform with the current year presentation.
2.
The Company had held-to-maturity securities (primarily treasury bills and time deposits) classified as cash equivalents.
3.
U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.
4.
Equity securities with a readily determinable fair value.
5.
Cost includes fair value hedge adjustment gains of $1 million at December 31, 2019 and losses of $18 million at December 31, 2018 on $3,490 million of debt at December 31, 2019 and $2,290 million of debt at December 31, 2018.
6.
Presented net of cash collateral where master netting arrangements allow.

Cost approximates fair value for all other financial instruments.

Debt Securities
The Company’s investments in debt securities are primarily classified as available-for-sale. The following table provides the investing results from available-for-sale securities for the years ended December 31, 2019, 2018 and 2017.

Investing Results
 
 
 
In millions
2019
2018
2017
Proceeds from sales of available-for-sale securities
$
1,138

$
1,053

$
245

Gross realized gains
$
51

$
21

$
5

Gross realized losses
$
18

$
30

$



131



The following table summarizes the contractual maturities of the Company’s investments in debt securities:

Contractual Maturities of Debt Securities at Dec 31, 2019 1
Amortized Cost
Fair Value
In millions
Within one year
$
36

$
39

One to five years
391

406

Six to ten years
534

554

After ten years
516

570

Total
$
1,477

$
1,569

1. Includes marketable securities with maturities of less than one year.

Portfolio managers regularly review the Company’s holdings to determine if any investments in debt securities are other-than-temporarily impaired. The analysis includes reviewing the amount of the impairment, as well as the length of time it has been impaired.

The credit rating of the issuer, current credit rating trends, the trends of the issuer’s overall sector, the ability of the issuer to pay expected cash flows and the length of time the security has been in a loss position are considered in determining whether unrealized losses represent an other-than-temporary impairment. The Company did not have any credit-related losses in 2019, 2018 or 2017.

The following table provides the fair value and gross unrealized losses of the Company’s investments in debt securities that were deemed to be temporarily impaired at December 31, 2019 and 2018, aggregated by investment category:

Temporarily Impaired Debt Securities at
Dec 31
Less than 12 months
12 months or more
Total
Fair
Value
Unrealized
Losses
Fair
Value
Unrealized
Losses
Fair Value
Unrealized Losses
In millions
2019
 
 
 
 
 
 
Government debt 1
$
55

$
(3
)
$
23

$
(8
)
$
78

$
(11
)
Corporate bonds
79

(3
)
52

(7
)
131

(10
)
Total temporarily impaired debt securities
$
134

$
(6
)
$
75

$
(15
)
$
209

$
(21
)
2018
 
 
 
 
 
 
Government debt 1
$
287

$
(17
)
$
187

$
(6
)
$
474

$
(23
)
Corporate bonds
724

(58
)
64

(5
)
788

(63
)
Total temporarily impaired debt securities
$
1,011

$
(75
)
$
251

$
(11
)
$
1,262

$
(86
)

1.
U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities' obligations.

Equity Securities
The Company’s investments in equity securities with a readily determinable fair value totaled $15 million at December 31, 2019 ($16 million at December 31, 2018). The net unrealized gains recognized in earnings on readily determinable equity securities totaled $5 million for the year ended December 31, 2019 ($7 million for the year ended December 31, 2018). The aggregate carrying value of the Company's investments in equity securities where fair value is not readily determinable totaled $189 million at December 31, 2019 ($204 million at December 31, 2018), reflecting the carrying value of the investments. There were no material adjustments to the carrying value of the not readily determinable investments for impairment or observable price changes for the year ended December 31, 2019.

Repurchase and Reverse Repurchase Agreement Transactions
The Company enters into repurchase and reverse repurchase agreements. These transactions are accounted for as collateralized borrowings and lending transactions bearing a specified rate of interest and are short-term in nature with original maturities of 30 days or less. The underlying collateral is typically treasury bills with longer maturities than the repurchase agreement. The impact of these transactions is not material to the Company’s results. There were no repurchase or reverse repurchase agreements outstanding at December 31, 2019 and 2018.

Risk Management
The Company’s business operations give rise to market risk exposure due to changes in foreign exchange rates, interest rates, commodity prices and other market factors such as equity prices. To manage such risks effectively, the Company enters into hedging transactions, pursuant to established guidelines and policies that enable it to mitigate the adverse effects of financial market risk. Derivatives used for this purpose are designated as hedges per the accounting guidance related to derivatives and

132



hedging activities, where appropriate. A secondary objective is to add value by creating additional non-specific exposure within established limits and policies; derivatives used for this purpose are not designated as hedges. The potential impact of creating such additional exposures is not material to the Company’s results. Accounting guidance requires companies to recognize all derivative instruments as either assets or liabilities at fair value.

The Company’s risk management program for interest rate, foreign currency and commodity risks is based on fundamental, mathematical and technical models that take into account the implicit cost of hedging. Risks created by derivative instruments and the mark-to-market valuations of positions are strictly monitored at all times, using value-at-risk and stress tests. Counterparty credit risk arising from these contracts is not significant because the Company minimizes counterparty concentration, deals primarily with major financial institutions of solid credit quality, and the majority of its hedging transactions mature in less than three months. In addition, the Company minimizes concentrations of credit risk through its global orientation by transacting with large, internationally diversified financial counterparties. It is the Company’s policy to not have credit risk-related contingent features in its derivative instruments. No significant concentration of counterparty credit risk existed at December 31, 2019. The Company does not anticipate losses from credit risk, and the net cash requirements arising from counterparty risk associated with risk management activities are not expected to be material in 2020.

The Company revises its strategies as market conditions dictate and management reviews its overall financial strategies and the impacts from using derivatives in its risk management program with the Company’s senior leadership who also reviews these strategies with the Dow Inc. Board and/or relevant committees thereof.

The notional amounts of the Company's derivative instruments presented on a net basis at December 31, 2019 and 2018, were as follows:

Notional Amounts - Net
Dec 31, 2019
Dec 31, 2018
In millions
Derivatives designated as hedging instruments:
 
 
Interest rate contracts
$
922

$
2,049

Foreign currency contracts
$
6,253

$
4,457

Derivatives not designated as hedging instruments:
 
 
Interest rate contracts
$
145

$
5

Foreign currency contracts
$
5,567

$
19,285


The notional amounts of the Company's commodity derivatives at December 31, 2019 and 2018, were as follows:

Commodity Notionals - Net
Dec 31, 2019
Dec 31, 2018
Notional Volume Unit
 
Derivatives designated as hedging instruments:
 
 
 
Hydrocarbon derivatives
6.1

39.9

million barrels of oil equivalent
Derivatives not designated as hedging instruments:
 
 
 
Hydrocarbon derivatives
0.1

1.2

million barrels of oil equivalent
Power derivatives
87.5

73.9

thousands of megawatt hours


Maturity Dates of Derivatives Designated as Hedges
Year
 
Interest rate contracts
2021
Foreign currency contracts 1
2020
Commodity contracts
2022
1.
The Company had foreign currency contracts primarily through 2020 with a nominal impact into the first quarter of 2021.

Interest Rate Risk Management
The main objective of interest rate risk management is to reduce the total funding cost to the Company and to alter the interest rate exposure to the desired risk profile. To achieve this objective, the Company hedges using interest rate swaps, “swaptions,” and exchange-traded instruments.


133



Foreign Currency Risk Management
The global nature of the Company's business requires active participation in the foreign exchange markets. The Company has assets, liabilities and cash flows in currencies other than the U.S. dollar. The primary objective of the Company's foreign currency risk management is to optimize the U.S. dollar value of net assets and cash flows. To achieve this objective, the Company hedges on a net exposure basis using foreign currency forward contracts, over-the-counter option contracts, cross-currency swaps and nonderivative instruments in foreign currencies. Exposures primarily relate to assets, liabilities and bonds denominated in foreign currencies, as well as economic exposure, which is derived from the risk that currency fluctuations could affect the dollar value of future cash flows related to operating activities.

Commodity Risk Management
The Company has exposure to the prices of commodities in its procurement of certain raw materials. The primary purpose of commodity hedging activities is to manage the price volatility associated with these forecasted inventory purchases.

Derivatives Not Designated in Hedging Relationships
Foreign Currency Contracts
The Company also uses foreign exchange forward contracts, options and cross-currency swaps that are not designated as hedging instruments primarily to manage foreign currency exposure.

Commodity Contracts
The Company utilizes futures, options and swap instruments that are effective as economic hedges of commodity price exposures, but do not meet hedge accounting criteria for derivatives and hedging, to reduce exposure to commodity price fluctuations on purchases of raw materials and inventory.

Interest Rate Contracts
The Company uses swap instruments that are not designated as hedging instruments to manage interest rate exposures. The Company uses interest rate swaps, "swaptions," and exchange-traded instruments to accomplish this objective.

Accounting for Derivative Instruments and Hedging Activities
Cash Flow Hedges
For derivatives that are designated and qualify as cash flow hedging instruments, the gain or loss on the derivative is recorded in AOCL; it is reclassified to income in the same period or periods that the hedged transaction affects income. The unrealized amounts in AOCL fluctuate based on changes in the fair value of open contracts at the end of each reporting period. The Company anticipates volatility in AOCL and net income from its cash flow hedges. The amount of volatility varies with the level of derivative activities and market conditions during any period.

The portion of the mark-to-market effects of the foreign currency contracts is recorded in AOCL; it is reclassified to income in the same period or periods that the underlying item affects income.

Commodity swaps, futures and option contracts with maturities of not more than 48 months are utilized and designated as cash flow hedges of forecasted commodity purchases. The designated portion of the mark-to-market effect of the cash flow hedge instrument is recorded in AOCL; it is reclassified to income in the same period or periods that the underlying commodity purchase affects income.
Fair Value Hedges
For interest rate instruments that are designated and qualify as fair value hedges, the gain or loss on the derivative as well as the offsetting loss or gain on the hedge item attributable to the hedged risk are recognized in current period income and reflected as “Interest expense and amortization of debt discount” in the consolidated statements of income, except for amounts excluded from the assessment of effectiveness that are recognized in earnings through an amortization approach.

Net Foreign Investment Hedges
The Company designates derivatives that qualify as effective net foreign investment hedges, the results of which are presented in the effect of derivative instruments table. In addition, the Company utilizes non-derivative instruments as net foreign investment hedges. The Company had outstanding foreign-currency denominated debt designated as a hedge of net foreign investment of $184 million at December 31, 2019 ($182 million at December 31, 2018).


134



The following tables provide the fair value and gross balance sheet classification of derivative instruments at December 31, 2019 and 2018:

Fair Value of Derivative Instruments
Dec 31, 2019
In millions
Balance Sheet Classification
Gross
Counterparty and Cash Collateral Netting 1
Net Amounts Included in the Consolidated Balance Sheets
Asset derivatives:
 
 
 
 
Derivatives designated as hedging instruments:
 
 
 
 
Interest rate contracts
Other current assets
$
21

$
(13
)
$
8

Foreign currency contracts
Other current assets
105

(36
)
69

Commodity contracts
Other current assets
44

(25
)
19

Commodity contracts
Deferred charges and other assets
28

(3
)
25

Total
 
$
198

$
(77
)
$
121

Derivatives not designated as hedging instruments:
 
 
 
 
Interest rate contracts
Other current assets
$
14

$
(14
)
$

Interest rate contracts
Deferred charges and other assets



Foreign currency contracts
Other current assets
44

(12
)
32

Commodity contracts
Other current assets
18

(3
)
15

Commodity contracts
Deferred charges and other assets



Total
 
$
76

$
(29
)
$
47

Total asset derivatives
 
$
274

$
(106
)
$
168

 
 
 
 
 
Liability derivatives:
 
 
 
 
Derivatives designated as hedging instruments:
 
 
 
 
Interest rate contracts
Accrued and other current liabilities
$
23

$
(13
)
$
10

Interest rate contracts
Other noncurrent obligations
1


1

Foreign currency contracts
Accrued and other current liabilities
46

(36
)
10

Commodity contracts
Accrued and other current liabilities
95

(29
)
66

Commodity contracts
Other noncurrent obligations
38

(4
)
34

Total
 
$
203

$
(82
)
$
121

Derivatives not designated as hedging instruments:
 
 
 
 
Interest rate contracts
Accrued and other current liabilities
$
136

$
(14
)
$
122

Interest rate contracts
Other noncurrent obligations
150


150

Foreign currency contracts
Accrued and other current liabilities
23

(12
)
11

Commodity contracts
Accrued and other current liabilities
17

(3
)
14

Commodity contracts
Other noncurrent obligations
1


1

Total
 
$
327

$
(29
)
$
298

Total liability derivatives
 
$
530

$
(111
)
$
419


1.
Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.


135



Fair Value of Derivative Instruments
Dec 31, 2018
In millions
Balance Sheet Classification
Gross
Counterparty and Cash Collateral Netting 1
Net Amounts Included in the Consolidated Balance Sheets
Asset derivatives:
 
 
 
 
Derivatives designated as hedging instruments:
 
 
 
 
Foreign currency contracts
Other current assets
$
98

$
(42
)
$
56

Commodity contracts
Other current assets
47

(13
)
34

Commodity contracts
Deferred charges and other assets
18

(3
)
15

Total
 
$
163

$
(58
)
$
105

Derivatives not designated as hedging instruments:
 
 
 
 
Foreign currency contracts
Other current assets
$
128

$
(64
)
$
64

Commodity contracts
Other current assets
41

(1
)
40

Commodity contracts
Deferred charges and other assets
4

(2
)
2

Total
 
$
173

$
(67
)
$
106

Total asset derivatives
 
$
336

$
(125
)
$
211

 
 
 
 
 
Liability derivatives:
 
 
 
 
Derivatives designated as hedging instruments:
 
 
 
 
Interest rate contracts
Other noncurrent obligations
$
64

$

$
64

Foreign currency contracts
Accrued and other current liabilities
46

(42
)
4

Commodity contracts
Accrued and other current liabilities
111

(18
)
93

Commodity contracts
Other noncurrent obligations
86

(9
)
77

Total
 
$
307

$
(69
)
$
238

Derivatives not designated as hedging instruments:
 
 
 
 
Foreign currency contracts
Accrued and other current liabilities
$
103

$
(64
)
$
39

Commodity contracts
Accrued and other current liabilities
7

(4
)
3

Commodity contracts
Other noncurrent obligations
8

(3
)
5

Total
 
$
118

$
(71
)
$
47

Total liability derivatives
 
$
425

$
(140
)
$
285


1.
Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.

Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash collateral of $5 million at December 31, 2019 ($26 million at December 31, 2018). Counterparties posted cash collateral of $3 million with the Company at December 31, 2019 ($34 million at December 31, 2018).


136



Effect of Derivative Instruments
Amount of gain (loss) recognized in OCI 1
Amount of gain (loss) recognized in income 2
 
In millions
2019
2018
2017
2019
2018
2017
Income Statement Classification
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
Fair value hedges:
 
 
 
 
 
 
 
Interest rate contracts
$

$

$

$
17

$

$
(2
)
Interest expense and amortization of debt discount 3
Excluded components 4
(3
)





 
Cash flow hedges:
 
 
 
 
 
 
 
Interest rate contracts
(316
)
26

2

1

(3
)
4

Interest expense and amortization of debt discount
Foreign currency contracts
16

19

(30
)
28

(18
)
7

Cost of sales
Foreign currency contracts
10

(3
)
(5
)
8


(17
)
Sundry income (expense) - net
Commodity contracts
(6
)
(46
)
37

(81
)
(69
)
10

Cost of sales
Net investment hedges:
 
 
 
 
 
 
 
Foreign currency contracts
(52
)
116

(73
)



 
Excluded components 4
162



99



Sundry income (expense) - net
Total derivatives designated as hedging instruments
$
(189
)
$
112

$
(69
)
$
72

$
(90
)
$
2

 
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
Interest rate contracts
$

$

$

$
(4
)
$

$

Interest expense and amortization of debt discount
Foreign currency contracts



45

101

(289
)
Sundry income (expense) - net
Commodity contracts



(28
)
(12
)
(9
)
Cost of sales
Total derivatives not designated as hedging instruments
$

$

$

$
13

$
89

$
(298
)
 
Total derivatives
$
(189
)
$
112

$
(69
)
$
85

$
(1
)
$
(296
)
 
1.
OCI is defined as other comprehensive income (loss).
2.
Pretax amounts.
3.
Gain (loss) recognized in income of derivatives is offset by gain (loss) recognized in income of the hedged item.
4.
The excluded components are related to the time value of the derivatives designated as hedges.

The following table provides the net after-tax amounts to be reclassified from AOCL to income within the next 12 months:

Expected Reclassifications from AOCL within the next 12 months
Dec 31,
2019
 
Cash flow hedges
 
Interest rate contracts
$
2

Commodity contracts
$
(23
)
Foreign currency contracts
$
5

Net investment hedges
 
Excluded components
$
26





137



NOTE 24 – FAIR VALUE MEASUREMENTS
Fair Value Measurements on a Recurring Basis
The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis:

Basis of Fair Value Measurements on a Recurring Basis 1
Dec 31, 2019
Dec 31, 2018
In millions
Level 1
Level 2
Total  
Level 1
Level 2
Total  
Assets at fair value:
 
 
 
 
 
 
Cash equivalents
 
 
 
 
 
 
Held to maturity securities 2
$

$
220

$
220

$

$
410

$
410

Money market funds

408

408


156

156

Marketable securities

21

21


100

100

Equity securities 3
15


15

16


16

Debt securities: 3
 
 
 


 
Government debt 4

555

555


700

700

Corporate bonds
22

992

1,014


983

983

Derivatives relating to: 5
 
 
 


 
Interest rates

35

35




Foreign currency

149

149


226

226

Commodities
23

67

90

17

93

110

Total assets at fair value
$
60

$
2,447

$
2,507

$
33

$
2,668

$
2,701

Liabilities at fair value:
 
 
 
 
 
 
Long-term debt including debt due within one year 6
$

$
18,661

$
18,661

$

$
20,212

$
20,212

Derivatives relating to: 5
 
 
 
 
 
 
Interest rates

310

310


64

64

Foreign currency

69

69


149

149

Commodities
14

137

151

23

189

212

Total liabilities at fair value
$
14

$
19,177

$
19,191

$
23

$
20,614

$
20,637


1.
Prior period amounts were updated to conform with the current year presentation.
2.
The Company had held-to-maturity securities (primary treasury bills and time deposits) classified as cash equivalents.
3.
The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.
4.
U.S. Treasury obligations, U.S. agency obligations, agency mortgage-backed securities and other municipalities’ obligations.
5.
See Note 23 for the classification of derivatives in the consolidated balance sheets.
6.
See Note 23 for information on fair value measurements of long-term debt.
For assets and liabilities classified as Level 1 measurements (measured using quoted prices in active markets), total fair value is either the price of the most recent trade at the time of the market close or the official close price, as defined by the exchange on which the asset is most actively traded on the last trading day of the period, multiplied by the number of units held without consideration of transaction costs.
For assets and liabilities classified as Level 2 measurements, where the security is frequently traded in less active markets, fair value is based on the closing price at the end of the period; where the security is less frequently traded, fair value is based on the price a dealer would pay for the security or similar securities, adjusted for any terms specific to that asset or liability, or by using observable market data points of similar, more liquid securities to imply the price. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance and quality checks.
For derivative assets and liabilities, standard industry models are used to calculate the fair value of the various financial instruments based on significant observable market inputs, such as foreign exchange rates, commodity prices, swap rates, interest rates and implied volatilities obtained from various market sources. Market inputs are obtained from well-established and recognized vendors of market data and subjected to tolerance/quality checks.
For all other assets and liabilities for which observable inputs are used, fair value is derived through the use of fair value models, such as a discounted cash flow model or other standard pricing models. See Note 23 for further information on the types of instruments used by the Company for risk management.
There were no transfers between Levels 1 and 2 in the years ended December 31, 2019 and 2018.

138



For assets classified as Level 3 measurements, the fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s interests held in trade accounts receivable conduits is determined by calculating the expected amount of cash to be received using the key input of anticipated credit losses in the portfolio of receivables sold that have not yet been collected. Given the short-term nature of the underlying receivables, discount rate and prepayments are not factors in determining the fair value of the interests. See Note 15 for further information on assets classified as Level 3 measurements.
For equity securities calculated at net asset value per share (or its equivalent), the Company had $117 million in private market securities and $18 million in real estate at December 31, 2019 ($120 million in private market securities and $29 million in real estate at December 31, 2018). There are no redemption restrictions and the underfunded commitments on these investments were $76 million at December 31, 2019 ($89 million at December 31, 2018).
The following table summarizes the changes in fair value measurements using Level 3 inputs for the year ended December 31, 2018:

Fair Value Measurements Using Level 3 Inputs for Interests Held in Trade Accounts Receivable Conduits 1
2018
In millions
Balance at Jan 1
$
677

Gain (loss) included in earnings 2
3

Settlements 3
(680
)
Balance at Dec 31
$


1.
Included in "Accounts and notes receivable – Other" in the consolidated balance sheets. See Note 15 for additional information.
2.
Included in "Selling, general and administrative expenses" in the consolidated statements of income.
3.
Includes noncash transactions of $23 million for the year ended December 31, 2018.

Fair Value Measurements on a Nonrecurring Basis
The following table summarizes the bases used to measure certain assets at fair value on a nonrecurring basis in the consolidated balance sheets in 2019, 2018 and 2017:

Basis of Fair Value Measurements on a Nonrecurring Basis at Dec 31
(Level 3)
Total Losses
In millions
2019
 
 
Assets at fair value:
 
 
Long-lived assets, other assets and equity method investments
$
162

$
(2,031
)
Goodwill
$

$
(1,039
)
2018
 
 
Assets at fair value:
 
 
Long-lived assets and other assets
$

$
(67
)
2017
 
 
Assets at fair value:
 
 
Long-lived assets, intangible assets, other assets and equity method investments
$
61

$
(955
)
Goodwill
$

$
(1,491
)


2019 Fair Value Measurements on a Nonrecurring Basis
As part of the Synergy Program, the Company has or will shut down and write-off several small manufacturing facilities, non-manufacturing assets and certain corporate facilities around the world. In 2019, manufacturing facilities associated with this plan were written down to zero. In addition, impairments of leased, non-manufacturing facilities, which were classified as Level 3 measurements, resulted in a write-down of right-of-use assets to a fair value of $152 million using unobservable inputs. The impairment charges related to the Synergy Program, totaling $143 million, were included in "Restructuring, goodwill impairment and asset related charges - net" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure ($2 million), Performance Materials & Coatings ($28 million) and Corporate ($113 million).

In 2019, the Company recognized an additional pretax impairment charge of $44 million related to capital additions made to Santa Vitoria, which was impaired in 2017. The assets were written down to zero in 2019. The impairment charge was included in “Restructuring, goodwill impairment and asset related charges - net” in the consolidated statements of income and related to Packaging & Specialty Plastics.


139



In 2019, the Company recognized impairment charges of $14 million related to non-manufacturing assets. The assets, classified as Level 3 measurements, were valued at $10 million using unobservable inputs. The impairment charges were included in "Restructuring, goodwill impairment and asset related charges - net" in the consolidated statements of income and related to Performance Materials & Coatings ($9 million) and Corporate ($5 million).

In 2019, the Company recognized an impairment charge of $75 million resulting from the planned divestiture of its acetone derivatives business to ALTIVIA Ketones & Additives, LLC. The transaction closed on November 1, 2019 and included the Company's acetone derivatives related inventory and production assets, located in Institute, West Virginia, in addition to the site infrastructure, land and utilities. The assets, classified as Level 3 measurements and valued using unobservable inputs, were written down to zero in 2019, except for inventory, which was sold at the lower of cost or market. The impairment charge was included in "Restructuring, goodwill impairment and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($24 million) and Corporate ($51 million).

In the fourth quarter of 2019, the Company performed its annual goodwill impairment testing utilizing a discounted cash flow methodology as its valuation technique. As a result, the Company determined the fair value of the C&PM reporting unit was lower than its carrying amount and recorded an impairment charge of $1,039 million, included in “Restructuring, goodwill impairment and asset related charges - net” in the consolidated statements of income and related to Performance Materials & Coatings. See Note 14 for additional information on the impairment charge.
 
In the fourth quarter of 2019, the Company concluded that its equity method investment in Sadara, classified as a Level 3 measurement and valued using unobservable inputs, was other-than-temporarily impaired and written down to zero. Additionally, the Company reserved certain accounts and notes receivable and accrued interest balances due to uncertainty on the timing of collection. As a result, the Company recorded a $1,755 million charge related to Sadara. The charge was included in “Restructuring, goodwill impairment and asset related charges - net” in the consolidated statements of income and related to Packaging & Specialty Plastics ($370 million), Industrial Intermediates & Infrastructure ($1,168 million) and Corporate ($217 million). See Note 13 for additional information.

2018 Fair Value Measurements on a Nonrecurring Basis
The Company has or will shut down a number of manufacturing and other non-manufacturing facilities and corporate facilities around the world as part of its restructuring programs. In 2018, the manufacturing facilities and related assets and corporate facilities associated with these programs were written down to zero. The impairment charges related to the restructuring programs, totaling $33 million, were included in "Restructuring, goodwill impairment and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($10 million), Performance Materials & Coatings ($7 million) and Corporate ($16 million).

In 2018, the Company recognized an additional pretax impairment charge of $34 million related primarily to capital additions made to Santa Vitoria, which was impaired in 2017. The assets were written down to zero in 2018. The impairment charge was included in “Restructuring, goodwill impairment and asset related charges - net” in the consolidated statements of income and related to the Packaging & Specialty Plastics segment.

2017 Fair Value Measurements on a Nonrecurring Basis
The Company has or will shut down a number of manufacturing, R&D and corporate facilities around the world as part of the Synergy Program. The manufacturing facilities and related assets (including intangible assets), corporate facilities and data centers associated with this plan were written down to zero in the fourth quarter of 2017. The impairment charges related to the Synergy Program, totaling $87 million, were included in "Restructuring, goodwill impairment and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($33 million), Industrial Intermediates & Infrastructure ($12 million), Performance Materials & Coatings ($9 million) and Corporate ($33 million). See Note 7 for additional information on the Company's restructuring activities.

In the fourth quarter of 2017, the Company recognized a $622 million pretax impairment charge related to Santa Vitoria. The Company determined it would not pursue an expansion of the facility’s ethanol mill into downstream derivative products, primarily as a result of cheaper ethane-based production as well as the Company’s new assets coming online on the U.S. Gulf Coast which can be used to meet growing market demands in Brazil. As a result of this decision, cash flow analysis indicated the carrying amount of the impacted assets was not recoverable and the assets were written down to zero in the fourth quarter of 2017. The impairment charge was included in “Restructuring, goodwill impairment and asset related charges - net” in the consolidated statements of income and related to the Packaging & Specialty Plastics segment. See Notes 7 and 25 for additional information.


140



The Company also recognized other pretax impairment charges of $246 million in the fourth quarter of 2017, including charges related to manufacturing assets of $159 million, an equity method investment of $81 million and other assets of $6 million. The assets, classified as Level 3 measurements, were valued at $61 million using unobservable inputs, including assumptions a market participant would use to measure the fair value of the group of assets, which included projected cash flows. The impairment charges were included in "Restructuring, goodwill impairment and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics ($83 million), Industrial Intermediates & Infrastructure ($5 million), Performance Materials & Coatings ($58 million) and Corporate ($100 million). See Note 7 for additional information.

In the fourth quarter of 2017, the Company performed its annual goodwill impairment testing utilizing a discounted cash flow methodology as its valuation technique. As a result, the Company determined the fair value of the C&PM reporting unit was lower than its carrying amount and recorded an impairment charge of $1,491 million, included in “Restructuring, goodwill impairment and asset related charges - net” in the consolidated statements of income and related to Performance Materials & Coatings. See Note 14 for additional information on the impairment charge.

See Note 7 for additional information on the Company's restructuring activities.


NOTE 25 – VARIABLE INTEREST ENTITIES
Consolidated Variable Interest Entities ("VIEs")
The Company holds a variable interest in the following joint ventures or entities for which it is the primary beneficiary:

Asia Pacific joint ventures
The Company has variable interests in two joint ventures that own and operate manufacturing and logistics facilities, which produce chemicals and provide services in Asia Pacific. The Company's variable interests in these joint ventures relate to arrangements between the joint ventures and the Company, involving the majority of the output on take-or-pay terms with pricing ensuring a guaranteed return to the joint ventures.

The Company was a 50 percent indirect owner in a propylene oxide ("PO") manufacturing joint venture in Asia Pacific. The Company had a variable interest in this joint venture relating to arrangements between the joint venture and the Company involving the majority of the output on take-or-pay terms, with pricing ensuring a guaranteed return to the joint venture. On April 30, 2019, the Company executed an agreement to acquire full ownership in the PO manufacturing joint venture. The transaction closed on October 1, 2019, for a cash purchase price of $331 million. Approximately half of the purchase price was attributed to the Company’s proportionate equity interest in the entity that owned the PO manufacturing joint venture, which is accounted for under the equity method of accounting, and was classified as "Investments in and loans to nonconsolidated affiliates" in the consolidated statements of cash flows. The remaining $166 million was classified as "Purchases of noncontrolling interests" in the consolidated statements of cash flows.

Ethylene storage joint venture
The Company has variable interests in a joint venture that provides ethylene storage in Alberta, Canada. The Company's variable interests relate to arrangements involving a majority of the joint venture's storage capacity on take-or-pay terms with pricing ensuring a guaranteed return to the joint venture; and favorably priced leases provided to the joint venture. The Company provides the joint venture with operation and maintenance services and utilities.

Cogeneration in Brazil
The Company holds variable interests in a cogeneration facility in Brazil related to the production of ethanol from sugarcane. The Company's variable interests are the result of a tolling arrangement where it provides fuel to the entity and purchases a majority of the cogeneration facility’s output on terms that ensure a return to the entity’s equity holders.

Assets and Liabilities of Consolidated VIEs
The Company's consolidated financial statements include the assets, liabilities and results of operations of VIEs for which the Company is the primary beneficiary. The other equity holders’ interests are reflected in "Net income attributable to noncontrolling interests" in the consolidated statements of income and "Noncontrolling interests" in the consolidated balance sheets.


141



The following table summarizes the carrying amounts of these entities’ assets and liabilities included in the Company’s consolidated balance sheets at December 31, 2019 and 2018:

Assets and Liabilities of Consolidated VIEs at Dec 31
 
 
In millions
2019
2018
Cash and cash equivalents
$
37

$
71

Other current assets
51

101

Net property
330

683

Other noncurrent assets
18

14

Total assets 1
$
436

$
869

Current liabilities
$
141

$
307

Long-term debt
34

75

Other noncurrent obligations
21

14

Total liabilities 2
$
196

$
396


1.
All assets were restricted at December 31, 2019 and 2018.
2.
All liabilities were nonrecourse at December 31, 2019 and 2018.

Amounts presented in the consolidated balance sheets and the table above as restricted assets or nonrecourse obligations relating to consolidated VIEs at December 31, 2019 and 2018 are adjusted for intercompany eliminations and parental guarantees.

Nonconsolidated VIEs
The Company holds a variable interest in the following entities for which the Company is not the primary beneficiary:

Silicon joint ventures
The Company holds minority voting interests in certain joint ventures that produce silicon inputs for the Company. These joint ventures operate under supply agreements that sell inventory to the equity owners using pricing mechanisms that guarantee a return, therefore shielding the joint ventures from the obligation to absorb expected losses. As a result of the pricing mechanisms of these agreements, these entities are determined to be VIEs. The Company is not the primary beneficiary, as it does not hold the power to direct the activities that most significantly impact the economic performance of these entities; therefore, the entities are accounted for under the equity method of accounting. The Company's maximum exposure to loss as a result of its involvement with these variable interest entities is determined to be the carrying value of the investment in these entities. At December 31, 2019, the Company's investment in these joint ventures was $100 million ($100 million at December 31, 2018), classified as "Investment in nonconsolidated affiliates" in the consolidated balance sheets, representing the Company's maximum exposure to loss.

AgroFresh Solutions Inc.
The Company held a variable interest in AgroFresh Solutions Inc. ("AFSI"), a company that produces and sells proprietary technologies for the horticultural market. The variable interest in AFSI related to a tax receivable agreement that entitled the Company to additional consideration in the form of tax savings, which was contingent on the operations and earnings of AFSI. The Company was not the primary beneficiary, as it is a minority shareholder in AFSI and AFSI is governed by a board of directors, the composition of which is mandated by AFSI's corporate governance requirements that a majority of the directors be independent. In December 2019, the Company and AFSI settled the tax receivable agreement and the Company's receivable with AFSI was zero at December 31, 2019 ($8 million at December 31, 2018, classified as "Accounts and notes receivable - Other" in the consolidated balance sheets). The Company continues to be a minority shareholder, but does not have a controlling financial interest in AFSI.


NOTE 26 – RELATED PARTY TRANSACTIONS
Effective with the separation from DowDuPont on April 1, 2019, TDCC became a wholly owned subsidiary of Dow Inc. and reported transactions with Dow Inc. as related party transactions. From the Merger date through March 31, 2019, TDCC reported transactions with DowDuPont and Historical DuPont and its affiliates as related party transactions.

TDCC
TDCC has committed to fund Dow Inc.'s dividends paid to common stockholders, share repurchases and certain governance expenses. Funding is accomplished through intercompany loans. TDCC's Board reviews and determines a dividend distribution to Dow Inc. to settle the intercompany loans. In the fourth quarter of 2019, TDCC declared and paid a dividend of $201 million to Dow Inc. At December 31, 2019, TDCC's intercompany loan balance with Dow Inc. was insignificant.

142



DowDuPont
Pursuant to the Merger Agreement, TDCC committed to fund a portion of DowDuPont's dividends paid to common stockholders and certain governance expenses. In addition, share repurchases by DowDuPont were partially funded by TDCC through 2018. Funding was accomplished through intercompany loans. On a quarterly basis, TDCC's Board reviewed and determined a dividend distribution to DowDuPont to settle the intercompany loans. The dividend distribution considered the level of TDCC’s earnings and cash flows and the outstanding intercompany loan balances. In 2019, TDCC declared and paid dividends to DowDuPont of $535 million ($3,711 million in 2018). At December 31, 2018, TDCC's outstanding intercompany loan balance was insignificant.

Historical DuPont and its Affiliates
Prior to the separation from DowDuPont, TDCC sold to and procured from Historical DuPont and its affiliates certain raw materials that were consumed in each company's manufacturing process. The following table presents amounts due to or due from Historical DuPont and its affiliates at December 31, 2018:

Balances Due To or Due From Historical DuPont and its Affiliates
Dec 31, 2018
In millions
Accounts and notes receivable - Other
$
89

Accounts payable - Other
$
19


The following table presents revenue earned and expenses incurred related to transactions with Historical DuPont and its affiliates, prior to the separation from DowDuPont:

Sales to Historical DuPont and its Affiliates
2019
2018
In millions
Net sales
$
12

$
55

Cost of sales
$
9

$
42



Purchases from Historical DuPont and its affiliates were insignificant for 2019 and 2018.


NOTE 27 – SEGMENTS AND GEOGRAPHIC REGIONS
Dow combines one of the broadest technology sets in the industry with asset integration, focused innovation and global scale to achieve profitable growth and become the most innovative, customer centric, inclusive and sustainable materials science company. Dow’s portfolio of performance materials, industrial intermediates and plastics businesses delivers a broad range of differentiated science-based products and solutions for our customers in high-growth segments, such as packaging, infrastructure and consumer care. Dow operates 109 manufacturing sites in 31 countries and employs approximately 36,500 people.

Effective with the Merger, TDCC's business activities were components of DowDuPont's business operations and were reported as a single operating segment. Following the separation from DowDuPont, the Company changed the manner in which its business activities were managed. The Company's portfolio now includes six global businesses which are organized into the following operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure and Performance Materials & Coatings. Corporate contains the reconciliation between the totals for the operating segments and the Company's totals. The Company did not aggregate any operating segments when determining its reportable segments.

Following the separation from DowDuPont, the Company changed its practice of transferring ethylene to its downstream derivative businesses at cost to transferring ethylene at market prices. The Company also changed certain of its Corporate segment allocation practices including costs previously assigned to AgCo and SpecCo, which are now allocated to the operating segments. These changes have been consistently applied to all periods presented.

Dow reported geographic information for the following regions: U.S. & Canada, Asia Pacific, Latin America, and EMEAI. As a result of the separation from DowDuPont, the Company changed the geographic alignment for the country of India to be reflected in EMEAI (previously reported in Asia Pacific).

Dow’s measure of profit/loss for segment reporting purposes is pro forma Operating EBIT as this is the manner in which the Company's chief operating decision maker ("CODM") assesses performance and allocates resources. The Company defines pro forma Operating EBIT as earnings (i.e., "Income from continuing operations before income taxes") before interest, plus pro forma adjustments, excluding the impact of significant items. Pro forma Operating EBIT by segment includes all operating items relating

143



to the businesses; items that principally apply to Dow as a whole are assigned to Corporate. Pro forma Operating EBIT has been reflected retrospectively for all periods presented, and reconciliations are provided at the end of this footnote. The Company also presents pro forma net sales in this footnote as it is included in management's measure of segment performance and is regularly reviewed by the CODM. Pro forma net sales includes the impact of ECP from January 1, 2017 through August 31, 2017, as well as the impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont.

Corporate Profile
Dow conducts its worldwide operations through global businesses which are reflected in the following reportable segments:

Packaging & Specialty Plastics
Packaging & Specialty Plastics consists of two highly integrated global businesses: Hydrocarbons & Energy and Packaging and Specialty Plastics. The segment employs the industry’s broadest polyolefin product portfolio, supported by the Company’s proprietary catalyst and manufacturing process technologies, to work at the customer’s design table throughout the value chain to deliver more reliable and durable, higher performing, and more sustainable plastics to customers in food and specialty packaging; industrial and consumer packaging; health and hygiene; caps, closures and pipe applications; consumer durables; automotive; and infrastructure. This segment includes the results of The Kuwait Styrene Company K.S.C.C. and The SCG-Dow Group, as well as a portion of the results of EQUATE, The Kuwait Olefins Company K.S.C.C. ("TKOC"), Map Ta Phut and Sadara, all joint ventures of the Company.

Industrial Intermediates & Infrastructure
Industrial Intermediates & Infrastructure consists of two customer-centric global businesses - Industrial Solutions and Polyurethanes & Construction Chemicals - that develop important intermediate chemicals that are essential to manufacturing processes, as well as downstream, customized materials and formulations that use advanced development technologies. These businesses primarily produce and market ethylene oxide and propylene oxide derivatives that are aligned to market segments as diverse as appliances, coatings, infrastructure and oil and gas. The global scale and reach of these businesses, world-class technology and R&D capabilities and materials science expertise enable the Company to be a premier solutions provider offering customers value-add sustainable solutions to enhance comfort, energy efficiency, product effectiveness and durability across a wide range of home comfort and appliances, building and construction, adhesives and lubricant applications, among others. This segment includes a portion of the Company's share of the results of EQUATE, TKOC, Map Ta Phut and Sadara.
 
Performance Materials & Coatings
Performance Materials & Coatings includes industry-leading franchises that deliver a wide array of solutions into consumer and infrastructure end-markets. The segment consists of two global businesses: Coatings & Performance Monomers and Consumer Solutions. These businesses primarily utilize the Company's acrylics-, cellulosics- and silicone-based technology platforms to serve the needs of the architectural and industrial coatings, home care and personal care end-markets. Both businesses employ materials science capabilities, global reach and unique products and technology to combine chemistry platforms to deliver differentiated offerings to customers.

Corporate
Corporate includes certain enterprise and governance activities (including insurance operations, environmental operations, etc.); non-business aligned joint ventures; non-business aligned litigation expenses; and discontinued or non-aligned businesses.

Sales are attributed to geographic region based on customer location; long-lived assets are attributed to geographic region based on asset location.

Geographic Region Information
United 
States
EMEAI
Rest of 
World
Total
In millions
2019
 
 
 
 
Sales to external customers
$
14,437

$
14,612

$
13,902

$
42,951

Long-lived assets
$
14,571

$
2,649

$
3,776

$
20,996

2018



 
Sales to external customers
$
16,613

$
17,406

$
15,585

$
49,604

Long-lived assets
$
14,750

$
2,657

$
4,011

$
21,418

2017
 
 
 
 
Sales to external customers
$
15,316

$
15,226

$
13,188

$
43,730

Long-lived assets
$
14,771

$
2,547

$
4,266

$
21,584



144



Segment Information
Pack. & Spec. Plastics
Ind. Interm. & Infrast.
Perf. Materials & Coatings
Corp.
Total
In millions
2019
 
 
 
 
 
Net sales
$
20,245

$
13,440

$
8,923

$
343

$
42,951

Pro forma net sales
20,245

13,449

8,961

343

42,998

Restructuring, goodwill impairment and asset related charges - net 1
439

1,175

1,076

529

3,219

Equity in earnings (losses) of nonconsolidated affiliates
162

(241
)
5

(20
)
(94
)
Pro forma Operating EBIT 2
2,904

845

918

(315
)
4,352

Depreciation and amortization
1,435

594

877

32

2,938

Total assets
29,522

11,753

14,059

5,190

60,524

Investments in nonconsolidated affiliates
675

568

101

60

1,404

Capital expenditures
1,039

452

470


1,961

2018
 
 
 
 
 
Net sales
$
24,195

$
15,447

$
9,677

$
285

$
49,604

Pro forma net sales
24,237

15,465

9,865

285

49,852

Restructuring, goodwill impairment and asset related charges - net 1
46

11

21

143

221

Equity in earnings (losses) of nonconsolidated affiliates
287

284

4

(20
)
555

Pro forma Operating EBIT 2
3,593

1,767

1,246

(370
)
6,236

Depreciation and amortization
1,385

607

888

29

2,909

Total assets 3
30,279

14,092

16,050

3,378

63,799

Investments in nonconsolidated affiliates
1,278

1,850

99

93

3,320

Capital expenditures
1,231

433

427


2,091

2017
 
 
 
 
 
Net sales
$
21,504

$
12,951

$
8,892

$
383

$
43,730

Pro forma net sales
22,546

12,951

8,892

383

44,772

Restructuring, goodwill impairment and asset related charges - net 1
716

17

1,578

428

2,739

Equity in earnings (losses) of nonconsolidated affiliates
190

172

40

(8
)
394

Pro forma Operating EBIT 2
3,712

1,470

817

(422
)
5,577

Depreciation and amortization
1,055

572

885

34

2,546

Total assets 3
30,633

14,115

17,483

4,342

66,573

Investments in nonconsolidated affiliates
1,184

1,700

103

120

3,107

Capital expenditures
2,034

310

463


2,807

1.
See Note 7 for information regarding the Company's restructuring programs, goodwill impairment and other asset related charges.
2.
Pro forma Operating EBIT for TDCC in 2019 is substantially the same as that of Dow Inc. (same for 2018 and 2017) and therefore is not disclosed separately in the table above. A reconciliation of "Income (loss) from continuing operations, net of tax" to pro forma Operating EBIT is provided on the following page.
3.
Excludes assets of discontinued operations of $19,900 million and $19,279 million for 2018 and 2017, respectively.

Reconciliation of "Income (loss) from continuing operations, net of tax" to Pro Forma Operating EBIT
2019
2018
2017
In millions
Income (loss) from continuing operations, net of tax
$
(1,717
)
$
2,940

$
(1,287
)
+ Provision for income taxes on continuing operations
470

809

1,524

Income (loss) from continuing operations before income taxes
$
(1,247
)
$
3,749

$
237

- Interest income
81

82

66

+ Interest expense and amortization of debt discount
933

1,063

914

+ Pro forma adjustments 1
65

180

1,120

- Significant items
(4,682
)
(1,326
)
(3,372
)
Pro forma Operating EBIT
$
4,352

$
6,236

$
5,577


1.
Pro forma adjustments include: (1) the margin impact of various manufacturing, supply and service related agreements entered into with DuPont and Corteva in connection with the separation which provide for different pricing than the historical intercompany and intracompany pricing practices of TDCC and Historical DuPont (included for 2019 and 2018 only), (2) the inclusion of ECP for the period of January 1, 2017 through August 31, 2017, (3) the removal of the amortization of ECP's inventory step-up recognized in connection with the Merger (4) the elimination of the impact of events directly attributable to the Merger, internal reorganization and business realignment, separation, distribution and other related transactions (e.g., one-time transaction costs) and (5) the elimination of the effect of a consummated divestiture agreed to with certain regulatory agencies as a condition of approval for the Merger.

145



The following tables summarize the pretax impact of significant items by segment that are excluded from pro forma Operating EBIT:

Significant Items by Segment for 2019
Pack. & Spec. Plastics
Ind. Interm. & Infrast.
Perf. Materials & Coatings
Corp.
Total
In millions
Indemnification and other transaction related costs 1
$

$

$

$
(144
)
$
(144
)
Integration and separation costs 2



(1,013
)
(1,013
)
Restructuring, goodwill impairment and asset related charges - net 3
(439
)
(1,175
)
(1,076
)
(529
)
(3,219
)
Loss on divestitures 4

(5
)

(44
)
(49
)
Loss on early extinguishment of debt 5



(102
)
(102
)
Environmental charges 6
(5
)
(8
)
(50
)
(336
)
(399
)
Warranty accrual adjustment of exited business 7



39

39

Litigation related charges, awards and adjustments 8
170



35

205

Total
$
(274
)
$
(1,188
)
$
(1,126
)
$
(2,094
)
$
(4,682
)
1.
Includes charges primarily associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.
2.
Costs related to post-Merger integration and business separation activities. Excludes one-time transaction costs directly attributable to the Merger.
3.
Includes Board approved restructuring plans and asset-related charges (see Note 7 for additional information); a charge related to Sadara (see Note 13 for additional information) and an impairment charge related to goodwill associated with the Coatings & Performance Monomers reporting unit (see Note 14 for additional information).
4.
Includes post-closing adjustments on previous divestitures.
5.
The Company retired outstanding long-term debt resulting in a loss on early extinguishment. See Note 16 for additional information.
6.
Related to environmental remediation, primarily resulting from the culmination of long-standing negotiations with regulators and/or agencies and review of additional costs to manage ongoing remediation activities resulting from Dow’s separation from DowDuPont and related agreements with Corteva and DuPont. See Note 17 for additional information.
7.
Includes an adjustment to the warranty accrual of an exited business.
8.
Includes a gain associated with a legal settlement with Nova, as well as a gain related to an adjustment of the Dow Silicones breast implant liability and a charge related to the settlement of the Dow Silicones commercial creditor matters. See Note 17 for additional information.

Significant Items by Segment for 2018
Pack. & Spec. Plastics
Ind. Interm. & Infrast.
Perf. Materials & Coatings
Corp.
Total
In millions
Impact of Dow Silicones ownership restructure 1
$

$

$
(20
)
$

$
(20
)
Integration and separation costs 2



(1,074
)
(1,074
)
Restructuring, goodwill impairment and asset related charges - net 3
(46
)
(11
)
(21
)
(120
)
(198
)
Gain on divestiture 4

20



20

Transaction costs and productivity actions 5



(54
)
(54
)
Total
$
(46
)
$
9

$
(41
)
$
(1,248
)
$
(1,326
)
1.
Includes a loss related to a post-closing adjustment related to the Dow Silicones ownership restructure.    
2.
Costs related to post-Merger integration and separation and distribution activities, and costs related to the Dow Silicones ownership restructure.
3.
Includes Board approved restructuring plans and asset-related charges, which include other asset impairments. See Note 7 for additional information.
4.
Includes a gain related to the Company's sale of its equity interest in MEGlobal.
5.
The Company retired outstanding notes payable resulting in a loss on early extinguishment. See Note 16 for additional information.

Significant Items by Segment for 2017

Pack. & Spec. Plastics
Ind. Interm. & Infrast.
Perf. Materials & Coatings
Corp.
Total
In millions
Litigation related charges, awards and adjustments 1
$
137

$

$

$

$
137

Integration and separation costs 2



(716
)
(716
)
Restructuring, goodwill impairment and asset related charges - net 3
(716
)
(17
)
(1,578
)
(431
)
(2,742
)
Gain on divestiture 4



7

7

Transaction costs and productivity actions 5



(58
)
(58
)
Total
$
(579
)
$
(17
)
$
(1,578
)
$
(1,198
)
$
(3,372
)
1.
Includes a gain associated with a patent infringement matter with Nova. See Note 17 for additional information.
2.
Costs related to post-Merger integration, separation and distribution activities, and costs related to the Dow Silicones ownership restructure.
3.
Includes Board approved restructuring plans, goodwill impairment and asset-related charges, which includes other asset impairments. See Note 7 for additional information.
4.
Includes post-closing adjustments related to the split-off of the Company's chlorine value chain.
5.
Includes implementation costs associated with the Company's restructuring programs and other productivity actions.

146



NOTE 28 - SELECTED QUARTERLY FINANCIAL DATA
2019
 
 
 
 
 
In millions, except per share amounts (Unaudited)
1st 1
2nd
3rd
4th
Year
Dow Inc.
 
 
 
 
 
Net sales
$
10,969

$
11,014

$
10,764

$
10,204

$
42,951

Cost of sales
$
9,142

$
9,420

$
9,377

$
8,718

$
36,657

Gross margin
$
1,827

$
1,594

$
1,387

$
1,486

$
6,294

Restructuring, goodwill impairment and asset related charges - net 2
$
156

$
65

$
147

$
2,851

$
3,219

Integration and separation costs 3
$
452

$
348

$
164

$
99

$
1,063

Income (loss) from continuing operations, net of tax
$
156

$
90

$
347

$
(2,310
)
$
(1,717
)
Income from discontinued operations net of tax
$
445

$

$

$

$
445

Net income (loss) 4
$
601

$
90

$
347

$
(2,310
)
$
(1,272
)
Net income (loss) attributable to Dow Inc.
$
556

$
75

$
333

$
(2,323
)
$
(1,359
)
Earnings (loss) per common share from continuing operations - basic 5
$
0.16

$
0.10

$
0.45

$
(3.14
)
$
(2.42
)
Earnings (loss) per common share from continuing operations -
diluted 5
$
0.16

$
0.10

$
0.45

$
(3.14
)
$
(2.42
)
Dividends declared per share of common stock 6
N/A

$
0.70

$
0.70

$
0.70

$
2.10

Market price range of common stock:
 
 
 
 
 
High 6
N/A

$
59.71

$
52.79

$
55.99

$
59.71

Low 6
N/A

$
46.76

$
40.71

$
43.85

$
40.71

TDCC
 
 
 
 
 
Net sales
$
10,969

$
11,014

$
10,764

$
10,204

$
42,951

Cost of sales
$
9,142

$
9,419

$
9,377

$
8,719

$
36,657

Gross margin
$
1,827

$
1,595

$
1,387

$
1,485

$
6,294

Restructuring, goodwill impairment and asset related charges - net 2
$
156

$
65

$
147

$
2,851

$
3,219

Integration and separation costs
$
452

$
324

$
164

$
99

$
1,039

Income (loss) from continuing operations, net of tax
$
156

$
217

$
324

$
(2,292
)
$
(1,595
)
Income from discontinued operations net of tax
$
445

$

$

$

$
445

Net income (loss) 3
$
601

$
217

$
324

$
(2,292
)
$
(1,150
)
Net income (loss) attributable to The Dow Chemical Company
$
556

$
202

$
310

$
(2,305
)
$
(1,237
)

1.
The amounts presented for the first quarter of 2019 have been updated from the amounts reported in the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2019, to reflect the effects of the separation from DowDuPont. See reconciliation on the following page.
2.
See Note 7 for additional information.
3.
See Note 4 for additional information.
4.
See Notes 4, 9, 16 and 17 for information on additional items materially impacting "Net income (loss)." The fourth quarter of 2019 included a gain related to the effects of Swiss tax reform and a loss on the early extinguishment of debt. The third quarter of 2019 included a charge related to environmental remediation, a charge related to the settlement of the Dow Silicones commercial creditor matters, a gain related to an adjustment to the Dow Silicones breast implant liability and a gain associated with a legal settlement with Nova. The second quarter of 2019 included charges associated with agreements entered into with DuPont and Corteva as part of the separation from DowDuPont.
5.
Earnings per common share amounts relate only to Dow Inc. as TDCC common shares are not publicly traded and are all owned by Dow Inc. Due to quarterly changes in the share count and the allocation of income to participating securities, the sum of the four quarters does not equal the earnings per share amount calculated for the year.
6.
Dow Inc.'s common stock was solely owned by DowDuPont through March 31, 2019, and on April 1, 2019, Dow Inc. became an independent, publicly traded company.


147



2018
 
 
 
 
 
In millions, except per share amounts (Unaudited)
1st
2nd
3rd
4th
Year
Net sales
$
12,237

$
12,789

$
12,634

$
11,944

$
49,604

Cost of sales
$
9,980

$
10,540

$
10,456

$
10,098

$
41,074

Gross margin
$
2,257

$
2,249

$
2,178

$
1,846

$
8,530

Restructuring, goodwill impairment and asset related charges - net 1
$
87

$
40

$
48

$
46

$
221

Integration and separation costs 2
$
224

$
262

$
313

$
380

$
1,179

Income from continuing operations, net of tax
$
925

$
810

$
714

$
491

$
2,940

Income from discontinued operations, net of tax
$
514

$
554

$
335

$
432

$
1,835

Net income 3
$
1,439

$
1,364

$
1,049

$
923

$
4,775

Net income attributable to Dow Inc. and The Dow Chemical Company
$
1,404

$
1,333

$
1,013

$
891

$
4,641

Earnings per common share from continuing operations - basic 4
$
1.21

$
1.05

$
0.91

$
0.63

$
3.80

Earnings per common share from continuing operations -
diluted 4
$
1.21

$
1.05

$
0.91

$
0.63

$
3.80


1.
See Note 7 for additional information.
2.
See Note 4 for additional information.
3.
Includes tax adjustments related to The Act, enacted on December 22, 2017. See Note 9 for additional information.
4.
Earnings per common share amounts relate only to Dow Inc. as TDCC common shares are not publicly traded and are all owned by Dow Inc.

Effective with the separation from DowDuPont, the Company's consolidated financial results reflect the distribution of AgCo and SpecCo as discontinued operations, as well as the receipt of ECP as a common control transaction from the closing of the Merger on August 31, 2017. The following table provides the reconciliation of the amounts reported in the Company's Quarterly Report on Form 10-Q for the period ended March 31, 2019, to the amounts presented for the first quarter of 2019 on the previous page. See Note 4 for additional information on the separation from DowDuPont.

Reconciliation - First Quarter 2019
As Filed
Distribution of AgCo and SpecCo
Receipt of ECP
Updated
In millions (Unaudited)
Net sales
$
13,582

$
(2,954
)
$
341

$
10,969

Cost of sales
$
10,707

$
(1,805
)
$
240

$
9,142

Gross margin
$
2,875

$
(1,149
)
$
101

$
1,827

Restructuring, goodwill impairment and asset related charges - net
$
232

$
(78
)
$
2

$
156

Integration and separation costs
$
408

$

$
44

$
452

Income from continuing operations, net of tax
$
586

$
(445
)
$
15

$
156

Income from discontinued operations, net of tax
$

$
445

$

$
445

Net income
$
586

$

$
15

$
601

Net income available for common stockholders
$
541

$

$
15

$
556




ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
Not applicable.



148



ITEM 9A. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this Annual Report on Form 10-K, Dow Inc. and The Dow Chemical Company (the "Companies") carried out an evaluation, under the supervision and with the participation of the Companies' Disclosure Committee and the Companies' management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Companies' disclosure controls and procedures pursuant to paragraph (b) of Exchange Act Rules 13a-15 and 15d-15. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Companies' disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting
There were no changes in the Companies' internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that was conducted during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Companies' internal control over financial reporting.

Management’s Report on Internal Control Over Financial Reporting
Management is responsible for establishing and maintaining adequate internal control over financial reporting. The Companies' internal control framework and processes are designed to provide reasonable assurance to management and the Board of Directors regarding the reliability of financial reporting and the preparation of the Companies' consolidated financial statements in accordance with accounting principles generally accepted in the United States of America.

The Companies' internal control over financial reporting includes those policies and procedures that:

pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Companies;
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Companies are being made only in accordance with authorizations of management and Directors of the Companies; and
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Companies' assets that could have a material effect on the consolidated financial statements.

Because of its inherent limitations, any system of internal control over financial reporting can provide only reasonable assurance and may not prevent or detect misstatements.

Management assessed the effectiveness of the Companies' internal control over financial reporting and concluded that, as of December 31, 2019, such internal control is effective. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”) in Internal Control—Integrated Framework (2013).

The Companies' independent auditors, Deloitte & Touche LLP, with direct access to the Companies' Board of Directors through the Audit Committee of Dow Inc., have audited the consolidated financial statements prepared by the Companies. Their reports on the consolidated financial statements are included in Part II, Item 8. Financial Statements and Supplementary Data. Deloitte & Touche LLP’s reports on the Companies' internal control over financial reporting are referenced therein and included herein.

February 7, 2020


/s/ JIM FITTERLING
 
/s/ HOWARD UNGERLEIDER
Jim Fitterling
 
Howard Ungerleider
Chief Executive Officer
 
President and Chief Financial Officer
 
 
 
 
 
 
/s/ RONALD C. EDMONDS
 
 
Ronald C. Edmonds
 
 
Controller and Vice President of Controllers and Tax
 
 



149



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholders and the Board of Directors of Dow Inc.
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of Dow Inc. and subsidiaries (the “Company”) as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2019, of the Company and the financial statement schedule listed in the Index at Item 15(a)2 and our report dated February 7, 2020, expressed an unqualified opinion on those financial statements and financial statement schedule and included an explanatory paragraph regarding a) a change in the method of accounting for revenue due to the adoption of Accounting Standards Codification (ASC) Topic 606, Revenue From Contracts with Customers, in the first quarter of 2018 and b) a change in the method of accounting for leases due to the adoption of ASC Topic 842, Leases, in the first quarter of 2019.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.


/S/ DELOITTE & TOUCHE LLP
Deloitte & Touche LLP
Midland, Michigan
February 7, 2020

150



REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Stockholder and the Board of Directors of The Dow Chemical Company
Opinion on Internal Control over Financial Reporting
We have audited the internal control over financial reporting of The Dow Chemical Company and subsidiaries (the “Company”) as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by COSO.
We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2019, of the Company and the financial statement schedule listed in the Index at Item 15(a)2 and our report dated February 7, 2020, expressed an unqualified opinion on those financial statements and financial statement schedule and included an explanatory paragraph regarding a) a change in the method of accounting for revenue due to the adoption of Accounting Standards Codification (ASC) Topic 606, Revenue From Contracts with Customers, in the first quarter of 2018 and b) a change in the method of accounting for leases due to the adoption of ASC Topic 842, Leases, in the first quarter of 2019.
Basis for Opinion
The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.


/S/ DELOITTE & TOUCHE LLP
Deloitte & Touche LLP
Midland, Michigan
February 7, 2020


151



ITEM 9B. OTHER INFORMATION
None.



152



Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
PART III
ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Information relating to Directors, certain executive officers and certain corporate governance matters (including identification of Audit Committee members and financial expert(s)) is contained in the definitive Proxy Statement for the 2020 Annual Meeting of Stockholders of Dow Inc. and is incorporated herein by reference. See also the information regarding executive officers of the registrant set forth in Part I, Item 1. Business under the caption "Executive Officers of the Registrant" in reliance on General Instruction G to Form 10-K.

This information is omitted for The Dow Chemical Company pursuant to General Instruction I of Form 10-K.


ITEM 11. EXECUTIVE COMPENSATION
Information relating to executive compensation and the Company's equity compensation plans is contained in the definitive Proxy Statement for the 2020 Annual Meeting of Stockholders of Dow Inc. and is incorporated herein by reference.

This information is omitted for The Dow Chemical Company pursuant to General Instruction I of Form 10-K.


ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
Information with respect to beneficial ownership of Dow Inc. common stock by each Director and all Directors and executive officers of the Company as a group is contained in the definitive Proxy Statement for the 2020 Annual Meeting of Stockholders of Dow Inc. and is incorporated herein by reference.

Information relating to any person who beneficially owns in excess of 5 percent of the total outstanding shares of Dow Inc. common stock is contained in the definitive Proxy Statement for the 2020 Annual Meeting of the Stockholders of Dow Inc. and is incorporated herein by reference.

Information with respect to compensation plans under which equity securities are authorized for issuance is contained in the definitive Proxy Statement for the 2020 Annual Meeting of Stockholders of Dow Inc. and is incorporated herein by reference.

This information is omitted for The Dow Chemical Company pursuant to General Instruction I of Form 10-K.


ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
Reportable relationships and related transactions, if any, as well as information relating to director independence are contained in the definitive Proxy Statement for the 2020 Annual Meeting of Stockholders of Dow Inc. and are incorporated herein by reference.

This information is omitted for The Dow Chemical Company pursuant to General Instruction I of Form 10-K.


ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
Independent Registered Public Accountants
Information with respect to fees and services related to the Company's independent auditors, Deloitte & Touche LLP, and the disclosure of the Audit Committee's pre-approval policies and procedures are contained in the definitive Proxy Statement for the 2020 Annual Meeting of Stockholders of Dow Inc. and are incorporated herein by reference.


153


The Audit Committee of Dow Inc. carefully considers the qualifications and competence of candidates for the independent registered public accounting firm. In accordance with its pre-approval policies and procedures, the Audit Committee pre-approved all professional services rendered by and associated fees paid to Deloitte, for the Companies, for the years ended December 31, 2019 and 2018. Professional services were performed by Deloitte, its member firms of Deloitte Touche Tohmatsu Limited, and their respective affiliates (“Deloitte Entities”). Total fees paid to the Deloitte Entities are shown by category in the following table:

Type of Fees
 
 
In thousands
2019
2018
Audit Fees 1
$
25,142

$
26,199

Audit-Related Fees 2
4,438

6,976

Tax Fees 3
2,780

600

Total
$
32,360

$
33,775

1.
The aggregate fees billed for the integrated audit of the Company's annual financial statements and internal control over financial reporting, the reviews of the financial statements in quarterly reports on Form 10-Q, comfort letters, consents, statutory audits, and other regulatory filings. For 2019, the fees include $850,000 associated with supporting the DuPont de Nemours, Inc. SEC filings for the period prior to the separation from DowDuPont Inc.
2.
The aggregate fees billed primarily for audits of carve-out financial statements, assessment of controls relating to outsourced services, audits and reviews supporting divestiture activities, and agreed-upon procedures engagements.
3.
The aggregate fees billed primarily for corporate tax consulting services, the preparation of expatriate employees' tax returns and tax compliance services.

154


Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
PART IV

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

(a)
The following documents are filed as part of this report:

(1)
The Company’s 2019 Consolidated Financial Statements and the Report of Independent Registered Public Accounting Firm are included in Part II, Item 8. Financial Statements and Supplementary Data.

(2)
Financial Statement Schedules – The following Financial Statement Schedule should be read in conjunction with the Consolidated Financial Statements and Report of Independent Registered Public Accounting Firm included in Part II, Item 8. Financial Statements and Supplementary Data:
Schedule II
Valuation and Qualifying Accounts
Schedules other than the one listed above are omitted due to the absence of conditions under which they are required or because the information called for is included in the Consolidated Financial Statements or the Notes to the Consolidated Financial Statements.

(3)
The following exhibits are filed with or incorporated by reference into this Annual Report on Form 10-K:

Exhibit No.
Description of Exhibit

2.1

2.2

2.2.1

2.3

2.3.1

3.1

3.2

3.3

3.4

155


4.1

4.1.1

4.1.2

4.1.3

4.2

4.2.1

4.2.2

4.3*

4.4
Dow Inc. agrees to provide the SEC, on request, copies of all other such indentures and instruments that define the rights of holders of long-term debt of Dow Inc. and its consolidated subsidiaries, including The Dow Chemical Company, pursuant to Item 601(b)(4)(iii)(A) of Regulation S-K.

4.5*

10.1

10.2

10.3

10.4

10.5


156


10.5.1

10.5.2

10.5.3

10.5.4

10.5.5

10.5.6

10.6

10.6.1

10.7

10.8

10.9

10.10

10.11

21*

23.1.1*

23.1.2*

23.2*

31.1*

31.2*

157


32.1*

32.2*

99.1

101.INS
The instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH
Inline XBRL Taxonomy Extension Schema Document.

101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104
Cover Page Interactive Data File. The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

*Filed herewith

A copy of any exhibit can be obtained via the Internet through the Investor Relations section of the Company's website (www.dow.com/investors), or the Company will provide a copy of any exhibit upon receipt of a written request for the particular exhibit or exhibits desired. All requests should be addressed to the Controller and Vice President of Controllers and Tax of the Company at the address of the Company’s principal executive offices. The referenced website and its content are not deemed incorporated by reference into this report.


ITEM 16. FORM 10-K SUMMARY
Not applicable.



158


 
Dow Inc. and Subsidiaries
 
 
The Dow Chemical Company and Subsidiaries
 
 
Valuation and Qualifying Accounts
Schedule II

(In millions) For the years ended Dec 31,
2019
2018
2017
Accounts Receivable - Allowance for Doubtful Receivables
 
 
 
Balance at beginning of year
$
42

$
59

$
51

Additions charged to expenses 1
24

10

23

Additions charged to other accounts 2

4

2

Deductions from reserves 3
(21
)
(31
)
(17
)
Balance at end of year
$
45

$
42

$
59

Inventory - Obsolescence Reserve
 
 
 
Balance at beginning of year
$
23

$
18

$
34

Additions charged to expenses
19

7

5

Deductions from reserves 4
(7
)
(2
)
(21
)
Balance at end of year
$
35

$
23

$
18

Reserves for Other Investments and Noncurrent Receivables
 
 
 
Balance at beginning of year
$
460

$
430

$
350

Additions charged to expenses 1
1,758

44

83

Deductions from reserves
(3
)
(14
)
(3
)
Balance at end of year
$
2,215

$
460

$
430

Deferred Tax Assets - Valuation Allowance
 
 
 
Balance at beginning of year
$
1,225

$
1,255

$
936

Additions charged to expenses
140

152

369

Deductions from reserves
(103
)
(182
)
(50
)
Balance at end of year
$
1,262

$
1,225

$
1,255

1.
In 2019, additions charged to expenses for "Accounts Receivable - Allowance for Doubtful Receivables" included $2 million and additions charged to expenses for "Reserves for Other Investments and Noncurrent Receivables" included $1,753 million related to the Company's investment in Sadara Chemical Company. See Note 13 to the Consolidated Financial Statements for additional information.
2.
Additions to allowance for doubtful accounts charged to other accounts were classified as "Accounts and notes receivable - Other" in the consolidated balance sheets. These reserves relate to the Company's sale of trade accounts receivable. Anticipated credit losses in the portfolio of receivables sold were used to fair value the Company's interests held in trade accounts receivable conduits. See Notes 15 and 24 to the Consolidated Financial Statements for additional information.
3.
Deductions included write-offs, recoveries, currency translation adjustments and other miscellaneous items.
4.
Deductions included disposals and currency translation adjustments.



159


 
 
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
 
 
 
 
Signatures
 
 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

DOW INC.
THE DOW CHEMICAL COMPANY
 
/s/ RONALD C. EDMONDS
Ronald C. Edmonds, Controller and Vice President of Controllers and Tax
February 7, 2020

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
 
 
/s/ SAMUEL R. ALLEN
 
/s/ JEFF M. FETTIG
Samuel R. Allen, Director, Dow Inc.
 
Jeff M. Fettig, Non-Executive Chairman, Dow Inc.
February 7, 2020
 
February 7, 2020
 
 
 
/s/ AJAY BANGA
 
/s/ JIM FITTERLING
Ajay Banga, Director, Dow Inc.
 
Jim Fitterling, Director and Chief Executive Officer, Dow Inc. and TDCC
February 7, 2020
 
February 7, 2020
 
 
 
/s/ JACQUELINE K. BARTON
 
/s/ JACQUELINE C. HINMAN
Jacqueline K. Barton, Director, Dow Inc.
 
Jacqueline C. Hinman, Director, Dow Inc.
February 7, 2020
 
February 7, 2020
 
 
 
/s/ JAMES A. BELL
 
/s/ RUTH G. SHAW
James A. Bell, Director, Dow Inc.
 
Ruth G. Shaw, Director, Dow Inc.
February 7, 2020
 
February 7, 2020
 
 
 
/s/ WESLEY G. BUSH
 
/s/ HOWARD UNGERLEIDER
Wesley G. Bush, Director, Dow Inc.
 
Howard Ungerleider, President and Chief Financial Officer, Dow Inc. and TDCC; Director, TDCC
February 7, 2020
 
February 7, 2020
 
 
 
/s/ RICHARD K. DAVIS
 
/s/ DANIEL W. YOHANNES
Richard K. Davis, Director, Dow Inc.
 
Daniel W. Yohannes, Director, Dow Inc.
February 7, 2020
 
February 7, 2020
 
 
 
/s/ RONALD C. EDMONDS
 
 
Ronald C. Edmonds, Controller and Vice President of Controllers and Tax
 
 
February 7, 2020
 
 

160


Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
Trademark Listing

The following trademarks or service marks of The Dow Chemical Company and certain affiliated companies of Dow appear in this report: ACOUSTICRYL, ACRYSOL, AFFINITY, AQUASET, AVANSE, CARBOWAX, DOW, DOWSIL, ECOFAST, ELITE, ENGAGE, EVOLV3D, EVOQUE, FORMASHIELD, IMAGIN3D, MAINCOTE, NORDEL, OPULUX, PRIMAL, RENUVA, RHOPLEX, SENTRY, SILASTIC, SYL-OFF, TAMOL, TERGITOL, TRITON, UCAR, UCARTHERM, UCON, VERSENE, VORARAD, WALOCEL

The following registered trademark of Disability:IN appears in this report: Disability Equality Index®

The following registered trademark of Incapital Holdings appears in this report: InterNotes®

The following registered service mark of American Chemistry Council in the United States appears in this report:
Responsible Care®

The following trademarks of E.I. du Pont de Nemours and Company or an affiliated company of DuPont appear in this report: GREAT STUFF, SMART DISPENSER






































® ™ Trademark of The Dow Chemical Company ("TDCC") or an affiliated company, except as otherwise specified.

161


 
 
 
 
EXHIBIT 4.3







THE DOW CHEMICAL COMPANY
as Issuer,
The Bank of New York Mellon Trust Company, N.A.,
as Trustee
AND
DOW INC.
as party to the sections described herein



INDENTURE
Dated as of July 26, 2019




162



CROSS REFERENCE SHEET/*/
Provisions of Trust Indenture Act of 1939, and Indenture dated as of July 26, 2019, among THE DOW CHEMICAL COMPANY, as Issuer, THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee, and DOW INC., as party to the sections described herein:

Section of the Act
 
Section of Indenture
310(a)
 
6.9 and 11.7
310(b)
 
6.8 and 6.10
311(a)
 
6.13
311(b)
 
6.13
312(a)
 
4.1 and 4.2(a)
312(b)
 
4.2(a) and (b)
312(c)
 
4.2(c)
313(a)
 
4.4(a)
313(b)(1)
 
Inapplicable
313(b)(2)
 
4.4
313(c)
 
4.4
313(d)
 
4.4
314(a)
 
4.3
314(b)
 
Inapplicable
314(c)(1) and (2)
 
11.5
314(c)(3)
 
Inapplicable
314(d)
 
Inapplicable
314(e)
 
11.5
314(f)
 
Inapplicable
315(a), (c) and (d)
 
6.1
315(b)
 
5.11
315(e)
 
5.12
316(a)(1)
 
5.9 and 5.10
316(a)(2)
 
Inapplicable
316(a) (last sentence)
 
7.4
316(b)
 
5.7
316(c)
 
7.6
317(a)
 
5.2
317(b)
 
3.4(a) and (b)
318(a)
 
11.7
 
 
 

*    This Cross Reference Sheet is not part of the Indenture.


163



TABLE OF CONTENTS
 
 
 
Page

ARTICLE ONE DEFINITIONS
1

 
Section 1.1
Certain Terms Defined
1

ARTICLE TWO SECURITIES
7

 
Section 2.1
Forms Generally
7

 
Section 2.2
Form of Trustee’s Certificate of Authentication
7

 
Section 2.3
Amount Unlimited; Issuable in Series
8

 
Section 2.4
Authentication and Delivery of Securities
10

 
Section 2.5
Execution of Securities
12

 
Section 2.6
Certificate of Authentication
12

 
Section 2.7
Denomination and Date of Securities; Payments of Interest
12

 
Section 2.8
Registration, Transfer and Exchange
14

 
Section 2.9
Mutilated, Defaced, Destroyed, Lost and Stolen Securities
17

 
Section 2.10
Cancellation of Securities, Destruction Thereof
18

 
Section 2.11
Temporary Securities
18

 
Section 2.12
Compliance with Certain Laws and Regulations
18

 
Section 2.13
Appointment of Agents With Respect to Certain Calculations
20

 
Section 2.14
CUSIP Numbers
20

ARTICLE THREE
21

A. COVENANTS OF THE ISSUER
21

 
Section 3.1
Payment of Principal and Interest
21

 
Section 3.2
Offices for Payment, etc.
21

 
Section 3.3
Appointment to Fill a Vacancy in Office of Trustee
22

 
Section 3.4
Paying Agents
22

    
        
i

164



 
Section 3.5
[Reserved]
23

 
Section 3.6
Limitation on Liens
23

 
Section 3.7
Limitation on Sale and Lease-Back Transactions
25

 
Section 3.8
Additional Amounts
26

B. GUARANTEE COVENANT OF DOW INC.
26

ARTICLE FOUR SECURITYHOLDERS’ LISTS AND REPORTS BY THE ISSUER AND THE TRUSTEE
27

 
Section 4.1
Company to Furnish Trustee Information as to Names and Addresses of Securityholders
27

 
Section 4.2
Preservation and Disclosure of Securityholders’ Lists
27

 
Section 4.3
Reports by the Company
28

 
Section 4.4
Reports by the Trustee
29

ARTICLE FIVE REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS ON EVENT OF DEFAULT
30

 
Section 5.1
Event of Default Defined; Acceleration of Maturity; Waiver of Default
30

 
Section 5.2
Collection of Indebtedness by Trustee; Trustee May Prove Debt
32

 
Section 5.3
Application of Proceeds
34

 
Section 5.4
Suits for Enforcement
35

 
Section 5.5
Restoration of Rights on Abandonment of Proceedings
35

 
Section 5.6
Limitations on Suits by Securityholders
35

 
Section 5.7
Unconditional Right of Securityholders to Institute Certain Suits
36

 
Section 5.8
Powers and Remedies Cumulative; Delay or Omission Not Waiver of Default
36

 
Section 5.9
Control by Securityholders
36

 
Section 5.10
Waiver of Past Defaults
37

 
Section 5.11
Trustee to Give Notice of Default, But May Withhold in Certain Circumstances
37

        
        
        
        

ii

165



 
Section 5.12
Right of Court to Require Filing of Undertaking to Pay Costs
37

ARTICLE SIX CONCERNING THE TRUSTEE
38

 
Section 6.1
Duties and Responsibilities of the Trustee; Prior to Default; During Default
38

 
Section 6.2
Certain Rights of the Trustee
39

 
Section 6.3
Trustee Not Responsible for Recitals, Disposition of Securities or Application of Proceeds Thereof
40

 
Section 6.4
Trustee and Agents May Hold Securities; Collections, etc.
41

 
Section 6.5
Moneys Held by Trustee
41

 
Section 6.6
Compensation and Indemnification of Trustee and Its Prior Claim
41

 
Section 6.7
Right of Trustee to Rely on Officer’s Certificate, etc.
42

 
Section 6.8
Disqualification of Trustee; Conflicting Interests
42

 
Section 6.9
Persons Eligible for Appointment as Trustee
42

 
Section 6.10
Resignation and Removal; Appointment of Successor Trustee
42

 
Section 6.11
Acceptance of Appointment by Successor Trustee
44

 
Section 6.12
Merger, Conversion, Consolidation or Succession to Business of Trustee
45

 
Section 6.13
Preferential Collection of Claims Against the Company
45

 
Section 6.14
Appointment of Authenticating Agent
45

ARTICLE SEVEN CONCERNING THE SECURITYHOLDERS
46

 
Section 7.1
Evidence of Action Taken by Securityholders
46

 
Section 7.2
Proof of Execution of Instruments
47

 
Section 7.3
Holders to Be Treated as Owners
47

 
Section 7.4
Securities Owned by Company Deemed Not Outstanding
47

 
Section 7.5
Right of Revocation of Action Taken
48

 
Section 7.6
Record Date for Determination of Holders Entitled to Vote
48

        
    


iii

166



ARTICLE EIGHT SUPPLEMENTAL INDENTURES
48

 
Section 8.1
Supplemental Indentures Without Consent of Securityholders
48

 
Section 8.2
Supplemental Indentures With Consent of Securityholders
50

 
Section 8.3
Effect of Supplemental Indenture
51

 
Section 8.4
Documents to Be Given to Trustee
51

 
Section 8.5
Notation on Securities in Respect of Supplemental Indentures
51

ARTICLE NINE CONSOLIDATION, MERGER, SALE OR CONVEYANCE
51

 
Section 9.1
Company May Consolidate, etc., on Certain Terms
51

 
Section 9.2
Successor Corporation Substituted
51

 
Section 9.3
Opinion of Counsel to Trustee
52

ARTICLE TEN SATISFACTION AND DISCHARGE OF INDENTURE; UNCLAIMED MONEYS
52

 
Section 10.1
Satisfaction and Discharge of Indenture
52

 
Section 10.2
Application by Trustee of Funds Deposited for Payment of Securities
54

 
Section 10.3
Repayment of Moneys Held by Paying Agent
55

 
Section 10.4
Return of Unclaimed Moneys Held by Trustee and Paying Agent
55

 
Section 10.5
Reinstatement of Company’s Obligations
55

ARTICLE ELEVEN MISCELLANEOUS PROVISIONS
55

 
Section 11.1
Incorporators, Stockholders, Officers and Directors of Company Exempt from Individual Liability
55

 
Section 11.2
Provisions of Indenture for the Sole Benefit of Parties and Securityholders
56

 
Section 11.3
Successors and Assigns of Company Bound by Indenture
56

 
Section 11.4
Notices and Demands on Company, Trustee and Securityholders
56

 
Section 11.5
Officer’s Certificates and Opinions of Counsel; Statements to Be Contained Therein
57






iv

167



 
Section 11.6
Payments Due on Saturdays, Sundays and Holidays
58

 
Section 11.7
Conflict of Any Provision of Indenture with Trust Indenture Act
58

 
Section 11.8
New York Law to Govern; Waiver of Jury Trial
58

 
Section 11.9
Counterparts
58

 
Section 11.10
Effect of Headings
58

 
Section 11.11
Determination of Principal Amount; Calculation of Original Issue Discount
58

 
Section 11.12
Force Majeure
59

ARTICLE TWELVE REDEMPTION OF SECURITIES AND SINKING FUNDS
59

 
Section 12.1
Applicability of Article
59

 
Section 12.2
Notice of Redemption; Partial Redemptions
59

 
Section 12.3
Payment of Securities Called for Redemption
60

 
Section 12.4
Exclusion of Certain Securities from Eligibility for Selection for Redemption
61

 
Section 12.5
Mandatory and Optional Sinking Funds
61


        
        
        
        









v

168



THIS INDENTURE, dated as of July 26, 2019, among THE DOW CHEMICAL COMPANY, a Delaware corporation (the “Company” or the “Issuer”), DOW INC., a Delaware corporation (“Dow”), as a party to this Indenture with respect to the sections described herein, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a national banking association, as trustee (the “Trustee”).
W I T N E S S E T H:
WHEREAS, the Company has duly authorized the issue from time to time of its unsecured debentures, notes or other evidences of indebtedness to be issued in one or more Series (the “Securities”) up to such principal amount or amounts as may from time to time be authorized in accordance with the terms of this Indenture and to provide, among other things, for the authentication, delivery and administration thereof, the Company has duly authorized the execution and delivery of this Indenture;
WHEREAS Dow has entered into this Indenture solely in connection with its obligation to issue a guarantee of Securities outstanding under the Indenture from time to time in accordance with Article 3.B hereof; and
WHEREAS, all things necessary to make this Indenture a valid and legally binding indenture and agreement according to its terms have been done;
NOW, THEREFORE:
In consideration of the premises and the purchases of the Securities by the holders thereof, the Company and the Trustee mutually covenant and agree for the equal and proportionate benefit of the respective holders from time to time of the Securities as follows:

ARTICLE ONE

DEFINITIONS

Section 1.1Certain Terms Defined. The following terms (except as otherwise expressly provided or unless the context otherwise clearly requires) for all purposes of this Indenture and of any indenture supplemental hereto shall have the respective meanings specified in this Section. All other terms used in this Indenture that are defined in the Trust Indenture Act or the definitions of which in the Securities Act are referred to in the Trust Indenture Act, including terms defined therein by reference to the Securities Act (except as herein otherwise expressly provided or unless the context otherwise clearly requires), shall have the meanings assigned to such terms in said Trust Indenture Act and in said Securities Act as in force at the date of this Indenture. All accounting terms used herein and not expressly defined shall have the meanings assigned to such terms in accordance with generally accepted accounting principles, and the term “generally accepted accounting principles” means such accounting principles as are generally accepted at the time of any computation. The words “herein,” “hereof” and “hereunder” and other words of similar import refer to this Indenture as a whole, as supplemented and amended from time to time, and not to any particular Article, Section or other subdivision. The terms defined in this Article have the meanings assigned to them in this Article and include the plural as well as the singular.




1

169



Authenticating Agent” means any Person authorized by the Trustee pursuant to Section 6.14 to act on behalf of the Trustee to authenticate Securities of one or more Series.
Board of Directors” means either the Board of Directors of the Company or any duly authorized committee thereof.
Board Resolution” means a copy of a resolution certified by the Secretary or an Assistant Secretary of the Company to have been duly adopted by the Board of Directors of the Company and to be in full force and effect on the date of such certification, and delivered to the Trustee.
Business Day” means, except as may otherwise be provided in the form of Securities of any particular Series, with respect to any Place of Payment, any day, other than a Saturday or Sunday, that is not a legal holiday, or a day on which banking institutions are authorized or required by law or regulation to close in The City of New York, Chicago or in that Place of Payment, or with respect to Securities denominated in a Foreign Currency, the capital city of the country of such Foreign Currency, or with respect to Securities denominated in euros, Brussels, Belgium.
Clearstream” means Clearstream Banking, société anonyme.
Commission” means the Securities and Exchange Commission, as from time to time constituted, created under the Exchange Act, or if at any time after the execution and delivery of this Indenture such Commission is not existing and performing the duties now assigned to it under the Trust Indenture Act, then the body performing such duties on such date.
Common Depositary” has the meaning specified in Section 2.11.
Company” means The Dow Chemical Company, a Delaware corporation, and, subject to Article Nine, its successors and assigns.
Company Order” or “Company Request” means a written order or request of the Company, signed in its name by its President, Chief Financial Officer or Treasurer and delivered to the Trustee.
Consolidated Net Tangible Assets” means the total assets of the Company and its Consolidated Subsidiaries as shown on or reflected in its balance sheet less (a) all current liabilities (excluding current liabilities which could be classified as long-term debt in conformity with generally accepted accounting principles and current liabilities which are by their terms extendible or renewable at the option of the obligor thereon to a time more than 12 months after the time as of which the amount thereof is being computed), (b) advances to entities accounted for on the equity method of accounting, and (c) intangible assets. “Intangible assets” means the aggregate value (net of any applicable reserves), as shown on or reflected in such balance sheet, of: (i) all trade names, trademarks, licenses, patents, copyrights and goodwill; (ii) organizational and development costs; (iii) deferred charges (other than prepaid items such as insurance, taxes, interest, commissions, rents and similar items and tangible assets being amortized); and (iv) unamortized debt discount and expense, less unamortized premium.



2

170



Consolidated Subsidiary” means, at any date, any Subsidiary or other entity the accounts of which would be consolidated with those of the Company in its consolidated financial statements if such statements were prepared as of such date.
Corporate Trust Office” means the principal office of the Trustee at which at any time its corporate trust business shall be administered, which office at the date hereof is located at 2 North LaSalle Street, Suite 700, Chicago, Illinois 60602, Attention: Corporate Trust Administration, or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or the principal corporate trust office of any successor Trustee (or such other address as such successor Trustee may designate from time to time by notice to the Holders and the Company).
Coupon” means any interest coupon appertaining to any Security.
Coupon Security” means any Security authenticated and delivered with one or more Coupons appertaining thereto.
Dollar” means the coin or currency of the United States which as of the time of payment is legal tender for the payment of public and private debts.
Euro” means the lawful currency of the member states of the European Economic and Monetary Union, pursuant to the Treaty establishing the European Community, as amended by the Treaty on European Union.
Euroclear” means Euroclear Bank S.A./N.V., as operator of the Euroclear System.
Event of Default” means any event or condition specified as such in Section 5.1.
Exchange Act” means the Securities Exchange Act of 1933, as amended.
Exempted Indebtedness” means the sum of (i) all outstanding indebtedness of the Company and its Restricted Subsidiaries incurred after the date of this Indenture and secured by liens proscribed in paragraph (a) of Section 3.6, and (ii) the aggregate of present values (discounted at a rate per annum equal to the average interest borne by all Outstanding Securities determined on a weighted average basis and compounded semi-annually) of the obligations of the Company or any Restricted Subsidiaries for rental payments during the remaining term of all leases (including any period for which any such lease has been extended or may, at the option of the lessor, be extended) of all Principal Property other than those leases expressly permitted by paragraph (a) of Section 3.7. The net amount of rent required to be paid under any such lease for any such term shall be the amount of the rent payable by the lessee with respect to such period, after excluding amounts required to be paid on account of maintenance and repairs, insurance, taxes, assessments, water rates and similar charges and contingent rents such as those based on sales. In the case of any such lease which is terminable by the lessee upon the payment of a penalty, such net amount shall also include the amount of such penalty, but no rent shall be considered as required to be paid under such lease subsequent to the first date upon which it may be so terminated.



3

171



Foreign Currency” means a currency issued by the government of any country other than the United States reasonably acceptable to the Trustee.
Guarantee” has the meaning specified in Article 3.B.
Holder,” “Holder of Securities,” “Securityholder” or other similar terms mean the holder of an Unregistered Security or a Registered Holder of a Registered Security and, when used with respect to any Coupon, means the holder thereof.
Indenture” means this instrument as originally executed and delivered or, if amended or supplemented as herein provided, as so amended or supplemented or both, and shall include the forms and terms of particular Series of Securities established as contemplated hereunder.
Internal Revenue Code” has the meaning specified in Section 3.6.
Officer’s Certificate” means a certificate signed by the President, Chief Financial Officer or Treasurer of the Company and delivered to the Trustee. Each such certificate shall include the statements provided for in Section 11.5.
Opinion of Counsel” means an opinion in writing signed by legal counsel who may be an employee of or counsel to the Company. Each such opinion shall include the statements provided for in Section 11.5.
Original Issue Date” of any Security (or portion thereof) means the earlier of (a) the date of such Security or (b) the date of any Security (or portion thereof) for which such Security was issued (directly or indirectly) on registration of transfer, exchange or substitution.
Original Issue Discount Security” means any Security which provides for an amount less than the stated principal amount thereof to be due and payable upon declaration of acceleration of the maturity thereof pursuant to Section 5.1.
Outstanding” (except as otherwise provided in Section 6.8), when used with reference to Securities, shall, subject to the provisions of Section 7.4, mean, as of any particular time, all Securities authenticated and delivered by the Trustee under this Indenture, except
(a)
Securities theretofore cancelled by the Trustee or delivered to the Trustee for cancellation;
(b)
Securities, or portions thereof, for the payment or redemption of which moneys in the necessary amount shall have been deposited in trust with the Trustee or with any paying agent (other than the Company) or shall have been set aside, segregated and held in trust by the Company for the holders of such Securities (if the Company shall act as its own paying agent), provided that if such Securities, or portions thereof, are to be redeemed prior to the maturity thereof, notice of such redemption shall have been given as herein provided, or provision satisfactory to the Trustee shall have been made for giving such notice; and


4

172



(c)
Securities in substitution for which other Securities shall have been authenticated and delivered, or which shall have been paid, pursuant to the terms of Section 2.9 (except with respect to any such Security as to which proof satisfactory to the Trustee is presented that such Security is held by a person in whose hands such Security is a legal, valid and binding obligation of the Company).
Paying Agent” means any Person (which may include the Company) authorized by the Company to pay the principal of or interest, if any, on any Security on behalf of the Company.
Periodic Offering” means an offering of Securities of a Series from time to time, the specific terms of which Securities, including, without limitation, the rate or rates of interest, if any, thereon, the stated maturity or maturities thereof and the redemption provisions, if any, with respect thereto, are to be determined by the Company or its agents upon the issuance of such Securities.

Person” means any individual, corporation, partnership, limited liability company, joint venture, association, joint stock company, trust, unincorporated organization or government or any agency or political subdivision thereof.
Place of Payment” when used with respect to the Securities of any Series, means the place or places where the principal of and interest, if any, on the Securities of that Series are payable as specified pursuant to Section 3.2.
principal” whenever used with reference to the Securities or any Security or any portion thereof, shall be deemed to include “and premium, if any.”
Principal Property” means any manufacturing facility owned by the Company or any Restricted Subsidiary and located within the United States (excluding its territories and possessions and the Commonwealth of Puerto Rico) the gross book value (without deduction of any depreciation reserves) of which on the date as of which the determination is being made exceeds one percent of Consolidated Net Tangible Assets, other than any such facility or portion thereof which the Board of Directors reasonably determines is not material to the business conducted by the Company and its Subsidiaries as a whole.
Registered Holder” when used with respect to a Registered Security means the person in whose name such Security is registered in the Security register.
Registered Security” means any Security registered in the Security register.
Responsible Officer” when used with respect to the Trustee shall mean any officer in the corporate trust department (or any successor group) of the Trustee including any vice president, assistant vice president, assistant secretary, assistant treasurer, trust officer or any other officer of the Trustee customarily performing functions similar to those performed by the persons who at the time shall be such officers, respectively, or to whom any corporate trust matter is referred at the Corporate Trust Office because of his or her knowledge of and familiarity with the particular subject and who shall have direct responsibility for the administration of the Indenture.


5

173



Restricted Subsidiary” means any Subsidiary: (i) substantially all of the property of which is located, and substantially all of the business of which is carried on, within the United States (excluding its territories and possessions and the Commonwealth of Puerto Rico); and (ii) which owns or operates one or more Principal Properties; provided, however, that Restricted Subsidiary shall not include a Subsidiary which is primarily engaged in the business of a finance or insurance company and branches thereof.
Revolving Credit Facility Agreement” means that certain $5,000,000,000 Five-Year Competitive Advance and Revolving Credit Facility Agreement, dated as of October 30, 2018, among the Company, the banks from time to time party thereto and Citibank, N.A., as administrative agent, as amended, modified, restated, renewed, refunded, replaced or refinanced from time to time, including any agreement extending the maturity of, refinancing, replacing or otherwise restructuring all of or substantially all of the indebtedness under such agreement or any such successor or replacement agreement and whether by the same or any other agent, lender or group of lenders (or other institutions).
Securities Act” means the Securities Act of 1933, as amended.
Security” or “Securities” (except as otherwise provided in Section 6.8) has the meaning stated in the first recital of this Indenture, or, as the case may be, Securities that have been authenticated and delivered under this Indenture.
Series” or “Series of Securities” means a series of Securities.
Specified Amount” has the meaning specified in Section 2.12.
Subsidiary” means any corporation, of which at least a majority of the Voting Stock is at the time owned directly or indirectly by the Company or by the Company and its other Subsidiaries. The term “Voting Stock” means outstanding shares of stock having voting power for the election of directors, whether at all times or only so long as no senior class of stock has such voting power because of default in dividends or some other default.
tranche” has the meaning specified in Section 2.3.
Trustee” means the Person identified as “Trustee” in the first paragraph hereof and, subject to the provisions of Article Six, any successor trustee.
Trust Indenture Act of 1939” or “Trust Indenture Act” (except as otherwise provided in Sections 8.1 and 8.2) means the Trust Indenture Act of 1939 as in force at the date as of which this Indenture was originally executed.
United States” means the United States of America (including the States and the District of Columbia), its territories, its possessions and other areas subject to its jurisdiction.
United States Alien” means any Person who, for United States Federal income tax purposes, is a foreign corporation, a non-resident alien individual, a non-resident alien fiduciary of a foreign estate or trust, or a foreign partnership one or more of the members of which is, for


6

174



United States Federal income tax purposes, a foreign corporation, a non-resident alien individual or a non-resident alien fiduciary of a foreign estate or trust.
Unregistered Security” means any Security not registered as to principal.
vice president” when used with respect to the Company or the Trustee, means any vice president, whether or not designated by a number or a word or words added before or after the title of “vice president.”
Yield to Maturity” means the yield to maturity on a series of Securities, calculated at the time of issuance of such series, or, if applicable, at the most recent redetermination of interest on such Series, and calculated by the Company in accordance with accepted financial practice.

ARTICLE TWO

SECURITIES

Section 2.1Forms Generally. The Securities of each Series (including any temporary or permanent global Securities) and the Coupons, if any, shall be substantially in such form (not inconsistent with this Indenture) as shall be established by or pursuant to a Board Resolution (or, to the extent established pursuant to, rather than set forth in, such Board Resolution, in an Officer’s Certificate) or in one or more indentures supplemental hereto, in each case with such appropriate insertions, omissions, substitutions and other variations as are required or permitted by this Indenture (the provisions of which shall be appropriate to reflect the terms of each Series of Securities, including the currency or denomination, which may be Dollars, Foreign Currency or ECU) and may have imprinted or otherwise reproduced thereon such legend or legends, not inconsistent with the provisions of this Indenture, as may be required to comply with any law or with any rules or regulations pursuant thereto, or with any rules of any securities exchange or to conform to general usage, all as may be determined by the officers executing such Securities and Coupons, if any, as evidenced by their execution of the Securities and Coupons, if any. The definitive Securities and Coupons, if any, shall be printed, lithographed or may be produced in any other manner, all as determined by the officers executing such Securities and Coupons, if any, as evidenced by their execution of such Securities and Coupons, if any.

Section 2.2Form of Trustee’s Certificate of Authentication. The Trustee’s certificate of authentication on all Securities shall be in substantially the following form:
This is one of the Securities of the Series designated herein and referred to in the within-mentioned Indenture.
The Bank of New York Mellon Trust Company, N.A.,
 
as Trustee
 
 
By:
 
 
Authorized Signatory
Dated:
 


7

175



Section 2.3Amount Unlimited; Issuable in Series. The aggregate principal amount of Securities which may be authenticated and delivered under this Indenture is unlimited.

The Securities may be issued in one or more Series. There shall be established in or pursuant to a Board Resolution, or to the extent established pursuant to, rather than set forth in, such resolution, established in an Officer’s Certificate, or established in one or more indentures supplemental hereto, prior to the issuance of Securities of any Series,
(1)
the title of the Securities of the Series (which title shall distinguish the Securities of the Series from all other Securities issued by the Company) and whether such Securities are senior or subordinated;
(2)
any limit upon the aggregate principal amount of the Securities of the Series that may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of the Series pursuant to Sections 2.8, 2.9, 2.11 or 12.3);
(3)
whether Securities of the Series are to be issuable as Registered Securities, Unregistered Securities or both, whether any Securities of the Series are to be issuable initially in temporary global form and whether any Securities of the Series are to be issuable in permanent global form with or without Coupons and, if so, (i) whether beneficial owners of interest in any such permanent global Security may exchange such interest for Securities of such Series and of like tenor of any authorized form and denomination and the circumstances under which any such exchanges may occur, if other than in the manner provided in Section 2.8 and (ii) the name of the depositary with respect to any global Security; if Securities are to be issuable as Unregistered Securities, the form of any required certifications
(4)
the Person to whom any interest in any Registered Security of the Series shall be payable, if other than the Person in whose name the Security (or one or more predecessor Securities) is registered at the close of business on the record date for such interest, the manner in which, or the Person to whom, any interest on any Unregistered Security of the Series shall be payable, if otherwise than upon presentation and surrender of the Coupons appertaining thereto as they severally mature, and the extent to which, or the manner in which, any interest payable on a temporary global Security on an interest payment date will be paid if other than in the manner provided in Section 2.11;
(5)
the date or dates on which the principal of the Securities of the Series is payable;
(6)
the rate or rates (or formula for determining such rates) at which the Securities of the Series shall bear interest, if any, the date or dates from which such interest shall accrue, the interest payment dates on which such interest shall be payable and the record dates for the determination of Holders to whom interest is payable; and the circumstances, if any, in which the Company may defer interest payments;





8

176



(7)
whether the interest rate or interest rate formula, as the case may be, for Securities of the Series may be reset at the option of the Company and, if so, the date or dates on which such interest rate or interest rate formula, as the case may be, may be reset;
(8)
the place or places where the principal and interest on Securities of the Series shall be payable (if other than as provided in Section 3.2), any Registered Securities of the Series may be surrendered for registration of transfer, Securities of the Series may be surrendered for exchange and notices and demands to or upon the Company in respect of the Securities of the Series and this Indenture may be served;
(9)
the price or prices at which, the period or periods within which and the terms and conditions upon which Securities of the Series may be redeemed or repurchased, in whole or in part, at the option of the Company or repaid at the option of the Holders;
(10)
the obligation, if any, of the Company to redeem, purchase or repay Securities of the Series pursuant to any sinking fund or analogous provisions or at the option of a Holder thereof and the price or prices at which and the period or periods within which and the terms and conditions upon which Securities of the Series shall be redeemed, purchased or repaid, in whole or in part, pursuant to such obligation;
(11)
the denominations in which any Registered Securities of the Series may be issued, if other than denominations of $1,000 and any integral multiple thereof, and the denomination or denominations in which any Unregistered Securities of the Series may be issued, if other than the denomination of $5,000;
(12)
the form of the Securities (or forms thereof if Unregistered and Registered Securities shall be issuable in such Series), including such legends as required by law or as the Company deems necessary or appropriate, the form of any Coupons or Temporary Global Security which may be issued and the forms of any certificates which may be required hereunder or which the Company may require in connection with the offering, sale, delivery or exchange of Unregistered Securities;
(13)
the currency or currencies, including composite currencies, in which payments of interest or principal are payable with respect to the Securities of the Series if other than the currency of the United States of America;
(14)
if the amount of payments of principal of or interest on the Securities of any Series may be determined with reference to the differences in the price of or rate of exchange between any indexes, currencies or commodities, the manner in which such amounts shall be determined;
(15)
if other than the principal amount thereof, the portion of the principal amount of Securities of the Series which thereof pursuant to Section 5.1 or provable in bankruptcy pursuant to Section 5.2;
(16)
any additional Events of Default or restrictive covenants with respect to the Securities of such Series which are not set forth herein;



9

177



(17)
whether Securities of the Series are issuable in tranches;
(18)
any other terms or conditions upon which the Securities of the Series are to be issued (which terms shall not be inconsistent with the provisions of this Indenture); and
(19)
any trustees, authenticating or paying agents, transfer agents or registrars or any other agents with respect to the Securities of such Series.
All Securities of any one Series shall be substantially identical except as to denomination, except in the case of a Periodic Offering, and except as may otherwise be provided in or pursuant to such Board Resolution or in any such indenture supplemental hereto. All Securities of any one Series need not be issued at the same time, and unless otherwise provided, a Series may be reopened for issuances of additional Securities of such Series.
A Series of Securities may include one or more tranches (each a “tranche”) of Securities, including Securities issued in a Periodic Offering. The Securities of different tranches may have one or more different terms, including authentication dates and public offering prices, but all the Securities within each such tranche shall have identical terms, including authentication date and public offering price. Notwithstanding any other provision of this Indenture, with respect to Sections 2.3, 2.7, 2.9, 2.11, 2.14, 8.2, 10.1 through 10.5, 11.6 and 12.1 through 12.5, if any Series of Securities includes more than one tranche, all provisions of such sections applicable to any Series of Securities shall be deemed equally applicable to each tranche of any Series of Securities in the same manner as though originally designated a Series unless otherwise provided with respect to such Series or tranche pursuant to this Section 2.3. In particular, and without limiting the scope of the next preceding sentence, any of the provisions of such sections which provide for or permit action to be taken with respect to a Series of Securities shall also be deemed to provide for and permit such action to be taken instead only with respect to Securities of one or more tranches within that Series (and such provisions shall be deemed satisfied thereby), even if no comparable action is taken with respect to Securities in the remaining tranches of that Series.

Section 2.4Authentication and Delivery of Securities. At any time and from time to time after the execution and delivery of this Indenture, the Company may deliver Securities of any Series having attached thereto appropriate Coupons, if any, executed by the Company to the Trustee for authentication, together with an Company Order for the authentication and delivery of such Securities, and the Trustee in accordance with the Company Order shall authenticate and deliver such Securities; provided, however, that in connection with its original issuance, no Unregistered Security shall be mailed or otherwise delivered to any location in the United States; and provided, further, that an Unregistered Security may be delivered in connection with its original issuance only if the Person entitled to receive such Unregistered Security shall have furnished a certificate in the form designated by the Company pursuant to Section 2.3 dated no earlier than 15 days prior to the earlier of the date on which such Unregistered Security is delivered and the date on which any temporary Security first becomes exchangeable for such Unregistered Security in accordance with the terms of such temporary Security and this Indenture. If any Security shall be represented by a permanent global Unregistered Security, then, for purposes of this Section and Section 2.11, the notation of a beneficial owner’s interest therein upon original issuance of such Security or upon exchange of a portion of a temporary global Security shall be





10

178



deemed to be delivered in connection with its original issuance of such beneficial owner’s interest in such permanent global Unregistered Security. In authenticating such Securities and accepting the additional responsibilities under this Indenture in relation to such Securities, the Trustee shall be provided with and (subject to Section 6.1) shall be fully protected in relying upon:

(1)
an Company Order requesting such authentication and setting forth delivery instructions if the Securities are not to be delivered to the Company;
(2)
any Board Resolution, Officer’s Certificate and/or supplemental indenture referred to in Sections 2.1 and 2.3 by or pursuant to which the forms of the Securities of any such Series were established;
(3)
an Officer’s Certificate setting forth the form and terms of the Securities stating that the form and terms of the Securities have been, or, in the case of a Periodic Offering, will be when established in accordance with such procedures as shall be referred to therein, established pursuant to Section 2.1 and 2.3 and comply with this Indenture, and covering such other matters as the Trustee may reasonably request;
(4)
an Opinion of Counsel to the effect that:
(a)
the form or forms and terms of such Securities have been, or, in the case of a Periodic Offering, will be when established in accordance with such procedures as shall be referred to therein, established pursuant to Sections 2.1 and 2.3 and comply with this Indenture;
(b)
the authentication and delivery of such Securities by the Trustee are authorized under the provisions of this Indenture;
(c)
such Securities, when authenticated and delivered by the Trustee and issued by the Company in the manner and subject to any conditions specified in such Opinion of Counsel, will constitute valid and binding obligations of the Company;
(d)
all laws and requirements in respect of the execution and delivery by the Company have been complied with; and
(e)
covering such other matters as the Trustee may reasonably request.

If all the Securities of any Series are not to be issued at one time, it shall not be necessary to deliver an Opinion of Counsel and an Officer’s Certificate at the time of issuance of each Security, but such opinion and certificate, with appropriate modifications, shall be delivered at or before the time of issuance of the first Security of such series. After any such first delivery, any separate written request by an Officer of the Company or any person designated in writing by an Officer that the Trustee authenticate and deliver Securities of such series for original issue will be deemed to be a certification by the Company that all conditions precedent provided for in this Indenture relating to authentication and delivery of such Securities continue to have been complied with and that no Event of Default with respect to any of the Securities has occurred or is continuing.



11

179



The Trustee shall have the right to decline to authenticate and deliver any Securities under this Section if the Trustee, being advised by counsel, determines that such action may not lawfully be taken by the Company or if the issue of such Securities pursuant to this Indenture will affect the Trustee’s own rights, duties or immunities under this Indenture in a manner not reasonably acceptable to the Trustee.
Section 2.5Execution of Securities. The Securities shall be signed on behalf of the Company by the Chairman of its Board of Directors or its president or any vice president or its treasurer or any assistant treasurer. Such signatures may be the manual or facsimile signatures of the present or any future such officers. Typographical and other minor errors or defects in any such reproduction of any such signature shall not affect the validity or enforceability of any Security that has been duly authenticated and delivered by the Trustee. Any Coupons attached to any Unregistered Security shall be executed on behalf of the Company by the manual or facsimile signature of any such officer of the Company.
In case any officer of the Company who shall have signed any of the Securities or Coupons shall cease to be such officer before the Security or Coupon so signed shall be authenticated and delivered by the Trustee or disposed of by the Company, such Security or Coupon nevertheless may be authenticated and delivered or disposed of as though the person who signed such Security or Coupon had not ceased to be such officer of the Company; and any Security or Coupon may be signed on behalf of the Company by such persons as, at the actual date of the execution of such Security or Coupon, shall be the proper officers of the Company, although at the date of the execution and delivery of this Indenture any such person was not such an officer.
Section 2.6Certificate of Authentication. Only such Securities and Coupons appertaining thereto as shall bear thereon a certificate of authentication substantially in the form hereinbefore recited, executed by the Trustee by the manual signature of one of its authorized signatories, shall be entitled to the benefits of this Indenture or be valid or obligatory for any purpose. Such certificate by the Trustee upon any Security executed by the Company shall be conclusive evidence that the Security so authenticated has been duly authenticated and delivered hereunder and that the Holder is entitled to the benefits of this Indenture.
The Trustee shall not authenticate or deliver any Unregistered Security until any matured Coupons appertaining thereto have been detached and canceled, except as otherwise provided or permitted by this Indenture.
Section 2.7Denomination and Date of Securities; Payments of Interest. The Securities shall be issuable in denominations as shall be specified as contemplated by Section 2.3. In the absence of any such specification with respect to the Securities of any Series, Registered Securities of such Series shall be issuable in denominations of $1,000 and any multiple thereof, and Unregistered Securities of such Series shall be issuable in denominations of $5,000, and interest shall be computed on the basis of a 360-day year of twelve 30-day months. The Securities shall be numbered, lettered, or otherwise distinguished in such manner or in accordance with such plan as the officers of the Company executing the same may determine with the approval of the Trustee as evidenced by the execution and authentication thereof.




12

180



Each Registered Security shall be dated the date of its authentication, each Unregistered Security shall be dated as of the date of original issuance of the first Security of such Series to be issued, shall bear interest from the date and shall be payable on the dates, in each case, which shall be specified as contemplated by Section 2.3.
Interest on any Security which is payable, and is punctually paid or duly provided for, on any interest payment date shall be paid, in the case of Registered Securities, to the person in whose name that Security (or one or more predecessor Securities) is registered at the close of business on the regular record date for the payment of such interest and, in the case of Unregistered Securities, upon surrender of the Coupon appertaining thereto in respect of the interest due on such interest payment date.
The term “record date” as used with respect to any interest payment date (except for a date for payment of defaulted interest) shall mean the date specified as such in the terms of the Securities of any particular Series, or, if no such date is so specified, if such interest payment date is the first day of a calendar month, the close of business on the fifteenth day of the next preceding calendar month or, if such interest payment date is the fifteenth day of a calendar month, the close of business on the first day of such calendar month, whether or not such record date is a Business Day.
Any interest on any Security of any Series which is payable, but is not punctually paid or duly provided for, on any interest payment date (called “defaulted interest” for the purpose of this Section) shall forthwith cease to be payable to the Registered Holder on the relevant regular record date by virtue of his having been such Holder; and such defaulted interest may be paid by the Company, at its election in each case, as provided in clause (1) or clause (2) below:
(1)
The Company may elect to make payment of any defaulted interest to the persons in whose names any such Registered Securities (or their respective predecessor Securities) are registered at the close of business on a special record date for the payment of such defaulted interest, which shall be fixed in the following manner. The Company shall notify the Trustee in writing of the amount of defaulted interest proposed to be paid on each Security of such Series and the date of the proposed payment, and at the same time the Company shall deposit with the Trustee an amount of money equal to the aggregate amount proposed to be paid in respect of such defaulted interest or shall make arrangements satisfactory to the Trustee for such deposit prior to the date of the proposed payment, such money when deposited to be held in trust for the benefit of the persons entitled to such defaulted interest as in this clause provided. Thereupon, the Trustee, in consultation with the Company, shall fix a special record date for the payment of such defaulted interest in respect of Registered Securities of such Series which shall be not more than 15 nor less than 10 days prior to the date of the proposed payment and not less than 10 days after the receipt by the Trustee of the notice of the proposed payment. The Trustee shall promptly notify the Company of such special record date and, in the name and at the expense of the Company, shall cause notice of the proposed payment of such defaulted interest and the special record date thereof to be mailed, first class postage prepaid, to each Registered Holder at his address as it appears in the Security register, not less than 10 days prior to such special record date. Notice of the proposed payment of such defaulted interest and the special record date therefor having been mailed as aforesaid, such defaulted interest in respect of Registered



13

181



Securities of such Series shall be paid to the person in whose names such Securities (or their respective predecessor Securities) are registered on such special record date and such defaulted interest shall no longer be payable pursuant to the following clause (2).
(2)
The Company may make payment of any defaulted interest on the Securities of any Series in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Securities of that Series may be listed, and upon such notice as may be required by such exchange, if, after notice given by the Company to the Trustee of the proposed payment pursuant to this clause, such payment shall be deemed practicable by the Trustee.
Any defaulted interest payable in respect of any Security of any Series which is not a Registered Security shall be payable pursuant to such procedures as may be satisfactory to the Trustee in such manner that there is no discrimination as between the Holders of Registered Securities and other Securities of the same Series, and notice of the payment date therefor shall be given by the Trustee, in the name and at the expense of the Company, in the manner specified in Section 11.4.
Subject to the foregoing provisions of this Section, each Security delivered under this Indenture upon transfer of or in exchange for or in lieu of any other Security shall carry the rights to interest accrued and unpaid, and to accrue, which were carried by such other Security.
Section 2.8Registration, Transfer and Exchange. The Company will keep at each office or agency to be maintained for the purpose as provided in Section 3.2 for each Series of Securities a register or registers in which, subject to such reasonable regulations as it may prescribe, it will register, and will register the transfer of, Registered Securities as in this Article provided. Such register shall be in written form in the English language or in any other form capable of being converted into such form within a reasonable time. At all reasonable times such register or registers shall be open for inspection by the Trustee.
Upon due presentation for registration of transfer of any Registered Security of any Series at any such office or agency to be maintained for the purpose as provided in Section 3.2, the Company shall execute and the Trustee shall authenticate and deliver in the name of the transferee or transferees a new Registered Security or Registered Securities of the same Series in authorized denominations for a like aggregate principal amount.
At the option of the Holder, Registered Securities of any Series may be exchanged for other Registered Securities of the same Series of any authorized denominations and of a like aggregate principal amount and tenor, upon surrender of the Securities to be exchanged at any such office or agency. Whenever any Securities are so surrendered for exchange, the Company shall execute, and the Trustee shall authenticate and deliver, the Securities which the Holder making the exchange is entitled to receive. Except as otherwise specified as contemplated by Section 2.3, Unregistered Securities may not be issued in exchange for Registered Securities.
At the option of the Holder, Unregistered Securities of any Series may be exchanged for Registered Securities of the same Series of any authorized denominations and of a like aggregate principal amount and tenor, upon surrender of the Unregistered Securities to be exchanged at any



14

182



such office or agency, with all unmatured Coupons, if any, and all matured Coupons, if any, in default thereto appertaining. If the Holder of an Unregistered Security is unable to produce any such unmatured Coupons and all matured Coupon or Coupons or matured Coupon or Coupons in default, such exchange may be effected if the Unregistered Securities are accompanied by payment in funds acceptable to the Company in an amount equal to the face amount of such missing Coupon or Coupons, or the surrender of such missing Coupon or Coupons may be waived by the Company and the Trustee if there is furnished to them such security or indemnity as they may require to save each of them and any Paying Agent harmless. If thereafter the Holder of such Security shall surrender to any Paying Agent any such missing Coupon in respect of which such a payment shall have been made, such Holder shall be entitled to receive the amount of such payment; provided, however, that, except as otherwise provided in Section 3.2, interest represented by Coupons shall be payable only upon presentation and surrender of those Coupons at an office or agency located outside the United States. Notwithstanding the foregoing, in case an Unregistered Security of any Series is surrendered at any such office or agency in exchange for a Registered Security of the same Series and like tenor after the close of business at such office or agency on any record date and before the opening of business at such office or agency on the relevant interest payment date, such Unregistered Security shall be surrendered without the Coupon relating to such interest payment date and interest will not be payable on such interest payment date in respect of the Registered Security issued in exchange for such Unregistered Security, but will be payable only to the Holder of such Coupon when due in accordance with the provisions of this Indenture.
Notwithstanding the foregoing, except as otherwise specified as contemplated by Section 2.3, any permanent global Security shall be exchangeable only as provided in this paragraph. If the beneficial owners of interests in a permanent global Security are entitled to exchange such interests for Securities of such Series and of like tenor and principal amount of another authorized form and denomination, as specified as contemplated by Section 2.3, then without unnecessary delay but in any event not later than the earliest date on which such interests may be so exchanged, the Company shall deliver to the Trustee definitive Securities of that Series in aggregate principal amount equal to the principal amount of such permanent global Security, executed by the Company. On or after the earliest date on which such interests may be so exchanged, such permanent global Securities shall be surrendered from time to time by the depositary holding such global security and in accordance with instructions given to the Trustee and such depositary (which instructions shall be in writing but need not comply with Section 11.5 or be accompanied by an Opinion of Counsel), as shall be specified in the Company Order with respect to the Trustee, as the Company’s agent for such purpose, to be exchanged, in whole or in part, for definitive Securities of the same Series without charge. The Trustee shall authenticate and make available for delivery, in exchange for each portion of such surrendered permanent global Security, a like aggregate principal amount of definitive Securities of the same Series of authorized denominations and of like tenor as the portion of such permanent global Security to be exchanged which (unless the Securities of the Series are not issuable both as Unregistered Securities and as Registered Securities, in which case the definitive Securities exchanged for the permanent global Security shall be issuable only in the form which the Securities are issuable, as specified as contemplated by Section 2.3) shall be in the form of Unregistered Securities or Registered Securities, or any combination thereof, as shall be specified by the beneficial owner thereof; provided, however, that no such exchanges may occur during a period beginning at the opening of business 15 days before any selection of Securities of that Series to be redeemed and ending on the relevant Redemption Date; and provided, further, that no Unregistered Security delivered in exchange for a portion of a


15

183



permanent global Security shall be mailed or otherwise delivered to any location in the United States. Promptly following any such exchange in part, such permanent global Security shall be returned by the Trustee to the depositary or such other depositary referred to above in accordance with the instructions of the Company referred to above. If a Registered Security is issued in exchange for any portion of a permanent global Security after the close of business at the office or agency where such exchange occurs on (i) any Regular Record Date and before the opening of business at such office or agency on the relevant Interest Payment Date, or (ii) any Special Record Date and before the opening of business at such office or agency on the related proposed date for payment of interest or Defaulted Interest, as the case may be, will not be payable on such Interest Payment Date or proposed date for payment, as the case may be, in respect of such Registered Security, but will be payable on such Interest Payment Date or proposed date for payment, as the case may be, only to the Person to whom interest in respect of such portion of such permanent global Security is payable in accordance with the provisions of this Indenture.
Upon presentation for registration of any Unregistered Securities of any Series which by its terms is registrable as to principal, at the office or agency of the Company to be maintained as provided in Section 3.2, such Security shall be registered as to principal in the name of the Holder thereof and such registration shall be noted on such Security. Any Security so registered shall be transferable on the registry books of the Company upon presentation of such Security at such office or agency for similar notation thereon, but such Security may be discharged from registration by being in a like manner transferred to bearer, whereupon transferability by delivery shall be restored. Unregistered Securities shall continue to be subject to successive registrations and discharges from registration at the option of the Holders thereof.
Unregistered Securities shall be transferable by delivery, except while registered as to principal. Registration of any Coupon Security shall not effect the transferability by delivery of the Coupons appertaining thereto which shall continue to be payable to bearer and transferable by delivery.
All Securities and Coupons issued upon any transfer or exchange of Securities shall be the valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under this Indenture, as the Securities and Coupons surrendered upon such transfer or exchange.
Every Security presented or surrendered for registration of transfer or exchange shall (if so required by the Company or the Trustee) be duly endorsed, or be accompanied by a written instrument of transfer in form satisfactory to the Company and the Security registrar duly executed, by the Holder thereof or his attorney duly authorized in writing.
No service charge shall be made for any registration of transfer or exchange of Securities, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in connection with any transfer or exchange of Securities, other than exchanges pursuant to Sections 2.11, 8.5 or 12.3 not involving any transfer.
The Company shall not be required (i) to issue, register the transfer of or exchange Securities of any Series during a period beginning at the opening of business 15 days before the mailing of a notice of redemption of Securities of that Series to be redeemed and ending at the close of business on (A) if Securities of the Series are issuable only as Registered Securities, the


16

184



day of the mailing of the relevant notice of redemption and (B) if Securities of the Series are issuable as Unregistered Securities, the day of the first publication of the relevant notice of redemption or, if Securities of the Series are also issuable as Registered Securities and there is no publication, the mailing of the relevant notice of redemption, or (ii) to register the transfer of or exchange any Registered Security so selected for redemption, in whole or in part, except the unredeemed portion of any Security being redeemed in part, or (iii) to exchange any Unregistered Security so selected for redemption except that such an Unregistered Security may be exchange for a Registered Security of that Series and like tenor, provided that such Registered Security shall be simultaneously surrendered for redemption.
All Securities issued upon any transfer or exchange of Securities shall be valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under this Indenture, as the Securities surrendered upon such transfer or exchange.
Section 2.9Mutilated, Defaced, Destroyed, Lost and Stolen Securities. In case any temporary or definitive Security or Coupon shall become mutilated, defaced or be destroyed, lost or stolen, the Company in its discretion may execute, and upon an Company Order, the Trustee shall authenticate and deliver, a new Security of the same Series or Coupon, bearing a number not contemporaneously outstanding, in exchange and substitution for the mutilated or defaced Security or Coupon, or in lieu of and substitution for the Security or Coupon so destroyed, lost or stolen. In every case the applicant for a substitute Security or Coupon shall furnish to the Company and to the Trustee and to any agent of the Company or the Trustee such security or indemnity as may be required by them to indemnify and defend and to save each of them harmless and, in every case of destruction, loss or theft, evidence to their satisfaction of the destruction, loss or theft of such Security or Coupon and of the ownership thereof.
Upon the issuance of any substitute Security or Coupon, the Company may require the payment of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation thereto and any other expenses (including the fees and expenses of the Trustee) connected therewith. In case any Security or Coupon which has matured or is about to mature or has been called for redemption in full shall become mutilated or defaced or be destroyed, lost or stolen, the Company may, instead of issuing a substitute Security or Coupon, pay or authorize the payment of the same (without surrender thereof except in the case of a mutilated or defaced Security or Coupon), if the applicant for such payment shall furnish to the Company and to the Trustee and any agent of the Company or the Trustee such security or indemnity as any of them may require to save each of them harmless, and, in every case of destruction, loss or theft, the applicant shall also furnish to the Company and the Trustee and any agent of the Company or the Trustee evidence to their satisfaction of the destruction, loss or theft of such Security or Coupon and of the ownership thereof.
Every substitute Security of any Series or Coupon issued pursuant to the provisions of this Section by virtue of the fact that any such Security or Coupon is destroyed, lost or stolen shall constitute an additional contractual obligation of the Company, whether or not the destroyed, lost or stolen Security or Coupon shall be at any time enforceable by anyone and shall be entitled to all the benefits of (but shall be subject to all the limitations of rights set forth in) this Indenture equally and proportionately with any and all other Securities of such Series or Coupons duly authenticated and delivered hereunder. All Securities or Coupons shall be held and owned upon the express



17

185



condition that, to the extent permitted by the law, the foregoing provisions are exclusive with respect to the replacement or payment of mutilated, defaced, destroyed, lost or stolen Securities or Coupons and shall preclude any and all other rights or remedies notwithstanding any law or statute existing or hereafter enacted to the contrary with respect to the replacement or payment of negotiable instruments or other securities without their surrender.
Section 2.10Cancellation of Securities, Destruction Thereof. All Securities surrendered for payment, redemption, registration of transfer or exchange, or for credit against any payment in respect of a sinking or analogous fund and all Coupons surrendered for payment or exchange, shall, if surrendered to the Company or any agent of the Company or the Trustee, be delivered to the Trustee for cancellation or, if surrendered to the Trustee, shall be cancelled by it; and no Securities or Coupons shall be issued in lieu thereof, except as expressly permitted by any of the provisions of this Indenture. The Trustee shall dispose of such cancelled Securities and Coupons in accordance with its customary practices. If the Company shall acquire any of the Securities and Coupons, such acquisition shall not operate as a redemption or satisfaction of the indebtedness represented by such Securities and Coupons unless and until the same are delivered to the Trustee for cancellation.

Section 2.11Temporary Securities. Pending the preparation of definitive Securities of any Series, the Company may execute, and upon Company Order the Trustee shall authenticate and deliver, temporary Securities which are printed, lithographed, typewritten, or otherwise produced, in any authorized denomination, substantially of the tenor of the definitive Securities in lieu of which they are issued, in registered form or, if authorized, in bearer form with one or more Coupons or without Coupons, and with such appropriate insertions, omissions, substitutions and other variations as the officers executing may determine, as evidenced by their execution of such Securities. In the case of any Series issuable as Unregistered Securities, such temporary Securities may be in global form.
Except in the case of temporary Securities in global form (which shall be exchanged in accordance with the provisions of the following paragraphs), if temporary Securities of any Series are issued, the Company will cause definitive Securities of that Series to be prepared without unreasonable delay. After the preparation of definitive Securities of such Series, the temporary Securities of such Series shall be exchangeable for definitive Securities of such Series upon surrender of the temporary Securities of such Series at the office or agency of the Company maintained pursuant to Section 3.2 for the purpose of exchanges of Securities of such Series, without charge to the Holder. Upon surrender for cancellation of any one or more temporary Securities of any Series (accompanied by any unmatured Coupons appertaining thereto) the Company shall execute and the Trustee shall authenticate and deliver in exchange therefor a like aggregate principal amount of definitive Securities of the same Series and of like tenor of authorized denominations; provided, however, that no definitive Unregistered Security shall be delivered in exchange for a temporary Registered Security; and provided, further, that a definitive Unregistered Security shall be delivered in exchange for a temporary Unregistered Security only in compliance with the conditions set forth in Section 2.4.
If temporary Securities of any Series are issued in global form, any such temporary global Security shall, unless otherwise provided therein, be delivered to a European office of a depositary (the “Common Depositary”), for the benefit of Euroclear and Clearstream, for credit to the



18

186



respective accounts of the beneficial owners of such Securities (or to such other accounts as they may direct).
Without unnecessary delay but in any event not later than the date specified in, or determined pursuant to the terms of, any such temporary global Security (the “Exchange Date”), the Company shall deliver to the Trustee definitive Securities, in aggregate principal amount equal to the principal amount of such temporary global Security, or, if so specified as contemplated by Section 2.3, a permanent global Security, in either case, executed by the Company. On or after the Exchange Date, such temporary global Security shall be surrendered by the Common Depositary to the Trustee, as the Company’s agent for such purpose, to be exchanged, in whole or from time to time in part, for definitive Securities without charge and the Trustee shall authenticate and deliver, in exchange for each portion of such temporary global Security, an equal aggregate principal amount of definitive Securities of the same Series of authorized denominations and of like tenor as the portion of such temporary global Security to be exchanged. The definitive Securities to be delivered in exchange for any such temporary global Security shall be in bearer form, registered form, permanent global bearer form or permanent global registered form, or any combination thereof, as specified as contemplated by Section 2.3, and, if any combination thereof is so specified, as requested by the beneficial owner thereof; provided, however, that, unless otherwise specified in such temporary global Security, upon such presentation by the Common Depositary, such temporary global Security is accompanied by a certificate dated the Exchange Date or a subsequent date and signed by Euroclear as to the portion of such temporary global Security held for its account then to be exchanged and a certificate dated the Exchange Date or a subsequent date and signed by Clearstream as to the portion of such temporary global Security held for its account then to be exchanged, each in the form designated by the Company pursuant to Section 2.3; and provided, further, that definitive Unregistered Securities shall be delivered in exchange for a portion of a temporary global Security only in compliance with the requirements of Section 2.4.
Unless otherwise specified in such temporary global Security, the interest of a beneficial owner of Securities of a Series in a temporary global Security shall be exchanged for definitive Securities of the same Series and of like tenor following the Exchange Date when the account holder instructs Euroclear or Clearstream, as the case may be, to request such exchange on his behalf and delivers to Euroclear or Clearstream, as the case may be, a certificate in the form designated by the Company pursuant to Section 2.3, dated no earlier than 15 days prior to the Exchange Date. Unless otherwise specified in such temporary global Security, any such exchange shall be made free of charge to the beneficial owners of such temporary global Security, except that a Person receiving definitive Securities must bear the cost of insurance, postage, transportation and the like in the event that such Person does not take delivery of such definitive Securities in person at the offices of Euroclear or Clearstream. Definitive Securities in bearer form to be delivered on exchange for any portion of a temporary global Security shall be delivered only outside the United States.
Until exchanged in full as hereinabove provided, the temporary Securities of any Series shall in all respects be entitled to the same benefits under this Indenture as definitive Securities of the same Series and of like tenor authenticated and delivered hereunder, except that, unless otherwise specified as contemplated by Section 2.3, interest payable on a temporary global Security on an interest payment date for Securities of such Series occurring prior to the applicable




19

187



Exchange Date shall be payable to Euroclear and Clearstream on such Interest Payment Date upon delivery by Euroclear and Clearstream to the Trustee of a certificate or certificates in the form designated by the Company pursuant to Section 2.3, for credit without further interest on or after such interest payment date to the respective accounts of the Persons who are the beneficial owners of such temporary global Security on such Interest Payment Date and who have each delivered to Euroclear and Clearstream, as the case may be, a certificate in the form designated by the Company pursuant to Section 2.3.
Any interest so received by Euroclear and Clearstream and not paid as herein provided shall be returned to the Trustee and then to the Company in accordance with Section 10.4.
Neither the Trustee nor any agent shall have responsibility for any actions taken or not taken by the Common Depositary.
Section 2.12Compliance with Certain Laws and Regulations. If any Unregistered Securities are to be issued in any Series of Securities, the Company will use reasonable efforts to provide for arrangements and procedures designed pursuant to then applicable laws and regulations, if any, to ensure that Unregistered Securities are sold or resold, exchanged, transferred and paid only in compliance with such laws and regulations and without adverse consequences to the Company.

Section 2.13Appointment of Agents With Respect to Certain Calculations. The Company may appoint an Agent or Agents with respect to one or more Series of Securities which Agent or Agents shall be authorized to determine the rate or rates of interest applicable to the Securities of any Series from time to time in effect, the amount of principal or premium, if any, payable on the Securities of any Series and the rates of exchange applicable to the Securities of any Series denominated in a currency other than United States dollars from time to time in effect, all in accordance with the terms of the Securities of such Series. Wherever reference is made in this Indenture to any such calculation by the Trustee, it shall be deemed to refer to the calculation by such agent or agents. Such agent, upon calculating the amounts so to be calculated pursuant to the terms of the Securities of any Series shall communicate promptly in writing the amounts so calculated to the Company and the Trustee. Absent manifest error, all amounts so calculated shall be binding on the Company, the Trustee and the Holders of the Securities of such Series.
Any such agent may resign at any time by giving written notice thereof to the Company and to the Trustee. The Company may at any time terminate the agency of any such agent by giving written notice thereof to such agent and to the Trustee. Upon receiving such a notice of resignation or upon such a termination, the Company may appoint a successor agent and shall give notice of such appointment to all Holders of Securities in the manner provided in Section 11.4.
Section 2.14CUSIP Numbers. The Company in issuing the Securities may use “CUSIP” numbers (if then generally in use), and, if so, the Trustee shall use “CUSIP” numbers in notices of redemption as a convenience to Holders; provided that any such notice may state that no representation is made as to the correctness of such numbers either as printed on the Securities or as contained in any notice of a redemption and that reliance may be placed only on the other identification numbers printed on the Securities, and any such redemption shall not be affected by






20

188



any defect in or omission of such numbers. The Company will promptly notify the Trustee of any change in the “CUSIP” numbers.

ARTICLE THREE

A.
COVENANTS OF THE ISSUER

Section 3.1Payment of Principal and Interest. The Company covenants and agrees for the benefit of each Series of Securities that it will duly and punctually pay or cause to be paid the principal of, and interest on, each of the Securities of such Series in accordance with the terms of the Securities of such Series, any Coupons appertaining thereto and this Indenture.
The interest on Unregistered Securities shall be payable only upon presentation and surrender of the Coupons for such interest installments as are evidenced thereby as they mature. The interest on any temporary Unregistered Security shall be paid, as to any installment of interest evidenced by a Coupon attached thereto, if any, only upon presentation and surrender of such Coupon, and, as to the other installments of interest, if any, only upon presentation of such Securities for notation thereon of the payment of such interest.
Section 3.2Offices for Payment, etc. If Securities of a Series are issuable only as Registered Securities, the Company will maintain an office or agency where Securities of that Series may be presented or surrendered for payment, where Securities of that Series may be surrendered for registration of transfer or exchange and where notices and demands to or upon the Company in respect of the Securities of that Series and this Indenture may be served. Except as otherwise specified as contemplated by Section 2.3, if Securities of a Series are issuable as Registered Securities and/or Unregistered Securities, the Company will maintain (A) in the Borough of Manhattan, The City of New York, or in the City of Chicago, an office or agency where any Registered Securities of that Series may be surrendered for registration of transfer, where Securities of that Series may be surrendered for exchange, where notices and demands to or upon the Company in respect of the Securities of that Series and this Indenture may be served and where Unregistered Securities of that Series and related Coupons may be presented or surrendered for payment in the circumstances described in the following paragraph (and not otherwise), (B) subject to any laws or regulations applicable thereto, outside the United States, an office or agency where Securities of that Series and related Coupons may be presented and surrendered for payment (including payment of any additional amounts payable on Securities of that Series pursuant to Section 3.8); provided, however, that if the Securities of that Series are listed on The International Stock Exchange, London, the Luxembourg Stock Exchange or any other stock exchange located outside the United States and such stock exchange shall so require, the Company will maintain a Paying Agent for the Securities of that Series in London, Luxembourg or any other required city located outside the United States, as the case may be, so long as the Securities of that Series are listed on such exchange, and (C) subject to any laws or regulations applicable thereto, outside the United States, an office or agency where any Registered Securities of that Series may be surrendered for registration of transfer, where Securities of that Series may be surrendered for exchange and where notices and demands to or upon the Company in respect of the Securities of that Series and this Indenture may be served. The Company will give prompt written notice to the Trustee and the Holders of the location, and any change in the location, of any such office or agency. If at any time the Company shall fail to maintain any such required office or agency in




21

189



respect of any Series of Securities or shall fail to furnish the Trustee with the address thereof, such presentations and surrenders of Securities of that Series may be made and notices and demands may be made or served at the Corporate Trust Office of the Trustee, except that Unregistered Securities of that Series and the related Coupons may be presented and surrendered for payment (including payment of any additional amounts payable on Unregistered Securities of that Series pursuant to Section 3.8) at an office maintained by the Trustee in New York, and the Company hereby appoints the same as its agent to receive such respective presentations, surrenders, notices and demands.
Except as otherwise specified as contemplated by Section 2.3, no payment of principal or interest on Unregistered Securities shall be made at any office or agency of the Company in the United States or by check mailed to any address in the United States or by transfer to an account maintained with a bank located in the United States, provided, however, that, if the Securities of a Series are denominated and payable in Dollars, payment of principal of and premium, if any, and interest on any Unregistered Security (including any additional amounts payable on Securities of such Series pursuant to Section 3.8) shall be made at the office of the Company’s Paying Agent in the Borough of Manhattan, The City of New York, or the City of Chicago, if (but only if) payment in Dollars of the full amount of such principal, premium, interest or additional amounts, as the case may be, at all offices or agencies outside the United States maintained for the purpose by the Company in accordance with this Indenture is illegal or effectively precluded by exchange controls or other similar restrictions.
The Company may also from time to time designate one or more other offices or agencies where the Securities of one or more Series may be presented or surrendered for any or all such purposes and may from time to time rescind such designations; provided, however, that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain an office or agency in accordance with the requirements set forth above for Securities of any Series for such purposes. The Company will give prompt written notice to the Trustee and the Holders of any such designation or rescission and of any change in the location of any such other office or agency.
Unless otherwise specified pursuant to Section 2.3, the Trustee is appointed Paying Agent and Registrar.
Section 3.3Appointment to Fill a Vacancy in Office of Trustee. The Company, whenever necessary to avoid or fill a vacancy in the office of Trustee, will appoint, in the manner provided in Section 6.10, a Trustee, so that there shall at all times be a Trustee with respect to each Series of Securities hereunder.

Section 3.4Paying Agents. Whenever the Company shall appoint a Paying Agent other than the Trustee with respect to the Securities of any Series, it will cause such Paying Agent to execute and deliver to the Trustee an instrument in which such Agent shall agree with the Trustee, subject to the provisions of this Section,
(a)
that it will hold all sums received by it as such Agent for the payment of the principal of or interest on the Securities of such Series or Coupons (whether such sums have been paid to it by the Company or by any other obligor on the Securities







22

190



of such Series or Coupons) in trust for the benefit of the Holders of the Securities of such Series or of the Trustee, and upon the occurrence of an Event of Default pay over all such sums received by it to the Trustee,
(b)
that it will give the Trustee written notice of any failure by the Company (or by any other obligor on the Securities of such Series) to make any payment of the principal of or interest on the Securities of such Series or Coupons when the same shall be due and payable, and
(c)
that it will give the Trustee written notice of any change of address of any Holder of which it is aware.
The Company will, on or prior to each due date of the principal of or interest on the Securities of such Series or Coupons, deposit with the Paying Agent a sum sufficient to pay such principal or interest so becoming due, and (unless such Paying Agent is the Trustee) the Company will promptly notify the Trustee in writing of any failure to take such action.
If the Company shall act as its own Paying Agent with respect to the Securities of any Series or Coupons, it will, on or before each due date of the principal of or interest on the Securities of such Series or Coupons, set aside, segregate and hold in trust for the benefit of the Holders of the Securities of such Series or Holders of such Coupons a sum sufficient to pay such principal or interest so becoming due. The Company will promptly notify the Trustee in writing of any failure to take such action.
Anything in this Section to the contrary notwithstanding, the Company may at any time, for the purpose of obtaining a satisfaction and discharge with respect to one or more or all Series of Securities or Coupons hereunder, or for any other reason, pay or cause to be paid to the Trustee all sums held in trust for any such Series by the Company or any Paying Agent hereunder, as required by this Section, such sums to be held by the Trustee upon the trusts herein contained.
Anything in this Section to the contrary notwithstanding, the agreement to hold sums in trust as provided in this Section is subject to the provisions of Sections 10.3 and 10.4.
Section 3.5    [Reserved]

Section 3.6Limitation on Liens. (a) So long as any of the Securities remain outstanding and unpaid, the Company will not create, assume or suffer to exist and will not cause, suffer or permit any Restricted Subsidiary to create, assume or suffer to exist, any mortgage, pledge, security interest or other lien or encumbrance of or upon any Principal Property or additions thereto or shares of capital stock of any Restricted Subsidiary, whether such Principal Property, additions thereto or shares of capital stock are owned at the date of this Indenture or thereafter acquired, without making effective provision, and the Company covenants that in any such case it will make or cause to be made effective provision, whereby the Securities then Outstanding from time to time shall be secured by such mortgage, pledge or lien equally and ratably with any and all other obligations and indebtedness thereby secured so long as such indebtedness is so secured; provided that the foregoing covenant shall not apply to any mortgage, pledge or lien (hereinafter in this Section 3.6 referred to as “liens”) of the following character:







23

191



(i)
liens on Principal Property existing at the time of acquisition of such Principal Property or to secure the payment of all or any part of the purchase price of such Principal Property or any addition thereto or to secure any indebtedness incurred at the time of, or within 120 days after, the acquisition of such Principal Property or any addition thereto for the purpose of financing all or any part of the purchase price thereof (provided such liens are limited to such Principal Property or additions thereto);
(ii)
liens existing on the date of this Indenture;
(iii)
liens on property or shares of capital stock, or arising out of any indebtedness of any corporation existing at the time such corporation became or was merged into the Company or a Restricted Subsidiary;
(iv)
liens executed by any Restricted Subsidiary and exclusively securing indebtedness or evidences of indebtedness incurred or issued by such Restricted Subsidiary either to the Company or to any Subsidiary;
(v)
liens arising from assignments of money due and to become due under contracts between the Company or any Restricted Subsidiary and the United States or any State, or any department, agency or political subdivision thereof;
(vi)
liens of carriers, warehousemen, mechanics and materialmen incurred in the ordinary course of business for sums not yet due or being contested in good faith;
(vii)
liens arising by reason of any judgment, decree or order of any court, so long as any appropriate legal proceedings which may have been duly initiated for the review of such judgment, decree or order shall not have been finally terminated or so long as the period within which such proceedings may be initiated shall not have expired; or pledges or deposits to secure payment of workmen’s compensation or other insurance, good faith deposits in connection with tenders, contracts (other than contracts for the payment of money) or leases, deposits to secure public or statutory obligations, deposits to secure public or statutory obligations, deposits to secure or in lieu of surety or appeal bonds, or deposits as security for the payment of taxes;
(viii)
liens in connection with the issuance of tax-exempt industrial development or pollution control bonds or other similar bonds issued pursuant to Section 103(b) of the Internal Revenue Code of 1986, as amended, or as hereafter amended (the “Internal Revenue Code”), to finance all or any part of the purchase price of or the cost of constructing, equipping or improving property; provided that such liens shall be limited to such property acquired (including personal property) or constructed or such improvement and to thereto substantially unimproved real property on which such construction







24

192



or improvement is located; and provided, further that the Company and Restricted Subsidiaries may further secure all or any part of such purchase price or the cost of construction of such improvements and personal property by an interest in additional property of the Company and Restricted Subsidiaries only to the extent necessary for the construction, maintenance and operation of, and access to, such property so acquired or constructed or such improvement;
(ix)
liens in favor of any customer arising in respect of partial, progress, advance or other payments made by or on behalf of such customer for goods produced for or services rendered to such customer in the ordinary course of business not exceeding the amount of such payments;
(x)
extensions, renewals or replacements, in whole or in part, of any lien referred to in the foregoing clauses (i) to (ix), inclusive, provided that the principal amount of indebtedness secured thereby shall not exceed the principal amount of indebtedness so secured at the time of such extension, renewal or replacement and that such extension, renewal or replacement shall be limited to all or any part of the same property that secured the lien extended, renewed or replaced (plus improvements on such property); and
(xi)
(A) liens for taxes or assessments or governmental charges or levies not yet due or delinquent, or which can thereafter be paid without penalty, or which are being contested in good faith by appropriate proceedings; (B) landlord’s liens on property held under lease, and tenants’ rights under leases; (C) easements; and (D) any other liens of a nature similar to those hereinabove described in this clause (xi); in each case, which do not, in the opinion of the Company, materially impair the use of such property subject to such lien or covenant in the operation of the business of the Company or a Restricted Subsidiary or the value of such property for the purposes of such business.
(b)
Notwithstanding the provisions of paragraph (a) of this Section 3.6, the Company or any Restricted Subsidiary may create or assume liens; provided that at the time of such creation or assumption, and after giving effect thereto, Exempted Indebtedness does not exceed 15 percent of Consolidated Net Tangible Assets at such time.

Section 3.7Limitation on Sale and Lease-Back Transactions. (a) The Company will not, nor will it permit any Restricted Subsidiary to, enter into any arrangement providing for the leasing by the Company or any Restricted Subsidiary of any Principal Property (except for temporary leases for a term, including any renewal thereof, of not more than three years and except for leases between the Company and a Subsidiary or between Subsidiaries), which Principal Property has been or is to be sold or transferred by the Company or such Restricted Subsidiary (herein referred to as a “Sale and Lease-Back Transaction”) unless the net proceeds of such sale are at least equal to the fair value (as determined by the Board of Directors) of such property.








25

193



b.
Notwithstanding the provisions of paragraph (a) of this Section 3.7, the Company or any Restricted Subsidiary may enter into Sale and Lease-Back Transactions, provided that at the time of such entering into, and after giving effect thereto, Exempted Indebtedness does not exceed 15 percent of Consolidated Net Tangible Assets at such time.

Section 3.8    Additional Amounts. If the Securities of a Series provide for the payment of additional amounts, the Company will pay to the Holder of any Security of such Series or any Coupon appertaining thereto additional amounts as provided therein. Whenever in this Indenture there is mentioned, in any context, the payment of the principal or premium, if any, of or interest on, or in respect of, any Security of any Series or payment of any related Coupon or the net proceeds received on the sale or exchange of any

Security of any Series, such mention shall be deemed to include mention of the payment of additional amounts provided for in this Section to the extent that, in such context, additional amounts are, were or would be payable in respect thereof pursuant to the provisions of this Section and express mention of the payment of additional amounts (if applicable) in any provisions hereof shall not be construed as excluding additional amounts in those provisions hereof where such express mention is not made.
If the Securities of a Series provide for the payment of additional amounts, at least 10 days prior to the first interest payment date with respect to that Series of Securities (or if the Securities of that Series will not bear interest prior to maturity, the first day on which a payment of principal is made), and at least 10 days prior to each date of payment of principal, premium, if any, or interest if there has been any change with respect to the matters set forth in the below-mentioned Officer’s Certificate, the Company will furnish the Trustee and the Company’s principal Paying Agent or Paying Agents, if other than the Trustee, with an Officer’s Certificate instructing the Trustee and such Paying Agent or Paying Agents whether such payment of principal of or interest on the Securities of that Series shall be made to Holders of Securities of that Series or any related Coupons who are United States Aliens without withholding for or on account of any tax, assessment or other governmental charge described in the Securities of that Series. If any such withholding shall be required, then such Officer’s Certificate shall specify by country the amount, if any, required to be withheld on such payments to such Holders of Securities or Coupons and the Company will pay to the Trustee or such Paying Agent the additional amounts required by this Section. The Company covenants to indemnify the Trustee and any Paying Agent for, and to hold them harmless against, any loss, liability or expense reasonably incurred without negligence or bad faith on their part arising out of or in connection with actions taken or omitted by any of them in reliance on any Officer’s Certificate furnished pursuant to this Section.
B.GUARANTEE COVENANT OF DOW INC. If Dow provides a guarantee in respect of outstanding or committed indebtedness under the Revolving Credit Facility Agreement, Dow shall, for the benefit of the Holders of Securities of each Series outstanding under the Indenture, from time to time and at any time, enter into a supplemental indenture with the Company and the Trustee substantially in the form attached as Exhibit A hereto, substantially concurrently with the issuance of such guarantee with respect to the Revolving Credit Facility Agreement, which supplemental indenture will provide for the issuance of a guarantee on all Securities outstanding under the Indenture from time to time (the “Guarantee”).






26

194



ARTICLE FOUR

SECURITYHOLDERS’ LISTS AND REPORTS BY THE
ISSUER AND THE TRUSTEE

Section 4.1    Company to Furnish Trustee Information as to Names and Addresses of Securityholders. The Company covenants and agrees that it will furnish or cause to be furnished to the Trustee a list in such form as the Trustee may reasonably require of the names and addresses of the Holders of the Registered Securities of each Series:

(a)
semiannually and not more than 10 days after each record date for the payment of interest on such Securities, as hereinabove specified, as of such record date and on dates to be determined pursuant to Section 2.3 for non-interest bearing securities in each year, and

(b)
at such other times as the Trustee may request in writing, within 30 days after receipt by the Company of any such request as of a date not more than 15 days prior to the time such information is furnished,
provided that if and so long as the Trustee shall be the Security registrar for such Series, such list shall not be required to be furnished but in any event the Company shall be required to furnish such information concerning the Holders of Unregistered Securities which is known to it; provided, further, that the Company shall have no obligation to investigate any matter relating to any Holder of an Unregistered Security or any Holder of a Coupon.
Section 4.2    Preservation and Disclosure of Securityholders’ Lists. (a) The Trustee shall preserve, in as current a form as is reasonably practicable, all information as to the names and addresses of the Holders of each Series of Securities contained in the most recent list furnished to it as provided in Section 4.1 or maintained by the Trustee in its capacity as Security registrar for such Series, if so acting. The Trustee may destroy any list furnished to it as provided in Section 4.1 upon receipt of a new list so furnished.

(b)
In case three or more Holders of Securities (hereinafter referred to as “applicants”) apply in writing to the Trustee and furnish to the Trustee reasonable proof that each such applicant has owned a Security for a period of at least six months preceding the date of such application, and such application states that the applicants desire to communicate with other Holders of Securities of a particular Series (in which case the applicants must all hold Securities of such Series) or with Holders of all Securities with respect to their rights under this Indenture or under such Securities and such application is accompanied by a copy of the form of proxy or other communication which such applicants propose to transmit, then the Trustee shall, within five business days after the receipt of such application, at its election, either

(i)
afford to such applicants access to the information preserved at the time by the Trustee in accordance with the provisions of subsection (a) of this Section, or







27

195



(ii)
inform such applicants as to the approximate number of Holders of Securities of such Series or all Securities, as the case may be, whose names and addresses appear in the information preserved at the time by the Trustee, in accordance with the provisions of subsection (a) of this Section, and as to the approximate cost of mailing to such Securityholders the form of proxy or other communication, if any, specified in such application.
If the Trustee shall elect not to afford to such applicants access to such information, the Trustee shall, upon the written request of such applicants, mail to each Securityholder of such Series or all Securities, as the case may be, whose name and address appear in the information preserved at the time by the Trustee in accordance with the provisions of subsection (a) of this Section, a copy of the form of proxy or other communication which is specified in such request, with reasonable promptness after a tender to the Trustee of the material to be mailed and of payment, or provision for the payment, of the reasonable expenses of mailing, unless within five days after such tender, the Trustee shall mail to such applicants and file with the Commission together with a copy of the material to be mailed, a written statement to the effect that, in the opinion of the Trustee, such mailing would be contrary to the best interests of the Holders of Securities of such Series or all Securities, as the case may be, or could be in violation of applicable law. Such written statement shall specify the basis of such opinion. If the Commission, after opportunity for a hearing upon the objections specified in the written statement so filed, shall enter an order refusing to sustain any of such objections or if, after the entry of such order sustaining one or more of such objections, the Commission shall find, after notice and opportunity for hearing, that all the objections so sustained have been met, and shall enter an order so declaring, the Trustee shall mail copies of such material to all such Securityholders with reasonable promptness after the entry of such order and the renewal of such tender; otherwise the Trustee shall be relieved of any obligation or duty to such applicants respecting their application.
(c)
Each and every Holder of Securities, by receiving and holding the same, agrees with the Company and the Trustee that neither the Company nor the Trustee nor any agent of the Company or the Trustee shall be held accountable by reason of the disclosure of any such information as to the names and addresses of the Holders of Securities in accordance with the provisions of subsection (b) of this Section, regardless of the source from which such information was derived, and that the Trustee shall not be held accountable by reason of mailing any material pursuant to a request made under such subsection (b).

Section 4.3Reports by the Company. The Company covenants:

(a)
to file with the Trustee, within 15 days after the Company files the same with the Commission, copies of the annual reports and of the information, documents, and other reports (or copies of such portions of any of the foregoing as the Commissioner may from time to time by rules and regulations prescribe) which the Company may be required to file with the Commission pursuant to Section 13 or Section 15(d) of the Exchange Act, and if the Company is not required to file





28

196



information, documents, or reports pursuant to either of such Sections, then to file with the Trustee and the Commission, in accordance with rules and regulations prescribed from time to time by the Commission, such of the supplementary and periodic information, documents, and reports which may be required pursuant to Section 13 of the Exchange Act, in respect of a security listed and registered on a national securities exchange as may be prescribed from time to time in such rules and regulations;
(b)
to file with the Trustee and the Commission, in accordance with rules and regulations prescribed from time to time by the Commission, such additional information, documents, and reports with respect to compliance by the Company with the conditions and covenants provided for in this Indenture as may be required from time to time by such rules and regulations; and
(c)
to transmit by mail to the Holders of Securities in the manner required by Section 11.4, within 30 days after the filing thereof with the Trustee, such summaries of any information, documents, and reports required to be filed by the Company pursuant to subsection (a) and (b) of this Section as may be required to be transmitted to such Holders by rules and regulations prescribed from time to time by the Commission; and
(d)
to furnish to the Trustee, not less often than annually, commencing on May 15, 2020, a brief certificate from the principal executive officer, principal financial officer or principal accounting officer of the Company as to his or her knowledge of the Company’s compliance with all conditions and covenants under this Indenture. For purposes of this paragraph, such compliance shall be determined without regard to any period of grace or requirement of notice provided under this Indenture.
Delivery of such reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (as to which the Trustee is entitled to rely exclusively on Officer’s Certificates).
Section 4.4    Reports by the Trustee. (a) The Trustee shall transmit to Holders such reports concerning the Trustee and its actions under this Indenture as may be required pursuant to the Trust Indenture Act at the times and in the manner provided pursuant thereto. If required by Section 313(a) of the Trust Indenture Act, the Trustee shall, within sixty days after each May 15, beginning May 15, 2020, deliver to Holders a brief report, dated as of such May 15, which complies with the provisions of such Section 313(a).

(b)
A copy of each such report shall, at the time of such transmission to Securityholders, be furnished to the Company and be filed by the Trustee with each stock exchange upon which the Securities of any applicable Series are listed and also with the Commission. The Company agrees to promptly notify the Trustee with respect to any Series when and as the Securities of such Series become








29

197



admitted to trading on any national securities exchange and of any delisting therefrom.

ARTICLE FIVE

REMEDIES OF THE TRUSTEE AND SECURITYHOLDERS
ON EVENT OF DEFAULT

Section 5.1Event of Default Defined; Acceleration of Maturity; Waiver of Default. “Event of Default” with respect to Securities of any Series whatever used herein means each one of the following events which shall have occurred and be continuing (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law or pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body):
(a)
default in the payment of any installment of interest upon any of the Securities of such Series as and when the same shall become due and payable, and continuance of such default for a period of 30 days; or
(b)
default in the payment of all or any part of the principal on any of the Securities of such Series as and when the same shall become due and payable either at maturity, upon redemption, by declaration or otherwise; or
(c)
default in the payment of any sinking fund installment as and when the same shall become due and payable by the terms of the Securities of such Series; or
(d)
default in the performance, or breach, of any covenant or warranty of the Company in respect of the Securities of such Series (other than a covenant or warranty in respect of the Securities of such Series a default in whose performance or whose breach is elsewhere in this Section specifically dealt with), and continuance of such default or breach for a period of 90 days after notice thereof has been received by the Company from the Trustee or the Holders of at least 25% in principal amount of the Outstanding Securities of such Series affected thereby, a written notice specifying such default or breach and requiring it to be remedied and stating that such notice is a “Notice of Default” hereunder; or
(e)
a court having jurisdiction in the premises shall enter a decree or order for relief in respect of the Company in an involuntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or appointing a receiver, liquidator, assignee, custodian, trustee or sequestrator (or similar official) of the Company or for any substantial part of its property or ordering the winding up or liquidation of its affairs, and such decree or order shall remain unstayed and in effect for a period of 60 consecutive days; or
(f)
the Company shall commence a voluntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or consent to the entry of an order for relief in an involuntary case under any such law, or consent to the appointment of or taking possession by a receiver, liquidator, assignee, custodian,








30

198



trustee or sequestrator (or similar official) of the Company or for any substantial part of its property, or make any general assignment for the benefit of creditors;
(g)
default by Dow in the performance, or breach by Dow, of the covenant to issue a guarantee pursuant to Article 3.B; or
(h)
any other Event of Default provided in the supplemental indenture or Board Resolution under which such Series of Securities is issued or in the form of Security for such Series.
If an Event of Default described in clauses (a), (b), (c), (d) ,(g) or (h) above (if the Event of Default under clause (d) or (h) is with respect to less than all Series of Securities then Outstanding) occurs and is continuing, then, and in each and every such case, unless the principal of all of the Securities of such Series shall have already become due and payable, either the Trustee or the Holders of not less than 25% in aggregate principal amount of the Securities of such Series then Outstanding hereunder (each such Series treated as a separate class), by notice in writing to the Company (and to the Trustee if given by the Securityholders), may declare the entire principal (or, if the Securities of that Series are Original Issue Discount Securities, such portion of the principal amount as may be specified in the terms of that Series) of all Securities of such Series and the interest accrued thereon to be due and payable immediately, and upon any such declaration the same shall become immediately due and payable. If an Event of Default described in clause (d) or (h) (if the Event of Default under clause (d) or (h) is with respect to all Series of Securities then Outstanding), shall have occurred and be continuing, then and in each and every such case, unless the principal of all the Securities shall have already become due and payable, either the Trustee or the Holders of not less than 25% in aggregate principal amount of all the Securities then Outstanding hereunder (treated as one class), by notice in writing to the Company (and to the Trustee if given by Securityholders), may declare the entire principal of all the Securities then Outstanding and interest accrued thereon to be due and payable immediately, and upon any such declaration the same shall become immediately due and payable. If an event of default described in clause (e) or (f) shall have occurred, the principal of all the Securities then Outstanding hereunder, together with interest accrued thereon, shall become due and payable immediately without any declaration or other act by the Trustee or any Holder.
The foregoing provisions, however, are subject to the condition that if, at any time after the principal (or, if the Securities are Original Issue Discount Securities, such portion of the principal as may be specified in the terms thereof) of the Securities of any Series (or of all the Securities, as the case may be) shall have been so declared due and payable, and before any judgment or decree for the payment of the moneys due shall have been obtained or entered as hereinafter provided, the Company shall pay or shall deposit with the Trustee a sum sufficient to pay all matured installments of interest upon all the Securities of such Series (or of all the Securities, as the case may be) and the principal of any and all Securities of such Series (or of all the Securities, as the case may be) which shall have become due otherwise than by acceleration (with interest upon such principal and, to the extent that payment of such interest is enforceable under applicable law, on overdue installments of interest, at the same rate as the rate of interest or Yield to Maturity (in the case of Original Issue Discount Securities) specified in the Securities of such Series (or at the respective rates of interest or Yields to Maturity of all the Securities, as the case may be) to the date of such payment or deposit), and such amount as shall be sufficient to cover compensation to



31

199



the Trustee, its agents, attorneys and counsel, and all other fees and expenses and liabilities incurred, and all advances made, by the Trustee except as a result of negligence or bad faith, and if any and all Events of Default under the Indenture, other than the nonpayment of the principal of Securities which shall have become due by acceleration, shall have been cured, waived or otherwise remedied as provided herein-then and in every such case the Holders of a majority in aggregate principal amount of all the Securities of such Series, each Series treated as a separate class (or of all the Securities, as the case may be, treated as a single class) then outstanding, by written notice to the Company and to the Trustee, may waive all defaults with respect to such Series (or with respect to all the Securities, as the case may be) and rescind and annul such declaration and its consequences, but no such waiver or rescission and annulment shall extend to or shall affect any subsequent default or shall impair any right consequent thereon.
For all purposes under this Indenture, if a portion of the principal of any Original Issue Discount Securities shall have been accelerated and declared due and payable pursuant to the provisions hereof, then, from and after such declaration, unless such declaration has been rescinded and annulled, the principal amount of such Original Issue Discount Securities shall be deemed, for all purposes hereunder, to be such portion of the principal thereof as shall be due and payable as a result of such acceleration, and payment of such portion of the principal thereof as shall be due and payable as a result of such acceleration, together with interest, if any, thereon and all other amounts owing thereunder, shall constitute payment in full of such Original Issue Discount Securities.
Section 5.2    Collection of Indebtedness by Trustee; Trustee May Prove Debt. The Company covenants that (a) in case default shall be made in the payment of any installment of interest on any of the Securities of any Series when such interest shall have become due and payable, and such default shall have continued for a period of 30 days or (b) in case default shall be made in the payment of all or any part of the principal of any of the Securities of any Series when the same shall have become due and payable, whether upon maturity of the Securities of such Series or upon any redemption or by declaration or otherwise, then upon demand of the Trustee, the Company will pay to the Trustee for the benefit of the Holders of the Securities of such Series and the Holders of any Coupons appertaining thereto the whole amount that then shall have become due and payable on all Securities of such Series or such Coupons for principal of or interest, as the case may be (with interest to the date of such payment upon the overdue principal and, to the extent that payment of such interest is enforceable under applicable law, on overdue installments of interest at the same rate as the rate of interest or Yield to Maturity (in the case of Original Issue Discount Securities) specified in the Securities of such Series); and in addition thereto, such further amount as shall be sufficient to cover the costs and expenses of collection, including compensation to the Trustee and each predecessor Trustee, their respective agents, attorneys and counsel, and any fees and expenses and liabilities incurred, and all advances made, by the Trustee and each predecessor Trustee except as a result of its negligence or bad faith.
Until such demand is made by the Trustee, the Company may pay the principal of and interest on the Securities of any Series to the persons entitled thereto, whether or not the principal of and interest on the Securities of such Series are overdue.
In case the Company shall fail forthwith to pay such amounts upon such demand, the Trustee, in its own name and as trustee of an express trust, shall be entitled and empowered to



32

200



institute any action or proceedings at law or in equity for the collection of the sums so due and unpaid, and may prosecute any such action or proceedings to judgment or final decree, and may enforce any such judgment or final decree against the Company or other obligor upon such Securities and collect in the manner provided by law out of the property of the Company or other obligor upon such Securities, wherever situated, the moneys adjudged or decreed to be payable.
In case there shall be pending proceedings relative to the Company or any other obligor upon the Securities under Title 11 of the United States Code or any other applicable Federal or state bankruptcy, insolvency or other similar law, or in case a receiver, assignee or trustee in bankruptcy or reorganization, liquidator, sequestrator or similar official shall have been appointed for or taken possession of the Company or its property or such other obligor or its respective property, or in case of any other comparable judicial proceedings relative to the Company or other obligor under the Securities of any Series, or to the creditors or property of the Company or such other obligor, the Trustee, irrespective of whether the principal of any Securities shall then be due and payable as therein expressed or by declaration or otherwise and irrespective of whether the Trustee shall have made any demand pursuant to the provisions of this Section, shall be entitled and empowered, by intervention in such proceedings or otherwise:
(a)
to file and prove a claim or claims for the whole amount of principal and interest owing and unpaid in respect of the Securities of any Series, and to file such other papers or documents as may be necessary or advisable in order to have the claims of the Trustee (including any claim for compensation to the Trustee and each predecessor Trustee, and their respective agents, attorneys and counsel, and for reimbursement of all fees and expenses and liabilities incurred, and all advances made, by the Trustee and each predecessor Trustee, except as a result of negligence or bad faith) and of the Securityholders and the Holders of any Coupons appertaining thereto allowed in any judicial proceedings relative to the Company or other obligor upon all Securities of any Series, or to the creditors or property of the Company or such other obligor,
(b)
unless prohibited by applicable law and regulations, to vote on behalf of the holders of the Securities of any Series in any election of a trustee or a standby trustee in arrangement, reorganization, liquidation or other bankruptcy or insolvency proceedings or person performing similar functions in comparable proceedings, and
(c)
to collect and receive any moneys or other property payable or deliverable on any such claims, and to distribute all amounts received with respect to the claims of the Securityholders and of the Trustee on their behalf; and any trustee, receiver, or liquidator, custodian or other similar official is hereby authorized by each of the Holders to make payments to the Trustee, and, in the event that the Trustee shall consent to the making of payments directly to the Securityholders, to pay to the Trustee such amounts as shall be sufficient to cover compensation to the Trustee, each predecessor Trustee and their respective agents, attorneys and counsel, and all other fees and expenses and liabilities incurred, and all advances made, by the Trustee and each predecessor Trustee except as a result of negligence or bad faith and all other amounts due to the Trustee or any predecessor Trustee pursuant to Section 6.6.






33

201



Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to or vote for or accept or adopt on behalf of any Securityholder any plan of reorganization, arrangement, adjustment or composition affecting the Securities of any Series or the rights of any Holder thereof, or to authorize the Trustee to vote in respect of the claim of any Securityholder in any such proceeding except, as aforesaid, to vote for the election of a trustee in bankruptcy or similar person.
All rights of action and of asserting claims under this Indenture, or under any of the Securities, may be enforced by the Trustee without the possession of any of the Securities or the production thereof at any trial or other proceedings relative thereto, and any such action or proceedings instituted by the Trustee shall be brought in its own name as trustee of an express trust, and any recovery of judgment, subject to the payment of the fees, expenses, disbursements and compensation of the Trustee, each predecessor Trustee and their respective agents and attorneys, shall be for the ratable benefit of the Holders of the Securities and Holders of any Coupons in respect of which such action was taken.
In any proceedings brought by the Trustee (and also any proceedings involving the interpretation of any provision of this Indenture to which the Trustee shall be a party), the Trustee shall be held to represent all the Holders of the Securities and Coupons appertaining thereto in respect to which such action was taken, and its shall not be necessary to make any Holders of such Securities and Coupons appertaining thereto parties to any such proceedings.
Section 5.3Application of Proceeds. Any moneys collected by the Trustee pursuant to this Article in respect of the Securities of any Series shall be applied in the following order at the date or dates fixed by the Trustee and, in case of the distribution of such moneys on account of principal or interest, upon presentation of the several Securities and any Coupons appertaining thereto in respect of which moneys have been collected and stamping (or otherwise noting) thereon the payment, or issuing Securities of such Series in reduced principal amounts in exchange for the presented Securities of like Series if only partially paid, or upon surrender thereof if fully paid:
FIRST: The Trustee and each predecessor Trustee and their respective agents and attorneys and of all fees and expenses and liabilities incurred, and all advances made, by the Trustee and each predecessor Trustee, except as a result of negligence or bad faith, and all other amounts due to the Trustee or any predecessor Trustee pursuant to Section 6.6;
SECOND: In case the principal of the Securities of such Series in respect of which moneys have been collected shall not have become and be then due and payable, to the payment of interest on the Securities of such Series in default in the order of the maturity of the installments of such interest, with interest (to the extent that such interest has been collected by the Trustee) upon the overdue installments of interest at the same rate as the rate of interest or Yield to Maturity (in the case of Original Issue Discount Securities) specified in such Securities, such payments to be made ratably to the persons entitled thereto, without discrimination or preference;
THIRD: In case the principal of the Securities of such Series in respect of which moneys have been collected shall have become and shall be then due and payable, to the payment of the whole amount then owing and unpaid upon all the Securities of such Series for principal and interest, with interest upon the overdue principal, and (to the extent that payment of such interest


34

202



is permissible by law and that such interest has been collected by the Trustee) upon overdue installments of interest at the same rate as the rate of interest or Yield to Maturity (in the case of Original Issue Discount Securities) specified in the Securities of such Series; and in case such moneys shall be insufficient to pay in full the whole amount so due and unpaid upon the Securities of such Series, then to the payment of such principal and interest or yield to maturity, without preference or priority of principal over interest or yield to maturity or of interest or yield to maturity over principal, or of any installment of interest over any other installment of interest, or of any Security of such Series over any other Security of such Series, ratably to the aggregate of such principal and accrued and unpaid interest; and
FOURTH: To the payment of the remainder, if any, to the Company or any Subsidiary of the Company designated by the Company in writing.
Section 5.4Suits for Enforcement. In case an Event of Default has occurred, has not been waived and is continuing, the Trustee may in its discretion proceed to protect and enforce the rights vested in it by this Indenture by such appropriate judicial proceedings as the Trustee shall deem necessary to protect and enforce any of such rights, either at law or in equity or in bankruptcy or otherwise, whether for the specific enforcement of any covenant or agreement contained in this Indenture or in aid of the exercise of any power granted in this Indenture or to enforce any other legal or equitable right vested in the Trustee by this Indenture or by law.
Section 5.5Restoration of Rights on Abandonment of Proceedings. In case the Trustee shall have proceeded to enforce any right under this Indenture and such proceedings shall have been discontinued or abandoned for any reason, or shall have been determined adversely to the Trustee, then and in every such case the Company and the Trustee shall be restored respectively to their former positions and rights hereunder, and all rights, remedies and powers of the Company, the Trustee and the Securityholders shall continue as though no such proceedings had been taken.
Section 5.6Limitations on Suits by Securityholders. No Holder of any Security of any Series or Holder of any Coupon shall have any right by virtue or by availing of any provision of this Indenture to institute any action or proceeding at law or in equity or in bankruptcy or otherwise upon or under or with respect to this Indenture, or for the appointment of a trustee, receiver, liquidator, custodian or other similar official or for any other remedy hereunder, unless such Holder previously shall have given to the Trustee written notice of default and of the continuance thereof, as hereinbefore provided, and unless also the Holders of not less than 25% in aggregate principal amount of the Securities of such Series then Outstanding shall have made written request upon the Trustee to institute such action or proceedings in its own name as trustee hereunder and shall have offered to the Trustee such indemnity satisfactory to the Trustee, as it may require against the costs, expenses and liabilities to be incurred therein or thereby and the Trustee for 60 days after its receipt of such notice, request and offer of indemnity shall have failed to institute any such action or proceeding and no direction inconsistent with such written request shall have been given to the Trustee pursuant to Section 5.9; it being understood and intended, and being expressly covenanted by the taker and Holder of every Security and by a Holder of each Coupon appertaining thereto with every other taker and Holder of a Security or Holder of any Coupon appertaining thereto and the Trustee, that no one or more Holders of Securities of any Series or one or more Holders of any Coupons appertaining thereto shall have any right in any manner whatever, by virtue or by availing of any provision of this Indenture to affect, disturb or




35

203



prejudice the rights of any other such Holder of Securities or any other Holders of such Coupons, or to obtain or seek to obtain priority over or preference to any other such Holder or to enforce any right under this Indenture, except in the manner herein provided and for the equal, ratable and common benefit of all Holders of Securities of the applicable Series and all the Holders of Coupons appertaining thereto (it being understood that the Trustee does not have an affirmative duty to ascertain whether or not such actions or forbearances are unduly prejudicial to such Holders). For the protection and enforcement of the provisions of this Section, each and every Securityholder and the Trustee shall be entitled to such relief as can be given either at law or in equity.
Section 5.7Unconditional Right of Securityholders to Institute Certain Suits. Notwithstanding any provision in this Indenture and any provision of any Security or Coupon, the right of any Holder of any Security and the right of any Holder of any Coupon appertaining thereto to receive payment of the principal of and interest on such Security on or after the respective due dates expressed in such Security, or to institute suit for the enforcement of any such payment on or after such respective dates, shall not be impaired or affected without the consent of such Holder.
Section 5.8Powers and Remedies Cumulative; Delay or Omission Not Waiver of Default. Except as provided in Section 5.6, no right or remedy herein conferred upon or reserved to the Trustee or to the Securityholders is intended to be exclusive of any other right or remedy, and every right and remedy shall, to the extent permitted by law, be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other appropriate right or remedy.
No delay or omission of the Trustee or of any Securityholder to exercise any right or power accruing upon any Event of Default occurring and continuing as aforesaid shall impair any such right or power or shall be construed to be a waiver of any such Event of Default or an acquiescence therein; and, subject to Section 5.6, every power and remedy given by this Indenture or by law to the Trustee, to the Securityholders or to the Holder of any Coupon appertaining thereto may be exercised from time to time, and as often as shall be deemed expedient, by the Trustee, the Securityholders or Holders of any Coupon.
Section 5.9Control by Securityholders. The Holders of a majority in aggregate principal amount of the Securities of each Series affected (with each Series treated as a separate class) at the time Outstanding shall have the right to direct the time, method, and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred on the Trustee with respect to the Securities of such Series by this Indenture; provided that such direction shall not be otherwise than in accordance with law and the provisions of this Indenture and provided further that (subject to the provisions of Section 6.1) the Trustee shall have the right to decline to follow any such direction if the Trustee, being advised by counsel, shall determine that the action or proceeding so directed may not lawfully be taken or if the Trustee in good faith by its board of directors, the executive committee, or a trust committee of directors or Responsible Officers of the Trustee shall determine that the action or proceedings so directed would involve the Trustee in personal liability or if the Trustee in good faith shall so determine that the actions or forebearances specified in or pursuant to such direction would be unduly prejudicial to the interests of Holders of the Securities of all Series or of the Holders of any Coupons appertaining thereto so affected not joining in the giving of said direction, it being




36

204



understood that (subject to Section 6.1) the Trustee shall have no duty to ascertain whether or not such actions or forbearances are unduly prejudicial to such Holders.
Nothing in this Indenture shall impair the right of the Trustee in its discretion to take any action deemed proper by the Trustee and which is not inconsistent with such direction or directions by Securityholders.
Section 5.10Waiver of Past Defaults. Prior to the declaration of the acceleration of the maturity of the Securities of any Series as provided in Section 5.1, in the case of any event specified in clause (d) or (g) of Section 5.1 (which relates to less than all Series of Securities then Outstanding), the Holders of a majority in aggregate principal amount of the Securities then Outstanding affected thereby (each Series treated as a separate class) may waive any such default or Event of Default, or, in the case of an event specified in clause (d), (g) (if the Event of Default under clause (d) or (g) relates to all Series of Securities then Outstanding), (e) or (f) of Section 5.1, the Holders of a majority in principal amount of all the Securities then Outstanding (treated as one class) may waive any such default or Event of Default and its consequences except a default in respect of a covenant or provision hereof which cannot be modified or amended without the consent of the Holder of each Security affected. In the case of any such waiver, the Company, the Trustee, the Holders of the Securities of such Series and the Holder of any Coupon appertaining thereto shall be restored to their former positions and rights hereunder, respectively; but no such waiver shall extend to any subsequent or other default or impair any right consequent thereon.
Upon any such waiver, such default shall cease to exist and be deemed to have been cured and not to have occurred, and any Event of Default arising therefrom shall be deemed to have been cured and not to have occurred for every purpose of this Indenture; but no such waiver shall extend to any subsequent or other default or Event of Default or impair any right consequent thereon.
Section 5.11Trustee to Give Notice of Default, But May Withhold in Certain Circumstances. The Trustee shall transmit to the Securityholders of any Series notice in the manner and to the extent provided in Section 11.4, of all defaults known to it which have occurred with respect to such Series, such notice to be transmitted within 90 days after the occurrence thereof, unless such defaults shall have been cured before the giving of such notice (the term “default” or “defaults” for the purposes of this Section being hereby defined to mean any event or condition which is, or with notice or lapse of time or both would become, an Event of Default); provided that, except in the case of default in the payment of the principal of or interest on any of the Securities of such Series or any default in the payment of any sinking fund installment or analogous obligation in respect of any of the Securities of such Series, the Trustee shall be protected in withholding such notice if and so long as the board of directors, the executive committee, or a trust committee of directors or trustees or Responsible Officers of the Trustee in good faith determines that the withholding of such notice is in the interests of the Securityholders of such Series.
Section 5.12Right of Court to Require Filing of Undertaking to Pay Costs. All parties to this Indenture agree, and each Holder of any Security and each Holder of any Coupon, by his acceptance thereof, shall be deemed to have agreed, that any court may in its discretion require, in any suit for the enforcement of any right or remedy under this Indenture or in any suit against the Trustee for any action taken, suffered or omitted by it as Trustee, the filing by any party



37

205



litigant in such suit of an undertaking to pay the costs of such suit, and that such court may in its discretion assess reasonable costs, including reasonable attorneys’ fees and expenses, against any party litigant in such suit, having due regard to the merits and good faith of the claims or defenses made by such party litigant; but the provisions of this Section shall not apply to any suit instituted by the Trustee, to any suit instituted by any Securityholder or group of Securityholders of any Series holding in the aggregate more than 10% in aggregate principal amount of the Securities of such Series, or, in the case of any suit relating to or arising under clause (d) or (g) of Section 5.1 (if the suit relates to Securities of more than one but less than all Series), 10% in aggregate principal amount of Securities Outstanding affected thereby, or in the case of any suit relating to or arising under clause (d), (g) (if the suit under clause (d) or (g) relates to all the Securities then Outstanding), (e) or (f) of Section 5.1, 10% in aggregate principal amount of all Securities Outstanding, or to any suit instituted by any Securityholder for the enforcement of the payment of the principal of or interest on any Security on or after the due date expressed in such Security.

ARTICLE SIX

CONCERNING THE TRUSTEE

Section 6.1Duties and Responsibilities of the Trustee; Prior to Default; During Default. With respect to the Holders of any Series of Securities issued hereunder, the Trustee, prior to the occurrence of an Event of Default with respect to the Securities of a particular Series and after the curing or waiving of all Events of Default which may have occurred with respect to such Series, undertakes to perform such duties and only such duties as are specifically set forth in this Indenture. In case an Event of Default with respect to the Securities of a Series has occurred (which has not been cured or waived) of which a Responsible Officer has actual knowledge, the Trustee shall exercise such of the rights and powers vested in it by this Indenture, and use the same degree of care and skill in their exercise, as a prudent person would exercise or use under the circumstances in the conduct of his or her own affairs.
No provision of this Indenture shall be construed to relieve the Trustee from liability for its own negligent action, its own negligent failure to act or its own willful misconduct, except that
(a)
prior to the occurrence of an Event of Default with respect to the Securities of any Series and after the curing or waiving of all such Events of Default with respect to such Series which may have occurred:
(i)
the duties and obligations of the Trustee with respect to the Securities of any Series shall be determined solely by the express provisions of this Indenture, and the Trustee shall not be liable except for the performance of such duties and obligations as are specifically set forth in this Indenture, and no implied covenants or obligations shall be read into this Indenture against the Trustee; and
(ii)
in the absence of bad faith on the part of the Trustee, the Trustee may conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon any statements, certificates or opinions furnished to the Trustee and conforming to the requirements of this






38

206



Indenture; but in the case of any such statements, certificates or opinions which by any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture (but need not confirm the accuracy or mathematical calculations or other facts stated therein);
(b)
the Trustee shall not be liable for any error of judgment made in good faith by a Responsible Officer or Responsible Officers of the Trustee, unless it shall be proved that the Trustee was negligent in ascertaining the pertinent facts; and
(c)
the Trustee shall not be liable with respect to any action taken or omitted to be taken by it in good faith in accordance with the direction of the Holders pursuant to Section 5.9 relating to the time, method and place of conducting any proceeding for any remedy available to the Trustee, or exercising any trust or power conferred upon the Trustee, under this Indenture.
None of the provisions contained in this Indenture shall require the Trustee to expend or risk its own funds or otherwise incur personal financial liability in the performance of any of its duties or in the exercise of any of its rights its rights or powers, if there shall be reasonable ground for believing that the repayment of such funds or adequate indemnity against such liability is not reasonably assured to it.
Section 6.2Certain Rights of the Trustee. Subject to Section 6.1:
(a)
the Trustee may conclusively rely and shall be protected in acting or refraining from acting upon any resolution, Officer’s Certificate or any other certificate, statement, instrument, opinion, report, notice, request, consent, order, bond, debenture, note, coupon, security or other paper or document believed by it to be genuine and to have been signed or presented by the proper party or parties;
(b)
any request, direction, order or demand of the Company mentioned herein shall be sufficiently evidenced by an Officer’s Certificate (unless other evidence in respect thereof be herein specifically prescribed); and any resolution of the Board of Directors may be evidenced to the Trustee by a copy thereof certified by the secretary or any assistant secretary of the Company;
(c)
the Trustee may consult with counsel of its selection and any advice or Opinion of Counsel shall be full and complete authorization and protection in respect of any action taken, suffered or omitted to be taken by it hereunder in good faith and in accordance with such advice or Opinion of Counsel;
(d)
the Trustee shall be under no obligation to exercise any of the trusts or powers vested in it by this Indenture at the request, order or direction of any of the Securityholders pursuant to the provisions of this Indenture, unless such Securityholders shall have offered to the Trustee reasonable security or indemnity satisfactory to the Trustee against the costs, expenses and liabilities which might be incurred therein or thereby;







39

207



(e)
the Trustee shall not be liable for any action taken or omitted by it in good faith and believed by it to be authorized or within the discretion, rights or powers conferred upon it by this Indenture;
(f)
the Trustee may execute any of the trusts or powers hereunder or perform any duties hereunder either directly or by or through agents or attorneys not regularly in its employ and the Trustee shall not be responsible for any misconduct or negligence on the part of any such agent or attorney appointed with due care by it hereunder;
(g)
whenever in the administration of this Indenture the Trustee shall deem it desirable that a matter be proved or established prior to taking, suffering or omitting any action hereunder, the Trustee (unless other evidence be herein specifically prescribed) may, in the absence of bad faith on its part, conclusively rely upon an Officer’s Certificate;
(h)
the Trustee shall not be bound to make any investigation into the facts or matters stated in any resolution, certificate, statement, instrument, opinion, report, notice, request, direction, consent, order, bond, debenture, note, other evidence of indebtedness or other paper or document, but the Trustee, in its discretion, may make such further inquiry or investigation into such facts or matters as it may see fit, and, if the Trustee shall determine to make such further inquiry or investigation, it shall be entitled to examine the books, records and premises of the Company, personally or by agent or attorney at the sole cost of the Company and shall incur no liability or additional liability of any kind by reason of such inquiry or investigation;
(i)
in no event shall the Trustee be responsible or liable for special, indirect, punitive or consequential loss or damage of any kind whatsoever (including, but not limited to, loss of profit) irrespective of whether the Trustee has been advised of the likelihood of such loss or damage and regardless of the form of action;
(j)
the Trustee shall not be deemed to have notice of any Default or Event of Default unless a written notice of any event which is in fact such a default is received by the Trustee at the Corporate Trust Office of the Trustee, and such notice references the Securities and this Indenture; and
(k)
the rights, privileges, protections, immunities and benefits given to the Trustee, including, without limitation, its right to be indemnified, are extended to, and shall be enforceable by, the Trustee in each of its capacities hereunder, and each agent, custodian and other Person employed to act hereunder.
Section 6.3Trustee Not Responsible for Recitals, Disposition of Securities or Application of Proceeds Thereof. The recitals contained herein and in the Securities, except the Trustee’s certificate of authentication, shall be taken as the statements of the Company, and the Trustee assumes no responsibility for the correctness of the same. The Trustee makes no representation as to the validity or sufficiency of this Indenture or of the Securities. The Trustee







40

208



shall not be accountable for the use or application by the Company of any of the Securities or of the proceeds thereof.
Section 6.4Trustee and Agents May Hold Securities; Collections, etc. The Trustee, any Paying Agent, Security registrar, or any agent of the Company or the Trustee, in its individual or any other capacity, may become the owner or pledgee of Securities or Coupons with the same rights it would have if it were not the Trustee or such agent and, subject to Sections 6.8 and 6.13, if operative, may otherwise deal with the Company and receive, collect, hold and retain collections from the Company with the same rights it would have if it were not the Trustee or such agent.
Section 6.5Moneys Held by Trustee. Subject to the provisions of Section 10.4 hereof, all moneys received by the Trustee shall, until used or applied as herein provided, be held in trust for the purposes for which they were received, but need not be segregated from other funds except to the extent required by mandatory provisions of law. Neither the Trustee nor any agent of the Company or the Trustee shall be under any liability for interest on any moneys received by it hereunder.
Section 6.6Compensation and Indemnification of Trustee and Its Prior Claim. The Company covenants and agrees to pay to the Trustee from time to time, and the Trustee shall be entitled to, such compensation as the Company and the Trustee shall from time to time agree in writing for all services rendered by it hereunder (which shall not be limited by any provision of law in regard to the compensation of a trustee of an express trust) and the Company covenants and agrees to pay or reimburse the Trustee and each predecessor Trustee upon its request for all reasonable expenses, disbursements and advances incurred or made by or on behalf of it in accordance with any of the provisions of this Indenture (including the reasonable compensation and properly documented out of pocket expenses and disbursements of its counsel and of all agents and other persons not regularly in its employ) except any such expense, disbursement or advance as shall be caused by its own negligence or willful misconduct. The Company also covenants to indemnify the Trustee and each predecessor Trustee for, and to hold it harmless against, any and all loss, liability, damage, claim or expense incurred without negligence or willful misconduct on its part, arising out of or in connection with the acceptance or administration of this Indenture or the trusts hereunder and its duties hereunder, including the reasonable costs and expenses (including the reasonable compensation and properly documented out of pocket expenses and disbursements of its agents and counsel) of defending itself against or investigating any claim of liability in the premises (whether asserted by the Company, any Holder or any other Person). The obligations of the Company under this Section to compensate and indemnify the Trustee and each predecessor Trustee and to pay or reimburse the Trustee and each predecessor Trustee for reasonable and properly documented out of pocket expenses, disbursements and advances shall constitute additional indebtedness hereunder. The provisions of this Section 6.6 shall survive the satisfaction and discharge of this Indenture and the resignation or removal of the Trustee. Such additional indebtedness shall be a senior claim to that of the Securities upon all property and funds held or collected by the Trustee as such, except funds held in trust for the benefit of the Holders of particular Securities or the Holders of particular Coupons, and the Securities are hereby subordinated to such senior claim. When the Trustee incurs expenses or renders services in connection with an Event of Default specified in Section 5.1 or in connection with Article Five hereof, the expenses (including the reasonable fees and expenses of its counsel) and the




41

209



compensation for the service in connection therewith are intended to constitute expenses of administration under any bankruptcy law.
Section 6.7Right of Trustee to Rely on Officer’s Certificate, etc. Subject to Sections 6.1 and 6.2, whenever in the administration of the trusts of this Indenture the Trustee shall deem it necessary or desirable that a matter be proved or established prior to taking or suffering or omitting any action hereunder, such matter (unless other evidence in respect thereof be herein specifically prescribed) may, in the absence of negligence or bad faith on the part of the Trustee, be deemed to be conclusively proved and established by an Officer’s Certificate delivered to the Trustee, and such certificate, in the absence of negligence or bad faith on the part of the Trustee, shall be full warrant to the Trustee for any action taken, suffered or omitted by it or under the provisions of this Indenture upon the faith thereof.
Section 6.8Disqualification of Trustee; Conflicting Interests. If the Trustee has or shall acquire any conflicting interest, as defined in the Trust Indenture Act, then, within 90 days after ascertaining that it has such conflicting interest, and if the default (as defined in the Trust Indenture Act) to which such conflicting interest relates has not been cured or waived or otherwise eliminated before the end of such 90-day period, the Trustee shall either eliminate such conflicting interest or resign in the manner and with the effect specified in the Trust Indenture Act and this Indenture.
Section 6.9Persons Eligible for Appointment as Trustee. The Trustee for each Series of Securities hereunder shall at all times be a corporation organized and doing business under the laws of the United States of America or of any State or the District of Columbia having a combined capital and surplus of at least $50,000,000, and which is authorized under such laws to exercise corporate trust powers and is subject to supervision or examination by Federal, State or District of Columbia authority. Such corporation shall have its principal place of business in the United States of America, if there be such a corporation in such location willing to act upon reasonable and customary terms and conditions. If such corporation publishes reports of condition at least annually, pursuant to law or to the requirements of the aforesaid supervising or examining authority, then for the purposes of this Section, the combined capital and surplus of such corporation shall be deemed to be its combined capital and surplus as set forth in its most recent report of condition so published. In case at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section, the Trustee shall resign immediately in the manner and with the effect specified in Section 6.10.
Section 6.10Resignation and Removal; Appointment of Successor Trustee. (a) The Trustee, or any trustee or trustees hereafter appointed, may at any time resign with respect to one or more or all Series of Securities by giving written notice of resignation to the Company and by mailing notice thereof to the Holders in the manner and to the extent provided in Section 11.4. Upon receiving such notice of resignation, the Company shall promptly appoint a successor trustee or trustees with respect to the applicable Series by written instrument in duplicate, executed by authority of the Board of Directors, one copy of which instrument shall be delivered to the resigning Trustee and one copy to the successor trustee or trustees. If no successor trustee shall have been so appointed with respect to any Series and have accepted appointment within 30 days after the mailing of such notice of resignation, the resigning trustee may petition any court of competent jurisdiction for the appointment of a successor trustee, or any Securityholder who has







42

210



been a bona fide Holder of a Security or Securities of the applicable Series for at least six months may, subject to the provisions of Section 5.12, on behalf of himself and all others similarly situated, petition any such court for the appointment of a successor trustee. Such court may thereupon, after such notice, if any, as it may deem proper and prescribe, appoint a successor trustee.
(b)
In case at any time any of the following shall occur:
(i)
the Trustee shall fail to comply with the provisions of Section 6.8 with respect to any Series of Securities after written request therefor by the Company or by any Securityholder who has been a bona fide Holder of a Security or Securities of such Series for at least six months; or
(ii)
the Trustee shall cease to be eligible in accordance with the provisions of Section 6.9 and shall fail to resign after written request therefor by the Company or by any Securityholder; or
(iii)
the Trustee shall become incapable of acting with respect to any Series of the Securities, or shall be adjudged a bankrupt or insolvent, or a receiver or liquidator of the Trustee or of its property shall be appointed, or any public officer shall take charge or control of the Trustee or of its property or affairs for the purpose of rehabilitation, conservation or liquidation;
then, in any such case, the Company may remove the Trustee with respect to the applicable Series of Securities and appoint a successor trustee for such Series by written instrument, in duplicate, executed by order of the Board of Directors of the Company, one copy of which instrument shall be delivered to the Trustee so removed and one copy to the successor trustee, or, subject to the provisions of Section 5.12, any Securityholder who has been a bona fide Holder of a Security or Securities of such Series for at least six months may on behalf of himself and all others similarly situated, petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor trustee with respect to such Series. Such court may thereupon, after such notice, if any, as it may deem proper and prescribe, remove the Trustee and appoint a successor trustee. If no successor Trustee shall be appointed with respect to any Series and have accepted appointment within 30 days after the giving of such notice of removal, the trustee being removed may petition at the expense of the Company any court of competent jurisdiction for the appointment of a successor trustee with respect to the Securities of such series.
(c)
The Holders of a majority in aggregate principal amount of the Securities of each Series at the time Outstanding may at any time remove the Trustee with respect to Securities of such Series and appoint a successor trustee with respect to the Securities of such Series by delivering to the Trustee so removed, to the successor trustee so appointed and to the Company the evidence provided for in Section 7.1 of the action in that regard taken by the Securityholders.








43

211



(d)
Any resignation or removal of the Trustee with respect to any Series and any appointment of a successor trustee with respect to such Series pursuant to any of the provisions of this Section 6.10 shall become effective upon acceptance of appointment by the successor trustee as provided in Section 6.11.
Section 6.11Acceptance of Appointment by Successor Trustee. Any successor trustee appointed as provided in Section 6.10 shall execute and deliver to the Company and to its predecessor Trustee an instrument accepting such appointment hereunder, and thereupon the resignation or removal of the predecessor Trustee with respect to all or any applicable Series shall become effective and such successor trustee, without any further act, deed or conveyance, shall become vested with all rights, powers, duties and obligations with respect to such Series of its predecessor hereunder, with like effect as if originally named as trustee for such Series hereunder; but, nevertheless, on the written request of the Company or of the successor trustee, upon payment of its charges then unpaid, the trustee ceasing to act shall, subject to Section 10.4, pay over to the successor trustee all moneys at the time held by it hereunder and shall execute and deliver an instrument transferring to such successor trustee all such rights, powers, duties and obligations. Upon request of any such successor trustee, the Company shall execute any and all instruments in writing for more fully and certainly vesting in and confirming to such successor trustee all such rights and powers. Any trustee ceasing to act shall, nevertheless, retain a prior claim upon all property or funds held or collected by such trustee to secure any amounts then due it pursuant to the provisions of Section 6.6.
If a successor trustee is appointed with respect to the Securities of one or more (but not all) Series, the Company, the predecessor Trustee and each successor trustee with respect to the Securities of any applicable Series shall execute and deliver an indenture supplemental hereto which shall contain such provisions as shall be deemed necessary or desirable to confirm that all the rights, powers, trusts and duties of the predecessor Trustee with respect to the Securities of any Series as to which the predecessor Trustee is not retiring shall continue to be vested in the predecessor Trustee, and shall add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one trustee, it being understood that nothing herein or in such supplemental indenture shall constitute such trustees co-trustees of the same trust and that each such trustee shall be trustee of a trust or trusts under separate indentures.
No successor trustee with respect to any Series of Securities shall accept appointment as provided in this Section 6.11 unless at the time of such acceptance such successor trustee shall be qualified under the provisions of Section 6.8 and eligible under the provisions of Section 6.9.
Upon acceptance of appointment by any successor trustee as provided in this Section 6.11, the Company shall give notice in the manner and to the extent provided in Section 11.4 to the Holders of Securities of any Series for which such successor trustee is acting as trustee at their last addresses as they shall appear in the Security register. If the acceptance of appointment is substantially contemporaneous with the resignation, then the notice called for by the preceding sentence may be combined with the notice called for by Section 6.10. If the Company fails to mail such notice within ten days after acceptance of appointment by the successor trustee, the successor trustee shall cause such notice to be mailed at the expense of the Company.



44

212



Section 6.12Merger, Conversion, Consolidation or Succession to Business of Trustee. Any corporation into which the Trustee may be merged or converted or with which it may be consolidated, or any corporation resulting from any merger, conversion or consolidation to which the Trustee shall be a party, or any corporation succeeding to all or substantially all the corporate trust business of the Trustee, shall be the successor of the Trustee hereunder, provided that such corporation shall be qualified under the provisions of Section 6.8 and eligible under the provisions of Section 6.9, without the execution or filing of any paper or any further act on the part of any of the parties hereto, anything herein to the contrary notwithstanding.
In case at the time such successor to the Trustee shall succeed to the trusts created by this Indenture any of the Securities of any Series shall have been authenticated but not delivered, any such successor to the Trustee may adopt the certificate of authentication of any predecessor Trustee and deliver such Securities so authenticated; and, in case at that time any of the Securities of any Series shall not have been authenticated, any successor to the Trustee may authenticate such Securities either in the name of any predecessor Trustee hereunder or in the name of the successor Trustee; and in all such cases such certificates shall have the full force which it is anywhere in the Securities of such Series or in this Indenture provided that the certificate of the Trustee shall have; provided, that the right to adopt the certificate of authentication of any predecessor Trustee or to authenticate Securities of any Series in the name of any predecessor Trustee shall apply only to its successor or successors by merger, conversion or consolidation.
Section 6.13Preferential Collection of Claims Against the Company. If and when the Trustee shall be or become a creditor of the Company (or any other obligor upon the Securities), the Trustee shall be subject to the provisions of the Trust Indenture Act regarding the collection of claims against the Company (or any such other obligor).
Section 6.14Appointment of Authenticating Agent. The Trustee may appoint an Authenticating Agent or Agents with respect to one or more Series of Securities which shall be authorized to act on behalf of the Trustee to authenticate Securities of such Series issued upon original issue or upon exchange, registration of transfer or partial redemption thereof or pursuant to Section 2.9, and Securities so authenticated shall be entitled to the benefits of this Indenture and shall be valid and obligatory for all purposes as if authenticated by the Trustee hereunder. Wherever reference is made in this Indenture to the authentication and delivery of Securities by the Trustee or the Trustee’s certificate of authentication or any other action in connection therewith, such reference shall be deemed to include authentication and delivery on behalf of the Trustee by an Authenticating Agent and a certificate of authentication executed on behalf of the Trustee by an Authenticating Agent and other action taken on behalf of the Trustee by an Authenticating Agent. Each Authenticating Agent shall be acceptable to the Company.
An Authenticating Agent may resign at any time by giving written notice thereof to the Trustee and to the Company. The Trustee may at any time terminate the agency of an Authenticating Agent by giving written notice thereof to such Authenticating Agent and to the Company. Upon receiving such a notice of resignation or upon such a termination, the Trustee may appoint a successor Authenticating Agent which shall be acceptable to the Company and shall give notice of such appointment to all Holders of Securities in the manner provided in Section 11.4. Any successor Authenticating Agent upon acceptance of its appointment hereunder shall become vested with all the rights, powers and duties of its predecessor hereunder, with the effect




45

213



as if originally named as an Authenticating Agent. No successor Authenticating Agent shall be appointed unless acceptable to the Company.
The Company agrees to pay to each Authenticating Agent from time to time reasonable compensation for its services under this Section.
If an appointment with respect to one or more Series of Securities is made pursuant to this Section, the Securities of such Series may have endorsed thereon, in addition to the Trustee’s certificate of authentication, an alternative certificate of authentication in the following form:
This is one of the Securities of the Series designated herein and referred to in the within-mentioned Indenture.
The Bank of New York Mellon Trust Company, N.A.,
 
as Trustee
 
 
By:
 
 
As Authenticating Agent
 
 
By:
 
 
Authorized Signatory
 
 
Dated:
 

ARTICLE SEVEN

CONCERNING THE SECURITYHOLDERS

Section 7.1Evidence of Action Taken by Securityholders. (a) Any request, demand, authorization, direction, notice, consent, waiver or other action provided by this Indenture to be given or taken by a specified percentage in principal amount of the Securityholders of any or all Series may be embodied in and evidenced by one or more instruments of substantially similar tenor signed by such specified percentage of Securityholders in person or by agent duly appointed in writing; and, except as herein otherwise expressly provided, such action shall become effective when such instrument or instruments are delivered to the Trustee. Proof of execution of any instrument or of a writing appointing any such agent shall be sufficient for any purpose of this Indenture and (subject to Sections 6.1 and 6.2) conclusive in favor of the Trustee and the Company, if made in the manner provided in this Article.
(b)
The ownership of Registered Securities shall be proved by the Security register.
(c)
The amount of Unregistered Securities held by any Person executing any instrument or writing as a Securityholder, the numbers of such Unregistered





46

214



Securities, and the date of his holding the same may be proved by the production of such Securities or by a certificate executed by any trust company, bank, broker or member of a national securities exchange (wherever situated), as depositary, if such certificate is in form satisfactory to the Trustee, showing that at the date therein mentioned such Person had on deposit with such depositary, or exhibited to it, the Unregistered Securities therein described; or such facts may be proved by the certificate or affidavit of the Person executing such instrument or writing as a Securityholder, if such certificate or affidavit is in form satisfactory to the Trustee. The Trustee and the Company may assume that such ownership of any Unregistered Security continues until (i) another certificate or affidavit bearing a later date issued in respect of the same Unregistered Security is produced, or (ii) such Unregistered Security is produced by some other person, or (iii) such Unregistered Security is surrendered in exchange for a Registered Security, or (iv) such Unregistered Security has been cancelled in accordance with Section 2.10.
Section 7.2Proof of Execution of Instruments. Subject to Sections 6.1 and 6.2, the execution of any instrument by a Securityholder or his agent or proxy may be proved in accordance with such reasonable rules and regulations as may be prescribed by the Trustee or in such manner as shall be satisfactory to the Trustee.
Section 7.3Holders to Be Treated as Owners. The Company, the Trustee and any Agent of the Company or the Trustee may deem and treat the person in whose name any Security shall be registered upon the Security register for such Series as the absolute owner of such Security (whether or not such Security shall be overdue and notwithstanding any notation of ownership or other writing thereon) for the purpose of receiving payment of or on account of the principal of and interest on such Security and for all other purposes; and neither the Company nor the Trustee nor any Agent of the Company or the Trustee shall be affected by any notice to the contrary. All such payments so made to any such person, or upon his order, shall be valid, and, to the extent of the sum or sums so paid, effectual to satisfy and discharge the liability for moneys payable upon any such Security.
Section 7.4Securities Owned by Company Deemed Not Outstanding. In determining whether the Holders of the requisite aggregate principal amount of Outstanding Securities of any or all Series have concurred in any direction, consent or waiver under this Indenture, Securities which are owned by the Company or any other obligor on the Securities with respect to which such determination is being made or by any person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company or any other obligor on the Securities with respect to which such determination is being made shall be disregarded and deemed not to be Outstanding for the purpose of any such determination, except that for the purpose of determining whether the Trustee shall be protected in conclusively relying on any such direction, consent or waiver only Securities which a Responsible Officer of the Trustee actually knows are so owned shall be so disregarded. Securities so owned which have been pledged in good faith may be regarded as Outstanding if the pledgee establishes to the satisfaction of the Trustee the pledgee’s right so to act with respect to such Securities and that the pledgee is not the Company or any other obligor upon the Securities or any person directly or indirectly controlling or controlled by or under direct or indirect common control with the Company or any other obligor on the Securities. In case of a dispute as to such right, the advice of counsel shall be




47

215



full protection in respect of any decision made by the Trustee in accordance with such advice. Upon request of the Trustee, the Company shall furnish to the Trustee promptly an Officer’s Certificate listing and identifying all Securities, if any, known by the Company to be owned or held by or for the account of any of the above-described persons; and, subject to Sections 6.1 and 6.2, the Trustee shall be entitled to accept such Officer’s Certificate as conclusive evidence of the facts therein set forth and of the fact that all Securities not listed therein are Outstanding for the purpose of any such determination.
Section 7.5Right of Revocation of Action Taken. At any time prior to (but not after) the evidencing to the Trustee, as provided in Section 7.1, of the taking of any action by the Holders of the percentage in aggregate principal amount of the Securities of any or all Series, as the case may be, specified in this Indenture in connection with such action, any Holder of a Security the serial number of which is shown by the evidence to be included among the serial numbers of the Securities the Holders of which have consented to such action may, by filing written notice at the Corporate Trust Office and upon proof of holding as provided in this Article, revoke such action so far as concerns such Security. Except as aforesaid any such action taken by the Holder of any Security shall be conclusive and binding upon such Holder and upon all future Holders and owners of such Security and of any Securities issued in exchange or substitution therefor, irrespective of whether or not any notation in regard thereto is made upon any such Security. Any action taken by the Holders of the percentage in aggregate principal amount of the Securities of any or all Series, as the case may be, specified in this Indenture in connection with such action shall be conclusively binding upon the Company, the Trustee and the Holders of all the Securities affected by such action.
Section 7.6    Record Date for Determination of Holders Entitled to Vote. The Company may, in the circumstances permitted by the Trust Indenture Act, set a record date for the purpose of determining the Securityholders entitled to give or take any request, demand, authorization, direction, notice, consent, waiver or other action, or to vote on any action, authorized or permitted to be given or taken by Securityholders. If not set by the Company prior to the first solicitation of a Securityholder made by any Person in respect of any such action, or, in the case of any such vote, prior to such vote, the record date for any such action or vote shall be the 30th day (or, if later, the date of the most recent list of Holders required to be provided pursuant to Section 4.1) prior to such first solicitation or vote, as the case may be. With regard to any record date, only the Holders on such date (or their duly appointed proxies) shall be entitled to give or take, or vote on, the relevant action.

ARTICLE EIGHT

SUPPLEMENTAL INDENTURES

Section 8.1Supplemental Indentures Without Consent of Securityholders. The Company, when authorized by a Board Resolution, and the Trustee may from time to time and at any time enter into an indenture or indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as in force at the date of the execution thereof) for one or more of the following purposes:










48

216



(a)
to convey, transfer, assign, mortgage or pledge to the Trustee as security for the Securities of one or more Series any property or assets;
(b)
to evidence the succession of another corporation to the Company, or successive successions, and the assumption by the successor corporation of the covenants, agreements and obligations of the Company pursuant to Article Nine;
(c)
to add to the covenants of the Company, or of any guarantor of the Securities, such further covenants, restrictions, conditions or provisions as its Board of Directors and the Trustee shall consider to be for the protection of the Holders of Securities, and to make the occurrence, or the occurrence and continuance, of a default in any such additional covenants, restrictions, conditions or provisions an Event of Default permitting the enforcement of all or any of the several remedies provided in this Indenture as herein set forth; provided, that in respect of any such additional covenant, restriction, condition or provision such supplemental indenture may provide for a particular period of grace after default (which period may be shorter or longer than that allowed in the case of other defaults) or may provide for an immediate enforcement upon such an Event of Default or may limit the remedies available to the Trustee upon such an Event of Default or may limit the right of the Holders of a majority in aggregate principal amount of the Securities of such Series to waive such an Event of Default;
(d)
to cure any ambiguity or to correct or supplement any provision contained herein or in any supplemental indenture which may be defective or inconsistent with any other provision contained herein or in any supplemental indenture; or to make such other provisions in regard to matters or questions arising under this Indenture or under any supplemental indenture as the Board of Directors may deem necessary or desirable and which shall not materially and adversely affect the interests of the Holders of the Securities or the Holders of any Coupons;
(e)
to establish the form or terms of Securities of any Series as permitted by Sections 2.1 and 2.3;
(f)
to evidence and provide for the acceptance of appointment hereunder by a successor trustee with respect to the Securities of one or more Series and to add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than the one trustee, pursuant to the requirements of Section 6.11;
(g)
to evidence the Guarantee by Dow pursuant to Article 3.B; or
(h)
to evidence a guarantee by any other entity that issues a guarantee in respect of the Securities.
The Trustee is hereby authorized to join with the Company in the execution of any such supplemental indenture, to make any further appropriate agreements and stipulations which may be therein contained and to accept the conveyance, transfer, assignment, mortgage or pledge of any property thereunder, but the Trustee shall not be obligated to enter into any such supplemental






49

217



indenture which affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise.
Any supplemental indenture authorized by the provisions of this Section may be executed without the consent of the Holders of any of the Securities at the time Outstanding, notwithstanding any of the provisions of Section 8.2.
Section 8.2    Supplemental Indentures With Consent of Securityholders. With the consent (evidenced as provided in Article Seven) of the Holders of more than 50% of the aggregate principal amount of the Securities at the time Outstanding of all Series affected by such supplemental indenture (treated as one class), the Company, when authorized by a Board Resolution, and the Trustee may, from time to time and at any time, enter into an indenture or indentures supplemental hereto (which shall conform to the provisions of the Trust Indenture Act as in force at the date of execution thereof) for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of this Indenture or of any supplemental indenture or of modifying in any manner the rights of the Holders of the Securities of each such Series; provided, that no such supplemental indenture shall (a) extend the final maturity of any Security, or reduce the principal amount thereof, or reduce the rate or extend the time of payment of interest thereon, or reduce any amount payable on redemption thereof, or reduce the amount of principal of an Original Issue Discount Security that would be due and payable upon an acceleration of the maturity thereof pursuant to Section 5.1 or the amount provable in bankruptcy pursuant to Section 5.2, or impair or affect the right of any Securityholder to institute suit for payment thereof or, if the Securities provide therefor, any right of repayment at the option of the Securityholder without the consent of the Holder of each Security so affected, or (b) reduce the aforesaid percentage of Securities of any Series, the consent of the Holders of which is required for any such supplemental indenture, without the consent of the Holders of each Security so affected.
Upon the request of the Company, accompanied by a copy of a Board Resolution authorizing the execution of any such supplemental indenture, and upon the filing with the Trustee of evidence of the consent of Securityholders as aforesaid and other documents, if any, required by Section 7.1, the Trustee shall join with the Company in the execution of such supplemental indenture unless such supplemental indenture affects the Trustee’s own rights, duties or immunities under this Indenture or otherwise, in which case the Trustee may in its discretion, but shall not be obligated to, enter into such supplemental indenture.
It shall not be necessary for the consent of the Securityholders under this Section to approve the particular form of any proposed supplemental indenture, but it shall be sufficient if such consent shall approve the substance thereof.
Promptly after the execution by the Company and the Trustee of any supplemental indenture pursuant to the provisions of this Section, the Company shall give notice in the manner and to the extent provided in Section 11.4 to the Holders of Securities of each Series affected thereby at their addresses as they shall appear on the registry books of the Company, setting forth in general terms the substance of such supplemental indenture. Any failure of the Company to mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture.




50

218



Section 8.3Effect of Supplemental Indenture. Upon the execution of any supplemental indenture pursuant to the provisions hereof, this Indenture shall be and be deemed to be modified and amended in accordance therewith and the respective rights, limitations of rights, obligations, duties and immunities under this Indenture of the Trustee, the Company and the Holders of Securities of each Series and Holders of Coupons affected thereby shall thereafter be determined, exercised and enforced hereunder subject in all respects to such modifications and amendments, and all the terms and conditions of any such supplemental indenture shall be and be deemed to be part of the terms and conditions of this Indenture for any and all purposes.
Section 8.4Documents to Be Given to Trustee. The Trustee, subject to the provisions of Sections 6.1 and 6.2, shall be provided with an Officer’s Certificate and an Opinion of Counsel as conclusive evidence that any supplemental indenture executed pursuant to this Article Eight complies with the applicable provisions and is authorized or permitted by of this Indenture.
Section 8.5    Notation on Securities in Respect of Supplemental Indentures. Securities of any Series authenticated and delivered after the execution of any supplemental indenture pursuant to the provisions of this Article may bear, upon the direction of the Company, a notation in form satisfactory to the Trustee for such Series as to any matter provided for by such supplemental indenture or as to any action taken at any such meeting. If the Company or the Trustee shall so determine, new Securities of any Series so modified as to conform, in the opinion of the Trustee and the Board of Directors, to any modification of this Indenture contained in any such supplemental indenture may be prepared by the Company, authenticated by the Trustee and delivered in exchange for the Securities of such Series then outstanding.

ARTICLE NINE

CONSOLIDATION, MERGER, SALE OR CONVEYANCE

Section 9.1Company May Consolidate, etc., on Certain Terms. The Company covenants that it will not merge or consolidate with any other corporation or sell or convey all or substantially all of its assets to any Person, unless (i) either the Company shall be the continuing corporation, or the successor corporation or the Person which acquires by sale or conveyance substantially all the assets of the Company (if other than the Company) shall be a corporation organized under the laws of the United States of America or any State thereof and shall expressly assume the due and punctual payment of the principal of and interest on all the Securities, according to their tenor, and the due and punctual performance and observance of all of the covenants and conditions of this Indenture to be performed or observed by the Company, by supplemental indenture satisfactory to the Trustee, executed and delivered to the Trustee by such corporation, and (ii) the Company or such successor corporation, as the case may be, shall not, immediately after such merger or consolidation, or such sale or conveyance, be in default in the performance of any such covenant or condition.
Section 9.2    Successor Corporation Substituted. In case of any such consolidation, merger, sale or conveyance, and following such an assumption by the successor corporation, such successor corporation shall succeed to and be substituted for the Company, with the same effect as if it had been named herein. Such successor corporation may cause to be signed, and may issue





51

219



either in its own name or in the name of the Company prior to such succession any or all of the Securities issuable hereunder which theretofore shall not have been signed by the Company and delivered to the Trustee; and, upon the Company Order of such successor corporation instead of the Company and subject to all the terms, conditions and limitations in this Indenture prescribed, the Trustee shall authenticate and shall deliver any Securities which previously shall have been signed and delivered by the officers of the Company to the Trustee for authentication, and any Securities which such successor corporation thereafter shall cause to be signed and delivered to the Trustee for that purpose. All of the Securities so issued shall in all respects have the same legal rank and benefit under this Indenture as the Securities theretofore or thereafter issued in accordance with the terms of this Indenture as though all of such Securities had been issued at the date of the execution hereof.
In case of any such consolidation, merger, sale, lease or conveyance such changes in phraseology and form (but not in substance) may be made in the Securities thereafter to be issued as may be appropriate.
In the event of any such sale or conveyance (other than a conveyance by way of lease) the Company or any successor corporation which shall theretofore have become such in the manner described in this Article shall be discharged from all obligations and covenants under this Indenture and the Securities and may be liquidated and dissolved.
Section 9.3    Opinion of Counsel to Trustee. The Trustee, subject to the provisions of Sections 6.1 and 6.2, shall be provided with an Opinion of Counsel, prepared in accordance with Section 11.5, as conclusive evidence that any such consolidation, merger, sale, lease or conveyance, and any such assumption, and any such liquidation or dissolution, complies with the applicable provisions of this Indenture.

ARTICLE TEN

SATISFACTION AND DISCHARGE OF INDENTURE; UNCLAIMED MONEYS

Section 10.1Satisfaction and Discharge of Indenture

(a)
If at any time (i) the Company shall have paid or caused to be paid the principal of and interest on all the Securities of any Series and Coupons, if any, appertaining thereto Outstanding hereunder (other than Securities and Coupons which have been destroyed, lost or stolen and which have been replaced or paid as provided in Section 2.9) as and when the same shall have become due and payable, or (ii) the Company shall have delivered to the Trustee for cancellation all Securities of any Series and Coupons theretofore authenticated (other than any Securities of such Series and Coupons which have been destroyed, lost or stolen and which shall have been replaced or paid as provided in Section 2.9) or (iii)(A) all the Securities of such Series and Coupons not theretofore delivered to the Trustee for cancellation shall have become due and payable, or are by their terms to become due and payable within one year or are to be called for redemption within one year under arrangements satisfactory to the Trustee for the giving of notice of redemption, and (B) the Company shall have irrevocably deposited or caused to be deposited with







52

220



the Trustee as trust funds the entire amount in cash (other than moneys repaid by the Trustee or any Paying Agent to the Company in accordance with Section 10.4) or U.S. Government Obligations, as defined below, maturing as to principal and interest in such amounts and at such times as will ensure the availability of cash sufficient to pay at maturity or upon redemption all Securities of such Series and Coupons (other than any Securities of such Series and Coupons which shall have been destroyed, lost or stolen and which shall have been replaced or paid as provided in Section 2.9) not theretofore delivered to the Trustee for cancellation, including principal and interest due or to become due to such date of maturity as the case may be, and if, in any such case, the Company shall also pay or cause to be paid all other sums payable hereunder by the Company with respect to Securities of such Series and Coupons, then this Indenture shall cease to be of further effect with respect to Securities of such Series and Coupons (except as to (i) rights of registration of transfer and exchange, and the Company’s right of optional redemption, (ii) substitution of mutilated, defaced, destroyed, lost or stolen Securities and Coupons, (iii) rights of Holders to receive payments of principal thereof and interest thereon upon the original stated due dates therefor (but not upon acceleration) and remaining rights of the Holders to receive mandatory sinking fund payments, if any, (iv) the rights, obligations and immunities of the Trustee hereunder and (v) the rights of the Securityholders of such Series as beneficiaries hereof with respect to the property so deposited with the Trustee payable to all or any of them), and the Trustee, on demand of the Company accompanied by an Officer’s Certificate and an Opinion of Counsel and at the cost and expense of the Company, shall execute proper instruments acknowledging such satisfaction of and discharging this Indenture with respect to such Series; provided, that the rights of Holders of the Securities and Holders of Coupons to receive amounts in respect of principal of and interest on the Securities and Coupons held by them shall not be delayed longer than required by then-applicable mandatory rules or policies of any securities exchange upon which the Securities are listed. The Company agrees to reimburse the Trustee for any costs or expenses thereafter reasonably and properly incurred and to compensate the Trustee for any services thereafter reasonably and properly rendered by the Trustee in connection with this Indenture, the Securities of such Series and Coupons.
(b)
In addition to the provisions of Section 10.1(a), the Company may terminate its obligations under the Securities of any Series and this Indenture with respect to such Series, except those obligations referred to in the penultimate paragraph of this Section 10.1, if the Company has irrevocably deposited or caused to be deposited with the Trustee, under the terms of an irrevocable trust agreement in form and substance satisfactory to the Trustee, as trust funds in trust solely for the benefit of the Securityholders of such Series for that purpose, (i) cash or (ii) direct noncallable obligations of, or noncallable obligations guaranteed by, the United States of America or an agency thereof for the payment of which guarantee or obligation the full faith and credit of the United States of America is pledged (“U.S. Government Obligations”), or a combination thereof, maturing as to principal and interest in such amounts and at such times as are sufficient, without consideration of any reinvestment of such principal or interest, to pay the principal of and interest




53

221



on the outstanding Securities of such Series and Coupons to maturity or redemption, as the case may be, provided that the Trustee shall have been irrevocably instructed to apply such money or the proceeds of such U.S. Government Obligations to the payment of said principal of and interest on the Outstanding Securities and Coupons of such Series.
Such irrevocable trust agreement shall include, among other things, provision for (1) payment of the principal of and interest on the Securities of such Series and Coupons when due (by redemption, sinking fund payments or otherwise), (2) the payment of the expenses of the Trustee incurred or to be incurred in connection with carrying out such trust provisions, (3) rights of registration, transfer, substitution and exchange of Securities of such Series and Coupons in accordance with the terms stated in this Indenture and (4) continuation of the rights and obligations and immunities of the Trustee as against the Securityholders of such Series as stated in this Indenture.
Notwithstanding the first paragraph of this Section 10.1(b), the Company’s obligations, if any, in Sections 2.8, 2.9, 3.1, 3.2, 5.1, 6.1, 6.2, 6.6, 6.10, 10.4 and 10.5 shall survive until the Securities of such Series and Coupons, if any, are no longer Outstanding; provided, however, that the Company’s obligations, if any, in Section 5.1 shall survive only with respect to Events of Default as defined in Sections 5.1(a), 5.1(b), and 5.1(c). Thereafter, the Company’s obligations, if any, in Sections 6.6, 10.4 and 10.5 shall survive such satisfaction and discharge.
After any such irrevocable deposit, in each case sufficient, in the opinion of an independent firm or certified public accountants, accompanied by an Officer’s Certificate which shall state that the provisions of the first two paragraphs of this Section 10.1(b) have been complied with, and upon delivery by the Company to the Trustee of an opinion of independent legal counsel who shall be satisfactory to the Trustee to the effect that Securityholders of such Series will not recognize income, gain or loss for Federal income tax purposes as a result of such deposit and discharge and will be subject to Federal income tax on the same amount and in the same manner and at the same time as would have been the case if such deposit and discharge had not occurred, then the Company shall be discharged of its obligations under the Securities of such Series and this Indenture with respect to such Series except for those surviving obligations specified above, and the Trustee upon request shall acknowledge in writing such discharge. Prior to the delivery of such acknowledgment, the Trustee may require the Company to deliver to it an Officer’s Certificate and Opinion of Counsel, each stating that all conditions precedent provided for herein relating to the deposit and discharge contemplated by this provision have been complied with, and the Trustee may also require that the Opinion of Counsel shall also state that such deposit does not violate applicable law.
Section 10.2    Application by Trustee of Funds Deposited for Payment of Securities. Subject to Section 10.4, all moneys deposited with the Trustee pursuant to Section 10.1 shall be held in trust and applied by it to the payment, either directly or through any Paying Agent








54

222



(including the Company acting as its own Paying Agent), to the Holders of the particular Securities of such Series and any Coupons appertaining thereto for the payment or redemption of which such moneys have been deposited with the Trustee, of all sums due and to become due thereon for principal and interest; but such money need not be segregated from other funds except to the extent required by law.
Section 10.3Repayment of Moneys Held by Paying Agent. In connection with the satisfaction and discharge of this Indenture with respect to Securities of any Series or Coupons, all moneys then held by any Paying Agent under the provisions of this Indenture with respect to such Series of Securities or Coupons shall, upon demand of the Company, be repaid to the Company or paid to the Trustee and thereupon such Paying Agent shall be released from all further liability with respect to such moneys.
Section 10.4Return of Unclaimed Moneys Held by Trustee and Paying Agent. Any moneys deposited with or paid to the Trustee or any Paying Agent for the payment of the principal of or interest on any Security of any Series or Coupons and not applied but remaining unclaimed for two years after the date upon which such principal or interest shall have become due and payable, shall, upon the written request of the Company and unless otherwise required by mandatory provisions of applicable escheat or abandoned or unclaimed property law, be repaid to the Company by the Trustee for such Series or such Paying Agent, and the Holder of the Security of such Series or Holders of Coupons appertaining thereto shall, unless otherwise required by mandatory provisions of applicable escheat or abandoned or unclaimed property laws, thereafter look only to the Company for any payment which such Holder may be entitled to collect, and all liability of the Trustee or any Paying Agent with respect to such moneys shall thereupon cease.
Section 10.5    Reinstatement of Company’s Obligations. If the Trustee is unable to apply any funds or U.S. Government Obligations in accordance with Section 10.1 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application, the Company’s obligations under this Indenture and the Securities of any Series for which such application is prohibited shall be revived and reinstated as if no deposit had occurred pursuant to Section 10.1 until such time as the Trustee is permitted to apply all such funds or U.S. Government Obligations in accordance with Section 10.1; provided, however, that if the Company has made any payment of interest on or principal of any of such Securities or Coupons because of the reinstatement of its obligations, the Company shall be subrogated to the rights of the Securityholders of such Securities to receive such payment from the funds or U.S. Government Obligations held by the Trustee.

ARTICLE ELEVEN

MISCELLANEOUS PROVISIONS

Section 11.1Incorporators, Stockholders, Officers and Directors of Company Exempt from Individual Liability. No recourse under or upon any obligation, covenant or agreement contained in this Indenture, in any Security or Coupon appertaining thereto, or because of any indebtedness evidenced thereby, shall be had against any incorporator, as such or against any past, present or future stockholder, officer or director, as such, of the Company or of any successor, either directly or through the Company or any successor, under any rule of law, statute






55

223



or constitutional provision or by the enforcement of any assessment or by any legal or equitable proceeding or otherwise, all such liability being expressly waived and released by the acceptance of the Securities by the Holders thereof and as part of the consideration for the issue of the Securities.
Section 11.2    Provisions of Indenture for the Sole Benefit of Parties and Securityholders. Nothing in this Indenture or in the Securities, expressed or implied, shall give or be construed to give to any Person, firm or corporation, other than the parties hereto, any Paying Agent and their successors hereunder and the Holders of the Securities and Coupons, if any, any legal or equitable right, remedy or claim under this Indenture or under any covenant or provision herein contained, all such covenants and provisions being for the sole benefit of the parties hereto and their successors and of the Holders of the Securities.
Section 11.3Successors and Assigns of Company Bound by Indenture. All the covenants, stipulations, promises and agreements in this Indenture contained by or on behalf of the Company shall bind its successors and assigns, whether so expressed or not.
Section 11.4Notices and Demands on Company, Trustee and Securityholders. Any notice or demand which by any provision of this Indenture is required or permitted to be given or served by the Trustee, by the Holders of Securities, or by the Holders of Coupons to or on the Company may be given or served by being deposited postage prepaid, first-class mail (except as otherwise specifically provided herein) addressed (until another address of the Company is filed by the Company with the Trustee) to The Dow Chemical Company and Dow Inc., 2211 H.H. Dow Way, Midland, Michigan 48674, Attention: Vice President and Treasurer, except that any notices required or permitted to be given under Section 5.1 hereof shall be given or served by registered or certified mail only. Any notice, direction, request or demand by the Company or any Securityholder to or upon the Trustee shall be deemed to have been sufficiently given or made, for all purposes, if given or made at the Corporate Trust Office.
Where this Indenture provides for notice to Holders of any event, (1) if any of the Securities affected by such event are Registered Securities, such notice shall be sufficiently given (unless otherwise herein expressly provided) if in writing and mailed by first-class mail, postage prepaid to such Registered Holders as their names and addresses appear in the Security register within the time prescribed or otherwise transmitted and (2) if any of the Securities affected by such event are Unregistered Securities, such notice shall be sufficiently given (unless otherwise herein expressly provided) if published once in a newspaper of general circulation in New York, New York and London, England and in such other city or cities as may be specified in such Securities within the time prescribed. Where this Indenture provides for notice in any manner, such notice may be waived in writing by the Person entitled to receive such notice, either before or after the event, and such waiver shall be the equivalent of such notice. Waivers of notice by Holders shall be filed with the Trustee, but such filing shall not be a condition precedent to the validity of any action taken in reliance upon such waiver. In any case where notice to Holders is given by mail, neither the failure to mail such notice, nor any defect in any notice so mailed to any particular Holder shall affect the sufficiency of such notice with respect to other Holders, and any notice which is mailed in the manner herein provided shall be conclusively presumed to have been duly given.





56

224



In case, by reason of the suspension of or irregularities in regular mail service, it shall be impracticable to mail notice to the Company and Securityholders when such notice is required to be given pursuant to any provision of this Indenture, then any manner of giving such notice as shall be satisfactory to the Trustee shall be deemed to be a sufficient giving of such notice.
Section 11.5Officer’s Certificates and Opinions of Counsel; Statements to Be Contained Therein. Upon any application or demand by the Company to the Trustee to take any action under any of the provisions of this Indenture, the Company shall furnish to the Trustee an Officer’s Certificate stating that all conditions precedent provided for in this Indenture relating to the proposed action have been complied with and an Opinion of Counsel stating that in the opinion of such counsel all such conditions precedent have been complied with, except that in the case of any such application or demand as to which the furnishing of such documents is specifically required by any provision of this Indenture relating to such particular application or demand, no additional certificate or opinion need be furnished.
Each certificate or opinion provided for in this Indenture and delivered to the Trustee with respect to compliance with a condition or covenant provided for in this Indenture (other than certificates provided pursuant to Section 4.3(d)) shall include (a) a statement that the person making such certificate or opinion has read such covenant or condition, (b) a brief statement as to the nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based, (c) a statement that, in the opinion of such person, he has made such examination or investigation as is necessary to enable him to express an informed opinion as to whether or not such covenant or condition has been complied with and (d) a statement as to whether or not, in the opinion of such person, such condition or covenant has been complied with.
Any certificate, statement or opinion of an officer of the Company may be based, insofar as it relates to legal matters, upon a certificate or opinion of or representations by counsel, unless such officer knows that the certificate or opinion or representations with respect to the matters upon which his certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise of reasonable care should know that the same are erroneous. Any certificate, statement or opinion of counsel may be based, insofar as it relates to factual matters, information with respect to which is in the possession of the Company, upon the certificate, statement or opinion of or representations by an officer or officers of the Company, unless such counsel knows that the certificate, statement or opinion or representations with respect to the matters upon which his certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise of reasonable care should know that the same are erroneous.
Any certificate, statement or opinion of an officer of the Company or of counsel may be based, insofar as it relates to accounting matters, upon a certificate or opinion of or representations by an accountant or firm of accountants in the employ of the Company, unless such officer or counsel, as the case may be, knows that the certificate or opinion or representations with respect to the accounting matters upon which his certificate, statement or opinion may be based as aforesaid are erroneous, or in the exercise of reasonable care should know that the same are erroneous.




57

225



Any certificate or opinion of any independent firm of public accountants filed with the Trustee shall contain a statement that such firm is independent.
Section 11.6Payments Due on Saturdays, Sundays and Holidays. If the date of maturity of interest on or principal or premium, if any, of the Securities of any Series or Coupons appertaining thereto or the date fixed for redemption or repayment of any such Security or Coupon shall not be a Business Day, then payment of interest, principal or premium, if any, need not be made on such date, but may be made on the next succeeding Business Day with the same force and effect as if made on the date of maturity or the date fixed for redemption, and no interest shall accrue for the period after such date.
Section 11.7Conflict of Any Provision of Indenture with Trust Indenture Act. If any provision of this Indenture limits, qualifies or conflicts with the duties imposed by any of Sections 310 through 317 of the Trust Indenture Act, by the operation of Section 318(c) thereof, such imposed duties shall control, except as, and to the extent, expressly excluded from this Indenture, as permitted by the Trust Indenture Act. If any provision of this Indenture modifies or excludes any provision of the Trust Indenture Act that may be so modified or excluded, the latter provision shall be deemed to apply to this Indenture as so modified or excluded, as the case may be.
Section 11.8New York Law to Govern; Waiver of Jury Trial. This Indenture and each Security shall be deemed to be a contract under the laws of the State of New York, and for all purposes shall be construed in accordance with the laws of such State without regard to conflicts of laws principles thereof.

EACH OF THE ISSUER AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THE INDENTURE, THE NOTES OR THE TRANSACTION CONTEMPLATED HEREBY.
Section 11.9Counterparts. This Indenture may be executed in any number of counterparts, each of which shall be an original; but such counterparts shall together constitute but one and the same instrument.
Section 11.10Effect of Headings. The Article and Section headings herein and the Table of Contents are for convenience only and shall not affect the construction hereof.
Section 11.11Determination of Principal Amount; Calculation of Original Issue Discount. In determining whether the Holders of the requisite principal amount of outstanding Securities of any Series have given any request, demand, authorization, direction, notice, consent or waiver hereunder, or whether sufficient funds are available for redemption or for any other purpose, the principal amount of an Original Issue Discount Security that shall be deemed to be outstanding for such purposes shall be the amount of the principal thereof that would be due and payable as of the date of such determination upon a declaration of acceleration of the maturity thereof pursuant to Section 5.1 and the principal amount of any Securities denominated in a Foreign Currency or ECU that shall be deemed to be outstanding for such purposes shall be determined by converting the Foreign Currency or the Specified Amount of each Component Currency into Dollars at the Market Exchange Rate as of the date of such determination.







58

226



The Company shall file with the Trustee promptly at the end of each calendar year (i) a written notice specifying the amount of original issue discount (including daily rates and accrual periods) accrued on Outstanding Securities as of the end of such year and (ii) such other specific information relating to such original issue discount as may then be relevant under the Internal Revenue Code.
Section 11.12    Force Majeure. In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of or caused by, directly or indirectly, any forces which are reasonably beyond its control, including, without limitation strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services (provided, in each such case, such forces are outside of the Trustee’s control) ; it being understood that the Trustee shall use reasonable efforts which are at least consistent with accepted practices in the banking industry and no less rigorous than those efforts expended on other clients similarly situated to the Company to resume performance as soon as practicable under the circumstances.

ARTICLE TWELVE

REDEMPTION OF SECURITIES AND SINKING FUNDS

Section 12.1Applicability of Article. The provisions of this Article shall be applicable to the Securities of any Series which are redeemable before their maturity or to any sinking fund for the retirement of Securities of a Series except as otherwise specified as contemplated by Section 2.3 for Securities of such Series.
Section 12.2    Notice of Redemption; Partial Redemptions. Notice of redemption to the Holders of Securities of any Series to be redeemed as a whole or in part at the option of the Company shall be given by giving notice of such redemption as provided in Section 11.4, at least 15 days and not more than 60 days prior to the date fixed for redemption to such Holders of Securities of such Series; provided that the Trustee be given at least five days’ notice prior to sending the notice of redemption. Failure to give notice by mail, or any defect in the notice to the Holder of any Security of a Series designated for redemption as a whole or in part shall not affect the validity of the proceedings for the redemption of any other Security of such Series.
The notice of redemption to each such Holder shall identify the Securities to be redeemed (including CUSIP number) and shall specify the date fixed for redemption, the redemption price (or the method of calculating the redemption price), the place or places of payment, that payment will be made upon presentation and surrender of such Securities, and that, unless otherwise specified in such notice, Coupon Securities, if any, surrendered for payment must be accompanied by all Coupons maturing subsequent to the redemption date, failing which the amount of any such missing Coupon or Coupons will be deducted from the sum due for payment, that such redemption is pursuant to the mandatory or optional sinking fund, or both, if such be the case, that interest accrued to the date fixed for redemption will be paid as specified in such notice and that on and after said date interest thereon or on the portions thereof to be redeemed will cease to accrue and





59

227



that, if less than all of the Outstanding Securities of a Series are to be redeemed, the identification and principal amount of the Securities to be redeemed, and if applicable, any condition to such redemption. In case any Security of a Series is to be redeemed in part, the notice of redemption shall state the portion of the principal amount thereof to be redeemed and shall state that on and after the date fixed for redemption, upon surrender of such Security, a new Security or Securities of such Series in principal amount equal to the unredeemed portion thereof will be issued.
The notice of redemption of Securities of any Series to be redeemed at the option of the Company shall be given by the Company or, at the Company’s written request, by the Trustee in the name and at the expense of the Company.
On or prior to 10:00 a.m., New York City time, the redemption date specified in the notice of redemption given as provided in this Section, the Company will deposit with the Trustee or with one or more paying agents (or, if the Company is acting as its own paying agent, set aside, segregate and hold in trust as provided in Section 3.4) an amount of money sufficient to redeem on the redemption date all the Securities of such Series so called for redemption at the appropriate redemption price, together with accrued interest to the date fixed for redemption. The Company will deliver to the Trustee at least 30 days prior to the date fixed for redemption an Officer’s Certificate stating the aggregate principal amount of Securities to be redeemed.
If less than all the Securities of a Series are to be redeemed, Securities of such Series to be redeemed in whole or in part shall be selected in accordance with the procedures of the depositary. Securities may be redeemed in part in multiples equal to the minimum authorized denomination for Securities of such Series or any multiple thereof. The Trustee shall promptly notify the Company in writing of the Securities of such Series selected for redemption and, in the case of any Securities of such Series selected for partial redemption, the principal amount thereof to be redeemed. For all purposes of this Indenture, unless the context otherwise requires, all provisions relating to the redemption of Securities of any Series shall relate, in the case of any Security redeemed or to be redeemed only in part, to the portion of the principal amount of such Security which has been or is to be redeemed.
Section 12.3Payment of Securities Called for Redemption. If notice of redemption has been given as above provided, the Securities or portions of Securities specified in such notice shall become due and payable on the date and at the place stated in such notice at the applicable redemption price, together with interest accrued to the date fixed for redemption, and on and after said date, subject to any condition stated therein (unless the Company shall default in the payment of such Securities at the redemption price, together with interest accrued to said date), interest on the Securities or portions of Securities so called for redemption shall cease to accrue and, except as provided in Sections 6.5 and 10.4, such Securities shall cease from and after the date fixed for redemption to be entitled to any benefit or security under this Indenture, and the Holders thereof shall have no right in respect of such Securities except the right to receive the redemption price thereof and unpaid interest to the date fixed for redemption. On presentation and surrender of such Securities at a place of payment specified in said notice, said Securities or the specified portions thereof shall be paid and redeemed by the Company at the applicable redemption price, together with interest accrued thereon to the date fixed for redemption; provided that any semiannual payment of interest on Registered Securities becoming due on the date fixed for redemption shall





60

228



be payable to the Holders of such Securities registered as such on the relevant record date subject to the terms and provisions of Section 2.7 hereof.
If any Security called for redemption shall not be so paid upon surrender thereof for redemption, the principal shall, until paid or duly provided for, bear interest from the date fixed for redemption at the rate of interest borne by the Security.
If any condition precedent has not been satisfied, the Company shall provide written notice to the Trustee prior to the close of business at least two Business Days prior to the redemption date (unless a shorter period of time shall be agreed to by the Trustee). Upon receipt of such notice, the notice of redemption shall be rescinded and the redemption of the Series of Securities shall not occur. Upon receipt, the Trustee shall provide such notice to each Holder of the Securities that were to be redeemed in the same manner in which the notice of redemption was given.
Upon presentation of any Security redeemed in part only and the Coupons appertaining thereto, the Company shall execute and the Trustee shall authenticate and deliver to or on the order of the Holder thereof, at the expense of the Company, a new Security or Securities and the Coupons appertaining thereto, of authorized denominations, in principal amount equal to the unredeemed portion of the Security so presented.
Section 12.4Exclusion of Certain Securities from Eligibility for Selection for Redemption. Securities shall be excluded from eligibility for selection for redemption if they are identified by registration and certificate number in a written statement signed by an authorized officer of the Company and delivered to the Trustee at least 60 days prior to the last date on which notice of redemption may be given as being owned of record and beneficially by, and not pledged or hypothecated by, either (a) the Company or (b) an entity specifically identified in such written statement directly or indirectly controlling or controlled by or under direct or indirect common control with the Company.
Section 12.5Mandatory and Optional Sinking Funds. The minimum amount of any sinking fund payment provided for by the terms of Securities of any Series is herein referred to as a “mandatory sinking fund payment,” and any payment in excess of such minimum amount provided for by the terms of Securities of any Series is herein referred to as an “optional sinking fund payment”. The date on which a sinking fund payment is to be made is herein referred to as the “sinking fund payment date”.
In lieu of making all or any part of any mandatory sinking fund payment with respect to any Series of Securities in cash, the Company may at its option (a) deliver to the Trustee Securities of such Series theretofore purchased or otherwise acquired (except upon redemption pursuant to the mandatory sinking fund) by the Company or receive credit for Securities of such Series (not previously so credited) theretofore purchased or otherwise acquired (except as aforesaid) by the Company and delivered to the Trustee for cancellation pursuant to Section 2.10, (b) receive credit for optional sinking fund payments (not previously so credited) made pursuant to this Section, or (c) receive credit for Securities of such Series (not previously so credited) redeemed by the Company through any optional redemption provision contained in the terms of such Series. Securities so delivered or credited shall be received or credited by the Trustee at the sinking fund redemption price specified in such Securities.




61

229



On or before the sixtieth day next preceding each sinking fund payment date for any Series, the Company will deliver to the Trustee an Officer’s Certificate (a) specifying the portion of the mandatory sinking fund payment to be satisfied by payment of cash and the portion to be satisfied by credit of Securities of such Series, (b) stating that none of the Securities of such Series has theretofore been so credited, (c) stating that no defaults in the payment of interest or Events of Default with respect to such Series have occurred (which have not been waived or cured) and are continuing, (d) stating whether or not the Company intends to exercise its right to make an optional sinking fund payment with respect to such Series and, if so, specifying the amount of such optional sinking fund payment which the Company intends to pay on or before the next succeeding sinking fund payment date and (e) specifying such sinking fund payment date. Any Securities of such Series to be credited and required to be delivered to the Trustee in order for the Company to be entitled to credit therefor as aforesaid which have not theretofore been delivered to the Trustee shall be delivered for cancellation pursuant to Section 2.10 to the Trustee with such Officers’ Certificate written statement (or reasonably promptly thereafter if acceptable to the Trustee). Such Officers’ Certificate shall be irrevocable and upon its receipt by the Trustee the Company shall become unconditionally obligated to make all the cash payments or payments therein referred to, if any, on or before the next succeeding sinking fund payment date. Failure of the Company, on or before any such sixtieth day, to deliver such written statement and Securities specified in this paragraph, if any, shall not constitute a default but shall constitute, on and as of such date, the irrevocable election of the Company (i) that the mandatory sinking fund payment for such Series due on the next succeeding sinking fund payment date shall be paid entirely in cash without the option to deliver or credit Securities of such Series in respect thereof and (ii) that the Company will make no optional sinking fund payment with respect to such Series as provided in this Section.
If the sinking fund payment or payments (mandatory or optional or both) to be made in cash on the next succeeding sinking fund payment date plus any unused balance of any preceding sinking fund payments made in cash shall exceed $50,000 (or a lesser sum if the Company shall so request) with respect to the Securities of any particular Series, such cash shall be applied on the next succeeding sinking fund payment date to the redemption of Securities of such Series at the sinking fund redemption price together with accrued interest to the date fixed for redemption. If such amount shall be $50,000 or less and the Company makes no such request then it shall be carried over until a sum in excess of $50,000 is available. The Trustee shall select, in the manner provided in Section 12.2, for redemption on such sinking fund payment date a sufficient principal amount of Securities of such Series to absorb said cash, as nearly as may be possible, and shall (if requested in writing by the Company) inform the Company of the serial numbers of the Securities of such Series (or portions thereof) so selected. Securities of any Series which are identified by registration and certificate number in an Officer’s Certificate at least 60 days prior to the sinking fund payment date as being beneficially owned by, and not pledged or hypothecated by, the Company or an entity directly or indirectly controlling or controlled by or under direct or indirect common control with the Company shall be excluded from Securities of such Series eligible for selection for redemption. The Trustee, in the name and at the expense of the Company (or the Company, if it shall so notify the Trustee in writing) shall cause notice of redemption of the Securities of such Series to be given in substantially the manner provided in Section 12.2 (and with the effect provided in Section 12.3) for the redemption of Securities of such Series in part at the option of the Company. The amount of any sinking fund payments not so applied or allocated to the redemption of Securities of such Series shall be added to the next cash sinking fund payment for such Series and, together with such payment, shall be applied in accordance with the provisions



62

230



of this Section. Any and all sinking fund moneys held on the stated maturity date of the Securities of any particular Series (or earlier, if such maturity is accelerated), which are not held for the payment or redemption of particular Securities of such Series shall be applied, together with other moneys, if necessary, sufficient for the purpose, to the payment of the principal of, and interest on, the Securities of such Series at maturity.
On or before each sinking fund payment date, the Company shall pay to the Trustee in cash or shall otherwise provide for the payment of all interest accrued to the date fixed for redemption on Securities to be redeemed on such sinking fund payment date.
The Trustee shall not redeem or cause to be redeemed any Securities of a Series with sinking fund moneys or mail or publish any notice of redemption of Securities for such Series by operation of the sinking fund during the continuance of a default in payment of interest on such Securities or of any Event of Default except that, where the mailing or publication of notice of redemption of any Securities shall theretofore have been made, the Trustee shall redeem or cause to be redeemed such Securities, provided that it shall have received from the Company a sum sufficient for such redemption. Except as aforesaid, any moneys in the sinking fund for such Series at the time when any such default or Event of Default shall occur, and any moneys thereafter paid into the sinking fund, shall, during the continuance of such default or Event of Default, be deemed to have been collected under Article Five and held for the payment of all such Securities. In case such Event of Default shall have been waived as provided in Section 5.10 or the default cured on or before the sixtieth day preceding the sinking fund payment date in any year, such moneys shall thereafter be applied on the next succeeding sinking fund payment date in accordance with this Section to the redemption of such Securities.



    



























63

231



IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed, all as of the day and year first above written.
THE DOW CHEMICAL COMPANY
as Issuer
 
 
By:
/s/Gary McGuire
 
Name: Gary McGuire
 
Title: Vice President and Treasurer
 
 
 
 
DOW INC.
as party with respect to sections described herein
 
 
By:
/s/Gary McGuire
 
Name: Gary McGuire
 
Title: Vice President and Treasurer
 
 
 
 
THE BANK OF NEW YORK MEELON TRUST COMPANY, N.A.
as Trustee
 
 
By:
/s/ Karen Yu
 
Name: Karen Yu
 
Title: Vice President

    
    













[Signature page to The Dow Chemical Company Indenture]


232



EXHIBIT A
        
    
    
FORM OF SUPPLEMENTAL INDENTURE
THIS [l] SUPPLEMENTAL INDENTURE, dated as of [l] (the “[l] Supplemental Indenture”), among THE DOW CHEMICAL COMPANY, a Delaware corporation (the “Company”), DOW INC., a Delaware corporation (“Dow”) and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., a national banking association, as trustee (the “Trustee”).
RECITALS OF THE COMPANY:
WHEREAS, the Company, Dow and the Trustee have heretofore executed and delivered an indenture, dated as of [l] (the “Indenture”), to provide for the issuance by the Company from time to time of Securities to be issued in one or more Series as provided in the Indenture;
WHEREAS, the Indenture provides for the entry of this [l] Supplemental Indenture substantially concurrently with the issuance by Dow of a guarantee in respect of outstanding or committed indebtedness under the Revolving Credit Facility Agreement.
WHEREAS, on the date hereof, Dow has guaranteed outstanding or committed indebtedness under the Revolving Credit Facility Agreement.
WHEREAS, Section 8.1(a) of the Indenture permits the Company and the Trustee to enter into indentures supplemental to the Indenture, without the consent of Securityholders, in connection with an issuance of a guarantee by Dow pursuant to Article 3.B of the Indenture; and
WHEREAS, all the conditions and requirements necessary to make this [l] Supplemental Indenture, when duly executed and delivered, a valid and binding agreement in accordance with its terms and for the purposes herein expressed, have been performed and fulfilled.
NOW THEREFORE, THIS SUPPLEMENTAL INDENTURE WITNESSETH:
The Company, Dow and the Trustee mutually covenant and agree for the equal and proportionate benefit of the respective Holders of the Securities of each Series outstanding from time to time under the Indenture as follows:



233



ARTICL ONE
RELATION TO INDENTURE; RULES OF CONSTRUCTION

Section 1.1 Relation to Indenture. This [l] Supplemental Indenture constitutes an integral part of the Indenture.

Section 1.2    Rules of Construction. For all purposes of this [l] Supplemental Indenture:

(a)
capitalized terms used herein without definition shall have the meanings specified in the Indenture;

(b)
all references herein to Articles and Sections, unless otherwise specified, refer to the corresponding Articles and Sections of this [l] Supplemental Indenture;

(c)
the terms “herein,” “hereof,” “hereunder” and other words of similar import refer to this [l] Supplemental Indenture; and

(d)
in the event of a conflict with the definition of terms in the Indenture, the definitions in this [l] Supplemental Indenture shall control.

ARTICLE TWO
DEFINITIONS

Section 2.1    For the benefit of the Holders of Securities outstanding from time to time under the Indenture, for so long as the Dow Guarantee is effective, the definitions of “Dow Consolidated Subsidiary,” “Dow Consolidated Net Tangible Assets,” “Dow Exempted Indebtedness,” “Dow intangible assets,” “Dow Guarantee,” “Dow Principal Property,” “Dow Subsidiary” and “Revolving Credit Facility Guarantee” in Section 1.1 of the Indenture shall be added in their proper alphabetical location:
“Dow Consolidated Subsidiary” means, at any date, any Subsidiary or other entity the accounts of which would be consolidated with those of Dow in its consolidated financial statements if such statements were prepared as of such date.
“Dow Consolidated Net Tangible Assets” means the total assets of Dow and Dow Consolidated Subsidiaries as shown on or reflected in its balance sheet less (a) all current liabilities (excluding current liabilities which could be classified as long-term debt in conformity with generally accepted accounting principles and current liabilities which are by their terms extendible or renewable at the option of the obligor thereon to a time more than 12 months after the time as of which the amount thereof is being computed), (b) advances to entities accounted for on the equity method of accounting, and (c) Dow intangible assets. “Dow intangible assets” means the aggregate value (net of any applicable reserves), as shown on or reflected in such balance sheet, of: (i) all trade names, trademarks, licenses, patents, copyrights and goodwill; (ii) organizational and development costs; (iii) deferred charges (other than prepaid items such as insurance, taxes, interest, commissions, rents and similar items and tangible assets being amortized); and (iv) unamortized debt discount and expense, less unamortized premium.
“Dow Exempted Indebtedness” means the sum of (i) all outstanding indebtedness of Dow and each of its Restricted Subsidiaries incurred after the date of this Indenture and
Ex A-2

234



secured by liens proscribed in paragraph (a) of Section 3.6, and (ii) the aggregate of present values (discounted at a rate per annum equal to the average interest borne by all Outstanding Securities determined on a weighted average basis and compounded semi- annually) of the obligations of Dow or any Restricted Subsidiaries for rental payments during the remaining term of all leases (including any period for which any such lease has been extended or may, at the option of the lessor, be extended) of all Dow Principal Property other than those leases expressly permitted by paragraph (a) of Section 3.7. The net amount of rent required to be paid under any such lease for any such term shall be the amount of the rent payable by the lessee with respect to such period, after excluding amounts required to be paid on account of maintenance and repairs, insurance, taxes, assessments, water rates and similar charges and contingent rents such as those based on sales. In the case of any such lease which is terminable by the lessee upon the payment of a penalty, such net amount shall also include the amount of such penalty, but no rent shall be considered as required to be paid under such lease subsequent to the first date upon which it may be so terminated.
“Dow Guarantee” means the irrevocable guarantee of Securities outstanding from time to time hereunder, on an unsecured basis and in accordance with the terms set forth in the [l] Supplemental Indenture.
“Dow Principal Property” means any manufacturing facility owned by Dow or any of its Restricted Subsidiaries and located within the United States (excluding its territories and possessions and the Commonwealth of Puerto Rico) the gross book value (without deduction of any depreciation reserves) of which on the date as of which the determination is being made exceeds one percent of Dow Consolidated Net Tangible Assets, other than any such facility or portion thereof which the board of directors of the Company or Dow, as the case may be, reasonably determines is not material to the business conducted by Dow and its Dow Subsidiaries as a whole.
“Dow Subsidiary” means any corporation, of which at least a majority of the Voting Stock is at the time owned directly or indirectly by Dow or by Dow and its other Dow Subsidiaries. The term “Voting Stock” means outstanding shares of stock having voting power for the election of directors, whether at all times or only so long as no senior class of stock has such voting power because of default in dividends or some other default.
“Revolving Credit Facility Guarantee” means the guarantee in respect of outstanding or committed indebtedness under the Revolving Credit Facility Agreement giving rise to the execution of the [l] Supplemental Indenture.
ARTICLE THREE
GUARANTEE

Section 3.1 Dow hereby irrevocably (except if terminated in accordance with the terms hereof), fully and unconditionally guarantees to the Trustee, for the benefit of the Trustee and for each Holder of Securities of each Series outstanding under the Indenture from time to time and their respective successors and assigns, (a) the full and punctual payment of the principal of and interest (and premium, if any) on the Securities of each Series outstanding under the Indenture from time to time when due, whether at maturity, by acceleration, by redemption or otherwise, and (b) the full and punctual performance within applicable grace periods of all other monetary obligations of the Company due and payable under the Indenture and the Securities of each Series outstanding under
Ex A-3

235



the Indenture from time to time (the Indenture and the Securities being hereinafter collectively called the “Guaranteed Obligations”). In case of the failure of the Company punctually to pay any Guaranteed Obligations, Dow hereby agrees to cause any such payment to be made punctually when and as the same shall become due, whether at maturity, by acceleration, by redemption or otherwise, and as if payment were made by the Company.
Section 3.2Dow hereby agrees that its obligations hereunder shall be as principal and not merely as surety, and shall be absolute, irrevocable (except if terminated in accordance with the terms hereof) and unconditional, irrespective of, and shall be unaffected by, any invalidity, irregularity or unenforceability of any Security, this [l] Supplemental Indenture or the Indenture, any failure to enforce the provisions of any Security, this [l] Supplemental Indenture or the Indenture, or any waiver, modification or consent granted with respect thereto by the Holder of such Security or the Trustee, the recovery of any judgment against the Company or any action to enforce the same, or any other circumstances which may otherwise constitute a legal or equitable discharge of a surety or guarantor.
As a separate and alternative stipulation, Dow unconditionally and irrevocably agrees that any sum expressed to be payable by the Company under the Guaranteed Obligations but which is for any reason (whether or not now known or becoming known to the Company, Dow, the Trustee or any Holder of any Guaranteed Obligation) not recoverable from Dow on the basis of a guarantee will nevertheless be recoverable from it as if it were the sole principal debtor and will be paid by it to the Trustee on demand. This indemnity constitutes a separate and independent obligation from the other obligations in this [l] Supplemental Indenture, gives rise to a separate and independent cause of action and will apply irrespective of any indulgence granted by the Trustee or any Holder of any Guaranteed Obligation.
Section 3.3 Dow hereby waives diligence, presentation to, demand of, payment from and protest to the Company of any of the Guaranteed Obligations and also waives notice of protest for nonpayment, filing of claims with any court in the event of merger insolvency or bankruptcy of the Company, any right to require a proceeding first against the Company, (ii) Dow waives notice of any default under the Securities or the Guaranteed Obligations, and (iii) the obligations of Dow hereunder shall not be affected by (a) the failure of any Holder or the Trustee to assert any claim or demand or to enforce any right or remedy against the Company or any other Person under the Indenture, the Securities or any other agreement or otherwise; (b) any extension or renewal of any thereof; (c) any rescission, waiver, amendment or modification of any of the terms or provisions of the Indenture or the Securities; (d) the failure of any Holder or the Trustee to exercise any right or remedy against any other guarantor of the Guaranteed Obligations; or (e) any change in the ownership of Dow.
Section 3.4Dow further agrees that the Dow Guarantee constitutes a guarantee of payment, and of performance and compliance with all payment obligations when due (and not a guarantee of collection), and waives any right to require that any resort be had by any Holder or the Trustee to any security held for payment of the Guaranteed Obligations.
Section 3.5The obligations of Dow hereunder shall not be subject to any reduction, limitation, impairment or termination for any reason, including any claim of waiver, release, surrender, alteration or compromise, and shall not be subject to any defense of setoff, counterclaim, recoupment or termination whatsoever or by reason of the invalidity, illegality or unenforceability of the Guaranteed Obligations or otherwise. Without limiting the generality of the foregoing, but



Ex A-4

236



without prejudice to the terms of the first paragraph of this Section 3.5, the obligations of Dow herein shall not be discharged or impaired or otherwise affected by the failure of any Holder or the Trustee to assert any claim or demand or to enforce any remedy under the Indenture or the Securities, by any waiver or modification of any term thereof, by any default, failure or delay, willful or otherwise, in the performance of the obligations, or by any other act or thing or omission or delay to do any other act or thing which may or might in any manner or to any extent vary the risk of Dow or would otherwise operate as a discharge of Dow as a matter of law or equity.
Section 3.6Dow further agrees that the Dow Guarantee herein shall continue to be effective or be reinstated, as the case may be, if at any time payment, or any part thereof, of principal of or interest on any Guaranteed Obligation is rescinded or must otherwise be restored by any Holder or the Trustee upon the bankruptcy or reorganization of the Company or otherwise.
Section 3.7Dow agrees that it shall not be entitled to any right of subrogation in respect of any Guaranteed Obligations guaranteed hereby until payment in full in cash of all Guaranteed Obligations, at which time Dow shall be fully subrogated to the rights of the Holders. Without prejudice to the terms of the Section 3.1, Dow further agrees that, as between it, on the one hand, and the Holders and the Trustee, on the other hand, (x) the maturity of the Guaranteed Obligations guaranteed hereby may be accelerated for the purposes of the Dow Guarantee, notwithstanding any stay, injunction or other prohibition preventing such acceleration in respect of the Guaranteed Obligations guaranteed hereby, and (y) in the event of any declaration of acceleration of such Guaranteed Obligations, such Guaranteed Obligations (whether or not due and payable) shall forthwith become due and payable by Dow for the purposes of this Section. Dow agrees that any right of indemnity, subrogation or contribution it may have under applicable law or otherwise shall be fully subordinated to the indefeasible payment in full in cash of the Guaranteed Obligations.
Section 3.8Dow also agrees to pay any and all reasonable out of pocket and documented costs and expenses (including reasonable attorneys’ fees) incurred by the Trustee or any Holder in enforcing any rights under the Dow Guarantee.
Section 3.9    The Dow Guarantee provided for in this Article Three shall terminate and shall be of no further force or effect upon any termination of the Revolving Credit Facility Guarantee provided if the Dow Guarantee has been terminated in accordance with this Section 3.9 and subsequent to such termination, the Revolving Credit Facility Guarantee shall have been subsequently provided by Dow, the Dow Guarantee shall be deemed reinstated and in force in all respects.

ARTICLE FOUR
AMENDMENTS TO THE INDENTURE
Section 4.1    For the benefit of the Holders of Securities of each Series outstanding under the Indenture from time to time, a new Section 3.9 of the Indenture is added as follows:
“SECTION 3.9 Limitation on Liens. (a) So long as any of the Securities remain outstanding and unpaid, Dow will not create, assume or suffer to exist and will cause, suffer or permit any of its Restricted Subsidiaries to create, assume or suffer to exist, any mortgage, pledge or lien of or upon any Dow Principal Property or additions thereto or shares of capital stock of any Restricted Subsidiary, whether owned at the date of this Indenture or thereafter acquired, without making effective provision, and Dow covenants that in any such case Dow


Ex A-5

237



will make or cause to be made effective provision, whereby the Securities then Outstanding shall be secured by such mortgage, pledge or lien equally and ratably with any and all other obligations and indebtedness thereby secured so long as such indebtedness is so secured; provided that the foregoing covenant shall not apply to any mortgage, pledge or lien (hereinafter in this Section 3.6 referred to as “liens”) of the following character:
(i)liens on Dow Principal Property existing at the time of acquisition of such Dow Principal Property or to secure the payment of all or any part of the purchase price of such Dow Principal Property or any addition thereto or to secure any indebtedness incurred at the time of, or within 120 days after, the acquisition of such Dow Principal Property or any addition thereto for the purpose of financing all or any part of the purchase price thereof (provided such liens are limited to such Dow Principal Property or additions thereto);
(ii)liens existing on the date of this Indenture;
(iii)liens on property or shares of capital stock, or arising out of any indebtedness of any corporation existing at the time such corporation became or was merged into Dow or a Restricted Subsidiary of Dow;
(iv)liens executed by any Restricted Subsidiary of Dow and exclusively securing indebtedness or evidences of indebtedness incurred or issued by such Restricted Subsidiary either to Dow or to any Dow Subsidiary;
(v)liens arising from assignments of money due and to become due under contracts between Dow or any of its Restricted Subsidiaries and the United States or any State, or any department, agency or political subdivision thereof;
(vi)liens of carriers, warehousemen, mechanics and materialmen incurred in the ordinary course of business for sums not yet due or being contested in good faith;
(vii)liens arising by reason of any judgment, decree or order of any court, so long as any appropriate legal proceedings which may have been duly initiated for the review of such judgment, decree or order shall not have been finally terminated or so long as the period within which such proceedings may be initiated shall not have expired; or pledges or deposits to secure payment of workmen’s compensation or other insurance, good faith deposits in connection with tenders, contracts (other than contracts for the payment of money) or leases, deposits to secure public or statutory obligations, deposits to secure public or statutory obligations, deposits to secure or in lieu of surety or appeal bonds, or deposits as security for the payment of taxes;
(viii)liens in connection with the issuance of tax-exempt industrial development or pollution control bonds or other similar bonds issued pursuant to Section 103(b) of the Internal Revenue Code, to finance all or any part of the purchase price of or the cost of constructing, equipping or improving property; provided that such liens shall be limited to such property acquired (including personal property) or constructed or such improvement and to thereto substantially unimproved real property on which such construction or improvement is located; and provided, further that Dow or any of its Restricted Subsidiaries may further secure all or any part of such purchase price or the cost of construction of such improvements and personal property by an interest in additional property of Dow and its Restricted Subsidiaries only to the extent necessary for the construction, maintenance and


Ex A-6

238



operation of, and access to, such property so acquired or constructed or such improvement;
(ix)liens in favor of any customer arising in respect of partial, progress, advance or other payments made by or on behalf of such customer for goods produced for or services rendered to such customer in the ordinary course of business not exceeding the amount of such payments;
(x)extensions, renewals or replacements, in whole or in part, of any lien referred to in the foregoing clauses (i) to (ix), inclusive, provided that the principal amount of indebtedness secured thereby shall not exceed the principal amount of indebtedness so secured at the time of such extension, renewal or replacement and that such extension, renewal or replacement shall be limited to all or any part of the same property that secured the lien extended, renewed or replaced (plus improvements on such property); and
(xi)(A) liens for taxes or assessments or governmental charges or levies not yet due or delinquent, or which can thereafter be paid without penalty, or which are being contested in good faith by appropriate proceedings; (B) landlord’s liens on property held under lease, and tenants’ rights under leases; (C) easements; and (D) any other liens of a nature similar to those hereinabove described in this clause (xi); in each case, which do not, in the opinion of Dow, materially impair the use of such property subject to such lien or covenant in the operation of the business of Dow or a Restricted Subsidiary or the value of such property for the purposes of such business.
b.Notwithstanding the provisions of paragraph (a) of this Section 3.6, Dow or any Restricted Subsidiary of Dow may create or assume liens; provided that at the time of such creation or assumption, and after giving effect thereto, Dow Exempted Indebtedness does not exceed 15 percent of Dow Consolidated Net Tangible Assets at such time.”
Section 4.2For the benefit of the Holders of Securities of each Series outstanding under the Indenture from time to time, a new Section 3.10 of the Indenture is added as follows:
“SECTION 3.10 Limitation on Sale and Lease-Back Transactions. (a) Dow will not, nor will Dow permit any of its Restricted Subsidiaries to, enter into any arrangement providing for the leasing by Dow or any Restricted Subsidiary of Dow of any Dow Principal Property (except for temporary leases for a term, including any renewal thereof, of not more than three years and except for leases between Dow and a Dow Subsidiary or between Dow Subsidiaries), which Dow Principal Property has been or is to be sold or transferred by Dow or such Restricted Subsidiary (herein referred to as a “Sale and Lease-Back Transaction”) unless the net proceeds of such sale are at least equal to the fair value (as determined by the board of directors of Dow) of such property.
(b) Notwithstanding the provisions of paragraph (a) of this Section 3.7, Dow or any Restricted Subsidiary of Dow may enter into Sale and Lease-Back Transactions, provided that at the time of such entering into, and after giving effect thereto, Dow Exempted Indebtedness does not exceed 15 percent of Dow Consolidated Net Tangible Assets at such time.”
Section 4.3For the benefit of the Holders of Securities of each Series outstanding under the Indenture from time to time, a paragraph (h) to Section 5.1 of the Indenture is added as follows:




Ex A-7

239



“(h)    the Dow Guarantee shall for any reason cease to be in full force and effect (except as contemplated by the terms of this Indenture) or be declared null and void or any senior officer of Dow denies in writing that it has any further liability under such guarantee or gives written notice to such effect, other than by reason of the termination of this Indenture or the release of the Dow Guarantee in accordance with this Indenture.”
Section 4.4    For the benefit of the Holders of Securities of each Series outstanding under the Indenture from time to time, paragraphs (d), (e) and (f) of Section 5.1 of the Indenture are amended and restated as follows:

“(d) default in the performance, or breach, of any covenant or warranty of the Company or Dow in respect of the Securities of such Series (other than a covenant or warranty in respect of the Securities of such Series a default in whose performance or whose breach is elsewhere in this Section specifically dealt with), and continuance of such default or breach for a period of 90 days after notice thereof has been received by Company or Dow, as applicable, from the Trustee or the Holders of at least 25% in principal amount of the Outstanding Securities of such Series affected thereby, a written notice specifying such default or breach and requiring it to be remedied and stating that such notice is a “Notice of Default” hereunder; or
(e) a court having jurisdiction in the premises shall enter a decree or order for relief in respect of the Company or Dow in an involuntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or appointing a receiver, liquidator, assignee, custodian, trustee or sequestrator (or similar official) of the Company or Dow or for any substantial part of its property or ordering the winding up or liquidation of its affairs, and such decree or order shall remain unstayed and in effect for a period of 60 consecutive days; or
(f) the Company or Dow shall commence a voluntary case under any applicable bankruptcy, insolvency or other similar law now or hereafter in effect, or consent to the entry of an order for relief in an involuntary case under any such law, or consent to the appointment of or taking possession by a receiver, liquidator, assignee, custodian, trustee or sequestrator (or similar official) of the Company or Dow or for any substantial part of its property, or make any general assignment for the benefit of creditors; or”
Section 4.5For the benefit of the Holders of Securities of each Series outstanding under the Indenture from time to time, Section 9.1 and Section 9.2 of the Indenture are amended and restated as follows:
“SECTION 9.1 The Company or Dow May Consolidate, etc., on Certain Terms. Each of the Company and Dow covenants that it will not merge or consolidate with any other corporation or sell or convey all or substantially all of its assets to any Person, unless (a) either (i) either the Company or Dow, as the case may be, shall be the continuing corporation, or the successor corporation or the Person (if other than the Company or Dow) which acquires by sale or conveyance substantially all the assets of the Company or Dow, as the case may be, shall be a corporation organized under the laws of the United States of America or any State thereof and shall expressly assume the obligations of the Company or Dow, as applicable, under this Indenture, including, the due and punctual payment of the principal of and interest on all the Securities, according to their tenor, and the due


Ex A-8

240



and punctual performance and observance of all of the covenants and conditions of this Indenture to be performed or observed by the Company or Dow, as applicable, by supplemental indenture satisfactory to the Trustee, executed and delivered to the Trustee by such corporation or (ii) in the case of consolidation or merger of Dow with the Company, Dow confirms in writing in a form reasonably satisfactory to the Trustee, that as a result of such consolidation or merger Dow has become the primary obligor on the Securities and assumed the Company’s obligations under the Securities and under this Indenture and (b) the Company or Dow or such successor corporation, as the case may be, shall not, immediately after such merger or consolidation, or such sale or conveyance, be in default in the performance of any such covenant or condition.
SECTION 9.2 Successor Corporation Substituted. In case of any such consolidation, merger, sale or conveyance, and following such an assumption by the successor corporation, such successor corporation shall succeed to and be substituted for the Company or Dow, as applicable, with the same effect as if it had been named herein. In the case of a consolidation, merger, sale or conveyance of the Company only, such successor corporation may cause to be signed, and may issue either in its own name or in the name of the Company prior to such succession, any or all of the Securities issuable hereunder which theretofore shall not have been signed by the Company and delivered to the Trustee; and, if applicable, in the case of a consolidation, merger, sale or conveyance of the Company only, upon the Company Order of such successor corporation instead of the Company and subject to all the terms, conditions and limitations in this Indenture prescribed, the Trustee shall authenticate and shall deliver any Securities which previously shall have been signed and delivered by the officers of the Company to the Trustee for authentication, and any Securities which such successor corporation thereafter shall cause to be signed and delivered to the Trustee for that purpose. All of the Securities so issued shall in all respects have the same legal rank and benefit under this Indenture as the Securities theretofore or thereafter issued in accordance with the terms of this Indenture as though all of such Securities had been issued at the date of the execution hereof.
In case of any such consolidation, merger, sale, lease or conveyance such changes in phraseology and form (but not in substance) may be made in the Securities to be issued or the [l] Supplemental Indenture as may be appropriate.
In the event of any such sale or conveyance (other than a conveyance by way of lease) of the Company or Dow or any successor corporation which shall theretofore have become such in the manner described in this Article shall be discharged from all obligations and covenants under this Indenture, the Securities and the Dow Guarantee, as the case may be, and may be liquidated and dissolved.”
Section 4.6For the benefit of the Holders of Securities of each Series outstanding under the Indenture from time to time, a paragraph (e) to Section 4.3 of the Indenture is added as follows:
“(e) For the avoidance of doubt, if, for any reason, the Company may cease filing separate periodic reports pursuant to Section 13 or Section 15(d) under the Exchange Act in virtue of the fact that the Company is a wholly owned subsidiary of Dow or based on the Dow Guarantee, then the delivery by Dow to the Trustee of annual reports and information, documents and other reports Dow is required to file with the Commission pursuant to Section 13 or Section 15(d) of the Exchange Act or any other information required by this Section 4.3 will be deemed to satisfy the Company’s obligations under this Section 4.3, if applicable.”


Ex A-9

241



ARTICLE FIVE
ARTICLE FIVE MISCELLANEOUS PROVISIONS
Section 5.1Ratification.    The Indenture, as supplemented and amended by this [l] Supplemental Indenture, is in all respects hereby adopted, ratified and confirmed.
Section 5.2Counterparts. This [l] Supplemental Indenture may be executed in any number of counterparts, each of which when so executed shall be deemed an original, and all such counterparts shall together constitute but one and the same instrument.
Section 5.3Governing Law. THIS [l] SUPPLEMENTAL INDENTURE AND THE SECURITIES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE CHOICE OF LAW PRINCIPLES THEREOF.
Section 5.4Trustee. The Trustee makes no representations as to the validity or sufficiency of this [l] Supplemental Indenture. The recitals herein are deemed to be those of the Company and Dow and not of the Trustee.

[signature page follows]



































Ex A-10

242



IN WITNESS WHEREOF, the parties hereto have caused this [l] Supplemental Indenture to be duly executed as of the day and year first above written.
THE DOW CHEMICAL COMPANY
 
 
By:
 
Name:
 
Title:
 
 
 
 
 
DOW INC.
 
 
By:
 
Name:
 
Title:
 
 
 
 
 
THE BANK OF NEW YORK MEELON TRUST COMPANY, N.A.,
 
as Trustee
 
 
By:
 
Name:
 
Title:
 






















[Signature page to [l] Supplemental Indenture]

243


 
 
 
 
EXHIBIT 4.5

DESCRIPTION OF REGISTRANTS’ SECURITIES
REGISTERED PURSUANT TO SECTION 12 OF THE
SECURITIES EXCHANGE ACT OF 1934

The following descriptions set forth certain material terms and provisions of Dow Inc. and The Dow Chemical Company’s securities that are registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). As of the date of the Annual Report on Form 10-K of which this exhibit is a part, the registrants have two classes of securities registered under Section 12 of the Exchange Act: (1) Dow Inc.’s common stock, $.01 par value per share, and (2) The Dow Chemical Company’s 4.625% Notes due October 1, 2044.
DESCRIPTION OF COMMON STOCK OF DOW INC.
The following summary of Dow Inc.’s common stock not purport to be complete and is subject to, and qualified in its entirety by reference to, the relevant provisions of Delaware law, and by Dow Inc.’s amended and restated certificate of incorporation and amended and restated bylaws, which are incorporated by reference as exhibits to the Annual Report on Form 10-K, of which exhibit is a part.
Dow Inc. is authorized to issue 5,250,000,000 shares of all classes of stock, 5,000,000,000 of which are shares of common stock, par value $0.01 per share, and 250,000,000 of which are shares of preferred stock, par value $0.01 per share. Dow Inc. had 751,408,800 shares of common stock, $0.01 par value, issued at January 31, 2020. Dow Inc. had 741,678,966 shares of common stock, $0.01 par value, outstanding at January 31, 2020. All issued and outstanding shares of common stock are fully paid and non-assessable. Any additional shares of common stock that Dow Inc. issues will be fully paid and non-assessable. Neither Dow Inc.’s common stockholders have, or will have, any preemptive rights.
Voting Rights
Dow Inc.’s amended and restated certificate of incorporation provides that, subject to all of the rights of holders of preferred stock provided for by the board of directors or by Delaware corporate law, the holders of common stock will have full voting rights on all matters requiring stockholder action, with each share of common stock being entitled to one vote and having equal rights of participation in the dividends and distributions of Dow Inc., including upon the dissolution of Dow Inc.
Board of Directors
Dow Inc.’s amended and restated bylaws provide that all of Dow Inc.’s directors are elected each year at Dow Inc.’s annual meeting for a term of one year and until his or her successor is duly elected and qualified. A quorum of directors consists of a majority of Dow Inc.’s entire board of directors then holding office.
Number, Filling of Vacancies and Removal of Directors
Dow Inc.’s amended and restated certificate of incorporation and amended and restated bylaws provide that its board of directors may not have less than six or more than twenty-one members. The actual number of directors is determined by a vote of a majority of Dow Inc.’s entire board of directors. Currently, Dow Inc. has eleven members on its board of directors. Vacancies on Dow Inc.’s board of directors and any newly created directorships are filled exclusively by a vote of the majority of the remaining directors then in office, even if less than a quorum or by the sole remaining director, and shall not be filled by the stockholders. Directors elected to fill a vacancy or a new position hold office until the next annual meeting of stockholders or until their successors are duly elected and qualified. Subject to the rights of holders of preferred stock, directors can be removed from office at any time, with or without cause, only by the affirmative vote of a majority of the voting power of all the outstanding shares of Dow Inc.’s capital stock then entitled to vote in the election of directors.

244



Dividends
Delaware corporate law generally provides that a corporation, subject to restrictions in its certificate of incorporation, including preferred stockholders’ rights to receive dividends prior to common stockholders, may declare and pay dividends out of:
surplus; or

net profits for the fiscal year in which the dividend is declared and/or the preceding fiscal year, if there is no surplus.

Dividends may not be declared or paid out of net profits if the capital of the corporation is less than the aggregate amount of capital represented by the issued and outstanding stock of all classes having a preference on the distribution of assets. Dividends on Dow Inc. common stock are not cumulative. Dow Inc.’s amended and restated certificate of incorporation does not contain any additional restrictions on the declaration or payment of dividends.
Selected Provisions in Dow Inc.’s Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws
Dow Inc.’s amended and restated certificate of incorporation and amended and restated bylaws contain a number of provisions that could have the effect of prohibiting or delaying a third party’s ability to take control of Dow Inc.
Advance Notice Provisions for Director Nominations and Stockholder Proposals at an Annual or Special Stockholders’ Meeting
Dow Inc.’s amended and restated bylaws provide that a stockholder may make a nomination of persons for election to the board of directors at an annual stockholders’ meeting only if the stockholder is a stockholder of record entitled to vote at such annual meeting and complies with the notice procedures and disclosure requirements as set forth below and may propose other business at an annual stockholders’ meeting only if such stockholder gives timely written notice thereof to Dow Inc.’s Secretary and any such business is a proper subject for stockholder action. The notice must be delivered to, or mailed and received by, Dow Inc.’s Secretary at Dow Inc.’s principal executive offices:
not later than the close of business on the 90th day or earlier than the close of business on the 120th day prior to the anniversary date on which Dow Inc. first distributed its proxy materials for the prior year’s annual meeting; or

if the annual meeting is more than 30 days before or after the anniversary date of the prior year’s annual meeting, not earlier than the close of business on the 120th day prior to such annual meeting and not later than the close of business on the later of the 90th day prior to such annual meeting or the 10th day after the date on which public disclosure, as defined in Dow Inc.’s amended and restated bylaws, of the date of the annual meeting is first made by Dow Inc.

The notice must include the following information as to each person whom the stockholder proposes to nominate for election or re-election as a director:
all information relating to such person that is required to be disclosed in solicitations of proxies for election of directors in an election contest, or is otherwise required, in each case pursuant to and in accordance with Regulation 14A under the Exchange Act;
such person’s written consent to being named in the proxy statement as a nominee and to serving as a director if elected and a representation by the nominee to the effect that, if elected, the nominee will agree to and abide by all policies of the board of directors as may be in place at any time and from time to time; and

245



any information required to be disclosed in the third following paragraph below if such person were a stockholder purporting to make a nomination or propose business.
In addition, the notice must include the following information as to any other business that the stockholder proposes to bring before the meeting:
a brief description of the business desired to be brought before the meeting;
the text of the proposal or business (including the text of any resolutions proposed for consideration and, in the event that such business includes a proposal to amend Dow Inc.’s amended and restated bylaws, the language of the proposed amendment);
the reasons for conducting such business at the meeting;
any substantial interest (within the meaning of Item 5 of Schedule 14A under the Exchange Act) in such business of such stockholder and the beneficial owner (within the meaning of Section 13(d) of the Exchange Act), if any, on whose behalf the business is being proposed;
any other information relating to such stockholder and beneficial owner, if any, required to be disclosed in a proxy statement or other filings required to be made in connection with solicitations of proxies for the proposal and pursuant to and in accordance with Section 14(/a) of the Exchange Act and the rules and regulations promulgated thereunder; and
a description of all agreements, arrangements, or understandings between or among such stockholder, or any affiliates or associates of such stockholder, and any other person or persons (including their names) in connection with the proposal of such business and any material interest of such stockholder or any affiliates or associates of such stockholder, in such business, including any anticipated benefit therefrom to such stockholder, or any affiliates or associates of such stockholder.
The notice must include information specified in Dow Inc.’s amended and restated bylaws as to the stockholder giving the notice and the beneficial owner, if any, on whose behalf the nomination is made or the other business is proposed, including:
the name and address of such stockholder, as they appear on Dow Inc.’s books, and the name and address of such beneficial owner;
the class and number of shares of Dow Inc.’s capital stock which are owned (beneficially or of record) by such stockholder and such beneficial owner as of the date of the notice and a representation that such stockholder will promptly notify Dow Inc. in writing of the same as of the record date for the meeting promptly following the later of the record date or the date notice of the record date is first publicly disclosed;
a written representation that the stockholder is the holder of record of Dow Inc.’s shares entitled to vote at the meeting and intends to appear in person or by proxy at the meeting to propose such nomination or other business;
a description of any agreement, arrangement or understanding (including any derivative or short positions, profit interests, options, hedging transactions, and borrowed or loaned shares) that has been entered into as of the date of the stockholder’s notice by, or on behalf of, such stockholder or beneficial owner, the effect or intent of which is to mitigate loss, manage risk or benefit from changes in the share price of any class of Dow Inc.’s capital stock, or maintain, increase or decrease the voting power of the stockholder or beneficial owner with respect to shares of Dow Inc. stock and a representation that such stockholder will promptly notify Dow Inc. in writing of the same as of the record date for the meeting promptly following the later of the record date or the date notice of the record date is first publicly disclosed;

246



a representation that the stockholder is a holder of record of Dow Inc.’s shares entitled to vote at the meeting and intends to appear in person or by proxy at the meeting to nominate the person or persons specified in the notice and that such stockholder will promptly notify Dow Inc. in writing of the same as of the record date for the meeting promptly following the later of the record date or the date notice of the record date is first publicly disclosed; and
a representation whether such stockholder intends to deliver a proxy statement and/or form of proxy to holders of at least the percentage of Dow Inc.’s outstanding capital stock required to approve the election of the nominee and/or otherwise to solicit proxies from stockholders in support of such election.
The notice must also include information specified in Dow Inc.’s amended and restated bylaws as to the stockholder giving the notice or, if the notice is given on behalf of a beneficial owner on whose behalf the nomination is made or the other business is proposed, as to such beneficial owner, including:
the class and number of shares of Dow Inc.’s capital stock which are beneficially owned (as defined in Dow Inc.’s amended and restated bylaws) as of the date of the notice, by the stockholder or the beneficial owner on whose behalf the notice is given and a representation that the stockholder shall notify Dow Inc. in writing within five business days after the record date for such meeting of the class and number of shares of Dow Inc.’s capital stock beneficially owned by such stockholder or beneficial owner as of the record date for the meeting;
a description of any agreement, arrangement or understanding with respect to the nomination or other business between or among such stockholder or beneficial owner and any other person, including without limitation any agreements that would be required to be disclosed pursuant to Item 5 or Item 6 of Exchange Act Schedule 13D (regardless of whether the requirement to file a Schedule 13D is applicable to the stockholder or beneficial owner) and a representation that the stockholder shall notify Dow Inc. in writing within five business days after the record date for such meeting of any such agreement, arrangement or understanding in effect as of the record date for the meeting; and
a description of any agreement, arrangement or understanding (including any derivative or short positions, profit interests, options, hedging transactions, and borrowed or loaned shares) that has been entered into as of the date of the stockholder’s notice by, or on behalf of, such stockholder or beneficial owner, the effect or intent of which is to mitigate loss, manage risk or benefit from changes in the share price of any class of Dow Inc.’s capital stock, or maintain, increase or decrease the voting power of the stockholder or beneficial owner with respect to shares of Dow Inc. stock and a representation that the stockholder shall notify Dow Inc. in writing within five business days after the record date for such meeting of any such agreement, arrangement or understanding in effect as of the record date for the meeting;
Special Meetings of Stockholders
Dow Inc.’s amended and restated certificate of incorporation provides that, subject to the rights of the holders of preferred stock, a special stockholders’ meeting for any purpose may be called by the board of directors by a resolution adopted by a majority of the entire board. A special stockholders’ meeting will be called by the Chairman upon a written request from stockholders holding at least twenty-five percent of the voting power entitled to vote on the matters to be brought before the special meeting and which request complies with the procedures for calling a special meeting of stockholders as set forth in Dow Inc.’s amended and restated bylaws.
Dow Inc.’s amended and restated bylaws provide that a stockholder notice requesting a special meeting must:
be delivered to, or mailed to and received by Dow Inc.’s Secretary at Dow Inc.’s principal executive offices;
be signed by each stockholder requesting the special meeting, or a duly authorized agent thereof;
set forth the purpose of the special meeting; and

247



include the same information required to be included in a stockholder’s notice for proposals to be brought before an annual meeting of stockholders (see “-Advance Notice Provisions for Director Nominations and Stockholder Proposals at an Annual or Special Stockholders’ Meeting”).
Subject to certain exceptions specified in Dow Inc.’s amended and restated bylaws, a special stockholders’ meeting will be held within 90 days after such stockholder request to call the special meeting is delivered to or received by Dow Inc.’s Secretary, at such date, time and place as determined by the board of directors. Only the business set forth in the stockholders’ notice and any business included in the notice of the special meeting by or at the direction of the board of directors shall be conducted at a special meeting of stockholders.
Stockholder Action by Written Consent
Dow Inc.’s amended and restated certificate of incorporation provides that any action required or permitted to be taken by the stockholders must be taken at a duly called annual or special stockholders’ meeting and may not be taken by written consent; provided, however, that any action required or permitted to be taken by the holders of any series of preferred stock, voting separately as a series or separately as a class with one or more other such series, may be taken without a meeting, without prior notice and without a vote, to the extent expressly so provided by the applicable certificate of designation for such series of preferred stock.
Transactions with Interested Stockholders and a Merger or Consolidation
Subject to certain limited exceptions, Delaware corporate law requires the approval of the board of directors and a majority of a corporation’s outstanding stock entitled to vote to authorize a merger or consolidation.
In general, Section 203 of the Delaware General Corporation Law (“DGCL”) prohibits a publicly held Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a three-year period following the time that such stockholder becomes an interested stockholder, unless the business combination is approved in a prescribed manner. Under Section 203, a business combination between a corporation and an interested stockholder is prohibited unless it satisfies one of the following conditions:
before the stockholder became interested, the board of directors approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder;
upon consummation of the transaction which resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, shares owned by persons who are directors and also officers, and employee stock plans, in some instances, but not the outstanding voting stock owned by the interested stockholder; or
at or after the time the stockholder became interested, the business combination was approved by the board of directors and authorized at an annual or special meeting of the stockholders by the affirmative vote of at least two-thirds of the outstanding voting stock which is not owned by the interested stockholder.
Section 203 defines a business combination to include:
any merger or consolidation involving the corporation and the interested stockholder;
any sale, transfer, lease, pledge or other disposition involving the interested stockholder of 10% or more of the assets of the corporation;
subject to exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;

248



subject to exceptions, any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; and
the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits provided by or through the corporation.
In general, Section 203 defines an interested stockholder as any entity or person beneficially owning 15% or more of the outstanding voting stock of the corporation and any entity or person affiliated with or controlling or controlled by the entity or person.
The DGCL allows a corporation to specify in its certificate of incorporation or bylaws that it will not be governed by the section relating to transactions with interested stockholders. Dow Inc. has not made that election in its amended and restated certificate of incorporation or amended and restated bylaws.
 DESCRIPTION OF THE DOW CHEMICAL COMPANY'S 4.625% NOTES DUE OCTOBER 1, 2044
The following description of The Dow Chemical Company's ("TDCC") 4.625% Notes due October 1, 2044 (the “Notes”) is a summary and does not purport to be complete. This description is subject to and qualified in its entirety by reference to the Indenture, dated as of May 1, 2008, between us and The Bank of New York Mellon Trust Company, N.A., as trustee.
The Notes are traded on The New York Stock Exchange under the bond trading symbol of “DOW/44”. Definitions of certain terms are set forth under “Certain Definitions” and throughout this description. Capitalized terms that are used but not otherwise defined herein have the meanings assigned to them in the Indenture, and those definitions are incorporated herein by reference. We encourage you to read the above referenced Indenture for additional information.
General
The Notes were initially issued in an aggregate principal amount of $500,000,000
The Notes bear interest at the rate of 4.625% per year from the September 16, 2014, payable semi-annually in arrears on April 1 and October 1 of each year, beginning April 1, 2015, to the holders of record at the close of business on the immediately preceding March 15 and September 15, respectively (whether or not a business day). Interest on the notes are computed on the basis of a 360-day year consisting of twelve 30-day months.
Ranking
The notes are senior unsecured obligations of TDCC and rank equal in right of payment to its other senior unsecured debt from time to time outstanding. The notes are effectively subordinated to all liabilities of our subsidiaries, including trade payables.
The Notes are represented by one or more global securities registered in the name of a nominee of DTC. Except as described in the prospectus supplement, the notes will not be issuable in certificated form.
Optional Redemption
The notes due 2044 are redeemable, at any time in whole or from time to time in part, prior to April 1, 2044 (six months prior to their maturity date), in each case at a redemption price equal to the greater of:
    (i)    100% of the principal amount of the notes to be redeemed on that redemption date; and
    (ii)    the sum of the present values of the remaining scheduled payments of principal and interest on the notes being redeemed on that redemption date (not including any portion of such payments of interest accrued as of the redemption date), discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting

249



of twelve 30-day months) at the Treasury Rate (as defined below), plus 25 basis points, plus accrued and unpaid interest thereon to, but excluding, the redemption date.
On and after April 1, 2044 (six months prior to the maturity date of the Notes), the Notes will be redeemable, at any time in whole or from time to time in part, at our option at par plus accrued and unpaid interest thereon to, but excluding, the redemption date.
Notwithstanding the foregoing, installments of interest on Notes that are due and payable on interest payment dates falling on or prior to a redemption date will be payable on the interest payment date to the registered holders as of the close of business on the relevant record date according to the notes and the indenture.
“Comparable Treasury Issue” means the United States Treasury security selected by the Quotation Agent as having a maturity comparable to the remaining term (as measured from the redemption date) of the series of the notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such series of notes.
“Comparable Treasury Price” means, with respect to any redemption date, (i) the average of four Reference Treasury Dealer Quotations for such redemption date, after excluding the highest and lowest such Reference
Treasury Dealer Quotations, or (ii) if the trustee obtains fewer than four such Reference Treasury Dealer Quotations, the average of all such quotations, or (iii) if only one Reference Treasury Dealer Quotation is received, such quotation.
“Quotation Agent” means any Reference Treasury Dealer appointed by us.
“Reference Treasury Dealer” means (i) each of Citigroup Global Markets Inc., Deutsche Bank Securities Inc., Mizuho Securities USA Inc. and RBS Securities Inc. (or their respective affiliates that are Primary Treasury Dealers) and their respective successors; provided, however, that if any of the foregoing shall cease to be a primary U.S. Government securities dealer in New York City (a “Primary Treasury Dealer”), we will substitute therefor another Primary Treasury Dealer, and (ii) any other Primary Treasury Dealer selected by us.
“Reference Treasury Dealer Quotations” means, with respect to each Reference Treasury Dealer and any redemption date, the average, as determined by the trustee, of the bid and asked prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted in writing to the trustee by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third business day preceding such redemption date.
“Treasury Rate” means, with respect to any redemption date, the rate per annum equal to the semi-annual equivalent yield to maturity of the Comparable Treasury Issue, assuming a price for the Comparable Treasury Issue (expressed as a percentage of its principal amount) equal to the Comparable Treasury Price for such redemption date.
Notice of any redemption will be mailed at least 30 days but not more than 60 days before the redemption date to each registered holder of the Notes by us or by the trustee on our behalf; provided that notice of redemption may be mailed more than 60 days prior to a redemption date if the notice is issued in connection with a defeasance of the notes or a satisfaction and discharge of the notes. Once notice of redemption is mailed, the notes called for redemption will become due and payable on the redemption date and at the applicable redemption price, plus accrued and unpaid interest to, but excluding, the redemption date.
Unless we default in payment of the redemption price, on and after the redemption date, interest will cease to accrue on the notes or portions thereof called for redemption. On or before the redemption date, we will deposit with a paying agent (or the trustee) money sufficient to pay the redemption price of and accrued interest on the notes to be redeemed on that date. If less than all of the Notes are to be redeemed, the notes to be redeemed shall be selected by lot by DTC, in the case of notes represented by a global security, or by the trustee by a method the trustee deems to be fair and appropriate, in the case of notes that are not represented by a global security.

250



Repurchase at the Option of Holders Upon a Change of Control Repurchase Event
If a Change of Control Repurchase Event (as defined below) occurs, unless we have exercised our right to redeem the Notes as described above, we will make an offer to each holder of notes to repurchase all or any part (no note of a principal amount of $2,000 or less will be repurchased in part) of that holder’s notes at a repurchase price in cash equal to 101% of the aggregate principal amount of notes repurchased plus any accrued and unpaid interest on the notes repurchased to the date of repurchase. Within 30 days following any Change of Control Repurchase Event or, at our option, prior to any Change of Control (as defined below), but after the public announcement of an impending Change of Control, we will mail a notice to each holder, with a copy to the trustee, describing the transaction or transactions that constitute or may constitute the Change of Control Repurchase Event and offering to repurchase notes on the payment date specified in the notice, which date will be no earlier than 30 days and no later than 60 days from the date such notice is mailed. The notice shall, if mailed prior to the date of consummation of the Change of Control, state that the offer to repurchase is conditioned on the Change of Control Repurchase Event occurring on or prior to the payment date specified in the notice.
We will comply with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations thereunder, to the extent those laws and regulations are applicable in connection with the repurchase of the notes as a result of a Change of Control Repurchase Event. To the extent that the provisions of any securities laws or regulations conflict with the Change of Control Repurchase Event provisions of the notes, we will comply with the applicable securities laws and regulations and will not be deemed to have breached our obligations under the Change of Control Repurchase Event provisions of the notes by virtue of such conflict.
On the Change of Control Repurchase Event payment date, we will, to the extent lawful:
accept for payment all notes or portions of notes (in a minimum principal amount of $2,000 and integral multiples of $1,000 above that amount) properly tendered pursuant to our offer;
deposit with the paying agent an amount equal to the aggregate purchase price in respect of all notes or portions of notes properly tendered; and
deliver or cause to be delivered to the trustee the notes properly accepted, together with an officer’s certificate stating the aggregate principal amount of notes being purchased by us.

The paying agent will promptly mail to each holder of notes properly tendered the purchase price for the notes, and the trustee will promptly authenticate and mail (or cause to be transferred by book-entry) to each holder a new note equal in principal amount to any unpurchased portion of any notes surrendered; provided, that each new note will be in a minimum principal amount of $2,000 or an integral multiple of $1,000 above that amount.
We will not be required to make an offer to repurchase the notes upon a Change of Control Repurchase Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by us and such third party purchases all notes properly tendered and not withdrawn under its offer.
We have no present intention to engage in a transaction involving a Change of Control, although it is possible that we would decide to do so in the future. We could, in the future, enter into certain transactions, including acquisitions, refinancings or other recapitalizations, that would not constitute a Change of Control, but that could increase the amount of debt outstanding at such time or otherwise affect our capital structure or credit ratings.
Definitions
“Below Investment Grade Rating Event” means the rating on the notes is lowered by each of the Rating Agencies and the notes are rated below Investment Grade by each of the Rating Agencies on any date from the date of the public notice of an arrangement that could result in a Change of Control until the end of the 60-day period following public notice of the occurrence of a Change of Control (which period shall be extended so long as the rating of the notes is under publicly announced consideration for possible downgrade by any of the Rating Agencies); provided that a Below Investment Grade Rating Event otherwise arising by virtue of a particular reduction in rating shall not be deemed to have occurred in respect of a particular Change of Control (and thus shall not be deemed a Below Investment Grade

251



Rating Event for purposes of the definition of Change of Control Repurchase Event hereunder) if any of the Rating Agencies making the reduction in rating to which this definition would otherwise apply does not announce or publicly confirm or inform the trustee in writing at its request that the reduction was the result, in whole or in part, of any event or circumstance comprised of or arising as a result of, or in respect of, the applicable Change of Control (whether or not the applicable Change of Control shall have occurred at the time of the Below Investment Grade Rating Event).
“Change of Control” means the occurrence of any of the following:
(1) the direct or indirect sale, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of our properties or assets and those of our subsidiaries taken as a whole to any “person” or “group” (as those terms are used for purposes of Section 13(d)(3) of the Exchange Act), other than us or one or more of our subsidiaries;
(2) the consummation of any transaction or series of related transactions (including, without limitation, any merger or consolidation) the result of which is that any “person” or “group” (as those terms are used for purposes of Section 13(d)(3) of the Exchange Act), other than us or one of our wholly-owned subsidiaries, becomes the beneficial owner, directly or indirectly, of more than 50% of the then outstanding number of shares of our Voting Stock, measured by voting power rather than number of shares;
(3) we consolidate with, or merge with or into, any person, or any person consolidates with, or merges with or into, us, in any such event pursuant to a transaction in which any of our outstanding Voting Stock or the Voting Stock of such other person is converted into or exchanged for cash, securities or other property, other than any such transaction where the shares of our Voting Stock outstanding immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving person or any direct or indirect parent company of the surviving person immediately after giving effect to such transaction;
(4) the first day on which a majority of the members of our Board of Directors are not Continuing Directors; or
(5) the adoption of a plan relating to our liquidation or dissolution.
Notwithstanding the foregoing, a transaction will not be considered to be a Change of Control under clause (2) above if (a) we become a direct or indirect wholly-owned subsidiary of a holding company and (b) (y) immediately following that transaction, the direct or indirect holders of the Voting Stock of the holding company are substantially the same as the holders of our Voting Stock immediately prior to that transaction or (z) immediately following that transaction, no person (as that term is used in Section 13(d)(3) of the Exchange Act) is the beneficial owner, directly or indirectly, of more than 50% of the Voting Stock of the holding company.
The definition of Change of Control includes a phrase relating to the direct or indirect sale, lease, transfer, conveyance or other disposition of “all or substantially all” of our properties or assets and those of our subsidiaries taken as a whole. Although there is a limited body of case law interpreting the phrase “substantially all” there is no precise established definition of the phrase under applicable law. Accordingly, the ability of a holder of notes to require us to repurchase its notes as a result of a sale, lease, transfer, conveyance or other disposition of less than all of our properties and assets and of those of our subsidiaries taken as a whole to another person or group may be uncertain.
“Change of Control Repurchase Event” means the occurrence of both a Change of Control and a Below Investment Grade Rating Event.
“Continuing Directors” means, as of any date of determination, any member of our Board of Directors who (1) was a member of such Board of Directors on the date of the issuance of the notes; or (2) was nominated for election or elected to such Board of Directors with the approval of a majority of the Continuing Directors who were members of such Board of Directors at the time of such nomination or election (either by a specific vote or by approval of our proxy statement in which such member was named as a nominee for election as a director).

252



Under a recent Delaware Chancery Court interpretation of the foregoing definition of “Continuing Directors,” our Board of Directors could approve, for purposes of such definition, a slate of stockholder-nominated directors without endorsing them, or while simultaneously recommending and endorsing its own slate instead. Accordingly, under such interpretation, our Board of Directors could approve a slate of directors that includes a majority of dissident directors nominated pursuant to a proxy contest, and the ultimate election of such dissident slate would not constitute a “Change of Control Repurchase Event” that would trigger a holder’s right to require us to repurchase the holder’s notes as described above.
“Fitch” means Fitch Ratings Ltd.
“Investment Grade” means a rating of BBB- or better by Fitch (or its equivalent under any successor rating categories of Fitch), Baa3 or better by Moody’s (or its equivalent under any successor rating categories of Moody’s) and a rating of BBB- or better by S&P (or its equivalent under any successor rating categories of S&P) or the equivalent investment grade credit rating from any additional Rating Agency or Rating Agencies selected by us.
“Moody’s” means Moody’s Investors Services Inc.
“Rating Agency” means (1) each of Fitch, Moody’s and S&P; and (2) if any of Fitch, Moody’s or S&P ceases to rate the notes or fails to make a rating of the notes publicly available for reasons outside of our control, a “nationally recognized statistical rating organization” registered pursuant to Section 15E of the Exchange Act, selected by us as a replacement agency for Fitch, Moody’s or S&P, as the case may be.
“S&P” means Standard & Poor’s Ratings Services, a division of McGraw-Hill, Inc.
“Voting Stock” means, with respect to any person, capital stock of any class or kind the holders of which are ordinarily, in the absence of contingencies, entitled to vote for the election of directors (or persons performing similar functions) of such person, even if the right so to vote has been suspended by the happening of such a contingency.
Sinking Fund
The notes are not be entitled to any sinking fund.

Book-Entry, Delivery and Form
The Notes were issued in the form of one or more global notes in definitive, fully registered, book-entry form. The global notes will be deposited with or on behalf of DTC and registered in the name of Cede & Co., as nominee of DTC.
DTC, Clearstream and Euroclear
Beneficial interests in the global notes will be represented through book-entry accounts of financial institutions acting on behalf of beneficial owners as direct and indirect participants in DTC. Investors may hold interests in the global notes through either DTC (in the United States), Clearstream Banking, société anonyme, which we refer to as Clearstream, or Euroclear Bank S.A./N.V., as operator of the Euroclear System, which we refer to as Euroclear, in Europe, either directly if they are participants in such systems or indirectly through organizations that are participants in such systems. Clearstream and Euroclear will hold interests on behalf of their participants through customers’ securities accounts in Clearstream’s and Euroclear’s names on the books of their U.S. depositaries, which in turn will hold such interests in customers’ securities accounts in the U.S. depositaries’ names on the books of DTC.

253



DTC has advised us that:
DTC is a limited-purpose trust company organized under the New York Banking Law, a “banking organization” within the meaning of the New York Banking Law, a member of the Federal Reserve System, a “clearing corporation” within the meaning of the New York Uniform Commercial Code and a “clearing agency” registered under Section 17A of the Exchange Act.
DTC holds securities that its participants deposit with DTC and facilitates the settlement among participants of securities transactions, such as transfers and pledges, in deposited securities through electronic computerized book-entry changes in participants’ accounts, thereby eliminating the need for physical movement of securities certificates.
Direct participants include securities brokers and dealers, banks, trust companies, clearing corporations and other organizations, some of whom, and/or their representatives, own DTC.
DTC is owned by a number of its direct participants and by The New York Stock Exchange, Inc., the American Stock Exchange LLC and the National Association of Securities Dealers, Inc.
Access to the DTC system is also available to others such as securities brokers and dealers, banks and trust companies that clear through or maintain a custodial relationship with a direct participant, either directly or indirectly.
The rules applicable to DTC and its direct and indirect participants are on file with the SEC.

Clearstream has advised us that it is incorporated under the laws of Luxembourg as a professional depositary. Clearstream holds securities for its customers and facilitates the clearance and settlement of securities transactions between its customers through electronic book-entry changes in accounts of its customers, thereby eliminating the need for physical movement of certificates. Clearstream provides to its customers, among other things, services for safekeeping, administration, clearance and settlement of internationally traded securities and securities lending and borrowing. Clearstream interfaces with domestic markets in several countries. As a professional depositary, Clearstream is subject to regulation by the Luxembourg Commission for the Supervision of the Financial Section. Clearstream customers are recognized financial institutions around the world, including underwriters, securities brokers and dealers, banks, trust companies, clearing corporations and other organizations and may include the underwriters. Indirect access to Clearstream is also available to others, such as banks, brokers, dealers and trust companies that clear through or maintain a custodial relationship with a Clearstream customer either directly or indirectly.
Euroclear has advised us that it was created in 1968 to hold securities for participants of Euroclear and to clear and settle transactions between Euroclear participants through simultaneous electronic book-entry delivery against payment, thereby eliminating the need for physical movement of certificates and any risk from lack of simultaneous transfers of securities and cash. Euroclear provides various other services, including securities lending and borrowing and interfaces with domestic markets in several countries. Euroclear is operated by Euroclear Bank S.A./N.V., which we refer to as the Euroclear Operator, under contract with Euroclear Clearance Systems S.C., a Belgian cooperative corporation, which we refer to as the Cooperative. All operations are conducted by the Euroclear Operator, and all Euroclear securities clearance accounts and Euroclear cash accounts are accounts with the Euroclear Operator, not the Cooperative. The Cooperative establishes policy for Euroclear on behalf of Euroclear participants. Euroclear participants include banks (including central banks), securities brokers and dealers, and other professional financial intermediaries and may include the underwriters. Indirect access to Euroclear is also available to other firms that clear through or maintain a custodial relationship with a Euroclear participant, either directly or indirectly.
We understand that the Euroclear Operator is licensed by the Belgian Banking and Finance Commission to carry out banking activities on a global basis. As a Belgian bank, it is regulated and examined by the Belgian Banking and Finance Commission.
We have provided the descriptions of the operations and procedures of DTC, Clearstream and Euroclear in this prospectus supplement solely as a matter of convenience. These operations and procedures are solely within the control of those organizations and are subject to change by them from time to time. None of us, the underwriters nor the trustee takes any responsibility for these operations or procedures, and you are urged to contact DTC, Clearstream and Euroclear or their participants directly to discuss these matters.

254



We expect that under procedures established by DTC:
upon deposit of the global notes with DTC or its custodian, DTC will credit on its internal system the accounts of direct participants designated by the underwriters with portions of the principal amounts of the global notes; and
ownership of the notes will be shown on, and the transfer of ownership thereof will be effected only through, records maintained by DTC or its nominee, with respect to interests of direct participants, and the records of direct and indirect participants, with respect to interests of persons other than participants.

The laws of some jurisdictions may require that purchasers of securities take physical delivery of those securities in definitive form. Accordingly, the ability to transfer interests in the notes represented by a global note to those persons may be limited. In addition, because DTC can act only on behalf of its participants, who in turn act on behalf of persons who hold interests through participants, the ability of a person having an interest in notes represented by a global note to pledge or transfer those interests to persons or entities that do not participate in DTC’s system, or otherwise to take actions in respect of such interest, may be affected by the lack of a physical definitive security in respect of such interest.
So long as DTC or its nominee is the registered owner of a global note, DTC or that nominee will be considered the sole owner or holder of the notes represented by that global note for all purposes under the indenture and under the notes. Except as provided below, owners of beneficial interests in a global note will not be entitled to have notes represented by that global note registered in their names, will not receive or be entitled to receive physical delivery of certificated notes and will not be considered the owners or holders thereof under the indenture or under the notes for any purpose, including with respect to the giving of any direction, instruction or approval to the trustee. Accordingly, each holder owning a beneficial interest in a global note must rely on the procedures of DTC and, if that holder is not a direct or indirect participant, on the procedures of the participant through which that holder owns its interest, to exercise any rights of a holder of notes under the indenture or a global note.
Neither we nor the trustee will have any responsibility or liability for any aspect of the records relating to or payments made on account of notes by DTC, Clearstream or Euroclear, or for maintaining, supervising or reviewing any records of those organizations relating to the notes.
Payments on the notes represented by the global notes will be made to DTC or its nominee, as the case may be, as the registered owner thereof. We expect that DTC or its nominee, upon receipt of any payment on the notes represented by a global note, will credit participants’ accounts with payments in amounts proportionate to their respective beneficial interests in the global note as shown in the records of DTC or its nominee. We also expect that payments by participants to owners of beneficial interests in the global note held through such participants will be governed by standing instructions and customary practice as is now the case with securities held for the accounts of customers registered in the names of nominees for such customers. The participants will be responsible for those payments.
Distributions on the notes held beneficially through Clearstream will be credited to cash accounts of its customers in accordance with its rules and procedures, to the extent received by the U.S. depositary for Clearstream.
Securities clearance accounts and cash accounts with the Euroclear Operator are governed by the Terms and Conditions Governing Use of Euroclear and the related Operating Procedures of the Euroclear System, and applicable Belgian law (collectively, the “Terms and Conditions”). The Terms and Conditions govern transfers of securities and cash within Euroclear, withdrawals of securities and cash from Euroclear, and receipts of payments with respect to securities in Euroclear. All securities in Euroclear are held on a fungible basis without attribution of specific certificates to specific securities clearance accounts. The Euroclear Operator acts under the Terms and Conditions only on behalf of Euroclear participants and has no record of or relationship with persons holding through Euroclear participants.
Distributions on the notes held beneficially through Euroclear will be credited to the cash accounts of its participants in accordance with the Terms and Conditions, to the extent received by the U.S. depositary for Euroclear.

255



Clearance and Settlement Procedures
Initial settlement for the notes were made in immediately available funds. Secondary market trading between DTC participants will occur in the ordinary way in accordance with DTC rules and will be settled in immediately available funds. Secondary market trading between Clearstream customers and/or Euroclear participants will occur in the ordinary way in accordance with the applicable rules and operating procedures of Clearstream and Euroclear, as applicable, and will be settled using the procedures applicable to conventional eurobonds in immediately available funds.
Cross-market transfers between persons holding directly or indirectly through DTC, on the one hand, and directly or indirectly through Clearstream customers or Euroclear participants, on the other, will be effected through DTC in accordance with DTC rules on behalf of the relevant European international clearing system by its U.S. depositary; however, such cross-market transactions will require delivery of instructions to the relevant European international clearing system by the counterparty in such system in accordance with its rules and procedures and within its established deadlines (European time). The relevant European international clearing system will, if the transaction meets its settlement requirements, deliver instructions to the U.S. depositary to take action to effect final settlement on its behalf by delivering or receiving the notes in DTC, and making or receiving payment in accordance with normal procedures for same-day funds settlement applicable to DTC. Clearstream customers and Euroclear participants may not deliver instructions directly to their U.S. depositaries.
Because of time-zone differences, credits of the notes received in Clearstream or Euroclear as a result of a transaction with a DTC participant will be made during subsequent securities settlement processing and dated the business day following the DTC settlement date. Such credits or any transactions in the notes settled during such processing will be reported to the relevant Clearstream customers or Euroclear participants on such business day. Cash received in Clearstream or Euroclear as a result of sales of the notes by or through a Clearstream customer or a Euroclear participant to a DTC participant will be received with value on the DTC settlement date but will be available in the relevant Clearstream or Euroclear cash account only as of the business day following settlement in DTC.
Although DTC, Clearstream and Euroclear have agreed to the foregoing procedures to facilitate transfers of the notes among participants of DTC, Clearstream and Euroclear, they are under no obligation to perform or continue to perform such procedures and such procedures may be changed or discontinued at any time.
Certificated Notes
Individual certificates in respect of the notes will not be issued in exchange for the global notes, except in very limited circumstances. We will issue or cause to be issued certificated notes to each person that DTC identifies as the beneficial owner of the notes represented by a global note upon surrender by DTC of the global note if:
DTC notifies us that it is no longer willing or able to act as a depositary for such global note or ceases to be a clearing agency registered under the Exchange Act, and we have not appointed a successor depositary within 90 days of that notice or becoming aware that DTC is no longer so registered;
an event of default has occurred and is continuing, and DTC requests the issuance of certificated notes; or
we determine not to have the notes of such series represented by a global note.

Neither we nor the trustee will be liable for any delay by DTC, its nominee or any direct or indirect participant in identifying the beneficial owners of the notes. We and the trustee may conclusively rely on, and will be protected in relying on, instructions from DTC or its nominee for all purposes, including with respect to the registration and delivery, and the respective principal amounts, of the certificated notes to be issued.

256



Certain Covenants Applicable to the Notes
Limitations on Liens
The indenture provides that, subject to the exceptions described below and those set forth under “Exempted Indebtedness,” Dow may not, and may not permit any restricted subsidiary to, create or permit to exist any lien on any principal property, additions to principal property or shares of capital stock of any restricted subsidiary without equally and ratably securing the debt securities. This restriction will not apply to permitted liens, including:

liens on principal property existing at the time of its acquisition or to secure the payment of all or part of the purchase price or any additions thereto or to secure any indebtedness incurred at the time of, or within 120 days after, the acquisition of such principal property or any addition thereto;
liens existing on the date of the indenture;
liens on property or shares of capital stock, or arising out of any indebtedness of any corporation existing at the time the corporation becomes or is merged into Dow or a restricted subsidiary;
liens which exclusively secure debt owing to Dow or a subsidiary by a restricted subsidiary;
liens of carriers, warehousemen, mechanics and materialmen incurred in the ordinary course of business for sums not yet due or being contested in good faith;
liens arising by reason of any judgment, decree or order of any court, so long as any appropriate legal proceedings which may have been duly initiated for the review of such judgment, decree or order shall not have been finally terminated or so long as the period within which such proceedings may be initiated shall not have expired; or pledges or deposits to secure payment of workmen’s compensation or other insurance, good faith deposits in connection with tenders, contracts (other than contracts for the payment of money) or leases, deposits to secure public or statutory obligations, deposits to secure public or statutory obligations, deposits to secure or in lieu of surety or appeal bonds, or deposits as security for the payment of taxes;
liens in connection with the issuance of tax-exempt industrial development or pollution control bonds or other similar bonds issued pursuant to Section 103(b) of the Internal Revenue Code to finance all or any part of the purchase price of or the cost of construction, equipping or improving property; provided that those liens are limited to the property acquired or constructed or the improvement and to substantially unimproved real property on which the construction or improvement is located; provided further, that Dow and its restricted subsidiaries may further secure all or any part of such purchase price or the cost of construction of any improvements and personal property by an interest on additional property of Dow and restricted subsidiaries only to the extent necessary for the construction, maintenance and operation of, and access to, the property so acquired or constructed or the improvement;
liens arising from assignments of money due under contracts of Dow or a restricted subsidiary with the United States or any State, or any department, agency or political subdivision of the United States or any State;
liens in favor of any customer arising in respect of payments made by or on behalf of a customer for goods produced for or services rendered to customers in the ordinary course of business not exceeding the amount of those payments;
any extension, renewal or replacement of any lien referred to in any of the previous clauses; and
statutory liens, liens for taxes or assessments or governmental charges or levies not yet due or delinquent or which can be paid without penalty or are being contested in good faith, landlord’s liens on leased property, easements and liens of a similar nature as those described above.
Limitation on Sale and Lease-Back Transactions
The senior indenture provides that, subject to the exceptions set forth below under the section of this prospectus captioned “Exempted Indebtedness,” sale and lease-back transactions by Dow or any restricted subsidiary of any principal property are prohibited (except for temporary leases for a term, including any renewal thereof, of not more than three years and except for leases between Dow and a subsidiary or between subsidiaries) unless the net proceeds of the sale and leaseback transaction are at least equal to the fair value of the property.

257



Exempted Indebtedness
Dow or any restricted subsidiary may create or assume liens or enter into sale and lease-back transactions not otherwise permitted under the limitations on liens and sale and lease-back transactions described above, so long as at that time and after giving effect to the lien or sale and lease-back transaction, the sum of:
(1) the aggregate outstanding indebtedness of Dow and its restricted subsidiaries incurred after the date of the indenture and secured by the proscribed liens relating to principal property; plus
(2) the aggregate discounted value of the obligations for rental payments in respect to the proscribed sale and lease-back transactions relating to principal property;
does not exceed 10% of consolidated net tangible assets at such time.
There are no covenants or provisions contained in the indenture which protect holders of debt securities in the event of a highly leveraged transaction.
Certain Definitions
The following are the meanings of terms that are important in understanding the covenants previously described:
“Consolidated net tangible assets” means the total assets of Dow and its consolidated subsidiaries as shown on or reflected in its balance sheet, less:

all current liabilities, excluding current liabilities that could be classified as long-term debt under generally accepted accounting principles and current liabilities that are by their terms extendible or renewable at the obligor’s option to a time more than 12 months after the time as of which the amount of current liabilities is being computed;
advances to entities accounted for on the equity method of accounting; and
intangible assets.
“Intangible assets” means the aggregate value, net of any applicable reserves, as shown on or reflected in Dow’s balance sheet, of:
all trade names, trademarks, licenses, patents, copyrights and goodwill;
organizational and development costs;
deferred charges, other than prepaid items such as insurance, taxes, interest, commissions, rents and similar items and tangible assets being amortized; and
amortized debt discount and expense, less unamortized premium.
“Principal property” means any manufacturing facility having a gross book value in excess of 1% of consolidated net tangible assets that is owned by Dow or any restricted subsidiary and located within the United States, excluding its territories and possessions and Puerto Rico, other than any facility or portion of a facility which Dow’s board of directors reasonably determines is not material to the business conducted by Dow and its subsidiaries as a whole.
“Restricted subsidiary” means any subsidiary:
of which substantially all of the property of is located, and substantially all of the business is carried on, within the United States, excluding its territories and possessions and Puerto Rico; and
that owns or operates one or more principal properties;
provided, however, restricted subsidiary shall not include a subsidiary that is primarily engaged in the business of a finance or insurance company, and branches of that finance or insurance company.

258



“Subsidiary” means each corporation of which more than 50% of the outstanding voting stock is owned, directly or indirectly, by Dow or by Dow and one or more of its subsidiaries.
Consolidation, Merger and Sale of Assets
Dow may not merge or consolidate or sell or convey all or substantially all of its assets unless:
the successor corporation is Dow or is a domestic corporation that assumes Dow’s obligations on the debt securities and under the indenture; and
after giving effect to the transaction, Dow or the successor corporation would not be in default under the indenture.
Events of Default
With respect to any series of debt securities, any one of the following events will constitute an event of default under the indenture:
(1) default by Dow for 30 days in the payment of any installment of interest on the debt securities of that series;
(2) default by Dow in the payment of any principal on the debt securities of that series;
(3) default by Dow in the payment of any sinking fund installment;
(4) default by Dow in the performance, or breach by Dow, of any of the covenants or warranties contained in the indenture for the benefit of the debt securities of that series which is not remedied within a period of 90 days after receipt of written notice by Dow from the trustee or the holders of not less than 25% in principal amount of the debt securities of that series then outstanding;
(5) Dow commences bankruptcy or insolvency proceedings or consents to any bankruptcy relief sought against it;
(6) Dow becomes involved in involuntary bankruptcy or insolvency proceedings and an order for relief is entered against it, if that order remains unstayed and in effect for more than 60 consecutive days; or
(7) any other event of default established in accordance with a supplemental indenture or board resolution with respect to any series of debt securities.
No event of default described in clauses (1), (2), (3), (4) or (7) above with respect to a particular series of debt securities necessarily constitutes an event of default with respect to any other series of debt securities.
The indenture provides that if an event of default under clauses (1), (2), (3), (4) or (7) above (but only if the event of default under clauses (4) or (7) is with respect to less than all series of debt securities then outstanding)
shall have occurred and be continuing, either the trustee or the holders of not less than 25% in aggregate principal amount of the then-outstanding debt securities of the series affected by the event of default, each affected series treated as a separate class, may declare the principal of all the debt securities of each affected series, together with accrued interest, to be due and payable immediately. If an event of default under clauses (4) or (7) above (but only if the event of default under clauses (4) or (7) is with respect to all of the series of debt securities then outstanding) shall have occurred and be continuing, either the trustee or the holders of not less than 25% in the aggregate principal amount of all the debt securities then outstanding, treated as one class, may declare the principal of all the debt securities, together with accrued interest, to be due and payable immediately. If an event of default under clauses (5) or (6) above shall have occurred, the principal of all the debt securities, together with accrued interest, will become due and payable immediately without any declaration or other act by the trustee or any holder.
If prior to any judgment or decree for the payment of money due being entered or obtained, Dow delivers to the trustee an amount of money sufficient to pay all interest then due and the principal of any securities that have matured (other than through acceleration) and the trustee’s expenses and Dow has cured any defaults under the indenture, then such declaration (including a declaration caused by a default in the payment of principal or interest, the payment for which has subsequently been provided) may be rescinded and annulled by the holders of a majority in principal amount

259



of the debt securities of the series then outstanding, each such series treated as a separate class, or all debt securities treated as one class, as the case may be, as were entitled to declare such default. In addition, past defaults may be waived by the holders of a majority in principal amount of the debt securities of the series then outstanding, each series treated as a separate class, or all debt securities treated as one class, as the case may be, as were entitled to declare such default, except a default in the payment of the principal of or interest on the debt securities or in respect of a covenant or provision of the indenture that cannot be modified or amended without the approval of the holder of each debt security so affected.
Notwithstanding the foregoing, at Dow’s election, the sole remedy for an event of default specified in clause (4) above relating to the failure by Dow to comply with the covenant in the indenture requiring Dow to file with the trustee copies of the reports and other information it files with the SEC (“Dow’s SEC filing obligations”) and for any failure by Dow to comply with the requirements of Section 314(a)(1) of the Trust Indenture Act of 1939, as amended (the “TIA”), which similarly requires Dow to file with the trustee copies of the reports and other information it files with the SEC, shall for the first 270 days after the occurrence of such an event of default consist exclusively of the right to receive additional interest on the debt securities of such series at an annual rate equal to 0.25% of the principal amount of the debt securities. This additional interest will accrue on the debt securities from and including the date on which an event of default relating to a failure to comply with Dow’s SEC filing obligations or the failure to comply with the requirements of Section 314(a)(1) of the TIA first occurs to but not including the 270th day thereafter (or such earlier date on which the event of default shall have been cured or waived). On such 270th day (or earlier, if such event of default is cured or waived prior to such 270th day), such additional interest will cease to accrue and, if such event of default has not been cured or waived prior to such 270th day, then either the trustee or the holders of not less than 25% in the aggregate principal amount of the debt securities of such series then outstanding may declare the principal of all the debt securities of such series, together with accrued interest, to be due and payable immediately. This provision shall not affect the rights of holders in the event of the occurrence of any other event of default.
The indenture contains a provision entitling the trustee, subject to the duty of the trustee during default to act with the required standard of care, to be indemnified by the holders of debt securities before exercising any right or power under the indenture at the request of the holders of the debt securities. The indenture also provides that the holders of a majority in principal amount of the outstanding debt securities of all series affected, each series treated as a separate class, may direct the time, method and place of conducting any proceeding for any remedy available to the trustee, or exercising any trust or power conferred on the trustee, with respect to the debt securities of such series.
The indenture requires Dow to file annually with the trustee a certificate as to the absence of any default or specifying any default that exists.

Satisfaction and Discharge of the TDCC Indenture
The TDCC indenture with respect to any series, except for the surviving obligations, including TDCC’s obligation to compensate the trustee and to pay the principal of and interest on the debt securities of that series, will be discharged and canceled upon the satisfaction of specified conditions, including:
payment of all the debt securities of that series; or
the deposit with the trustee of cash or U.S. government obligations or a combination of cash and U.S. government obligations sufficient for the payment or redemption in accordance with the TDCC indenture and the terms of the debt securities of that series.

260



Modification and Waiver
TDCC and the trustee may modify and amend the TDCC indenture with the consent of the holders of more than 50% of the principal amount of the outstanding debt securities of each series which is affected. No supplemental indenture may, without the consent of the holders of all outstanding debt securities:
extend the final maturity of, reduce the rate or extend the time of payment of interest on, reduce the principal amount of, or reduce any amount payable on any redemption of, any debt securities; or
reduce the percentage in principal amount of outstanding debt securities of any series, the consent of whose holders is required for any supplemental indenture.
Governing Law
The indenture and the Notes are governed by and construed in accordance with the laws of the State of New York, without regard to conflict of laws principles thereof.
Information About the Trustee
The Trustee’s corporate trust office is located at 2 North LaSalle Street, Suite 700, Chicago, Illinois 60602. The Trustee’s affiliate corporate trust office in New York City is located at 240 Greenwich Street, New York, New York 10286.


261


 
 
 
 
 
 
 
 Subsidiaries of Dow Inc.
EXHIBIT 21
 
 
 
 
 
 
 
At December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Location*
This list includes companies for which the effective ownership by Dow Inc. is 50 percent or more.
Dow Inc.
Delaware
 
The Dow Chemical Company
Delaware
 
 
AM Robin LLC
Delaware
 
 
 
Warbler I LLC
Delaware
 
 
American Mortell Corporation
Texas
 
 
 
Mortell Company
Delaware
 
 
Arabian Chemical Company (Latex) Ltd. (1)
Saudi Arabia
 
 
Arabian Chemical Company (Polystyrene) Limited (1)
Saudi Arabia
 
 
Battleground Water Company
Texas
 
 
Chemars III LLC
Delaware
 
 
Chemtech II L.P.
Delaware
 
 
DCOMCO, Inc.
Delaware
 
 
Dow Chemical (China) Investment Company Limited
China
 
 
 
Dow Chemical (Guangzhou) Company Limited
China
 
 
 
Dow Chemical (Shanghai) Company Limited
China
 
 
 
Dow Chemical (Sichuan) Co., Ltd.
China
 
 
 
Dow Chemical (Zhangjiagang) Company Limited
China
 
 
 
Zhejiang Pacific Chemical Corporation
China
 
 
Dow Chemical (Singapore) Private Limited
Singapore
 
 
Dow Chemical China Holdings Pte. Ltd.
Singapore
 
 
Dow Chemical Costa Rica S.A.
Costa Rica
 
 
Dow Chemical Delaware Corp.
Delaware
 
 
 
Chemtech II L.P.
Delaware
 
 
 
 
Chemtech Portfolio Inc.
Texas
 
 
 
 
Chemtech Portfolio II Inc.
Michigan
 
 
Dow Chemical International Ltd.
Delaware
 
 
 
Dow Chemical Costa Rica S.A.
Costa Rica
 
 
 
Dow Chemical Thailand Ltd.
Thailand
 
 
 
 
MTP HPPO Manufacturing Company Limited
Thailand
 
 
 
Dow International Holdings Company
Delaware
 
 
 
Petroquimica-Dow S.A. (Petrodow)
Chile
 
 
 
Univation Technologies, LLC
Delaware
 
 
 
 
Univation Technologies (Hong Kong) Limited
Hong Kong
 
 
 
 
 
Univation (Zhangjiagang) Chemical Company Limited
China
 
 
 
 
Univation Technologies International, LLC
Delaware
 
 
Dow Chemical Kuwait B.V.
Netherlands
 
 
Dow Chemical Singapore Holdings Pte. Ltd.
Singapore
 
 
Dow Chemical Telecommunications Corp.
Delaware
 
 
Dow Silicones Corporation
Michigan
 
 
 
AM Robin LLC
Delaware
 
 
 
DC Alabama, Inc.
Delaware
 
 
 
DCC Litigation Facility, Inc.
Delaware
 
 
 
Devonshire Underwriters Ltd.
District of Columbia
 
 
 
Dow (Shanghai) Management Co., Ltd.
China
 
 
 
Dow (Zhangjiagang) Holding Co., Ltd.
China
 
 
 
Dow Chemical International Private Limited
India
 
 
 
Dow Corning (Thailand) Limited
Thailand
 
 
 
Dow Corning China Limited
Hong Kong
 
 
 
Dow Luxembourg Spectrum Holding S.a.r.l.
Luxembourg

262



 
 
 
 
 
 
 
 Subsidiaries of Dow Inc.
EXHIBIT 21
 
 
 
 
 
 
 
At December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Location*
This list includes companies for which the effective ownership by Dow Inc. is 50 percent or more.
 
 
 
Dow Netherlands Tulip Holding B.V.
Netherlands
 
 
 
Dow Silicones (Zhangjiagang) Co., Ltd.
China
 
 
 
Dow Silicones Deutschland GmbH
Germany
 
 
 
Valley Asset Leasing, LLC
Delaware
 
 
Dow Deutschland Inc.
Delaware
 
 
 
Dow Chemical Inter-American Limited
Delaware
 
 
 
 
Dow Quimica de Colombia S.A.
Colombia
 
 
Dow Engineering Company
Delaware
 
 
 
Dow Engineering, Inc.
Michigan
 
 
Dow Financial Services Inc.
Delaware
 
 
Dow Global Financial Management, Inc.
Delaware
 
 
Dow Global Technologies LLC
Delaware
 
 
 
Chemtech Portfolio Inc.
Texas
 
 
 
Dow Technology Investments LLC
Delaware
 
 
Dow Hydrocarbons and Resources LLC
Delaware
 
 
 
Cayuse Pipeline, Inc.
Texas
 
 
 
Dow Intrastate Gas Company
Louisiana
 
 
 
Dow Pipeline Company
Texas
 
 
 
Fort Saskatchewan Ethylene Storage Corporation (1)
Canada
 
 
 
 
Fort Saskatchewan Ethylene Storage Limited Partnership
Canada
 
 
 
K/D/S Promix, LLC (1)
Texas
 
 
Dow Internacional Mexicana S.A. de C.V.
Mexico
 
 
Dow International Holdings Company
Delaware
 
 
 
Dow Luxembourg Spectrum Holding S.a.r.l.
Luxembourg
 
 
 
 
Dow Luxembourg Galaxy Holding S.a.r.l.
Luxembourg
 
 
 
 
 
Dow Switzerland Holding GmbH
Switzerland
 
 
 
 
 
 
Dow (Shanghai) Holding Co., Ltd.
China
 
 
 
 
 
 
Dow Corning Silicones Malaysia Sdn. Bhd.
Malaysia
 
 
 
 
 
 
Dow Corning Singapore Pte. Ltd.
Singapore
 
 
 
 
 
 
 
Dow Corning (Thailand) Limited
Thailand
 
 
 
 
 
 
Dow International Holdings S.A.
Switzerland
 
 
 
 
 
 
 
Dow Europe Holding B.V.
Netherlands
 
 
 
 
 
 
 
 
BASF DOW HPPO B.V. (1)
Netherlands
 
 
 
 
 
 
 
 
BASF DOW HPPO Technology B.V. (1)
Netherlands
 
 
 
 
 
 
 
 
DoNedPa B.V.
Netherlands
 
 
 
 
 
 
 
 
Dow Austria Gesellschaft m.b.H.
Austria
 
 
 
 
 
 
 
 
Dow Belgium B.V.B.A.
Belgium
 
 
 
 
 
 
 
 
Dow Benelux B.V.
Netherlands
 
 
 
 
 
 
 
 
 
Polyol Belgium B.V.B.A.
Belgium
 
 
 
 
 
 
 
 
 
Terneuzen Partnership Services B.V.
Netherlands
 
 
 
 
 
 
 
 
 
 
Valuepark Terneuzen C.V. (1)
Netherlands
 
 
 
 
 
 
 
 
 
Valuepark Terneuzen Beheer B.V. (1)
Netherlands
 
 
 
 
 
 
 
 
 
 
Valuepark Terneuzen C.V. (1)
Netherlands
 
 
 
 
 
 
 
 
Dow Chemical Company Limited
United Kingdom
 
 
 
 
 
 
 
 
 
Dow Chemical Services UK Limited
United Kingdom
 
 
 
 
 
 
 
 
 
Dow Limited
United Kingdom
 
 
 
 
 
 
 
 
 
Dow Services Trustees UK Limited
United Kingdom
 
 
 
 
 
 
 
 
 
Dow Trent Limited
United Kingdom
 
 
 
 
 
 
 
 
 
 
Dow Thames Limited
United Kingdom

263



 
 
 
 
 
 
 
 Subsidiaries of Dow Inc.
EXHIBIT 21
 
 
 
 
 
 
 
At December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Location*
This list includes companies for which the effective ownership by Dow Inc. is 50 percent or more.
 
 
 
 
 
 
 
 
 
Hyperlast Limited
United Kingdom
 
 
 
 
 
 
 
 
 
Dow UK Limited
United Kingdom
 
 
 
 
 
 
 
 
Dow Chemical East Africa Limited
Kenya
 
 
 
 
 
 
 
 
Dow Chemical Iberica S.L.
Spain
 
 
 
 
 
 
 
 
 
Terminal de Atraque de Productos Petroquimicos, A.I.E. (1)
Spain
 
 
 
 
 
 
 
 
 
Transformadora de Etileno A.I.E. (1)
Spain
 
 
 
 
 
 
 
 
Dow Chemical Korea Limited
Korea
 
 
 
 
 
 
 
 
Dow Chemical OOO
Russia
 
 
 
 
 
 
 
 
Dow Chemical Romania S.R.L.
Romania
 
 
 
 
 
 
 
 
Dow Chemical West Africa Limited
Ghana
 
 
 
 
 
 
 
 
Dow Corning Australia Pty. Ltd.
Australia
 
 
 
 
 
 
 
 
 
Dow Corning (Thailand) Limited
Thailand
 
 
 
 
 
 
 
 
Dow Corning de Argentina S.R.L.
Argentina
 
 
 
 
 
 
 
 
Dow Danmark A/S
Denmark
 
 
 
 
 
 
 
 
Dow Europe GmbH
Switzerland
 
 
 
 
 
 
 
 
 
Dow Chemical IMEA GmbH
Switzerland
 
 
 
 
 
 
 
 
 
Dow Egypt Services Limited
Egypt
 
 
 
 
 
 
 
 
 
Dow International Finance S.a.r.l.
Luxembourg
 
 
 
 
 
 
 
 
 
Dow Mideast Systems S.A.E. (JSC)
Egypt
 
 
 
 
 
 
 
 
Dow Hellas A.E.
Greece
 
 
 
 
 
 
 
 
Dow Hungary Kft.
Hungary
 
 
 
 
 
 
 
 
Dow Industrial Chemical Products Nigeria Limited
Nigeria
 
 
 
 
 
 
 
 
Dow InterBranch B.V.
Netherlands
 
 
 
 
 
 
 
 
 
Dow Benelux Integrated Center B.V.
Netherlands
 
 
 
 
 
 
 
 
 
Dow Chemical East Africa Limited
Kenya
 
 
 
 
 
 
 
 
 
Dow Industrial Chemical Products Nigeria Limited
Nigeria
 
 
 
 
 
 
 
 
 
Dow Material Sciences Ltd.
Israel
 
 
 
 
 
 
 
 
 
Dow Materials Science Saudi Arabia Limited
Saudi Arabia
 
 
 
 
 
 
 
 
 
Dow Mideast Systems S.A.E. (JSC)
Egypt
 
 
 
 
 
 
 
 
 
Dow Morocco SARL
Morocco
 
 
 
 
 
 
 
 
 
Dow Norge A/S
Norway
 
 
 
 
 
 
 
 
 
Dow Quimica de Colombia S.A.
Colombia
 
 
 
 
 
 
 
 
 
Dow Silicones Belgium SPRL
Belgium
 
 
 
 
 
 
 
 
 
PT Rohm and Haas Indonesia
Indonesia
 
 
 
 
 
 
 
 
 
Rohm and Haas International SNC
France
 
 
 
 
 
 
 
 
 
Rohm and Haas Latinoamerica, S. de R.L. de C.V.
Mexico
 
 
 
 
 
 
 
 
 
Rohm and Haas Mexico, S. de R.L. de C.V.
Mexico
 
 
 
 
 
 
 
 
 
Santa Vitoria Acucar e Alcool Ltda.
Brazil
 
 
 
 
 
 
 
 
Dow Italia s.r.l.
Italy
 
 
 
 
 
 
 
 
 
Dow Italia Divisione Commerciale s.r.l.
Italy
 
 
 
 
 
 
 
 
 
Rohm and Haas Italia S.r.l.
Italy
 
 
 
 
 
 
 
 
Dow Material Sciences Ltd.
Israel
 
 
 
 
 
 
 
 
Dow Mideast Systems S.A.E. (JSC)
Egypt
 
 
 
 
 
 
 
 
 
Dow Egypt Services Limited
Egypt
 
 
 
 
 
 
 
 
Dow Morocco SARL
Morocco
 
 
 
 
 
 
 
 
Dow Olefinverbund GmbH
Germany
 
 
 
 
 
 
 
 
 
Dow Deutschland Anlagengesellschaft mbH
Germany
 
 
 
 
 
 
 
 
 
Dow Deutschland Verwaltungs Vertriebs GmbH
Germany
 
 
 
 
 
 
 
 
 
 
Dow Produktions und Vertriebs GmbH & Co. OHG
Germany

264



 
 
 
 
 
 
 
 Subsidiaries of Dow Inc.
EXHIBIT 21
 
 
 
 
 
 
 
At December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Location*
This list includes companies for which the effective ownership by Dow Inc. is 50 percent or more.
 
 
 
 
 
 
 
 
 
 
Dow Stade Produktions GmbH & Co. OHG
Germany
 
 
 
 
 
 
 
 
 
Dow MF Verwaltungs GmbH
Germany
 
 
 
 
 
 
 
 
 
 
Dow Produktions und Vertriebs GmbH & Co. OHG
Germany
 
 
 
 
 
 
 
 
 
 
Dow Stade Produktions GmbH & Co. OHG
Germany
 
 
 
 
 
 
 
 
 
Dow Pipeline Gesellschaft mbH & Co. KG
Germany
 
 
 
 
 
 
 
 
 
Dow Pipeline Verwaltungsgesellschaft mbH
Germany
 
 
 
 
 
 
 
 
 
Dow Silicones Deutschland GmbH
Germany
 
 
 
 
 
 
 
 
 
ROH Venture GmbH
Germany
 
 
 
 
 
 
 
 
Dow Performance Materials (Australia) Pty Ltd
Australia
 
 
 
 
 
 
 
 
Dow Polska Sp.z.o.o.
Poland
 
 
 
 
 
 
 
 
Dow Portugal - Produtos Quimicos, Sociedade Unipessoal, Lda.
Portugal
 
 
 
 
 
 
 
 
Dow Saudi Arabia Holding B.V.
Netherlands
 
 
 
 
 
 
 
 
Dow Saudi Arabia Investment B.V.
Netherlands
 
 
 
 
 
 
 
 
 
Dow Materials Science Saudi Arabia Limited
Saudi Arabia
 
 
 
 
 
 
 
 
Dow Saudi Arabia Product Marketing B.V.
Netherlands
 
 
 
 
 
 
 
 
Dow Silicones Belgium SPRL
Belgium
 
 
 
 
 
 
 
 
Dow Silicones UK Limited
United Kingdom
 
 
 
 
 
 
 
 
Dow Southern Africa (Pty) Ltd
South Africa
 
 
 
 
 
 
 
 
Dow Starfish Holding B.V.
Netherlands
 
 
 
 
 
 
 
 
Dow Suomi OY
Finland
 
 
 
 
 
 
 
 
Dow Sverige AB
Sweden
 
 
 
 
 
 
 
 
Dow Turkiye Kimya Sanayi ve Ticaret Limited Sirketi
Turkey
 
 
 
 
 
 
 
 
 
Rohm and Haas Kimya Sanayi Limited Sirketi
Turkey
 
 
 
 
 
 
 
 
DowAksa Advanced Composites Holdings B.V. (1)
Netherlands
 
 
 
 
 
 
 
 
EQUATE Marketing Company E.C. (1)
Bahrain
 
 
 
 
 
 
 
 
Finndisp Ltd.
Russia
 
 
 
 
 
 
 
 
HPPO Holding & Finance C.V. (1)
Netherlands
 
 
 
 
 
 
 
 
MTP HPJV C.V.
Netherlands
 
 
 
 
 
 
 
 
MTP HPJV Management B.V.
Netherlands
 
 
 
 
 
 
 
 
Palmyra do Brasil Indústria e Comércio de Silício Metálico e Recursos Naturais Ltda.
Brazil
 
 
 
 
 
 
 
 
Polyol Belgium B.V.B.A.
Belgium
 
 
 
 
 
 
 
 
Rohm and Haas (UK) Limited
United Kingdom
 
 
 
 
 
 
 
 
Rohm and Haas Denmark Holding Company ApS
Denmark
 
 
 
 
 
 
 
 
 
Rohm and Haas Espana Production Holding, S.L.
Spain
 
 
 
 
 
 
 
 
 
 
Rohm and Haas Espana, S.L.
Spain
 
 
 
 
 
 
 
 
 
Rohm and Haas Europe Services ApS
Denmark
 
 
 
 
 
 
 
 
 
Rohm and Haas Europe Trading ApS
Denmark
 
 
 
 
 
 
 
 
 
Rohm and Haas Kimyasal Urunler Uretim Dagitim ve Ticaret A.S.
Turkey
 
 
 
 
 
 
 
 
Rohm and Haas Electronic Materials Europe Ltd.
United Kingdom
 
 
 
 
 
 
 
 
Rohm and Haas International SNC
France
 
 
 
 
 
 
 
 
 
Dow France S.A.S.
France
 
 
 
 
 
 
 
 
Rohm and Haas Nederland B.V.
Netherlands
 
 
 
 
 
 
 
 
RUS Polyurethanes Holding B.V.
Netherlands
 
 
 
 
 
 
 
 
 
Dow Izolan OOO
Russia
 
 
 
 
 
 
 
 
 
Dow Izolan Ukraine LLC
Ukraine
 
 
 
 
 
 
Dow Silicones (Shanghai) Co., Ltd.
China
 
 
 
 
 
 
Dow Silicones Holding Japan G.K.
Japan
 
 
 
 
 
 
 
Dow Toray Co., Ltd.
Japan
 
 
 
 
 
 
 
 
Site Services Japan, Co., Ltd.
Japan

265



 
 
 
 
 
 
 
 Subsidiaries of Dow Inc.
EXHIBIT 21
 
 
 
 
 
 
 
At December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Location*
This list includes companies for which the effective ownership by Dow Inc. is 50 percent or more.
 
 
 
 
 
 
Dow Silicones Netherlands Holding B.V.
Netherlands
 
 
 
 
 
 
 
Dow Chemical Silicones Korea Ltd.
Korea
 
 
 
 
 
 
Dow Siloxane (Zhangjiagang) Holding Co. Private Ltd.
Singapore
 
 
 
 
 
 
 
Dow Siloxanes (Zhangjiagang) Co., Ltd.
China
 
 
 
DowBrands Inc.
Delaware
 
 
 
Rohm and Haas Company
Delaware
 
 
 
 
Charles Lennig & Company LLC
Delaware
 
 
 
 
 
Rohm and Haas Chile Limitada
Chile
 
 
 
 
Dow Japan Holdings K.K.
Japan
 
 
 
 
 
Dow Chemical Japan Limited
Japan
 
 
 
 
 
 
Japan Acrylic Chemical Co., Ltd.
Japan
 
 
 
 
ROH Holdings 1, LLC
Delaware
 
 
 
 
 
Rohm and Haas Equity Corporation
Delaware
 
 
 
 
 
 
Dow Luxembourg Spectrum Holding S.a.r.l.
Luxembourg
 
 
 
 
 
 
ROH Holdings 2, LLC
Delaware
 
 
 
 
 
 
 
Rohm and Haas Chemicals LLC
Delaware
 
 
 
 
 
 
 
 
Morton International, LLC
Indiana
 
 
 
 
 
 
Rohm and Haas (Far East) Limited
Hong Kong
 
 
 
 
 
 
Rohm and Haas Chemical (Thailand) Limited
Thailand
 
 
 
 
 
 
Rohm and Haas China, Inc.
Delaware
 
 
 
 
 
 
 
Beijing Eastern Rohm and Haas Company Limited
China
 
 
 
 
 
 
 
Rohm and Haas International Trading (Shanghai) Co. Ltd.
China
 
 
 
 
 
 
 
Shanghai Eastern Rohm and Haas Co., Ltd.
China
 
 
 
 
 
 
Rohm and Haas Denmark Finance A/S
Denmark
 
 
 
 
 
 
 
Dow Chemical International Private Limited
India
 
 
 
 
 
 
 
PT Rohm and Haas Indonesia
Indonesia
 
 
 
 
 
 
 
RH DK Mexico Holding ApS
Denmark
 
 
 
 
 
 
 
RH DK Vietnam Holdings ApS
Denmark
 
 
 
 
 
 
 
 
Rohm and Haas Vietnam Co., Ltd.
Vietnam
 
 
 
 
 
 
 
Rohm and Haas (China) Holding Co., Ltd.
China
 
 
 
 
 
 
 
Rohm and Haas (Foshan) Specialty Materials Co., Ltd.
China
 
 
 
 
 
 
 
Rohm and Haas Chemicals Singapore Pte. Ltd.
Singapore
 
 
 
 
 
 
 
Rohm and Haas Denmark China Investment ApS
Denmark
 
 
 
 
 
 
 
Rohm and Haas Latinoamerica, S. de R.L. de C.V.
Mexico
 
 
 
 
 
 
 
Rohm and Haas Singapore (Pte.) Ltd.
Singapore
 
 
 
 
 
 
Rohm and Haas Korea Co., Ltd.
Korea
 
 
 
 
 
 
Rohm and Haas Malaysia Sdn Bhd
Malaysia
 
 
 
 
 
 
Rohm and Haas Texas Incorporated
Texas
 
 
 
 
 
 
 
Battleground Water Company
Texas
 
 
 
 
Rohm and Haas Chile Limitada
Chile
 
 
 
 
Rohm and Haas Equity Corporation
Delaware
 
 
 
 
Rohm and Haas New Zealand Limited
New Zealand
 
 
 
 
Dow Chemical Philippines, Inc.
Philippines
 
 
 
 
Rohm and Haas Quimica Ltda.
Brazil
 
 
Dow International Technology Corporation
Delaware
 
 
Dow Olefinverbund GmbH
Germany
 
 
Dow Peru S.A.
Peru
 
 
Dow Quimica Chilena S.A.
Chile
 
 
Dow Quimica de Colombia S.A.
Colombia

266



 
 
 
 
 
 
 
 Subsidiaries of Dow Inc.
EXHIBIT 21
 
 
 
 
 
 
 
At December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Location*
This list includes companies for which the effective ownership by Dow Inc. is 50 percent or more.
 
 
 
Rohm and Haas Colombia Ltda
Colombia
 
 
Dow Quimica Mexicana S.A. de C.V.
Mexico
 
 
Dow Roofing Systems LLC
Delaware
 
 
Dow South Africa Holdings (Pty) Ltd.
South Africa
 
 
 
Sentrachem Limited
South Africa
 
 
 
 
Cisvaal (Proprietary) Limited
South Africa
 
 
Dow Verwaltungsgesellschaft mbH
Germany
 
 
DowBrands Inc.
Delaware
 
 
DuPont Asia Pacific Limited
Delaware
 
 
 
DuPont (Taiwan) Electronic Materials Limited
Taiwan
 
 
 
DuPont Performance Materials (Shanghai) Co., Ltd.
China
 
 
 
Materials Science (India) Private Limited
India
 
 
 
Performance Material Products Korea Ltd.
Korea
 
 
 
Performance Materials (Australia) Pty Ltd
Australia
 
 
 
Performance Materials (Thailand) Limited
Thailand
 
 
 
Performance Materials Japan Kabushiki Kaisha
Delaware
 
 
 
 
Dow-Mitsui Polychemicals Company, Ltd (1)
Japan
 
 
 
 
PM International Holding 3 B.V.
Netherlands
 
 
 
 
 
Performance Materials do Brasil Comercio de Plasticos e Polimeros Ltda.
Brazil
 
 
 
 
 
SP International Holding 5 B.V.
Netherlands
 
 
 
 
 
 
Performance Materials do Brasil Comercio de Plasticos e Polimeros Ltda.
Brazil
 
 
 
Performance Specialty Products (Hong Kong) Limited
Hong Kong
 
 
 
PM EMEA Holding 2 B.V.
Netherlands
 
 
 
 
PM EMEA Holding 3 B.V.
Netherlands
 
 
 
PM EMEA Holding 3 B.V.
Netherlands
 
 
 
 
Performance Materials Rus LLC
Russia
 
 
 
PM International 1 B.V.
Netherlands
 
 
 
 
Performance Materials Products (Singapore) Pte. Ltd.
Singapore
 
 
 
 
Performance Materials (Thailand) Limited
Thailand
 
 
 
PM Japan, Inc.
Delaware
 
 
 
PM LATAM, Inc.
Delaware
 
 
 
 
Performance Materials Argentina SAU
Argentina
 
 
 
 
Performance Materials Colombia S.A.S.
Colombia
 
 
Essex Chemical Corporation
New Jersey
 
 
Flexible Products Company
Georgia
 
 
Forbanco Inc.
Delaware
 
 
General Latex and Chemical Corporation
Massachusetts
 
 
GNS Enterprises, LLC
Georgia
 
 
GWN Holding, LLC
Delaware
 
 
 
Dow Netherlands Pacific Holding B.V.
Netherlands
 
 
 
 
Dow Netherlands Tulip Holding B.V.
Netherlands
 
 
 
 
 
Dow Brasil Industria e Comercio de Produtos Quimicos Ltda.
Brazil
 
 
 
 
 
Dow Chemical Pacific (Singapore) Private Limited
Singapore
 
 
 
 
 
 
Dow Chemical (Malaysia) Sdn. Bhd.
Malaysia
 
 
 
 
 
 
Dow Chemical (Myanmar) Limited
Myanmar
 
 
 
 
 
 
Dow Chemical Bangladesh Private Limited
Bangladesh
 
 
 
 
 
 
Dow Chemical International Private Limited
India
 
 
 
 
 
 
Dow Chemical Pacific Limited
Hong Kong
 
 
 
 
 
 
Dow Chemical Vietnam Limited Liability Company
Vietnam

267



 
 
 
 
 
 
 
 Subsidiaries of Dow Inc.
EXHIBIT 21
 
 
 
 
 
 
 
At December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Location*
This list includes companies for which the effective ownership by Dow Inc. is 50 percent or more.
 
 
 
 
 
 
PT Dow Indonesia
Indonesia
 
 
 
 
 
 
Voltas Water Solutions Private Limited (1)
India
 
 
 
 
 
Rohm and Haas Canada Investments Limited
Canada
 
 
 
 
 
 
3229809 Nova Scotia Company
Canada
 
 
 
 
 
 
 
Dow Investment Argentina S.R.L.
Argentina
 
 
 
 
 
 
 
 
Dow Quimica Argentina S.R.L.
Argentina
 
 
 
 
 
 
 
 
PBBPolisur S.R.L.
Argentina
 
 
 
 
 
 
 
 
 
Dow Quimica Argentina S.R.L.
Argentina
 
 
 
 
 
 
 
 
 
Rohm and Haas Argentina S.R.L.
Argentina
 
 
 
 
 
 
 
 
Rohm and Haas Argentina S.R.L.
Argentina
 
 
 
 
 
 
 
PBBPolisur S.R.L.
Argentina
 
 
 
 
 
 
 
Rohm and Haas Canada LP
Canada
 
 
 
 
 
 
3308597 Nova Scotia Company
Canada
 
 
 
 
 
 
Dow Investment Argentina S.R.L.
Argentina
 
 
 
 
 
 
Rohm and Haas Canada LP
Canada
 
 
 
 
 
 
 
Dow Chemical Canada ULC
Canada
 
 
 
 
 
 
 
 
3308597 Nova Scotia Company
Canada
 
 
 
 
 
 
 
 
 
3294027 Nova Scotia Limited
Canada
 
 
 
 
 
 
 
 
 
Dow Netherlands Holding 1 B.V.
Netherlands
 
 
 
 
 
 
 
 
 
 
Dow Brasil Industria e Comercio de Produtos Quimicos Ltda.
Brazil
 
 
 
 
 
 
 
 
 
 
 
Dow Brasil Sudeste Industrial Ltda.
Brazil
 
 
 
 
 
 
 
 
 
 
 
 
Dow Especialidades Quimicas Ltda.
Brazil
 
 
 
 
 
 
 
 
 
 
 
Dow Especialidades Quimicas Ltda.
Brazil
 
 
 
 
 
 
 
 
 
 
 
 
Dow Brasil Sudeste Industrial Ltda.
Brazil
 
 
 
 
 
 
 
 
 
 
 
 
 
Rohm and Haas Quimica Ltda.
Brazil
 
 
 
 
 
 
 
 
Dow Corning de Argentina S.R.L.
Argentina
 
 
 
 
 
 
 
 
Dow Quimica de Colombia S.A.
Colombia
 
 
 
 
 
 
 
 
Fort Saskatchewan Ethylene Storage Limited Partnership
Canada
 
 
 
 
 
 
 
 
Palmyra do Brasil Indústria e Comércio de Silício Metálico e Recursos Naturais Ltda.
Brazil
 
 
 
 
 
 
 
 
Pétromont and Company, Limited Partnership (1)
Canada
 
 
 
 
 
 
 
 
Pétromont Inc. (1)
Canada
 
 
 
 
 
 
SD Group Service Company Limited (1)
Thailand
 
 
 
 
 
 
Siam Polyethylene Company Limited (1)
Thailand
 
 
 
 
 
Sentrachem Limited
South Africa
 
 
Ifco Inc.
Delaware
 
 
 
Chemtech II L.P.
Delaware
 
 
Liana Limited
Delaware
 
 
 
Dorinco Reinsurance Company
Michigan
 
 
 
Dorintal Reinsurance Limited
Vermont
 
 
Materials Science Holding, LLC
Delaware
 
 
 
Rohm and Haas International Holdings Inc.
Delaware
 
 
 
 
Dow Chemical Singapore Holdings Pte. Ltd.
Singapore
 
 
 
 
 
Dow Chemical (Australia) Pty Ltd
Australia
 
 
 
 
 
Dow Chemical (Myanmar) Limited
Myanmar
 
 
 
 
 
Dow Chemical (NZ) Limited
New Zealand
 
 
 
 
 
Dow Chemical Bangladesh Private Limited
Bangladesh
 
 
 
 
 
Dow Chemical International Private Limited
India
 
 
 
 
 
Dow Chemical Korea Limited
Korea
 
 
 
 
 
PT Dow Indonesia
Indonesia

268



 
 
 
 
 
 
 
 Subsidiaries of Dow Inc.
EXHIBIT 21
 
 
 
 
 
 
 
At December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Location*
This list includes companies for which the effective ownership by Dow Inc. is 50 percent or more.
 
 
 
 
 
Terneuzen Investments Holding B.V.
Netherlands
 
 
 
 
 
 
Dow Chemical Taiwan Limited
Taiwan
 
 
 
 
 
 
Rohm and Haas Taiwan, Inc.
Taiwan
 
 
NuvoSun, Inc.
California
 
 
 
NuvoSun (Shanghai) Co. Ltd.
China
 
 
Performance Materials NA, Inc.
Delaware
 
 
Performance Science Materials Company
Canada
 
 
PM EMEA Holding 1 B.V.
Netherlands
 
 
 
Performance Materials Netherlands B.V.
Netherlands
 
 
 
 
DuPont Performance Materials Deutschland GmbH
Germany
 
 
 
 
DuPont Performance Materials Proprietary Limited
South Africa
 
 
 
 
E&C EMEA Holding 1 B.V.
Netherlands
 
 
 
 
 
DuPont Performance Materials International Sarl
Switzerland
 
 
 
 
Material Science de Mexico DDM, S. de R.L. de C.V.
Mexico
 
 
 
 
Performance Materials (Thailand) Limited
Thailand
 
 
 
 
Performance Materials Belgium BVBA
Belgium
 
 
 
 
 
PM EMEA Cooperatief U.A.
Netherlands
 
 
 
 
Performance Materials Bulgaria EOOD
Bulgaria
 
 
 
 
Performance Materials Czech Republic s.r.o.
Czech Republic
 
 
 
 
Performance Materials Finland Oy
Finland
 
 
 
 
Performance Materials France SAS
France
 
 
 
 
Performance Materials Iberica, S.L.
Spain
 
 
 
 
Performance Materials Italy srl
Italy
 
 
 
 
Performance Materials Poland Sp. z o.o.
Poland
 
 
 
 
Performance Materials Ukraine LLC
Ukraine
 
 
 
 
Performance Specialty Products Pakistan (Pvt.) Limited
Pakistan
 
 
 
 
PM EMEA Cooperatief U.A.
Netherlands
 
 
 
 
 
DuPont Performance Materials UK Limited
United Kingdom
 
 
 
 
 
Performance Materials Belgium BVBA
Belgium
 
 
 
Performance Materials Ukraine LLC
Ukraine
 
 
 
PM EMEA Holding 4 B.V.
Netherlands
 
 
 
 
Performance Materials Turkey Endustri Urunleri Limited Sirketi
Turkey
 
 
PM Mexico, LLC
Delaware
 
 
 
Material Science de Mexico DDM, S. de R.L. de C.V.
Mexico
 
 
 
 
Material Science Servicos de Mexico DDM, S. de R.L. de C.V.
Mexico
 
 
 
Material Science Servicos de Mexico DDM, S. de R.L. de C.V.
Mexico
 
 
POLY-CARB, Inc.
Ohio
 
 
Rofan Services LLC
Delaware
 
 
 
H Hotel Holding LLC
Delaware
 
 
 
 
MVCC Limited Partnership
Delaware
 
 
 
MVCC Limited Partnership
Delaware
 
 
Rohm and Haas Colombia Ltda
Colombia
 
 
Rohm and Haas Mexico, S. de R.L. de C.V.
Mexico
 
 
Santa Vitoria Acucar e Alcool Ltda.
Brazil
 
 
Sentrachem US, Inc.
Delaware
 
 
 
Hampshire Holdings, Inc.
Delaware
 
 
 
 
Hampshire Chemical Corp.
Delaware
 
 
Siam Polystyrene Company Limited (1)
Thailand
 
 
Siam Styrene Monomer Company Limited (1)
Thailand

269



 
 
 
 
 
 
 
 Subsidiaries of Dow Inc.
EXHIBIT 21
 
 
 
 
 
 
 
At December 31, 2019
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Location*
This list includes companies for which the effective ownership by Dow Inc. is 50 percent or more.
 
 
Siam Synthetic Latex Company Limited (1)
Thailand
 
 
Terra Two Taiwan Limited
Taiwan
 
 
Tianjin Panda Terminal Holdings Pte. Ltd.
Singapore
 
 
 
Tianjin Panda Terminal (Hong Kong) Limited
Hong Kong
 
 
Union Carbide Corporation
New York
 
 
 
Amerchol Corporation
Delaware
 
 
 
Calidria Corporation
Delaware
 
 
 
Carbide Chemical (Thailand) Limited
Thailand
 
 
 
Dow Internacional Mexicana S.A. de C.V.
Mexico
 
 
 
Dow International Holdings Company
Delaware
 
 
 
Dow Quimica Mexicana S.A. de C.V.
Mexico
 
 
 
Global Industrial Corporation
New York
 
 
 
Peñuelas Technology Park LLC
Delaware
 
 
 
Seadrift Pipeline Corporation
Delaware
 
 
 
South Charleston Sewage Treatment Company
West Virginia
 
 
 
UCAR Louisiana Pipeline Company
Delaware
 
 
 
UCAR Pipeline Incorporated
Delaware
 
 
 
 
Dow Quimica Chilena S.A.
Chile
 
 
 
 
Dow Peru S.A.
Peru
 
 
 
 
UCAR Emulsion Systems FZE
Dubai
 
 
 
Umetco Minerals Corporation
Delaware
 
 
 
 
Predate Properties (Pty) Ltd.
South Africa
 
 
 
Union Carbide Asia Limited
Hong Kong
 
 
 
Union Carbide Asia Pacific, Inc.
Delaware
 
 
 
Union Carbide Chemicals & Plastics Technology LLC
Delaware
 
 
 
 
Dow Technology Investments LLC
Delaware
 
 
 
Union Carbide Customer Services Pte. Ltd.
Singapore
 
 
 
Union Carbide Middle East Limited
Delaware
 
 
 
Union Carbide Philippines (Far East), Inc.
Philippines
 
 
 
Union Carbide South Africa (Proprietary) Limited
South Africa
 
 
 
Westbridge Insurance Ltd.
Vermont
*
Location of incorporation or organization. Primary location of organization is reported for partnerships.

1.
These companies are 50 percent owned, nonconsolidated affiliates of Dow Inc. and are accounted for using the equity method. Separate financial statements of these companies are not included in this Annual Report on Form 10-K. These companies are not controlled, directly or indirectly, by Dow Inc. Subsidiaries of these companies, if any, are not listed in this Exhibit 21.

270


 
Consent of Independent Registered Public Accounting Firm
EXHIBIT 23.1.1
 
 
 

We consent to the incorporation by reference of our reports dated February 7, 2020, relating to (i) the consolidated financial statements and financial statement schedule (which report expresses an unqualified opinion and includes an explanatory paragraph regarding a change in the method of accounting for revenue due to the adoption of Accounting Standards Codification (“ASC”) Topic 606, Revenue From Contracts with Customers, and a change in the method of accounting for leases due to the adoption of ASC Topic 842, Leases) of Dow Inc. and subsidiaries (the “Company”), and (ii) the effectiveness of the Company's internal control over financial reporting, appearing in the Annual Report on Form 10-K, filed jointly by Dow Inc. and The Dow Chemical Company, for the year ended December 31, 2019, in the following Registration Statements of Dow Inc.:


Form S-3:
 
 
 
No.
333-230668
 
333-232862
 
 
Form S-8:
 
 
 
Nos.
333-220352-01
 
333-230680
 
333-230681


/s/ DELOITTE & TOUCHE LLP
Deloitte & Touche LLP
Midland, Michigan
February 7, 2020




271


 
Consent of Independent Registered Public Accounting Firm
EXHIBIT 23.1.2
 
 
 

We consent to the incorporation by reference of our reports dated February 7, 2020 relating to (i) the consolidated financial statements and financial statement schedule (which report expresses an unqualified opinion and includes an explanatory paragraph regarding a change in the method of accounting for revenue due to the adoption of Accounting Standards Codification (“ASC”) Topic 606, Revenue From Contracts with Customers, and a change in the method of accounting for leases due to the adoption of ASC Topic 842, Leases), of The Dow Chemical Company and subsidiaries (“TDCC”) and (ii) the effectiveness of TDCC's internal control over financial reporting, appearing in the Annual Report on Form 10-K, filed jointly by Dow Inc. and The Dow Chemical Company, for the year ended December 31, 2019, in the following Registration Statements of The Dow Chemical Company:


Form S-3:
 
 
 
No.
333-232862-01
 
 
Form S-4:
 
 
 
No.
333-88443
 
333-234108
 
 
Form S-8:
 
 
 
Nos.
33-61795
 
333-40271
 
333-91027
 
333-103519
 
333-220352


/s/ DELOITTE & TOUCHE LLP
Deloitte & Touche LLP
Midland, Michigan
February 7, 2020




272


 
Ankura Consulting Group, LLC's Consent
EXHIBIT 23.2
 
 
 

Ankura Consulting Group, LLC ("Ankura") hereby consents to the use of Ankura's name and the reference to Ankura's reports in this Annual Report on Form 10-K of Dow Inc. and The Dow Chemical Company for the year ended December 31, 2019, and the incorporation by reference thereof in the following Registration Statements of Dow Inc. and The Dow Chemical Company:

DOW INC.
Form S-3:
 
 
 
No.
333-230668
 
333-232862
 
 
Form S-8:
 
 
 
Nos.
333-220352-01
 
333-230680
 
333-230681


THE DOW CHEMICAL COMPANY
Form S-3:
 
 
 
No.
333-232862-01
 
 
Form S-4:
 
 
 
No.
333-88443
 
333-234108
 
 
Form S-8:
 
 
 
Nos.
33-61795
 
333-40271
 
333-91027
 
333-103519
 
333-220352


/s/ AMY BROCKMAN
Amy Brockman
Senior Managing Director
Ankura Consulting Group, LLC
February 7, 2020




273


 
 
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
 
EXHIBIT 31.1
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002


I, Jim Fitterling, certify that:

1.
I have reviewed this Annual Report on Form 10-K of Dow Inc. and The Dow Chemical Company;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrants as of, and for, the periods presented in this report;

4.
The registrants' other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrants and have:

a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrants, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)
evaluated the effectiveness of the registrants' disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)
disclosed in this report any change in the registrants' internal control over financial reporting that occurred during the registrants' most recent fiscal quarter (the registrants' fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants' internal control over financial reporting; and

5.
The registrants' other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants' auditors and the audit committee of registrants' board of directors (or persons performing the equivalent function):

a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants' ability to record, process, summarize and report financial information; and

b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants' internal control over financial reporting.


/s/ JIM FITTERLING
Jim Fitterling
Chief Executive Officer
February 7, 2020


274


 
 
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
 
EXHIBIT 31.2
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002


I, Howard Ungerleider, certify that:

1.
I have reviewed this Annual Report on Form 10-K of Dow Inc. and The Dow Chemical Company;

2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrants as of, and for, the periods presented in this report;

4.
The registrants' other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrants and have:

a)
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrants, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)
evaluated the effectiveness of the registrants' disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)
disclosed in this report any change in the registrants' internal control over financial reporting that occurred during the registrants' most recent fiscal quarter (the registrants' fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants' internal control over financial reporting; and

5.
The registrants' other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants' auditors and the audit committee of registrants' board of directors (or persons performing the equivalent function):

a)
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants' ability to record, process, summarize and report financial information; and

b)
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants' internal control over financial reporting.


/s/ HOWARD UNGERLEIDER
Howard Ungerleider
President and Chief Financial Officer
February 7, 2020


275


 
 
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
 
EXHIBIT 32.1
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, Jim Fitterling, Chief Executive Officer of Dow Inc. and The Dow Chemical Company (the “Companies”), certify that:

1.
the Annual Report on Form 10-K of the Companies for the year ended December 31, 2019 as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Companies.
 

/s/ JIM FITTERLING
Jim Fitterling
Chief Executive Officer
February 7, 2020


276


 
 
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
 
EXHIBIT 32.2
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

I, Howard Ungerleider, President and Chief Financial Officer of Dow Inc. and The Dow Chemical Company (the “Companies”), certify that:

1.
the Annual Report on Form 10-K of the Companies for the year ended December 31, 2019 as filed with the Securities and Exchange Commission (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Companies.
 

/s/ HOWARD UNGERLEIDER
Howard Ungerleider
President and Chief Financial Officer
February 7, 2020


277